data_6k4i_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6k4i _Structure_validation_residue.Date_analyzed 2019-10-25 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.469 0.481 0 N-CA-C 111.25 0.093 . . . . 0.0 111.25 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -121.48 157.57 30.33 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 176.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.0 pt -132.37 169.96 20.88 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 C-N-CA 125.287 1.435 . . . . 0.0 108.346 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -126.24 149.53 49.02 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 124.925 1.29 . . . . 0.0 107.89 178.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.5 t -139.62 131.48 34.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -97.6 117.78 32.65 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.3 p -83.27 168.79 16.37 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.027 0.931 . . . . 0.0 110.976 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.9 -5.0 22.99 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.582 0.753 . . . . 0.0 112.632 178.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.0 p -93.28 -14.14 27.36 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 177.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.18 7.13 57.45 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 124.903 1.24 . . . . 0.0 111.349 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.82 163.95 23.06 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 119.084 1.442 . . . . 0.0 107.567 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.2 m -120.5 137.42 54.37 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 103.629 -2.73 . . . . 0.0 103.629 178.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.2 mm -114.69 157.02 15.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 38.1 m -134.73 124.26 24.95 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 127.954 2.502 . . . . 0.0 104.343 178.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 29.5 mt -139.93 150.81 45.0 Favored 'General case' 0 CA--C 1.515 -0.373 0 C-N-CA 124.79 1.236 . . . . 0.0 111.589 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -98.25 119.01 36.17 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 127.274 2.23 . . . . 0.0 106.519 178.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.0 m -134.09 -171.19 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 125.949 1.7 . . . . 0.0 108.287 -179.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -142.38 161.17 51.52 Favored Pre-proline 0 CA--C 1.536 0.437 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -61.25 -18.01 56.16 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.442 2.095 . . . . 0.0 112.899 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.8 m -114.96 30.97 6.99 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 124.216 1.007 . . . . 0.0 111.402 -177.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -93.06 130.95 38.49 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 126.277 1.831 . . . . 0.0 106.825 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.3 p -77.15 158.18 30.54 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 119.775 1.171 . . . . 0.0 110.301 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.7 mm -63.61 -30.72 50.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -61.24 -37.36 82.81 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 119.348 0.976 . . . . 0.0 111.554 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -73.46 -53.33 10.89 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 123.94 0.896 . . . . 0.0 108.591 179.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.2 t -55.94 -38.16 51.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 123.035 0.534 . . . . 0.0 110.723 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.8 ttpt -75.14 -16.55 60.52 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 118.172 -0.918 . . . . 0.0 110.952 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.69 -45.38 14.53 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 177.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.6 mttm -50.98 -40.17 57.19 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.953 1.301 . . . . 0.0 112.105 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.3 pt -64.71 -27.29 42.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 O-C-N 120.978 -1.076 . . . . 0.0 111.001 179.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -76.6 -22.81 53.7 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 119.399 0.999 . . . . 0.0 109.162 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.76 -40.17 63.68 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.296 87.1 mttt -92.42 -15.32 27.35 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-O 117.435 -1.269 . . . . 0.0 114.257 -179.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -140.46 150.58 43.98 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 121.881 2.128 . . . . 0.0 106.682 178.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -83.47 87.15 1.5 Allowed Glycine 0 C--N 1.334 0.428 0 CA-C-O 118.977 -0.902 . . . . 0.0 111.782 -178.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.5 pt -137.46 108.22 8.62 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 124.271 1.028 . . . . 0.0 111.45 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -69.83 170.13 17.39 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 124.786 3.657 . . . . 0.0 110.733 178.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -82.39 54.72 5.05 Favored 'Trans proline' 0 CA--C 1.547 1.143 0 N-CA-C 107.827 -1.644 . . . . 0.0 107.827 177.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -150.53 135.91 17.94 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 127.898 2.479 . . . . 0.0 105.519 -178.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 54.7 mm-40 53.03 46.47 26.69 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 128.024 2.53 . . . . 0.0 106.175 -176.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -156.38 135.93 12.37 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.231 1.012 . . . . 0.0 111.919 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.1 ttm-85 -154.93 136.08 13.93 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 127.13 2.172 . . . . 0.0 105.995 178.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 23.7 tp -87.97 137.37 32.39 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.643 0.777 . . . . 0.0 109.481 -178.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.4 mm -135.3 148.57 28.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 125.644 1.578 . . . . 0.0 108.796 -178.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -138.51 121.13 16.26 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 178.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.0 33.52 12.04 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 119.315 0.961 . . . . 0.0 111.353 -179.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.15 -7.79 62.66 Favored Glycine 0 CA--C 1.532 1.099 0 O-C-N 121.298 -0.876 . . . . 0.0 113.123 -179.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.2 tpmt? -78.64 118.11 20.43 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 104.743 -2.317 . . . . 0.0 104.743 179.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.5 mp0 -74.95 133.0 41.82 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.2 mt -114.12 155.47 25.96 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.558 1.143 . . . . 0.0 109.837 -178.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -157.25 174.72 15.02 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.458 1.503 . . . . 0.0 108.161 178.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -73.73 159.8 32.44 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.401 1.48 . . . . 0.0 112.327 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 106.07 -27.53 17.03 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 126.46 1.981 . . . . 0.0 109.526 -178.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 46.0 mtt180 -107.39 169.26 8.69 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 118.124 0.962 . . . . 0.0 110.689 178.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 80.4 p -119.02 168.95 10.33 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 126.268 1.827 . . . . 0.0 110.72 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.8 mp -52.4 -42.89 64.43 Favored 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 123.625 0.77 . . . . 0.0 112.784 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 68.9 m -65.81 -32.63 74.27 Favored 'General case' 0 N--CA 1.462 0.125 0 CA-C-N 118.929 0.786 . . . . 0.0 112.535 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -64.09 -44.38 92.5 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -81.45 1.61 32.42 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.592 1.157 . . . . 0.0 111.519 178.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 55.45 46.73 22.59 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 127.167 2.187 . . . . 0.0 112.326 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 15.0 mt -96.18 123.78 48.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 86.8 mm-40 -101.24 178.25 4.71 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.978 1.311 . . . . 0.0 110.609 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.1 pttt -64.47 156.65 28.9 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 122.87 0.468 . . . . 0.0 111.279 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 48.43 41.06 16.13 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.386 2.274 . . . . 0.0 112.585 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.5 p -87.2 153.79 21.22 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.408 1.083 . . . . 0.0 108.082 177.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 14.4 m -118.72 114.57 22.92 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.5 mp -101.07 168.29 9.69 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.786 1.635 . . . . 0.0 110.861 -178.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.7 m80 -119.96 154.76 34.01 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 127.106 2.162 . . . . 0.0 109.327 178.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 16.7 mt -123.44 125.08 44.29 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 178.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.4 m -139.79 166.15 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 CA-C-N 120.789 1.631 . . . . 0.0 113.436 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.464 0.259 0 C-N-CA 125.983 1.713 . . . . 0.0 110.898 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.3 ttt . . . . . 0 N--CA 1.473 0.676 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -120.77 158.72 26.92 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 114.668 1.359 . . . . 0.0 114.668 -177.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.9 pp -131.57 168.78 23.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 176.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -126.66 149.79 49.33 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 125.262 1.425 . . . . 0.0 108.106 179.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.8 t -138.68 125.47 25.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -89.99 116.39 28.0 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 103.085 -2.932 . . . . 0.0 103.085 177.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.5 p -72.55 168.75 17.93 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 122.574 1.178 . . . . 0.0 113.294 -178.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -67.75 -12.64 60.98 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 114.648 -1.16 . . . . 0.0 111.094 178.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 65.9 p -102.64 -12.56 17.61 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.771 1.169 . . . . 0.0 110.882 179.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.61 7.31 34.37 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 124.883 1.23 . . . . 0.0 114.89 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.2 mmmm -80.88 165.24 22.0 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 120.069 1.935 . . . . 0.0 108.053 178.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 83.7 m -119.06 130.4 55.6 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 104.233 -2.506 . . . . 0.0 104.233 178.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.0 mm -115.78 154.2 17.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 125.398 1.479 . . . . 0.0 107.775 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.2 m -135.13 128.59 32.43 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 178.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 74.4 mt -139.8 150.47 44.76 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 118.678 0.672 . . . . 0.0 111.05 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -94.32 118.48 31.66 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.231 1.412 . . . . 0.0 107.771 178.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.8 m -134.57 179.23 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 126.581 1.953 . . . . 0.0 108.461 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -147.98 162.69 30.22 Favored Pre-proline 0 CA--C 1.536 0.42 0 O-C-N 120.908 -1.12 . . . . 0.0 109.401 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -51.95 -22.56 14.55 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.773 2.982 . . . . 0.0 115.572 -179.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.6 t -114.6 30.92 6.98 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 119.951 1.251 . . . . 0.0 111.051 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -95.22 129.4 42.36 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 103.759 -2.682 . . . . 0.0 103.759 177.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.6 p -76.74 159.53 30.08 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 118.775 0.716 . . . . 0.0 109.764 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 39.8 mm -58.98 -26.0 31.41 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 CA-C-O 118.611 -0.709 . . . . 0.0 110.084 178.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -64.28 -46.18 84.79 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 125.108 1.363 . . . . 0.0 109.645 178.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.5 m-80 -62.22 -52.51 63.46 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.3 t -57.18 -37.36 55.55 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 122.725 0.41 . . . . 0.0 109.922 178.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.7 ttpt -75.02 -19.84 59.89 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 120.903 -1.123 . . . . 0.0 110.547 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.29 -45.36 26.5 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 104.908 -2.256 . . . . 0.0 104.908 177.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.6 mttm -54.53 -43.29 71.8 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.156 1.382 . . . . 0.0 111.385 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.1 pt -63.81 -28.24 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-N 120.148 1.34 . . . . 0.0 110.456 178.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -76.16 -22.64 55.16 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 119.926 1.239 . . . . 0.0 110.897 -179.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.27 -23.24 51.2 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 177.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -99.56 -23.96 14.91 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 114.387 1.255 . . . . 0.0 114.387 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -152.37 149.54 28.73 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 178.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -88.78 87.15 1.47 Allowed Glycine 0 CA--C 1.519 0.296 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.2 pt -132.23 107.4 13.54 Favored Pre-proline 0 CA--C 1.539 0.548 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.23 156.86 15.45 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.062 2.508 . . . . 0.0 113.315 -179.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -83.31 55.96 5.25 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.572 2.181 . . . . 0.0 107.763 178.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -156.6 137.53 13.49 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 128.585 2.754 . . . . 0.0 106.165 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 50.56 45.27 26.84 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 127.405 2.282 . . . . 0.0 108.228 -178.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -157.75 135.46 10.59 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 129.042 2.937 . . . . 0.0 106.212 178.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.7 ttm105 -151.66 141.06 21.52 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 121.424 1.92 . . . . 0.0 106.539 177.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -88.25 140.19 29.73 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 124.393 1.077 . . . . 0.0 109.48 -178.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.9 mm -135.49 146.41 29.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 125.275 1.43 . . . . 0.0 108.887 -179.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -135.82 115.09 12.48 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 125.005 1.322 . . . . 0.0 108.679 178.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.88 41.25 14.23 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.281 1.432 . . . . 0.0 111.771 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.17 -14.95 52.02 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 125.696 1.617 . . . . 0.0 113.959 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.6 tpmt? -79.69 124.82 28.91 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -74.44 137.06 42.38 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 178.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.6 mt -114.01 142.21 46.45 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -152.8 176.28 11.97 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.661 1.984 . . . . 0.0 107.86 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -72.57 159.81 33.3 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 125.457 1.503 . . . . 0.0 111.089 -178.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 105.99 -29.14 11.68 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 127.769 2.604 . . . . 0.0 110.618 -178.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.343 34.3 mtm105 -109.91 168.41 9.44 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 60.9 p -120.49 171.31 8.63 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 126.702 2.001 . . . . 0.0 111.504 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.2 mp -51.26 -41.5 60.43 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 124.358 1.063 . . . . 0.0 111.674 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 11.4 t -59.17 -45.78 90.12 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.418 1.487 . . . . 0.0 110.422 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -62.21 -44.51 96.4 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.969 0.908 . . . . 0.0 110.615 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -82.16 -2.04 50.89 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.926 0.891 . . . . 0.0 112.833 -179.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 40.8 t30 53.7 46.34 26.12 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 126.237 1.815 . . . . 0.0 110.631 -179.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 93.2 mt -85.02 123.23 39.05 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.153 0 N-CA-C 104.6 -2.37 . . . . 0.0 104.6 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 92.8 mm-40 -89.27 166.79 13.55 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.606 -178.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 46.6 pttt -64.44 155.39 32.77 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.007 178.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 45.33 34.67 1.56 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 128.338 2.655 . . . . 0.0 112.179 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 51.6 m -77.3 160.57 28.75 Favored 'General case' 0 N--CA 1.462 0.174 0 O-C-N 120.908 -1.12 . . . . 0.0 111.42 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.9 m -115.15 113.66 24.27 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.5 mp -108.68 163.51 13.19 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.72 1.608 . . . . 0.0 109.763 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -119.39 162.33 18.99 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.605 1.162 . . . . 0.0 112.131 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.2 mt -121.42 129.91 53.28 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 126.434 1.894 . . . . 0.0 106.37 178.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.4 m -135.42 173.06 14.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 C-N-CA 125.0 1.32 . . . . 0.0 108.695 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.4 pp . . . . . 0 N--CA 1.455 -0.22 0 C-N-CA 123.69 0.796 . . . . 0.0 110.271 179.455 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.9 ttt . . . . . 0 CA--C 1.514 -0.431 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -120.6 156.95 30.56 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.2 pt -132.85 169.8 21.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.553 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 177.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -124.9 152.45 44.05 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 125.799 1.64 . . . . 0.0 108.23 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.4 t -138.33 125.13 26.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 178.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -90.64 116.25 28.38 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 104.035 -2.58 . . . . 0.0 104.035 178.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 44.1 p -72.42 166.81 21.83 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.317 0.579 . . . . 0.0 110.291 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -67.48 -12.08 59.44 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.199 178.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.7 p -96.78 -12.71 23.31 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 127.693 2.397 . . . . 0.0 112.273 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.57 6.43 56.41 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 125.895 1.712 . . . . 0.0 114.074 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -82.99 165.47 19.63 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-N 118.954 1.377 . . . . 0.0 107.322 178.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 43.6 m -123.07 132.43 54.1 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.7 mm -107.17 155.47 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 179.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.1 m -132.86 130.38 39.68 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 103.76 -2.682 . . . . 0.0 103.76 178.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 76.1 mt -139.6 150.52 45.09 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -100.56 118.49 36.84 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 104.189 -2.523 . . . . 0.0 104.189 178.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.6 m -131.89 -170.74 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 125.036 1.334 . . . . 0.0 109.937 -178.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -147.34 159.29 42.41 Favored Pre-proline 0 CA--C 1.534 0.345 0 O-C-N 121.007 -1.058 . . . . 0.0 109.972 178.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -56.8 -23.58 51.08 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.971 2.447 . . . . 0.0 114.856 -179.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 43.5 m -115.24 32.59 5.95 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.676 0.79 . . . . 0.0 111.124 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -92.83 129.63 38.69 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 104.125 -2.546 . . . . 0.0 104.125 178.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.1 p -77.18 159.5 29.67 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 119.777 1.171 . . . . 0.0 111.833 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.1 mm -63.59 -30.73 50.62 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -56.39 -39.52 73.12 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.823 0.849 . . . . 0.0 110.551 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -74.79 -55.53 5.74 Favored 'General case' 0 C--O 1.224 -0.275 0 C-N-CA 123.486 0.714 . . . . 0.0 109.339 178.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.6 t -54.02 -46.18 65.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 124.819 1.248 . . . . 0.0 113.068 -177.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -75.0 -15.64 60.65 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.612 0.765 . . . . 0.0 111.137 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.59 -41.63 11.87 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 177.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.0 mttm -53.77 -40.56 66.35 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.231 1.012 . . . . 0.0 110.573 179.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 29.2 pt -60.45 -27.22 39.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-O 118.128 -0.939 . . . . 0.0 111.16 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -80.43 -20.17 44.5 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.099 1.36 . . . . 0.0 111.087 179.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -88.46 -24.3 23.03 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.974 1.31 . . . . 0.0 109.11 178.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 32.7 tptt -99.0 -20.54 16.7 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.122 1.769 . . . . 0.0 112.389 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -144.37 150.28 37.51 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.838 2.055 . . . . 0.0 106.174 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -82.28 82.37 1.63 Allowed Glycine 0 C--N 1.333 0.374 0 CA-C-O 118.793 -1.004 . . . . 0.0 111.784 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.7 pt -131.18 108.29 15.0 Favored Pre-proline 0 CA--C 1.546 0.796 0 CA-C-N 118.413 1.107 . . . . 0.0 109.866 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -58.66 155.96 34.55 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.98 3.12 . . . . 0.0 114.001 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -86.2 57.17 3.95 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 123.469 2.779 . . . . 0.0 106.624 177.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -146.15 136.68 24.05 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 129.471 3.109 . . . . 0.0 103.726 -178.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.4 pt20 48.01 50.92 15.28 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.468 1.507 . . . . 0.0 112.29 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -145.41 148.71 33.63 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 121.052 -1.03 . . . . 0.0 110.371 179.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -154.59 135.04 13.37 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 125.14 1.376 . . . . 0.0 109.514 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 54.9 tp -89.08 136.55 32.95 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 125.106 1.362 . . . . 0.0 110.178 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.3 mm -133.92 145.88 32.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 125.24 1.416 . . . . 0.0 111.08 -178.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -138.92 126.47 21.84 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 176.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.58 34.76 16.36 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.708 1.203 . . . . 0.0 111.719 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.32 -8.02 59.35 Favored Glycine 0 CA--C 1.531 1.033 0 O-C-N 120.919 -1.113 . . . . 0.0 114.203 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.2 mmtp -92.17 130.37 37.9 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 125.864 1.666 . . . . 0.0 109.169 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -73.68 136.37 43.78 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.794 0.838 . . . . 0.0 108.868 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.9 mt -115.19 150.43 36.11 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 179.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -152.09 176.31 11.67 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -72.18 156.23 39.38 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 122.112 0.958 . . . . 0.0 110.555 -178.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.98 -21.14 30.06 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 126.416 1.96 . . . . 0.0 109.855 -178.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 40.3 mmt-85 -107.12 169.38 8.59 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.364 1.466 . . . . 0.0 111.948 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.9 p -123.65 167.59 13.77 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.905 1.682 . . . . 0.0 111.327 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -52.41 -47.22 66.41 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.158 0.983 . . . . 0.0 112.39 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.2 t -65.26 -31.43 72.57 Favored 'General case' 0 C--O 1.227 -0.115 0 C-N-CA 123.77 0.828 . . . . 0.0 112.763 -179.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -59.6 -47.36 85.87 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 119.996 1.271 . . . . 0.0 109.271 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -82.09 0.69 39.44 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.22 0.608 . . . . 0.0 110.236 178.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.5 t30 53.96 47.49 23.32 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 127.639 2.376 . . . . 0.0 110.646 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.5 mt -85.26 122.5 38.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 104.318 -2.475 . . . . 0.0 104.318 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -92.83 175.35 6.83 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.289 0.566 . . . . 0.0 110.189 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.8 pttt -64.71 156.76 29.36 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.293 0.568 . . . . 0.0 110.295 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 52.72 35.34 18.21 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 128.252 2.621 . . . . 0.0 111.608 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 72.3 m -85.82 158.22 20.03 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 120.848 -1.157 . . . . 0.0 109.467 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 28.3 m -119.16 120.35 36.83 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.612 1.165 . . . . 0.0 110.246 -178.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.2 mp -107.36 162.69 13.69 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.865 1.666 . . . . 0.0 110.722 -179.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -119.91 160.59 22.41 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 126.008 1.723 . . . . 0.0 111.616 179.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 90.4 mt -123.64 131.9 53.73 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.427 1.491 . . . . 0.0 110.257 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.4 m -140.5 161.7 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-N 119.63 1.104 . . . . 0.0 111.19 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.466 0.364 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.5 ttt . . . . . 0 CA--C 1.509 -0.618 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -119.29 145.64 45.95 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 124.279 0.987 . . . . 0.0 109.734 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.2 pt -134.17 169.7 21.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 C-N-CA 125.288 1.435 . . . . 0.0 108.077 177.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -124.47 149.91 46.31 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.882 1.673 . . . . 0.0 110.47 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.6 t -139.77 131.57 33.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 177.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -97.58 117.14 31.18 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 105.426 -2.065 . . . . 0.0 105.426 177.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 41.6 p -74.29 165.85 24.47 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 118.522 0.601 . . . . 0.0 111.067 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -67.63 -10.54 53.08 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.32 178.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 77.2 p -91.71 -12.46 33.97 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.569 1.547 . . . . 0.0 110.66 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.1 5.88 57.09 Favored Glycine 0 C--N 1.34 0.791 0 C-N-CA 126.177 1.846 . . . . 0.0 112.9 179.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.8 164.04 23.01 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 119.151 1.475 . . . . 0.0 107.801 179.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 50.1 m -114.08 133.57 55.45 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 102.599 -3.111 . . . . 0.0 102.599 177.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 40.1 mm -114.57 157.87 15.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 C-N-CA 125.849 1.66 . . . . 0.0 107.837 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.6 m -131.36 130.8 43.11 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 128.823 2.849 . . . . 0.0 104.886 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.8 mt -140.17 144.47 36.65 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 124.018 0.927 . . . . 0.0 110.349 179.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -105.26 110.5 22.89 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 127.382 2.273 . . . . 0.0 105.621 177.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.1 m -134.34 -169.16 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -141.8 160.6 55.4 Favored Pre-proline 0 C--O 1.238 0.459 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -56.43 -18.55 25.51 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.734 2.29 . . . . 0.0 113.386 178.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 39.1 m -115.66 30.43 7.35 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 119.023 0.828 . . . . 0.0 112.991 -178.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -94.74 134.17 37.63 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 104.993 -2.225 . . . . 0.0 104.993 177.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.1 p -73.54 157.55 36.51 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 119.07 -1.052 . . . . 0.0 109.204 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.2 mm -64.1 -26.29 40.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 177.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -56.58 -42.06 78.0 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.82 1.248 . . . . 0.0 109.647 179.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -74.14 -54.93 6.75 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 123.786 0.834 . . . . 0.0 109.73 178.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.7 t -54.32 -40.03 46.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -178.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -75.68 -16.28 60.2 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.395 0.678 . . . . 0.0 111.015 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.58 -41.73 11.82 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.395 1.078 . . . . 0.0 109.142 178.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.0 mttm -53.17 -40.46 64.36 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 118.727 0.694 . . . . 0.0 110.129 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.3 pt -62.3 -26.88 41.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 O-C-N 120.703 -1.248 . . . . 0.0 111.665 179.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -76.53 -20.11 57.23 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.344 1.058 . . . . 0.0 109.575 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.18 -39.43 40.82 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 177.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.3 mttm -88.59 -16.25 33.01 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 -178.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -141.41 150.54 42.48 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 179.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -87.08 85.65 1.54 Allowed Glycine 0 CA--C 1.52 0.392 0 O-C-N 121.419 -0.801 . . . . 0.0 111.987 -178.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.0 pt -134.18 107.97 11.38 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 124.608 1.163 . . . . 0.0 108.149 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -69.29 168.46 20.87 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 124.197 3.265 . . . . 0.0 113.755 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -82.35 56.83 5.91 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 122.975 2.45 . . . . 0.0 108.427 177.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -154.1 136.57 15.04 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 129.695 3.198 . . . . 0.0 103.713 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 62.4 mm-40 53.76 50.17 17.61 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.441 1.096 . . . . 0.0 108.333 -178.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -142.0 134.43 28.02 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -178.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 47.5 ttm-85 -159.56 132.27 6.74 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 30.6 tp -99.4 137.25 38.16 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 124.218 1.007 . . . . 0.0 109.47 -178.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.5 mm -135.06 141.9 41.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.235 1.014 . . . . 0.0 109.305 -178.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -138.99 126.1 21.26 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.02 33.22 14.35 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.027 0.531 . . . . 0.0 110.674 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.42 -16.21 19.58 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 124.74 1.162 . . . . 0.0 112.73 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -79.35 126.52 30.92 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 119.33 1.565 . . . . 0.0 108.133 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.7 mp0 -75.61 137.12 40.55 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.102 -1.074 . . . . 0.0 108.102 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.6 mt -114.26 154.64 27.59 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.716 1.207 . . . . 0.0 108.794 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -162.47 175.25 11.69 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 179.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -72.76 160.96 31.35 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 126.879 2.072 . . . . 0.0 114.078 -177.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.47 -29.39 12.0 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 127.578 2.513 . . . . 0.0 109.081 -178.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 50.0 mtt180 -107.95 169.01 8.88 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 117.979 0.89 . . . . 0.0 110.961 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 37.5 p -117.5 171.58 7.91 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.488 1.115 . . . . 0.0 112.033 -178.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.7 mp -52.2 -41.77 62.97 Favored 'General case' 0 C--O 1.227 -0.128 0 C-N-CA 123.572 0.749 . . . . 0.0 111.157 178.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.1 t -59.21 -46.0 89.62 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.559 1.544 . . . . 0.0 109.983 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -64.2 -39.66 94.45 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 123.533 0.733 . . . . 0.0 110.152 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -84.68 -0.69 54.44 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.54 0.736 . . . . 0.0 111.487 179.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 61.3 t30 53.85 46.12 26.38 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.887 2.075 . . . . 0.0 112.383 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 84.6 mt -93.7 126.09 46.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 -179.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -100.48 172.68 6.97 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 123.963 0.905 . . . . 0.0 111.19 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 49.2 pttt -66.62 156.77 34.22 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 54.92 35.58 24.78 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.511 1.524 . . . . 0.0 111.778 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.0 p -86.79 158.53 19.35 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 120.323 -1.486 . . . . 0.0 107.485 177.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 26.7 m -126.12 119.91 28.79 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 178.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.7 mp -106.06 169.53 8.44 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.252 1.021 . . . . 0.0 110.873 -179.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 21.4 m80 -118.54 153.07 34.82 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.865 1.666 . . . . 0.0 108.694 178.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 17.9 mt -123.03 126.47 47.17 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.866 1.666 . . . . 0.0 106.72 178.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.1 m -139.03 172.61 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 124.538 1.135 . . . . 0.0 111.367 -178.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.532 0.276 0 C-N-CA 125.251 1.42 . . . . 0.0 108.085 177.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 ttt . . . . . 0 N--CA 1.467 0.424 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -121.0 151.66 39.49 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 177.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 28.7 pt -132.84 169.62 21.65 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 178.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -123.13 151.85 41.69 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 124.517 1.127 . . . . 0.0 108.913 179.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 56.7 t -137.32 127.01 37.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 106.56 -1.645 . . . . 0.0 106.56 178.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -94.24 116.56 28.96 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 103.981 -2.6 . . . . 0.0 103.981 177.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.6 p -77.75 168.1 20.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 118.418 0.554 . . . . 0.0 110.335 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -67.23 -12.51 60.25 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.204 1.001 . . . . 0.0 111.512 178.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.5 p -93.74 -12.67 28.65 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.819 1.648 . . . . 0.0 111.129 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.06 7.3 56.39 Favored Glycine 0 CA--C 1.531 1.067 0 O-C-N 121.365 -0.834 . . . . 0.0 111.917 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.8 164.62 22.57 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 119.055 1.428 . . . . 0.0 107.276 179.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.5 m -121.73 131.75 54.25 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 105.05 -2.204 . . . . 0.0 105.05 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.1 mm -114.64 157.18 15.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 105.689 -1.967 . . . . 0.0 105.689 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 56.0 m -134.33 125.47 27.7 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 104.067 -2.568 . . . . 0.0 104.067 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.5 mt -137.73 147.72 44.99 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -104.89 107.11 17.91 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 127.561 2.344 . . . . 0.0 106.322 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.8 m -127.89 -168.45 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 125.791 1.636 . . . . 0.0 109.2 -178.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -141.85 159.53 59.2 Favored Pre-proline 0 N--CA 1.451 -0.377 0 C-N-CA 124.09 0.956 . . . . 0.0 109.654 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -55.44 -17.02 15.29 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.856 3.037 . . . . 0.0 113.004 178.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.7 m -114.23 31.31 6.67 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 124.03 0.932 . . . . 0.0 112.575 -178.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -98.8 132.22 44.32 Favored 'General case' 0 C--O 1.242 0.666 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 176.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -72.66 157.89 36.67 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 119.42 1.009 . . . . 0.0 110.998 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.8 mm -63.71 -29.74 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 177.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -53.37 -48.9 68.19 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.96 1.304 . . . . 0.0 109.729 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 41.6 m-20 -67.83 -52.87 31.83 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.846 0.858 . . . . 0.0 109.551 179.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.2 t -54.04 -42.92 57.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 123.736 0.815 . . . . 0.0 111.381 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 20.0 ttpt -75.53 -16.04 60.32 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 118.432 -0.794 . . . . 0.0 111.094 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -88.07 -43.66 11.52 Favored 'General case' 0 C--O 1.226 -0.165 0 CA-C-N 119.857 1.208 . . . . 0.0 108.244 177.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -50.08 -40.0 44.15 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.0 1.32 . . . . 0.0 110.434 179.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 35.8 pt -66.09 -25.26 35.41 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 O-C-N 121.267 -0.896 . . . . 0.0 112.584 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -76.16 -23.84 54.78 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 120.014 1.279 . . . . 0.0 109.094 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.88 -39.14 57.0 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.243 -0.911 . . . . 0.0 108.641 179.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.0 mttm -89.72 -19.91 24.21 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 115.99 1.848 . . . . 0.0 115.99 -179.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -136.53 158.86 43.45 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 121.819 2.099 . . . . 0.0 108.886 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.01 63.43 4.3 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 110.524 -1.03 . . . . 0.0 110.524 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.5 pt -131.38 107.3 14.62 Favored Pre-proline 0 CA--C 1.538 0.503 0 CA-C-N 117.91 0.855 . . . . 0.0 108.718 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -77.13 169.94 20.55 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 123.925 3.084 . . . . 0.0 109.805 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -76.56 58.64 5.93 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 123.087 2.524 . . . . 0.0 108.19 177.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -146.82 135.41 22.04 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 128.926 2.891 . . . . 0.0 105.319 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.6 mm-40 52.17 48.15 23.28 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.234 1.814 . . . . 0.0 108.368 -177.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -154.85 134.9 13.04 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.526 1.131 . . . . 0.0 109.62 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.0 ttm-85 -151.2 133.52 15.37 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 101.986 -3.339 . . . . 0.0 101.986 178.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.4 tp -87.9 142.01 28.13 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -177.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.2 mm -134.21 144.94 33.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 125.02 1.328 . . . . 0.0 109.584 -178.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -135.54 115.76 13.42 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 177.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.31 42.86 26.36 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.389 1.076 . . . . 0.0 110.692 -179.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.25 -13.93 30.72 Favored Glycine 0 CA--C 1.531 1.037 0 CA-C-O 118.519 -1.156 . . . . 0.0 114.518 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.9 ttmt -79.59 125.87 30.16 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 120.671 2.235 . . . . 0.0 107.554 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.4 mp0 -74.74 136.2 41.76 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 179.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.8 mt -122.34 153.35 39.09 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.618 1.167 . . . . 0.0 109.757 -178.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -160.09 175.69 12.66 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 124.679 1.192 . . . . 0.0 108.755 178.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -71.73 158.17 36.61 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 122.78 1.276 . . . . 0.0 111.86 -177.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 108.59 -29.44 9.94 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 127.448 2.452 . . . . 0.0 108.591 -177.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 46.4 mtt180 -107.75 165.56 11.35 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.0 1.72 . . . . 0.0 111.76 178.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 65.9 p -117.61 173.92 6.45 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.299 1.839 . . . . 0.0 112.655 -178.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.9 mp -52.14 -49.9 62.81 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 123.678 0.791 . . . . 0.0 111.541 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.55 -31.56 72.37 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 112.351 0.501 . . . . 0.0 112.351 -179.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -65.29 -47.15 77.62 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.415 1.007 . . . . 0.0 109.325 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -81.29 -2.5 49.22 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.1 t30 57.68 46.94 16.57 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 130.363 3.465 . . . . 0.0 112.215 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 79.3 mt -85.71 123.19 39.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 105.531 -2.026 . . . . 0.0 105.531 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 75.1 mm-40 -95.47 173.47 7.49 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 123.255 0.622 . . . . 0.0 109.747 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 43.6 pttt -69.72 157.0 38.12 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.116 0.484 . . . . 0.0 110.783 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 53.58 38.8 29.04 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 127.154 2.182 . . . . 0.0 110.992 -179.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.4 p -87.26 163.23 16.98 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.957 1.303 . . . . 0.0 109.459 178.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 93.7 m -126.05 110.22 13.3 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.7 mp -98.5 160.19 14.44 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 126.233 1.813 . . . . 0.0 108.53 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 45.1 m80 -119.28 160.37 22.34 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 124.982 1.313 . . . . 0.0 110.161 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.7 mt -122.82 126.76 48.01 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 104.964 -2.236 . . . . 0.0 104.964 177.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.2 m -140.62 161.45 24.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 CA-C-O 121.447 0.641 . . . . 0.0 110.421 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.237 0.428 0 C-N-CA 124.32 1.048 . . . . 0.0 108.585 177.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.7 ttt . . . . . 0 N--CA 1.47 0.535 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -120.64 151.1 39.91 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 178.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 32.5 pt -132.53 170.08 20.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 C-N-CA 124.929 1.292 . . . . 0.0 108.014 178.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -126.22 150.85 48.09 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.934 1.294 . . . . 0.0 109.005 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.0 t -138.52 133.07 42.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 178.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -103.03 118.35 36.61 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.213 1.005 . . . . 0.0 108.428 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 48.5 p -72.57 171.05 13.15 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.712 0.768 . . . . 0.0 110.059 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -70.45 -12.49 61.61 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.834 -0.541 . . . . 0.0 111.457 177.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.0 p -94.03 -12.1 29.34 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 126.409 1.884 . . . . 0.0 112.627 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.85 7.5 50.43 Favored Glycine 0 C--N 1.339 0.741 0 C-N-CA 124.0 0.81 . . . . 0.0 113.764 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -80.56 164.66 22.77 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 119.017 1.408 . . . . 0.0 107.279 179.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 86.9 m -123.65 132.34 53.83 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 103.523 -2.769 . . . . 0.0 103.523 177.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.5 mm -115.05 148.3 17.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 105.577 -2.009 . . . . 0.0 105.577 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 78.5 m -124.42 126.15 45.46 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 105.312 -2.106 . . . . 0.0 105.312 178.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.6 mt -128.72 150.66 50.17 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 118.339 0.518 . . . . 0.0 110.302 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -101.47 115.54 30.73 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 103.257 -2.868 . . . . 0.0 103.257 178.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.1 m -131.26 -169.92 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 124.415 1.086 . . . . 0.0 109.457 -178.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -143.66 160.84 49.26 Favored Pre-proline 0 N--CA 1.448 -0.568 0 C-N-CA 126.264 1.826 . . . . 0.0 106.591 178.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -58.09 -18.15 34.94 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.864 2.376 . . . . 0.0 113.079 178.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.6 m -116.25 32.95 5.81 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.827 1.251 . . . . 0.0 112.148 -179.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -90.29 128.86 36.53 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 103.187 -2.894 . . . . 0.0 103.187 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.5 p -77.8 159.03 29.28 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 118.965 0.802 . . . . 0.0 112.659 -177.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 23.9 mm -63.56 -29.81 48.23 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.324 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 178.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -59.0 -42.1 89.25 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.2 0.909 . . . . 0.0 110.44 179.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -73.88 -52.75 11.94 Favored 'General case' 0 CA--C 1.521 -0.166 0 C-N-CA 124.665 1.186 . . . . 0.0 109.792 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.4 t -57.44 -38.39 62.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-N 119.62 1.1 . . . . 0.0 110.585 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -74.64 -14.27 60.74 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.208 -0.933 . . . . 0.0 110.592 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.98 -47.19 8.01 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 176.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.6 mttm -49.46 -40.31 36.61 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.333 1.853 . . . . 0.0 111.017 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 36.6 pt -65.69 -28.05 43.09 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-N 118.81 0.732 . . . . 0.0 112.556 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -76.28 -23.06 54.38 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 119.946 1.248 . . . . 0.0 109.742 -178.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.44 -36.3 45.63 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 178.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -86.55 -21.47 26.88 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 114.144 1.164 . . . . 0.0 114.144 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -147.51 150.99 35.6 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 120.99 1.723 . . . . 0.0 106.778 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.1 80.99 1.66 Allowed Glycine 0 CA--C 1.521 0.408 0 CA-C-O 119.244 -0.753 . . . . 0.0 111.846 -179.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.2 pt -133.95 106.14 11.53 Favored Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 106.773 -1.565 . . . . 0.0 106.773 178.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -62.87 166.09 14.85 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 124.571 3.514 . . . . 0.0 115.462 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -83.02 55.9 5.37 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.599 2.199 . . . . 0.0 108.295 177.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -147.26 134.52 20.6 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 128.839 2.856 . . . . 0.0 105.247 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.7 mm-40 47.76 49.36 16.66 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.858 1.663 . . . . 0.0 108.032 -177.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -143.67 134.09 24.71 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 60.3 ttm-85 -156.24 133.82 10.93 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 125.978 1.711 . . . . 0.0 106.868 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 22.1 tp -87.9 140.88 29.06 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -178.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.0 mm -131.53 143.87 39.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 126.036 1.734 . . . . 0.0 109.376 -178.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -138.38 124.58 20.33 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 178.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.79 36.07 20.37 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.464 1.106 . . . . 0.0 110.439 -179.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.18 -14.09 29.48 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 125.343 1.449 . . . . 0.0 113.502 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.1 ttmt -79.57 129.3 34.35 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 119.752 1.776 . . . . 0.0 108.258 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.9 mp0 -74.59 137.42 42.32 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 178.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.6 mt -113.21 155.33 25.24 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.252 1.021 . . . . 0.0 108.352 -178.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -151.87 175.15 12.76 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.673 1.189 . . . . 0.0 109.446 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -72.75 157.97 36.48 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 125.229 1.412 . . . . 0.0 111.127 -178.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.17 -21.25 38.22 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 126.226 1.87 . . . . 0.0 110.383 -178.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 39.4 mtt180 -108.28 168.95 8.94 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 118.37 1.085 . . . . 0.0 113.534 178.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 49.0 p -117.45 172.46 7.31 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.945 2.098 . . . . 0.0 111.068 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -51.96 -50.67 60.78 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.286 1.435 . . . . 0.0 112.622 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.06 -31.83 73.25 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 123.021 0.528 . . . . 0.0 112.258 -178.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -60.25 -44.95 94.83 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 119.449 1.022 . . . . 0.0 109.469 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -82.27 1.22 37.78 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.189 0.595 . . . . 0.0 111.085 178.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 57.89 46.84 16.12 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 128.405 2.682 . . . . 0.0 110.794 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.3 mt -85.82 122.64 38.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 105.013 -2.218 . . . . 0.0 105.013 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -97.62 177.46 5.49 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.73 0.812 . . . . 0.0 108.94 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 43.9 pttt -68.19 156.56 37.3 Favored 'General case' 0 C--O 1.239 0.531 0 O-C-N 121.681 -0.637 . . . . 0.0 110.87 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 49.52 35.05 7.62 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.613 1.965 . . . . 0.0 111.088 -178.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.4 p -77.16 158.24 30.49 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 178.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 59.9 m -125.47 110.64 14.15 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.4 mp -96.04 165.67 12.14 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 124.429 1.091 . . . . 0.0 109.814 -178.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 25.3 m80 -118.77 156.34 29.55 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 125.423 1.489 . . . . 0.0 110.19 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 25.7 mt -123.34 124.68 43.5 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 178.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.1 m -139.12 167.75 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.239 0.534 0 C-N-CA 127.154 2.182 . . . . 0.0 109.687 178.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 ttp . . . . . 0 N--CA 1.467 0.394 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -120.69 157.1 30.34 Favored 'General case' 0 CA--C 1.53 0.18 0 O-C-N 121.1 -1.0 . . . . 0.0 112.146 -178.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.3 pt -132.81 169.32 22.23 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 176.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -126.44 152.19 46.72 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.806 1.242 . . . . 0.0 107.822 179.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.9 t -138.96 128.49 30.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.2 tppp? -96.23 117.86 31.63 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 119.081 0.855 . . . . 0.0 109.485 178.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.8 p -81.09 165.62 21.46 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.051 0.94 . . . . 0.0 110.433 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.43 -4.88 12.49 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.062 0.945 . . . . 0.0 113.212 178.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.0 p -92.41 -12.61 31.76 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.487 1.115 . . . . 0.0 110.704 178.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.88 5.93 58.3 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 125.806 1.67 . . . . 0.0 111.434 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.56 164.24 16.2 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.351 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.6 m -123.97 142.46 51.14 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 178.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.3 mm -114.79 155.21 16.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 C-N-CA 126.557 1.943 . . . . 0.0 106.169 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 54.8 m -126.23 128.15 46.76 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 104.124 -2.547 . . . . 0.0 104.124 178.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.4 mt -133.21 150.07 51.98 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -105.14 110.97 23.56 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 103.671 -2.715 . . . . 0.0 103.671 178.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.3 m -134.72 -174.78 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -146.44 166.7 15.9 Favored Pre-proline 0 C--N 1.327 -0.372 0 O-C-N 120.842 -1.161 . . . . 0.0 109.508 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -54.27 -18.81 15.07 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.096 2.531 . . . . 0.0 114.034 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.4 m -115.03 31.22 6.83 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 123.922 0.889 . . . . 0.0 112.453 -178.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -99.08 130.05 45.38 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 103.94 -2.615 . . . . 0.0 103.94 176.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.9 p -78.06 158.14 29.3 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 119.425 1.011 . . . . 0.0 111.711 -178.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.3 mm -63.77 -28.27 44.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -57.1 -42.79 81.43 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.881 0.872 . . . . 0.0 109.383 178.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -73.04 -52.54 13.97 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 124.889 1.275 . . . . 0.0 109.417 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.3 t -54.74 -38.42 43.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-N 119.227 0.921 . . . . 0.0 110.764 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -74.82 -15.55 60.73 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 121.252 -0.905 . . . . 0.0 111.642 -179.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.9 -45.27 8.86 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.552 1.541 . . . . 0.0 108.193 176.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.8 mttm -50.44 -40.4 50.31 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.608 1.563 . . . . 0.0 110.406 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 36.1 pt -64.07 -25.34 37.87 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 O-C-N 121.54 -0.725 . . . . 0.0 112.113 178.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -76.27 -23.64 54.45 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 120.145 1.339 . . . . 0.0 109.262 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.99 -36.33 41.5 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.6 mmtt -85.65 -22.11 28.08 Favored 'General case' 0 C--N 1.337 0.061 0 CA-C-O 117.391 -1.29 . . . . 0.0 114.204 -178.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -150.63 158.04 43.68 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 121.582 1.992 . . . . 0.0 108.808 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.7 82.35 1.59 Allowed Glycine 0 C--N 1.333 0.366 0 N-CA-C 111.843 -0.503 . . . . 0.0 111.843 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.4 pt -140.89 106.62 6.3 Favored Pre-proline 0 CA--C 1.543 0.692 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -71.1 169.59 20.2 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 124.763 3.642 . . . . 0.0 112.658 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -78.65 56.91 6.11 Favored 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 123.054 2.503 . . . . 0.0 109.6 177.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -146.84 130.13 16.62 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 127.857 2.463 . . . . 0.0 104.639 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.2 mm-40 51.01 53.52 12.91 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -177.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -143.06 133.1 24.27 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.275 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 55.8 ttm-85 -161.57 133.33 5.58 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 125.853 1.661 . . . . 0.0 107.174 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 24.2 tp -88.64 142.5 27.63 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.309 1.044 . . . . 0.0 109.674 -178.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.7 mm -135.03 144.56 34.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 125.908 1.683 . . . . 0.0 109.955 -178.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -133.45 117.23 16.95 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 106.714 -1.588 . . . . 0.0 106.714 178.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.57 43.46 20.24 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.933 1.293 . . . . 0.0 111.141 -179.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.45 -17.67 13.34 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-O 118.351 -1.249 . . . . 0.0 114.635 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.3 ttmt -79.25 128.71 33.65 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 120.603 2.201 . . . . 0.0 107.149 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.4 mp0 -74.56 136.87 42.11 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.9 mt -113.19 155.05 25.71 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -178.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -151.99 175.05 12.91 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 124.381 1.072 . . . . 0.0 109.076 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -73.05 160.03 32.68 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 126.197 1.799 . . . . 0.0 111.412 -179.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.0 -27.51 19.16 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 126.271 1.891 . . . . 0.0 109.85 -178.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.9 mtt180 -107.11 170.52 7.9 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.95 1.3 . . . . 0.0 111.449 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 67.2 p -117.3 171.01 8.25 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 127.108 2.163 . . . . 0.0 111.905 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.21 -48.56 65.03 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.06 0.944 . . . . 0.0 112.419 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.03 -31.72 73.01 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 118.932 -0.556 . . . . 0.0 111.512 -179.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -61.13 -44.03 97.96 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 119.352 0.978 . . . . 0.0 108.696 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -82.0 1.7 34.33 Favored 'General case' 0 C--O 1.237 0.4 0 O-C-N 121.603 -0.686 . . . . 0.0 110.814 178.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 52.9 t30 56.48 47.19 19.25 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 127.087 2.155 . . . . 0.0 110.07 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.5 mt -84.48 122.79 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -178.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 57.2 mm-40 -89.57 169.14 11.6 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.447 -0.797 . . . . 0.0 108.995 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 51.8 pttt -69.18 156.73 38.22 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.012 0.434 . . . . 0.0 111.354 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 49.55 34.2 6.69 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 128.407 2.683 . . . . 0.0 111.5 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.2 p -80.17 163.95 23.68 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.2 m -125.31 112.51 16.45 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.1 mp -96.19 168.14 10.77 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.961 1.304 . . . . 0.0 108.666 -179.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.3 m80 -119.64 154.92 33.27 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.155 1.382 . . . . 0.0 109.878 179.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 18.1 mt -123.22 123.47 40.85 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 103.866 -2.642 . . . . 0.0 103.866 177.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.7 m -141.59 170.96 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-N 120.06 1.3 . . . . 0.0 113.635 -179.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.235 0.332 0 C-N-CA 126.354 1.862 . . . . 0.0 109.576 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.8 ttt . . . . . 0 N--CA 1.471 0.59 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -120.82 157.14 30.4 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 178.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.7 pt -132.69 169.4 22.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 178.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -126.13 151.01 47.83 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.2 t -138.52 129.6 35.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 179.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.4 tppt? -96.24 119.08 34.09 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 177.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 45.7 p -71.15 167.25 19.73 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 118.663 0.665 . . . . 0.0 109.352 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -67.72 -12.96 61.65 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 119.201 -0.428 . . . . 0.0 111.191 178.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.4 p -94.1 -12.48 28.39 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.815 1.246 . . . . 0.0 111.273 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.41 7.77 48.19 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-N 118.845 0.748 . . . . 0.0 113.524 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.22 164.82 23.87 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 104.507 -2.405 . . . . 0.0 104.507 178.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 45.1 m -123.2 131.21 53.6 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 -179.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.8 mm -116.28 155.25 17.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 127.531 2.332 . . . . 0.0 107.802 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.6 m -135.18 130.4 35.29 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 128.146 2.578 . . . . 0.0 105.428 178.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 79.5 mt -139.01 151.27 46.69 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.722 1.147 . . . . 0.0 110.84 -179.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -102.28 117.94 35.82 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 179.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.7 m -131.28 -170.67 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 124.622 1.169 . . . . 0.0 109.982 -177.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -144.1 160.66 48.5 Favored Pre-proline 0 C--O 1.238 0.494 0 N-CA-C 106.517 -1.661 . . . . 0.0 106.517 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -57.96 -17.98 33.26 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.461 2.108 . . . . 0.0 112.941 178.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 29.3 m -114.64 31.62 6.52 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 119.219 0.918 . . . . 0.0 111.464 -178.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -91.27 129.42 37.26 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 101.302 -3.592 . . . . 0.0 101.302 177.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.0 p -71.03 158.25 36.83 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 121.392 -0.817 . . . . 0.0 109.439 -178.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.0 mm -63.33 -29.35 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 178.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -56.27 -49.32 74.53 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 126.045 1.738 . . . . 0.0 108.834 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 20.1 m-80 -65.43 -52.15 55.26 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 124.67 1.188 . . . . 0.0 109.552 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 84.4 t -54.05 -44.03 61.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 123.328 0.651 . . . . 0.0 110.744 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 24.2 ttpt -75.57 -12.83 60.3 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.279 1.032 . . . . 0.0 112.166 -178.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.04 -46.93 8.16 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.608 1.563 . . . . 0.0 107.513 177.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.4 mttm -50.98 -40.51 58.06 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.405 1.482 . . . . 0.0 110.418 179.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 43.3 pt -64.58 -25.69 38.48 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 O-C-N 121.334 -0.854 . . . . 0.0 112.31 178.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -76.35 -22.77 54.46 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 120.598 1.545 . . . . 0.0 109.262 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -82.27 -22.94 35.53 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.737 1.215 . . . . 0.0 108.607 177.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.1 mmtt -97.68 -16.01 20.14 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 120.481 -1.387 . . . . 0.0 114.347 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -152.04 160.68 43.39 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 121.116 1.78 . . . . 0.0 107.063 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.02 70.98 2.97 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.8 pt -130.8 108.27 15.52 Favored Pre-proline 0 CA--C 1.543 0.703 0 CA-C-N 117.988 0.894 . . . . 0.0 110.752 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -77.82 169.74 20.18 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.822 3.015 . . . . 0.0 110.092 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -79.19 57.0 6.27 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.855 2.37 . . . . 0.0 109.195 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -150.61 135.32 17.38 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 127.206 2.203 . . . . 0.0 105.862 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 55.2 mm-40 53.89 48.78 20.49 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.799 1.64 . . . . 0.0 106.788 -177.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -146.19 143.07 29.03 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 123.711 0.805 . . . . 0.0 110.535 -178.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 43.9 ttm-85 -162.3 134.06 5.38 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.879 1.218 . . . . 0.0 108.289 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 18.9 tp -93.21 140.01 29.99 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.627 1.171 . . . . 0.0 111.204 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.5 mm -135.54 145.35 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 126.229 1.812 . . . . 0.0 108.816 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -139.11 119.77 14.12 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.923 1.289 . . . . 0.0 108.376 178.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.72 35.2 17.85 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.233 1.013 . . . . 0.0 111.151 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.55 -13.75 33.42 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 124.887 1.232 . . . . 0.0 113.248 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.5 ttmt -80.56 129.76 34.71 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 119.484 1.642 . . . . 0.0 107.746 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.8 mp0 -74.47 134.05 42.33 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 51.6 mt -114.01 148.96 36.1 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.576 1.15 . . . . 0.0 108.571 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -151.55 176.73 11.05 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 124.868 1.267 . . . . 0.0 108.217 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.29 160.59 32.14 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.793 1.637 . . . . 0.0 111.767 -177.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.32 -25.6 26.48 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 125.53 1.538 . . . . 0.0 111.243 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 42.7 mtt180 -108.09 168.85 9.0 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.554 1.141 . . . . 0.0 112.908 178.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.4 p -117.71 169.48 9.55 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.876 1.67 . . . . 0.0 109.167 178.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.0 mp -52.5 -43.1 64.85 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.207 0.603 . . . . 0.0 111.202 178.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.1 t -58.2 -45.91 86.77 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 125.916 1.686 . . . . 0.0 111.156 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -59.74 -45.2 92.96 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 118.586 0.63 . . . . 0.0 109.973 -178.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -82.1 1.71 34.71 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.492 0.717 . . . . 0.0 112.088 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.6 t30 55.45 46.42 23.23 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 127.581 2.352 . . . . 0.0 111.026 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 40.6 mt -86.09 123.05 39.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -93.64 169.98 9.92 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.264 0.554 . . . . 0.0 111.469 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.7 pttt -66.32 156.98 32.88 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.237 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 51.22 37.52 18.71 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 126.41 1.884 . . . . 0.0 112.001 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.7 p -87.13 164.15 16.57 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.761 1.224 . . . . 0.0 108.615 178.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.9 m -125.93 113.92 17.83 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.4 mp -96.91 161.64 13.75 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.259 1.023 . . . . 0.0 109.09 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 17.2 m80 -115.78 156.4 26.1 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.903 1.281 . . . . 0.0 109.85 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.8 mt -122.83 124.87 44.28 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.026 1.73 . . . . 0.0 107.891 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 23.3 m -141.38 171.57 11.77 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 124.795 1.238 . . . . 0.0 113.753 -178.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.534 0.345 0 C-N-CA 125.485 1.514 . . . . 0.0 108.389 176.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.4 ttt . . . . . 0 N--CA 1.474 0.73 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -121.51 157.27 31.03 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.226 0.611 . . . . 0.0 109.813 178.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.7 pt -132.75 171.12 18.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 C-N-CA 125.493 1.517 . . . . 0.0 107.668 177.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -126.19 152.49 45.96 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.188 0.995 . . . . 0.0 108.623 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.3 t -138.34 128.8 35.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.2 tptp -96.64 117.53 31.18 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.3 p -77.03 166.15 23.69 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 118.511 0.596 . . . . 0.0 110.084 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -71.34 -10.09 59.2 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 121.651 -0.656 . . . . 0.0 111.615 178.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -91.85 -10.96 37.84 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 128.368 2.667 . . . . 0.0 111.737 -179.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.45 7.09 56.2 Favored Glycine 0 C--N 1.34 0.797 0 C-N-CA 125.605 1.574 . . . . 0.0 114.137 178.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.2 mmmm -80.53 166.66 20.96 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 119.089 1.444 . . . . 0.0 109.622 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.5 m -123.72 131.28 53.57 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 103.453 -2.795 . . . . 0.0 103.453 177.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.5 mm -116.43 156.24 17.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 126.338 1.855 . . . . 0.0 107.214 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.1 m -132.93 128.9 37.51 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.156 1.782 . . . . 0.0 106.504 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.9 mt -139.47 151.0 45.85 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.188 0.995 . . . . 0.0 111.322 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -97.54 117.84 32.71 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 127.005 2.122 . . . . 0.0 105.383 178.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.1 m -134.91 -175.61 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 125.071 1.349 . . . . 0.0 109.631 -179.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -144.41 164.27 29.56 Favored Pre-proline 0 CA--C 1.532 0.278 0 C-N-CA 124.323 1.049 . . . . 0.0 109.817 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -57.87 -18.87 36.68 Favored 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 122.87 2.38 . . . . 0.0 113.865 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.3 m -115.86 31.65 6.58 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 119.21 0.914 . . . . 0.0 110.856 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -92.45 128.81 38.44 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 102.294 -3.224 . . . . 0.0 102.294 177.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.4 p -78.53 158.14 28.64 Favored 'General case' 0 CA--C 1.519 -0.232 0 O-C-N 121.2 -0.938 . . . . 0.0 110.917 -178.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.7 mm -64.08 -25.45 38.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 177.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -56.29 -49.83 73.16 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.518 1.127 . . . . 0.0 108.63 178.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -66.44 -52.63 44.35 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.851 1.26 . . . . 0.0 109.842 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.7 t -55.42 -38.62 49.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-N 118.623 0.647 . . . . 0.0 110.903 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -75.27 -18.11 60.15 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 120.956 -1.09 . . . . 0.0 111.412 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.93 -45.03 9.5 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.532 1.533 . . . . 0.0 110.328 178.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.4 mttm -54.31 -40.24 67.76 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 118.631 0.65 . . . . 0.0 111.039 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 34.6 pt -62.59 -24.9 36.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 CA-C-O 119.011 -0.519 . . . . 0.0 111.644 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.506 HE21 ' HB3' ' A' ' 38' ' ' PRO . 34.9 mt-30 -77.0 -23.11 52.25 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 120.162 1.346 . . . . 0.0 109.392 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.98 -32.59 26.93 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 176.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 51.2 mmtt -87.17 -15.37 38.55 Favored 'General case' 0 C--N 1.343 0.303 0 N-CA-C 115.499 1.666 . . . . 0.0 115.499 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -150.66 157.89 43.51 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 121.051 1.75 . . . . 0.0 106.567 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -80.99 74.83 2.37 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-O 119.177 -0.791 . . . . 0.0 111.256 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.3 pt -135.82 107.69 9.84 Favored Pre-proline 0 CA--C 1.545 0.784 0 CA-C-N 118.404 1.102 . . . . 0.0 111.155 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -71.13 169.3 20.94 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 123.336 2.691 . . . . 0.0 110.764 178.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.506 ' HB3' HE21 ' A' ' 31' ' ' GLN . 88.1 Cg_endo -80.52 56.31 6.03 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 122.701 2.267 . . . . 0.0 109.679 178.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -146.7 135.14 21.92 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 127.874 2.47 . . . . 0.0 105.083 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 71.1 mm-40 50.05 49.97 19.39 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.769 1.628 . . . . 0.0 109.55 -177.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 12.2 m-80 -148.09 134.85 19.99 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.519 1.128 . . . . 0.0 109.52 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 45.8 ttm-85 -153.0 134.18 14.17 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 127.293 2.237 . . . . 0.0 107.475 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 23.3 tp -88.18 139.89 30.04 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.037 1.335 . . . . 0.0 109.154 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.3 mm -132.47 145.9 33.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 125.743 1.617 . . . . 0.0 108.161 -179.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -136.62 117.5 14.16 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 124.727 1.211 . . . . 0.0 108.465 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.85 43.53 21.46 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.708 1.203 . . . . 0.0 110.944 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.38 -15.66 22.42 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 124.899 1.237 . . . . 0.0 114.23 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -80.69 124.34 28.93 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 119.874 1.837 . . . . 0.0 107.531 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.5 mp0 -74.47 135.96 42.27 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.7 mt -114.19 156.17 24.76 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 125.187 1.395 . . . . 0.0 109.944 -178.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -151.07 174.14 13.53 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 178.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -76.52 159.91 29.94 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.85 1.26 . . . . 0.0 111.761 -179.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.01 -27.81 14.96 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 125.811 1.672 . . . . 0.0 109.709 -178.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 44.5 mtt180 -106.59 167.04 10.13 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 118.973 1.386 . . . . 0.0 111.353 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.6 p -117.7 170.46 8.76 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 125.995 1.718 . . . . 0.0 111.169 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.6 mp -52.67 -43.56 65.63 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 123.506 0.723 . . . . 0.0 111.869 179.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.7 m -59.78 -38.32 81.54 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 118.632 0.651 . . . . 0.0 112.172 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -62.44 -47.08 85.62 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 123.068 0.547 . . . . 0.0 109.992 -178.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -82.66 1.36 38.81 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.083 0.953 . . . . 0.0 111.698 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 48.0 t30 54.4 46.24 25.45 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 127.53 2.332 . . . . 0.0 111.17 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 81.8 mt -88.25 123.06 40.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 179.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -101.47 175.75 5.47 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.5 pttt -64.81 157.11 28.58 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.285 0.564 . . . . 0.0 110.661 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 55.59 35.64 25.59 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.737 2.015 . . . . 0.0 111.682 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.9 p -86.19 164.17 17.37 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 120.683 -1.261 . . . . 0.0 108.367 178.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.9 m -126.03 115.48 19.93 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.3 mp -103.73 160.72 14.53 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.576 1.151 . . . . 0.0 108.779 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 43.3 m80 -119.46 159.62 23.91 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 125.236 1.414 . . . . 0.0 110.13 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 61.8 mt -123.24 124.29 42.66 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 125.188 1.395 . . . . 0.0 109.22 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.8 m -141.01 170.16 14.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -178.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.5 pt? . . . . . 0 C--O 1.236 0.367 0 C-N-CA 127.989 2.516 . . . . 0.0 108.288 178.453 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.6 ttt . . . . . 0 N--CA 1.473 0.686 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -122.31 144.92 48.7 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 177.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.9 pt -132.81 168.86 23.2 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 177.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -126.39 152.27 46.54 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 125.082 1.353 . . . . 0.0 109.327 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.4 t -138.72 131.1 38.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 178.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.51 117.8 33.76 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 178.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 54.9 p -74.17 171.12 14.15 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.007 0.923 . . . . 0.0 112.191 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -74.99 -7.75 54.54 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.069 177.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.3 p -94.61 -13.01 26.35 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.858 1.663 . . . . 0.0 111.15 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.81 6.08 57.29 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 126.565 2.031 . . . . 0.0 113.553 178.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.7 mmmm -81.95 164.84 21.23 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 118.416 1.108 . . . . 0.0 108.031 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.7 m -120.35 132.39 55.26 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 104.2 -2.518 . . . . 0.0 104.2 178.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 22.1 mm -107.7 156.96 8.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 125.949 1.699 . . . . 0.0 106.754 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.0 m -135.29 126.27 27.71 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 179.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.7 mt -140.21 147.39 39.99 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.335 1.054 . . . . 0.0 111.199 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -104.9 106.73 17.35 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 126.694 1.998 . . . . 0.0 107.585 178.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.2 m -135.7 -170.63 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 125.041 1.336 . . . . 0.0 108.457 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -147.24 167.94 12.45 Favored Pre-proline 0 C--O 1.232 0.165 0 O-C-N 120.615 -1.303 . . . . 0.0 111.047 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -55.56 -17.6 17.57 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 123.058 2.505 . . . . 0.0 112.821 178.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.1 m -112.57 30.2 7.31 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 119.948 1.249 . . . . 0.0 111.773 -177.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -104.48 140.59 37.74 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 107.518 -1.289 . . . . 0.0 107.518 176.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.2 p -78.72 158.29 28.34 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 122.408 1.099 . . . . 0.0 111.258 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.3 mm -64.74 -25.23 37.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 176.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -55.23 -49.61 71.54 Favored 'General case' 0 C--N 1.344 0.351 0 CA-C-N 119.385 0.993 . . . . 0.0 108.834 178.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.7 m-20 -60.37 -52.3 65.84 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 42.9 t -55.52 -41.36 63.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-O 119.111 -0.471 . . . . 0.0 111.231 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -74.74 -18.36 60.51 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-N 119.275 0.943 . . . . 0.0 111.424 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.24 -46.13 9.01 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 119.652 1.115 . . . . 0.0 108.432 177.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -53.41 -40.21 64.93 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.519 1.128 . . . . 0.0 111.211 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 41.8 pt -63.33 -26.82 41.75 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 CA-C-N 118.808 0.731 . . . . 0.0 111.43 178.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -76.3 -22.69 54.7 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 119.828 1.195 . . . . 0.0 109.323 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.71 -39.49 36.31 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 120.597 -1.315 . . . . 0.0 108.783 178.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -86.98 -15.89 37.42 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 114.549 1.314 . . . . 0.0 114.549 -178.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -148.16 151.27 35.29 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 179.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.1 87.29 1.36 Allowed Glycine 0 C--N 1.335 0.485 0 CA-C-O 119.555 -0.581 . . . . 0.0 112.715 -178.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.5 pt -144.32 107.13 4.81 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 124.448 1.099 . . . . 0.0 109.769 178.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -70.8 170.59 17.46 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 124.05 3.167 . . . . 0.0 110.282 178.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -80.27 55.58 5.72 Favored 'Trans proline' 0 CA--C 1.545 1.061 0 C-N-CA 122.656 2.237 . . . . 0.0 107.607 177.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -146.68 131.33 17.86 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 128.239 2.616 . . . . 0.0 104.765 -179.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 60.1 mm-40 53.95 49.51 18.83 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.992 1.317 . . . . 0.0 107.579 -177.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -155.2 133.35 11.62 Favored 'General case' 0 N--CA 1.452 -0.365 0 O-C-N 121.695 -0.628 . . . . 0.0 110.621 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 53.9 ttm-85 -152.1 137.39 17.53 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 105.319 -2.104 . . . . 0.0 105.319 179.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 28.2 tp -88.31 139.41 30.52 Favored 'General case' 0 C--O 1.226 -0.181 0 C-N-CA 124.182 0.993 . . . . 0.0 109.567 -178.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.6 mm -135.28 144.22 34.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 124.728 1.211 . . . . 0.0 109.093 -178.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -134.69 119.37 18.2 Favored 'General case' 0 C--O 1.226 -0.156 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 178.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.72 38.78 16.18 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.307 1.043 . . . . 0.0 112.077 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.47 -15.77 22.3 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 123.973 0.796 . . . . 0.0 113.582 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.1 ttmt -80.49 118.47 22.13 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 178.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.0 mp0 -75.27 136.68 40.9 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.4 mt -119.82 155.04 33.35 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 126.708 2.003 . . . . 0.0 109.548 -178.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -155.14 176.08 13.01 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 124.604 1.162 . . . . 0.0 108.517 177.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -72.17 160.82 31.8 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 126.116 1.767 . . . . 0.0 112.363 -178.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.62 -27.27 21.0 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 126.042 1.782 . . . . 0.0 110.484 -178.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 47.2 mtt180 -107.33 168.9 8.9 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 124.292 1.037 . . . . 0.0 110.333 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.5 p -117.22 165.56 13.29 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 123.445 0.698 . . . . 0.0 111.601 -179.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.9 mp -52.3 -41.8 63.24 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.714 0.806 . . . . 0.0 111.236 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.9 t -60.52 -45.23 94.61 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 126.391 1.876 . . . . 0.0 110.032 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -60.26 -46.12 90.93 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -81.11 -3.86 53.41 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.212 0.605 . . . . 0.0 111.375 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.9 t30 53.8 47.84 22.73 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 127.718 2.407 . . . . 0.0 112.605 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 82.3 mt -85.61 126.52 40.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 105.499 -2.037 . . . . 0.0 105.499 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 78.0 mm-40 -89.92 169.25 11.39 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.551 0.691 . . . . 0.0 110.939 -179.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -68.02 157.24 35.59 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.389 1.076 . . . . 0.0 109.513 178.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 52.27 35.76 17.81 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.406 1.482 . . . . 0.0 112.879 179.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.4 p -86.32 162.89 17.99 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.728 1.211 . . . . 0.0 110.052 178.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.0 m -126.72 108.77 11.37 Favored 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.4 mp -96.25 169.6 9.83 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.828 1.251 . . . . 0.0 110.658 -178.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -120.05 154.17 35.01 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 126.889 2.076 . . . . 0.0 108.946 178.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.4 mt -123.47 123.89 41.64 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 176.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.9 m -140.75 172.73 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-N 119.53 1.059 . . . . 0.0 112.315 -178.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.236 0.355 0 C-N-CA 126.333 1.853 . . . . 0.0 108.93 178.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.6 ttt . . . . . 0 N--CA 1.471 0.624 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -120.84 156.09 32.7 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 177.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.3 pt -132.33 169.45 21.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -123.32 149.54 44.73 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.541 1.136 . . . . 0.0 108.61 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.6 t -139.19 127.59 27.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -93.36 116.95 29.49 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.141 0.976 . . . . 0.0 109.161 178.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 80.4 p -84.06 167.6 16.67 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.983 0.913 . . . . 0.0 111.904 179.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.7 -3.98 10.82 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 126.342 1.857 . . . . 0.0 113.048 177.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.0 p -99.02 -15.49 19.04 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.699 1.199 . . . . 0.0 109.484 178.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.67 6.25 57.36 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 127.01 2.243 . . . . 0.0 112.041 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.1 mmmm -80.34 163.44 23.91 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 119.441 1.621 . . . . 0.0 107.144 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.6 m -124.62 132.04 53.44 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 104.351 -2.463 . . . . 0.0 104.351 178.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.8 mm -104.6 157.73 5.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 -179.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 97.8 m -133.95 123.48 24.73 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 104.236 -2.505 . . . . 0.0 104.236 178.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 66.3 mt -139.59 150.7 45.32 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.682 0.793 . . . . 0.0 109.775 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 71.9 tt0 -93.83 117.89 30.71 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 105.132 -2.173 . . . . 0.0 105.132 178.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.0 m -131.59 -171.47 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 124.561 1.144 . . . . 0.0 109.078 -178.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -147.09 164.59 22.49 Favored Pre-proline 0 CA--C 1.537 0.47 0 C-N-CA 123.976 0.91 . . . . 0.0 110.112 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -62.68 -18.87 66.29 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 121.92 1.747 . . . . 0.0 112.721 178.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.54 31.66 6.48 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.894 0.877 . . . . 0.0 111.873 -177.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -92.67 131.84 37.41 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 178.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.0 p -75.08 157.6 34.51 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 119.817 1.189 . . . . 0.0 109.013 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 30.1 mm -64.27 -31.18 52.41 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.282 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 177.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -55.91 -48.54 75.49 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.907 1.283 . . . . 0.0 110.045 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.7 m-20 -64.34 -52.38 58.67 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.191 0.996 . . . . 0.0 109.482 179.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.2 t -55.13 -41.72 61.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 122.81 0.444 . . . . 0.0 110.405 179.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.1 ttpt -74.88 -13.28 60.53 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 118.107 -0.949 . . . . 0.0 110.94 -179.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.34 -47.18 8.21 Favored 'General case' 0 C--O 1.226 -0.154 0 CA-C-N 120.269 1.395 . . . . 0.0 108.791 178.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -52.34 -40.06 61.45 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.056 0.942 . . . . 0.0 111.466 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 40.3 pt -63.96 -25.36 37.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 O-C-N 121.727 -0.608 . . . . 0.0 111.582 178.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -76.77 -23.15 52.93 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 119.921 1.237 . . . . 0.0 109.382 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.38 -39.51 59.08 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 177.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.6 mttm -86.62 -18.26 31.82 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 115.659 1.725 . . . . 0.0 115.659 -177.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -141.97 150.79 41.85 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 120.686 1.585 . . . . 0.0 108.039 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.59 82.03 1.61 Allowed Glycine 0 C--N 1.334 0.421 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.7 pt -136.09 108.38 9.69 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 124.622 1.169 . . . . 0.0 109.515 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -78.62 169.32 19.93 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.497 2.798 . . . . 0.0 109.016 179.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -77.84 56.68 5.76 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 123.56 2.84 . . . . 0.0 109.632 178.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -146.65 135.27 22.11 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 104.716 -2.328 . . . . 0.0 104.716 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 64.1 mm-40 53.22 48.65 21.65 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 126.17 1.788 . . . . 0.0 109.235 -177.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 -154.73 138.95 16.58 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.567 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 52.1 ttm-85 -155.97 135.33 12.3 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 127.859 2.464 . . . . 0.0 105.412 178.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 23.8 tp -87.75 139.45 30.52 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.2 mm -133.63 144.65 35.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 126.05 1.74 . . . . 0.0 108.096 -178.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -138.8 124.99 20.19 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 178.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.59 39.27 12.92 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.799 0.839 . . . . 0.0 111.608 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.03 -16.72 14.44 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 125.064 1.316 . . . . 0.0 113.948 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.5 ttmt -78.92 129.06 34.09 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 119.811 1.806 . . . . 0.0 108.172 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.5 mp0 -74.1 136.18 42.97 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 106.749 -1.575 . . . . 0.0 106.749 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.5 mt -119.19 155.88 30.87 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 125.268 1.427 . . . . 0.0 110.419 -179.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -160.23 176.18 12.03 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 126.186 1.794 . . . . 0.0 107.971 178.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -71.88 161.0 31.6 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 126.792 2.037 . . . . 0.0 113.106 -178.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.42 -27.52 19.54 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 126.465 1.983 . . . . 0.0 110.222 -179.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 47.9 mtt180 -107.99 169.31 8.69 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.374 1.07 . . . . 0.0 111.694 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 45.7 p -122.83 171.16 9.4 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.946 1.298 . . . . 0.0 112.145 -178.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.3 mp -52.56 -41.72 63.82 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 123.296 0.638 . . . . 0.0 110.564 178.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.8 t -58.53 -45.48 88.78 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.899 1.68 . . . . 0.0 110.628 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -61.58 -47.06 87.24 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.816 0.846 . . . . 0.0 109.522 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -81.76 -1.21 46.38 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 118.763 -0.637 . . . . 0.0 112.473 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 52.7 t30 54.24 46.68 24.73 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 127.571 2.348 . . . . 0.0 111.267 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.2 mt -87.5 123.83 40.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 87.8 mm-40 -94.09 172.46 8.21 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 123.23 0.612 . . . . 0.0 111.846 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 41.3 pttt -66.7 157.21 33.24 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 50.79 41.78 26.83 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 125.907 1.683 . . . . 0.0 110.664 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.0 p -86.86 163.22 17.32 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 178.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.3 m -126.34 106.28 9.39 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 179.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.1 mp -98.16 161.16 13.85 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 125.109 1.364 . . . . 0.0 108.614 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 11.4 m80 -119.3 155.6 31.54 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 123.927 0.891 . . . . 0.0 109.223 178.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 16.9 mt -122.53 123.35 41.05 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 102.571 -3.122 . . . . 0.0 102.571 178.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.6 m -141.7 168.93 14.66 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 -178.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.472 0.65 0 C-N-CA 124.277 1.031 . . . . 0.0 111.692 177.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.0 ttt . . . . . 0 CA--C 1.512 -0.519 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -121.22 156.69 31.89 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 178.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 34.9 pt -133.14 170.15 20.57 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 C-N-CA 125.515 1.526 . . . . 0.0 106.993 177.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -126.21 152.82 45.53 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 178.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.9 t -137.94 124.62 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.8 tppp? -93.28 109.58 21.11 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 104.348 -2.464 . . . . 0.0 104.348 178.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.3 p -72.6 165.37 24.83 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 121.074 0.464 . . . . 0.0 110.597 -179.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -69.0 -6.85 30.38 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.468 0.707 . . . . 0.0 111.36 178.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.1 p -93.88 -12.36 29.09 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.692 1.197 . . . . 0.0 109.692 179.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.51 5.78 57.71 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 126.862 2.172 . . . . 0.0 111.508 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.86 164.76 22.42 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 118.454 1.127 . . . . 0.0 108.933 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.1 m -124.42 132.31 53.51 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 179.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.5 mm -114.09 156.83 14.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 125.963 1.705 . . . . 0.0 106.468 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 31.6 m -132.45 123.66 27.07 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 127.239 2.216 . . . . 0.0 105.832 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.4 mt -133.92 150.83 51.34 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 119.09 0.859 . . . . 0.0 109.922 -179.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -103.41 109.12 20.64 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 104.735 -2.32 . . . . 0.0 104.735 178.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.3 m -123.37 -172.33 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 125.53 1.532 . . . . 0.0 109.816 -177.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -146.17 162.42 35.17 Favored Pre-proline 0 C--O 1.234 0.279 0 O-C-N 121.357 -0.839 . . . . 0.0 109.637 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -58.46 -18.53 39.52 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.407 2.071 . . . . 0.0 113.21 179.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.2 m -114.38 31.34 6.67 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 118.763 0.71 . . . . 0.0 111.573 -177.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -98.17 129.34 44.95 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 104.007 -2.59 . . . . 0.0 104.007 178.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.7 p -78.09 157.47 29.5 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 119.814 1.188 . . . . 0.0 110.128 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 51.3 mm -64.5 -26.0 39.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 177.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -55.4 -44.13 75.87 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.356 1.462 . . . . 0.0 109.436 178.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -70.97 -52.37 20.16 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.623 1.169 . . . . 0.0 108.545 179.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.7 t -54.74 -38.52 43.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 124.222 1.009 . . . . 0.0 111.41 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -76.56 -18.54 58.62 Favored 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 124.192 0.997 . . . . 0.0 111.097 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -88.74 -42.27 12.05 Favored 'General case' 0 C--O 1.228 -0.049 0 CA-C-N 119.633 1.106 . . . . 0.0 110.145 179.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -54.16 -40.58 67.59 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.216 0.606 . . . . 0.0 110.86 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.5 pt -63.05 -25.42 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 O-C-N 120.851 -1.156 . . . . 0.0 111.549 178.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -77.93 -21.63 50.82 Favored 'General case' 0 C--N 1.332 -0.169 0 O-C-N 120.79 -1.194 . . . . 0.0 109.967 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -78.11 -30.61 49.58 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.8 mttm -100.57 -15.05 17.95 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 115.799 1.777 . . . . 0.0 115.799 -179.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -139.52 158.71 43.66 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 121.437 1.926 . . . . 0.0 108.936 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.31 70.22 3.13 Favored Glycine 0 CA--C 1.524 0.622 0 C-N-CA 124.87 1.224 . . . . 0.0 110.914 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.6 pt -137.23 107.62 8.72 Favored Pre-proline 0 CA--C 1.544 0.731 0 CA-C-N 118.826 1.313 . . . . 0.0 111.579 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -76.05 168.98 23.03 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 123.756 2.971 . . . . 0.0 109.33 178.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -78.74 57.23 6.28 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.572 2.181 . . . . 0.0 109.875 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -149.4 135.91 19.31 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 128.401 2.68 . . . . 0.0 105.451 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 47.1 mm-40 54.03 48.54 20.88 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.474 1.509 . . . . 0.0 108.501 -177.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -147.83 134.53 19.95 Favored 'General case' 0 C--N 1.339 0.137 0 O-C-N 121.39 -0.819 . . . . 0.0 110.323 -179.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 52.4 ttm-85 -155.55 133.55 11.42 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 29.1 tp -89.14 135.31 33.63 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.826 1.65 . . . . 0.0 110.581 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.4 mm -135.74 147.33 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 125.03 1.332 . . . . 0.0 108.009 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -139.0 115.14 10.28 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 178.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.49 40.75 15.72 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.085 1.354 . . . . 0.0 110.505 -178.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.71 -10.03 53.22 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 125.481 1.515 . . . . 0.0 114.955 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.6 ttmt -79.71 129.84 34.83 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 120.488 2.144 . . . . 0.0 107.732 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.5 mp0 -74.31 125.53 28.66 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.4 mt -114.15 140.73 48.28 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 106.095 -1.816 . . . . 0.0 106.095 179.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -162.88 -179.91 7.13 Favored 'General case' 0 C--N 1.32 -0.686 0 O-C-N 121.658 -0.651 . . . . 0.0 110.206 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -70.49 160.13 32.98 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.089 1.356 . . . . 0.0 112.8 -176.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.85 -29.55 12.26 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 128.153 2.787 . . . . 0.0 110.067 -178.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 49.8 mtt180 -108.28 169.6 8.53 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 126.191 1.796 . . . . 0.0 112.065 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 78.3 p -117.73 167.52 11.29 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 126.865 2.066 . . . . 0.0 111.04 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.7 mp -52.4 -42.02 63.66 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 123.282 0.633 . . . . 0.0 111.131 178.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.7 t -58.65 -43.17 89.72 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.48 1.512 . . . . 0.0 110.605 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -59.87 -46.9 87.85 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 118.741 0.7 . . . . 0.0 109.574 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -81.83 -4.08 55.59 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.246 1.018 . . . . 0.0 113.476 -179.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 37.6 t30 58.34 47.44 13.92 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.609 1.964 . . . . 0.0 110.963 -178.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.9 mt -86.28 122.99 39.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 104.775 -2.306 . . . . 0.0 104.775 179.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 92.1 mm-40 -93.37 170.32 9.7 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 122.862 0.465 . . . . 0.0 110.677 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 49.4 pttt -68.76 157.36 36.52 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.238 0.542 . . . . 0.0 111.228 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 53.16 37.83 26.0 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 127.379 2.272 . . . . 0.0 110.566 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.3 p -87.14 161.69 17.95 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.121 1.368 . . . . 0.0 109.63 178.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 95.2 m -126.33 110.17 13.08 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.3 mp -97.17 158.84 15.25 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.202 1.801 . . . . 0.0 108.857 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 72.1 m80 -120.07 163.64 17.36 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 125.341 1.456 . . . . 0.0 111.823 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 54.5 mt -120.19 133.45 55.49 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 125.13 1.372 . . . . 0.0 107.49 178.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.1 m -140.63 168.98 16.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 C-N-CA 124.413 1.085 . . . . 0.0 109.664 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.236 0.376 0 C-N-CA 125.123 1.369 . . . . 0.0 107.338 176.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 33.6 ttm . . . . . 0 N--CA 1.469 0.477 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -122.67 150.48 42.65 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 175.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.9 pt -132.65 168.63 23.74 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 176.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -126.1 151.79 46.74 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 123.892 0.877 . . . . 0.0 109.587 -179.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.9 t -138.37 133.06 42.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 178.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -98.27 117.27 32.28 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 105.241 -2.133 . . . . 0.0 105.241 177.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.3 p -80.36 167.08 20.66 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 118.878 0.763 . . . . 0.0 110.471 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -71.94 -7.98 51.8 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 122.747 0.419 . . . . 0.0 111.173 177.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.4 p -93.51 -12.35 29.84 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.549 1.14 . . . . 0.0 109.411 178.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.77 7.48 55.44 Favored Glycine 0 C--N 1.342 0.861 0 C-N-CA 125.005 1.288 . . . . 0.0 112.622 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -80.86 164.34 22.73 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 119.617 1.709 . . . . 0.0 108.186 179.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.2 m -124.11 131.46 53.55 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 102.953 -2.98 . . . . 0.0 102.953 177.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.9 mm -115.11 157.4 15.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 C-N-CA 125.81 1.644 . . . . 0.0 106.686 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 42.2 m -134.68 125.97 28.16 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 128.503 2.721 . . . . 0.0 104.945 177.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 81.1 mt -139.89 149.21 43.11 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.85 1.26 . . . . 0.0 110.17 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -102.13 114.25 28.22 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 126.116 1.767 . . . . 0.0 107.372 178.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.2 m -134.33 -175.0 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 124.77 1.228 . . . . 0.0 108.118 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -142.45 168.89 12.1 Favored Pre-proline 0 C--O 1.236 0.364 0 O-C-N 121.235 -0.916 . . . . 0.0 110.256 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -54.56 -22.12 26.93 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.683 2.256 . . . . 0.0 114.388 -179.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.5 m -115.11 31.77 6.48 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -178.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -95.68 128.92 42.96 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 101.133 -3.655 . . . . 0.0 101.133 175.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.2 p -76.57 159.0 30.71 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 119.778 1.172 . . . . 0.0 109.762 -179.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 51.8 mm -62.54 -26.19 39.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -53.86 -49.24 68.91 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.599 1.16 . . . . 0.0 108.457 178.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 -68.24 -52.02 38.73 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 126.436 1.894 . . . . 0.0 110.345 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.3 t -53.92 -43.68 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-N 119.232 0.923 . . . . 0.0 110.122 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -75.21 -13.48 60.45 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.182 0.993 . . . . 0.0 112.05 -178.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.51 -45.14 9.62 Favored 'General case' 0 C--O 1.225 -0.229 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 177.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.3 mtmm -50.84 -39.74 54.23 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.187 1.395 . . . . 0.0 110.385 179.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 37.5 pt -65.88 -25.41 36.16 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 CA-C-N 118.956 0.798 . . . . 0.0 112.332 178.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -76.37 -23.45 54.13 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 120.017 1.281 . . . . 0.0 109.372 -179.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.02 -38.88 56.75 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 177.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 45.6 mttm -87.43 -16.01 36.08 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 116.526 2.047 . . . . 0.0 116.526 -178.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -147.55 160.62 42.42 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 121.371 1.896 . . . . 0.0 110.511 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.31 64.09 4.23 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 124.427 1.013 . . . . 0.0 113.393 -179.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.1 pt -134.72 106.39 10.73 Favored Pre-proline 0 CA--C 1.541 0.61 0 CA-C-N 119.114 1.457 . . . . 0.0 108.341 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -71.54 169.45 20.93 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 123.7 2.933 . . . . 0.0 112.374 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -78.23 56.91 5.98 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 123.567 2.844 . . . . 0.0 110.263 178.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -149.5 136.16 19.41 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 127.958 2.503 . . . . 0.0 105.099 179.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 64.2 mm-40 51.91 48.83 22.01 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.303 1.441 . . . . 0.0 107.819 -177.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -152.55 133.14 13.85 Favored 'General case' 0 N--CA 1.455 -0.207 0 O-C-N 121.21 -0.932 . . . . 0.0 109.979 -178.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.0 ttm-85 -154.4 136.17 14.45 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 106.206 -1.775 . . . . 0.0 106.206 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 18.5 tp -88.22 137.85 31.96 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 124.427 1.091 . . . . 0.0 108.265 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.9 mm -135.12 150.2 29.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 126.002 1.721 . . . . 0.0 108.348 -178.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -137.17 115.41 11.72 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 178.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.39 42.32 18.04 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.884 1.274 . . . . 0.0 111.161 -178.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.33 -12.48 38.65 Favored Glycine 0 CA--C 1.53 0.97 0 CA-C-O 118.283 -1.287 . . . . 0.0 114.429 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.0 ttmt -79.11 125.17 29.06 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 120.86 2.33 . . . . 0.0 105.96 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.3 mp0 -74.31 136.0 42.56 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -179.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.3 mt -122.91 153.89 39.06 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -162.98 178.45 8.34 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 126.886 2.074 . . . . 0.0 107.802 177.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -71.78 160.56 32.39 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.057 1.343 . . . . 0.0 112.269 -177.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 108.34 -29.51 9.98 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 127.709 2.576 . . . . 0.0 108.626 -178.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 44.1 mtt180 -108.44 166.37 10.82 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.598 1.159 . . . . 0.0 112.329 178.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 49.5 p -117.44 169.59 9.4 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 126.067 1.747 . . . . 0.0 110.292 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.3 mp -52.73 -42.22 64.68 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 122.901 0.48 . . . . 0.0 111.207 178.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.2 t -59.06 -45.61 90.33 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.853 1.261 . . . . 0.0 110.799 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -59.46 -44.92 92.88 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.21 0.604 . . . . 0.0 110.506 -179.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -82.22 -0.3 44.58 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.518 0.727 . . . . 0.0 112.21 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 44.8 t30 53.65 47.49 23.71 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 127.141 2.176 . . . . 0.0 110.611 -179.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.1 mt -85.05 130.95 35.25 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 N-CA-C 104.397 -2.446 . . . . 0.0 104.397 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 68.7 mm-40 -89.63 167.14 13.16 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 123.079 0.551 . . . . 0.0 111.566 -178.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -72.74 156.68 38.68 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 177.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 50.86 35.74 13.06 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.205 1.402 . . . . 0.0 111.358 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.6 p -81.85 164.77 21.38 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.422 1.889 . . . . 0.0 109.494 179.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.5 m -125.97 107.03 10.06 Favored 'General case' 0 N--CA 1.461 0.12 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.6 mp -97.61 164.51 12.39 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.124 1.37 . . . . 0.0 109.21 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.2 m80 -119.93 157.66 28.31 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 126.028 1.731 . . . . 0.0 110.949 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 34.6 mt -123.16 125.47 45.2 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.584 1.554 . . . . 0.0 107.479 178.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.8 m -140.98 172.63 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-N 119.722 1.147 . . . . 0.0 113.937 -178.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.537 0.461 0 C-N-CA 126.478 1.911 . . . . 0.0 109.41 177.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ttt . . . . . 0 N--CA 1.473 0.691 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -121.08 156.16 32.85 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 179.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.2 pt -133.71 170.85 19.02 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 C-N-CA 126.601 1.96 . . . . 0.0 107.883 177.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -126.14 152.43 45.96 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.187 1.395 . . . . 0.0 109.161 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.2 t -138.1 126.15 30.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 178.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -92.83 117.5 30.09 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 106.144 -1.799 . . . . 0.0 106.144 178.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 64.4 p -73.12 164.39 26.76 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -67.67 -12.63 60.9 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.7 178.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.6 p -92.55 -12.11 32.68 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.396 1.879 . . . . 0.0 110.454 179.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.55 6.92 56.24 Favored Glycine 0 C--N 1.338 0.644 0 O-C-N 121.091 -1.006 . . . . 0.0 112.752 179.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.01 163.36 23.32 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 104.996 -2.224 . . . . 0.0 104.996 178.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 47.3 m -125.1 140.54 52.79 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 178.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.2 mm -114.82 156.22 15.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 126.338 1.855 . . . . 0.0 106.001 179.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 47.6 m -132.23 125.84 32.07 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 103.571 -2.751 . . . . 0.0 103.571 178.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.2 mt -138.73 151.49 47.17 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.024 0.93 . . . . 0.0 110.397 -178.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -99.69 118.62 36.6 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 128.362 2.665 . . . . 0.0 105.728 178.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.1 m -134.21 -171.27 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 125.512 1.525 . . . . 0.0 108.467 -178.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -146.72 161.8 36.28 Favored Pre-proline 0 CA--C 1.536 0.435 0 C-N-CA 124.197 0.999 . . . . 0.0 108.344 179.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -51.19 -24.98 16.19 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.316 2.678 . . . . 0.0 114.844 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.4 m -115.42 33.09 5.65 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.756 0.822 . . . . 0.0 111.563 -179.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -90.69 129.65 36.77 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 103.131 -2.915 . . . . 0.0 103.131 178.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 21.3 p -69.58 158.08 35.96 Favored 'General case' 0 C--O 1.237 0.421 0 O-C-N 121.728 -0.607 . . . . 0.0 110.69 -178.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.7 mm -64.25 -32.14 56.3 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.47 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 177.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -55.49 -39.71 70.79 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 125.823 1.649 . . . . 0.0 110.171 179.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -73.86 -53.46 10.15 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.1 t -57.92 -39.13 70.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 O-C-N 121.162 -0.961 . . . . 0.0 112.397 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 27.2 ttpt -75.01 -15.75 60.64 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.622 1.169 . . . . 0.0 110.921 -179.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.75 -47.1 7.84 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.108 1.763 . . . . 0.0 108.14 177.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.1 mttm -50.36 -40.5 49.5 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.217 1.407 . . . . 0.0 110.898 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.3 pt -64.32 -27.94 43.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 O-C-N 121.472 -0.768 . . . . 0.0 111.667 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -78.02 -22.09 49.77 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.824 1.249 . . . . 0.0 110.412 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.34 -37.76 60.52 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 177.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -94.18 -17.75 22.42 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 116.104 1.891 . . . . 0.0 116.104 -179.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -136.45 150.21 48.61 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 121.401 1.909 . . . . 0.0 107.13 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -83.46 85.76 1.52 Allowed Glycine 0 CA--C 1.521 0.434 0 CA-C-O 119.14 -0.811 . . . . 0.0 111.285 -179.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.5 pt -141.17 108.78 6.29 Favored Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 118.327 1.064 . . . . 0.0 111.79 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -62.62 161.9 26.6 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 122.666 2.244 . . . . 0.0 110.547 178.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -84.23 56.66 5.03 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.569 2.179 . . . . 0.0 108.041 179.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -144.82 134.15 23.04 Favored 'General case' 0 CA--C 1.514 -0.415 0 C-N-CA 130.602 3.561 . . . . 0.0 103.515 -178.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 43.3 mm-40 50.89 49.55 20.86 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 125.353 1.461 . . . . 0.0 107.324 -176.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -147.89 133.0 18.27 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.771 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 42.9 ttm-85 -154.73 133.58 12.22 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 178.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 26.5 tp -88.25 137.06 32.66 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.17 1.388 . . . . 0.0 107.834 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.3 mm -127.98 144.46 37.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 125.718 1.607 . . . . 0.0 108.844 -178.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -136.77 126.07 24.85 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 178.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.36 33.15 9.48 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.049 0.94 . . . . 0.0 111.288 -179.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.27 -11.95 41.09 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 124.514 1.054 . . . . 0.0 112.483 -179.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -79.55 129.02 34.09 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 119.58 1.69 . . . . 0.0 107.515 179.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.9 mp0 -74.4 136.03 42.41 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.6 mt -122.98 155.67 36.31 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.29 1.036 . . . . 0.0 109.744 -178.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -161.7 -178.33 6.47 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 127.747 2.419 . . . . 0.0 107.393 177.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -70.63 160.42 32.6 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 127.621 2.368 . . . . 0.0 113.055 -176.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.5 -28.82 13.92 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 126.576 2.036 . . . . 0.0 110.264 -178.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 46.6 mtt180 -108.23 165.16 11.7 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.019 1.328 . . . . 0.0 112.3 179.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 64.4 p -118.52 174.21 6.39 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 126.87 2.068 . . . . 0.0 111.855 -179.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.67 -46.37 63.76 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.459 1.104 . . . . 0.0 110.98 179.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.1 t -58.6 -45.3 89.45 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.037 1.735 . . . . 0.0 111.503 -179.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -60.29 -45.09 94.56 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 122.966 0.506 . . . . 0.0 110.52 -178.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -81.53 1.84 31.74 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.04 0.536 . . . . 0.0 111.197 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.2 t30 54.72 46.19 25.15 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 128.039 2.535 . . . . 0.0 111.202 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 89.6 mt -88.38 125.51 41.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 81.5 mm-40 -101.93 176.94 5.04 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.253 1.021 . . . . 0.0 110.613 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.9 pttt -64.72 156.67 29.66 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 123.588 0.755 . . . . 0.0 110.431 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 49.17 39.33 15.2 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.518 1.927 . . . . 0.0 111.694 -178.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.8 p -83.95 161.64 20.73 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 120.447 -1.408 . . . . 0.0 108.129 178.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.5 m -126.29 108.8 11.6 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.4 mp -95.78 162.16 13.71 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.269 1.428 . . . . 0.0 109.004 -179.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -119.77 163.12 17.94 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.21 1.404 . . . . 0.0 109.928 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.3 mt -123.0 127.34 48.67 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.01 1.724 . . . . 0.0 108.337 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.6 m -141.21 163.44 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 114.255 1.205 . . . . 0.0 114.255 -178.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.536 0.413 0 C-N-CA 127.353 2.261 . . . . 0.0 108.819 177.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.2 ttm . . . . . 0 N--CA 1.468 0.466 0 N-CA-C 110.354 -0.239 . . . . 0.0 110.354 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -121.04 156.45 32.17 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 176.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.2 pt -132.98 169.39 22.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 178.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -126.12 149.57 48.84 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 179.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.7 t -138.33 124.52 25.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -92.8 117.78 30.39 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 105.345 -2.095 . . . . 0.0 105.345 178.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 50.1 p -72.19 167.06 21.12 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 121.564 0.697 . . . . 0.0 109.734 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -67.26 -12.51 60.3 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.62 0.768 . . . . 0.0 111.738 178.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.3 p -97.44 -12.71 22.38 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.908 1.683 . . . . 0.0 112.249 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.35 6.65 47.44 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-O 118.313 -1.271 . . . . 0.0 113.863 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.3 163.52 20.62 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 120.138 1.969 . . . . 0.0 105.983 178.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.5 m -124.57 132.76 53.44 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.5 mm -115.66 156.9 16.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 127.458 2.303 . . . . 0.0 108.228 -179.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.7 m -133.54 130.55 38.62 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 127.85 2.46 . . . . 0.0 106.276 178.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 92.5 mt -134.3 151.87 51.49 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 126.16 1.784 . . . . 0.0 110.845 -179.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -102.68 117.69 35.21 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 104.548 -2.389 . . . . 0.0 104.548 177.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.1 m -135.18 -168.96 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 124.657 1.183 . . . . 0.0 109.768 -179.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -150.43 163.54 23.8 Favored Pre-proline 0 CA--C 1.537 0.462 0 C-N-CA 125.308 1.443 . . . . 0.0 109.196 178.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -57.12 -18.41 29.07 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.705 2.27 . . . . 0.0 113.274 178.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.4 m -114.22 31.27 6.7 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 123.74 0.816 . . . . 0.0 111.517 -178.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -94.97 130.07 41.76 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 102.309 -3.219 . . . . 0.0 102.309 176.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.5 p -71.62 156.69 39.1 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 119.798 1.181 . . . . 0.0 109.726 -179.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.7 mm -65.04 -29.33 47.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 177.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -57.74 -49.63 75.92 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 126.101 1.761 . . . . 0.0 107.9 178.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -63.04 -52.08 64.25 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.143 0.977 . . . . 0.0 109.421 178.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.8 t -56.37 -38.91 57.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 O-C-N 121.508 -0.745 . . . . 0.0 110.618 179.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -74.74 -17.83 60.59 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-O 117.763 -1.113 . . . . 0.0 109.948 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.29 -47.36 10.13 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 120.2 1.364 . . . . 0.0 108.177 178.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.0 mttm -50.32 -43.16 53.68 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.672 1.189 . . . . 0.0 111.808 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 36.8 pt -62.78 -27.73 43.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 O-C-N 121.501 -0.749 . . . . 0.0 112.684 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -77.21 -20.66 55.01 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 119.519 1.054 . . . . 0.0 110.479 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -82.74 -38.08 23.76 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.171 -0.956 . . . . 0.0 108.974 178.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -86.03 -21.42 27.77 Favored 'General case' 0 N--CA 1.471 0.575 0 O-C-N 121.044 -1.035 . . . . 0.0 113.682 -178.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -140.5 150.81 44.22 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 178.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -80.89 85.29 1.38 Allowed Glycine 0 C--N 1.332 0.317 0 CA-C-N 118.907 0.776 . . . . 0.0 113.038 -178.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.3 pt -140.14 106.87 6.74 Favored Pre-proline 0 CA--C 1.54 0.59 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -66.09 170.4 11.85 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 123.772 2.982 . . . . 0.0 111.309 178.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -83.46 55.99 5.19 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 N-CA-C 106.645 -2.098 . . . . 0.0 106.645 178.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -146.52 133.94 20.78 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 128.402 2.681 . . . . 0.0 106.746 -177.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 39.6 mm-40 46.84 49.43 14.39 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.073 1.749 . . . . 0.0 108.348 -177.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -154.3 134.41 13.18 Favored 'General case' 0 C--N 1.341 0.207 0 C-N-CA 124.761 1.224 . . . . 0.0 110.106 -179.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 52.1 ttm-85 -151.59 141.47 21.99 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 179.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 20.0 tp -88.45 138.89 31.02 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.749 1.22 . . . . 0.0 108.818 -179.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.2 mm -135.16 149.98 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 C-N-CA 125.989 1.716 . . . . 0.0 107.083 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -137.61 122.71 19.15 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 178.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.1 36.61 9.1 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.04 0.936 . . . . 0.0 111.494 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.76 -13.95 33.64 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-O 118.773 -1.015 . . . . 0.0 114.028 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.3 ttmt -79.76 128.97 34.07 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 120.304 2.052 . . . . 0.0 106.145 178.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.7 mp0 -73.75 136.17 43.63 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.141 1.376 . . . . 0.0 108.924 -178.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.4 mt -123.86 155.03 38.8 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.345 1.058 . . . . 0.0 109.069 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -161.78 179.46 8.08 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.269 1.428 . . . . 0.0 108.316 178.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -70.97 161.12 31.66 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 127.219 2.208 . . . . 0.0 112.993 -176.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.37 -25.18 29.08 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 126.24 1.876 . . . . 0.0 110.434 -178.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 47.3 mtt180 -108.29 171.56 7.34 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 118.715 1.257 . . . . 0.0 112.194 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.8 p -118.17 171.62 7.99 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 126.457 1.903 . . . . 0.0 109.322 178.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.7 mp -52.86 -42.16 64.97 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.357 0.663 . . . . 0.0 110.548 177.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.9 t -58.68 -45.44 89.42 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 126.251 1.82 . . . . 0.0 111.553 -179.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -57.73 -47.09 83.39 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 119.384 0.993 . . . . 0.0 109.871 -179.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -81.72 1.25 35.23 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.888 0.875 . . . . 0.0 112.378 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 54.8 t30 53.93 46.08 26.36 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 127.422 2.289 . . . . 0.0 111.405 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.0 mt -86.29 126.71 40.66 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.9 mm-40 -97.2 173.3 7.3 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.402 0.681 . . . . 0.0 111.215 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 42.8 pttt -66.06 156.77 32.83 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 51.81 35.33 15.16 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 127.328 2.251 . . . . 0.0 110.901 -179.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.3 p -75.59 162.74 28.02 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 178.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.3 m -122.77 106.24 10.75 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 -179.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.5 mp -101.63 159.4 15.34 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.314 1.446 . . . . 0.0 109.552 -178.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 4.1 m80 -120.25 163.64 17.47 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 126.406 1.882 . . . . 0.0 111.145 179.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 69.4 mt -122.24 125.41 45.99 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 177.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.9 m -139.77 163.75 24.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-O 121.85 0.833 . . . . 0.0 111.64 -179.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.6 pt? . . . . . 0 C--N 1.332 -0.173 0 C-N-CA 127.278 2.231 . . . . 0.0 108.409 178.719 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 30.3 ttm . . . . . 0 CA--C 1.514 -0.415 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -120.99 148.43 44.11 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 178.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 34.0 pt -132.11 168.34 24.28 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 O-C-N 120.993 -1.067 . . . . 0.0 108.448 179.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -126.22 149.84 48.78 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.7 t -138.3 124.64 25.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -90.42 118.95 30.29 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 126.914 2.086 . . . . 0.0 111.071 179.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 51.1 p -83.05 163.98 20.61 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 177.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.66 -5.65 16.79 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.426 1.09 . . . . 0.0 112.881 178.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.9 p -92.77 -14.23 28.17 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.794 2.037 . . . . 0.0 110.555 178.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.5 6.39 57.47 Favored Glycine 0 C--N 1.337 0.593 0 C-N-CA 125.637 1.589 . . . . 0.0 112.459 179.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.8 mmmm -81.77 164.48 21.66 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 118.28 1.04 . . . . 0.0 108.334 179.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.1 m -125.09 137.19 54.2 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 177.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 48.8 mm -115.95 154.0 17.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 105.507 -2.034 . . . . 0.0 105.507 178.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.8 m -132.71 130.13 39.63 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 178.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 78.5 mt -139.17 151.2 46.42 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 124.899 1.28 . . . . 0.0 111.857 -178.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -98.94 117.63 33.89 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 127.482 2.313 . . . . 0.0 105.024 178.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.6 m -134.39 -171.99 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 125.323 1.449 . . . . 0.0 109.729 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -148.09 165.59 17.98 Favored Pre-proline 0 CA--C 1.536 0.406 0 C-N-CA 124.136 0.974 . . . . 0.0 110.507 179.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.78 -19.27 14.34 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.725 2.95 . . . . 0.0 115.547 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.1 m -115.73 30.83 7.1 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 119.132 0.878 . . . . 0.0 111.693 -179.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -91.46 129.31 37.46 Favored 'General case' 0 C--O 1.244 0.784 0 N-CA-C 102.846 -3.02 . . . . 0.0 102.846 177.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.9 p -76.65 158.34 31.13 Favored 'General case' 0 C--O 1.233 0.205 0 O-C-N 121.118 -0.989 . . . . 0.0 110.697 -178.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.2 mm -63.07 -27.02 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 179.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -54.18 -46.5 72.4 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.387 1.075 . . . . 0.0 109.633 178.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 56.7 m-80 -69.57 -52.36 26.95 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.659 1.584 . . . . 0.0 109.445 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.4 t -54.45 -40.98 51.57 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 CA-C-N 118.835 0.743 . . . . 0.0 109.971 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.1 ttpt -75.49 -12.92 60.33 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.953 1.301 . . . . 0.0 111.637 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.11 -47.44 7.82 Favored 'General case' 0 CA--C 1.52 -0.198 0 C-N-CA 124.614 1.166 . . . . 0.0 109.46 178.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 55.7 mttm -51.21 -40.24 58.29 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.918 1.287 . . . . 0.0 110.485 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.7 pt -61.64 -31.0 49.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-O 118.44 -0.79 . . . . 0.0 112.413 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -77.38 -19.97 55.41 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.029 1.332 . . . . 0.0 110.724 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -83.89 -40.03 19.12 Favored 'General case' 0 CA--C 1.53 0.193 0 O-C-N 121.412 -0.805 . . . . 0.0 110.484 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.8 mttm -89.87 -14.97 33.18 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 -179.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -138.95 150.79 46.29 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.72 64.54 4.19 Favored Glycine 0 CA--C 1.524 0.603 0 CA-C-O 118.136 -1.369 . . . . 0.0 112.729 -179.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.5 pt -127.41 106.72 21.28 Favored Pre-proline 0 CA--C 1.552 1.02 0 CA-C-N 118.928 1.364 . . . . 0.0 111.162 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -65.88 165.41 23.7 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 124.13 3.22 . . . . 0.0 114.694 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -81.79 57.52 6.35 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 124.756 3.637 . . . . 0.0 110.163 178.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -145.12 134.06 22.49 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 128.69 2.796 . . . . 0.0 105.501 -178.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.8 mm-40 44.23 51.1 7.57 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 126.603 1.961 . . . . 0.0 110.05 -177.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 23.3 m-20 -150.59 134.2 16.51 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.3 ttm-85 -153.28 142.65 21.63 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 124.883 1.273 . . . . 0.0 107.638 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.0 tp -88.62 142.9 27.31 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 125.246 1.419 . . . . 0.0 112.698 -177.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.6 mm -135.55 148.15 28.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 126.934 2.094 . . . . 0.0 108.265 179.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -138.18 115.07 10.76 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 177.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.45 43.06 19.46 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.268 1.027 . . . . 0.0 110.784 -178.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.66 -13.19 36.99 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 124.63 1.11 . . . . 0.0 114.738 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.6 ttmm -79.48 129.21 34.26 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 119.757 1.778 . . . . 0.0 109.33 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -74.81 129.36 37.54 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 125.82 1.648 . . . . 0.0 109.577 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 9.8 mt -123.74 148.85 46.24 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 123.726 0.811 . . . . 0.0 110.43 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.1 pm0 -151.61 175.96 11.83 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.12 1.368 . . . . 0.0 108.464 178.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -72.13 161.03 31.46 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 125.493 1.517 . . . . 0.0 113.628 -177.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.82 -22.52 39.97 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 125.672 1.606 . . . . 0.0 110.724 -179.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -107.27 169.97 8.24 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 118.572 1.186 . . . . 0.0 111.347 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 79.4 p -117.09 171.14 8.12 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.604 1.562 . . . . 0.0 113.026 -178.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.57 -47.13 67.02 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.074 0.95 . . . . 0.0 108.829 177.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.2 m -62.04 -32.5 73.02 Favored 'General case' 0 N--CA 1.46 0.063 0 C-N-CA 124.823 1.249 . . . . 0.0 112.93 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -67.41 -45.67 75.47 Favored 'General case' 0 CA--C 1.515 -0.398 0 O-C-N 121.077 -1.014 . . . . 0.0 109.819 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -82.95 1.39 39.91 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 119.208 -0.425 . . . . 0.0 110.93 178.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 36.5 t30 56.01 46.71 21.3 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 127.76 2.424 . . . . 0.0 111.167 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.6 mt -89.76 126.98 42.64 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 178.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -101.84 178.43 4.62 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 123.039 0.536 . . . . 0.0 110.216 179.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 58.4 pttt -64.68 156.88 28.85 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.176 0.59 . . . . 0.0 110.661 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 52.26 46.1 27.25 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.216 1.407 . . . . 0.0 111.221 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.1 p -88.75 161.26 16.89 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.994 1.718 . . . . 0.0 109.912 177.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.37 117.05 22.17 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 178.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mp -109.04 160.57 15.94 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 124.298 1.039 . . . . 0.0 109.256 -179.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 43.7 m80 -120.05 161.11 21.51 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 126.39 1.876 . . . . 0.0 109.526 178.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 33.6 mt -122.82 125.14 44.86 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 126.728 2.011 . . . . 0.0 108.014 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.0 m -141.02 166.14 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -178.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.6 pt? . . . . . 0 CA--C 1.535 0.373 0 C-N-CA 125.384 1.474 . . . . 0.0 108.955 177.088 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.0 ttm . . . . . 0 N--CA 1.471 0.624 0 CA-C-O 118.719 -0.658 . . . . 0.0 110.356 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -121.74 154.41 36.96 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 176.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.9 pt -133.42 169.22 22.34 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 176.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -123.04 149.53 44.26 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 179.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.7 t -138.95 125.69 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.1 tppp? -94.14 117.56 30.29 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.946 0.898 . . . . 0.0 108.903 178.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 37.4 p -83.22 166.18 18.8 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.889 0.768 . . . . 0.0 111.025 179.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -70.29 -2.56 13.81 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.35 0.66 . . . . 0.0 111.909 177.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 47.0 p -92.62 -15.16 27.19 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.915 1.286 . . . . 0.0 109.369 178.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.5 6.08 57.6 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 126.825 2.155 . . . . 0.0 112.435 179.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.3 mmmm -81.91 164.18 21.72 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 119.172 1.486 . . . . 0.0 109.636 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.5 m -113.2 132.08 55.63 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 101.896 -3.372 . . . . 0.0 101.896 176.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.8 mm -115.77 148.06 18.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 179.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.9 m -125.37 130.05 51.15 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 106.392 -1.706 . . . . 0.0 106.392 178.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 76.3 mt -139.12 143.26 38.16 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.518 0.727 . . . . 0.0 110.072 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -99.57 107.1 19.17 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.902 2.081 . . . . 0.0 106.58 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.4 m -133.58 -172.6 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 124.988 1.315 . . . . 0.0 109.929 -178.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -144.13 166.07 20.84 Favored Pre-proline 0 C--O 1.235 0.315 0 CA-C-N 121.031 1.741 . . . . 0.0 112.178 -178.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.05 -22.47 31.28 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 123.246 2.63 . . . . 0.0 115.416 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.5 m -115.11 31.03 6.96 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 118.527 0.603 . . . . 0.0 112.369 -178.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -104.31 136.17 44.41 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 103.974 -2.602 . . . . 0.0 103.974 175.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.4 p -78.09 157.97 29.32 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 122.017 0.913 . . . . 0.0 112.065 -178.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.1 mm -64.02 -25.43 38.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-O 118.373 -0.823 . . . . 0.0 110.018 178.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -55.83 -38.66 70.32 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 119.739 1.154 . . . . 0.0 109.382 179.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 57.7 m-20 -74.42 -52.96 10.56 Favored 'General case' 0 CA--C 1.521 -0.14 0 C-N-CA 124.723 1.209 . . . . 0.0 109.552 178.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 24.8 t -54.23 -42.65 57.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 123.036 0.534 . . . . 0.0 111.348 -179.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -74.95 -14.54 60.64 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.653 0.781 . . . . 0.0 111.421 -178.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.19 -45.65 8.95 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.397 1.079 . . . . 0.0 108.602 177.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.5 mttm -52.64 -39.92 62.25 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 124.715 1.206 . . . . 0.0 111.446 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 32.2 pt -60.53 -29.01 43.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-N 118.445 0.566 . . . . 0.0 111.08 178.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -76.91 -23.43 52.52 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 119.445 1.02 . . . . 0.0 109.983 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.54 -24.31 45.76 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 177.247 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.6 mmtt -93.56 -20.35 20.32 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -150.83 161.76 42.06 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 120.796 1.634 . . . . 0.0 109.526 -178.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -80.95 77.29 2.04 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 124.225 0.917 . . . . 0.0 111.957 -179.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.1 pt -135.41 108.51 10.25 Favored Pre-proline 0 CA--C 1.546 0.805 0 CA-C-N 118.245 1.023 . . . . 0.0 111.759 -179.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -65.22 166.69 18.29 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 123.151 2.567 . . . . 0.0 110.465 178.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -88.23 56.64 2.57 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.408 2.072 . . . . 0.0 107.813 179.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -145.91 136.01 23.71 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 127.909 2.484 . . . . 0.0 105.045 -178.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.0 mm-40 51.14 49.53 20.93 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.83 1.652 . . . . 0.0 109.192 -177.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 23.7 m-80 -148.68 133.75 18.22 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.4 ttm-85 -151.72 137.17 17.69 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 126.967 2.107 . . . . 0.0 105.547 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 28.6 tp -87.27 139.39 30.61 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.603 1.161 . . . . 0.0 108.794 -178.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.4 mm -132.26 145.6 34.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 126.05 1.74 . . . . 0.0 108.475 -178.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -133.4 119.22 19.36 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 178.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.05 39.88 24.25 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.355 1.062 . . . . 0.0 110.451 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.48 -16.59 17.82 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-O 118.506 -1.163 . . . . 0.0 113.905 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.4 ttmt -79.52 128.78 33.8 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 120.519 2.16 . . . . 0.0 106.661 178.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.1 mp0 -74.55 136.94 42.12 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -179.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.9 mt -122.39 155.84 35.22 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 126.078 1.751 . . . . 0.0 109.978 -179.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -151.99 176.38 11.55 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.922 1.289 . . . . 0.0 109.162 178.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -72.6 160.9 31.5 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 126.082 1.753 . . . . 0.0 110.959 -178.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.84 -26.08 24.41 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 125.06 1.314 . . . . 0.0 110.098 -178.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 30.3 mtt180 -106.55 170.34 7.99 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 118.736 1.268 . . . . 0.0 110.165 179.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.1 p -117.49 167.59 11.16 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.51 1.524 . . . . 0.0 110.086 179.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.4 mp -52.88 -41.66 64.56 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 121.5 -0.75 . . . . 0.0 111.087 178.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.4 t -58.33 -44.22 88.6 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.274 1.43 . . . . 0.0 110.608 -179.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -57.94 -46.9 84.35 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.348 0.659 . . . . 0.0 109.884 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -81.72 -4.31 55.95 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -179.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 31.8 t30 56.66 46.37 20.34 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.996 2.118 . . . . 0.0 109.997 -178.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 84.2 mt -86.35 127.22 40.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 N-CA-C 103.782 -2.673 . . . . 0.0 103.782 178.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 94.6 mm-40 -101.74 173.21 6.51 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 122.918 0.487 . . . . 0.0 110.851 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.1 pttt -64.71 157.25 27.9 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 51.6 39.08 24.18 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 125.562 1.545 . . . . 0.0 111.231 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.1 p -87.34 163.44 16.81 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 120.87 -1.144 . . . . 0.0 108.263 177.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 33.0 m -126.4 105.98 9.17 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.4 mp -97.09 160.25 14.45 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.655 1.582 . . . . 0.0 108.805 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 4.2 m80 -120.01 157.63 28.47 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 125.36 1.464 . . . . 0.0 108.194 178.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.1 mt -122.99 123.47 40.96 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 105.223 -2.139 . . . . 0.0 105.223 178.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.5 m -141.8 172.43 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-N 120.11 1.323 . . . . 0.0 113.582 -179.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.343 0.301 0 C-N-CA 124.718 1.207 . . . . 0.0 111.071 178.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.3 ttt . . . . . 0 N--CA 1.469 0.502 0 N-CA-C 110.606 -0.146 . . . . 0.0 110.606 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -120.71 156.96 30.68 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 177.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.4 pt -132.51 169.46 21.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 178.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -122.58 150.03 43.16 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 124.867 1.267 . . . . 0.0 108.239 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.8 t -139.17 125.24 23.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 O-C-N 121.788 -0.57 . . . . 0.0 109.585 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -91.0 111.27 22.65 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 178.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.5 p -83.15 160.61 21.81 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.655 0.661 . . . . 0.0 110.397 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -67.52 -2.72 6.97 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.407 1.083 . . . . 0.0 112.744 179.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.9 p -91.3 -12.62 34.56 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 125.264 1.426 . . . . 0.0 110.039 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.64 7.46 57.84 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.3 mmmm -97.07 165.1 12.23 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 118.006 0.903 . . . . 0.0 109.078 179.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.46 132.81 53.5 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 103.911 -2.626 . . . . 0.0 103.911 178.027 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.0 mm -114.56 153.26 16.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 -178.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 89.8 m -124.77 130.11 51.76 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 104.395 -2.446 . . . . 0.0 104.395 178.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 75.1 mt -138.8 151.2 46.85 Favored 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 124.226 1.01 . . . . 0.0 111.04 -179.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -97.59 118.7 34.69 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 127.22 2.208 . . . . 0.0 107.17 179.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 23.0 m -134.36 -174.94 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.005 0.922 . . . . 0.0 110.094 -179.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -147.68 159.14 41.82 Favored Pre-proline 0 C--O 1.234 0.278 0 C-N-CA 124.231 1.012 . . . . 0.0 109.469 178.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -53.37 -23.35 23.72 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 123.349 2.699 . . . . 0.0 115.005 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 42.2 m -115.62 30.83 7.1 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -178.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -94.91 135.47 36.38 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 176.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.3 p -71.44 158.86 35.54 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 119.558 1.072 . . . . 0.0 112.686 -178.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.7 mm -63.78 -28.89 45.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 O-C-N 121.475 -0.766 . . . . 0.0 109.018 178.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -61.08 -49.83 75.73 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -61.08 -52.48 64.73 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 124.134 0.973 . . . . 0.0 109.635 179.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.0 t -56.53 -38.55 57.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 124.165 0.986 . . . . 0.0 111.421 -179.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.4 ttpt -80.59 -12.51 59.5 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 118.361 -0.828 . . . . 0.0 111.473 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.6 -43.01 11.07 Favored 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 125.211 1.404 . . . . 0.0 109.213 178.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.6 mttm -51.89 -39.71 59.48 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 121.423 -0.798 . . . . 0.0 111.723 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.1 pt -65.0 -25.01 36.7 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 O-C-N 121.679 -0.638 . . . . 0.0 111.683 178.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -76.15 -20.67 57.36 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.916 1.234 . . . . 0.0 108.911 -179.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.45 -38.92 40.06 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 120.936 -1.103 . . . . 0.0 108.234 177.267 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 51.4 mttm -86.95 -21.81 25.99 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 -178.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -140.29 150.16 43.7 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 121.266 1.848 . . . . 0.0 106.406 178.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.75 82.96 1.55 Allowed Glycine 0 N--CA 1.451 -0.323 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.8 pt -134.94 108.72 10.66 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 125.533 1.533 . . . . 0.0 106.865 179.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -82.87 170.23 12.68 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 124.532 3.488 . . . . 0.0 112.129 -179.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -74.9 55.39 3.88 Favored 'Trans proline' 0 CA--C 1.553 1.439 0 C-N-CA 123.056 2.504 . . . . 0.0 111.089 178.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -150.01 127.09 11.23 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 104.475 -2.417 . . . . 0.0 104.475 179.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 71.0 mm-40 54.72 50.81 15.0 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.066 1.346 . . . . 0.0 108.347 -176.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -143.21 132.42 23.2 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 179.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.6 ttm-85 -158.93 133.42 7.94 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 125.362 1.465 . . . . 0.0 107.32 -179.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 21.8 tp -92.92 140.63 29.28 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.057 0.943 . . . . 0.0 112.178 -178.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.0 mm -135.55 146.45 29.86 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 127.21 2.204 . . . . 0.0 108.209 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -137.69 120.57 16.46 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 125.95 1.7 . . . . 0.0 106.797 178.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.38 41.25 16.25 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.299 1.039 . . . . 0.0 111.535 -179.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.8 -17.39 11.3 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.644 1.116 . . . . 0.0 113.95 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.3 ttmt -79.67 128.46 33.43 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 125.389 1.476 . . . . 0.0 108.994 -179.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.6 mp0 -76.15 136.48 39.79 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 124.954 1.302 . . . . 0.0 109.468 -179.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 9.6 mt -121.09 154.23 36.4 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 124.729 1.212 . . . . 0.0 109.646 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -151.68 175.99 11.83 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 123.518 0.727 . . . . 0.0 109.471 179.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -72.35 160.04 33.02 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.726 1.61 . . . . 0.0 111.229 -178.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.21 -29.22 12.96 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 126.415 1.959 . . . . 0.0 110.856 -178.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 51.7 mtt180 -107.94 174.48 5.86 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 119.305 1.552 . . . . 0.0 112.813 179.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 50.3 p -117.55 175.67 5.53 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.984 1.714 . . . . 0.0 114.253 -177.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.17 -49.35 63.98 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.964 1.306 . . . . 0.0 112.253 179.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.37 -33.59 76.32 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 118.386 -0.816 . . . . 0.0 111.829 -179.03 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -59.59 -47.22 86.42 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.77 1.168 . . . . 0.0 108.658 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -82.05 1.64 34.87 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.171 0.988 . . . . 0.0 112.673 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.0 t30 54.3 46.77 24.46 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 126.873 2.069 . . . . 0.0 112.56 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 74.8 mt -89.25 122.99 41.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 104.148 -2.538 . . . . 0.0 104.148 178.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -101.88 177.56 4.86 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 123.163 0.585 . . . . 0.0 110.627 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -64.21 155.27 32.34 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-O 121.618 0.723 . . . . 0.0 112.315 -178.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 47.59 35.39 4.32 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 127.985 2.514 . . . . 0.0 112.454 -179.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.1 p -80.6 163.79 23.39 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.224 1.009 . . . . 0.0 109.316 178.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 43.9 m -126.22 111.08 14.17 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.6 mp -96.69 161.65 13.79 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.387 1.075 . . . . 0.0 109.469 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.4 m80 -119.2 153.45 34.92 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 125.284 1.433 . . . . 0.0 109.823 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.7 mt -122.58 126.76 48.39 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 126.35 1.86 . . . . 0.0 106.477 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.4 m -138.22 169.74 17.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -179.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.7 pt? . . . . . 0 N--CA 1.467 0.399 0 C-N-CA 126.846 2.058 . . . . 0.0 109.094 178.105 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 ttt . . . . . 0 CA--C 1.507 -0.711 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -121.18 156.81 31.58 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 177.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.4 pt -132.1 168.21 24.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 178.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -116.29 150.7 37.21 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 124.865 1.266 . . . . 0.0 107.999 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.2 t -137.96 125.31 29.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 178.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -91.21 117.33 29.55 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 178.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.9 p -72.53 165.3 24.93 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 179.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -67.42 -9.31 40.47 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.115 0.566 . . . . 0.0 112.077 178.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.3 p -102.64 -12.48 17.68 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 127.527 2.331 . . . . 0.0 113.024 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.03 6.5 42.59 Favored Glycine 0 C--N 1.335 0.518 0 CA-C-O 118.279 -1.29 . . . . 0.0 114.973 178.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.6 mmmm -81.22 163.52 22.96 Favored 'General case' 0 C--N 1.343 0.295 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 178.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.6 m -124.55 131.48 53.48 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 103.724 -2.695 . . . . 0.0 103.724 177.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.5 mm -105.49 157.38 6.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 -179.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 69.8 m -130.29 122.55 28.19 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 129.428 3.091 . . . . 0.0 103.229 178.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 72.4 mt -138.3 146.16 42.09 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.353 1.061 . . . . 0.0 110.037 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -95.71 117.46 30.56 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.47 1.508 . . . . 0.0 108.07 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.5 m -129.03 -168.97 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.431 0 C-N-CA 125.623 1.569 . . . . 0.0 109.456 -178.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -150.38 161.89 29.23 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 125.24 1.416 . . . . 0.0 107.702 178.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -59.48 -18.7 48.0 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.523 2.149 . . . . 0.0 114.34 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.2 m -114.72 30.48 7.3 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 118.753 0.706 . . . . 0.0 111.498 -178.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -92.96 129.59 38.83 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.9 p -77.88 158.25 29.51 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 119.918 1.235 . . . . 0.0 111.592 -178.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.1 mm -63.42 -29.88 48.38 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.316 0 CA-C-O 117.933 -1.032 . . . . 0.0 109.979 178.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -59.94 -40.45 88.98 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.916 1.234 . . . . 0.0 110.299 -179.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -67.42 -53.08 32.22 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.7 t -57.07 -40.09 70.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 123.045 0.538 . . . . 0.0 110.95 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt -75.34 -16.0 60.44 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.654 1.182 . . . . 0.0 111.798 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.86 -46.03 8.84 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 177.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.5 mttm -52.03 -40.05 60.47 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 124.713 1.205 . . . . 0.0 111.498 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 34.1 pt -63.61 -27.05 42.16 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-N 118.925 0.784 . . . . 0.0 111.279 178.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -77.02 -22.74 52.6 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 119.603 1.092 . . . . 0.0 109.548 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.84 -39.29 61.7 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 177.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 51.1 mttm -87.36 -22.52 25.02 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 115.281 1.586 . . . . 0.0 115.281 -178.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -138.68 150.9 46.7 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 120.633 1.56 . . . . 0.0 107.804 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.6 89.3 1.41 Allowed Glycine 0 C--N 1.334 0.426 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 -179.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.0 pt -141.49 107.61 6.06 Favored Pre-proline 0 CA--C 1.543 0.685 0 CA-C-N 118.11 0.955 . . . . 0.0 110.777 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -64.7 168.15 13.94 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 123.057 2.505 . . . . 0.0 110.858 178.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -84.1 55.46 4.68 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 122.251 1.967 . . . . 0.0 108.49 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -146.56 136.03 22.94 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 130.516 3.526 . . . . 0.0 104.456 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 66.5 mm-40 51.24 47.52 24.7 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.26 1.824 . . . . 0.0 109.594 -178.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -154.86 132.47 11.31 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 179.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 51.8 ttm-85 -157.52 135.13 10.58 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 103.533 -2.766 . . . . 0.0 103.533 179.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 15.5 tp -87.92 141.91 28.21 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -178.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.3 mm -134.41 141.52 43.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 125.923 1.689 . . . . 0.0 108.1 -178.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -139.39 125.86 20.39 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.29 33.32 15.32 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.528 0.68 . . . . 0.0 111.919 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.97 -13.19 32.63 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 124.461 1.029 . . . . 0.0 112.511 -179.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.5 tpmt? -78.58 123.11 26.75 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 -179.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -75.91 136.29 40.1 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.5 mt -115.17 154.76 28.41 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 123.867 0.867 . . . . 0.0 109.462 -178.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -158.98 179.52 8.99 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 126.302 1.841 . . . . 0.0 107.46 178.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.22 160.95 31.91 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.914 1.285 . . . . 0.0 112.458 -176.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.43 -27.13 21.87 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 113.784 -1.553 . . . . 0.0 111.303 -179.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 44.8 mtt180 -106.6 168.06 9.43 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 119.033 1.417 . . . . 0.0 111.074 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.1 p -117.81 173.1 6.94 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.599 1.559 . . . . 0.0 113.181 -178.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.44 -48.95 65.49 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.151 0.98 . . . . 0.0 111.657 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.4 -32.48 74.11 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 118.474 0.579 . . . . 0.0 111.493 -179.436 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -63.79 -45.68 88.6 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 119.498 1.044 . . . . 0.0 108.774 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -82.16 2.08 33.26 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.683 -0.636 . . . . 0.0 111.69 179.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 54.47 47.12 23.51 Favored 'General case' 0 C--N 1.342 0.277 0 C-N-CA 128.041 2.536 . . . . 0.0 111.193 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 74.2 mt -89.99 122.27 41.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 103.553 -2.758 . . . . 0.0 103.553 178.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 94.2 mm-40 -98.57 177.48 5.31 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 40.8 pttt -64.51 156.05 30.94 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -179.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.255 5.4 mp0 45.65 44.38 10.24 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.935 2.094 . . . . 0.0 113.597 179.486 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.8 p -87.94 164.85 15.62 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.619 1.968 . . . . 0.0 109.508 177.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.2 m -126.51 107.3 10.12 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 119.437 1.017 . . . . 0.0 108.755 178.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.1 mp -96.44 163.18 13.16 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.788 1.635 . . . . 0.0 110.547 -178.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 16.1 m80 -119.26 161.0 21.14 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.133 1.373 . . . . 0.0 111.815 178.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 39.9 mt -123.29 128.85 50.52 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.897 1.679 . . . . 0.0 107.855 178.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.1 m -140.66 162.74 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-N 118.868 0.758 . . . . 0.0 112.253 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.463 0.198 0 C-N-CA 126.394 1.878 . . . . 0.0 109.51 178.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.6 ttt . . . . . 0 N--CA 1.469 0.516 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -121.83 154.23 37.3 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 175.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 32.8 pt -132.55 169.72 21.38 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 177.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -123.49 150.07 44.37 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.9 t -138.21 125.23 27.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 178.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.9 tppp? -91.42 117.47 29.71 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 104.624 -2.361 . . . . 0.0 104.624 178.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.0 p -72.8 168.99 17.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 118.456 0.571 . . . . 0.0 110.277 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -66.87 -12.59 59.79 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 121.11 -0.236 . . . . 0.0 111.044 178.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.7 p -93.74 -12.4 29.27 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.572 1.949 . . . . 0.0 112.023 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.8 7.28 55.63 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-O 118.801 -1.0 . . . . 0.0 113.49 178.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -79.88 164.01 23.9 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-N 119.484 1.642 . . . . 0.0 106.992 179.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.1 m -114.7 130.43 56.82 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 103.289 -2.856 . . . . 0.0 103.289 178.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.8 mm -115.55 154.08 17.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 105.602 -1.999 . . . . 0.0 105.602 179.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.2 m -134.96 125.3 26.36 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 126.924 2.09 . . . . 0.0 105.395 179.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 82.1 mt -140.13 151.05 44.99 Favored 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 124.543 1.137 . . . . 0.0 109.851 -179.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -94.84 118.33 31.59 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 105.504 -2.036 . . . . 0.0 105.504 178.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.6 m -129.82 -174.2 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 124.523 1.129 . . . . 0.0 108.824 -179.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -149.71 168.35 11.18 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 124.404 1.082 . . . . 0.0 108.574 -179.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -59.54 -21.24 61.16 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.473 2.115 . . . . 0.0 113.48 178.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.3 m -114.85 31.78 6.45 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 118.463 0.574 . . . . 0.0 111.857 -178.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -91.69 128.21 37.44 Favored 'General case' 0 C--O 1.242 0.711 1 N-CA-C 99.671 -4.196 . . . . 0.0 99.671 177.194 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.1 p -76.72 158.59 30.85 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -179.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.8 mm -63.49 -27.31 42.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 119.254 -0.978 . . . . 0.0 109.388 178.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -61.58 -37.84 85.34 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.885 1.221 . . . . 0.0 109.017 178.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.0 m-80 -69.24 -52.93 22.8 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 178.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 25.8 t -55.73 -38.53 51.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-N 119.049 0.84 . . . . 0.0 110.93 179.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.1 ttpt -75.08 -18.18 60.33 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.327 1.051 . . . . 0.0 111.686 -179.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.01 -46.83 8.24 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 126.767 2.027 . . . . 0.0 109.187 178.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -51.5 -40.68 60.03 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.407 1.483 . . . . 0.0 110.831 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 31.6 pt -64.79 -25.21 37.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 O-C-N 121.138 -0.976 . . . . 0.0 111.879 179.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -76.85 -23.37 52.69 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 120.671 -1.268 . . . . 0.0 109.626 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.78 -24.57 55.99 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 176.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.2 mttm -100.74 -15.29 17.73 Favored 'General case' 0 C--N 1.341 0.203 0 N-CA-C 116.236 1.939 . . . . 0.0 116.236 -179.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -145.55 158.56 43.83 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 120.918 1.69 . . . . 0.0 108.111 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.14 68.64 3.4 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.6 pt -131.6 108.57 14.5 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 118.131 0.966 . . . . 0.0 110.507 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -75.18 169.58 22.22 Favored 'Trans proline' 0 CA--C 1.544 0.992 0 C-N-CA 123.172 2.581 . . . . 0.0 109.372 178.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -78.69 56.62 6.01 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.374 2.049 . . . . 0.0 110.665 179.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -146.78 135.93 22.58 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 129.218 3.007 . . . . 0.0 106.939 -179.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 68.9 mm-40 52.73 47.91 23.65 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 127.928 2.491 . . . . 0.0 109.524 -178.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 25.9 m-80 -153.0 136.44 15.87 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 121.785 -0.572 . . . . 0.0 109.754 179.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 54.4 ttm-85 -151.92 134.91 15.72 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 126.558 1.943 . . . . 0.0 105.891 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 19.6 tp -87.74 140.83 29.11 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 124.09 0.956 . . . . 0.0 109.484 -178.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.2 mm -132.7 144.7 35.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 125.655 1.582 . . . . 0.0 109.355 -178.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -138.36 121.27 16.58 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 177.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.22 40.59 26.44 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.463 1.105 . . . . 0.0 110.55 -179.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.13 -16.13 18.32 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 125.264 1.412 . . . . 0.0 113.85 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.0 ttmt -79.05 128.93 33.89 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 119.832 1.816 . . . . 0.0 109.014 -179.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.0 mp0 -74.26 134.36 42.65 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.0 mt -117.93 154.98 31.01 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.826 1.25 . . . . 0.0 109.537 -179.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -162.5 176.91 9.96 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 126.803 2.041 . . . . 0.0 107.404 177.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -71.44 161.59 30.8 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.205 1.402 . . . . 0.0 112.285 -178.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 108.43 -28.98 10.56 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 127.386 2.422 . . . . 0.0 108.049 -178.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 46.2 mtt180 -107.62 169.83 8.35 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 124.934 1.294 . . . . 0.0 110.473 178.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 80.8 p -123.84 169.45 11.56 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 127.161 2.184 . . . . 0.0 110.178 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.9 mp -53.01 -42.07 65.29 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 123.064 0.545 . . . . 0.0 111.259 177.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.4 t -59.31 -44.96 92.5 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.595 1.158 . . . . 0.0 109.916 -179.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -58.96 -46.37 88.22 Favored 'General case' 0 C--N 1.341 0.233 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -81.35 1.32 33.31 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -179.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 36.9 t30 54.31 45.91 26.25 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.199 1.799 . . . . 0.0 111.228 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 81.3 mt -87.98 123.4 40.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 87.5 mm-40 -95.1 175.16 6.73 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.43 0.633 . . . . 0.0 111.203 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -70.99 157.11 38.77 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.386 0.674 . . . . 0.0 109.201 178.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 54.1 35.37 22.12 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.441 1.496 . . . . 0.0 110.958 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.9 p -87.2 162.12 17.65 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.529 1.132 . . . . 0.0 109.19 178.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.1 m -124.96 107.93 11.35 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 122.365 1.079 . . . . 0.0 109.539 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.2 mp -96.44 160.46 14.39 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.734 1.214 . . . . 0.0 108.802 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -119.07 160.7 21.57 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.709 1.204 . . . . 0.0 111.745 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 25.6 mt -123.08 124.61 43.49 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.987 1.715 . . . . 0.0 108.16 179.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.9 m -141.1 167.9 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 124.775 1.23 . . . . 0.0 113.174 -179.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.531 0.215 0 C-N-CA 125.262 1.425 . . . . 0.0 110.076 177.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.469 0.481 0 N-CA-C 111.25 0.093 . . . . 0.0 111.25 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -121.48 157.57 30.33 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 176.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.0 pt -132.37 169.96 20.88 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 C-N-CA 125.287 1.435 . . . . 0.0 108.346 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -126.24 149.53 49.02 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 124.925 1.29 . . . . 0.0 107.89 178.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.5 t -139.62 131.48 34.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -97.6 117.78 32.65 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.3 p -83.27 168.79 16.37 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.027 0.931 . . . . 0.0 110.976 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.9 -5.0 22.99 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.582 0.753 . . . . 0.0 112.632 178.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.0 p -93.28 -14.14 27.36 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 177.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.18 7.13 57.45 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 124.903 1.24 . . . . 0.0 111.349 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.82 163.95 23.06 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 119.084 1.442 . . . . 0.0 107.567 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.2 m -120.5 137.42 54.37 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 103.629 -2.73 . . . . 0.0 103.629 178.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.2 mm -114.69 157.02 15.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 38.1 m -134.73 124.26 24.95 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 127.954 2.502 . . . . 0.0 104.343 178.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 29.5 mt -139.93 150.81 45.0 Favored 'General case' 0 CA--C 1.515 -0.373 0 C-N-CA 124.79 1.236 . . . . 0.0 111.589 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -98.25 119.01 36.17 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 127.274 2.23 . . . . 0.0 106.519 178.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.0 m -134.09 -171.19 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 125.949 1.7 . . . . 0.0 108.287 -179.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -142.38 161.17 51.52 Favored Pre-proline 0 CA--C 1.536 0.437 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -61.25 -18.01 56.16 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.442 2.095 . . . . 0.0 112.899 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.8 m -114.96 30.97 6.99 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 124.216 1.007 . . . . 0.0 111.402 -177.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -93.06 130.95 38.49 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 126.277 1.831 . . . . 0.0 106.825 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.3 p -77.15 158.18 30.54 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 119.775 1.171 . . . . 0.0 110.301 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.7 mm -63.61 -30.72 50.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -61.24 -37.36 82.81 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 119.348 0.976 . . . . 0.0 111.554 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -73.46 -53.33 10.89 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 123.94 0.896 . . . . 0.0 108.591 179.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.2 t -55.94 -38.16 51.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 123.035 0.534 . . . . 0.0 110.723 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.8 ttpt -75.14 -16.55 60.52 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 118.172 -0.918 . . . . 0.0 110.952 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.69 -45.38 14.53 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 177.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.6 mttm -50.98 -40.17 57.19 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.953 1.301 . . . . 0.0 112.105 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.3 pt -64.71 -27.29 42.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 O-C-N 120.978 -1.076 . . . . 0.0 111.001 179.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -76.6 -22.81 53.7 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 119.399 0.999 . . . . 0.0 109.162 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.76 -40.17 63.68 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.296 87.1 mttt -92.42 -15.32 27.35 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-O 117.435 -1.269 . . . . 0.0 114.257 -179.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -140.46 150.58 43.98 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 121.881 2.128 . . . . 0.0 106.682 178.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -83.47 87.15 1.5 Allowed Glycine 0 C--N 1.334 0.428 0 CA-C-O 118.977 -0.902 . . . . 0.0 111.782 -178.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.5 pt -137.46 108.22 8.62 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 124.271 1.028 . . . . 0.0 111.45 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -69.83 170.13 17.39 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 124.786 3.657 . . . . 0.0 110.733 178.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -82.39 54.72 5.05 Favored 'Trans proline' 0 CA--C 1.547 1.143 0 N-CA-C 107.827 -1.644 . . . . 0.0 107.827 177.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -150.53 135.91 17.94 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 127.898 2.479 . . . . 0.0 105.519 -178.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 54.7 mm-40 53.03 46.47 26.69 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 128.024 2.53 . . . . 0.0 106.175 -176.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -156.38 135.93 12.37 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.231 1.012 . . . . 0.0 111.919 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.1 ttm-85 -154.93 136.08 13.93 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 127.13 2.172 . . . . 0.0 105.995 178.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 23.7 tp -87.97 137.37 32.39 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.643 0.777 . . . . 0.0 109.481 -178.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.4 mm -135.3 148.57 28.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 125.644 1.578 . . . . 0.0 108.796 -178.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -138.51 121.13 16.26 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 178.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.0 33.52 12.04 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 119.315 0.961 . . . . 0.0 111.353 -179.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.15 -7.79 62.66 Favored Glycine 0 CA--C 1.532 1.099 0 O-C-N 121.298 -0.876 . . . . 0.0 113.123 -179.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.2 tpmt? -78.64 118.11 20.43 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 104.743 -2.317 . . . . 0.0 104.743 179.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.5 mp0 -74.95 133.0 41.82 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.2 mt -114.12 155.47 25.96 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.558 1.143 . . . . 0.0 109.837 -178.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -157.25 174.72 15.02 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.458 1.503 . . . . 0.0 108.161 178.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -73.73 159.8 32.44 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.401 1.48 . . . . 0.0 112.327 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 106.07 -27.53 17.03 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 126.46 1.981 . . . . 0.0 109.526 -178.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 46.0 mtt180 -107.39 169.26 8.69 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 118.124 0.962 . . . . 0.0 110.689 178.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 80.4 p -119.02 168.95 10.33 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 126.268 1.827 . . . . 0.0 110.72 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.8 mp -52.4 -42.89 64.43 Favored 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 123.625 0.77 . . . . 0.0 112.784 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 68.9 m -65.81 -32.63 74.27 Favored 'General case' 0 N--CA 1.462 0.125 0 CA-C-N 118.929 0.786 . . . . 0.0 112.535 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -64.09 -44.38 92.5 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -81.45 1.61 32.42 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.592 1.157 . . . . 0.0 111.519 178.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 55.45 46.73 22.59 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 127.167 2.187 . . . . 0.0 112.326 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 15.0 mt -96.18 123.78 48.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 86.8 mm-40 -101.24 178.25 4.71 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.978 1.311 . . . . 0.0 110.609 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.1 pttt -64.47 156.65 28.9 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 122.87 0.468 . . . . 0.0 111.279 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 48.43 41.06 16.13 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.386 2.274 . . . . 0.0 112.585 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.5 p -87.2 153.79 21.22 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.408 1.083 . . . . 0.0 108.082 177.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 14.4 m -118.72 114.57 22.92 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.5 mp -101.07 168.29 9.69 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.786 1.635 . . . . 0.0 110.861 -178.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.7 m80 -119.96 154.76 34.01 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 127.106 2.162 . . . . 0.0 109.327 178.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 16.7 mt -123.44 125.08 44.29 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 178.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.4 m -139.79 166.15 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 CA-C-N 120.789 1.631 . . . . 0.0 113.436 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -134.2 -170.43 2.52 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 125.983 1.713 . . . . 0.0 110.898 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -152.54 131.59 12.64 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 178.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -145.06 135.01 23.74 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -178.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 44.0 mmm-85 -106.18 -11.51 16.04 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 123.413 0.685 . . . . 0.0 111.651 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -85.68 18.43 30.08 Favored Glycine 0 CA--C 1.537 1.428 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 177.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.954 0 N-CA-C 105.256 -3.138 . . . . 0.0 105.256 -179.348 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.3 ttt . . . . . 0 N--CA 1.473 0.676 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -120.77 158.72 26.92 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 114.668 1.359 . . . . 0.0 114.668 -177.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.9 pp -131.57 168.78 23.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 176.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -126.66 149.79 49.33 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 125.262 1.425 . . . . 0.0 108.106 179.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.8 t -138.68 125.47 25.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -89.99 116.39 28.0 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 103.085 -2.932 . . . . 0.0 103.085 177.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.5 p -72.55 168.75 17.93 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 122.574 1.178 . . . . 0.0 113.294 -178.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -67.75 -12.64 60.98 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 114.648 -1.16 . . . . 0.0 111.094 178.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 65.9 p -102.64 -12.56 17.61 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.771 1.169 . . . . 0.0 110.882 179.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.61 7.31 34.37 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 124.883 1.23 . . . . 0.0 114.89 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.2 mmmm -80.88 165.24 22.0 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 120.069 1.935 . . . . 0.0 108.053 178.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 83.7 m -119.06 130.4 55.6 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 104.233 -2.506 . . . . 0.0 104.233 178.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.0 mm -115.78 154.2 17.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 125.398 1.479 . . . . 0.0 107.775 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.2 m -135.13 128.59 32.43 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 178.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 74.4 mt -139.8 150.47 44.76 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 118.678 0.672 . . . . 0.0 111.05 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -94.32 118.48 31.66 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.231 1.412 . . . . 0.0 107.771 178.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.8 m -134.57 179.23 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 126.581 1.953 . . . . 0.0 108.461 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -147.98 162.69 30.22 Favored Pre-proline 0 CA--C 1.536 0.42 0 O-C-N 120.908 -1.12 . . . . 0.0 109.401 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -51.95 -22.56 14.55 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.773 2.982 . . . . 0.0 115.572 -179.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.6 t -114.6 30.92 6.98 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 119.951 1.251 . . . . 0.0 111.051 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -95.22 129.4 42.36 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 103.759 -2.682 . . . . 0.0 103.759 177.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.6 p -76.74 159.53 30.08 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 118.775 0.716 . . . . 0.0 109.764 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 39.8 mm -58.98 -26.0 31.41 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 CA-C-O 118.611 -0.709 . . . . 0.0 110.084 178.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -64.28 -46.18 84.79 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 125.108 1.363 . . . . 0.0 109.645 178.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.5 m-80 -62.22 -52.51 63.46 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.3 t -57.18 -37.36 55.55 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 122.725 0.41 . . . . 0.0 109.922 178.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.7 ttpt -75.02 -19.84 59.89 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 120.903 -1.123 . . . . 0.0 110.547 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.29 -45.36 26.5 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 104.908 -2.256 . . . . 0.0 104.908 177.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.6 mttm -54.53 -43.29 71.8 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.156 1.382 . . . . 0.0 111.385 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.1 pt -63.81 -28.24 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-N 120.148 1.34 . . . . 0.0 110.456 178.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -76.16 -22.64 55.16 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 119.926 1.239 . . . . 0.0 110.897 -179.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.27 -23.24 51.2 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 177.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -99.56 -23.96 14.91 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 114.387 1.255 . . . . 0.0 114.387 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -152.37 149.54 28.73 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 178.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -88.78 87.15 1.47 Allowed Glycine 0 CA--C 1.519 0.296 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.2 pt -132.23 107.4 13.54 Favored Pre-proline 0 CA--C 1.539 0.548 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.23 156.86 15.45 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.062 2.508 . . . . 0.0 113.315 -179.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -83.31 55.96 5.25 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.572 2.181 . . . . 0.0 107.763 178.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -156.6 137.53 13.49 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 128.585 2.754 . . . . 0.0 106.165 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 50.56 45.27 26.84 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 127.405 2.282 . . . . 0.0 108.228 -178.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -157.75 135.46 10.59 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 129.042 2.937 . . . . 0.0 106.212 178.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.7 ttm105 -151.66 141.06 21.52 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 121.424 1.92 . . . . 0.0 106.539 177.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -88.25 140.19 29.73 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 124.393 1.077 . . . . 0.0 109.48 -178.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.9 mm -135.49 146.41 29.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 125.275 1.43 . . . . 0.0 108.887 -179.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -135.82 115.09 12.48 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 125.005 1.322 . . . . 0.0 108.679 178.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.88 41.25 14.23 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.281 1.432 . . . . 0.0 111.771 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.17 -14.95 52.02 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 125.696 1.617 . . . . 0.0 113.959 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.6 tpmt? -79.69 124.82 28.91 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -74.44 137.06 42.38 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 178.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.6 mt -114.01 142.21 46.45 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -152.8 176.28 11.97 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.661 1.984 . . . . 0.0 107.86 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -72.57 159.81 33.3 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 125.457 1.503 . . . . 0.0 111.089 -178.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 105.99 -29.14 11.68 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 127.769 2.604 . . . . 0.0 110.618 -178.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.343 34.3 mtm105 -109.91 168.41 9.44 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 60.9 p -120.49 171.31 8.63 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 126.702 2.001 . . . . 0.0 111.504 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.2 mp -51.26 -41.5 60.43 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 124.358 1.063 . . . . 0.0 111.674 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 11.4 t -59.17 -45.78 90.12 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.418 1.487 . . . . 0.0 110.422 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -62.21 -44.51 96.4 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.969 0.908 . . . . 0.0 110.615 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -82.16 -2.04 50.89 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.926 0.891 . . . . 0.0 112.833 -179.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 40.8 t30 53.7 46.34 26.12 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 126.237 1.815 . . . . 0.0 110.631 -179.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 93.2 mt -85.02 123.23 39.05 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.153 0 N-CA-C 104.6 -2.37 . . . . 0.0 104.6 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 92.8 mm-40 -89.27 166.79 13.55 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.606 -178.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 46.6 pttt -64.44 155.39 32.77 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.007 178.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 45.33 34.67 1.56 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 128.338 2.655 . . . . 0.0 112.179 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 51.6 m -77.3 160.57 28.75 Favored 'General case' 0 N--CA 1.462 0.174 0 O-C-N 120.908 -1.12 . . . . 0.0 111.42 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.9 m -115.15 113.66 24.27 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.5 mp -108.68 163.51 13.19 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.72 1.608 . . . . 0.0 109.763 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -119.39 162.33 18.99 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.605 1.162 . . . . 0.0 112.131 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.2 mt -121.42 129.91 53.28 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 126.434 1.894 . . . . 0.0 106.37 178.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.4 m -135.42 173.06 14.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 C-N-CA 125.0 1.32 . . . . 0.0 108.695 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.4 pp -141.46 -172.09 3.45 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.69 0.796 . . . . 0.0 110.271 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.18 142.08 12.84 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 128.087 2.555 . . . . 0.0 104.174 178.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.4 mt -137.56 121.8 18.07 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 119.803 1.183 . . . . 0.0 109.553 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.264 18.3 mmm-85 -109.34 -0.08 19.24 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 127.19 2.196 . . . . 0.0 112.396 177.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -78.84 37.43 1.91 Allowed Glycine 0 CA--C 1.528 0.871 0 O-C-N 120.636 -1.29 . . . . 0.0 114.526 -177.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.018 0 C-N-CA 126.539 2.019 . . . . 0.0 108.933 179.547 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.9 ttt . . . . . 0 CA--C 1.514 -0.431 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -120.6 156.95 30.56 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.2 pt -132.85 169.8 21.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.553 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 177.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -124.9 152.45 44.05 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 125.799 1.64 . . . . 0.0 108.23 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.4 t -138.33 125.13 26.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 178.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -90.64 116.25 28.38 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 104.035 -2.58 . . . . 0.0 104.035 178.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 44.1 p -72.42 166.81 21.83 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.317 0.579 . . . . 0.0 110.291 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -67.48 -12.08 59.44 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.199 178.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.7 p -96.78 -12.71 23.31 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 127.693 2.397 . . . . 0.0 112.273 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.57 6.43 56.41 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 125.895 1.712 . . . . 0.0 114.074 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -82.99 165.47 19.63 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-N 118.954 1.377 . . . . 0.0 107.322 178.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 43.6 m -123.07 132.43 54.1 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.7 mm -107.17 155.47 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 179.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.1 m -132.86 130.38 39.68 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 103.76 -2.682 . . . . 0.0 103.76 178.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 76.1 mt -139.6 150.52 45.09 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -100.56 118.49 36.84 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 104.189 -2.523 . . . . 0.0 104.189 178.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.6 m -131.89 -170.74 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 125.036 1.334 . . . . 0.0 109.937 -178.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -147.34 159.29 42.41 Favored Pre-proline 0 CA--C 1.534 0.345 0 O-C-N 121.007 -1.058 . . . . 0.0 109.972 178.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -56.8 -23.58 51.08 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.971 2.447 . . . . 0.0 114.856 -179.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 43.5 m -115.24 32.59 5.95 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.676 0.79 . . . . 0.0 111.124 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -92.83 129.63 38.69 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 104.125 -2.546 . . . . 0.0 104.125 178.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.1 p -77.18 159.5 29.67 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 119.777 1.171 . . . . 0.0 111.833 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.1 mm -63.59 -30.73 50.62 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -56.39 -39.52 73.12 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.823 0.849 . . . . 0.0 110.551 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -74.79 -55.53 5.74 Favored 'General case' 0 C--O 1.224 -0.275 0 C-N-CA 123.486 0.714 . . . . 0.0 109.339 178.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.6 t -54.02 -46.18 65.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 124.819 1.248 . . . . 0.0 113.068 -177.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -75.0 -15.64 60.65 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.612 0.765 . . . . 0.0 111.137 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.59 -41.63 11.87 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 177.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.0 mttm -53.77 -40.56 66.35 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.231 1.012 . . . . 0.0 110.573 179.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 29.2 pt -60.45 -27.22 39.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-O 118.128 -0.939 . . . . 0.0 111.16 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -80.43 -20.17 44.5 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.099 1.36 . . . . 0.0 111.087 179.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -88.46 -24.3 23.03 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.974 1.31 . . . . 0.0 109.11 178.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 32.7 tptt -99.0 -20.54 16.7 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.122 1.769 . . . . 0.0 112.389 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -144.37 150.28 37.51 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.838 2.055 . . . . 0.0 106.174 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -82.28 82.37 1.63 Allowed Glycine 0 C--N 1.333 0.374 0 CA-C-O 118.793 -1.004 . . . . 0.0 111.784 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.7 pt -131.18 108.29 15.0 Favored Pre-proline 0 CA--C 1.546 0.796 0 CA-C-N 118.413 1.107 . . . . 0.0 109.866 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -58.66 155.96 34.55 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.98 3.12 . . . . 0.0 114.001 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -86.2 57.17 3.95 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 123.469 2.779 . . . . 0.0 106.624 177.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -146.15 136.68 24.05 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 129.471 3.109 . . . . 0.0 103.726 -178.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.4 pt20 48.01 50.92 15.28 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.468 1.507 . . . . 0.0 112.29 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -145.41 148.71 33.63 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 121.052 -1.03 . . . . 0.0 110.371 179.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -154.59 135.04 13.37 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 125.14 1.376 . . . . 0.0 109.514 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 54.9 tp -89.08 136.55 32.95 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 125.106 1.362 . . . . 0.0 110.178 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.3 mm -133.92 145.88 32.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 125.24 1.416 . . . . 0.0 111.08 -178.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -138.92 126.47 21.84 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 176.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.58 34.76 16.36 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.708 1.203 . . . . 0.0 111.719 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.32 -8.02 59.35 Favored Glycine 0 CA--C 1.531 1.033 0 O-C-N 120.919 -1.113 . . . . 0.0 114.203 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.2 mmtp -92.17 130.37 37.9 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 125.864 1.666 . . . . 0.0 109.169 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -73.68 136.37 43.78 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.794 0.838 . . . . 0.0 108.868 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.9 mt -115.19 150.43 36.11 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 179.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -152.09 176.31 11.67 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -72.18 156.23 39.38 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 122.112 0.958 . . . . 0.0 110.555 -178.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.98 -21.14 30.06 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 126.416 1.96 . . . . 0.0 109.855 -178.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 40.3 mmt-85 -107.12 169.38 8.59 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.364 1.466 . . . . 0.0 111.948 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.9 p -123.65 167.59 13.77 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.905 1.682 . . . . 0.0 111.327 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -52.41 -47.22 66.41 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.158 0.983 . . . . 0.0 112.39 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.2 t -65.26 -31.43 72.57 Favored 'General case' 0 C--O 1.227 -0.115 0 C-N-CA 123.77 0.828 . . . . 0.0 112.763 -179.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -59.6 -47.36 85.87 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 119.996 1.271 . . . . 0.0 109.271 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -82.09 0.69 39.44 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.22 0.608 . . . . 0.0 110.236 178.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.5 t30 53.96 47.49 23.32 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 127.639 2.376 . . . . 0.0 110.646 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.5 mt -85.26 122.5 38.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 104.318 -2.475 . . . . 0.0 104.318 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -92.83 175.35 6.83 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.289 0.566 . . . . 0.0 110.189 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.8 pttt -64.71 156.76 29.36 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.293 0.568 . . . . 0.0 110.295 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 52.72 35.34 18.21 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 128.252 2.621 . . . . 0.0 111.608 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 72.3 m -85.82 158.22 20.03 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 120.848 -1.157 . . . . 0.0 109.467 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 28.3 m -119.16 120.35 36.83 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.612 1.165 . . . . 0.0 110.246 -178.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.2 mp -107.36 162.69 13.69 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.865 1.666 . . . . 0.0 110.722 -179.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -119.91 160.59 22.41 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 126.008 1.723 . . . . 0.0 111.616 179.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 90.4 mt -123.64 131.9 53.73 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.427 1.491 . . . . 0.0 110.257 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.4 m -140.5 161.7 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-N 119.63 1.104 . . . . 0.0 111.19 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -143.7 -172.04 3.65 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 178.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.1 mmt-85 -159.93 127.98 4.79 Favored 'General case' 0 C--N 1.344 0.335 0 C-N-CA 125.362 1.465 . . . . 0.0 109.064 176.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 12.6 mt -157.02 142.07 17.1 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 127.824 2.449 . . . . 0.0 107.493 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -107.42 -28.14 10.02 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 118.77 0.714 . . . . 0.0 111.208 177.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -93.52 18.93 55.4 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 125.367 1.46 . . . . 0.0 110.897 178.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.189 0 C-N-CA 128.366 2.888 . . . . 0.0 106.422 -179.836 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.5 ttt . . . . . 0 CA--C 1.509 -0.618 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -119.29 145.64 45.95 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 124.279 0.987 . . . . 0.0 109.734 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.2 pt -134.17 169.7 21.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 C-N-CA 125.288 1.435 . . . . 0.0 108.077 177.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -124.47 149.91 46.31 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.882 1.673 . . . . 0.0 110.47 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.6 t -139.77 131.57 33.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 177.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -97.58 117.14 31.18 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 105.426 -2.065 . . . . 0.0 105.426 177.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 41.6 p -74.29 165.85 24.47 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 118.522 0.601 . . . . 0.0 111.067 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -67.63 -10.54 53.08 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.32 178.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 77.2 p -91.71 -12.46 33.97 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.569 1.547 . . . . 0.0 110.66 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.1 5.88 57.09 Favored Glycine 0 C--N 1.34 0.791 0 C-N-CA 126.177 1.846 . . . . 0.0 112.9 179.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.8 164.04 23.01 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 119.151 1.475 . . . . 0.0 107.801 179.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 50.1 m -114.08 133.57 55.45 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 102.599 -3.111 . . . . 0.0 102.599 177.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 40.1 mm -114.57 157.87 15.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 C-N-CA 125.849 1.66 . . . . 0.0 107.837 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.6 m -131.36 130.8 43.11 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 128.823 2.849 . . . . 0.0 104.886 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.8 mt -140.17 144.47 36.65 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 124.018 0.927 . . . . 0.0 110.349 179.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -105.26 110.5 22.89 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 127.382 2.273 . . . . 0.0 105.621 177.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.1 m -134.34 -169.16 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -141.8 160.6 55.4 Favored Pre-proline 0 C--O 1.238 0.459 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -56.43 -18.55 25.51 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.734 2.29 . . . . 0.0 113.386 178.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 39.1 m -115.66 30.43 7.35 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 119.023 0.828 . . . . 0.0 112.991 -178.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -94.74 134.17 37.63 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 104.993 -2.225 . . . . 0.0 104.993 177.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.1 p -73.54 157.55 36.51 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 119.07 -1.052 . . . . 0.0 109.204 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.2 mm -64.1 -26.29 40.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 177.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -56.58 -42.06 78.0 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.82 1.248 . . . . 0.0 109.647 179.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -74.14 -54.93 6.75 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 123.786 0.834 . . . . 0.0 109.73 178.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.7 t -54.32 -40.03 46.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -178.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -75.68 -16.28 60.2 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.395 0.678 . . . . 0.0 111.015 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.58 -41.73 11.82 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.395 1.078 . . . . 0.0 109.142 178.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.0 mttm -53.17 -40.46 64.36 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 118.727 0.694 . . . . 0.0 110.129 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.3 pt -62.3 -26.88 41.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 O-C-N 120.703 -1.248 . . . . 0.0 111.665 179.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -76.53 -20.11 57.23 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.344 1.058 . . . . 0.0 109.575 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.18 -39.43 40.82 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 177.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.3 mttm -88.59 -16.25 33.01 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 -178.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -141.41 150.54 42.48 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 179.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -87.08 85.65 1.54 Allowed Glycine 0 CA--C 1.52 0.392 0 O-C-N 121.419 -0.801 . . . . 0.0 111.987 -178.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.0 pt -134.18 107.97 11.38 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 124.608 1.163 . . . . 0.0 108.149 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -69.29 168.46 20.87 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 124.197 3.265 . . . . 0.0 113.755 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -82.35 56.83 5.91 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 122.975 2.45 . . . . 0.0 108.427 177.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -154.1 136.57 15.04 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 129.695 3.198 . . . . 0.0 103.713 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 62.4 mm-40 53.76 50.17 17.61 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.441 1.096 . . . . 0.0 108.333 -178.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -142.0 134.43 28.02 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -178.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 47.5 ttm-85 -159.56 132.27 6.74 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 30.6 tp -99.4 137.25 38.16 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 124.218 1.007 . . . . 0.0 109.47 -178.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.5 mm -135.06 141.9 41.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.235 1.014 . . . . 0.0 109.305 -178.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -138.99 126.1 21.26 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.02 33.22 14.35 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.027 0.531 . . . . 0.0 110.674 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.42 -16.21 19.58 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 124.74 1.162 . . . . 0.0 112.73 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -79.35 126.52 30.92 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 119.33 1.565 . . . . 0.0 108.133 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.7 mp0 -75.61 137.12 40.55 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.102 -1.074 . . . . 0.0 108.102 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.6 mt -114.26 154.64 27.59 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.716 1.207 . . . . 0.0 108.794 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -162.47 175.25 11.69 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 179.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -72.76 160.96 31.35 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 126.879 2.072 . . . . 0.0 114.078 -177.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.47 -29.39 12.0 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 127.578 2.513 . . . . 0.0 109.081 -178.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 50.0 mtt180 -107.95 169.01 8.88 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 117.979 0.89 . . . . 0.0 110.961 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 37.5 p -117.5 171.58 7.91 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.488 1.115 . . . . 0.0 112.033 -178.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.7 mp -52.2 -41.77 62.97 Favored 'General case' 0 C--O 1.227 -0.128 0 C-N-CA 123.572 0.749 . . . . 0.0 111.157 178.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.1 t -59.21 -46.0 89.62 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.559 1.544 . . . . 0.0 109.983 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -64.2 -39.66 94.45 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 123.533 0.733 . . . . 0.0 110.152 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -84.68 -0.69 54.44 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.54 0.736 . . . . 0.0 111.487 179.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 61.3 t30 53.85 46.12 26.38 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.887 2.075 . . . . 0.0 112.383 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 84.6 mt -93.7 126.09 46.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 -179.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -100.48 172.68 6.97 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 123.963 0.905 . . . . 0.0 111.19 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 49.2 pttt -66.62 156.77 34.22 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 54.92 35.58 24.78 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.511 1.524 . . . . 0.0 111.778 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.0 p -86.79 158.53 19.35 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 120.323 -1.486 . . . . 0.0 107.485 177.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 26.7 m -126.12 119.91 28.79 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 178.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.7 mp -106.06 169.53 8.44 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.252 1.021 . . . . 0.0 110.873 -179.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 21.4 m80 -118.54 153.07 34.82 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.865 1.666 . . . . 0.0 108.694 178.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 17.9 mt -123.03 126.47 47.17 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.866 1.666 . . . . 0.0 106.72 178.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.1 m -139.03 172.61 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 124.538 1.135 . . . . 0.0 111.367 -178.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -142.79 -170.93 3.33 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.251 1.42 . . . . 0.0 108.085 177.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.7 tpt180 -151.11 129.12 11.76 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 104.72 -2.326 . . . . 0.0 104.72 177.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -145.88 134.01 21.58 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -178.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 40.9 mmm-85 -104.3 -14.42 15.8 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 123.352 0.661 . . . . 0.0 110.044 179.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -84.03 18.38 22.27 Favored Glycine 0 CA--C 1.539 1.541 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 177.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.235 0 N-CA-C 103.86 -3.696 . . . . 0.0 103.86 -179.755 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 ttt . . . . . 0 N--CA 1.467 0.424 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -121.0 151.66 39.49 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 177.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 28.7 pt -132.84 169.62 21.65 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 178.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -123.13 151.85 41.69 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 124.517 1.127 . . . . 0.0 108.913 179.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 56.7 t -137.32 127.01 37.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 106.56 -1.645 . . . . 0.0 106.56 178.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -94.24 116.56 28.96 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 103.981 -2.6 . . . . 0.0 103.981 177.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.6 p -77.75 168.1 20.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 118.418 0.554 . . . . 0.0 110.335 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -67.23 -12.51 60.25 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.204 1.001 . . . . 0.0 111.512 178.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.5 p -93.74 -12.67 28.65 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.819 1.648 . . . . 0.0 111.129 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.06 7.3 56.39 Favored Glycine 0 CA--C 1.531 1.067 0 O-C-N 121.365 -0.834 . . . . 0.0 111.917 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.8 164.62 22.57 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 119.055 1.428 . . . . 0.0 107.276 179.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.5 m -121.73 131.75 54.25 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 105.05 -2.204 . . . . 0.0 105.05 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.1 mm -114.64 157.18 15.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 105.689 -1.967 . . . . 0.0 105.689 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 56.0 m -134.33 125.47 27.7 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 104.067 -2.568 . . . . 0.0 104.067 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.5 mt -137.73 147.72 44.99 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -104.89 107.11 17.91 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 127.561 2.344 . . . . 0.0 106.322 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.8 m -127.89 -168.45 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 125.791 1.636 . . . . 0.0 109.2 -178.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -141.85 159.53 59.2 Favored Pre-proline 0 N--CA 1.451 -0.377 0 C-N-CA 124.09 0.956 . . . . 0.0 109.654 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -55.44 -17.02 15.29 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.856 3.037 . . . . 0.0 113.004 178.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.7 m -114.23 31.31 6.67 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 124.03 0.932 . . . . 0.0 112.575 -178.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -98.8 132.22 44.32 Favored 'General case' 0 C--O 1.242 0.666 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 176.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -72.66 157.89 36.67 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 119.42 1.009 . . . . 0.0 110.998 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.8 mm -63.71 -29.74 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 177.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -53.37 -48.9 68.19 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.96 1.304 . . . . 0.0 109.729 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 41.6 m-20 -67.83 -52.87 31.83 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.846 0.858 . . . . 0.0 109.551 179.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.2 t -54.04 -42.92 57.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 123.736 0.815 . . . . 0.0 111.381 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 20.0 ttpt -75.53 -16.04 60.32 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 118.432 -0.794 . . . . 0.0 111.094 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -88.07 -43.66 11.52 Favored 'General case' 0 C--O 1.226 -0.165 0 CA-C-N 119.857 1.208 . . . . 0.0 108.244 177.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -50.08 -40.0 44.15 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.0 1.32 . . . . 0.0 110.434 179.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 35.8 pt -66.09 -25.26 35.41 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 O-C-N 121.267 -0.896 . . . . 0.0 112.584 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -76.16 -23.84 54.78 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 120.014 1.279 . . . . 0.0 109.094 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.88 -39.14 57.0 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.243 -0.911 . . . . 0.0 108.641 179.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.0 mttm -89.72 -19.91 24.21 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 115.99 1.848 . . . . 0.0 115.99 -179.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -136.53 158.86 43.45 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 121.819 2.099 . . . . 0.0 108.886 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.01 63.43 4.3 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 110.524 -1.03 . . . . 0.0 110.524 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.5 pt -131.38 107.3 14.62 Favored Pre-proline 0 CA--C 1.538 0.503 0 CA-C-N 117.91 0.855 . . . . 0.0 108.718 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -77.13 169.94 20.55 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 123.925 3.084 . . . . 0.0 109.805 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -76.56 58.64 5.93 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 123.087 2.524 . . . . 0.0 108.19 177.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -146.82 135.41 22.04 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 128.926 2.891 . . . . 0.0 105.319 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.6 mm-40 52.17 48.15 23.28 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.234 1.814 . . . . 0.0 108.368 -177.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -154.85 134.9 13.04 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.526 1.131 . . . . 0.0 109.62 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.0 ttm-85 -151.2 133.52 15.37 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 101.986 -3.339 . . . . 0.0 101.986 178.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.4 tp -87.9 142.01 28.13 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -177.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.2 mm -134.21 144.94 33.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 125.02 1.328 . . . . 0.0 109.584 -178.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -135.54 115.76 13.42 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 177.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.31 42.86 26.36 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.389 1.076 . . . . 0.0 110.692 -179.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.25 -13.93 30.72 Favored Glycine 0 CA--C 1.531 1.037 0 CA-C-O 118.519 -1.156 . . . . 0.0 114.518 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.9 ttmt -79.59 125.87 30.16 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 120.671 2.235 . . . . 0.0 107.554 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.4 mp0 -74.74 136.2 41.76 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 179.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.8 mt -122.34 153.35 39.09 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.618 1.167 . . . . 0.0 109.757 -178.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -160.09 175.69 12.66 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 124.679 1.192 . . . . 0.0 108.755 178.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -71.73 158.17 36.61 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 122.78 1.276 . . . . 0.0 111.86 -177.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 108.59 -29.44 9.94 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 127.448 2.452 . . . . 0.0 108.591 -177.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 46.4 mtt180 -107.75 165.56 11.35 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.0 1.72 . . . . 0.0 111.76 178.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 65.9 p -117.61 173.92 6.45 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.299 1.839 . . . . 0.0 112.655 -178.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.9 mp -52.14 -49.9 62.81 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 123.678 0.791 . . . . 0.0 111.541 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.55 -31.56 72.37 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 112.351 0.501 . . . . 0.0 112.351 -179.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -65.29 -47.15 77.62 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.415 1.007 . . . . 0.0 109.325 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -81.29 -2.5 49.22 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.1 t30 57.68 46.94 16.57 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 130.363 3.465 . . . . 0.0 112.215 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 79.3 mt -85.71 123.19 39.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 105.531 -2.026 . . . . 0.0 105.531 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 75.1 mm-40 -95.47 173.47 7.49 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 123.255 0.622 . . . . 0.0 109.747 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 43.6 pttt -69.72 157.0 38.12 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.116 0.484 . . . . 0.0 110.783 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 53.58 38.8 29.04 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 127.154 2.182 . . . . 0.0 110.992 -179.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.4 p -87.26 163.23 16.98 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.957 1.303 . . . . 0.0 109.459 178.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 93.7 m -126.05 110.22 13.3 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.7 mp -98.5 160.19 14.44 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 126.233 1.813 . . . . 0.0 108.53 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 45.1 m80 -119.28 160.37 22.34 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 124.982 1.313 . . . . 0.0 110.161 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.7 mt -122.82 126.76 48.01 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 104.964 -2.236 . . . . 0.0 104.964 177.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.2 m -140.62 161.45 24.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 CA-C-O 121.447 0.641 . . . . 0.0 110.421 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -134.71 -172.07 2.94 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.32 1.048 . . . . 0.0 108.585 177.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.5 tpt180 -158.67 138.1 11.68 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 103.098 -2.927 . . . . 0.0 103.098 178.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.1 tt -145.21 129.71 17.91 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 -179.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 47.1 mmm-85 -88.36 -2.37 58.56 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 118.905 0.775 . . . . 0.0 111.93 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -86.7 37.57 3.16 Favored Glycine 0 CA--C 1.54 1.619 0 N-CA-C 106.286 -2.726 . . . . 0.0 106.286 175.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.102 0 C-N-CA 129.781 3.562 . . . . 0.0 105.895 -179.102 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.7 ttt . . . . . 0 N--CA 1.47 0.535 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -120.64 151.1 39.91 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 178.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 32.5 pt -132.53 170.08 20.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 C-N-CA 124.929 1.292 . . . . 0.0 108.014 178.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -126.22 150.85 48.09 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.934 1.294 . . . . 0.0 109.005 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.0 t -138.52 133.07 42.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 178.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -103.03 118.35 36.61 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.213 1.005 . . . . 0.0 108.428 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 48.5 p -72.57 171.05 13.15 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.712 0.768 . . . . 0.0 110.059 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -70.45 -12.49 61.61 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.834 -0.541 . . . . 0.0 111.457 177.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.0 p -94.03 -12.1 29.34 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 126.409 1.884 . . . . 0.0 112.627 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.85 7.5 50.43 Favored Glycine 0 C--N 1.339 0.741 0 C-N-CA 124.0 0.81 . . . . 0.0 113.764 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -80.56 164.66 22.77 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 119.017 1.408 . . . . 0.0 107.279 179.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 86.9 m -123.65 132.34 53.83 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 103.523 -2.769 . . . . 0.0 103.523 177.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.5 mm -115.05 148.3 17.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 105.577 -2.009 . . . . 0.0 105.577 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 78.5 m -124.42 126.15 45.46 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 105.312 -2.106 . . . . 0.0 105.312 178.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.6 mt -128.72 150.66 50.17 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 118.339 0.518 . . . . 0.0 110.302 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -101.47 115.54 30.73 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 103.257 -2.868 . . . . 0.0 103.257 178.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.1 m -131.26 -169.92 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 124.415 1.086 . . . . 0.0 109.457 -178.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -143.66 160.84 49.26 Favored Pre-proline 0 N--CA 1.448 -0.568 0 C-N-CA 126.264 1.826 . . . . 0.0 106.591 178.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -58.09 -18.15 34.94 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.864 2.376 . . . . 0.0 113.079 178.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.6 m -116.25 32.95 5.81 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.827 1.251 . . . . 0.0 112.148 -179.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -90.29 128.86 36.53 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 103.187 -2.894 . . . . 0.0 103.187 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.5 p -77.8 159.03 29.28 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 118.965 0.802 . . . . 0.0 112.659 -177.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 23.9 mm -63.56 -29.81 48.23 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.324 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 178.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -59.0 -42.1 89.25 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.2 0.909 . . . . 0.0 110.44 179.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -73.88 -52.75 11.94 Favored 'General case' 0 CA--C 1.521 -0.166 0 C-N-CA 124.665 1.186 . . . . 0.0 109.792 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.4 t -57.44 -38.39 62.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-N 119.62 1.1 . . . . 0.0 110.585 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -74.64 -14.27 60.74 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.208 -0.933 . . . . 0.0 110.592 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.98 -47.19 8.01 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 176.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.6 mttm -49.46 -40.31 36.61 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.333 1.853 . . . . 0.0 111.017 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 36.6 pt -65.69 -28.05 43.09 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-N 118.81 0.732 . . . . 0.0 112.556 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -76.28 -23.06 54.38 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 119.946 1.248 . . . . 0.0 109.742 -178.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.44 -36.3 45.63 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 178.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -86.55 -21.47 26.88 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 114.144 1.164 . . . . 0.0 114.144 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -147.51 150.99 35.6 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 120.99 1.723 . . . . 0.0 106.778 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.1 80.99 1.66 Allowed Glycine 0 CA--C 1.521 0.408 0 CA-C-O 119.244 -0.753 . . . . 0.0 111.846 -179.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.2 pt -133.95 106.14 11.53 Favored Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 106.773 -1.565 . . . . 0.0 106.773 178.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -62.87 166.09 14.85 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 124.571 3.514 . . . . 0.0 115.462 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -83.02 55.9 5.37 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.599 2.199 . . . . 0.0 108.295 177.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -147.26 134.52 20.6 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 128.839 2.856 . . . . 0.0 105.247 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.7 mm-40 47.76 49.36 16.66 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.858 1.663 . . . . 0.0 108.032 -177.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -143.67 134.09 24.71 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 60.3 ttm-85 -156.24 133.82 10.93 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 125.978 1.711 . . . . 0.0 106.868 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 22.1 tp -87.9 140.88 29.06 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -178.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.0 mm -131.53 143.87 39.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 126.036 1.734 . . . . 0.0 109.376 -178.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -138.38 124.58 20.33 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 178.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.79 36.07 20.37 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.464 1.106 . . . . 0.0 110.439 -179.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.18 -14.09 29.48 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 125.343 1.449 . . . . 0.0 113.502 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.1 ttmt -79.57 129.3 34.35 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 119.752 1.776 . . . . 0.0 108.258 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.9 mp0 -74.59 137.42 42.32 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 178.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 7.6 mt -113.21 155.33 25.24 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.252 1.021 . . . . 0.0 108.352 -178.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -151.87 175.15 12.76 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.673 1.189 . . . . 0.0 109.446 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -72.75 157.97 36.48 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 125.229 1.412 . . . . 0.0 111.127 -178.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.17 -21.25 38.22 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 126.226 1.87 . . . . 0.0 110.383 -178.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 39.4 mtt180 -108.28 168.95 8.94 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 118.37 1.085 . . . . 0.0 113.534 178.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 49.0 p -117.45 172.46 7.31 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.945 2.098 . . . . 0.0 111.068 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -51.96 -50.67 60.78 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.286 1.435 . . . . 0.0 112.622 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.06 -31.83 73.25 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 123.021 0.528 . . . . 0.0 112.258 -178.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -60.25 -44.95 94.83 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 119.449 1.022 . . . . 0.0 109.469 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -82.27 1.22 37.78 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.189 0.595 . . . . 0.0 111.085 178.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 57.89 46.84 16.12 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 128.405 2.682 . . . . 0.0 110.794 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.3 mt -85.82 122.64 38.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 105.013 -2.218 . . . . 0.0 105.013 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -97.62 177.46 5.49 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.73 0.812 . . . . 0.0 108.94 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 43.9 pttt -68.19 156.56 37.3 Favored 'General case' 0 C--O 1.239 0.531 0 O-C-N 121.681 -0.637 . . . . 0.0 110.87 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 49.52 35.05 7.62 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.613 1.965 . . . . 0.0 111.088 -178.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.4 p -77.16 158.24 30.49 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 178.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 59.9 m -125.47 110.64 14.15 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.4 mp -96.04 165.67 12.14 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 124.429 1.091 . . . . 0.0 109.814 -178.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 25.3 m80 -118.77 156.34 29.55 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 125.423 1.489 . . . . 0.0 110.19 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 25.7 mt -123.34 124.68 43.5 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 178.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.1 m -139.12 167.75 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -142.05 -169.74 3.0 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 127.154 2.182 . . . . 0.0 109.687 178.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -152.1 130.18 11.87 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 105.22 -2.141 . . . . 0.0 105.22 177.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -148.45 138.81 22.63 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 105.312 -2.107 . . . . 0.0 105.312 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 40.2 mmm-85 -106.11 -13.28 15.49 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 119.269 0.94 . . . . 0.0 112.788 179.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -81.51 19.74 8.41 Favored Glycine 0 CA--C 1.534 1.237 0 CA-C-O 118.684 -1.065 . . . . 0.0 111.658 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.05 0 N-CA-C 105.665 -2.974 . . . . 0.0 105.665 -179.638 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 ttp . . . . . 0 N--CA 1.467 0.394 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -120.69 157.1 30.34 Favored 'General case' 0 CA--C 1.53 0.18 0 O-C-N 121.1 -1.0 . . . . 0.0 112.146 -178.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.3 pt -132.81 169.32 22.23 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 176.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -126.44 152.19 46.72 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.806 1.242 . . . . 0.0 107.822 179.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.9 t -138.96 128.49 30.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.2 tppp? -96.23 117.86 31.63 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 119.081 0.855 . . . . 0.0 109.485 178.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.8 p -81.09 165.62 21.46 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.051 0.94 . . . . 0.0 110.433 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.43 -4.88 12.49 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.062 0.945 . . . . 0.0 113.212 178.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.0 p -92.41 -12.61 31.76 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.487 1.115 . . . . 0.0 110.704 178.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.88 5.93 58.3 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 125.806 1.67 . . . . 0.0 111.434 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.56 164.24 16.2 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.351 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.6 m -123.97 142.46 51.14 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 178.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.3 mm -114.79 155.21 16.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 C-N-CA 126.557 1.943 . . . . 0.0 106.169 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 54.8 m -126.23 128.15 46.76 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 104.124 -2.547 . . . . 0.0 104.124 178.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.4 mt -133.21 150.07 51.98 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -105.14 110.97 23.56 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 103.671 -2.715 . . . . 0.0 103.671 178.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.3 m -134.72 -174.78 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -146.44 166.7 15.9 Favored Pre-proline 0 C--N 1.327 -0.372 0 O-C-N 120.842 -1.161 . . . . 0.0 109.508 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -54.27 -18.81 15.07 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.096 2.531 . . . . 0.0 114.034 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.4 m -115.03 31.22 6.83 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 123.922 0.889 . . . . 0.0 112.453 -178.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -99.08 130.05 45.38 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 103.94 -2.615 . . . . 0.0 103.94 176.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.9 p -78.06 158.14 29.3 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 119.425 1.011 . . . . 0.0 111.711 -178.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.3 mm -63.77 -28.27 44.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -57.1 -42.79 81.43 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.881 0.872 . . . . 0.0 109.383 178.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -73.04 -52.54 13.97 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 124.889 1.275 . . . . 0.0 109.417 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.3 t -54.74 -38.42 43.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-N 119.227 0.921 . . . . 0.0 110.764 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -74.82 -15.55 60.73 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 121.252 -0.905 . . . . 0.0 111.642 -179.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.9 -45.27 8.86 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.552 1.541 . . . . 0.0 108.193 176.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.8 mttm -50.44 -40.4 50.31 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.608 1.563 . . . . 0.0 110.406 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 36.1 pt -64.07 -25.34 37.87 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 O-C-N 121.54 -0.725 . . . . 0.0 112.113 178.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -76.27 -23.64 54.45 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 120.145 1.339 . . . . 0.0 109.262 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.99 -36.33 41.5 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.6 mmtt -85.65 -22.11 28.08 Favored 'General case' 0 C--N 1.337 0.061 0 CA-C-O 117.391 -1.29 . . . . 0.0 114.204 -178.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -150.63 158.04 43.68 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 121.582 1.992 . . . . 0.0 108.808 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.7 82.35 1.59 Allowed Glycine 0 C--N 1.333 0.366 0 N-CA-C 111.843 -0.503 . . . . 0.0 111.843 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.4 pt -140.89 106.62 6.3 Favored Pre-proline 0 CA--C 1.543 0.692 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -71.1 169.59 20.2 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 124.763 3.642 . . . . 0.0 112.658 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -78.65 56.91 6.11 Favored 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 123.054 2.503 . . . . 0.0 109.6 177.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -146.84 130.13 16.62 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 127.857 2.463 . . . . 0.0 104.639 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.2 mm-40 51.01 53.52 12.91 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -177.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -143.06 133.1 24.27 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.275 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 55.8 ttm-85 -161.57 133.33 5.58 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 125.853 1.661 . . . . 0.0 107.174 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 24.2 tp -88.64 142.5 27.63 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.309 1.044 . . . . 0.0 109.674 -178.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.7 mm -135.03 144.56 34.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 125.908 1.683 . . . . 0.0 109.955 -178.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -133.45 117.23 16.95 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 106.714 -1.588 . . . . 0.0 106.714 178.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.57 43.46 20.24 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.933 1.293 . . . . 0.0 111.141 -179.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.45 -17.67 13.34 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-O 118.351 -1.249 . . . . 0.0 114.635 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.3 ttmt -79.25 128.71 33.65 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 120.603 2.201 . . . . 0.0 107.149 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.4 mp0 -74.56 136.87 42.11 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.9 mt -113.19 155.05 25.71 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -178.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -151.99 175.05 12.91 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 124.381 1.072 . . . . 0.0 109.076 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -73.05 160.03 32.68 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 126.197 1.799 . . . . 0.0 111.412 -179.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.0 -27.51 19.16 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 126.271 1.891 . . . . 0.0 109.85 -178.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.9 mtt180 -107.11 170.52 7.9 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.95 1.3 . . . . 0.0 111.449 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 67.2 p -117.3 171.01 8.25 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 127.108 2.163 . . . . 0.0 111.905 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.21 -48.56 65.03 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.06 0.944 . . . . 0.0 112.419 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.03 -31.72 73.01 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 118.932 -0.556 . . . . 0.0 111.512 -179.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -61.13 -44.03 97.96 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 119.352 0.978 . . . . 0.0 108.696 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -82.0 1.7 34.33 Favored 'General case' 0 C--O 1.237 0.4 0 O-C-N 121.603 -0.686 . . . . 0.0 110.814 178.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 52.9 t30 56.48 47.19 19.25 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 127.087 2.155 . . . . 0.0 110.07 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.5 mt -84.48 122.79 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -178.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 57.2 mm-40 -89.57 169.14 11.6 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.447 -0.797 . . . . 0.0 108.995 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 51.8 pttt -69.18 156.73 38.22 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.012 0.434 . . . . 0.0 111.354 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 49.55 34.2 6.69 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 128.407 2.683 . . . . 0.0 111.5 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.2 p -80.17 163.95 23.68 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.2 m -125.31 112.51 16.45 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.1 mp -96.19 168.14 10.77 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.961 1.304 . . . . 0.0 108.666 -179.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.3 m80 -119.64 154.92 33.27 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.155 1.382 . . . . 0.0 109.878 179.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 18.1 mt -123.22 123.47 40.85 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 103.866 -2.642 . . . . 0.0 103.866 177.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.7 m -141.59 170.96 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-N 120.06 1.3 . . . . 0.0 113.635 -179.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.8 -169.82 2.89 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 126.354 1.862 . . . . 0.0 109.576 178.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.4 tpt180 -150.39 129.16 12.41 Favored 'General case' 0 CA--C 1.521 -0.144 0 N-CA-C 103.413 -2.81 . . . . 0.0 103.413 177.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.403 HD22 ' H ' ' A' ' 75' ' ' GLY . 1.1 tt -139.68 127.64 22.2 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 -179.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 49.4 mmm-85 -103.3 -7.43 21.11 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 118.817 0.735 . . . . 0.0 112.157 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.403 ' H ' HD22 ' A' ' 73' ' ' LEU . . . -92.45 21.29 39.03 Favored Glycine 0 CA--C 1.536 1.384 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 177.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.881 0 N-CA-C 106.399 -2.68 . . . . 0.0 106.399 -179.45 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.8 ttt . . . . . 0 N--CA 1.471 0.59 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -120.82 157.14 30.4 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 178.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.7 pt -132.69 169.4 22.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 178.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -126.13 151.01 47.83 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.2 t -138.52 129.6 35.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 179.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.4 tppt? -96.24 119.08 34.09 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 177.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 45.7 p -71.15 167.25 19.73 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 118.663 0.665 . . . . 0.0 109.352 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -67.72 -12.96 61.65 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 119.201 -0.428 . . . . 0.0 111.191 178.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.4 p -94.1 -12.48 28.39 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.815 1.246 . . . . 0.0 111.273 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.41 7.77 48.19 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-N 118.845 0.748 . . . . 0.0 113.524 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.22 164.82 23.87 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 104.507 -2.405 . . . . 0.0 104.507 178.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 45.1 m -123.2 131.21 53.6 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 -179.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.8 mm -116.28 155.25 17.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 127.531 2.332 . . . . 0.0 107.802 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.6 m -135.18 130.4 35.29 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 128.146 2.578 . . . . 0.0 105.428 178.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 79.5 mt -139.01 151.27 46.69 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.722 1.147 . . . . 0.0 110.84 -179.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -102.28 117.94 35.82 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 179.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.7 m -131.28 -170.67 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 124.622 1.169 . . . . 0.0 109.982 -177.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -144.1 160.66 48.5 Favored Pre-proline 0 C--O 1.238 0.494 0 N-CA-C 106.517 -1.661 . . . . 0.0 106.517 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -57.96 -17.98 33.26 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.461 2.108 . . . . 0.0 112.941 178.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 29.3 m -114.64 31.62 6.52 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 119.219 0.918 . . . . 0.0 111.464 -178.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -91.27 129.42 37.26 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 101.302 -3.592 . . . . 0.0 101.302 177.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.0 p -71.03 158.25 36.83 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 121.392 -0.817 . . . . 0.0 109.439 -178.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.0 mm -63.33 -29.35 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 178.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -56.27 -49.32 74.53 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 126.045 1.738 . . . . 0.0 108.834 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 20.1 m-80 -65.43 -52.15 55.26 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 124.67 1.188 . . . . 0.0 109.552 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 84.4 t -54.05 -44.03 61.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 123.328 0.651 . . . . 0.0 110.744 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 24.2 ttpt -75.57 -12.83 60.3 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.279 1.032 . . . . 0.0 112.166 -178.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.04 -46.93 8.16 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.608 1.563 . . . . 0.0 107.513 177.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.4 mttm -50.98 -40.51 58.06 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.405 1.482 . . . . 0.0 110.418 179.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 43.3 pt -64.58 -25.69 38.48 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 O-C-N 121.334 -0.854 . . . . 0.0 112.31 178.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -76.35 -22.77 54.46 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 120.598 1.545 . . . . 0.0 109.262 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -82.27 -22.94 35.53 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.737 1.215 . . . . 0.0 108.607 177.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.1 mmtt -97.68 -16.01 20.14 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 120.481 -1.387 . . . . 0.0 114.347 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -152.04 160.68 43.39 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 121.116 1.78 . . . . 0.0 107.063 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.02 70.98 2.97 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.8 pt -130.8 108.27 15.52 Favored Pre-proline 0 CA--C 1.543 0.703 0 CA-C-N 117.988 0.894 . . . . 0.0 110.752 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -77.82 169.74 20.18 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.822 3.015 . . . . 0.0 110.092 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -79.19 57.0 6.27 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.855 2.37 . . . . 0.0 109.195 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -150.61 135.32 17.38 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 127.206 2.203 . . . . 0.0 105.862 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 55.2 mm-40 53.89 48.78 20.49 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.799 1.64 . . . . 0.0 106.788 -177.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -146.19 143.07 29.03 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 123.711 0.805 . . . . 0.0 110.535 -178.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 43.9 ttm-85 -162.3 134.06 5.38 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.879 1.218 . . . . 0.0 108.289 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 18.9 tp -93.21 140.01 29.99 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.627 1.171 . . . . 0.0 111.204 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.5 mm -135.54 145.35 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 126.229 1.812 . . . . 0.0 108.816 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -139.11 119.77 14.12 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.923 1.289 . . . . 0.0 108.376 178.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.72 35.2 17.85 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.233 1.013 . . . . 0.0 111.151 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.55 -13.75 33.42 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 124.887 1.232 . . . . 0.0 113.248 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.5 ttmt -80.56 129.76 34.71 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 119.484 1.642 . . . . 0.0 107.746 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.8 mp0 -74.47 134.05 42.33 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 51.6 mt -114.01 148.96 36.1 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.576 1.15 . . . . 0.0 108.571 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -151.55 176.73 11.05 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 124.868 1.267 . . . . 0.0 108.217 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.29 160.59 32.14 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.793 1.637 . . . . 0.0 111.767 -177.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.32 -25.6 26.48 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 125.53 1.538 . . . . 0.0 111.243 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 42.7 mtt180 -108.09 168.85 9.0 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.554 1.141 . . . . 0.0 112.908 178.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.4 p -117.71 169.48 9.55 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.876 1.67 . . . . 0.0 109.167 178.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.0 mp -52.5 -43.1 64.85 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.207 0.603 . . . . 0.0 111.202 178.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.1 t -58.2 -45.91 86.77 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 125.916 1.686 . . . . 0.0 111.156 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -59.74 -45.2 92.96 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 118.586 0.63 . . . . 0.0 109.973 -178.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -82.1 1.71 34.71 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.492 0.717 . . . . 0.0 112.088 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.6 t30 55.45 46.42 23.23 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 127.581 2.352 . . . . 0.0 111.026 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 40.6 mt -86.09 123.05 39.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -93.64 169.98 9.92 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.264 0.554 . . . . 0.0 111.469 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.7 pttt -66.32 156.98 32.88 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.237 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 51.22 37.52 18.71 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 126.41 1.884 . . . . 0.0 112.001 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.7 p -87.13 164.15 16.57 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.761 1.224 . . . . 0.0 108.615 178.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.9 m -125.93 113.92 17.83 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.4 mp -96.91 161.64 13.75 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.259 1.023 . . . . 0.0 109.09 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 17.2 m80 -115.78 156.4 26.1 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.903 1.281 . . . . 0.0 109.85 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.8 mt -122.83 124.87 44.28 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.026 1.73 . . . . 0.0 107.891 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 23.3 m -141.38 171.57 11.77 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 124.795 1.238 . . . . 0.0 113.753 -178.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -143.02 -170.72 3.31 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.485 1.514 . . . . 0.0 108.389 176.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.8 tpt180 -151.83 129.4 11.47 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 104.358 -2.46 . . . . 0.0 104.358 177.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.2 mt -151.2 138.57 19.43 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 118.357 0.526 . . . . 0.0 110.587 -178.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 56.8 mmm-85 -99.46 -24.15 14.88 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 177.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -88.81 37.3 3.32 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 126.587 2.042 . . . . 0.0 108.743 177.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.912 0 N-CA-C 106.623 -2.591 . . . . 0.0 106.623 -179.18 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.4 ttt . . . . . 0 N--CA 1.474 0.73 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -121.51 157.27 31.03 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.226 0.611 . . . . 0.0 109.813 178.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.7 pt -132.75 171.12 18.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 C-N-CA 125.493 1.517 . . . . 0.0 107.668 177.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -126.19 152.49 45.96 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.188 0.995 . . . . 0.0 108.623 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.3 t -138.34 128.8 35.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.2 tptp -96.64 117.53 31.18 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.3 p -77.03 166.15 23.69 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 118.511 0.596 . . . . 0.0 110.084 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -71.34 -10.09 59.2 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 121.651 -0.656 . . . . 0.0 111.615 178.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -91.85 -10.96 37.84 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 128.368 2.667 . . . . 0.0 111.737 -179.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.45 7.09 56.2 Favored Glycine 0 C--N 1.34 0.797 0 C-N-CA 125.605 1.574 . . . . 0.0 114.137 178.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.2 mmmm -80.53 166.66 20.96 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 119.089 1.444 . . . . 0.0 109.622 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.5 m -123.72 131.28 53.57 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 103.453 -2.795 . . . . 0.0 103.453 177.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.5 mm -116.43 156.24 17.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 126.338 1.855 . . . . 0.0 107.214 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.1 m -132.93 128.9 37.51 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.156 1.782 . . . . 0.0 106.504 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.9 mt -139.47 151.0 45.85 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.188 0.995 . . . . 0.0 111.322 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -97.54 117.84 32.71 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 127.005 2.122 . . . . 0.0 105.383 178.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.1 m -134.91 -175.61 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 125.071 1.349 . . . . 0.0 109.631 -179.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -144.41 164.27 29.56 Favored Pre-proline 0 CA--C 1.532 0.278 0 C-N-CA 124.323 1.049 . . . . 0.0 109.817 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -57.87 -18.87 36.68 Favored 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 122.87 2.38 . . . . 0.0 113.865 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.3 m -115.86 31.65 6.58 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 119.21 0.914 . . . . 0.0 110.856 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -92.45 128.81 38.44 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 102.294 -3.224 . . . . 0.0 102.294 177.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.4 p -78.53 158.14 28.64 Favored 'General case' 0 CA--C 1.519 -0.232 0 O-C-N 121.2 -0.938 . . . . 0.0 110.917 -178.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.7 mm -64.08 -25.45 38.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 177.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -56.29 -49.83 73.16 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.518 1.127 . . . . 0.0 108.63 178.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -66.44 -52.63 44.35 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.851 1.26 . . . . 0.0 109.842 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.7 t -55.42 -38.62 49.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-N 118.623 0.647 . . . . 0.0 110.903 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -75.27 -18.11 60.15 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 120.956 -1.09 . . . . 0.0 111.412 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.93 -45.03 9.5 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.532 1.533 . . . . 0.0 110.328 178.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.4 mttm -54.31 -40.24 67.76 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 118.631 0.65 . . . . 0.0 111.039 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 34.6 pt -62.59 -24.9 36.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 CA-C-O 119.011 -0.519 . . . . 0.0 111.644 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.506 HE21 ' HB3' ' A' ' 38' ' ' PRO . 34.9 mt-30 -77.0 -23.11 52.25 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 120.162 1.346 . . . . 0.0 109.392 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.98 -32.59 26.93 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 176.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 51.2 mmtt -87.17 -15.37 38.55 Favored 'General case' 0 C--N 1.343 0.303 0 N-CA-C 115.499 1.666 . . . . 0.0 115.499 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -150.66 157.89 43.51 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 121.051 1.75 . . . . 0.0 106.567 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -80.99 74.83 2.37 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-O 119.177 -0.791 . . . . 0.0 111.256 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.3 pt -135.82 107.69 9.84 Favored Pre-proline 0 CA--C 1.545 0.784 0 CA-C-N 118.404 1.102 . . . . 0.0 111.155 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -71.13 169.3 20.94 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 123.336 2.691 . . . . 0.0 110.764 178.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.506 ' HB3' HE21 ' A' ' 31' ' ' GLN . 88.1 Cg_endo -80.52 56.31 6.03 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 122.701 2.267 . . . . 0.0 109.679 178.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -146.7 135.14 21.92 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 127.874 2.47 . . . . 0.0 105.083 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 71.1 mm-40 50.05 49.97 19.39 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.769 1.628 . . . . 0.0 109.55 -177.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 12.2 m-80 -148.09 134.85 19.99 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.519 1.128 . . . . 0.0 109.52 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 45.8 ttm-85 -153.0 134.18 14.17 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 127.293 2.237 . . . . 0.0 107.475 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 23.3 tp -88.18 139.89 30.04 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.037 1.335 . . . . 0.0 109.154 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.3 mm -132.47 145.9 33.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 125.743 1.617 . . . . 0.0 108.161 -179.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -136.62 117.5 14.16 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 124.727 1.211 . . . . 0.0 108.465 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.85 43.53 21.46 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.708 1.203 . . . . 0.0 110.944 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.38 -15.66 22.42 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 124.899 1.237 . . . . 0.0 114.23 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -80.69 124.34 28.93 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 119.874 1.837 . . . . 0.0 107.531 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.5 mp0 -74.47 135.96 42.27 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.7 mt -114.19 156.17 24.76 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 125.187 1.395 . . . . 0.0 109.944 -178.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -151.07 174.14 13.53 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 178.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -76.52 159.91 29.94 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.85 1.26 . . . . 0.0 111.761 -179.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.01 -27.81 14.96 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 125.811 1.672 . . . . 0.0 109.709 -178.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 44.5 mtt180 -106.59 167.04 10.13 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 118.973 1.386 . . . . 0.0 111.353 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.6 p -117.7 170.46 8.76 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 125.995 1.718 . . . . 0.0 111.169 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.6 mp -52.67 -43.56 65.63 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 123.506 0.723 . . . . 0.0 111.869 179.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.7 m -59.78 -38.32 81.54 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 118.632 0.651 . . . . 0.0 112.172 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -62.44 -47.08 85.62 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 123.068 0.547 . . . . 0.0 109.992 -178.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -82.66 1.36 38.81 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.083 0.953 . . . . 0.0 111.698 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 48.0 t30 54.4 46.24 25.45 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 127.53 2.332 . . . . 0.0 111.17 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 81.8 mt -88.25 123.06 40.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 179.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -101.47 175.75 5.47 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.5 pttt -64.81 157.11 28.58 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.285 0.564 . . . . 0.0 110.661 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 55.59 35.64 25.59 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.737 2.015 . . . . 0.0 111.682 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.9 p -86.19 164.17 17.37 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 120.683 -1.261 . . . . 0.0 108.367 178.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.9 m -126.03 115.48 19.93 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.3 mp -103.73 160.72 14.53 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.576 1.151 . . . . 0.0 108.779 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 43.3 m80 -119.46 159.62 23.91 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 125.236 1.414 . . . . 0.0 110.13 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 61.8 mt -123.24 124.29 42.66 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 125.188 1.395 . . . . 0.0 109.22 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.8 m -141.01 170.16 14.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -178.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -141.58 -170.49 3.11 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 127.989 2.516 . . . . 0.0 108.288 178.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -157.27 128.84 6.95 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 104.727 -2.323 . . . . 0.0 104.727 177.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 66.7 mt -150.09 142.05 23.88 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.473 1.109 . . . . 0.0 108.848 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 56.1 mmm-85 -100.94 -25.77 13.96 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 124.731 1.213 . . . . 0.0 111.471 179.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -81.24 18.43 10.31 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-O 119.046 -0.863 . . . . 0.0 114.622 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.804 0 CA-C-N 120.489 2.145 . . . . 0.0 107.746 179.512 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.6 ttt . . . . . 0 N--CA 1.473 0.686 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -122.31 144.92 48.7 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 177.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.9 pt -132.81 168.86 23.2 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 177.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -126.39 152.27 46.54 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 125.082 1.353 . . . . 0.0 109.327 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.4 t -138.72 131.1 38.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 178.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.51 117.8 33.76 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 178.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 54.9 p -74.17 171.12 14.15 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.007 0.923 . . . . 0.0 112.191 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -74.99 -7.75 54.54 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.069 177.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.3 p -94.61 -13.01 26.35 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.858 1.663 . . . . 0.0 111.15 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.81 6.08 57.29 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 126.565 2.031 . . . . 0.0 113.553 178.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.7 mmmm -81.95 164.84 21.23 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 118.416 1.108 . . . . 0.0 108.031 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.7 m -120.35 132.39 55.26 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 104.2 -2.518 . . . . 0.0 104.2 178.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 22.1 mm -107.7 156.96 8.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 125.949 1.699 . . . . 0.0 106.754 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.0 m -135.29 126.27 27.71 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 179.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.7 mt -140.21 147.39 39.99 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.335 1.054 . . . . 0.0 111.199 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -104.9 106.73 17.35 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 126.694 1.998 . . . . 0.0 107.585 178.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.2 m -135.7 -170.63 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 125.041 1.336 . . . . 0.0 108.457 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -147.24 167.94 12.45 Favored Pre-proline 0 C--O 1.232 0.165 0 O-C-N 120.615 -1.303 . . . . 0.0 111.047 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -55.56 -17.6 17.57 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 123.058 2.505 . . . . 0.0 112.821 178.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.1 m -112.57 30.2 7.31 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 119.948 1.249 . . . . 0.0 111.773 -177.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -104.48 140.59 37.74 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 107.518 -1.289 . . . . 0.0 107.518 176.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.2 p -78.72 158.29 28.34 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 122.408 1.099 . . . . 0.0 111.258 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.3 mm -64.74 -25.23 37.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 176.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -55.23 -49.61 71.54 Favored 'General case' 0 C--N 1.344 0.351 0 CA-C-N 119.385 0.993 . . . . 0.0 108.834 178.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.7 m-20 -60.37 -52.3 65.84 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 42.9 t -55.52 -41.36 63.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-O 119.111 -0.471 . . . . 0.0 111.231 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -74.74 -18.36 60.51 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-N 119.275 0.943 . . . . 0.0 111.424 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.24 -46.13 9.01 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 119.652 1.115 . . . . 0.0 108.432 177.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -53.41 -40.21 64.93 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.519 1.128 . . . . 0.0 111.211 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 41.8 pt -63.33 -26.82 41.75 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 CA-C-N 118.808 0.731 . . . . 0.0 111.43 178.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -76.3 -22.69 54.7 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 119.828 1.195 . . . . 0.0 109.323 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.71 -39.49 36.31 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 120.597 -1.315 . . . . 0.0 108.783 178.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -86.98 -15.89 37.42 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 114.549 1.314 . . . . 0.0 114.549 -178.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -148.16 151.27 35.29 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 179.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.1 87.29 1.36 Allowed Glycine 0 C--N 1.335 0.485 0 CA-C-O 119.555 -0.581 . . . . 0.0 112.715 -178.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.5 pt -144.32 107.13 4.81 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 124.448 1.099 . . . . 0.0 109.769 178.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -70.8 170.59 17.46 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 124.05 3.167 . . . . 0.0 110.282 178.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -80.27 55.58 5.72 Favored 'Trans proline' 0 CA--C 1.545 1.061 0 C-N-CA 122.656 2.237 . . . . 0.0 107.607 177.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -146.68 131.33 17.86 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 128.239 2.616 . . . . 0.0 104.765 -179.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 60.1 mm-40 53.95 49.51 18.83 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.992 1.317 . . . . 0.0 107.579 -177.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -155.2 133.35 11.62 Favored 'General case' 0 N--CA 1.452 -0.365 0 O-C-N 121.695 -0.628 . . . . 0.0 110.621 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 53.9 ttm-85 -152.1 137.39 17.53 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 105.319 -2.104 . . . . 0.0 105.319 179.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 28.2 tp -88.31 139.41 30.52 Favored 'General case' 0 C--O 1.226 -0.181 0 C-N-CA 124.182 0.993 . . . . 0.0 109.567 -178.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.6 mm -135.28 144.22 34.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 124.728 1.211 . . . . 0.0 109.093 -178.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -134.69 119.37 18.2 Favored 'General case' 0 C--O 1.226 -0.156 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 178.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.72 38.78 16.18 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.307 1.043 . . . . 0.0 112.077 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.47 -15.77 22.3 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 123.973 0.796 . . . . 0.0 113.582 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.1 ttmt -80.49 118.47 22.13 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 178.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.0 mp0 -75.27 136.68 40.9 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.4 mt -119.82 155.04 33.35 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 126.708 2.003 . . . . 0.0 109.548 -178.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -155.14 176.08 13.01 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 124.604 1.162 . . . . 0.0 108.517 177.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -72.17 160.82 31.8 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 126.116 1.767 . . . . 0.0 112.363 -178.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.62 -27.27 21.0 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 126.042 1.782 . . . . 0.0 110.484 -178.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 47.2 mtt180 -107.33 168.9 8.9 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 124.292 1.037 . . . . 0.0 110.333 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.5 p -117.22 165.56 13.29 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 123.445 0.698 . . . . 0.0 111.601 -179.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.9 mp -52.3 -41.8 63.24 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.714 0.806 . . . . 0.0 111.236 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.9 t -60.52 -45.23 94.61 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 126.391 1.876 . . . . 0.0 110.032 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -60.26 -46.12 90.93 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -81.11 -3.86 53.41 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.212 0.605 . . . . 0.0 111.375 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.9 t30 53.8 47.84 22.73 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 127.718 2.407 . . . . 0.0 112.605 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 82.3 mt -85.61 126.52 40.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 105.499 -2.037 . . . . 0.0 105.499 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 78.0 mm-40 -89.92 169.25 11.39 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.551 0.691 . . . . 0.0 110.939 -179.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -68.02 157.24 35.59 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.389 1.076 . . . . 0.0 109.513 178.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 52.27 35.76 17.81 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.406 1.482 . . . . 0.0 112.879 179.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.4 p -86.32 162.89 17.99 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.728 1.211 . . . . 0.0 110.052 178.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.0 m -126.72 108.77 11.37 Favored 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.4 mp -96.25 169.6 9.83 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.828 1.251 . . . . 0.0 110.658 -178.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -120.05 154.17 35.01 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 126.889 2.076 . . . . 0.0 108.946 178.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.4 mt -123.47 123.89 41.64 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 176.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.9 m -140.75 172.73 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-N 119.53 1.059 . . . . 0.0 112.315 -178.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -141.38 -170.8 3.16 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 126.333 1.853 . . . . 0.0 108.93 178.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -158.82 129.87 6.23 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 104.721 -2.325 . . . . 0.0 104.721 176.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.418 ' CD2' ' H ' ' A' ' 75' ' ' GLY . 1.2 tt -139.41 140.4 37.37 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 -178.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 58.4 mmm-85 -104.97 -2.57 24.37 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.538 0.735 . . . . 0.0 112.36 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.418 ' H ' ' CD2' ' A' ' 73' ' ' LEU . . . -91.07 18.38 51.54 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 124.72 1.153 . . . . 0.0 110.597 178.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.003 0 N-CA-C 105.215 -3.154 . . . . 0.0 105.215 -179.59 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.6 ttt . . . . . 0 N--CA 1.471 0.624 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -120.84 156.09 32.7 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 177.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.3 pt -132.33 169.45 21.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -123.32 149.54 44.73 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.541 1.136 . . . . 0.0 108.61 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.6 t -139.19 127.59 27.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -93.36 116.95 29.49 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.141 0.976 . . . . 0.0 109.161 178.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 80.4 p -84.06 167.6 16.67 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.983 0.913 . . . . 0.0 111.904 179.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.7 -3.98 10.82 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 126.342 1.857 . . . . 0.0 113.048 177.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.0 p -99.02 -15.49 19.04 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.699 1.199 . . . . 0.0 109.484 178.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.67 6.25 57.36 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 127.01 2.243 . . . . 0.0 112.041 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.1 mmmm -80.34 163.44 23.91 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 119.441 1.621 . . . . 0.0 107.144 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.6 m -124.62 132.04 53.44 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 104.351 -2.463 . . . . 0.0 104.351 178.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.8 mm -104.6 157.73 5.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 -179.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 97.8 m -133.95 123.48 24.73 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 104.236 -2.505 . . . . 0.0 104.236 178.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 66.3 mt -139.59 150.7 45.32 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.682 0.793 . . . . 0.0 109.775 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 71.9 tt0 -93.83 117.89 30.71 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 105.132 -2.173 . . . . 0.0 105.132 178.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.0 m -131.59 -171.47 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 124.561 1.144 . . . . 0.0 109.078 -178.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -147.09 164.59 22.49 Favored Pre-proline 0 CA--C 1.537 0.47 0 C-N-CA 123.976 0.91 . . . . 0.0 110.112 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -62.68 -18.87 66.29 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 121.92 1.747 . . . . 0.0 112.721 178.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.54 31.66 6.48 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.894 0.877 . . . . 0.0 111.873 -177.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -92.67 131.84 37.41 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 178.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.0 p -75.08 157.6 34.51 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 119.817 1.189 . . . . 0.0 109.013 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 30.1 mm -64.27 -31.18 52.41 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.282 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 177.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -55.91 -48.54 75.49 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.907 1.283 . . . . 0.0 110.045 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.7 m-20 -64.34 -52.38 58.67 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.191 0.996 . . . . 0.0 109.482 179.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.2 t -55.13 -41.72 61.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 122.81 0.444 . . . . 0.0 110.405 179.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.1 ttpt -74.88 -13.28 60.53 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 118.107 -0.949 . . . . 0.0 110.94 -179.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.34 -47.18 8.21 Favored 'General case' 0 C--O 1.226 -0.154 0 CA-C-N 120.269 1.395 . . . . 0.0 108.791 178.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -52.34 -40.06 61.45 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.056 0.942 . . . . 0.0 111.466 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 40.3 pt -63.96 -25.36 37.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 O-C-N 121.727 -0.608 . . . . 0.0 111.582 178.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -76.77 -23.15 52.93 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 119.921 1.237 . . . . 0.0 109.382 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.38 -39.51 59.08 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 177.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.6 mttm -86.62 -18.26 31.82 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 115.659 1.725 . . . . 0.0 115.659 -177.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -141.97 150.79 41.85 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 120.686 1.585 . . . . 0.0 108.039 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.59 82.03 1.61 Allowed Glycine 0 C--N 1.334 0.421 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.7 pt -136.09 108.38 9.69 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 124.622 1.169 . . . . 0.0 109.515 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -78.62 169.32 19.93 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.497 2.798 . . . . 0.0 109.016 179.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -77.84 56.68 5.76 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 123.56 2.84 . . . . 0.0 109.632 178.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -146.65 135.27 22.11 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 104.716 -2.328 . . . . 0.0 104.716 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 64.1 mm-40 53.22 48.65 21.65 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 126.17 1.788 . . . . 0.0 109.235 -177.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 -154.73 138.95 16.58 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.567 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 52.1 ttm-85 -155.97 135.33 12.3 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 127.859 2.464 . . . . 0.0 105.412 178.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 23.8 tp -87.75 139.45 30.52 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.2 mm -133.63 144.65 35.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 126.05 1.74 . . . . 0.0 108.096 -178.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -138.8 124.99 20.19 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 178.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.59 39.27 12.92 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.799 0.839 . . . . 0.0 111.608 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.03 -16.72 14.44 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 125.064 1.316 . . . . 0.0 113.948 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.5 ttmt -78.92 129.06 34.09 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 119.811 1.806 . . . . 0.0 108.172 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.5 mp0 -74.1 136.18 42.97 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 106.749 -1.575 . . . . 0.0 106.749 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.5 mt -119.19 155.88 30.87 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 125.268 1.427 . . . . 0.0 110.419 -179.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -160.23 176.18 12.03 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 126.186 1.794 . . . . 0.0 107.971 178.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -71.88 161.0 31.6 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 126.792 2.037 . . . . 0.0 113.106 -178.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.42 -27.52 19.54 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 126.465 1.983 . . . . 0.0 110.222 -179.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 47.9 mtt180 -107.99 169.31 8.69 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.374 1.07 . . . . 0.0 111.694 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 45.7 p -122.83 171.16 9.4 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.946 1.298 . . . . 0.0 112.145 -178.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.3 mp -52.56 -41.72 63.82 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 123.296 0.638 . . . . 0.0 110.564 178.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.8 t -58.53 -45.48 88.78 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.899 1.68 . . . . 0.0 110.628 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -61.58 -47.06 87.24 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.816 0.846 . . . . 0.0 109.522 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -81.76 -1.21 46.38 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 118.763 -0.637 . . . . 0.0 112.473 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 52.7 t30 54.24 46.68 24.73 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 127.571 2.348 . . . . 0.0 111.267 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.2 mt -87.5 123.83 40.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 87.8 mm-40 -94.09 172.46 8.21 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 123.23 0.612 . . . . 0.0 111.846 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 41.3 pttt -66.7 157.21 33.24 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 50.79 41.78 26.83 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 125.907 1.683 . . . . 0.0 110.664 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.0 p -86.86 163.22 17.32 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 178.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.3 m -126.34 106.28 9.39 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 179.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.1 mp -98.16 161.16 13.85 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 125.109 1.364 . . . . 0.0 108.614 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 11.4 m80 -119.3 155.6 31.54 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 123.927 0.891 . . . . 0.0 109.223 178.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 16.9 mt -122.53 123.35 41.05 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 102.571 -3.122 . . . . 0.0 102.571 178.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.6 m -141.7 168.93 14.66 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 -178.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -142.06 -174.11 4.0 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.277 1.031 . . . . 0.0 111.692 177.265 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.1 ttt180 -161.2 130.33 4.65 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 124.752 1.221 . . . . 0.0 108.481 178.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 33.6 mt -138.87 137.91 36.97 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 120.154 1.343 . . . . 0.0 108.317 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 37.1 mmm-85 -89.11 -11.01 45.17 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 178.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -90.94 18.42 51.03 Favored Glycine 0 CA--C 1.538 1.499 0 N-CA-C 109.266 -1.533 . . . . 0.0 109.266 177.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.853 0 N-CA-C 107.914 -2.074 . . . . 0.0 107.914 -179.724 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.0 ttt . . . . . 0 CA--C 1.512 -0.519 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -121.22 156.69 31.89 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 178.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 34.9 pt -133.14 170.15 20.57 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 C-N-CA 125.515 1.526 . . . . 0.0 106.993 177.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -126.21 152.82 45.53 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 178.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.9 t -137.94 124.62 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.8 tppp? -93.28 109.58 21.11 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 104.348 -2.464 . . . . 0.0 104.348 178.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.3 p -72.6 165.37 24.83 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 121.074 0.464 . . . . 0.0 110.597 -179.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -69.0 -6.85 30.38 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.468 0.707 . . . . 0.0 111.36 178.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.1 p -93.88 -12.36 29.09 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.692 1.197 . . . . 0.0 109.692 179.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.51 5.78 57.71 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 126.862 2.172 . . . . 0.0 111.508 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.86 164.76 22.42 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 118.454 1.127 . . . . 0.0 108.933 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.1 m -124.42 132.31 53.51 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 179.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.5 mm -114.09 156.83 14.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 125.963 1.705 . . . . 0.0 106.468 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 31.6 m -132.45 123.66 27.07 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 127.239 2.216 . . . . 0.0 105.832 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.4 mt -133.92 150.83 51.34 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 119.09 0.859 . . . . 0.0 109.922 -179.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -103.41 109.12 20.64 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 104.735 -2.32 . . . . 0.0 104.735 178.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.3 m -123.37 -172.33 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 125.53 1.532 . . . . 0.0 109.816 -177.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -146.17 162.42 35.17 Favored Pre-proline 0 C--O 1.234 0.279 0 O-C-N 121.357 -0.839 . . . . 0.0 109.637 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -58.46 -18.53 39.52 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.407 2.071 . . . . 0.0 113.21 179.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.2 m -114.38 31.34 6.67 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 118.763 0.71 . . . . 0.0 111.573 -177.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -98.17 129.34 44.95 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 104.007 -2.59 . . . . 0.0 104.007 178.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.7 p -78.09 157.47 29.5 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 119.814 1.188 . . . . 0.0 110.128 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 51.3 mm -64.5 -26.0 39.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 177.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -55.4 -44.13 75.87 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.356 1.462 . . . . 0.0 109.436 178.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -70.97 -52.37 20.16 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.623 1.169 . . . . 0.0 108.545 179.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.7 t -54.74 -38.52 43.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 124.222 1.009 . . . . 0.0 111.41 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -76.56 -18.54 58.62 Favored 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 124.192 0.997 . . . . 0.0 111.097 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -88.74 -42.27 12.05 Favored 'General case' 0 C--O 1.228 -0.049 0 CA-C-N 119.633 1.106 . . . . 0.0 110.145 179.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -54.16 -40.58 67.59 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.216 0.606 . . . . 0.0 110.86 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.5 pt -63.05 -25.42 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 O-C-N 120.851 -1.156 . . . . 0.0 111.549 178.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -77.93 -21.63 50.82 Favored 'General case' 0 C--N 1.332 -0.169 0 O-C-N 120.79 -1.194 . . . . 0.0 109.967 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -78.11 -30.61 49.58 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.8 mttm -100.57 -15.05 17.95 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 115.799 1.777 . . . . 0.0 115.799 -179.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -139.52 158.71 43.66 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 121.437 1.926 . . . . 0.0 108.936 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.31 70.22 3.13 Favored Glycine 0 CA--C 1.524 0.622 0 C-N-CA 124.87 1.224 . . . . 0.0 110.914 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.6 pt -137.23 107.62 8.72 Favored Pre-proline 0 CA--C 1.544 0.731 0 CA-C-N 118.826 1.313 . . . . 0.0 111.579 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -76.05 168.98 23.03 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 123.756 2.971 . . . . 0.0 109.33 178.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -78.74 57.23 6.28 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.572 2.181 . . . . 0.0 109.875 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -149.4 135.91 19.31 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 128.401 2.68 . . . . 0.0 105.451 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 47.1 mm-40 54.03 48.54 20.88 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.474 1.509 . . . . 0.0 108.501 -177.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -147.83 134.53 19.95 Favored 'General case' 0 C--N 1.339 0.137 0 O-C-N 121.39 -0.819 . . . . 0.0 110.323 -179.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 52.4 ttm-85 -155.55 133.55 11.42 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 29.1 tp -89.14 135.31 33.63 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.826 1.65 . . . . 0.0 110.581 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.4 mm -135.74 147.33 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 125.03 1.332 . . . . 0.0 108.009 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -139.0 115.14 10.28 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 178.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.49 40.75 15.72 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.085 1.354 . . . . 0.0 110.505 -178.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.71 -10.03 53.22 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 125.481 1.515 . . . . 0.0 114.955 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.6 ttmt -79.71 129.84 34.83 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 120.488 2.144 . . . . 0.0 107.732 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.5 mp0 -74.31 125.53 28.66 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.4 mt -114.15 140.73 48.28 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 106.095 -1.816 . . . . 0.0 106.095 179.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -162.88 -179.91 7.13 Favored 'General case' 0 C--N 1.32 -0.686 0 O-C-N 121.658 -0.651 . . . . 0.0 110.206 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -70.49 160.13 32.98 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.089 1.356 . . . . 0.0 112.8 -176.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.85 -29.55 12.26 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 128.153 2.787 . . . . 0.0 110.067 -178.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 49.8 mtt180 -108.28 169.6 8.53 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 126.191 1.796 . . . . 0.0 112.065 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 78.3 p -117.73 167.52 11.29 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 126.865 2.066 . . . . 0.0 111.04 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.7 mp -52.4 -42.02 63.66 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 123.282 0.633 . . . . 0.0 111.131 178.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.7 t -58.65 -43.17 89.72 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.48 1.512 . . . . 0.0 110.605 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -59.87 -46.9 87.85 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 118.741 0.7 . . . . 0.0 109.574 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -81.83 -4.08 55.59 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.246 1.018 . . . . 0.0 113.476 -179.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 37.6 t30 58.34 47.44 13.92 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.609 1.964 . . . . 0.0 110.963 -178.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.9 mt -86.28 122.99 39.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 104.775 -2.306 . . . . 0.0 104.775 179.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 92.1 mm-40 -93.37 170.32 9.7 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 122.862 0.465 . . . . 0.0 110.677 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 49.4 pttt -68.76 157.36 36.52 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.238 0.542 . . . . 0.0 111.228 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 53.16 37.83 26.0 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 127.379 2.272 . . . . 0.0 110.566 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.3 p -87.14 161.69 17.95 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.121 1.368 . . . . 0.0 109.63 178.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 95.2 m -126.33 110.17 13.08 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.3 mp -97.17 158.84 15.25 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.202 1.801 . . . . 0.0 108.857 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 72.1 m80 -120.07 163.64 17.36 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 125.341 1.456 . . . . 0.0 111.823 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 54.5 mt -120.19 133.45 55.49 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 125.13 1.372 . . . . 0.0 107.49 178.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.1 m -140.63 168.98 16.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 C-N-CA 124.413 1.085 . . . . 0.0 109.664 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.25 -170.6 3.3 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.123 1.369 . . . . 0.0 107.338 176.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.4 tpt180 -151.07 133.93 15.8 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 103.724 -2.695 . . . . 0.0 103.724 178.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -155.3 125.01 6.47 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 118.823 0.738 . . . . 0.0 109.051 -178.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 30.3 mmm-85 -89.1 -15.82 33.01 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 118.991 0.814 . . . . 0.0 111.023 179.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -80.93 18.54 9.11 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-O 119.186 -0.786 . . . . 0.0 112.485 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.186 0 N-CA-C 105.781 -2.927 . . . . 0.0 105.781 -179.817 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 33.6 ttm . . . . . 0 N--CA 1.469 0.477 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -122.67 150.48 42.65 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 175.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.9 pt -132.65 168.63 23.74 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 176.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -126.1 151.79 46.74 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 123.892 0.877 . . . . 0.0 109.587 -179.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.9 t -138.37 133.06 42.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 178.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -98.27 117.27 32.28 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 105.241 -2.133 . . . . 0.0 105.241 177.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.3 p -80.36 167.08 20.66 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 118.878 0.763 . . . . 0.0 110.471 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -71.94 -7.98 51.8 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 122.747 0.419 . . . . 0.0 111.173 177.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.4 p -93.51 -12.35 29.84 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.549 1.14 . . . . 0.0 109.411 178.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.77 7.48 55.44 Favored Glycine 0 C--N 1.342 0.861 0 C-N-CA 125.005 1.288 . . . . 0.0 112.622 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -80.86 164.34 22.73 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 119.617 1.709 . . . . 0.0 108.186 179.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.2 m -124.11 131.46 53.55 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 102.953 -2.98 . . . . 0.0 102.953 177.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.9 mm -115.11 157.4 15.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 C-N-CA 125.81 1.644 . . . . 0.0 106.686 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 42.2 m -134.68 125.97 28.16 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 128.503 2.721 . . . . 0.0 104.945 177.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 81.1 mt -139.89 149.21 43.11 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.85 1.26 . . . . 0.0 110.17 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -102.13 114.25 28.22 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 126.116 1.767 . . . . 0.0 107.372 178.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.2 m -134.33 -175.0 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 124.77 1.228 . . . . 0.0 108.118 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -142.45 168.89 12.1 Favored Pre-proline 0 C--O 1.236 0.364 0 O-C-N 121.235 -0.916 . . . . 0.0 110.256 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -54.56 -22.12 26.93 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.683 2.256 . . . . 0.0 114.388 -179.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.5 m -115.11 31.77 6.48 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -178.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -95.68 128.92 42.96 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 101.133 -3.655 . . . . 0.0 101.133 175.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.2 p -76.57 159.0 30.71 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 119.778 1.172 . . . . 0.0 109.762 -179.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 51.8 mm -62.54 -26.19 39.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -53.86 -49.24 68.91 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.599 1.16 . . . . 0.0 108.457 178.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 -68.24 -52.02 38.73 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 126.436 1.894 . . . . 0.0 110.345 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.3 t -53.92 -43.68 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-N 119.232 0.923 . . . . 0.0 110.122 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -75.21 -13.48 60.45 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.182 0.993 . . . . 0.0 112.05 -178.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.51 -45.14 9.62 Favored 'General case' 0 C--O 1.225 -0.229 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 177.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 12.3 mtmm -50.84 -39.74 54.23 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.187 1.395 . . . . 0.0 110.385 179.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 37.5 pt -65.88 -25.41 36.16 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 CA-C-N 118.956 0.798 . . . . 0.0 112.332 178.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -76.37 -23.45 54.13 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 120.017 1.281 . . . . 0.0 109.372 -179.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.02 -38.88 56.75 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 177.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 45.6 mttm -87.43 -16.01 36.08 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 116.526 2.047 . . . . 0.0 116.526 -178.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -147.55 160.62 42.42 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 121.371 1.896 . . . . 0.0 110.511 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.31 64.09 4.23 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 124.427 1.013 . . . . 0.0 113.393 -179.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.1 pt -134.72 106.39 10.73 Favored Pre-proline 0 CA--C 1.541 0.61 0 CA-C-N 119.114 1.457 . . . . 0.0 108.341 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -71.54 169.45 20.93 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 123.7 2.933 . . . . 0.0 112.374 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -78.23 56.91 5.98 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 123.567 2.844 . . . . 0.0 110.263 178.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -149.5 136.16 19.41 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 127.958 2.503 . . . . 0.0 105.099 179.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 64.2 mm-40 51.91 48.83 22.01 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.303 1.441 . . . . 0.0 107.819 -177.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -152.55 133.14 13.85 Favored 'General case' 0 N--CA 1.455 -0.207 0 O-C-N 121.21 -0.932 . . . . 0.0 109.979 -178.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.0 ttm-85 -154.4 136.17 14.45 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 106.206 -1.775 . . . . 0.0 106.206 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 18.5 tp -88.22 137.85 31.96 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 124.427 1.091 . . . . 0.0 108.265 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.9 mm -135.12 150.2 29.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 126.002 1.721 . . . . 0.0 108.348 -178.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -137.17 115.41 11.72 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 178.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.39 42.32 18.04 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.884 1.274 . . . . 0.0 111.161 -178.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.33 -12.48 38.65 Favored Glycine 0 CA--C 1.53 0.97 0 CA-C-O 118.283 -1.287 . . . . 0.0 114.429 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.0 ttmt -79.11 125.17 29.06 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 120.86 2.33 . . . . 0.0 105.96 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.3 mp0 -74.31 136.0 42.56 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -179.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.3 mt -122.91 153.89 39.06 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -162.98 178.45 8.34 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 126.886 2.074 . . . . 0.0 107.802 177.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -71.78 160.56 32.39 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.057 1.343 . . . . 0.0 112.269 -177.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 108.34 -29.51 9.98 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 127.709 2.576 . . . . 0.0 108.626 -178.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 44.1 mtt180 -108.44 166.37 10.82 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.598 1.159 . . . . 0.0 112.329 178.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 49.5 p -117.44 169.59 9.4 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 126.067 1.747 . . . . 0.0 110.292 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.3 mp -52.73 -42.22 64.68 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 122.901 0.48 . . . . 0.0 111.207 178.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.2 t -59.06 -45.61 90.33 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.853 1.261 . . . . 0.0 110.799 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -59.46 -44.92 92.88 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.21 0.604 . . . . 0.0 110.506 -179.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -82.22 -0.3 44.58 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.518 0.727 . . . . 0.0 112.21 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 44.8 t30 53.65 47.49 23.71 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 127.141 2.176 . . . . 0.0 110.611 -179.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.1 mt -85.05 130.95 35.25 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 N-CA-C 104.397 -2.446 . . . . 0.0 104.397 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 68.7 mm-40 -89.63 167.14 13.16 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 123.079 0.551 . . . . 0.0 111.566 -178.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -72.74 156.68 38.68 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 177.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 50.86 35.74 13.06 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.205 1.402 . . . . 0.0 111.358 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.6 p -81.85 164.77 21.38 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.422 1.889 . . . . 0.0 109.494 179.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.5 m -125.97 107.03 10.06 Favored 'General case' 0 N--CA 1.461 0.12 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.6 mp -97.61 164.51 12.39 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.124 1.37 . . . . 0.0 109.21 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.2 m80 -119.93 157.66 28.31 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 126.028 1.731 . . . . 0.0 110.949 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 34.6 mt -123.16 125.47 45.2 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.584 1.554 . . . . 0.0 107.479 178.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.8 m -140.98 172.63 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-N 119.722 1.147 . . . . 0.0 113.937 -178.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -142.43 -170.49 3.2 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.478 1.911 . . . . 0.0 109.41 177.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -156.09 132.91 10.43 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 103.988 -2.597 . . . . 0.0 103.988 178.183 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.1 mt -147.81 140.65 24.81 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.6 mmm-85 -105.5 -14.1 15.41 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 118.939 0.79 . . . . 0.0 110.939 178.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -82.74 18.4 15.77 Favored Glycine 0 CA--C 1.537 1.459 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 177.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.83 0 N-CA-C 104.38 -3.488 . . . . 0.0 104.38 -179.578 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ttt . . . . . 0 N--CA 1.473 0.691 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -121.08 156.16 32.85 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 179.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.2 pt -133.71 170.85 19.02 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 C-N-CA 126.601 1.96 . . . . 0.0 107.883 177.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -126.14 152.43 45.96 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.187 1.395 . . . . 0.0 109.161 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.2 t -138.1 126.15 30.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 178.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -92.83 117.5 30.09 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 106.144 -1.799 . . . . 0.0 106.144 178.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 64.4 p -73.12 164.39 26.76 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -67.67 -12.63 60.9 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.7 178.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.6 p -92.55 -12.11 32.68 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.396 1.879 . . . . 0.0 110.454 179.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.55 6.92 56.24 Favored Glycine 0 C--N 1.338 0.644 0 O-C-N 121.091 -1.006 . . . . 0.0 112.752 179.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.01 163.36 23.32 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 104.996 -2.224 . . . . 0.0 104.996 178.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 47.3 m -125.1 140.54 52.79 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 178.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.2 mm -114.82 156.22 15.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 126.338 1.855 . . . . 0.0 106.001 179.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 47.6 m -132.23 125.84 32.07 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 103.571 -2.751 . . . . 0.0 103.571 178.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.2 mt -138.73 151.49 47.17 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.024 0.93 . . . . 0.0 110.397 -178.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -99.69 118.62 36.6 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 128.362 2.665 . . . . 0.0 105.728 178.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.1 m -134.21 -171.27 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 125.512 1.525 . . . . 0.0 108.467 -178.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -146.72 161.8 36.28 Favored Pre-proline 0 CA--C 1.536 0.435 0 C-N-CA 124.197 0.999 . . . . 0.0 108.344 179.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -51.19 -24.98 16.19 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.316 2.678 . . . . 0.0 114.844 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.4 m -115.42 33.09 5.65 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.756 0.822 . . . . 0.0 111.563 -179.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -90.69 129.65 36.77 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 103.131 -2.915 . . . . 0.0 103.131 178.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 21.3 p -69.58 158.08 35.96 Favored 'General case' 0 C--O 1.237 0.421 0 O-C-N 121.728 -0.607 . . . . 0.0 110.69 -178.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.7 mm -64.25 -32.14 56.3 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.47 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 177.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -55.49 -39.71 70.79 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 125.823 1.649 . . . . 0.0 110.171 179.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -73.86 -53.46 10.15 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.1 t -57.92 -39.13 70.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 O-C-N 121.162 -0.961 . . . . 0.0 112.397 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 27.2 ttpt -75.01 -15.75 60.64 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.622 1.169 . . . . 0.0 110.921 -179.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.75 -47.1 7.84 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.108 1.763 . . . . 0.0 108.14 177.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.1 mttm -50.36 -40.5 49.5 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.217 1.407 . . . . 0.0 110.898 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.3 pt -64.32 -27.94 43.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 O-C-N 121.472 -0.768 . . . . 0.0 111.667 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -78.02 -22.09 49.77 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.824 1.249 . . . . 0.0 110.412 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.34 -37.76 60.52 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 177.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -94.18 -17.75 22.42 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 116.104 1.891 . . . . 0.0 116.104 -179.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -136.45 150.21 48.61 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 121.401 1.909 . . . . 0.0 107.13 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -83.46 85.76 1.52 Allowed Glycine 0 CA--C 1.521 0.434 0 CA-C-O 119.14 -0.811 . . . . 0.0 111.285 -179.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.5 pt -141.17 108.78 6.29 Favored Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 118.327 1.064 . . . . 0.0 111.79 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -62.62 161.9 26.6 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 122.666 2.244 . . . . 0.0 110.547 178.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -84.23 56.66 5.03 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.569 2.179 . . . . 0.0 108.041 179.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -144.82 134.15 23.04 Favored 'General case' 0 CA--C 1.514 -0.415 0 C-N-CA 130.602 3.561 . . . . 0.0 103.515 -178.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 43.3 mm-40 50.89 49.55 20.86 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 125.353 1.461 . . . . 0.0 107.324 -176.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -147.89 133.0 18.27 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.771 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 42.9 ttm-85 -154.73 133.58 12.22 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 178.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 26.5 tp -88.25 137.06 32.66 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.17 1.388 . . . . 0.0 107.834 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.3 mm -127.98 144.46 37.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 125.718 1.607 . . . . 0.0 108.844 -178.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -136.77 126.07 24.85 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 178.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.36 33.15 9.48 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.049 0.94 . . . . 0.0 111.288 -179.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.27 -11.95 41.09 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 124.514 1.054 . . . . 0.0 112.483 -179.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -79.55 129.02 34.09 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 119.58 1.69 . . . . 0.0 107.515 179.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.9 mp0 -74.4 136.03 42.41 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.6 mt -122.98 155.67 36.31 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.29 1.036 . . . . 0.0 109.744 -178.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -161.7 -178.33 6.47 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 127.747 2.419 . . . . 0.0 107.393 177.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -70.63 160.42 32.6 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 127.621 2.368 . . . . 0.0 113.055 -176.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.5 -28.82 13.92 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 126.576 2.036 . . . . 0.0 110.264 -178.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 46.6 mtt180 -108.23 165.16 11.7 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.019 1.328 . . . . 0.0 112.3 179.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 64.4 p -118.52 174.21 6.39 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 126.87 2.068 . . . . 0.0 111.855 -179.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.67 -46.37 63.76 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.459 1.104 . . . . 0.0 110.98 179.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.1 t -58.6 -45.3 89.45 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.037 1.735 . . . . 0.0 111.503 -179.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -60.29 -45.09 94.56 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 122.966 0.506 . . . . 0.0 110.52 -178.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -81.53 1.84 31.74 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.04 0.536 . . . . 0.0 111.197 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.2 t30 54.72 46.19 25.15 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 128.039 2.535 . . . . 0.0 111.202 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 89.6 mt -88.38 125.51 41.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 81.5 mm-40 -101.93 176.94 5.04 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.253 1.021 . . . . 0.0 110.613 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.9 pttt -64.72 156.67 29.66 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 123.588 0.755 . . . . 0.0 110.431 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 49.17 39.33 15.2 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.518 1.927 . . . . 0.0 111.694 -178.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.8 p -83.95 161.64 20.73 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 120.447 -1.408 . . . . 0.0 108.129 178.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.5 m -126.29 108.8 11.6 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.4 mp -95.78 162.16 13.71 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.269 1.428 . . . . 0.0 109.004 -179.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -119.77 163.12 17.94 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.21 1.404 . . . . 0.0 109.928 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.3 mt -123.0 127.34 48.67 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.01 1.724 . . . . 0.0 108.337 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.6 m -141.21 163.44 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 114.255 1.205 . . . . 0.0 114.255 -178.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -142.86 -170.63 3.28 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 127.353 2.261 . . . . 0.0 108.819 177.305 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -159.35 129.38 5.64 Favored 'General case' 0 CA--C 1.521 -0.137 0 N-CA-C 105.021 -2.214 . . . . 0.0 105.021 176.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.6 mt -148.83 141.21 24.19 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 34.7 mmm-85 -91.68 -17.64 25.17 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 177.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -84.1 20.42 13.19 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 126.606 2.051 . . . . 0.0 110.923 178.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.158 0 N-CA-C 108.591 -1.804 . . . . 0.0 108.591 -179.562 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.2 ttm . . . . . 0 N--CA 1.468 0.466 0 N-CA-C 110.354 -0.239 . . . . 0.0 110.354 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -121.04 156.45 32.17 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 176.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.2 pt -132.98 169.39 22.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 178.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -126.12 149.57 48.84 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 179.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.7 t -138.33 124.52 25.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -92.8 117.78 30.39 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 105.345 -2.095 . . . . 0.0 105.345 178.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 50.1 p -72.19 167.06 21.12 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 121.564 0.697 . . . . 0.0 109.734 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -67.26 -12.51 60.3 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.62 0.768 . . . . 0.0 111.738 178.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.3 p -97.44 -12.71 22.38 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.908 1.683 . . . . 0.0 112.249 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.35 6.65 47.44 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-O 118.313 -1.271 . . . . 0.0 113.863 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.3 163.52 20.62 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 120.138 1.969 . . . . 0.0 105.983 178.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.5 m -124.57 132.76 53.44 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.5 mm -115.66 156.9 16.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 127.458 2.303 . . . . 0.0 108.228 -179.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.7 m -133.54 130.55 38.62 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 127.85 2.46 . . . . 0.0 106.276 178.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 92.5 mt -134.3 151.87 51.49 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 126.16 1.784 . . . . 0.0 110.845 -179.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -102.68 117.69 35.21 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 104.548 -2.389 . . . . 0.0 104.548 177.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.1 m -135.18 -168.96 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 124.657 1.183 . . . . 0.0 109.768 -179.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -150.43 163.54 23.8 Favored Pre-proline 0 CA--C 1.537 0.462 0 C-N-CA 125.308 1.443 . . . . 0.0 109.196 178.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -57.12 -18.41 29.07 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.705 2.27 . . . . 0.0 113.274 178.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.4 m -114.22 31.27 6.7 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 123.74 0.816 . . . . 0.0 111.517 -178.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -94.97 130.07 41.76 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 102.309 -3.219 . . . . 0.0 102.309 176.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.5 p -71.62 156.69 39.1 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 119.798 1.181 . . . . 0.0 109.726 -179.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.7 mm -65.04 -29.33 47.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 177.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -57.74 -49.63 75.92 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 126.101 1.761 . . . . 0.0 107.9 178.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -63.04 -52.08 64.25 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.143 0.977 . . . . 0.0 109.421 178.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.8 t -56.37 -38.91 57.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 O-C-N 121.508 -0.745 . . . . 0.0 110.618 179.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -74.74 -17.83 60.59 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-O 117.763 -1.113 . . . . 0.0 109.948 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.29 -47.36 10.13 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 120.2 1.364 . . . . 0.0 108.177 178.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.0 mttm -50.32 -43.16 53.68 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.672 1.189 . . . . 0.0 111.808 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 36.8 pt -62.78 -27.73 43.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 O-C-N 121.501 -0.749 . . . . 0.0 112.684 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -77.21 -20.66 55.01 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 119.519 1.054 . . . . 0.0 110.479 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -82.74 -38.08 23.76 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.171 -0.956 . . . . 0.0 108.974 178.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -86.03 -21.42 27.77 Favored 'General case' 0 N--CA 1.471 0.575 0 O-C-N 121.044 -1.035 . . . . 0.0 113.682 -178.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -140.5 150.81 44.22 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 178.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -80.89 85.29 1.38 Allowed Glycine 0 C--N 1.332 0.317 0 CA-C-N 118.907 0.776 . . . . 0.0 113.038 -178.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.3 pt -140.14 106.87 6.74 Favored Pre-proline 0 CA--C 1.54 0.59 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -66.09 170.4 11.85 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 123.772 2.982 . . . . 0.0 111.309 178.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -83.46 55.99 5.19 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 N-CA-C 106.645 -2.098 . . . . 0.0 106.645 178.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -146.52 133.94 20.78 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 128.402 2.681 . . . . 0.0 106.746 -177.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 39.6 mm-40 46.84 49.43 14.39 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.073 1.749 . . . . 0.0 108.348 -177.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -154.3 134.41 13.18 Favored 'General case' 0 C--N 1.341 0.207 0 C-N-CA 124.761 1.224 . . . . 0.0 110.106 -179.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 52.1 ttm-85 -151.59 141.47 21.99 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 179.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 20.0 tp -88.45 138.89 31.02 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.749 1.22 . . . . 0.0 108.818 -179.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.2 mm -135.16 149.98 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 C-N-CA 125.989 1.716 . . . . 0.0 107.083 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -137.61 122.71 19.15 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 178.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.1 36.61 9.1 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.04 0.936 . . . . 0.0 111.494 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.76 -13.95 33.64 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-O 118.773 -1.015 . . . . 0.0 114.028 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.3 ttmt -79.76 128.97 34.07 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 120.304 2.052 . . . . 0.0 106.145 178.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.7 mp0 -73.75 136.17 43.63 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.141 1.376 . . . . 0.0 108.924 -178.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.4 mt -123.86 155.03 38.8 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.345 1.058 . . . . 0.0 109.069 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -161.78 179.46 8.08 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.269 1.428 . . . . 0.0 108.316 178.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -70.97 161.12 31.66 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 127.219 2.208 . . . . 0.0 112.993 -176.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.37 -25.18 29.08 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 126.24 1.876 . . . . 0.0 110.434 -178.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 47.3 mtt180 -108.29 171.56 7.34 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 118.715 1.257 . . . . 0.0 112.194 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.8 p -118.17 171.62 7.99 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 126.457 1.903 . . . . 0.0 109.322 178.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.7 mp -52.86 -42.16 64.97 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.357 0.663 . . . . 0.0 110.548 177.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.9 t -58.68 -45.44 89.42 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 126.251 1.82 . . . . 0.0 111.553 -179.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -57.73 -47.09 83.39 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 119.384 0.993 . . . . 0.0 109.871 -179.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -81.72 1.25 35.23 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.888 0.875 . . . . 0.0 112.378 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 54.8 t30 53.93 46.08 26.36 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 127.422 2.289 . . . . 0.0 111.405 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.0 mt -86.29 126.71 40.66 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.9 mm-40 -97.2 173.3 7.3 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.402 0.681 . . . . 0.0 111.215 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 42.8 pttt -66.06 156.77 32.83 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 51.81 35.33 15.16 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 127.328 2.251 . . . . 0.0 110.901 -179.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.3 p -75.59 162.74 28.02 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 178.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.3 m -122.77 106.24 10.75 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 -179.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.5 mp -101.63 159.4 15.34 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.314 1.446 . . . . 0.0 109.552 -178.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 4.1 m80 -120.25 163.64 17.47 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 126.406 1.882 . . . . 0.0 111.145 179.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 69.4 mt -122.24 125.41 45.99 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 177.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.9 m -139.77 163.75 24.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-O 121.85 0.833 . . . . 0.0 111.64 -179.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -141.94 -169.12 2.85 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 127.278 2.231 . . . . 0.0 108.409 178.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.9 tpt180 -151.92 130.07 11.92 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 102.27 -3.233 . . . . 0.0 102.27 176.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -143.09 123.22 13.67 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 -179.151 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 48.1 mmm-85 -97.7 -11.83 23.05 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 123.107 0.563 . . . . 0.0 111.753 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -82.39 18.42 14.39 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 124.599 1.095 . . . . 0.0 111.259 178.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.039 0 N-CA-C 105.564 -3.014 . . . . 0.0 105.564 179.953 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 30.3 ttm . . . . . 0 CA--C 1.514 -0.415 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -120.99 148.43 44.11 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 178.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 34.0 pt -132.11 168.34 24.28 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 O-C-N 120.993 -1.067 . . . . 0.0 108.448 179.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -126.22 149.84 48.78 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.7 t -138.3 124.64 25.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -90.42 118.95 30.29 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 126.914 2.086 . . . . 0.0 111.071 179.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 51.1 p -83.05 163.98 20.61 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 177.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.66 -5.65 16.79 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.426 1.09 . . . . 0.0 112.881 178.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.9 p -92.77 -14.23 28.17 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.794 2.037 . . . . 0.0 110.555 178.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.5 6.39 57.47 Favored Glycine 0 C--N 1.337 0.593 0 C-N-CA 125.637 1.589 . . . . 0.0 112.459 179.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.8 mmmm -81.77 164.48 21.66 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 118.28 1.04 . . . . 0.0 108.334 179.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.1 m -125.09 137.19 54.2 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 177.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 48.8 mm -115.95 154.0 17.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 105.507 -2.034 . . . . 0.0 105.507 178.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.8 m -132.71 130.13 39.63 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 178.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 78.5 mt -139.17 151.2 46.42 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 124.899 1.28 . . . . 0.0 111.857 -178.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -98.94 117.63 33.89 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 127.482 2.313 . . . . 0.0 105.024 178.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.6 m -134.39 -171.99 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 125.323 1.449 . . . . 0.0 109.729 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -148.09 165.59 17.98 Favored Pre-proline 0 CA--C 1.536 0.406 0 C-N-CA 124.136 0.974 . . . . 0.0 110.507 179.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.78 -19.27 14.34 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.725 2.95 . . . . 0.0 115.547 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.1 m -115.73 30.83 7.1 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 119.132 0.878 . . . . 0.0 111.693 -179.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -91.46 129.31 37.46 Favored 'General case' 0 C--O 1.244 0.784 0 N-CA-C 102.846 -3.02 . . . . 0.0 102.846 177.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.9 p -76.65 158.34 31.13 Favored 'General case' 0 C--O 1.233 0.205 0 O-C-N 121.118 -0.989 . . . . 0.0 110.697 -178.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.2 mm -63.07 -27.02 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 179.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -54.18 -46.5 72.4 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.387 1.075 . . . . 0.0 109.633 178.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 56.7 m-80 -69.57 -52.36 26.95 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.659 1.584 . . . . 0.0 109.445 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.4 t -54.45 -40.98 51.57 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 CA-C-N 118.835 0.743 . . . . 0.0 109.971 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.1 ttpt -75.49 -12.92 60.33 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.953 1.301 . . . . 0.0 111.637 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.11 -47.44 7.82 Favored 'General case' 0 CA--C 1.52 -0.198 0 C-N-CA 124.614 1.166 . . . . 0.0 109.46 178.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 55.7 mttm -51.21 -40.24 58.29 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.918 1.287 . . . . 0.0 110.485 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.7 pt -61.64 -31.0 49.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-O 118.44 -0.79 . . . . 0.0 112.413 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -77.38 -19.97 55.41 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.029 1.332 . . . . 0.0 110.724 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -83.89 -40.03 19.12 Favored 'General case' 0 CA--C 1.53 0.193 0 O-C-N 121.412 -0.805 . . . . 0.0 110.484 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.8 mttm -89.87 -14.97 33.18 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 -179.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -138.95 150.79 46.29 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.72 64.54 4.19 Favored Glycine 0 CA--C 1.524 0.603 0 CA-C-O 118.136 -1.369 . . . . 0.0 112.729 -179.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.5 pt -127.41 106.72 21.28 Favored Pre-proline 0 CA--C 1.552 1.02 0 CA-C-N 118.928 1.364 . . . . 0.0 111.162 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -65.88 165.41 23.7 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 124.13 3.22 . . . . 0.0 114.694 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -81.79 57.52 6.35 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 124.756 3.637 . . . . 0.0 110.163 178.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -145.12 134.06 22.49 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 128.69 2.796 . . . . 0.0 105.501 -178.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.8 mm-40 44.23 51.1 7.57 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 126.603 1.961 . . . . 0.0 110.05 -177.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 23.3 m-20 -150.59 134.2 16.51 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.3 ttm-85 -153.28 142.65 21.63 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 124.883 1.273 . . . . 0.0 107.638 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.0 tp -88.62 142.9 27.31 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 125.246 1.419 . . . . 0.0 112.698 -177.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.6 mm -135.55 148.15 28.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 126.934 2.094 . . . . 0.0 108.265 179.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -138.18 115.07 10.76 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 177.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.45 43.06 19.46 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.268 1.027 . . . . 0.0 110.784 -178.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.66 -13.19 36.99 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 124.63 1.11 . . . . 0.0 114.738 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.6 ttmm -79.48 129.21 34.26 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 119.757 1.778 . . . . 0.0 109.33 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -74.81 129.36 37.54 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 125.82 1.648 . . . . 0.0 109.577 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 9.8 mt -123.74 148.85 46.24 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 123.726 0.811 . . . . 0.0 110.43 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.1 pm0 -151.61 175.96 11.83 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.12 1.368 . . . . 0.0 108.464 178.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -72.13 161.03 31.46 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 125.493 1.517 . . . . 0.0 113.628 -177.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.82 -22.52 39.97 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 125.672 1.606 . . . . 0.0 110.724 -179.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -107.27 169.97 8.24 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 118.572 1.186 . . . . 0.0 111.347 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 79.4 p -117.09 171.14 8.12 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.604 1.562 . . . . 0.0 113.026 -178.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.57 -47.13 67.02 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.074 0.95 . . . . 0.0 108.829 177.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.2 m -62.04 -32.5 73.02 Favored 'General case' 0 N--CA 1.46 0.063 0 C-N-CA 124.823 1.249 . . . . 0.0 112.93 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -67.41 -45.67 75.47 Favored 'General case' 0 CA--C 1.515 -0.398 0 O-C-N 121.077 -1.014 . . . . 0.0 109.819 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -82.95 1.39 39.91 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 119.208 -0.425 . . . . 0.0 110.93 178.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 36.5 t30 56.01 46.71 21.3 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 127.76 2.424 . . . . 0.0 111.167 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.6 mt -89.76 126.98 42.64 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 178.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -101.84 178.43 4.62 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 123.039 0.536 . . . . 0.0 110.216 179.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 58.4 pttt -64.68 156.88 28.85 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.176 0.59 . . . . 0.0 110.661 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 52.26 46.1 27.25 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.216 1.407 . . . . 0.0 111.221 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.1 p -88.75 161.26 16.89 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.994 1.718 . . . . 0.0 109.912 177.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.37 117.05 22.17 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 178.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mp -109.04 160.57 15.94 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 124.298 1.039 . . . . 0.0 109.256 -179.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 43.7 m80 -120.05 161.11 21.51 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 126.39 1.876 . . . . 0.0 109.526 178.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 33.6 mt -122.82 125.14 44.86 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 126.728 2.011 . . . . 0.0 108.014 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.0 m -141.02 166.14 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -178.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -142.79 -172.32 3.63 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.384 1.474 . . . . 0.0 108.955 177.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.79 128.66 5.08 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 103.926 -2.62 . . . . 0.0 103.926 177.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 76.4 mt -146.98 140.69 25.75 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.5 mmm180 -102.43 -15.35 16.53 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.675 0.79 . . . . 0.0 110.629 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -85.66 19.38 24.84 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 125.583 1.563 . . . . 0.0 110.88 178.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.126 0 N-CA-C 105.246 -3.142 . . . . 0.0 105.246 -179.762 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.0 ttm . . . . . 0 N--CA 1.471 0.624 0 CA-C-O 118.719 -0.658 . . . . 0.0 110.356 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -121.74 154.41 36.96 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 176.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.9 pt -133.42 169.22 22.34 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 176.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -123.04 149.53 44.26 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 179.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.7 t -138.95 125.69 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.1 tppp? -94.14 117.56 30.29 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.946 0.898 . . . . 0.0 108.903 178.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 37.4 p -83.22 166.18 18.8 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.889 0.768 . . . . 0.0 111.025 179.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -70.29 -2.56 13.81 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.35 0.66 . . . . 0.0 111.909 177.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 47.0 p -92.62 -15.16 27.19 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.915 1.286 . . . . 0.0 109.369 178.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.5 6.08 57.6 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 126.825 2.155 . . . . 0.0 112.435 179.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.3 mmmm -81.91 164.18 21.72 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 119.172 1.486 . . . . 0.0 109.636 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.5 m -113.2 132.08 55.63 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 101.896 -3.372 . . . . 0.0 101.896 176.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.8 mm -115.77 148.06 18.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 179.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.9 m -125.37 130.05 51.15 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 106.392 -1.706 . . . . 0.0 106.392 178.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 76.3 mt -139.12 143.26 38.16 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.518 0.727 . . . . 0.0 110.072 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -99.57 107.1 19.17 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.902 2.081 . . . . 0.0 106.58 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.4 m -133.58 -172.6 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 124.988 1.315 . . . . 0.0 109.929 -178.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -144.13 166.07 20.84 Favored Pre-proline 0 C--O 1.235 0.315 0 CA-C-N 121.031 1.741 . . . . 0.0 112.178 -178.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.05 -22.47 31.28 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 123.246 2.63 . . . . 0.0 115.416 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.5 m -115.11 31.03 6.96 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 118.527 0.603 . . . . 0.0 112.369 -178.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -104.31 136.17 44.41 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 103.974 -2.602 . . . . 0.0 103.974 175.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.4 p -78.09 157.97 29.32 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 122.017 0.913 . . . . 0.0 112.065 -178.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.1 mm -64.02 -25.43 38.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-O 118.373 -0.823 . . . . 0.0 110.018 178.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -55.83 -38.66 70.32 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 119.739 1.154 . . . . 0.0 109.382 179.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 57.7 m-20 -74.42 -52.96 10.56 Favored 'General case' 0 CA--C 1.521 -0.14 0 C-N-CA 124.723 1.209 . . . . 0.0 109.552 178.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 24.8 t -54.23 -42.65 57.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 123.036 0.534 . . . . 0.0 111.348 -179.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -74.95 -14.54 60.64 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.653 0.781 . . . . 0.0 111.421 -178.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.19 -45.65 8.95 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.397 1.079 . . . . 0.0 108.602 177.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.5 mttm -52.64 -39.92 62.25 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 124.715 1.206 . . . . 0.0 111.446 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 32.2 pt -60.53 -29.01 43.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-N 118.445 0.566 . . . . 0.0 111.08 178.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -76.91 -23.43 52.52 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 119.445 1.02 . . . . 0.0 109.983 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.54 -24.31 45.76 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 177.247 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.6 mmtt -93.56 -20.35 20.32 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -150.83 161.76 42.06 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 120.796 1.634 . . . . 0.0 109.526 -178.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -80.95 77.29 2.04 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 124.225 0.917 . . . . 0.0 111.957 -179.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.1 pt -135.41 108.51 10.25 Favored Pre-proline 0 CA--C 1.546 0.805 0 CA-C-N 118.245 1.023 . . . . 0.0 111.759 -179.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -65.22 166.69 18.29 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 123.151 2.567 . . . . 0.0 110.465 178.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -88.23 56.64 2.57 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.408 2.072 . . . . 0.0 107.813 179.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -145.91 136.01 23.71 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 127.909 2.484 . . . . 0.0 105.045 -178.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.0 mm-40 51.14 49.53 20.93 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.83 1.652 . . . . 0.0 109.192 -177.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 23.7 m-80 -148.68 133.75 18.22 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.4 ttm-85 -151.72 137.17 17.69 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 126.967 2.107 . . . . 0.0 105.547 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 28.6 tp -87.27 139.39 30.61 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.603 1.161 . . . . 0.0 108.794 -178.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.4 mm -132.26 145.6 34.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 126.05 1.74 . . . . 0.0 108.475 -178.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -133.4 119.22 19.36 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 178.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.05 39.88 24.25 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.355 1.062 . . . . 0.0 110.451 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.48 -16.59 17.82 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-O 118.506 -1.163 . . . . 0.0 113.905 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.4 ttmt -79.52 128.78 33.8 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 120.519 2.16 . . . . 0.0 106.661 178.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.1 mp0 -74.55 136.94 42.12 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -179.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.9 mt -122.39 155.84 35.22 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 126.078 1.751 . . . . 0.0 109.978 -179.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -151.99 176.38 11.55 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.922 1.289 . . . . 0.0 109.162 178.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -72.6 160.9 31.5 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 126.082 1.753 . . . . 0.0 110.959 -178.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.84 -26.08 24.41 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 125.06 1.314 . . . . 0.0 110.098 -178.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 30.3 mtt180 -106.55 170.34 7.99 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 118.736 1.268 . . . . 0.0 110.165 179.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.1 p -117.49 167.59 11.16 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.51 1.524 . . . . 0.0 110.086 179.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.4 mp -52.88 -41.66 64.56 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 121.5 -0.75 . . . . 0.0 111.087 178.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.4 t -58.33 -44.22 88.6 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.274 1.43 . . . . 0.0 110.608 -179.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -57.94 -46.9 84.35 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.348 0.659 . . . . 0.0 109.884 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -81.72 -4.31 55.95 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -179.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 31.8 t30 56.66 46.37 20.34 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.996 2.118 . . . . 0.0 109.997 -178.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 84.2 mt -86.35 127.22 40.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 N-CA-C 103.782 -2.673 . . . . 0.0 103.782 178.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 94.6 mm-40 -101.74 173.21 6.51 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 122.918 0.487 . . . . 0.0 110.851 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.1 pttt -64.71 157.25 27.9 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 51.6 39.08 24.18 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 125.562 1.545 . . . . 0.0 111.231 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.1 p -87.34 163.44 16.81 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 120.87 -1.144 . . . . 0.0 108.263 177.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 33.0 m -126.4 105.98 9.17 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.4 mp -97.09 160.25 14.45 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.655 1.582 . . . . 0.0 108.805 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 4.2 m80 -120.01 157.63 28.47 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 125.36 1.464 . . . . 0.0 108.194 178.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.1 mt -122.99 123.47 40.96 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 105.223 -2.139 . . . . 0.0 105.223 178.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.5 m -141.8 172.43 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-N 120.11 1.323 . . . . 0.0 113.582 -179.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.44 -172.99 3.64 Favored 'General case' 0 C--N 1.343 0.301 0 C-N-CA 124.718 1.207 . . . . 0.0 111.071 178.031 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 13.8 ttt180 -161.04 130.71 4.87 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 177.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -155.7 122.64 5.36 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 105.909 -1.886 . . . . 0.0 105.909 178.638 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.41 24.1 mmm-85 -91.12 -0.89 57.81 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -83.03 18.72 14.99 Favored Glycine 0 CA--C 1.539 1.586 0 N-CA-C 108.019 -2.032 . . . . 0.0 108.019 176.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.935 0 C-N-CA 129.423 3.392 . . . . 0.0 105.856 -179.859 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.3 ttt . . . . . 0 N--CA 1.469 0.502 0 N-CA-C 110.606 -0.146 . . . . 0.0 110.606 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -120.71 156.96 30.68 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 177.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.4 pt -132.51 169.46 21.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 178.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -122.58 150.03 43.16 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 124.867 1.267 . . . . 0.0 108.239 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.8 t -139.17 125.24 23.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 O-C-N 121.788 -0.57 . . . . 0.0 109.585 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -91.0 111.27 22.65 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 178.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.5 p -83.15 160.61 21.81 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.655 0.661 . . . . 0.0 110.397 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -67.52 -2.72 6.97 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.407 1.083 . . . . 0.0 112.744 179.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.9 p -91.3 -12.62 34.56 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 125.264 1.426 . . . . 0.0 110.039 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.64 7.46 57.84 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.3 mmmm -97.07 165.1 12.23 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 118.006 0.903 . . . . 0.0 109.078 179.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.46 132.81 53.5 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 103.911 -2.626 . . . . 0.0 103.911 178.027 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.0 mm -114.56 153.26 16.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 -178.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 89.8 m -124.77 130.11 51.76 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 104.395 -2.446 . . . . 0.0 104.395 178.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 75.1 mt -138.8 151.2 46.85 Favored 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 124.226 1.01 . . . . 0.0 111.04 -179.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -97.59 118.7 34.69 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 127.22 2.208 . . . . 0.0 107.17 179.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 23.0 m -134.36 -174.94 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.005 0.922 . . . . 0.0 110.094 -179.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -147.68 159.14 41.82 Favored Pre-proline 0 C--O 1.234 0.278 0 C-N-CA 124.231 1.012 . . . . 0.0 109.469 178.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -53.37 -23.35 23.72 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 123.349 2.699 . . . . 0.0 115.005 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 42.2 m -115.62 30.83 7.1 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -178.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -94.91 135.47 36.38 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 176.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.3 p -71.44 158.86 35.54 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 119.558 1.072 . . . . 0.0 112.686 -178.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.7 mm -63.78 -28.89 45.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 O-C-N 121.475 -0.766 . . . . 0.0 109.018 178.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -61.08 -49.83 75.73 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -61.08 -52.48 64.73 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 124.134 0.973 . . . . 0.0 109.635 179.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.0 t -56.53 -38.55 57.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 124.165 0.986 . . . . 0.0 111.421 -179.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.4 ttpt -80.59 -12.51 59.5 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 118.361 -0.828 . . . . 0.0 111.473 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.6 -43.01 11.07 Favored 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 125.211 1.404 . . . . 0.0 109.213 178.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.6 mttm -51.89 -39.71 59.48 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 121.423 -0.798 . . . . 0.0 111.723 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.1 pt -65.0 -25.01 36.7 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 O-C-N 121.679 -0.638 . . . . 0.0 111.683 178.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -76.15 -20.67 57.36 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.916 1.234 . . . . 0.0 108.911 -179.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.45 -38.92 40.06 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 120.936 -1.103 . . . . 0.0 108.234 177.267 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 51.4 mttm -86.95 -21.81 25.99 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 -178.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -140.29 150.16 43.7 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 121.266 1.848 . . . . 0.0 106.406 178.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.75 82.96 1.55 Allowed Glycine 0 N--CA 1.451 -0.323 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.8 pt -134.94 108.72 10.66 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 125.533 1.533 . . . . 0.0 106.865 179.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -82.87 170.23 12.68 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 124.532 3.488 . . . . 0.0 112.129 -179.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -74.9 55.39 3.88 Favored 'Trans proline' 0 CA--C 1.553 1.439 0 C-N-CA 123.056 2.504 . . . . 0.0 111.089 178.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -150.01 127.09 11.23 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 104.475 -2.417 . . . . 0.0 104.475 179.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 71.0 mm-40 54.72 50.81 15.0 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.066 1.346 . . . . 0.0 108.347 -176.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -143.21 132.42 23.2 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 179.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.6 ttm-85 -158.93 133.42 7.94 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 125.362 1.465 . . . . 0.0 107.32 -179.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 21.8 tp -92.92 140.63 29.28 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.057 0.943 . . . . 0.0 112.178 -178.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.0 mm -135.55 146.45 29.86 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 127.21 2.204 . . . . 0.0 108.209 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -137.69 120.57 16.46 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 125.95 1.7 . . . . 0.0 106.797 178.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.38 41.25 16.25 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.299 1.039 . . . . 0.0 111.535 -179.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.8 -17.39 11.3 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.644 1.116 . . . . 0.0 113.95 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.3 ttmt -79.67 128.46 33.43 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 125.389 1.476 . . . . 0.0 108.994 -179.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.6 mp0 -76.15 136.48 39.79 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 124.954 1.302 . . . . 0.0 109.468 -179.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 9.6 mt -121.09 154.23 36.4 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 124.729 1.212 . . . . 0.0 109.646 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -151.68 175.99 11.83 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 123.518 0.727 . . . . 0.0 109.471 179.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -72.35 160.04 33.02 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.726 1.61 . . . . 0.0 111.229 -178.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.21 -29.22 12.96 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 126.415 1.959 . . . . 0.0 110.856 -178.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 51.7 mtt180 -107.94 174.48 5.86 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 119.305 1.552 . . . . 0.0 112.813 179.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 50.3 p -117.55 175.67 5.53 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.984 1.714 . . . . 0.0 114.253 -177.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.17 -49.35 63.98 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.964 1.306 . . . . 0.0 112.253 179.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.37 -33.59 76.32 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 118.386 -0.816 . . . . 0.0 111.829 -179.03 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -59.59 -47.22 86.42 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.77 1.168 . . . . 0.0 108.658 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -82.05 1.64 34.87 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.171 0.988 . . . . 0.0 112.673 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.0 t30 54.3 46.77 24.46 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 126.873 2.069 . . . . 0.0 112.56 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 74.8 mt -89.25 122.99 41.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 104.148 -2.538 . . . . 0.0 104.148 178.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -101.88 177.56 4.86 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 123.163 0.585 . . . . 0.0 110.627 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -64.21 155.27 32.34 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-O 121.618 0.723 . . . . 0.0 112.315 -178.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 47.59 35.39 4.32 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 127.985 2.514 . . . . 0.0 112.454 -179.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.1 p -80.6 163.79 23.39 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.224 1.009 . . . . 0.0 109.316 178.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 43.9 m -126.22 111.08 14.17 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.6 mp -96.69 161.65 13.79 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.387 1.075 . . . . 0.0 109.469 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.4 m80 -119.2 153.45 34.92 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 125.284 1.433 . . . . 0.0 109.823 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.7 mt -122.58 126.76 48.39 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 126.35 1.86 . . . . 0.0 106.477 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.4 m -138.22 169.74 17.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -179.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -142.42 -171.0 3.31 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.846 2.058 . . . . 0.0 109.094 178.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -159.27 129.11 5.59 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 105.15 -2.167 . . . . 0.0 105.15 178.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 19.0 mt -141.16 141.13 34.15 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 120.372 1.442 . . . . 0.0 110.235 -179.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 49.0 mmm-85 -95.89 -22.34 17.5 Favored 'General case' 0 C--O 1.225 -0.185 0 C-N-CA 124.252 1.021 . . . . 0.0 110.768 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -81.2 18.8 9.2 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-N 118.865 0.757 . . . . 0.0 112.085 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.139 0 N-CA-C 106.309 -2.716 . . . . 0.0 106.309 -179.82 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 ttt . . . . . 0 CA--C 1.507 -0.711 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -121.18 156.81 31.58 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 177.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.4 pt -132.1 168.21 24.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 178.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -116.29 150.7 37.21 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 124.865 1.266 . . . . 0.0 107.999 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.2 t -137.96 125.31 29.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 178.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -91.21 117.33 29.55 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 178.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.9 p -72.53 165.3 24.93 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 179.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -67.42 -9.31 40.47 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.115 0.566 . . . . 0.0 112.077 178.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.3 p -102.64 -12.48 17.68 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 127.527 2.331 . . . . 0.0 113.024 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.03 6.5 42.59 Favored Glycine 0 C--N 1.335 0.518 0 CA-C-O 118.279 -1.29 . . . . 0.0 114.973 178.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.6 mmmm -81.22 163.52 22.96 Favored 'General case' 0 C--N 1.343 0.295 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 178.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.6 m -124.55 131.48 53.48 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 103.724 -2.695 . . . . 0.0 103.724 177.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.5 mm -105.49 157.38 6.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 -179.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 69.8 m -130.29 122.55 28.19 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 129.428 3.091 . . . . 0.0 103.229 178.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 72.4 mt -138.3 146.16 42.09 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.353 1.061 . . . . 0.0 110.037 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -95.71 117.46 30.56 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.47 1.508 . . . . 0.0 108.07 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.5 m -129.03 -168.97 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.431 0 C-N-CA 125.623 1.569 . . . . 0.0 109.456 -178.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -150.38 161.89 29.23 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 125.24 1.416 . . . . 0.0 107.702 178.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -59.48 -18.7 48.0 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.523 2.149 . . . . 0.0 114.34 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.2 m -114.72 30.48 7.3 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 118.753 0.706 . . . . 0.0 111.498 -178.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -92.96 129.59 38.83 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.9 p -77.88 158.25 29.51 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 119.918 1.235 . . . . 0.0 111.592 -178.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.1 mm -63.42 -29.88 48.38 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.316 0 CA-C-O 117.933 -1.032 . . . . 0.0 109.979 178.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -59.94 -40.45 88.98 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.916 1.234 . . . . 0.0 110.299 -179.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -67.42 -53.08 32.22 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.7 t -57.07 -40.09 70.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 123.045 0.538 . . . . 0.0 110.95 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt -75.34 -16.0 60.44 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.654 1.182 . . . . 0.0 111.798 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.86 -46.03 8.84 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 177.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.5 mttm -52.03 -40.05 60.47 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 124.713 1.205 . . . . 0.0 111.498 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 34.1 pt -63.61 -27.05 42.16 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-N 118.925 0.784 . . . . 0.0 111.279 178.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -77.02 -22.74 52.6 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 119.603 1.092 . . . . 0.0 109.548 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.84 -39.29 61.7 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 177.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 51.1 mttm -87.36 -22.52 25.02 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 115.281 1.586 . . . . 0.0 115.281 -178.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -138.68 150.9 46.7 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 120.633 1.56 . . . . 0.0 107.804 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.6 89.3 1.41 Allowed Glycine 0 C--N 1.334 0.426 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 -179.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.0 pt -141.49 107.61 6.06 Favored Pre-proline 0 CA--C 1.543 0.685 0 CA-C-N 118.11 0.955 . . . . 0.0 110.777 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -64.7 168.15 13.94 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 123.057 2.505 . . . . 0.0 110.858 178.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -84.1 55.46 4.68 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 122.251 1.967 . . . . 0.0 108.49 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -146.56 136.03 22.94 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 130.516 3.526 . . . . 0.0 104.456 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 66.5 mm-40 51.24 47.52 24.7 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.26 1.824 . . . . 0.0 109.594 -178.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -154.86 132.47 11.31 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 179.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 51.8 ttm-85 -157.52 135.13 10.58 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 103.533 -2.766 . . . . 0.0 103.533 179.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 15.5 tp -87.92 141.91 28.21 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -178.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.3 mm -134.41 141.52 43.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 125.923 1.689 . . . . 0.0 108.1 -178.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -139.39 125.86 20.39 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.29 33.32 15.32 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.528 0.68 . . . . 0.0 111.919 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.97 -13.19 32.63 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 124.461 1.029 . . . . 0.0 112.511 -179.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.5 tpmt? -78.58 123.11 26.75 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 -179.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -75.91 136.29 40.1 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.5 mt -115.17 154.76 28.41 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 123.867 0.867 . . . . 0.0 109.462 -178.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -158.98 179.52 8.99 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 126.302 1.841 . . . . 0.0 107.46 178.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.22 160.95 31.91 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.914 1.285 . . . . 0.0 112.458 -176.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.43 -27.13 21.87 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 113.784 -1.553 . . . . 0.0 111.303 -179.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 44.8 mtt180 -106.6 168.06 9.43 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 119.033 1.417 . . . . 0.0 111.074 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.1 p -117.81 173.1 6.94 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.599 1.559 . . . . 0.0 113.181 -178.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.44 -48.95 65.49 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.151 0.98 . . . . 0.0 111.657 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.4 -32.48 74.11 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 118.474 0.579 . . . . 0.0 111.493 -179.436 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -63.79 -45.68 88.6 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 119.498 1.044 . . . . 0.0 108.774 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -82.16 2.08 33.26 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.683 -0.636 . . . . 0.0 111.69 179.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 54.47 47.12 23.51 Favored 'General case' 0 C--N 1.342 0.277 0 C-N-CA 128.041 2.536 . . . . 0.0 111.193 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 74.2 mt -89.99 122.27 41.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 103.553 -2.758 . . . . 0.0 103.553 178.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 94.2 mm-40 -98.57 177.48 5.31 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 40.8 pttt -64.51 156.05 30.94 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -179.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.255 5.4 mp0 45.65 44.38 10.24 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.935 2.094 . . . . 0.0 113.597 179.486 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.8 p -87.94 164.85 15.62 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.619 1.968 . . . . 0.0 109.508 177.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.2 m -126.51 107.3 10.12 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 119.437 1.017 . . . . 0.0 108.755 178.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.1 mp -96.44 163.18 13.16 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.788 1.635 . . . . 0.0 110.547 -178.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 16.1 m80 -119.26 161.0 21.14 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.133 1.373 . . . . 0.0 111.815 178.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 39.9 mt -123.29 128.85 50.52 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.897 1.679 . . . . 0.0 107.855 178.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.1 m -140.66 162.74 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-N 118.868 0.758 . . . . 0.0 112.253 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -140.55 -172.37 3.43 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 126.394 1.878 . . . . 0.0 109.51 178.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -158.88 130.05 6.26 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 177.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.6 mt -142.55 140.37 31.75 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 -179.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 49.0 mmm-85 -106.43 -11.94 15.79 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.101 0.961 . . . . 0.0 110.548 179.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -82.58 17.78 18.31 Favored Glycine 0 CA--C 1.537 1.459 0 N-CA-C 110.576 -1.01 . . . . 0.0 110.576 177.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.118 0 N-CA-C 104.366 -3.494 . . . . 0.0 104.366 -179.649 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.6 ttt . . . . . 0 N--CA 1.469 0.516 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -121.83 154.23 37.3 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 175.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 32.8 pt -132.55 169.72 21.38 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 177.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -123.49 150.07 44.37 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.9 t -138.21 125.23 27.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 178.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.9 tppp? -91.42 117.47 29.71 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 104.624 -2.361 . . . . 0.0 104.624 178.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.0 p -72.8 168.99 17.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 118.456 0.571 . . . . 0.0 110.277 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -66.87 -12.59 59.79 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 121.11 -0.236 . . . . 0.0 111.044 178.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.7 p -93.74 -12.4 29.27 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.572 1.949 . . . . 0.0 112.023 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.8 7.28 55.63 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-O 118.801 -1.0 . . . . 0.0 113.49 178.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -79.88 164.01 23.9 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-N 119.484 1.642 . . . . 0.0 106.992 179.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.1 m -114.7 130.43 56.82 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 103.289 -2.856 . . . . 0.0 103.289 178.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.8 mm -115.55 154.08 17.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 105.602 -1.999 . . . . 0.0 105.602 179.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.2 m -134.96 125.3 26.36 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 126.924 2.09 . . . . 0.0 105.395 179.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 82.1 mt -140.13 151.05 44.99 Favored 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 124.543 1.137 . . . . 0.0 109.851 -179.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -94.84 118.33 31.59 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 105.504 -2.036 . . . . 0.0 105.504 178.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.6 m -129.82 -174.2 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 124.523 1.129 . . . . 0.0 108.824 -179.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -149.71 168.35 11.18 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 124.404 1.082 . . . . 0.0 108.574 -179.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -59.54 -21.24 61.16 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.473 2.115 . . . . 0.0 113.48 178.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.3 m -114.85 31.78 6.45 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 118.463 0.574 . . . . 0.0 111.857 -178.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -91.69 128.21 37.44 Favored 'General case' 0 C--O 1.242 0.711 1 N-CA-C 99.671 -4.196 . . . . 0.0 99.671 177.194 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.1 p -76.72 158.59 30.85 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -179.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.8 mm -63.49 -27.31 42.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 119.254 -0.978 . . . . 0.0 109.388 178.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -61.58 -37.84 85.34 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.885 1.221 . . . . 0.0 109.017 178.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.0 m-80 -69.24 -52.93 22.8 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 178.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 25.8 t -55.73 -38.53 51.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-N 119.049 0.84 . . . . 0.0 110.93 179.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.1 ttpt -75.08 -18.18 60.33 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.327 1.051 . . . . 0.0 111.686 -179.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.01 -46.83 8.24 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 126.767 2.027 . . . . 0.0 109.187 178.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -51.5 -40.68 60.03 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.407 1.483 . . . . 0.0 110.831 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 31.6 pt -64.79 -25.21 37.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 O-C-N 121.138 -0.976 . . . . 0.0 111.879 179.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -76.85 -23.37 52.69 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 120.671 -1.268 . . . . 0.0 109.626 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.78 -24.57 55.99 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 176.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.2 mttm -100.74 -15.29 17.73 Favored 'General case' 0 C--N 1.341 0.203 0 N-CA-C 116.236 1.939 . . . . 0.0 116.236 -179.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -145.55 158.56 43.83 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 120.918 1.69 . . . . 0.0 108.111 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.14 68.64 3.4 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.6 pt -131.6 108.57 14.5 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 118.131 0.966 . . . . 0.0 110.507 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -75.18 169.58 22.22 Favored 'Trans proline' 0 CA--C 1.544 0.992 0 C-N-CA 123.172 2.581 . . . . 0.0 109.372 178.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -78.69 56.62 6.01 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.374 2.049 . . . . 0.0 110.665 179.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -146.78 135.93 22.58 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 129.218 3.007 . . . . 0.0 106.939 -179.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 68.9 mm-40 52.73 47.91 23.65 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 127.928 2.491 . . . . 0.0 109.524 -178.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 25.9 m-80 -153.0 136.44 15.87 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 121.785 -0.572 . . . . 0.0 109.754 179.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 54.4 ttm-85 -151.92 134.91 15.72 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 126.558 1.943 . . . . 0.0 105.891 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 19.6 tp -87.74 140.83 29.11 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 124.09 0.956 . . . . 0.0 109.484 -178.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.2 mm -132.7 144.7 35.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 125.655 1.582 . . . . 0.0 109.355 -178.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -138.36 121.27 16.58 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 177.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.22 40.59 26.44 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.463 1.105 . . . . 0.0 110.55 -179.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.13 -16.13 18.32 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 125.264 1.412 . . . . 0.0 113.85 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.0 ttmt -79.05 128.93 33.89 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 119.832 1.816 . . . . 0.0 109.014 -179.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.0 mp0 -74.26 134.36 42.65 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.0 mt -117.93 154.98 31.01 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.826 1.25 . . . . 0.0 109.537 -179.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -162.5 176.91 9.96 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 126.803 2.041 . . . . 0.0 107.404 177.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -71.44 161.59 30.8 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.205 1.402 . . . . 0.0 112.285 -178.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 108.43 -28.98 10.56 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 127.386 2.422 . . . . 0.0 108.049 -178.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 46.2 mtt180 -107.62 169.83 8.35 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 124.934 1.294 . . . . 0.0 110.473 178.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 80.8 p -123.84 169.45 11.56 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 127.161 2.184 . . . . 0.0 110.178 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.9 mp -53.01 -42.07 65.29 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 123.064 0.545 . . . . 0.0 111.259 177.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.4 t -59.31 -44.96 92.5 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.595 1.158 . . . . 0.0 109.916 -179.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -58.96 -46.37 88.22 Favored 'General case' 0 C--N 1.341 0.233 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -81.35 1.32 33.31 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -179.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 36.9 t30 54.31 45.91 26.25 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.199 1.799 . . . . 0.0 111.228 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 81.3 mt -87.98 123.4 40.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 87.5 mm-40 -95.1 175.16 6.73 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.43 0.633 . . . . 0.0 111.203 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -70.99 157.11 38.77 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.386 0.674 . . . . 0.0 109.201 178.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 54.1 35.37 22.12 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.441 1.496 . . . . 0.0 110.958 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.9 p -87.2 162.12 17.65 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.529 1.132 . . . . 0.0 109.19 178.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.1 m -124.96 107.93 11.35 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 122.365 1.079 . . . . 0.0 109.539 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.2 mp -96.44 160.46 14.39 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.734 1.214 . . . . 0.0 108.802 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -119.07 160.7 21.57 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.709 1.204 . . . . 0.0 111.745 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 25.6 mt -123.08 124.61 43.49 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.987 1.715 . . . . 0.0 108.16 179.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.9 m -141.1 167.9 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 124.775 1.23 . . . . 0.0 113.174 -179.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.83 -170.98 3.25 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.262 1.425 . . . . 0.0 110.076 177.457 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -155.23 132.75 11.17 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 103.339 -2.837 . . . . 0.0 103.339 178.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -147.66 131.62 17.17 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 105.297 -2.112 . . . . 0.0 105.297 -179.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 50.0 mmm-85 -105.03 -10.93 16.87 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 118.577 -0.725 . . . . 0.0 111.324 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -86.52 19.1 30.03 Favored Glycine 0 CA--C 1.537 1.421 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 177.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.991 0 C-N-CA 129.136 3.255 . . . . 0.0 105.061 -179.947 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.469 0.481 0 N-CA-C 111.25 0.093 . . . . 0.0 111.25 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -121.48 157.57 30.33 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 176.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.0 pt -132.37 169.96 20.88 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 C-N-CA 125.287 1.435 . . . . 0.0 108.346 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -126.24 149.53 49.02 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 124.925 1.29 . . . . 0.0 107.89 178.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.5 t -139.62 131.48 34.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -97.6 117.78 32.65 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.078 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.3 p -83.27 168.79 16.37 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.027 0.931 . . . . 0.0 110.976 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.9 -5.0 22.99 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.582 0.753 . . . . 0.0 112.632 178.143 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.0 p -93.28 -14.14 27.36 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 177.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.18 7.13 57.45 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 124.903 1.24 . . . . 0.0 111.349 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.82 163.95 23.06 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 119.084 1.442 . . . . 0.0 107.567 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.2 m -120.5 137.42 54.37 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 103.629 -2.73 . . . . 0.0 103.629 178.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.2 mm -114.69 157.02 15.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 38.1 m -134.73 124.26 24.95 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 127.954 2.502 . . . . 0.0 104.343 178.033 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 29.5 mt -139.93 150.81 45.0 Favored 'General case' 0 CA--C 1.515 -0.373 0 C-N-CA 124.79 1.236 . . . . 0.0 111.589 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -98.25 119.01 36.17 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 127.274 2.23 . . . . 0.0 106.519 178.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.0 m -134.09 -171.19 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 125.949 1.7 . . . . 0.0 108.287 -179.032 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -142.38 161.17 51.52 Favored Pre-proline 0 CA--C 1.536 0.437 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -61.25 -18.01 56.16 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.442 2.095 . . . . 0.0 112.899 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.8 m -114.96 30.97 6.99 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 124.216 1.007 . . . . 0.0 111.402 -177.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -93.06 130.95 38.49 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 126.277 1.831 . . . . 0.0 106.825 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.3 p -77.15 158.18 30.54 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 119.775 1.171 . . . . 0.0 110.301 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.7 mm -63.61 -30.72 50.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.243 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -61.24 -37.36 82.81 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 119.348 0.976 . . . . 0.0 111.554 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -73.46 -53.33 10.89 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 123.94 0.896 . . . . 0.0 108.591 179.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.2 t -55.94 -38.16 51.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 123.035 0.534 . . . . 0.0 110.723 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.8 ttpt -75.14 -16.55 60.52 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 118.172 -0.918 . . . . 0.0 110.952 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.69 -45.38 14.53 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 177.3 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.6 mttm -50.98 -40.17 57.19 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.953 1.301 . . . . 0.0 112.105 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.3 pt -64.71 -27.29 42.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 O-C-N 120.978 -1.076 . . . . 0.0 111.001 179.295 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -76.6 -22.81 53.7 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 119.399 0.999 . . . . 0.0 109.162 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.76 -40.17 63.68 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.731 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.296 87.1 mttt -92.42 -15.32 27.35 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-O 117.435 -1.269 . . . . 0.0 114.257 -179.534 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -140.46 150.58 43.98 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 121.881 2.128 . . . . 0.0 106.682 178.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -83.47 87.15 1.5 Allowed Glycine 0 C--N 1.334 0.428 0 CA-C-O 118.977 -0.902 . . . . 0.0 111.782 -178.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.5 pt -137.46 108.22 8.62 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 124.271 1.028 . . . . 0.0 111.45 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -69.83 170.13 17.39 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 124.786 3.657 . . . . 0.0 110.733 178.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -82.39 54.72 5.05 Favored 'Trans proline' 0 CA--C 1.547 1.143 0 N-CA-C 107.827 -1.644 . . . . 0.0 107.827 177.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -150.53 135.91 17.94 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 127.898 2.479 . . . . 0.0 105.519 -178.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 54.7 mm-40 53.03 46.47 26.69 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 128.024 2.53 . . . . 0.0 106.175 -176.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -156.38 135.93 12.37 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.231 1.012 . . . . 0.0 111.919 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.1 ttm-85 -154.93 136.08 13.93 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 127.13 2.172 . . . . 0.0 105.995 178.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 23.7 tp -87.97 137.37 32.39 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.643 0.777 . . . . 0.0 109.481 -178.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.4 mm -135.3 148.57 28.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 125.644 1.578 . . . . 0.0 108.796 -178.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -138.51 121.13 16.26 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 178.226 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.0 33.52 12.04 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 119.315 0.961 . . . . 0.0 111.353 -179.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.15 -7.79 62.66 Favored Glycine 0 CA--C 1.532 1.099 0 O-C-N 121.298 -0.876 . . . . 0.0 113.123 -179.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.2 tpmt? -78.64 118.11 20.43 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 104.743 -2.317 . . . . 0.0 104.743 179.048 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.5 mp0 -74.95 133.0 41.82 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.2 mt -114.12 155.47 25.96 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.558 1.143 . . . . 0.0 109.837 -178.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -157.25 174.72 15.02 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.458 1.503 . . . . 0.0 108.161 178.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -73.73 159.8 32.44 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.401 1.48 . . . . 0.0 112.327 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 106.07 -27.53 17.03 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 126.46 1.981 . . . . 0.0 109.526 -178.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 46.0 mtt180 -107.39 169.26 8.69 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 118.124 0.962 . . . . 0.0 110.689 178.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 80.4 p -119.02 168.95 10.33 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 126.268 1.827 . . . . 0.0 110.72 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.8 mp -52.4 -42.89 64.43 Favored 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 123.625 0.77 . . . . 0.0 112.784 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 68.9 m -65.81 -32.63 74.27 Favored 'General case' 0 N--CA 1.462 0.125 0 CA-C-N 118.929 0.786 . . . . 0.0 112.535 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -64.09 -44.38 92.5 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -81.45 1.61 32.42 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.592 1.157 . . . . 0.0 111.519 178.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 55.45 46.73 22.59 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 127.167 2.187 . . . . 0.0 112.326 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 15.0 mt -96.18 123.78 48.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 86.8 mm-40 -101.24 178.25 4.71 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.978 1.311 . . . . 0.0 110.609 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.1 pttt -64.47 156.65 28.9 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 122.87 0.468 . . . . 0.0 111.279 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 48.43 41.06 16.13 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.386 2.274 . . . . 0.0 112.585 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.5 p -87.2 153.79 21.22 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.408 1.083 . . . . 0.0 108.082 177.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 14.4 m -118.72 114.57 22.92 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.5 mp -101.07 168.29 9.69 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.786 1.635 . . . . 0.0 110.861 -178.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.7 m80 -119.96 154.76 34.01 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 127.106 2.162 . . . . 0.0 109.327 178.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 16.7 mt -123.44 125.08 44.29 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 178.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.4 m -139.79 166.15 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 CA-C-N 120.789 1.631 . . . . 0.0 113.436 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.464 0.259 0 C-N-CA 125.983 1.713 . . . . 0.0 110.898 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.3 ttt . . . . . 0 N--CA 1.473 0.676 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -120.77 158.72 26.92 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 114.668 1.359 . . . . 0.0 114.668 -177.126 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.9 pp -131.57 168.78 23.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 176.409 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -126.66 149.79 49.33 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 125.262 1.425 . . . . 0.0 108.106 179.145 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.8 t -138.68 125.47 25.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -89.99 116.39 28.0 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 103.085 -2.932 . . . . 0.0 103.085 177.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.5 p -72.55 168.75 17.93 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 122.574 1.178 . . . . 0.0 113.294 -178.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -67.75 -12.64 60.98 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 114.648 -1.16 . . . . 0.0 111.094 178.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 65.9 p -102.64 -12.56 17.61 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.771 1.169 . . . . 0.0 110.882 179.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.61 7.31 34.37 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 124.883 1.23 . . . . 0.0 114.89 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.2 mmmm -80.88 165.24 22.0 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 120.069 1.935 . . . . 0.0 108.053 178.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 83.7 m -119.06 130.4 55.6 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 104.233 -2.506 . . . . 0.0 104.233 178.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.0 mm -115.78 154.2 17.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 125.398 1.479 . . . . 0.0 107.775 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.2 m -135.13 128.59 32.43 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 178.247 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 74.4 mt -139.8 150.47 44.76 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 118.678 0.672 . . . . 0.0 111.05 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -94.32 118.48 31.66 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.231 1.412 . . . . 0.0 107.771 178.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.8 m -134.57 179.23 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 126.581 1.953 . . . . 0.0 108.461 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -147.98 162.69 30.22 Favored Pre-proline 0 CA--C 1.536 0.42 0 O-C-N 120.908 -1.12 . . . . 0.0 109.401 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -51.95 -22.56 14.55 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.773 2.982 . . . . 0.0 115.572 -179.038 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.6 t -114.6 30.92 6.98 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 119.951 1.251 . . . . 0.0 111.051 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -95.22 129.4 42.36 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 103.759 -2.682 . . . . 0.0 103.759 177.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.6 p -76.74 159.53 30.08 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 118.775 0.716 . . . . 0.0 109.764 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 39.8 mm -58.98 -26.0 31.41 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 CA-C-O 118.611 -0.709 . . . . 0.0 110.084 178.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -64.28 -46.18 84.79 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 125.108 1.363 . . . . 0.0 109.645 178.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.5 m-80 -62.22 -52.51 63.46 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.3 t -57.18 -37.36 55.55 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 122.725 0.41 . . . . 0.0 109.922 178.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.7 ttpt -75.02 -19.84 59.89 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 120.903 -1.123 . . . . 0.0 110.547 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.29 -45.36 26.5 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 104.908 -2.256 . . . . 0.0 104.908 177.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.6 mttm -54.53 -43.29 71.8 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.156 1.382 . . . . 0.0 111.385 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.1 pt -63.81 -28.24 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-N 120.148 1.34 . . . . 0.0 110.456 178.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -76.16 -22.64 55.16 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 119.926 1.239 . . . . 0.0 110.897 -179.168 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.27 -23.24 51.2 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 177.525 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -99.56 -23.96 14.91 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 114.387 1.255 . . . . 0.0 114.387 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -152.37 149.54 28.73 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 178.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -88.78 87.15 1.47 Allowed Glycine 0 CA--C 1.519 0.296 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.2 pt -132.23 107.4 13.54 Favored Pre-proline 0 CA--C 1.539 0.548 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.23 156.86 15.45 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.062 2.508 . . . . 0.0 113.315 -179.301 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -83.31 55.96 5.25 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.572 2.181 . . . . 0.0 107.763 178.29 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -156.6 137.53 13.49 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 128.585 2.754 . . . . 0.0 106.165 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 50.56 45.27 26.84 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 127.405 2.282 . . . . 0.0 108.228 -178.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -157.75 135.46 10.59 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 129.042 2.937 . . . . 0.0 106.212 178.309 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.7 ttm105 -151.66 141.06 21.52 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 121.424 1.92 . . . . 0.0 106.539 177.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.416 ' O ' HD13 ' A' ' 44' ' ' ILE . 0.5 OUTLIER -88.25 140.19 29.73 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 124.393 1.077 . . . . 0.0 109.48 -178.966 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.416 HD13 ' O ' ' A' ' 43' ' ' LEU . 3.9 mm -135.49 146.41 29.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 125.275 1.43 . . . . 0.0 108.887 -179.206 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -135.82 115.09 12.48 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 125.005 1.322 . . . . 0.0 108.679 178.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.88 41.25 14.23 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.281 1.432 . . . . 0.0 111.771 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.17 -14.95 52.02 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 125.696 1.617 . . . . 0.0 113.959 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.6 tpmt? -79.69 124.82 28.91 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -74.44 137.06 42.38 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 178.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.6 mt -114.01 142.21 46.45 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -152.8 176.28 11.97 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.661 1.984 . . . . 0.0 107.86 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -72.57 159.81 33.3 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 125.457 1.503 . . . . 0.0 111.089 -178.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 105.99 -29.14 11.68 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 127.769 2.604 . . . . 0.0 110.618 -178.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.343 34.3 mtm105 -109.91 168.41 9.44 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 60.9 p -120.49 171.31 8.63 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 126.702 2.001 . . . . 0.0 111.504 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.2 mp -51.26 -41.5 60.43 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 124.358 1.063 . . . . 0.0 111.674 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 11.4 t -59.17 -45.78 90.12 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.418 1.487 . . . . 0.0 110.422 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -62.21 -44.51 96.4 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.969 0.908 . . . . 0.0 110.615 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -82.16 -2.04 50.89 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.926 0.891 . . . . 0.0 112.833 -179.341 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 40.8 t30 53.7 46.34 26.12 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 126.237 1.815 . . . . 0.0 110.631 -179.174 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 93.2 mt -85.02 123.23 39.05 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.153 0 N-CA-C 104.6 -2.37 . . . . 0.0 104.6 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 92.8 mm-40 -89.27 166.79 13.55 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.606 -178.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 46.6 pttt -64.44 155.39 32.77 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.007 178.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 45.33 34.67 1.56 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 128.338 2.655 . . . . 0.0 112.179 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 51.6 m -77.3 160.57 28.75 Favored 'General case' 0 N--CA 1.462 0.174 0 O-C-N 120.908 -1.12 . . . . 0.0 111.42 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.9 m -115.15 113.66 24.27 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.5 mp -108.68 163.51 13.19 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.72 1.608 . . . . 0.0 109.763 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -119.39 162.33 18.99 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.605 1.162 . . . . 0.0 112.131 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.2 mt -121.42 129.91 53.28 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 126.434 1.894 . . . . 0.0 106.37 178.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.4 m -135.42 173.06 14.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 C-N-CA 125.0 1.32 . . . . 0.0 108.695 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.4 pp . . . . . 0 N--CA 1.455 -0.22 0 C-N-CA 123.69 0.796 . . . . 0.0 110.271 179.455 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.9 ttt . . . . . 0 CA--C 1.514 -0.431 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -120.6 156.95 30.56 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.2 pt -132.85 169.8 21.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.553 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 177.479 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -124.9 152.45 44.05 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 125.799 1.64 . . . . 0.0 108.23 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.4 t -138.33 125.13 26.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 178.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -90.64 116.25 28.38 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 104.035 -2.58 . . . . 0.0 104.035 178.077 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 44.1 p -72.42 166.81 21.83 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.317 0.579 . . . . 0.0 110.291 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -67.48 -12.08 59.44 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.199 178.304 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.7 p -96.78 -12.71 23.31 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 127.693 2.397 . . . . 0.0 112.273 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.57 6.43 56.41 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 125.895 1.712 . . . . 0.0 114.074 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -82.99 165.47 19.63 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-N 118.954 1.377 . . . . 0.0 107.322 178.307 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 43.6 m -123.07 132.43 54.1 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.7 mm -107.17 155.47 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 179.001 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.1 m -132.86 130.38 39.68 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 103.76 -2.682 . . . . 0.0 103.76 178.302 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 76.1 mt -139.6 150.52 45.09 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -100.56 118.49 36.84 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 104.189 -2.523 . . . . 0.0 104.189 178.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.6 m -131.89 -170.74 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 125.036 1.334 . . . . 0.0 109.937 -178.239 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -147.34 159.29 42.41 Favored Pre-proline 0 CA--C 1.534 0.345 0 O-C-N 121.007 -1.058 . . . . 0.0 109.972 178.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -56.8 -23.58 51.08 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.971 2.447 . . . . 0.0 114.856 -179.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 43.5 m -115.24 32.59 5.95 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.676 0.79 . . . . 0.0 111.124 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -92.83 129.63 38.69 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 104.125 -2.546 . . . . 0.0 104.125 178.077 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.1 p -77.18 159.5 29.67 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 119.777 1.171 . . . . 0.0 111.833 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.1 mm -63.59 -30.73 50.62 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.003 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -56.39 -39.52 73.12 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.823 0.849 . . . . 0.0 110.551 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -74.79 -55.53 5.74 Favored 'General case' 0 C--O 1.224 -0.275 0 C-N-CA 123.486 0.714 . . . . 0.0 109.339 178.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.6 t -54.02 -46.18 65.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 124.819 1.248 . . . . 0.0 113.068 -177.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -75.0 -15.64 60.65 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.612 0.765 . . . . 0.0 111.137 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.59 -41.63 11.87 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 177.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.0 mttm -53.77 -40.56 66.35 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.231 1.012 . . . . 0.0 110.573 179.189 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 29.2 pt -60.45 -27.22 39.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-O 118.128 -0.939 . . . . 0.0 111.16 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -80.43 -20.17 44.5 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.099 1.36 . . . . 0.0 111.087 179.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -88.46 -24.3 23.03 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.974 1.31 . . . . 0.0 109.11 178.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 32.7 tptt -99.0 -20.54 16.7 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.122 1.769 . . . . 0.0 112.389 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -144.37 150.28 37.51 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.838 2.055 . . . . 0.0 106.174 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -82.28 82.37 1.63 Allowed Glycine 0 C--N 1.333 0.374 0 CA-C-O 118.793 -1.004 . . . . 0.0 111.784 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.7 pt -131.18 108.29 15.0 Favored Pre-proline 0 CA--C 1.546 0.796 0 CA-C-N 118.413 1.107 . . . . 0.0 109.866 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -58.66 155.96 34.55 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.98 3.12 . . . . 0.0 114.001 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -86.2 57.17 3.95 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 123.469 2.779 . . . . 0.0 106.624 177.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -146.15 136.68 24.05 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 129.471 3.109 . . . . 0.0 103.726 -178.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.4 pt20 48.01 50.92 15.28 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.468 1.507 . . . . 0.0 112.29 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -145.41 148.71 33.63 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 121.052 -1.03 . . . . 0.0 110.371 179.116 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -154.59 135.04 13.37 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 125.14 1.376 . . . . 0.0 109.514 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 54.9 tp -89.08 136.55 32.95 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 125.106 1.362 . . . . 0.0 110.178 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.3 mm -133.92 145.88 32.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 125.24 1.416 . . . . 0.0 111.08 -178.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -138.92 126.47 21.84 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 176.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.58 34.76 16.36 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.708 1.203 . . . . 0.0 111.719 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.32 -8.02 59.35 Favored Glycine 0 CA--C 1.531 1.033 0 O-C-N 120.919 -1.113 . . . . 0.0 114.203 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.2 mmtp -92.17 130.37 37.9 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 125.864 1.666 . . . . 0.0 109.169 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -73.68 136.37 43.78 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.794 0.838 . . . . 0.0 108.868 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.9 mt -115.19 150.43 36.11 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 179.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -152.09 176.31 11.67 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -72.18 156.23 39.38 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 122.112 0.958 . . . . 0.0 110.555 -178.318 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.98 -21.14 30.06 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 126.416 1.96 . . . . 0.0 109.855 -178.012 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 40.3 mmt-85 -107.12 169.38 8.59 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.364 1.466 . . . . 0.0 111.948 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.9 p -123.65 167.59 13.77 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.905 1.682 . . . . 0.0 111.327 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -52.41 -47.22 66.41 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.158 0.983 . . . . 0.0 112.39 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.2 t -65.26 -31.43 72.57 Favored 'General case' 0 C--O 1.227 -0.115 0 C-N-CA 123.77 0.828 . . . . 0.0 112.763 -179.124 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -59.6 -47.36 85.87 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 119.996 1.271 . . . . 0.0 109.271 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -82.09 0.69 39.44 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.22 0.608 . . . . 0.0 110.236 178.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.5 t30 53.96 47.49 23.32 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 127.639 2.376 . . . . 0.0 110.646 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.5 mt -85.26 122.5 38.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 104.318 -2.475 . . . . 0.0 104.318 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -92.83 175.35 6.83 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.289 0.566 . . . . 0.0 110.189 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.8 pttt -64.71 156.76 29.36 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.293 0.568 . . . . 0.0 110.295 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 52.72 35.34 18.21 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 128.252 2.621 . . . . 0.0 111.608 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 72.3 m -85.82 158.22 20.03 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 120.848 -1.157 . . . . 0.0 109.467 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 28.3 m -119.16 120.35 36.83 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.612 1.165 . . . . 0.0 110.246 -178.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.2 mp -107.36 162.69 13.69 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.865 1.666 . . . . 0.0 110.722 -179.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -119.91 160.59 22.41 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 126.008 1.723 . . . . 0.0 111.616 179.459 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 90.4 mt -123.64 131.9 53.73 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.427 1.491 . . . . 0.0 110.257 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.4 m -140.5 161.7 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-N 119.63 1.104 . . . . 0.0 111.19 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.466 0.364 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.5 ttt . . . . . 0 CA--C 1.509 -0.618 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -119.29 145.64 45.95 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 124.279 0.987 . . . . 0.0 109.734 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.2 pt -134.17 169.7 21.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 C-N-CA 125.288 1.435 . . . . 0.0 108.077 177.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -124.47 149.91 46.31 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.882 1.673 . . . . 0.0 110.47 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.6 t -139.77 131.57 33.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 177.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -97.58 117.14 31.18 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 105.426 -2.065 . . . . 0.0 105.426 177.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 41.6 p -74.29 165.85 24.47 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 118.522 0.601 . . . . 0.0 111.067 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.452 HD23 HG23 ' A' ' 9' ' ' THR . 1.1 pt? -67.63 -10.54 53.08 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.32 178.28 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.452 HG23 HD23 ' A' ' 8' ' ' LEU . 77.2 p -91.71 -12.46 33.97 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.569 1.547 . . . . 0.0 110.66 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.1 5.88 57.09 Favored Glycine 0 C--N 1.34 0.791 0 C-N-CA 126.177 1.846 . . . . 0.0 112.9 179.086 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.8 164.04 23.01 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 119.151 1.475 . . . . 0.0 107.801 179.538 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 50.1 m -114.08 133.57 55.45 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 102.599 -3.111 . . . . 0.0 102.599 177.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 40.1 mm -114.57 157.87 15.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 C-N-CA 125.849 1.66 . . . . 0.0 107.837 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.6 m -131.36 130.8 43.11 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 128.823 2.849 . . . . 0.0 104.886 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.646 HD11 HG23 ' A' ' 30' ' ' ILE . 12.8 mt -140.17 144.47 36.65 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 124.018 0.927 . . . . 0.0 110.349 179.018 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -105.26 110.5 22.89 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 127.382 2.273 . . . . 0.0 105.621 177.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.1 m -134.34 -169.16 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -141.8 160.6 55.4 Favored Pre-proline 0 C--O 1.238 0.459 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -56.43 -18.55 25.51 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.734 2.29 . . . . 0.0 113.386 178.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 39.1 m -115.66 30.43 7.35 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 119.023 0.828 . . . . 0.0 112.991 -178.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -94.74 134.17 37.63 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 104.993 -2.225 . . . . 0.0 104.993 177.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.1 p -73.54 157.55 36.51 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 119.07 -1.052 . . . . 0.0 109.204 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.2 mm -64.1 -26.29 40.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 177.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -56.58 -42.06 78.0 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.82 1.248 . . . . 0.0 109.647 179.033 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -74.14 -54.93 6.75 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 123.786 0.834 . . . . 0.0 109.73 178.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.7 t -54.32 -40.03 46.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -178.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -75.68 -16.28 60.2 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.395 0.678 . . . . 0.0 111.015 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.58 -41.73 11.82 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.395 1.078 . . . . 0.0 109.142 178.155 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.0 mttm -53.17 -40.46 64.36 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 118.727 0.694 . . . . 0.0 110.129 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.646 HG23 HD11 ' A' ' 15' ' ' LEU . 38.3 pt -62.3 -26.88 41.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 O-C-N 120.703 -1.248 . . . . 0.0 111.665 179.199 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -76.53 -20.11 57.23 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.344 1.058 . . . . 0.0 109.575 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.18 -39.43 40.82 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 177.189 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.3 mttm -88.59 -16.25 33.01 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 -178.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -141.41 150.54 42.48 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 179.286 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -87.08 85.65 1.54 Allowed Glycine 0 CA--C 1.52 0.392 0 O-C-N 121.419 -0.801 . . . . 0.0 111.987 -178.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.0 pt -134.18 107.97 11.38 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 124.608 1.163 . . . . 0.0 108.149 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -69.29 168.46 20.87 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 124.197 3.265 . . . . 0.0 113.755 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -82.35 56.83 5.91 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 122.975 2.45 . . . . 0.0 108.427 177.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -154.1 136.57 15.04 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 129.695 3.198 . . . . 0.0 103.713 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 62.4 mm-40 53.76 50.17 17.61 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.441 1.096 . . . . 0.0 108.333 -178.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -142.0 134.43 28.02 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -178.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 47.5 ttm-85 -159.56 132.27 6.74 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 30.6 tp -99.4 137.25 38.16 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 124.218 1.007 . . . . 0.0 109.47 -178.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.5 mm -135.06 141.9 41.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.235 1.014 . . . . 0.0 109.305 -178.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -138.99 126.1 21.26 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.102 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.02 33.22 14.35 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.027 0.531 . . . . 0.0 110.674 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.42 -16.21 19.58 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 124.74 1.162 . . . . 0.0 112.73 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -79.35 126.52 30.92 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 119.33 1.565 . . . . 0.0 108.133 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.7 mp0 -75.61 137.12 40.55 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.102 -1.074 . . . . 0.0 108.102 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.6 mt -114.26 154.64 27.59 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.716 1.207 . . . . 0.0 108.794 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -162.47 175.25 11.69 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 179.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -72.76 160.96 31.35 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 126.879 2.072 . . . . 0.0 114.078 -177.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.47 -29.39 12.0 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 127.578 2.513 . . . . 0.0 109.081 -178.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 50.0 mtt180 -107.95 169.01 8.88 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 117.979 0.89 . . . . 0.0 110.961 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 37.5 p -117.5 171.58 7.91 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.488 1.115 . . . . 0.0 112.033 -178.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.7 mp -52.2 -41.77 62.97 Favored 'General case' 0 C--O 1.227 -0.128 0 C-N-CA 123.572 0.749 . . . . 0.0 111.157 178.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.1 t -59.21 -46.0 89.62 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.559 1.544 . . . . 0.0 109.983 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -64.2 -39.66 94.45 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 123.533 0.733 . . . . 0.0 110.152 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -84.68 -0.69 54.44 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.54 0.736 . . . . 0.0 111.487 179.008 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 61.3 t30 53.85 46.12 26.38 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.887 2.075 . . . . 0.0 112.383 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 84.6 mt -93.7 126.09 46.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 -179.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -100.48 172.68 6.97 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 123.963 0.905 . . . . 0.0 111.19 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 49.2 pttt -66.62 156.77 34.22 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 54.92 35.58 24.78 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.511 1.524 . . . . 0.0 111.778 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.0 p -86.79 158.53 19.35 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 120.323 -1.486 . . . . 0.0 107.485 177.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 26.7 m -126.12 119.91 28.79 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 178.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.7 mp -106.06 169.53 8.44 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.252 1.021 . . . . 0.0 110.873 -179.138 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 21.4 m80 -118.54 153.07 34.82 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.865 1.666 . . . . 0.0 108.694 178.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 17.9 mt -123.03 126.47 47.17 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.866 1.666 . . . . 0.0 106.72 178.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.1 m -139.03 172.61 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 124.538 1.135 . . . . 0.0 111.367 -178.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.532 0.276 0 C-N-CA 125.251 1.42 . . . . 0.0 108.085 177.216 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 ttt . . . . . 0 N--CA 1.467 0.424 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -121.0 151.66 39.49 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 177.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 28.7 pt -132.84 169.62 21.65 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 178.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -123.13 151.85 41.69 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 124.517 1.127 . . . . 0.0 108.913 179.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 56.7 t -137.32 127.01 37.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 106.56 -1.645 . . . . 0.0 106.56 178.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -94.24 116.56 28.96 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 103.981 -2.6 . . . . 0.0 103.981 177.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.6 p -77.75 168.1 20.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 118.418 0.554 . . . . 0.0 110.335 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -67.23 -12.51 60.25 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.204 1.001 . . . . 0.0 111.512 178.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.5 p -93.74 -12.67 28.65 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.819 1.648 . . . . 0.0 111.129 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.06 7.3 56.39 Favored Glycine 0 CA--C 1.531 1.067 0 O-C-N 121.365 -0.834 . . . . 0.0 111.917 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.8 164.62 22.57 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 119.055 1.428 . . . . 0.0 107.276 179.023 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.5 m -121.73 131.75 54.25 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 105.05 -2.204 . . . . 0.0 105.05 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.1 mm -114.64 157.18 15.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 105.689 -1.967 . . . . 0.0 105.689 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 56.0 m -134.33 125.47 27.7 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 104.067 -2.568 . . . . 0.0 104.067 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.5 mt -137.73 147.72 44.99 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -104.89 107.11 17.91 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 127.561 2.344 . . . . 0.0 106.322 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.8 m -127.89 -168.45 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 125.791 1.636 . . . . 0.0 109.2 -178.103 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -141.85 159.53 59.2 Favored Pre-proline 0 N--CA 1.451 -0.377 0 C-N-CA 124.09 0.956 . . . . 0.0 109.654 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -55.44 -17.02 15.29 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.856 3.037 . . . . 0.0 113.004 178.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.7 m -114.23 31.31 6.67 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 124.03 0.932 . . . . 0.0 112.575 -178.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -98.8 132.22 44.32 Favored 'General case' 0 C--O 1.242 0.666 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 176.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -72.66 157.89 36.67 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 119.42 1.009 . . . . 0.0 110.998 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.8 mm -63.71 -29.74 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 177.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -53.37 -48.9 68.19 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.96 1.304 . . . . 0.0 109.729 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 41.6 m-20 -67.83 -52.87 31.83 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.846 0.858 . . . . 0.0 109.551 179.16 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.2 t -54.04 -42.92 57.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 123.736 0.815 . . . . 0.0 111.381 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 20.0 ttpt -75.53 -16.04 60.32 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 118.432 -0.794 . . . . 0.0 111.094 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -88.07 -43.66 11.52 Favored 'General case' 0 C--O 1.226 -0.165 0 CA-C-N 119.857 1.208 . . . . 0.0 108.244 177.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -50.08 -40.0 44.15 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.0 1.32 . . . . 0.0 110.434 179.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 35.8 pt -66.09 -25.26 35.41 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 O-C-N 121.267 -0.896 . . . . 0.0 112.584 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -76.16 -23.84 54.78 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 120.014 1.279 . . . . 0.0 109.094 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.88 -39.14 57.0 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.243 -0.911 . . . . 0.0 108.641 179.059 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.0 mttm -89.72 -19.91 24.21 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 115.99 1.848 . . . . 0.0 115.99 -179.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -136.53 158.86 43.45 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 121.819 2.099 . . . . 0.0 108.886 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.01 63.43 4.3 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 110.524 -1.03 . . . . 0.0 110.524 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.5 pt -131.38 107.3 14.62 Favored Pre-proline 0 CA--C 1.538 0.503 0 CA-C-N 117.91 0.855 . . . . 0.0 108.718 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -77.13 169.94 20.55 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 123.925 3.084 . . . . 0.0 109.805 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -76.56 58.64 5.93 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 123.087 2.524 . . . . 0.0 108.19 177.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -146.82 135.41 22.04 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 128.926 2.891 . . . . 0.0 105.319 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.6 mm-40 52.17 48.15 23.28 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.234 1.814 . . . . 0.0 108.368 -177.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -154.85 134.9 13.04 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.526 1.131 . . . . 0.0 109.62 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.0 ttm-85 -151.2 133.52 15.37 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 101.986 -3.339 . . . . 0.0 101.986 178.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.4 tp -87.9 142.01 28.13 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -177.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.2 mm -134.21 144.94 33.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 125.02 1.328 . . . . 0.0 109.584 -178.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -135.54 115.76 13.42 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 177.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.31 42.86 26.36 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.389 1.076 . . . . 0.0 110.692 -179.09 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.25 -13.93 30.72 Favored Glycine 0 CA--C 1.531 1.037 0 CA-C-O 118.519 -1.156 . . . . 0.0 114.518 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.9 ttmt -79.59 125.87 30.16 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 120.671 2.235 . . . . 0.0 107.554 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.4 mp0 -74.74 136.2 41.76 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 179.282 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.8 mt -122.34 153.35 39.09 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.618 1.167 . . . . 0.0 109.757 -178.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -160.09 175.69 12.66 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 124.679 1.192 . . . . 0.0 108.755 178.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -71.73 158.17 36.61 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 122.78 1.276 . . . . 0.0 111.86 -177.217 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 108.59 -29.44 9.94 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 127.448 2.452 . . . . 0.0 108.591 -177.191 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 46.4 mtt180 -107.75 165.56 11.35 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.0 1.72 . . . . 0.0 111.76 178.198 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 65.9 p -117.61 173.92 6.45 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.299 1.839 . . . . 0.0 112.655 -178.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.9 mp -52.14 -49.9 62.81 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 123.678 0.791 . . . . 0.0 111.541 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.55 -31.56 72.37 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 112.351 0.501 . . . . 0.0 112.351 -179.034 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -65.29 -47.15 77.62 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.415 1.007 . . . . 0.0 109.325 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -81.29 -2.5 49.22 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.1 t30 57.68 46.94 16.57 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 130.363 3.465 . . . . 0.0 112.215 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 79.3 mt -85.71 123.19 39.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 105.531 -2.026 . . . . 0.0 105.531 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 75.1 mm-40 -95.47 173.47 7.49 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 123.255 0.622 . . . . 0.0 109.747 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 43.6 pttt -69.72 157.0 38.12 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.116 0.484 . . . . 0.0 110.783 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 53.58 38.8 29.04 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 127.154 2.182 . . . . 0.0 110.992 -179.127 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.4 p -87.26 163.23 16.98 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.957 1.303 . . . . 0.0 109.459 178.383 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 93.7 m -126.05 110.22 13.3 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.7 mp -98.5 160.19 14.44 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 126.233 1.813 . . . . 0.0 108.53 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 45.1 m80 -119.28 160.37 22.34 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 124.982 1.313 . . . . 0.0 110.161 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.7 mt -122.82 126.76 48.01 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 104.964 -2.236 . . . . 0.0 104.964 177.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.2 m -140.62 161.45 24.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 CA-C-O 121.447 0.641 . . . . 0.0 110.421 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.237 0.428 0 C-N-CA 124.32 1.048 . . . . 0.0 108.585 177.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.7 ttt . . . . . 0 N--CA 1.47 0.535 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -120.64 151.1 39.91 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 178.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 32.5 pt -132.53 170.08 20.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 C-N-CA 124.929 1.292 . . . . 0.0 108.014 178.176 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -126.22 150.85 48.09 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.934 1.294 . . . . 0.0 109.005 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.0 t -138.52 133.07 42.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 178.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -103.03 118.35 36.61 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.213 1.005 . . . . 0.0 108.428 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 48.5 p -72.57 171.05 13.15 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.712 0.768 . . . . 0.0 110.059 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -70.45 -12.49 61.61 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.834 -0.541 . . . . 0.0 111.457 177.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.0 p -94.03 -12.1 29.34 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 126.409 1.884 . . . . 0.0 112.627 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.85 7.5 50.43 Favored Glycine 0 C--N 1.339 0.741 0 C-N-CA 124.0 0.81 . . . . 0.0 113.764 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -80.56 164.66 22.77 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 119.017 1.408 . . . . 0.0 107.279 179.302 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 86.9 m -123.65 132.34 53.83 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 103.523 -2.769 . . . . 0.0 103.523 177.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.5 mm -115.05 148.3 17.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 105.577 -2.009 . . . . 0.0 105.577 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 78.5 m -124.42 126.15 45.46 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 105.312 -2.106 . . . . 0.0 105.312 178.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.6 mt -128.72 150.66 50.17 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 118.339 0.518 . . . . 0.0 110.302 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -101.47 115.54 30.73 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 103.257 -2.868 . . . . 0.0 103.257 178.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.1 m -131.26 -169.92 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 124.415 1.086 . . . . 0.0 109.457 -178.141 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -143.66 160.84 49.26 Favored Pre-proline 0 N--CA 1.448 -0.568 0 C-N-CA 126.264 1.826 . . . . 0.0 106.591 178.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -58.09 -18.15 34.94 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.864 2.376 . . . . 0.0 113.079 178.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.6 m -116.25 32.95 5.81 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.827 1.251 . . . . 0.0 112.148 -179.156 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -90.29 128.86 36.53 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 103.187 -2.894 . . . . 0.0 103.187 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.5 p -77.8 159.03 29.28 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 118.965 0.802 . . . . 0.0 112.659 -177.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 23.9 mm -63.56 -29.81 48.23 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.324 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 178.283 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -59.0 -42.1 89.25 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.2 0.909 . . . . 0.0 110.44 179.308 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -73.88 -52.75 11.94 Favored 'General case' 0 CA--C 1.521 -0.166 0 C-N-CA 124.665 1.186 . . . . 0.0 109.792 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.4 t -57.44 -38.39 62.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-N 119.62 1.1 . . . . 0.0 110.585 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -74.64 -14.27 60.74 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.208 -0.933 . . . . 0.0 110.592 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.98 -47.19 8.01 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 176.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.6 mttm -49.46 -40.31 36.61 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.333 1.853 . . . . 0.0 111.017 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 36.6 pt -65.69 -28.05 43.09 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-N 118.81 0.732 . . . . 0.0 112.556 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -76.28 -23.06 54.38 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 119.946 1.248 . . . . 0.0 109.742 -178.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.44 -36.3 45.63 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 178.232 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -86.55 -21.47 26.88 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 114.144 1.164 . . . . 0.0 114.144 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -147.51 150.99 35.6 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 120.99 1.723 . . . . 0.0 106.778 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.1 80.99 1.66 Allowed Glycine 0 CA--C 1.521 0.408 0 CA-C-O 119.244 -0.753 . . . . 0.0 111.846 -179.124 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.2 pt -133.95 106.14 11.53 Favored Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 106.773 -1.565 . . . . 0.0 106.773 178.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -62.87 166.09 14.85 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 124.571 3.514 . . . . 0.0 115.462 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -83.02 55.9 5.37 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.599 2.199 . . . . 0.0 108.295 177.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -147.26 134.52 20.6 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 128.839 2.856 . . . . 0.0 105.247 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.7 mm-40 47.76 49.36 16.66 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.858 1.663 . . . . 0.0 108.032 -177.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -143.67 134.09 24.71 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 60.3 ttm-85 -156.24 133.82 10.93 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 125.978 1.711 . . . . 0.0 106.868 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 22.1 tp -87.9 140.88 29.06 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -178.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.0 mm -131.53 143.87 39.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 126.036 1.734 . . . . 0.0 109.376 -178.162 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -138.38 124.58 20.33 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 178.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.79 36.07 20.37 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.464 1.106 . . . . 0.0 110.439 -179.039 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.18 -14.09 29.48 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 125.343 1.449 . . . . 0.0 113.502 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.1 ttmt -79.57 129.3 34.35 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 119.752 1.776 . . . . 0.0 108.258 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.9 mp0 -74.59 137.42 42.32 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 178.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.422 HD22 ' CD1' ' A' ' 59' ' ' TYR . 7.6 mt -113.21 155.33 25.24 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.252 1.021 . . . . 0.0 108.352 -178.657 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -151.87 175.15 12.76 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.673 1.189 . . . . 0.0 109.446 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -72.75 157.97 36.48 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 125.229 1.412 . . . . 0.0 111.127 -178.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.17 -21.25 38.22 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 126.226 1.87 . . . . 0.0 110.383 -178.23 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 39.4 mtt180 -108.28 168.95 8.94 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 118.37 1.085 . . . . 0.0 113.534 178.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 49.0 p -117.45 172.46 7.31 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.945 2.098 . . . . 0.0 111.068 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -51.96 -50.67 60.78 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.286 1.435 . . . . 0.0 112.622 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.06 -31.83 73.25 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 123.021 0.528 . . . . 0.0 112.258 -178.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -60.25 -44.95 94.83 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 119.449 1.022 . . . . 0.0 109.469 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.422 ' CD1' HD22 ' A' ' 50' ' ' LEU . 76.7 m-85 -82.27 1.22 37.78 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.189 0.595 . . . . 0.0 111.085 178.19 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 57.89 46.84 16.12 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 128.405 2.682 . . . . 0.0 110.794 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.3 mt -85.82 122.64 38.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 105.013 -2.218 . . . . 0.0 105.013 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -97.62 177.46 5.49 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.73 0.812 . . . . 0.0 108.94 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 43.9 pttt -68.19 156.56 37.3 Favored 'General case' 0 C--O 1.239 0.531 0 O-C-N 121.681 -0.637 . . . . 0.0 110.87 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 49.52 35.05 7.62 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.613 1.965 . . . . 0.0 111.088 -178.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.4 p -77.16 158.24 30.49 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 178.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 59.9 m -125.47 110.64 14.15 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.4 mp -96.04 165.67 12.14 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 124.429 1.091 . . . . 0.0 109.814 -178.617 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 25.3 m80 -118.77 156.34 29.55 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 125.423 1.489 . . . . 0.0 110.19 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 25.7 mt -123.34 124.68 43.5 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 178.374 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.1 m -139.12 167.75 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.239 0.534 0 C-N-CA 127.154 2.182 . . . . 0.0 109.687 178.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 ttp . . . . . 0 N--CA 1.467 0.394 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -120.69 157.1 30.34 Favored 'General case' 0 CA--C 1.53 0.18 0 O-C-N 121.1 -1.0 . . . . 0.0 112.146 -178.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.3 pt -132.81 169.32 22.23 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 176.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -126.44 152.19 46.72 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.806 1.242 . . . . 0.0 107.822 179.156 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.9 t -138.96 128.49 30.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.2 tppp? -96.23 117.86 31.63 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 119.081 0.855 . . . . 0.0 109.485 178.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.8 p -81.09 165.62 21.46 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.051 0.94 . . . . 0.0 110.433 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.43 -4.88 12.49 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.062 0.945 . . . . 0.0 113.212 178.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.0 p -92.41 -12.61 31.76 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.487 1.115 . . . . 0.0 110.704 178.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.88 5.93 58.3 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 125.806 1.67 . . . . 0.0 111.434 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.56 164.24 16.2 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.351 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.6 m -123.97 142.46 51.14 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 178.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.3 mm -114.79 155.21 16.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 C-N-CA 126.557 1.943 . . . . 0.0 106.169 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 54.8 m -126.23 128.15 46.76 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 104.124 -2.547 . . . . 0.0 104.124 178.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.4 mt -133.21 150.07 51.98 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -105.14 110.97 23.56 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 103.671 -2.715 . . . . 0.0 103.671 178.099 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.3 m -134.72 -174.78 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -146.44 166.7 15.9 Favored Pre-proline 0 C--N 1.327 -0.372 0 O-C-N 120.842 -1.161 . . . . 0.0 109.508 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -54.27 -18.81 15.07 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.096 2.531 . . . . 0.0 114.034 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.4 m -115.03 31.22 6.83 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 123.922 0.889 . . . . 0.0 112.453 -178.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -99.08 130.05 45.38 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 103.94 -2.615 . . . . 0.0 103.94 176.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.9 p -78.06 158.14 29.3 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 119.425 1.011 . . . . 0.0 111.711 -178.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.3 mm -63.77 -28.27 44.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -57.1 -42.79 81.43 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.881 0.872 . . . . 0.0 109.383 178.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -73.04 -52.54 13.97 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 124.889 1.275 . . . . 0.0 109.417 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.3 t -54.74 -38.42 43.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-N 119.227 0.921 . . . . 0.0 110.764 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -74.82 -15.55 60.73 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 121.252 -0.905 . . . . 0.0 111.642 -179.262 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.9 -45.27 8.86 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.552 1.541 . . . . 0.0 108.193 176.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.8 mttm -50.44 -40.4 50.31 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.608 1.563 . . . . 0.0 110.406 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 36.1 pt -64.07 -25.34 37.87 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 O-C-N 121.54 -0.725 . . . . 0.0 112.113 178.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -76.27 -23.64 54.45 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 120.145 1.339 . . . . 0.0 109.262 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.99 -36.33 41.5 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.6 mmtt -85.65 -22.11 28.08 Favored 'General case' 0 C--N 1.337 0.061 0 CA-C-O 117.391 -1.29 . . . . 0.0 114.204 -178.303 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -150.63 158.04 43.68 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 121.582 1.992 . . . . 0.0 108.808 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.7 82.35 1.59 Allowed Glycine 0 C--N 1.333 0.366 0 N-CA-C 111.843 -0.503 . . . . 0.0 111.843 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.4 pt -140.89 106.62 6.3 Favored Pre-proline 0 CA--C 1.543 0.692 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -71.1 169.59 20.2 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 124.763 3.642 . . . . 0.0 112.658 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -78.65 56.91 6.11 Favored 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 123.054 2.503 . . . . 0.0 109.6 177.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -146.84 130.13 16.62 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 127.857 2.463 . . . . 0.0 104.639 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.2 mm-40 51.01 53.52 12.91 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -177.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -143.06 133.1 24.27 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.275 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 55.8 ttm-85 -161.57 133.33 5.58 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 125.853 1.661 . . . . 0.0 107.174 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 24.2 tp -88.64 142.5 27.63 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.309 1.044 . . . . 0.0 109.674 -178.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.7 mm -135.03 144.56 34.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 125.908 1.683 . . . . 0.0 109.955 -178.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -133.45 117.23 16.95 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 106.714 -1.588 . . . . 0.0 106.714 178.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.57 43.46 20.24 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.933 1.293 . . . . 0.0 111.141 -179.055 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.45 -17.67 13.34 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-O 118.351 -1.249 . . . . 0.0 114.635 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.3 ttmt -79.25 128.71 33.65 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 120.603 2.201 . . . . 0.0 107.149 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.4 mp0 -74.56 136.87 42.11 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.51 HD22 ' CD1' ' A' ' 59' ' ' TYR . 8.9 mt -113.19 155.05 25.71 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -178.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -151.99 175.05 12.91 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 124.381 1.072 . . . . 0.0 109.076 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -73.05 160.03 32.68 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 126.197 1.799 . . . . 0.0 111.412 -179.079 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.0 -27.51 19.16 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 126.271 1.891 . . . . 0.0 109.85 -178.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.9 mtt180 -107.11 170.52 7.9 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.95 1.3 . . . . 0.0 111.449 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 67.2 p -117.3 171.01 8.25 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 127.108 2.163 . . . . 0.0 111.905 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.21 -48.56 65.03 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.06 0.944 . . . . 0.0 112.419 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.03 -31.72 73.01 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 118.932 -0.556 . . . . 0.0 111.512 -179.121 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -61.13 -44.03 97.96 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 119.352 0.978 . . . . 0.0 108.696 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.51 ' CD1' HD22 ' A' ' 50' ' ' LEU . 92.7 m-85 -82.0 1.7 34.33 Favored 'General case' 0 C--O 1.237 0.4 0 O-C-N 121.603 -0.686 . . . . 0.0 110.814 178.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 52.9 t30 56.48 47.19 19.25 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 127.087 2.155 . . . . 0.0 110.07 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.5 mt -84.48 122.79 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -178.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 57.2 mm-40 -89.57 169.14 11.6 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.447 -0.797 . . . . 0.0 108.995 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 51.8 pttt -69.18 156.73 38.22 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.012 0.434 . . . . 0.0 111.354 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 49.55 34.2 6.69 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 128.407 2.683 . . . . 0.0 111.5 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.2 p -80.17 163.95 23.68 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.2 m -125.31 112.51 16.45 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.1 mp -96.19 168.14 10.77 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.961 1.304 . . . . 0.0 108.666 -179.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.3 m80 -119.64 154.92 33.27 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.155 1.382 . . . . 0.0 109.878 179.189 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 18.1 mt -123.22 123.47 40.85 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 103.866 -2.642 . . . . 0.0 103.866 177.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.7 m -141.59 170.96 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-N 120.06 1.3 . . . . 0.0 113.635 -179.041 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.235 0.332 0 C-N-CA 126.354 1.862 . . . . 0.0 109.576 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.8 ttt . . . . . 0 N--CA 1.471 0.59 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -120.82 157.14 30.4 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 178.345 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.7 pt -132.69 169.4 22.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 178.043 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -126.13 151.01 47.83 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.2 t -138.52 129.6 35.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 179.054 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.4 tppt? -96.24 119.08 34.09 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 177.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 45.7 p -71.15 167.25 19.73 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 118.663 0.665 . . . . 0.0 109.352 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -67.72 -12.96 61.65 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 119.201 -0.428 . . . . 0.0 111.191 178.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.4 p -94.1 -12.48 28.39 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.815 1.246 . . . . 0.0 111.273 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.41 7.77 48.19 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-N 118.845 0.748 . . . . 0.0 113.524 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.22 164.82 23.87 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 104.507 -2.405 . . . . 0.0 104.507 178.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 45.1 m -123.2 131.21 53.6 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 -179.037 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.8 mm -116.28 155.25 17.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 127.531 2.332 . . . . 0.0 107.802 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.6 m -135.18 130.4 35.29 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 128.146 2.578 . . . . 0.0 105.428 178.51 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 79.5 mt -139.01 151.27 46.69 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.722 1.147 . . . . 0.0 110.84 -179.365 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -102.28 117.94 35.82 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 179.009 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.7 m -131.28 -170.67 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 124.622 1.169 . . . . 0.0 109.982 -177.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -144.1 160.66 48.5 Favored Pre-proline 0 C--O 1.238 0.494 0 N-CA-C 106.517 -1.661 . . . . 0.0 106.517 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -57.96 -17.98 33.26 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.461 2.108 . . . . 0.0 112.941 178.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 29.3 m -114.64 31.62 6.52 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 119.219 0.918 . . . . 0.0 111.464 -178.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -91.27 129.42 37.26 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 101.302 -3.592 . . . . 0.0 101.302 177.181 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.0 p -71.03 158.25 36.83 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 121.392 -0.817 . . . . 0.0 109.439 -178.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.0 mm -63.33 -29.35 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 178.04 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -56.27 -49.32 74.53 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 126.045 1.738 . . . . 0.0 108.834 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 20.1 m-80 -65.43 -52.15 55.26 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 124.67 1.188 . . . . 0.0 109.552 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 84.4 t -54.05 -44.03 61.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 123.328 0.651 . . . . 0.0 110.744 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 24.2 ttpt -75.57 -12.83 60.3 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.279 1.032 . . . . 0.0 112.166 -178.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.04 -46.93 8.16 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.608 1.563 . . . . 0.0 107.513 177.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.4 mttm -50.98 -40.51 58.06 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.405 1.482 . . . . 0.0 110.418 179.129 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 43.3 pt -64.58 -25.69 38.48 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 O-C-N 121.334 -0.854 . . . . 0.0 112.31 178.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -76.35 -22.77 54.46 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 120.598 1.545 . . . . 0.0 109.262 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -82.27 -22.94 35.53 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.737 1.215 . . . . 0.0 108.607 177.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.1 mmtt -97.68 -16.01 20.14 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 120.481 -1.387 . . . . 0.0 114.347 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -152.04 160.68 43.39 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 121.116 1.78 . . . . 0.0 107.063 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.02 70.98 2.97 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.8 pt -130.8 108.27 15.52 Favored Pre-proline 0 CA--C 1.543 0.703 0 CA-C-N 117.988 0.894 . . . . 0.0 110.752 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -77.82 169.74 20.18 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.822 3.015 . . . . 0.0 110.092 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -79.19 57.0 6.27 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.855 2.37 . . . . 0.0 109.195 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -150.61 135.32 17.38 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 127.206 2.203 . . . . 0.0 105.862 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 55.2 mm-40 53.89 48.78 20.49 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.799 1.64 . . . . 0.0 106.788 -177.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -146.19 143.07 29.03 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 123.711 0.805 . . . . 0.0 110.535 -178.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 43.9 ttm-85 -162.3 134.06 5.38 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.879 1.218 . . . . 0.0 108.289 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 18.9 tp -93.21 140.01 29.99 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.627 1.171 . . . . 0.0 111.204 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.5 mm -135.54 145.35 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 126.229 1.812 . . . . 0.0 108.816 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -139.11 119.77 14.12 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.923 1.289 . . . . 0.0 108.376 178.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.72 35.2 17.85 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.233 1.013 . . . . 0.0 111.151 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.55 -13.75 33.42 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 124.887 1.232 . . . . 0.0 113.248 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.5 ttmt -80.56 129.76 34.71 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 119.484 1.642 . . . . 0.0 107.746 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.8 mp0 -74.47 134.05 42.33 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 51.6 mt -114.01 148.96 36.1 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.576 1.15 . . . . 0.0 108.571 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -151.55 176.73 11.05 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 124.868 1.267 . . . . 0.0 108.217 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.29 160.59 32.14 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.793 1.637 . . . . 0.0 111.767 -177.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.32 -25.6 26.48 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 125.53 1.538 . . . . 0.0 111.243 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 42.7 mtt180 -108.09 168.85 9.0 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.554 1.141 . . . . 0.0 112.908 178.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.4 p -117.71 169.48 9.55 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.876 1.67 . . . . 0.0 109.167 178.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.0 mp -52.5 -43.1 64.85 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.207 0.603 . . . . 0.0 111.202 178.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.1 t -58.2 -45.91 86.77 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 125.916 1.686 . . . . 0.0 111.156 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -59.74 -45.2 92.96 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 118.586 0.63 . . . . 0.0 109.973 -178.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -82.1 1.71 34.71 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.492 0.717 . . . . 0.0 112.088 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.6 t30 55.45 46.42 23.23 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 127.581 2.352 . . . . 0.0 111.026 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 40.6 mt -86.09 123.05 39.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -93.64 169.98 9.92 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.264 0.554 . . . . 0.0 111.469 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.7 pttt -66.32 156.98 32.88 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.237 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 51.22 37.52 18.71 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 126.41 1.884 . . . . 0.0 112.001 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.7 p -87.13 164.15 16.57 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.761 1.224 . . . . 0.0 108.615 178.148 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.9 m -125.93 113.92 17.83 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.4 mp -96.91 161.64 13.75 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.259 1.023 . . . . 0.0 109.09 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 17.2 m80 -115.78 156.4 26.1 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.903 1.281 . . . . 0.0 109.85 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.8 mt -122.83 124.87 44.28 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.026 1.73 . . . . 0.0 107.891 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 23.3 m -141.38 171.57 11.77 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 124.795 1.238 . . . . 0.0 113.753 -178.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.534 0.345 0 C-N-CA 125.485 1.514 . . . . 0.0 108.389 176.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.4 ttt . . . . . 0 N--CA 1.474 0.73 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -121.51 157.27 31.03 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.226 0.611 . . . . 0.0 109.813 178.094 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.7 pt -132.75 171.12 18.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 C-N-CA 125.493 1.517 . . . . 0.0 107.668 177.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -126.19 152.49 45.96 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.188 0.995 . . . . 0.0 108.623 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.3 t -138.34 128.8 35.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.2 tptp -96.64 117.53 31.18 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.3 p -77.03 166.15 23.69 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 118.511 0.596 . . . . 0.0 110.084 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -71.34 -10.09 59.2 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 121.651 -0.656 . . . . 0.0 111.615 178.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -91.85 -10.96 37.84 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 128.368 2.667 . . . . 0.0 111.737 -179.392 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.45 7.09 56.2 Favored Glycine 0 C--N 1.34 0.797 0 C-N-CA 125.605 1.574 . . . . 0.0 114.137 178.249 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.2 mmmm -80.53 166.66 20.96 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 119.089 1.444 . . . . 0.0 109.622 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.5 m -123.72 131.28 53.57 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 103.453 -2.795 . . . . 0.0 103.453 177.149 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.5 mm -116.43 156.24 17.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 126.338 1.855 . . . . 0.0 107.214 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.1 m -132.93 128.9 37.51 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.156 1.782 . . . . 0.0 106.504 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.9 mt -139.47 151.0 45.85 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.188 0.995 . . . . 0.0 111.322 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -97.54 117.84 32.71 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 127.005 2.122 . . . . 0.0 105.383 178.009 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.1 m -134.91 -175.61 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 125.071 1.349 . . . . 0.0 109.631 -179.08 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -144.41 164.27 29.56 Favored Pre-proline 0 CA--C 1.532 0.278 0 C-N-CA 124.323 1.049 . . . . 0.0 109.817 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -57.87 -18.87 36.68 Favored 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 122.87 2.38 . . . . 0.0 113.865 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.3 m -115.86 31.65 6.58 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 119.21 0.914 . . . . 0.0 110.856 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -92.45 128.81 38.44 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 102.294 -3.224 . . . . 0.0 102.294 177.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.4 p -78.53 158.14 28.64 Favored 'General case' 0 CA--C 1.519 -0.232 0 O-C-N 121.2 -0.938 . . . . 0.0 110.917 -178.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.7 mm -64.08 -25.45 38.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 177.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -56.29 -49.83 73.16 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.518 1.127 . . . . 0.0 108.63 178.022 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -66.44 -52.63 44.35 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.851 1.26 . . . . 0.0 109.842 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.7 t -55.42 -38.62 49.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-N 118.623 0.647 . . . . 0.0 110.903 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -75.27 -18.11 60.15 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 120.956 -1.09 . . . . 0.0 111.412 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.93 -45.03 9.5 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.532 1.533 . . . . 0.0 110.328 178.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.4 mttm -54.31 -40.24 67.76 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 118.631 0.65 . . . . 0.0 111.039 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 34.6 pt -62.59 -24.9 36.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 CA-C-O 119.011 -0.519 . . . . 0.0 111.644 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -77.0 -23.11 52.25 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 120.162 1.346 . . . . 0.0 109.392 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.98 -32.59 26.93 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 176.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 51.2 mmtt -87.17 -15.37 38.55 Favored 'General case' 0 C--N 1.343 0.303 0 N-CA-C 115.499 1.666 . . . . 0.0 115.499 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -150.66 157.89 43.51 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 121.051 1.75 . . . . 0.0 106.567 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -80.99 74.83 2.37 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-O 119.177 -0.791 . . . . 0.0 111.256 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.3 pt -135.82 107.69 9.84 Favored Pre-proline 0 CA--C 1.545 0.784 0 CA-C-N 118.404 1.102 . . . . 0.0 111.155 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -71.13 169.3 20.94 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 123.336 2.691 . . . . 0.0 110.764 178.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -80.52 56.31 6.03 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 122.701 2.267 . . . . 0.0 109.679 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -146.7 135.14 21.92 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 127.874 2.47 . . . . 0.0 105.083 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 71.1 mm-40 50.05 49.97 19.39 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.769 1.628 . . . . 0.0 109.55 -177.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 12.2 m-80 -148.09 134.85 19.99 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.519 1.128 . . . . 0.0 109.52 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 45.8 ttm-85 -153.0 134.18 14.17 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 127.293 2.237 . . . . 0.0 107.475 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 23.3 tp -88.18 139.89 30.04 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.037 1.335 . . . . 0.0 109.154 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.3 mm -132.47 145.9 33.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 125.743 1.617 . . . . 0.0 108.161 -179.188 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -136.62 117.5 14.16 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 124.727 1.211 . . . . 0.0 108.465 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.85 43.53 21.46 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.708 1.203 . . . . 0.0 110.944 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.38 -15.66 22.42 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 124.899 1.237 . . . . 0.0 114.23 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -80.69 124.34 28.93 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 119.874 1.837 . . . . 0.0 107.531 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.5 mp0 -74.47 135.96 42.27 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.7 mt -114.19 156.17 24.76 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 125.187 1.395 . . . . 0.0 109.944 -178.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -151.07 174.14 13.53 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 178.133 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -76.52 159.91 29.94 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.85 1.26 . . . . 0.0 111.761 -179.03 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.01 -27.81 14.96 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 125.811 1.672 . . . . 0.0 109.709 -178.193 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 44.5 mtt180 -106.59 167.04 10.13 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 118.973 1.386 . . . . 0.0 111.353 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.6 p -117.7 170.46 8.76 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 125.995 1.718 . . . . 0.0 111.169 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.6 mp -52.67 -43.56 65.63 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 123.506 0.723 . . . . 0.0 111.869 179.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.7 m -59.78 -38.32 81.54 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 118.632 0.651 . . . . 0.0 112.172 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -62.44 -47.08 85.62 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 123.068 0.547 . . . . 0.0 109.992 -178.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -82.66 1.36 38.81 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.083 0.953 . . . . 0.0 111.698 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 48.0 t30 54.4 46.24 25.45 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 127.53 2.332 . . . . 0.0 111.17 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 81.8 mt -88.25 123.06 40.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 179.099 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -101.47 175.75 5.47 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.265 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.5 pttt -64.81 157.11 28.58 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.285 0.564 . . . . 0.0 110.661 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 55.59 35.64 25.59 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.737 2.015 . . . . 0.0 111.682 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.9 p -86.19 164.17 17.37 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 120.683 -1.261 . . . . 0.0 108.367 178.344 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.9 m -126.03 115.48 19.93 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.3 mp -103.73 160.72 14.53 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.576 1.151 . . . . 0.0 108.779 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 43.3 m80 -119.46 159.62 23.91 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 125.236 1.414 . . . . 0.0 110.13 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 61.8 mt -123.24 124.29 42.66 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 125.188 1.395 . . . . 0.0 109.22 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.8 m -141.01 170.16 14.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -178.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.5 pt? . . . . . 0 C--O 1.236 0.367 0 C-N-CA 127.989 2.516 . . . . 0.0 108.288 178.453 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.6 ttt . . . . . 0 N--CA 1.473 0.686 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -122.31 144.92 48.7 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 177.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.9 pt -132.81 168.86 23.2 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 177.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -126.39 152.27 46.54 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 125.082 1.353 . . . . 0.0 109.327 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.4 t -138.72 131.1 38.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 178.162 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.51 117.8 33.76 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 178.717 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 54.9 p -74.17 171.12 14.15 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.007 0.923 . . . . 0.0 112.191 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -74.99 -7.75 54.54 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.069 177.194 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.3 p -94.61 -13.01 26.35 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.858 1.663 . . . . 0.0 111.15 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.81 6.08 57.29 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 126.565 2.031 . . . . 0.0 113.553 178.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.7 mmmm -81.95 164.84 21.23 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 118.416 1.108 . . . . 0.0 108.031 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.7 m -120.35 132.39 55.26 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 104.2 -2.518 . . . . 0.0 104.2 178.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 22.1 mm -107.7 156.96 8.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 125.949 1.699 . . . . 0.0 106.754 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.0 m -135.29 126.27 27.71 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 179.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.7 mt -140.21 147.39 39.99 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.335 1.054 . . . . 0.0 111.199 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -104.9 106.73 17.35 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 126.694 1.998 . . . . 0.0 107.585 178.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.2 m -135.7 -170.63 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 125.041 1.336 . . . . 0.0 108.457 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -147.24 167.94 12.45 Favored Pre-proline 0 C--O 1.232 0.165 0 O-C-N 120.615 -1.303 . . . . 0.0 111.047 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -55.56 -17.6 17.57 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 123.058 2.505 . . . . 0.0 112.821 178.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.1 m -112.57 30.2 7.31 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 119.948 1.249 . . . . 0.0 111.773 -177.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -104.48 140.59 37.74 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 107.518 -1.289 . . . . 0.0 107.518 176.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.2 p -78.72 158.29 28.34 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 122.408 1.099 . . . . 0.0 111.258 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.3 mm -64.74 -25.23 37.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 176.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -55.23 -49.61 71.54 Favored 'General case' 0 C--N 1.344 0.351 0 CA-C-N 119.385 0.993 . . . . 0.0 108.834 178.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.7 m-20 -60.37 -52.3 65.84 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.108 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 42.9 t -55.52 -41.36 63.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-O 119.111 -0.471 . . . . 0.0 111.231 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -74.74 -18.36 60.51 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-N 119.275 0.943 . . . . 0.0 111.424 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.24 -46.13 9.01 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 119.652 1.115 . . . . 0.0 108.432 177.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -53.41 -40.21 64.93 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.519 1.128 . . . . 0.0 111.211 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 41.8 pt -63.33 -26.82 41.75 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 CA-C-N 118.808 0.731 . . . . 0.0 111.43 178.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -76.3 -22.69 54.7 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 119.828 1.195 . . . . 0.0 109.323 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.71 -39.49 36.31 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 120.597 -1.315 . . . . 0.0 108.783 178.188 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -86.98 -15.89 37.42 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 114.549 1.314 . . . . 0.0 114.549 -178.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -148.16 151.27 35.29 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 179.107 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.1 87.29 1.36 Allowed Glycine 0 C--N 1.335 0.485 0 CA-C-O 119.555 -0.581 . . . . 0.0 112.715 -178.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.5 pt -144.32 107.13 4.81 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 124.448 1.099 . . . . 0.0 109.769 178.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -70.8 170.59 17.46 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 124.05 3.167 . . . . 0.0 110.282 178.311 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -80.27 55.58 5.72 Favored 'Trans proline' 0 CA--C 1.545 1.061 0 C-N-CA 122.656 2.237 . . . . 0.0 107.607 177.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -146.68 131.33 17.86 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 128.239 2.616 . . . . 0.0 104.765 -179.04 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 60.1 mm-40 53.95 49.51 18.83 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.992 1.317 . . . . 0.0 107.579 -177.485 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -155.2 133.35 11.62 Favored 'General case' 0 N--CA 1.452 -0.365 0 O-C-N 121.695 -0.628 . . . . 0.0 110.621 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 53.9 ttm-85 -152.1 137.39 17.53 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 105.319 -2.104 . . . . 0.0 105.319 179.295 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 28.2 tp -88.31 139.41 30.52 Favored 'General case' 0 C--O 1.226 -0.181 0 C-N-CA 124.182 0.993 . . . . 0.0 109.567 -178.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.6 mm -135.28 144.22 34.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 124.728 1.211 . . . . 0.0 109.093 -178.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -134.69 119.37 18.2 Favored 'General case' 0 C--O 1.226 -0.156 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 178.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.72 38.78 16.18 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.307 1.043 . . . . 0.0 112.077 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.47 -15.77 22.3 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 123.973 0.796 . . . . 0.0 113.582 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.1 ttmt -80.49 118.47 22.13 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 178.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.0 mp0 -75.27 136.68 40.9 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.4 mt -119.82 155.04 33.35 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 126.708 2.003 . . . . 0.0 109.548 -178.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -155.14 176.08 13.01 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 124.604 1.162 . . . . 0.0 108.517 177.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -72.17 160.82 31.8 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 126.116 1.767 . . . . 0.0 112.363 -178.046 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.62 -27.27 21.0 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 126.042 1.782 . . . . 0.0 110.484 -178.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 47.2 mtt180 -107.33 168.9 8.9 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 124.292 1.037 . . . . 0.0 110.333 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.5 p -117.22 165.56 13.29 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 123.445 0.698 . . . . 0.0 111.601 -179.178 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.9 mp -52.3 -41.8 63.24 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.714 0.806 . . . . 0.0 111.236 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.9 t -60.52 -45.23 94.61 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 126.391 1.876 . . . . 0.0 110.032 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -60.26 -46.12 90.93 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -81.11 -3.86 53.41 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.212 0.605 . . . . 0.0 111.375 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.9 t30 53.8 47.84 22.73 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 127.718 2.407 . . . . 0.0 112.605 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 82.3 mt -85.61 126.52 40.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 105.499 -2.037 . . . . 0.0 105.499 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 78.0 mm-40 -89.92 169.25 11.39 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.551 0.691 . . . . 0.0 110.939 -179.328 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -68.02 157.24 35.59 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.389 1.076 . . . . 0.0 109.513 178.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 52.27 35.76 17.81 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.406 1.482 . . . . 0.0 112.879 179.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.4 p -86.32 162.89 17.99 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.728 1.211 . . . . 0.0 110.052 178.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.0 m -126.72 108.77 11.37 Favored 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.4 mp -96.25 169.6 9.83 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.828 1.251 . . . . 0.0 110.658 -178.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -120.05 154.17 35.01 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 126.889 2.076 . . . . 0.0 108.946 178.227 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.4 mt -123.47 123.89 41.64 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 176.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.9 m -140.75 172.73 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-N 119.53 1.059 . . . . 0.0 112.315 -178.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.236 0.355 0 C-N-CA 126.333 1.853 . . . . 0.0 108.93 178.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.6 ttt . . . . . 0 N--CA 1.471 0.624 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -120.84 156.09 32.7 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 177.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.3 pt -132.33 169.45 21.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.489 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -123.32 149.54 44.73 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.541 1.136 . . . . 0.0 108.61 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.6 t -139.19 127.59 27.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -93.36 116.95 29.49 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.141 0.976 . . . . 0.0 109.161 178.666 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 80.4 p -84.06 167.6 16.67 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.983 0.913 . . . . 0.0 111.904 179.169 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.7 -3.98 10.82 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 126.342 1.857 . . . . 0.0 113.048 177.594 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.0 p -99.02 -15.49 19.04 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.699 1.199 . . . . 0.0 109.484 178.578 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.67 6.25 57.36 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 127.01 2.243 . . . . 0.0 112.041 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.1 mmmm -80.34 163.44 23.91 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 119.441 1.621 . . . . 0.0 107.144 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.6 m -124.62 132.04 53.44 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 104.351 -2.463 . . . . 0.0 104.351 178.384 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.8 mm -104.6 157.73 5.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 -179.383 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 97.8 m -133.95 123.48 24.73 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 104.236 -2.505 . . . . 0.0 104.236 178.163 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 66.3 mt -139.59 150.7 45.32 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.682 0.793 . . . . 0.0 109.775 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 71.9 tt0 -93.83 117.89 30.71 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 105.132 -2.173 . . . . 0.0 105.132 178.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.0 m -131.59 -171.47 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 124.561 1.144 . . . . 0.0 109.078 -178.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -147.09 164.59 22.49 Favored Pre-proline 0 CA--C 1.537 0.47 0 C-N-CA 123.976 0.91 . . . . 0.0 110.112 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -62.68 -18.87 66.29 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 121.92 1.747 . . . . 0.0 112.721 178.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.54 31.66 6.48 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.894 0.877 . . . . 0.0 111.873 -177.534 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -92.67 131.84 37.41 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 178.399 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.0 p -75.08 157.6 34.51 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 119.817 1.189 . . . . 0.0 109.013 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 30.1 mm -64.27 -31.18 52.41 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.282 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 177.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -55.91 -48.54 75.49 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.907 1.283 . . . . 0.0 110.045 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.7 m-20 -64.34 -52.38 58.67 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.191 0.996 . . . . 0.0 109.482 179.452 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.2 t -55.13 -41.72 61.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 122.81 0.444 . . . . 0.0 110.405 179.564 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.1 ttpt -74.88 -13.28 60.53 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 118.107 -0.949 . . . . 0.0 110.94 -179.057 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.34 -47.18 8.21 Favored 'General case' 0 C--O 1.226 -0.154 0 CA-C-N 120.269 1.395 . . . . 0.0 108.791 178.283 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -52.34 -40.06 61.45 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.056 0.942 . . . . 0.0 111.466 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 40.3 pt -63.96 -25.36 37.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 O-C-N 121.727 -0.608 . . . . 0.0 111.582 178.63 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -76.77 -23.15 52.93 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 119.921 1.237 . . . . 0.0 109.382 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.38 -39.51 59.08 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 177.461 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.6 mttm -86.62 -18.26 31.82 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 115.659 1.725 . . . . 0.0 115.659 -177.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -141.97 150.79 41.85 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 120.686 1.585 . . . . 0.0 108.039 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.59 82.03 1.61 Allowed Glycine 0 C--N 1.334 0.421 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.7 pt -136.09 108.38 9.69 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 124.622 1.169 . . . . 0.0 109.515 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -78.62 169.32 19.93 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.497 2.798 . . . . 0.0 109.016 179.047 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -77.84 56.68 5.76 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 123.56 2.84 . . . . 0.0 109.632 178.446 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -146.65 135.27 22.11 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 104.716 -2.328 . . . . 0.0 104.716 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 64.1 mm-40 53.22 48.65 21.65 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 126.17 1.788 . . . . 0.0 109.235 -177.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 -154.73 138.95 16.58 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.567 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 52.1 ttm-85 -155.97 135.33 12.3 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 127.859 2.464 . . . . 0.0 105.412 178.207 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 23.8 tp -87.75 139.45 30.52 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.2 mm -133.63 144.65 35.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 126.05 1.74 . . . . 0.0 108.096 -178.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -138.8 124.99 20.19 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 178.567 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.59 39.27 12.92 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.799 0.839 . . . . 0.0 111.608 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.03 -16.72 14.44 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 125.064 1.316 . . . . 0.0 113.948 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.5 ttmt -78.92 129.06 34.09 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 119.811 1.806 . . . . 0.0 108.172 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.5 mp0 -74.1 136.18 42.97 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 106.749 -1.575 . . . . 0.0 106.749 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.5 mt -119.19 155.88 30.87 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 125.268 1.427 . . . . 0.0 110.419 -179.159 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -160.23 176.18 12.03 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 126.186 1.794 . . . . 0.0 107.971 178.085 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -71.88 161.0 31.6 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 126.792 2.037 . . . . 0.0 113.106 -178.029 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.42 -27.52 19.54 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 126.465 1.983 . . . . 0.0 110.222 -179.006 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 47.9 mtt180 -107.99 169.31 8.69 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.374 1.07 . . . . 0.0 111.694 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 45.7 p -122.83 171.16 9.4 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.946 1.298 . . . . 0.0 112.145 -178.239 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.3 mp -52.56 -41.72 63.82 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 123.296 0.638 . . . . 0.0 110.564 178.216 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.8 t -58.53 -45.48 88.78 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.899 1.68 . . . . 0.0 110.628 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -61.58 -47.06 87.24 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.816 0.846 . . . . 0.0 109.522 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -81.76 -1.21 46.38 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 118.763 -0.637 . . . . 0.0 112.473 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 52.7 t30 54.24 46.68 24.73 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 127.571 2.348 . . . . 0.0 111.267 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.2 mt -87.5 123.83 40.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 87.8 mm-40 -94.09 172.46 8.21 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 123.23 0.612 . . . . 0.0 111.846 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 41.3 pttt -66.7 157.21 33.24 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.012 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 50.79 41.78 26.83 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 125.907 1.683 . . . . 0.0 110.664 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.0 p -86.86 163.22 17.32 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 178.011 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.3 m -126.34 106.28 9.39 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 179.273 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.1 mp -98.16 161.16 13.85 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 125.109 1.364 . . . . 0.0 108.614 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 11.4 m80 -119.3 155.6 31.54 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 123.927 0.891 . . . . 0.0 109.223 178.367 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 16.9 mt -122.53 123.35 41.05 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 102.571 -3.122 . . . . 0.0 102.571 178.122 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.6 m -141.7 168.93 14.66 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 -178.485 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.472 0.65 0 C-N-CA 124.277 1.031 . . . . 0.0 111.692 177.265 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.0 ttt . . . . . 0 CA--C 1.512 -0.519 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -121.22 156.69 31.89 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 178.453 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 34.9 pt -133.14 170.15 20.57 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 C-N-CA 125.515 1.526 . . . . 0.0 106.993 177.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -126.21 152.82 45.53 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 178.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.9 t -137.94 124.62 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.8 tppp? -93.28 109.58 21.11 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 104.348 -2.464 . . . . 0.0 104.348 178.401 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.414 ' HA ' HD12 ' A' ' 69' ' ' LEU . 25.3 p -72.6 165.37 24.83 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 121.074 0.464 . . . . 0.0 110.597 -179.162 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -69.0 -6.85 30.38 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.468 0.707 . . . . 0.0 111.36 178.343 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.1 p -93.88 -12.36 29.09 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.692 1.197 . . . . 0.0 109.692 179.335 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.51 5.78 57.71 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 126.862 2.172 . . . . 0.0 111.508 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.86 164.76 22.42 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 118.454 1.127 . . . . 0.0 108.933 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.1 m -124.42 132.31 53.51 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 179.216 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.5 mm -114.09 156.83 14.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 125.963 1.705 . . . . 0.0 106.468 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 31.6 m -132.45 123.66 27.07 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 127.239 2.216 . . . . 0.0 105.832 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.4 mt -133.92 150.83 51.34 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 119.09 0.859 . . . . 0.0 109.922 -179.145 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -103.41 109.12 20.64 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 104.735 -2.32 . . . . 0.0 104.735 178.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.3 m -123.37 -172.33 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 125.53 1.532 . . . . 0.0 109.816 -177.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -146.17 162.42 35.17 Favored Pre-proline 0 C--O 1.234 0.279 0 O-C-N 121.357 -0.839 . . . . 0.0 109.637 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -58.46 -18.53 39.52 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.407 2.071 . . . . 0.0 113.21 179.52 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.2 m -114.38 31.34 6.67 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 118.763 0.71 . . . . 0.0 111.573 -177.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -98.17 129.34 44.95 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 104.007 -2.59 . . . . 0.0 104.007 178.108 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.7 p -78.09 157.47 29.5 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 119.814 1.188 . . . . 0.0 110.128 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 51.3 mm -64.5 -26.0 39.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 177.475 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -55.4 -44.13 75.87 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.356 1.462 . . . . 0.0 109.436 178.582 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -70.97 -52.37 20.16 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.623 1.169 . . . . 0.0 108.545 179.049 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.7 t -54.74 -38.52 43.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 124.222 1.009 . . . . 0.0 111.41 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -76.56 -18.54 58.62 Favored 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 124.192 0.997 . . . . 0.0 111.097 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -88.74 -42.27 12.05 Favored 'General case' 0 C--O 1.228 -0.049 0 CA-C-N 119.633 1.106 . . . . 0.0 110.145 179.154 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -54.16 -40.58 67.59 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.216 0.606 . . . . 0.0 110.86 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.5 pt -63.05 -25.42 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 O-C-N 120.851 -1.156 . . . . 0.0 111.549 178.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -77.93 -21.63 50.82 Favored 'General case' 0 C--N 1.332 -0.169 0 O-C-N 120.79 -1.194 . . . . 0.0 109.967 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -78.11 -30.61 49.58 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.021 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.8 mttm -100.57 -15.05 17.95 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 115.799 1.777 . . . . 0.0 115.799 -179.5 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -139.52 158.71 43.66 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 121.437 1.926 . . . . 0.0 108.936 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.31 70.22 3.13 Favored Glycine 0 CA--C 1.524 0.622 0 C-N-CA 124.87 1.224 . . . . 0.0 110.914 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.6 pt -137.23 107.62 8.72 Favored Pre-proline 0 CA--C 1.544 0.731 0 CA-C-N 118.826 1.313 . . . . 0.0 111.579 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -76.05 168.98 23.03 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 123.756 2.971 . . . . 0.0 109.33 178.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -78.74 57.23 6.28 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.572 2.181 . . . . 0.0 109.875 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -149.4 135.91 19.31 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 128.401 2.68 . . . . 0.0 105.451 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 47.1 mm-40 54.03 48.54 20.88 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.474 1.509 . . . . 0.0 108.501 -177.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -147.83 134.53 19.95 Favored 'General case' 0 C--N 1.339 0.137 0 O-C-N 121.39 -0.819 . . . . 0.0 110.323 -179.345 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 52.4 ttm-85 -155.55 133.55 11.42 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 29.1 tp -89.14 135.31 33.63 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.826 1.65 . . . . 0.0 110.581 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.4 mm -135.74 147.33 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 125.03 1.332 . . . . 0.0 108.009 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -139.0 115.14 10.28 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 178.064 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.49 40.75 15.72 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.085 1.354 . . . . 0.0 110.505 -178.137 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.71 -10.03 53.22 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 125.481 1.515 . . . . 0.0 114.955 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.6 ttmt -79.71 129.84 34.83 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 120.488 2.144 . . . . 0.0 107.732 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.5 mp0 -74.31 125.53 28.66 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.4 mt -114.15 140.73 48.28 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 106.095 -1.816 . . . . 0.0 106.095 179.023 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -162.88 -179.91 7.13 Favored 'General case' 0 C--N 1.32 -0.686 0 O-C-N 121.658 -0.651 . . . . 0.0 110.206 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -70.49 160.13 32.98 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.089 1.356 . . . . 0.0 112.8 -176.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.85 -29.55 12.26 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 128.153 2.787 . . . . 0.0 110.067 -178.299 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 49.8 mtt180 -108.28 169.6 8.53 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 126.191 1.796 . . . . 0.0 112.065 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 78.3 p -117.73 167.52 11.29 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 126.865 2.066 . . . . 0.0 111.04 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.7 mp -52.4 -42.02 63.66 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 123.282 0.633 . . . . 0.0 111.131 178.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.7 t -58.65 -43.17 89.72 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.48 1.512 . . . . 0.0 110.605 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -59.87 -46.9 87.85 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 118.741 0.7 . . . . 0.0 109.574 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -81.83 -4.08 55.59 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.246 1.018 . . . . 0.0 113.476 -179.247 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 37.6 t30 58.34 47.44 13.92 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.609 1.964 . . . . 0.0 110.963 -178.46 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.9 mt -86.28 122.99 39.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 104.775 -2.306 . . . . 0.0 104.775 179.036 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 92.1 mm-40 -93.37 170.32 9.7 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 122.862 0.465 . . . . 0.0 110.677 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 49.4 pttt -68.76 157.36 36.52 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.238 0.542 . . . . 0.0 111.228 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 53.16 37.83 26.0 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 127.379 2.272 . . . . 0.0 110.566 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.3 p -87.14 161.69 17.95 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.121 1.368 . . . . 0.0 109.63 178.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 95.2 m -126.33 110.17 13.08 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.3 mp -97.17 158.84 15.25 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.202 1.801 . . . . 0.0 108.857 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 72.1 m80 -120.07 163.64 17.36 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 125.341 1.456 . . . . 0.0 111.823 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 7' ' ' THR . 54.5 mt -120.19 133.45 55.49 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 125.13 1.372 . . . . 0.0 107.49 178.277 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.1 m -140.63 168.98 16.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 C-N-CA 124.413 1.085 . . . . 0.0 109.664 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.236 0.376 0 C-N-CA 125.123 1.369 . . . . 0.0 107.338 176.537 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 33.6 ttm . . . . . 0 N--CA 1.469 0.477 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -122.67 150.48 42.65 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 175.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.9 pt -132.65 168.63 23.74 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 176.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -126.1 151.79 46.74 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 123.892 0.877 . . . . 0.0 109.587 -179.563 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.9 t -138.37 133.06 42.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 178.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -98.27 117.27 32.28 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 105.241 -2.133 . . . . 0.0 105.241 177.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.3 p -80.36 167.08 20.66 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 118.878 0.763 . . . . 0.0 110.471 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -71.94 -7.98 51.8 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 122.747 0.419 . . . . 0.0 111.173 177.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.4 p -93.51 -12.35 29.84 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.549 1.14 . . . . 0.0 109.411 178.63 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.77 7.48 55.44 Favored Glycine 0 C--N 1.342 0.861 0 C-N-CA 125.005 1.288 . . . . 0.0 112.622 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -80.86 164.34 22.73 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 119.617 1.709 . . . . 0.0 108.186 179.085 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.2 m -124.11 131.46 53.55 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 102.953 -2.98 . . . . 0.0 102.953 177.481 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.9 mm -115.11 157.4 15.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 C-N-CA 125.81 1.644 . . . . 0.0 106.686 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 42.2 m -134.68 125.97 28.16 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 128.503 2.721 . . . . 0.0 104.945 177.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 81.1 mt -139.89 149.21 43.11 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.85 1.26 . . . . 0.0 110.17 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -102.13 114.25 28.22 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 126.116 1.767 . . . . 0.0 107.372 178.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.456 HG12 ' HE3' ' A' ' 29' ' ' LYS . 2.2 m -134.33 -175.0 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 124.77 1.228 . . . . 0.0 108.118 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -142.45 168.89 12.1 Favored Pre-proline 0 C--O 1.236 0.364 0 O-C-N 121.235 -0.916 . . . . 0.0 110.256 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -54.56 -22.12 26.93 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.683 2.256 . . . . 0.0 114.388 -179.561 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.5 m -115.11 31.77 6.48 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -178.447 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -95.68 128.92 42.96 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 101.133 -3.655 . . . . 0.0 101.133 175.361 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.2 p -76.57 159.0 30.71 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 119.778 1.172 . . . . 0.0 109.762 -179.336 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 51.8 mm -62.54 -26.19 39.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.525 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -53.86 -49.24 68.91 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.599 1.16 . . . . 0.0 108.457 178.229 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 -68.24 -52.02 38.73 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 126.436 1.894 . . . . 0.0 110.345 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.3 t -53.92 -43.68 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-N 119.232 0.923 . . . . 0.0 110.122 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -75.21 -13.48 60.45 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.182 0.993 . . . . 0.0 112.05 -178.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.51 -45.14 9.62 Favored 'General case' 0 C--O 1.225 -0.229 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 177.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.456 ' HE3' HG12 ' A' ' 17' ' ' VAL . 12.3 mtmm -50.84 -39.74 54.23 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.187 1.395 . . . . 0.0 110.385 179.166 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 37.5 pt -65.88 -25.41 36.16 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 CA-C-N 118.956 0.798 . . . . 0.0 112.332 178.475 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -76.37 -23.45 54.13 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 120.017 1.281 . . . . 0.0 109.372 -179.294 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.02 -38.88 56.75 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 177.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 45.6 mttm -87.43 -16.01 36.08 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 116.526 2.047 . . . . 0.0 116.526 -178.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -147.55 160.62 42.42 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 121.371 1.896 . . . . 0.0 110.511 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.31 64.09 4.23 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 124.427 1.013 . . . . 0.0 113.393 -179.085 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.1 pt -134.72 106.39 10.73 Favored Pre-proline 0 CA--C 1.541 0.61 0 CA-C-N 119.114 1.457 . . . . 0.0 108.341 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -71.54 169.45 20.93 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 123.7 2.933 . . . . 0.0 112.374 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -78.23 56.91 5.98 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 123.567 2.844 . . . . 0.0 110.263 178.081 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -149.5 136.16 19.41 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 127.958 2.503 . . . . 0.0 105.099 179.397 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 64.2 mm-40 51.91 48.83 22.01 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.303 1.441 . . . . 0.0 107.819 -177.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -152.55 133.14 13.85 Favored 'General case' 0 N--CA 1.455 -0.207 0 O-C-N 121.21 -0.932 . . . . 0.0 109.979 -178.187 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.0 ttm-85 -154.4 136.17 14.45 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 106.206 -1.775 . . . . 0.0 106.206 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 18.5 tp -88.22 137.85 31.96 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 124.427 1.091 . . . . 0.0 108.265 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.9 mm -135.12 150.2 29.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 126.002 1.721 . . . . 0.0 108.348 -178.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -137.17 115.41 11.72 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 178.058 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.39 42.32 18.04 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.884 1.274 . . . . 0.0 111.161 -178.587 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.33 -12.48 38.65 Favored Glycine 0 CA--C 1.53 0.97 0 CA-C-O 118.283 -1.287 . . . . 0.0 114.429 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.0 ttmt -79.11 125.17 29.06 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 120.86 2.33 . . . . 0.0 105.96 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.3 mp0 -74.31 136.0 42.56 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -179.027 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.3 mt -122.91 153.89 39.06 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -162.98 178.45 8.34 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 126.886 2.074 . . . . 0.0 107.802 177.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -71.78 160.56 32.39 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.057 1.343 . . . . 0.0 112.269 -177.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 108.34 -29.51 9.98 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 127.709 2.576 . . . . 0.0 108.626 -178.13 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 44.1 mtt180 -108.44 166.37 10.82 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.598 1.159 . . . . 0.0 112.329 178.541 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 49.5 p -117.44 169.59 9.4 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 126.067 1.747 . . . . 0.0 110.292 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.3 mp -52.73 -42.22 64.68 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 122.901 0.48 . . . . 0.0 111.207 178.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.2 t -59.06 -45.61 90.33 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.853 1.261 . . . . 0.0 110.799 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -59.46 -44.92 92.88 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.21 0.604 . . . . 0.0 110.506 -179.315 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -82.22 -0.3 44.58 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.518 0.727 . . . . 0.0 112.21 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 44.8 t30 53.65 47.49 23.71 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 127.141 2.176 . . . . 0.0 110.611 -179.365 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.1 mt -85.05 130.95 35.25 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 N-CA-C 104.397 -2.446 . . . . 0.0 104.397 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 68.7 mm-40 -89.63 167.14 13.16 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 123.079 0.551 . . . . 0.0 111.566 -178.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -72.74 156.68 38.68 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 177.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 50.86 35.74 13.06 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.205 1.402 . . . . 0.0 111.358 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.6 p -81.85 164.77 21.38 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.422 1.889 . . . . 0.0 109.494 179.091 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.5 m -125.97 107.03 10.06 Favored 'General case' 0 N--CA 1.461 0.12 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.6 mp -97.61 164.51 12.39 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.124 1.37 . . . . 0.0 109.21 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.2 m80 -119.93 157.66 28.31 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 126.028 1.731 . . . . 0.0 110.949 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 34.6 mt -123.16 125.47 45.2 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.584 1.554 . . . . 0.0 107.479 178.388 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.8 m -140.98 172.63 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-N 119.722 1.147 . . . . 0.0 113.937 -178.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.537 0.461 0 C-N-CA 126.478 1.911 . . . . 0.0 109.41 177.37 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ttt . . . . . 0 N--CA 1.473 0.691 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -121.08 156.16 32.85 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 179.252 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.2 pt -133.71 170.85 19.02 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 C-N-CA 126.601 1.96 . . . . 0.0 107.883 177.596 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -126.14 152.43 45.96 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.187 1.395 . . . . 0.0 109.161 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.2 t -138.1 126.15 30.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 178.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -92.83 117.5 30.09 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 106.144 -1.799 . . . . 0.0 106.144 178.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 64.4 p -73.12 164.39 26.76 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -67.67 -12.63 60.9 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.7 178.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.6 p -92.55 -12.11 32.68 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.396 1.879 . . . . 0.0 110.454 179.379 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.55 6.92 56.24 Favored Glycine 0 C--N 1.338 0.644 0 O-C-N 121.091 -1.006 . . . . 0.0 112.752 179.411 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.01 163.36 23.32 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 104.996 -2.224 . . . . 0.0 104.996 178.323 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 47.3 m -125.1 140.54 52.79 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 178.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.2 mm -114.82 156.22 15.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 126.338 1.855 . . . . 0.0 106.001 179.189 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 47.6 m -132.23 125.84 32.07 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 103.571 -2.751 . . . . 0.0 103.571 178.448 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.2 mt -138.73 151.49 47.17 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.024 0.93 . . . . 0.0 110.397 -178.322 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -99.69 118.62 36.6 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 128.362 2.665 . . . . 0.0 105.728 178.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.1 m -134.21 -171.27 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 125.512 1.525 . . . . 0.0 108.467 -178.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -146.72 161.8 36.28 Favored Pre-proline 0 CA--C 1.536 0.435 0 C-N-CA 124.197 0.999 . . . . 0.0 108.344 179.312 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -51.19 -24.98 16.19 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.316 2.678 . . . . 0.0 114.844 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.4 m -115.42 33.09 5.65 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.756 0.822 . . . . 0.0 111.563 -179.231 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -90.69 129.65 36.77 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 103.131 -2.915 . . . . 0.0 103.131 178.447 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 21.3 p -69.58 158.08 35.96 Favored 'General case' 0 C--O 1.237 0.421 0 O-C-N 121.728 -0.607 . . . . 0.0 110.69 -178.223 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.7 mm -64.25 -32.14 56.3 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.47 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 177.107 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -55.49 -39.71 70.79 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 125.823 1.649 . . . . 0.0 110.171 179.453 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -73.86 -53.46 10.15 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.1 t -57.92 -39.13 70.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 O-C-N 121.162 -0.961 . . . . 0.0 112.397 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 27.2 ttpt -75.01 -15.75 60.64 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.622 1.169 . . . . 0.0 110.921 -179.195 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.75 -47.1 7.84 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.108 1.763 . . . . 0.0 108.14 177.176 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.1 mttm -50.36 -40.5 49.5 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.217 1.407 . . . . 0.0 110.898 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.3 pt -64.32 -27.94 43.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 O-C-N 121.472 -0.768 . . . . 0.0 111.667 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -78.02 -22.09 49.77 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.824 1.249 . . . . 0.0 110.412 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.34 -37.76 60.52 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 177.64 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -94.18 -17.75 22.42 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 116.104 1.891 . . . . 0.0 116.104 -179.185 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -136.45 150.21 48.61 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 121.401 1.909 . . . . 0.0 107.13 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -83.46 85.76 1.52 Allowed Glycine 0 CA--C 1.521 0.434 0 CA-C-O 119.14 -0.811 . . . . 0.0 111.285 -179.325 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.5 pt -141.17 108.78 6.29 Favored Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 118.327 1.064 . . . . 0.0 111.79 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -62.62 161.9 26.6 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 122.666 2.244 . . . . 0.0 110.547 178.318 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -84.23 56.66 5.03 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.569 2.179 . . . . 0.0 108.041 179.107 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -144.82 134.15 23.04 Favored 'General case' 0 CA--C 1.514 -0.415 0 C-N-CA 130.602 3.561 . . . . 0.0 103.515 -178.015 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 43.3 mm-40 50.89 49.55 20.86 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 125.353 1.461 . . . . 0.0 107.324 -176.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -147.89 133.0 18.27 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.771 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 42.9 ttm-85 -154.73 133.58 12.22 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 178.64 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 26.5 tp -88.25 137.06 32.66 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.17 1.388 . . . . 0.0 107.834 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.3 mm -127.98 144.46 37.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 125.718 1.607 . . . . 0.0 108.844 -178.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -136.77 126.07 24.85 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 178.035 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.36 33.15 9.48 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.049 0.94 . . . . 0.0 111.288 -179.317 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.27 -11.95 41.09 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 124.514 1.054 . . . . 0.0 112.483 -179.153 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -79.55 129.02 34.09 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 119.58 1.69 . . . . 0.0 107.515 179.566 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.9 mp0 -74.4 136.03 42.41 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.6 mt -122.98 155.67 36.31 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.29 1.036 . . . . 0.0 109.744 -178.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -161.7 -178.33 6.47 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 127.747 2.419 . . . . 0.0 107.393 177.361 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -70.63 160.42 32.6 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 127.621 2.368 . . . . 0.0 113.055 -176.61 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.5 -28.82 13.92 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 126.576 2.036 . . . . 0.0 110.264 -178.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 46.6 mtt180 -108.23 165.16 11.7 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.019 1.328 . . . . 0.0 112.3 179.07 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 64.4 p -118.52 174.21 6.39 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 126.87 2.068 . . . . 0.0 111.855 -179.342 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.67 -46.37 63.76 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.459 1.104 . . . . 0.0 110.98 179.211 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.1 t -58.6 -45.3 89.45 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.037 1.735 . . . . 0.0 111.503 -179.088 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -60.29 -45.09 94.56 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 122.966 0.506 . . . . 0.0 110.52 -178.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -81.53 1.84 31.74 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.04 0.536 . . . . 0.0 111.197 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.2 t30 54.72 46.19 25.15 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 128.039 2.535 . . . . 0.0 111.202 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 89.6 mt -88.38 125.51 41.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 81.5 mm-40 -101.93 176.94 5.04 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.253 1.021 . . . . 0.0 110.613 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.9 pttt -64.72 156.67 29.66 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 123.588 0.755 . . . . 0.0 110.431 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 49.17 39.33 15.2 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.518 1.927 . . . . 0.0 111.694 -178.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.8 p -83.95 161.64 20.73 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 120.447 -1.408 . . . . 0.0 108.129 178.204 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.5 m -126.29 108.8 11.6 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.4 mp -95.78 162.16 13.71 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.269 1.428 . . . . 0.0 109.004 -179.036 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -119.77 163.12 17.94 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.21 1.404 . . . . 0.0 109.928 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.3 mt -123.0 127.34 48.67 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.01 1.724 . . . . 0.0 108.337 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.6 m -141.21 163.44 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 114.255 1.205 . . . . 0.0 114.255 -178.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.536 0.413 0 C-N-CA 127.353 2.261 . . . . 0.0 108.819 177.305 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.2 ttm . . . . . 0 N--CA 1.468 0.466 0 N-CA-C 110.354 -0.239 . . . . 0.0 110.354 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -121.04 156.45 32.17 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 176.385 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.2 pt -132.98 169.39 22.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 178.119 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -126.12 149.57 48.84 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 179.006 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.7 t -138.33 124.52 25.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -92.8 117.78 30.39 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 105.345 -2.095 . . . . 0.0 105.345 178.537 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 50.1 p -72.19 167.06 21.12 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 121.564 0.697 . . . . 0.0 109.734 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.403 ' H ' HD23 ' A' ' 8' ' ' LEU . 2.6 pt? -67.26 -12.51 60.3 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.62 0.768 . . . . 0.0 111.738 178.787 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.3 p -97.44 -12.71 22.38 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.908 1.683 . . . . 0.0 112.249 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.35 6.65 47.44 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-O 118.313 -1.271 . . . . 0.0 113.863 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.3 163.52 20.62 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 120.138 1.969 . . . . 0.0 105.983 178.388 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.5 m -124.57 132.76 53.44 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.5 mm -115.66 156.9 16.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 127.458 2.303 . . . . 0.0 108.228 -179.579 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.7 m -133.54 130.55 38.62 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 127.85 2.46 . . . . 0.0 106.276 178.334 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 92.5 mt -134.3 151.87 51.49 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 126.16 1.784 . . . . 0.0 110.845 -179.017 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -102.68 117.69 35.21 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 104.548 -2.389 . . . . 0.0 104.548 177.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.1 m -135.18 -168.96 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 124.657 1.183 . . . . 0.0 109.768 -179.053 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -150.43 163.54 23.8 Favored Pre-proline 0 CA--C 1.537 0.462 0 C-N-CA 125.308 1.443 . . . . 0.0 109.196 178.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -57.12 -18.41 29.07 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.705 2.27 . . . . 0.0 113.274 178.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.4 m -114.22 31.27 6.7 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 123.74 0.816 . . . . 0.0 111.517 -178.375 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -94.97 130.07 41.76 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 102.309 -3.219 . . . . 0.0 102.309 176.713 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.5 p -71.62 156.69 39.1 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 119.798 1.181 . . . . 0.0 109.726 -179.256 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.7 mm -65.04 -29.33 47.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 177.03 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -57.74 -49.63 75.92 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 126.101 1.761 . . . . 0.0 107.9 178.313 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -63.04 -52.08 64.25 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.143 0.977 . . . . 0.0 109.421 178.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.8 t -56.37 -38.91 57.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 O-C-N 121.508 -0.745 . . . . 0.0 110.618 179.151 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -74.74 -17.83 60.59 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-O 117.763 -1.113 . . . . 0.0 109.948 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.29 -47.36 10.13 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 120.2 1.364 . . . . 0.0 108.177 178.103 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.0 mttm -50.32 -43.16 53.68 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.672 1.189 . . . . 0.0 111.808 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 36.8 pt -62.78 -27.73 43.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 O-C-N 121.501 -0.749 . . . . 0.0 112.684 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.423 HE22 ' HB3' ' A' ' 38' ' ' PRO . 34.8 mt-30 -77.21 -20.66 55.01 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 119.519 1.054 . . . . 0.0 110.479 -179.307 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -82.74 -38.08 23.76 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.171 -0.956 . . . . 0.0 108.974 178.27 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -86.03 -21.42 27.77 Favored 'General case' 0 N--CA 1.471 0.575 0 O-C-N 121.044 -1.035 . . . . 0.0 113.682 -178.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -140.5 150.81 44.22 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 178.64 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -80.89 85.29 1.38 Allowed Glycine 0 C--N 1.332 0.317 0 CA-C-N 118.907 0.776 . . . . 0.0 113.038 -178.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.3 pt -140.14 106.87 6.74 Favored Pre-proline 0 CA--C 1.54 0.59 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -66.09 170.4 11.85 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 123.772 2.982 . . . . 0.0 111.309 178.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.423 ' HB3' HE22 ' A' ' 31' ' ' GLN . 52.4 Cg_endo -83.46 55.99 5.19 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 N-CA-C 106.645 -2.098 . . . . 0.0 106.645 178.261 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -146.52 133.94 20.78 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 128.402 2.681 . . . . 0.0 106.746 -177.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 39.6 mm-40 46.84 49.43 14.39 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.073 1.749 . . . . 0.0 108.348 -177.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -154.3 134.41 13.18 Favored 'General case' 0 C--N 1.341 0.207 0 C-N-CA 124.761 1.224 . . . . 0.0 110.106 -179.422 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 52.1 ttm-85 -151.59 141.47 21.99 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 179.594 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 20.0 tp -88.45 138.89 31.02 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.749 1.22 . . . . 0.0 108.818 -179.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.2 mm -135.16 149.98 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 C-N-CA 125.989 1.716 . . . . 0.0 107.083 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -137.61 122.71 19.15 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 178.566 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.1 36.61 9.1 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.04 0.936 . . . . 0.0 111.494 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.76 -13.95 33.64 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-O 118.773 -1.015 . . . . 0.0 114.028 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.3 ttmt -79.76 128.97 34.07 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 120.304 2.052 . . . . 0.0 106.145 178.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.7 mp0 -73.75 136.17 43.63 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.141 1.376 . . . . 0.0 108.924 -178.491 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.4 mt -123.86 155.03 38.8 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.345 1.058 . . . . 0.0 109.069 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -161.78 179.46 8.08 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.269 1.428 . . . . 0.0 108.316 178.149 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -70.97 161.12 31.66 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 127.219 2.208 . . . . 0.0 112.993 -176.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.37 -25.18 29.08 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 126.24 1.876 . . . . 0.0 110.434 -178.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 47.3 mtt180 -108.29 171.56 7.34 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 118.715 1.257 . . . . 0.0 112.194 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.8 p -118.17 171.62 7.99 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 126.457 1.903 . . . . 0.0 109.322 178.27 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.7 mp -52.86 -42.16 64.97 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.357 0.663 . . . . 0.0 110.548 177.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.9 t -58.68 -45.44 89.42 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 126.251 1.82 . . . . 0.0 111.553 -179.247 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -57.73 -47.09 83.39 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 119.384 0.993 . . . . 0.0 109.871 -179.527 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -81.72 1.25 35.23 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.888 0.875 . . . . 0.0 112.378 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 54.8 t30 53.93 46.08 26.36 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 127.422 2.289 . . . . 0.0 111.405 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.0 mt -86.29 126.71 40.66 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.9 mm-40 -97.2 173.3 7.3 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.402 0.681 . . . . 0.0 111.215 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 42.8 pttt -66.06 156.77 32.83 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.021 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 51.81 35.33 15.16 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 127.328 2.251 . . . . 0.0 110.901 -179.319 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.3 p -75.59 162.74 28.02 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 178.645 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.3 m -122.77 106.24 10.75 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 -179.454 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.5 mp -101.63 159.4 15.34 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.314 1.446 . . . . 0.0 109.552 -178.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 4.1 m80 -120.25 163.64 17.47 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 126.406 1.882 . . . . 0.0 111.145 179.121 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 69.4 mt -122.24 125.41 45.99 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 177.737 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.9 m -139.77 163.75 24.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-O 121.85 0.833 . . . . 0.0 111.64 -179.348 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.6 pt? . . . . . 0 C--N 1.332 -0.173 0 C-N-CA 127.278 2.231 . . . . 0.0 108.409 178.719 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 30.3 ttm . . . . . 0 CA--C 1.514 -0.415 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -120.99 148.43 44.11 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 178.122 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 34.0 pt -132.11 168.34 24.28 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 O-C-N 120.993 -1.067 . . . . 0.0 108.448 179.127 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -126.22 149.84 48.78 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.7 t -138.3 124.64 25.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -90.42 118.95 30.29 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 126.914 2.086 . . . . 0.0 111.071 179.262 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 51.1 p -83.05 163.98 20.61 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 177.516 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.66 -5.65 16.79 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.426 1.09 . . . . 0.0 112.881 178.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.9 p -92.77 -14.23 28.17 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.794 2.037 . . . . 0.0 110.555 178.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.5 6.39 57.47 Favored Glycine 0 C--N 1.337 0.593 0 C-N-CA 125.637 1.589 . . . . 0.0 112.459 179.526 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.8 mmmm -81.77 164.48 21.66 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 118.28 1.04 . . . . 0.0 108.334 179.562 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.1 m -125.09 137.19 54.2 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 177.643 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 48.8 mm -115.95 154.0 17.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 105.507 -2.034 . . . . 0.0 105.507 178.373 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.8 m -132.71 130.13 39.63 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 178.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 78.5 mt -139.17 151.2 46.42 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 124.899 1.28 . . . . 0.0 111.857 -178.301 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -98.94 117.63 33.89 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 127.482 2.313 . . . . 0.0 105.024 178.064 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.6 m -134.39 -171.99 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 125.323 1.449 . . . . 0.0 109.729 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -148.09 165.59 17.98 Favored Pre-proline 0 CA--C 1.536 0.406 0 C-N-CA 124.136 0.974 . . . . 0.0 110.507 179.419 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.78 -19.27 14.34 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.725 2.95 . . . . 0.0 115.547 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.1 m -115.73 30.83 7.1 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 119.132 0.878 . . . . 0.0 111.693 -179.342 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -91.46 129.31 37.46 Favored 'General case' 0 C--O 1.244 0.784 0 N-CA-C 102.846 -3.02 . . . . 0.0 102.846 177.044 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.9 p -76.65 158.34 31.13 Favored 'General case' 0 C--O 1.233 0.205 0 O-C-N 121.118 -0.989 . . . . 0.0 110.697 -178.539 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.2 mm -63.07 -27.02 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 179.193 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -54.18 -46.5 72.4 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.387 1.075 . . . . 0.0 109.633 178.737 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 56.7 m-80 -69.57 -52.36 26.95 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.659 1.584 . . . . 0.0 109.445 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.4 t -54.45 -40.98 51.57 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 CA-C-N 118.835 0.743 . . . . 0.0 109.971 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.1 ttpt -75.49 -12.92 60.33 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.953 1.301 . . . . 0.0 111.637 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.11 -47.44 7.82 Favored 'General case' 0 CA--C 1.52 -0.198 0 C-N-CA 124.614 1.166 . . . . 0.0 109.46 178.011 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 55.7 mttm -51.21 -40.24 58.29 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.918 1.287 . . . . 0.0 110.485 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.7 pt -61.64 -31.0 49.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-O 118.44 -0.79 . . . . 0.0 112.413 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -77.38 -19.97 55.41 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.029 1.332 . . . . 0.0 110.724 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -83.89 -40.03 19.12 Favored 'General case' 0 CA--C 1.53 0.193 0 O-C-N 121.412 -0.805 . . . . 0.0 110.484 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.8 mttm -89.87 -14.97 33.18 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 -179.414 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -138.95 150.79 46.29 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.72 64.54 4.19 Favored Glycine 0 CA--C 1.524 0.603 0 CA-C-O 118.136 -1.369 . . . . 0.0 112.729 -179.018 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.5 pt -127.41 106.72 21.28 Favored Pre-proline 0 CA--C 1.552 1.02 0 CA-C-N 118.928 1.364 . . . . 0.0 111.162 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -65.88 165.41 23.7 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 124.13 3.22 . . . . 0.0 114.694 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -81.79 57.52 6.35 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 124.756 3.637 . . . . 0.0 110.163 178.544 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -145.12 134.06 22.49 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 128.69 2.796 . . . . 0.0 105.501 -178.527 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.8 mm-40 44.23 51.1 7.57 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 126.603 1.961 . . . . 0.0 110.05 -177.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 23.3 m-20 -150.59 134.2 16.51 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.3 ttm-85 -153.28 142.65 21.63 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 124.883 1.273 . . . . 0.0 107.638 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.0 tp -88.62 142.9 27.31 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 125.246 1.419 . . . . 0.0 112.698 -177.72 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.6 mm -135.55 148.15 28.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 126.934 2.094 . . . . 0.0 108.265 179.532 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -138.18 115.07 10.76 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 177.375 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.45 43.06 19.46 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.268 1.027 . . . . 0.0 110.784 -178.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.66 -13.19 36.99 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 124.63 1.11 . . . . 0.0 114.738 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.6 ttmm -79.48 129.21 34.26 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 119.757 1.778 . . . . 0.0 109.33 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -74.81 129.36 37.54 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 125.82 1.648 . . . . 0.0 109.577 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 9.8 mt -123.74 148.85 46.24 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 123.726 0.811 . . . . 0.0 110.43 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.1 pm0 -151.61 175.96 11.83 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.12 1.368 . . . . 0.0 108.464 178.36 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -72.13 161.03 31.46 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 125.493 1.517 . . . . 0.0 113.628 -177.339 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.82 -22.52 39.97 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 125.672 1.606 . . . . 0.0 110.724 -179.058 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -107.27 169.97 8.24 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 118.572 1.186 . . . . 0.0 111.347 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 79.4 p -117.09 171.14 8.12 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.604 1.562 . . . . 0.0 113.026 -178.415 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.57 -47.13 67.02 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.074 0.95 . . . . 0.0 108.829 177.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.2 m -62.04 -32.5 73.02 Favored 'General case' 0 N--CA 1.46 0.063 0 C-N-CA 124.823 1.249 . . . . 0.0 112.93 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -67.41 -45.67 75.47 Favored 'General case' 0 CA--C 1.515 -0.398 0 O-C-N 121.077 -1.014 . . . . 0.0 109.819 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -82.95 1.39 39.91 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 119.208 -0.425 . . . . 0.0 110.93 178.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 36.5 t30 56.01 46.71 21.3 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 127.76 2.424 . . . . 0.0 111.167 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.6 mt -89.76 126.98 42.64 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 178.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -101.84 178.43 4.62 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 123.039 0.536 . . . . 0.0 110.216 179.385 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 58.4 pttt -64.68 156.88 28.85 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.176 0.59 . . . . 0.0 110.661 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 52.26 46.1 27.25 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.216 1.407 . . . . 0.0 111.221 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.1 p -88.75 161.26 16.89 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.994 1.718 . . . . 0.0 109.912 177.285 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.37 117.05 22.17 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 178.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mp -109.04 160.57 15.94 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 124.298 1.039 . . . . 0.0 109.256 -179.411 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 43.7 m80 -120.05 161.11 21.51 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 126.39 1.876 . . . . 0.0 109.526 178.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 33.6 mt -122.82 125.14 44.86 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 126.728 2.011 . . . . 0.0 108.014 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.0 m -141.02 166.14 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -178.607 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.6 pt? . . . . . 0 CA--C 1.535 0.373 0 C-N-CA 125.384 1.474 . . . . 0.0 108.955 177.088 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.0 ttm . . . . . 0 N--CA 1.471 0.624 0 CA-C-O 118.719 -0.658 . . . . 0.0 110.356 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -121.74 154.41 36.96 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 176.666 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.9 pt -133.42 169.22 22.34 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 176.697 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -123.04 149.53 44.26 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 179.103 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.7 t -138.95 125.69 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.1 tppp? -94.14 117.56 30.29 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.946 0.898 . . . . 0.0 108.903 178.428 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 37.4 p -83.22 166.18 18.8 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.889 0.768 . . . . 0.0 111.025 179.239 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -70.29 -2.56 13.81 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.35 0.66 . . . . 0.0 111.909 177.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 47.0 p -92.62 -15.16 27.19 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.915 1.286 . . . . 0.0 109.369 178.484 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.5 6.08 57.6 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 126.825 2.155 . . . . 0.0 112.435 179.091 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.3 mmmm -81.91 164.18 21.72 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 119.172 1.486 . . . . 0.0 109.636 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.5 m -113.2 132.08 55.63 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 101.896 -3.372 . . . . 0.0 101.896 176.479 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.8 mm -115.77 148.06 18.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 179.367 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.9 m -125.37 130.05 51.15 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 106.392 -1.706 . . . . 0.0 106.392 178.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 76.3 mt -139.12 143.26 38.16 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.518 0.727 . . . . 0.0 110.072 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -99.57 107.1 19.17 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.902 2.081 . . . . 0.0 106.58 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.4 m -133.58 -172.6 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 124.988 1.315 . . . . 0.0 109.929 -178.579 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -144.13 166.07 20.84 Favored Pre-proline 0 C--O 1.235 0.315 0 CA-C-N 121.031 1.741 . . . . 0.0 112.178 -178.665 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.05 -22.47 31.28 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 123.246 2.63 . . . . 0.0 115.416 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.5 m -115.11 31.03 6.96 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 118.527 0.603 . . . . 0.0 112.369 -178.56 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -104.31 136.17 44.41 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 103.974 -2.602 . . . . 0.0 103.974 175.201 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.4 p -78.09 157.97 29.32 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 122.017 0.913 . . . . 0.0 112.065 -178.537 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.1 mm -64.02 -25.43 38.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-O 118.373 -0.823 . . . . 0.0 110.018 178.233 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -55.83 -38.66 70.32 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 119.739 1.154 . . . . 0.0 109.382 179.007 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 57.7 m-20 -74.42 -52.96 10.56 Favored 'General case' 0 CA--C 1.521 -0.14 0 C-N-CA 124.723 1.209 . . . . 0.0 109.552 178.448 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 24.8 t -54.23 -42.65 57.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 123.036 0.534 . . . . 0.0 111.348 -179.176 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -74.95 -14.54 60.64 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.653 0.781 . . . . 0.0 111.421 -178.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.19 -45.65 8.95 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.397 1.079 . . . . 0.0 108.602 177.173 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.5 mttm -52.64 -39.92 62.25 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 124.715 1.206 . . . . 0.0 111.446 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 32.2 pt -60.53 -29.01 43.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-N 118.445 0.566 . . . . 0.0 111.08 178.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -76.91 -23.43 52.52 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 119.445 1.02 . . . . 0.0 109.983 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.54 -24.31 45.76 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 177.247 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.6 mmtt -93.56 -20.35 20.32 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -150.83 161.76 42.06 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 120.796 1.634 . . . . 0.0 109.526 -178.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -80.95 77.29 2.04 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 124.225 0.917 . . . . 0.0 111.957 -179.438 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.1 pt -135.41 108.51 10.25 Favored Pre-proline 0 CA--C 1.546 0.805 0 CA-C-N 118.245 1.023 . . . . 0.0 111.759 -179.329 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -65.22 166.69 18.29 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 123.151 2.567 . . . . 0.0 110.465 178.488 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -88.23 56.64 2.57 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.408 2.072 . . . . 0.0 107.813 179.333 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -145.91 136.01 23.71 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 127.909 2.484 . . . . 0.0 105.045 -178.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.0 mm-40 51.14 49.53 20.93 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.83 1.652 . . . . 0.0 109.192 -177.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 23.7 m-80 -148.68 133.75 18.22 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.356 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.4 ttm-85 -151.72 137.17 17.69 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 126.967 2.107 . . . . 0.0 105.547 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 28.6 tp -87.27 139.39 30.61 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.603 1.161 . . . . 0.0 108.794 -178.221 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.4 mm -132.26 145.6 34.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 126.05 1.74 . . . . 0.0 108.475 -178.426 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -133.4 119.22 19.36 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 178.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.05 39.88 24.25 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.355 1.062 . . . . 0.0 110.451 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.48 -16.59 17.82 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-O 118.506 -1.163 . . . . 0.0 113.905 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.4 ttmt -79.52 128.78 33.8 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 120.519 2.16 . . . . 0.0 106.661 178.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.1 mp0 -74.55 136.94 42.12 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -179.182 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.9 mt -122.39 155.84 35.22 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 126.078 1.751 . . . . 0.0 109.978 -179.406 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -151.99 176.38 11.55 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.922 1.289 . . . . 0.0 109.162 178.084 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -72.6 160.9 31.5 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 126.082 1.753 . . . . 0.0 110.959 -178.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.84 -26.08 24.41 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 125.06 1.314 . . . . 0.0 110.098 -178.662 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 30.3 mtt180 -106.55 170.34 7.99 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 118.736 1.268 . . . . 0.0 110.165 179.176 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.1 p -117.49 167.59 11.16 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.51 1.524 . . . . 0.0 110.086 179.222 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.4 mp -52.88 -41.66 64.56 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 121.5 -0.75 . . . . 0.0 111.087 178.161 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.4 t -58.33 -44.22 88.6 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.274 1.43 . . . . 0.0 110.608 -179.683 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -57.94 -46.9 84.35 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.348 0.659 . . . . 0.0 109.884 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -81.72 -4.31 55.95 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -179.286 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 31.8 t30 56.66 46.37 20.34 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.996 2.118 . . . . 0.0 109.997 -178.651 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 84.2 mt -86.35 127.22 40.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 N-CA-C 103.782 -2.673 . . . . 0.0 103.782 178.459 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 94.6 mm-40 -101.74 173.21 6.51 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 122.918 0.487 . . . . 0.0 110.851 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.1 pttt -64.71 157.25 27.9 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.25 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 51.6 39.08 24.18 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 125.562 1.545 . . . . 0.0 111.231 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.1 p -87.34 163.44 16.81 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 120.87 -1.144 . . . . 0.0 108.263 177.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 33.0 m -126.4 105.98 9.17 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.4 mp -97.09 160.25 14.45 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.655 1.582 . . . . 0.0 108.805 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 4.2 m80 -120.01 157.63 28.47 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 125.36 1.464 . . . . 0.0 108.194 178.135 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.1 mt -122.99 123.47 40.96 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 105.223 -2.139 . . . . 0.0 105.223 178.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.5 m -141.8 172.43 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-N 120.11 1.323 . . . . 0.0 113.582 -179.18 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.343 0.301 0 C-N-CA 124.718 1.207 . . . . 0.0 111.071 178.031 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.3 ttt . . . . . 0 N--CA 1.469 0.502 0 N-CA-C 110.606 -0.146 . . . . 0.0 110.606 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -120.71 156.96 30.68 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 177.476 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.4 pt -132.51 169.46 21.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 178.233 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -122.58 150.03 43.16 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 124.867 1.267 . . . . 0.0 108.239 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.8 t -139.17 125.24 23.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 O-C-N 121.788 -0.57 . . . . 0.0 109.585 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -91.0 111.27 22.65 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 178.05 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.5 p -83.15 160.61 21.81 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.655 0.661 . . . . 0.0 110.397 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -67.52 -2.72 6.97 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.407 1.083 . . . . 0.0 112.744 179.283 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.9 p -91.3 -12.62 34.56 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 125.264 1.426 . . . . 0.0 110.039 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.64 7.46 57.84 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.3 mmmm -97.07 165.1 12.23 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 118.006 0.903 . . . . 0.0 109.078 179.367 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.46 132.81 53.5 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 103.911 -2.626 . . . . 0.0 103.911 178.027 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.0 mm -114.56 153.26 16.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 -178.72 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 89.8 m -124.77 130.11 51.76 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 104.395 -2.446 . . . . 0.0 104.395 178.148 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 75.1 mt -138.8 151.2 46.85 Favored 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 124.226 1.01 . . . . 0.0 111.04 -179.041 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -97.59 118.7 34.69 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 127.22 2.208 . . . . 0.0 107.17 179.247 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 23.0 m -134.36 -174.94 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.005 0.922 . . . . 0.0 110.094 -179.064 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -147.68 159.14 41.82 Favored Pre-proline 0 C--O 1.234 0.278 0 C-N-CA 124.231 1.012 . . . . 0.0 109.469 178.619 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -53.37 -23.35 23.72 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 123.349 2.699 . . . . 0.0 115.005 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 42.2 m -115.62 30.83 7.1 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -178.749 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -94.91 135.47 36.38 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 176.229 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.3 p -71.44 158.86 35.54 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 119.558 1.072 . . . . 0.0 112.686 -178.488 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.7 mm -63.78 -28.89 45.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 O-C-N 121.475 -0.766 . . . . 0.0 109.018 178.218 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -61.08 -49.83 75.73 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -61.08 -52.48 64.73 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 124.134 0.973 . . . . 0.0 109.635 179.249 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.0 t -56.53 -38.55 57.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 124.165 0.986 . . . . 0.0 111.421 -179.68 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.4 ttpt -80.59 -12.51 59.5 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 118.361 -0.828 . . . . 0.0 111.473 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.6 -43.01 11.07 Favored 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 125.211 1.404 . . . . 0.0 109.213 178.403 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.6 mttm -51.89 -39.71 59.48 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 121.423 -0.798 . . . . 0.0 111.723 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.1 pt -65.0 -25.01 36.7 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 O-C-N 121.679 -0.638 . . . . 0.0 111.683 178.737 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -76.15 -20.67 57.36 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.916 1.234 . . . . 0.0 108.911 -179.378 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.45 -38.92 40.06 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 120.936 -1.103 . . . . 0.0 108.234 177.267 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 51.4 mttm -86.95 -21.81 25.99 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 -178.777 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -140.29 150.16 43.7 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 121.266 1.848 . . . . 0.0 106.406 178.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.75 82.96 1.55 Allowed Glycine 0 N--CA 1.451 -0.323 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.8 pt -134.94 108.72 10.66 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 125.533 1.533 . . . . 0.0 106.865 179.365 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -82.87 170.23 12.68 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 124.532 3.488 . . . . 0.0 112.129 -179.172 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -74.9 55.39 3.88 Favored 'Trans proline' 0 CA--C 1.553 1.439 0 C-N-CA 123.056 2.504 . . . . 0.0 111.089 178.589 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -150.01 127.09 11.23 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 104.475 -2.417 . . . . 0.0 104.475 179.249 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 71.0 mm-40 54.72 50.81 15.0 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.066 1.346 . . . . 0.0 108.347 -176.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -143.21 132.42 23.2 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 179.344 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.6 ttm-85 -158.93 133.42 7.94 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 125.362 1.465 . . . . 0.0 107.32 -179.341 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 21.8 tp -92.92 140.63 29.28 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.057 0.943 . . . . 0.0 112.178 -178.46 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.0 mm -135.55 146.45 29.86 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 127.21 2.204 . . . . 0.0 108.209 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -137.69 120.57 16.46 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 125.95 1.7 . . . . 0.0 106.797 178.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.38 41.25 16.25 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.299 1.039 . . . . 0.0 111.535 -179.647 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.8 -17.39 11.3 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.644 1.116 . . . . 0.0 113.95 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.3 ttmt -79.67 128.46 33.43 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 125.389 1.476 . . . . 0.0 108.994 -179.087 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.6 mp0 -76.15 136.48 39.79 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 124.954 1.302 . . . . 0.0 109.468 -179.09 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 9.6 mt -121.09 154.23 36.4 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 124.729 1.212 . . . . 0.0 109.646 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -151.68 175.99 11.83 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 123.518 0.727 . . . . 0.0 109.471 179.05 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -72.35 160.04 33.02 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.726 1.61 . . . . 0.0 111.229 -178.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.21 -29.22 12.96 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 126.415 1.959 . . . . 0.0 110.856 -178.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 51.7 mtt180 -107.94 174.48 5.86 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 119.305 1.552 . . . . 0.0 112.813 179.442 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 50.3 p -117.55 175.67 5.53 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.984 1.714 . . . . 0.0 114.253 -177.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.17 -49.35 63.98 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.964 1.306 . . . . 0.0 112.253 179.457 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.37 -33.59 76.32 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 118.386 -0.816 . . . . 0.0 111.829 -179.03 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -59.59 -47.22 86.42 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.77 1.168 . . . . 0.0 108.658 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -82.05 1.64 34.87 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.171 0.988 . . . . 0.0 112.673 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.0 t30 54.3 46.77 24.46 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 126.873 2.069 . . . . 0.0 112.56 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 74.8 mt -89.25 122.99 41.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 104.148 -2.538 . . . . 0.0 104.148 178.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -101.88 177.56 4.86 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 123.163 0.585 . . . . 0.0 110.627 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -64.21 155.27 32.34 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-O 121.618 0.723 . . . . 0.0 112.315 -178.455 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 47.59 35.39 4.32 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 127.985 2.514 . . . . 0.0 112.454 -179.415 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.1 p -80.6 163.79 23.39 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.224 1.009 . . . . 0.0 109.316 178.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 43.9 m -126.22 111.08 14.17 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.6 mp -96.69 161.65 13.79 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.387 1.075 . . . . 0.0 109.469 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.4 m80 -119.2 153.45 34.92 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 125.284 1.433 . . . . 0.0 109.823 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.7 mt -122.58 126.76 48.39 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 126.35 1.86 . . . . 0.0 106.477 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.4 m -138.22 169.74 17.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -179.378 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.7 pt? . . . . . 0 N--CA 1.467 0.399 0 C-N-CA 126.846 2.058 . . . . 0.0 109.094 178.105 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 ttt . . . . . 0 CA--C 1.507 -0.711 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -121.18 156.81 31.58 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 177.795 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.4 pt -132.1 168.21 24.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 178.216 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -116.29 150.7 37.21 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 124.865 1.266 . . . . 0.0 107.999 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.2 t -137.96 125.31 29.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 178.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -91.21 117.33 29.55 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 178.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.9 p -72.53 165.3 24.93 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 179.335 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -67.42 -9.31 40.47 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.115 0.566 . . . . 0.0 112.077 178.454 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.3 p -102.64 -12.48 17.68 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 127.527 2.331 . . . . 0.0 113.024 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.03 6.5 42.59 Favored Glycine 0 C--N 1.335 0.518 0 CA-C-O 118.279 -1.29 . . . . 0.0 114.973 178.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.6 mmmm -81.22 163.52 22.96 Favored 'General case' 0 C--N 1.343 0.295 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 178.092 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.6 m -124.55 131.48 53.48 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 103.724 -2.695 . . . . 0.0 103.724 177.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.5 mm -105.49 157.38 6.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 -179.546 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 69.8 m -130.29 122.55 28.19 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 129.428 3.091 . . . . 0.0 103.229 178.703 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 72.4 mt -138.3 146.16 42.09 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.353 1.061 . . . . 0.0 110.037 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -95.71 117.46 30.56 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.47 1.508 . . . . 0.0 108.07 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.5 m -129.03 -168.97 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.431 0 C-N-CA 125.623 1.569 . . . . 0.0 109.456 -178.264 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -150.38 161.89 29.23 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 125.24 1.416 . . . . 0.0 107.702 178.072 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -59.48 -18.7 48.0 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.523 2.149 . . . . 0.0 114.34 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.2 m -114.72 30.48 7.3 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 118.753 0.706 . . . . 0.0 111.498 -178.162 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -92.96 129.59 38.83 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.9 p -77.88 158.25 29.51 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 119.918 1.235 . . . . 0.0 111.592 -178.523 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.1 mm -63.42 -29.88 48.38 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.316 0 CA-C-O 117.933 -1.032 . . . . 0.0 109.979 178.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -59.94 -40.45 88.98 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.916 1.234 . . . . 0.0 110.299 -179.565 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -67.42 -53.08 32.22 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.243 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.7 t -57.07 -40.09 70.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 123.045 0.538 . . . . 0.0 110.95 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt -75.34 -16.0 60.44 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.654 1.182 . . . . 0.0 111.798 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.86 -46.03 8.84 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 177.498 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.5 mttm -52.03 -40.05 60.47 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 124.713 1.205 . . . . 0.0 111.498 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 34.1 pt -63.61 -27.05 42.16 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-N 118.925 0.784 . . . . 0.0 111.279 178.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -77.02 -22.74 52.6 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 119.603 1.092 . . . . 0.0 109.548 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.84 -39.29 61.7 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 177.867 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 51.1 mttm -87.36 -22.52 25.02 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 115.281 1.586 . . . . 0.0 115.281 -178.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -138.68 150.9 46.7 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 120.633 1.56 . . . . 0.0 107.804 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.6 89.3 1.41 Allowed Glycine 0 C--N 1.334 0.426 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 -179.53 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.0 pt -141.49 107.61 6.06 Favored Pre-proline 0 CA--C 1.543 0.685 0 CA-C-N 118.11 0.955 . . . . 0.0 110.777 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -64.7 168.15 13.94 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 123.057 2.505 . . . . 0.0 110.858 178.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -84.1 55.46 4.68 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 122.251 1.967 . . . . 0.0 108.49 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -146.56 136.03 22.94 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 130.516 3.526 . . . . 0.0 104.456 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 66.5 mm-40 51.24 47.52 24.7 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.26 1.824 . . . . 0.0 109.594 -178.211 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -154.86 132.47 11.31 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 179.276 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 51.8 ttm-85 -157.52 135.13 10.58 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 103.533 -2.766 . . . . 0.0 103.533 179.011 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 15.5 tp -87.92 141.91 28.21 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -178.131 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.3 mm -134.41 141.52 43.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 125.923 1.689 . . . . 0.0 108.1 -178.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -139.39 125.86 20.39 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.656 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.29 33.32 15.32 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.528 0.68 . . . . 0.0 111.919 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.97 -13.19 32.63 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 124.461 1.029 . . . . 0.0 112.511 -179.324 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.5 tpmt? -78.58 123.11 26.75 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 -179.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -75.91 136.29 40.1 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.465 HD22 ' CG ' ' A' ' 59' ' ' TYR . 3.5 mt -115.17 154.76 28.41 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 123.867 0.867 . . . . 0.0 109.462 -178.543 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -158.98 179.52 8.99 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 126.302 1.841 . . . . 0.0 107.46 178.565 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.22 160.95 31.91 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.914 1.285 . . . . 0.0 112.458 -176.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.43 -27.13 21.87 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 113.784 -1.553 . . . . 0.0 111.303 -179.399 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 44.8 mtt180 -106.6 168.06 9.43 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 119.033 1.417 . . . . 0.0 111.074 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.1 p -117.81 173.1 6.94 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.599 1.559 . . . . 0.0 113.181 -178.665 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.44 -48.95 65.49 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.151 0.98 . . . . 0.0 111.657 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.4 -32.48 74.11 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 118.474 0.579 . . . . 0.0 111.493 -179.436 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -63.79 -45.68 88.6 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 119.498 1.044 . . . . 0.0 108.774 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.465 ' CG ' HD22 ' A' ' 50' ' ' LEU . 59.3 m-85 -82.16 2.08 33.26 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.683 -0.636 . . . . 0.0 111.69 179.366 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 54.47 47.12 23.51 Favored 'General case' 0 C--N 1.342 0.277 0 C-N-CA 128.041 2.536 . . . . 0.0 111.193 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 74.2 mt -89.99 122.27 41.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 103.553 -2.758 . . . . 0.0 103.553 178.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 94.2 mm-40 -98.57 177.48 5.31 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.038 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 40.8 pttt -64.51 156.05 30.94 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -179.358 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.255 5.4 mp0 45.65 44.38 10.24 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.935 2.094 . . . . 0.0 113.597 179.486 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.8 p -87.94 164.85 15.62 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.619 1.968 . . . . 0.0 109.508 177.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.2 m -126.51 107.3 10.12 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 119.437 1.017 . . . . 0.0 108.755 178.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.1 mp -96.44 163.18 13.16 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.788 1.635 . . . . 0.0 110.547 -178.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 16.1 m80 -119.26 161.0 21.14 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.133 1.373 . . . . 0.0 111.815 178.775 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 39.9 mt -123.29 128.85 50.52 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.897 1.679 . . . . 0.0 107.855 178.093 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.1 m -140.66 162.74 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-N 118.868 0.758 . . . . 0.0 112.253 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.463 0.198 0 C-N-CA 126.394 1.878 . . . . 0.0 109.51 178.604 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.6 ttt . . . . . 0 N--CA 1.469 0.516 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -121.83 154.23 37.3 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 175.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 32.8 pt -132.55 169.72 21.38 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 177.64 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -123.49 150.07 44.37 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.9 t -138.21 125.23 27.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 178.554 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.9 tppp? -91.42 117.47 29.71 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 104.624 -2.361 . . . . 0.0 104.624 178.188 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.0 p -72.8 168.99 17.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 118.456 0.571 . . . . 0.0 110.277 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -66.87 -12.59 59.79 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 121.11 -0.236 . . . . 0.0 111.044 178.155 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.7 p -93.74 -12.4 29.27 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.572 1.949 . . . . 0.0 112.023 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.8 7.28 55.63 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-O 118.801 -1.0 . . . . 0.0 113.49 178.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -79.88 164.01 23.9 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-N 119.484 1.642 . . . . 0.0 106.992 179.425 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.1 m -114.7 130.43 56.82 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 103.289 -2.856 . . . . 0.0 103.289 178.398 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.8 mm -115.55 154.08 17.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 105.602 -1.999 . . . . 0.0 105.602 179.269 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.2 m -134.96 125.3 26.36 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 126.924 2.09 . . . . 0.0 105.395 179.033 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 82.1 mt -140.13 151.05 44.99 Favored 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 124.543 1.137 . . . . 0.0 109.851 -179.348 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -94.84 118.33 31.59 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 105.504 -2.036 . . . . 0.0 105.504 178.239 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.6 m -129.82 -174.2 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 124.523 1.129 . . . . 0.0 108.824 -179.008 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -149.71 168.35 11.18 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 124.404 1.082 . . . . 0.0 108.574 -179.408 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -59.54 -21.24 61.16 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.473 2.115 . . . . 0.0 113.48 178.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.3 m -114.85 31.78 6.45 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 118.463 0.574 . . . . 0.0 111.857 -178.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -91.69 128.21 37.44 Favored 'General case' 0 C--O 1.242 0.711 1 N-CA-C 99.671 -4.196 . . . . 0.0 99.671 177.194 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.1 p -76.72 158.59 30.85 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -179.04 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.8 mm -63.49 -27.31 42.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 119.254 -0.978 . . . . 0.0 109.388 178.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -61.58 -37.84 85.34 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.885 1.221 . . . . 0.0 109.017 178.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.0 m-80 -69.24 -52.93 22.8 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 178.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 25.8 t -55.73 -38.53 51.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-N 119.049 0.84 . . . . 0.0 110.93 179.555 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.1 ttpt -75.08 -18.18 60.33 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.327 1.051 . . . . 0.0 111.686 -179.284 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.01 -46.83 8.24 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 126.767 2.027 . . . . 0.0 109.187 178.292 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -51.5 -40.68 60.03 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.407 1.483 . . . . 0.0 110.831 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 31.6 pt -64.79 -25.21 37.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 O-C-N 121.138 -0.976 . . . . 0.0 111.879 179.137 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -76.85 -23.37 52.69 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 120.671 -1.268 . . . . 0.0 109.626 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.78 -24.57 55.99 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 176.842 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.2 mttm -100.74 -15.29 17.73 Favored 'General case' 0 C--N 1.341 0.203 0 N-CA-C 116.236 1.939 . . . . 0.0 116.236 -179.222 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -145.55 158.56 43.83 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 120.918 1.69 . . . . 0.0 108.111 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.14 68.64 3.4 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.6 pt -131.6 108.57 14.5 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 118.131 0.966 . . . . 0.0 110.507 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -75.18 169.58 22.22 Favored 'Trans proline' 0 CA--C 1.544 0.992 0 C-N-CA 123.172 2.581 . . . . 0.0 109.372 178.531 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -78.69 56.62 6.01 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.374 2.049 . . . . 0.0 110.665 179.376 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -146.78 135.93 22.58 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 129.218 3.007 . . . . 0.0 106.939 -179.137 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 68.9 mm-40 52.73 47.91 23.65 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 127.928 2.491 . . . . 0.0 109.524 -178.348 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 25.9 m-80 -153.0 136.44 15.87 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 121.785 -0.572 . . . . 0.0 109.754 179.435 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 54.4 ttm-85 -151.92 134.91 15.72 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 126.558 1.943 . . . . 0.0 105.891 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 19.6 tp -87.74 140.83 29.11 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 124.09 0.956 . . . . 0.0 109.484 -178.348 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.2 mm -132.7 144.7 35.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 125.655 1.582 . . . . 0.0 109.355 -178.502 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -138.36 121.27 16.58 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 177.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.22 40.59 26.44 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.463 1.105 . . . . 0.0 110.55 -179.257 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.13 -16.13 18.32 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 125.264 1.412 . . . . 0.0 113.85 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.0 ttmt -79.05 128.93 33.89 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 119.832 1.816 . . . . 0.0 109.014 -179.095 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.0 mp0 -74.26 134.36 42.65 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.0 mt -117.93 154.98 31.01 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.826 1.25 . . . . 0.0 109.537 -179.33 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -162.5 176.91 9.96 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 126.803 2.041 . . . . 0.0 107.404 177.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -71.44 161.59 30.8 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.205 1.402 . . . . 0.0 112.285 -178.008 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 108.43 -28.98 10.56 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 127.386 2.422 . . . . 0.0 108.049 -178.122 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 46.2 mtt180 -107.62 169.83 8.35 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 124.934 1.294 . . . . 0.0 110.473 178.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 80.8 p -123.84 169.45 11.56 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 127.161 2.184 . . . . 0.0 110.178 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.9 mp -53.01 -42.07 65.29 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 123.064 0.545 . . . . 0.0 111.259 177.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.4 t -59.31 -44.96 92.5 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.595 1.158 . . . . 0.0 109.916 -179.465 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -58.96 -46.37 88.22 Favored 'General case' 0 C--N 1.341 0.233 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -81.35 1.32 33.31 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -179.31 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 36.9 t30 54.31 45.91 26.25 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.199 1.799 . . . . 0.0 111.228 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 81.3 mt -87.98 123.4 40.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 87.5 mm-40 -95.1 175.16 6.73 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.43 0.633 . . . . 0.0 111.203 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -70.99 157.11 38.77 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.386 0.674 . . . . 0.0 109.201 178.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 54.1 35.37 22.12 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.441 1.496 . . . . 0.0 110.958 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.9 p -87.2 162.12 17.65 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.529 1.132 . . . . 0.0 109.19 178.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.1 m -124.96 107.93 11.35 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 122.365 1.079 . . . . 0.0 109.539 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.2 mp -96.44 160.46 14.39 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.734 1.214 . . . . 0.0 108.802 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -119.07 160.7 21.57 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.709 1.204 . . . . 0.0 111.745 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 25.6 mt -123.08 124.61 43.49 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.987 1.715 . . . . 0.0 108.16 179.467 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.9 m -141.1 167.9 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 124.775 1.23 . . . . 0.0 113.174 -179.19 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.531 0.215 0 C-N-CA 125.262 1.425 . . . . 0.0 110.076 177.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.469 0.481 0 N-CA-C 111.25 0.093 . . . . 0.0 111.25 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -121.48 157.57 30.33 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 176.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.0 pt -132.37 169.96 20.88 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 C-N-CA 125.287 1.435 . . . . 0.0 108.346 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -126.24 149.53 49.02 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 124.925 1.29 . . . . 0.0 107.89 178.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.5 t -139.62 131.48 34.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -97.6 117.78 32.65 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.3 p -83.27 168.79 16.37 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.027 0.931 . . . . 0.0 110.976 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.9 -5.0 22.99 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.582 0.753 . . . . 0.0 112.632 178.143 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.0 p -93.28 -14.14 27.36 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 177.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.18 7.13 57.45 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 124.903 1.24 . . . . 0.0 111.349 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.82 163.95 23.06 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 119.084 1.442 . . . . 0.0 107.567 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.2 m -120.5 137.42 54.37 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 103.629 -2.73 . . . . 0.0 103.629 178.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.2 mm -114.69 157.02 15.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 38.1 m -134.73 124.26 24.95 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 127.954 2.502 . . . . 0.0 104.343 178.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 29.5 mt -139.93 150.81 45.0 Favored 'General case' 0 CA--C 1.515 -0.373 0 C-N-CA 124.79 1.236 . . . . 0.0 111.589 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -98.25 119.01 36.17 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 127.274 2.23 . . . . 0.0 106.519 178.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.0 m -134.09 -171.19 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 125.949 1.7 . . . . 0.0 108.287 -179.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -142.38 161.17 51.52 Favored Pre-proline 0 CA--C 1.536 0.437 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -61.25 -18.01 56.16 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.442 2.095 . . . . 0.0 112.899 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.8 m -114.96 30.97 6.99 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 124.216 1.007 . . . . 0.0 111.402 -177.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -93.06 130.95 38.49 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 126.277 1.831 . . . . 0.0 106.825 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.3 p -77.15 158.18 30.54 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 119.775 1.171 . . . . 0.0 110.301 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.7 mm -63.61 -30.72 50.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -61.24 -37.36 82.81 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 119.348 0.976 . . . . 0.0 111.554 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -73.46 -53.33 10.89 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 123.94 0.896 . . . . 0.0 108.591 179.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.2 t -55.94 -38.16 51.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 123.035 0.534 . . . . 0.0 110.723 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.8 ttpt -75.14 -16.55 60.52 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 118.172 -0.918 . . . . 0.0 110.952 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.69 -45.38 14.53 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 177.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.6 mttm -50.98 -40.17 57.19 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.953 1.301 . . . . 0.0 112.105 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.3 pt -64.71 -27.29 42.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 O-C-N 120.978 -1.076 . . . . 0.0 111.001 179.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -76.6 -22.81 53.7 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 119.399 0.999 . . . . 0.0 109.162 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.76 -40.17 63.68 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.296 87.1 mttt -92.42 -15.32 27.35 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-O 117.435 -1.269 . . . . 0.0 114.257 -179.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -140.46 150.58 43.98 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 121.881 2.128 . . . . 0.0 106.682 178.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -83.47 87.15 1.5 Allowed Glycine 0 C--N 1.334 0.428 0 CA-C-O 118.977 -0.902 . . . . 0.0 111.782 -178.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.5 pt -137.46 108.22 8.62 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 124.271 1.028 . . . . 0.0 111.45 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -69.83 170.13 17.39 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 124.786 3.657 . . . . 0.0 110.733 178.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -82.39 54.72 5.05 Favored 'Trans proline' 0 CA--C 1.547 1.143 0 N-CA-C 107.827 -1.644 . . . . 0.0 107.827 177.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -150.53 135.91 17.94 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 127.898 2.479 . . . . 0.0 105.519 -178.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 54.7 mm-40 53.03 46.47 26.69 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 128.024 2.53 . . . . 0.0 106.175 -176.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -156.38 135.93 12.37 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.231 1.012 . . . . 0.0 111.919 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.1 ttm-85 -154.93 136.08 13.93 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 127.13 2.172 . . . . 0.0 105.995 178.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 23.7 tp -87.97 137.37 32.39 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.643 0.777 . . . . 0.0 109.481 -178.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.4 mm -135.3 148.57 28.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 125.644 1.578 . . . . 0.0 108.796 -178.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -138.51 121.13 16.26 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 178.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.0 33.52 12.04 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 119.315 0.961 . . . . 0.0 111.353 -179.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.15 -7.79 62.66 Favored Glycine 0 CA--C 1.532 1.099 0 O-C-N 121.298 -0.876 . . . . 0.0 113.123 -179.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.2 tpmt? -78.64 118.11 20.43 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 104.743 -2.317 . . . . 0.0 104.743 179.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.5 mp0 -74.95 133.0 41.82 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.2 mt -114.12 155.47 25.96 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.558 1.143 . . . . 0.0 109.837 -178.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -157.25 174.72 15.02 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.458 1.503 . . . . 0.0 108.161 178.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -73.73 159.8 32.44 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.401 1.48 . . . . 0.0 112.327 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 106.07 -27.53 17.03 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 126.46 1.981 . . . . 0.0 109.526 -178.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 46.0 mtt180 -107.39 169.26 8.69 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 118.124 0.962 . . . . 0.0 110.689 178.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 80.4 p -119.02 168.95 10.33 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 126.268 1.827 . . . . 0.0 110.72 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.8 mp -52.4 -42.89 64.43 Favored 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 123.625 0.77 . . . . 0.0 112.784 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 68.9 m -65.81 -32.63 74.27 Favored 'General case' 0 N--CA 1.462 0.125 0 CA-C-N 118.929 0.786 . . . . 0.0 112.535 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -64.09 -44.38 92.5 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -81.45 1.61 32.42 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.592 1.157 . . . . 0.0 111.519 178.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 55.45 46.73 22.59 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 127.167 2.187 . . . . 0.0 112.326 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 15.0 mt -96.18 123.78 48.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 86.8 mm-40 -101.24 178.25 4.71 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.978 1.311 . . . . 0.0 110.609 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.1 pttt -64.47 156.65 28.9 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 122.87 0.468 . . . . 0.0 111.279 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 48.43 41.06 16.13 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.386 2.274 . . . . 0.0 112.585 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.5 p -87.2 153.79 21.22 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.408 1.083 . . . . 0.0 108.082 177.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 14.4 m -118.72 114.57 22.92 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.5 mp -101.07 168.29 9.69 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.786 1.635 . . . . 0.0 110.861 -178.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.7 m80 -119.96 154.76 34.01 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 127.106 2.162 . . . . 0.0 109.327 178.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 16.7 mt -123.44 125.08 44.29 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 178.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.4 m -139.79 166.15 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 CA-C-N 120.789 1.631 . . . . 0.0 113.436 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -134.2 -170.43 2.52 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 125.983 1.713 . . . . 0.0 110.898 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -152.54 131.59 12.64 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 178.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.442 HD23 ' H ' ' A' ' 75' ' ' GLY . 0.5 OUTLIER -145.06 135.01 23.74 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -178.911 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 44.0 mmm-85 -106.18 -11.51 16.04 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 123.413 0.685 . . . . 0.0 111.651 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.442 ' H ' HD23 ' A' ' 73' ' ' LEU . . . -85.68 18.43 30.08 Favored Glycine 0 CA--C 1.537 1.428 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 177.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.954 0 N-CA-C 105.256 -3.138 . . . . 0.0 105.256 -179.348 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.3 ttt . . . . . 0 N--CA 1.473 0.676 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -120.77 158.72 26.92 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 114.668 1.359 . . . . 0.0 114.668 -177.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.9 pp -131.57 168.78 23.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 176.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -126.66 149.79 49.33 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 125.262 1.425 . . . . 0.0 108.106 179.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.8 t -138.68 125.47 25.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -89.99 116.39 28.0 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 103.085 -2.932 . . . . 0.0 103.085 177.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.5 p -72.55 168.75 17.93 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 122.574 1.178 . . . . 0.0 113.294 -178.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -67.75 -12.64 60.98 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 114.648 -1.16 . . . . 0.0 111.094 178.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 65.9 p -102.64 -12.56 17.61 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.771 1.169 . . . . 0.0 110.882 179.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.61 7.31 34.37 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 124.883 1.23 . . . . 0.0 114.89 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.2 mmmm -80.88 165.24 22.0 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 120.069 1.935 . . . . 0.0 108.053 178.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 83.7 m -119.06 130.4 55.6 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 104.233 -2.506 . . . . 0.0 104.233 178.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.0 mm -115.78 154.2 17.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 125.398 1.479 . . . . 0.0 107.775 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.2 m -135.13 128.59 32.43 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 178.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 74.4 mt -139.8 150.47 44.76 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 118.678 0.672 . . . . 0.0 111.05 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -94.32 118.48 31.66 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.231 1.412 . . . . 0.0 107.771 178.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.8 m -134.57 179.23 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 126.581 1.953 . . . . 0.0 108.461 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -147.98 162.69 30.22 Favored Pre-proline 0 CA--C 1.536 0.42 0 O-C-N 120.908 -1.12 . . . . 0.0 109.401 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -51.95 -22.56 14.55 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.773 2.982 . . . . 0.0 115.572 -179.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.6 t -114.6 30.92 6.98 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 119.951 1.251 . . . . 0.0 111.051 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -95.22 129.4 42.36 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 103.759 -2.682 . . . . 0.0 103.759 177.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.6 p -76.74 159.53 30.08 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 118.775 0.716 . . . . 0.0 109.764 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 39.8 mm -58.98 -26.0 31.41 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 CA-C-O 118.611 -0.709 . . . . 0.0 110.084 178.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -64.28 -46.18 84.79 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 125.108 1.363 . . . . 0.0 109.645 178.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.5 m-80 -62.22 -52.51 63.46 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.3 t -57.18 -37.36 55.55 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 122.725 0.41 . . . . 0.0 109.922 178.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.7 ttpt -75.02 -19.84 59.89 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 120.903 -1.123 . . . . 0.0 110.547 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.29 -45.36 26.5 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 104.908 -2.256 . . . . 0.0 104.908 177.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.6 mttm -54.53 -43.29 71.8 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.156 1.382 . . . . 0.0 111.385 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.1 pt -63.81 -28.24 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-N 120.148 1.34 . . . . 0.0 110.456 178.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -76.16 -22.64 55.16 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 119.926 1.239 . . . . 0.0 110.897 -179.168 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.27 -23.24 51.2 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 177.525 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -99.56 -23.96 14.91 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 114.387 1.255 . . . . 0.0 114.387 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -152.37 149.54 28.73 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 178.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -88.78 87.15 1.47 Allowed Glycine 0 CA--C 1.519 0.296 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.2 pt -132.23 107.4 13.54 Favored Pre-proline 0 CA--C 1.539 0.548 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.23 156.86 15.45 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.062 2.508 . . . . 0.0 113.315 -179.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -83.31 55.96 5.25 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.572 2.181 . . . . 0.0 107.763 178.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -156.6 137.53 13.49 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 128.585 2.754 . . . . 0.0 106.165 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 50.56 45.27 26.84 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 127.405 2.282 . . . . 0.0 108.228 -178.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -157.75 135.46 10.59 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 129.042 2.937 . . . . 0.0 106.212 178.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.7 ttm105 -151.66 141.06 21.52 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 121.424 1.92 . . . . 0.0 106.539 177.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.416 ' O ' HD13 ' A' ' 44' ' ' ILE . 0.5 OUTLIER -88.25 140.19 29.73 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 124.393 1.077 . . . . 0.0 109.48 -178.966 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.416 HD13 ' O ' ' A' ' 43' ' ' LEU . 3.9 mm -135.49 146.41 29.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 125.275 1.43 . . . . 0.0 108.887 -179.206 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -135.82 115.09 12.48 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 125.005 1.322 . . . . 0.0 108.679 178.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.88 41.25 14.23 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.281 1.432 . . . . 0.0 111.771 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.17 -14.95 52.02 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 125.696 1.617 . . . . 0.0 113.959 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.6 tpmt? -79.69 124.82 28.91 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -74.44 137.06 42.38 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 178.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.6 mt -114.01 142.21 46.45 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -152.8 176.28 11.97 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.661 1.984 . . . . 0.0 107.86 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -72.57 159.81 33.3 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 125.457 1.503 . . . . 0.0 111.089 -178.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 105.99 -29.14 11.68 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 127.769 2.604 . . . . 0.0 110.618 -178.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.343 34.3 mtm105 -109.91 168.41 9.44 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 60.9 p -120.49 171.31 8.63 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 126.702 2.001 . . . . 0.0 111.504 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.2 mp -51.26 -41.5 60.43 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 124.358 1.063 . . . . 0.0 111.674 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 11.4 t -59.17 -45.78 90.12 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.418 1.487 . . . . 0.0 110.422 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -62.21 -44.51 96.4 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.969 0.908 . . . . 0.0 110.615 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -82.16 -2.04 50.89 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.926 0.891 . . . . 0.0 112.833 -179.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 40.8 t30 53.7 46.34 26.12 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 126.237 1.815 . . . . 0.0 110.631 -179.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 93.2 mt -85.02 123.23 39.05 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.153 0 N-CA-C 104.6 -2.37 . . . . 0.0 104.6 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 92.8 mm-40 -89.27 166.79 13.55 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.606 -178.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 46.6 pttt -64.44 155.39 32.77 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.007 178.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 45.33 34.67 1.56 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 128.338 2.655 . . . . 0.0 112.179 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 51.6 m -77.3 160.57 28.75 Favored 'General case' 0 N--CA 1.462 0.174 0 O-C-N 120.908 -1.12 . . . . 0.0 111.42 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.9 m -115.15 113.66 24.27 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.5 mp -108.68 163.51 13.19 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.72 1.608 . . . . 0.0 109.763 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -119.39 162.33 18.99 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.605 1.162 . . . . 0.0 112.131 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.2 mt -121.42 129.91 53.28 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 126.434 1.894 . . . . 0.0 106.37 178.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.4 m -135.42 173.06 14.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 C-N-CA 125.0 1.32 . . . . 0.0 108.695 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.4 pp -141.46 -172.09 3.45 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.69 0.796 . . . . 0.0 110.271 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.18 142.08 12.84 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 128.087 2.555 . . . . 0.0 104.174 178.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.4 mt -137.56 121.8 18.07 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 119.803 1.183 . . . . 0.0 109.553 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.264 18.3 mmm-85 -109.34 -0.08 19.24 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 127.19 2.196 . . . . 0.0 112.396 177.509 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -78.84 37.43 1.91 Allowed Glycine 0 CA--C 1.528 0.871 0 O-C-N 120.636 -1.29 . . . . 0.0 114.526 -177.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.018 0 C-N-CA 126.539 2.019 . . . . 0.0 108.933 179.547 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.9 ttt . . . . . 0 CA--C 1.514 -0.431 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -120.6 156.95 30.56 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.2 pt -132.85 169.8 21.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.553 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 177.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -124.9 152.45 44.05 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 125.799 1.64 . . . . 0.0 108.23 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.4 t -138.33 125.13 26.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 178.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -90.64 116.25 28.38 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 104.035 -2.58 . . . . 0.0 104.035 178.077 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 44.1 p -72.42 166.81 21.83 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.317 0.579 . . . . 0.0 110.291 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -67.48 -12.08 59.44 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.199 178.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.7 p -96.78 -12.71 23.31 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 127.693 2.397 . . . . 0.0 112.273 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.57 6.43 56.41 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 125.895 1.712 . . . . 0.0 114.074 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -82.99 165.47 19.63 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-N 118.954 1.377 . . . . 0.0 107.322 178.307 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 43.6 m -123.07 132.43 54.1 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.7 mm -107.17 155.47 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 179.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.1 m -132.86 130.38 39.68 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 103.76 -2.682 . . . . 0.0 103.76 178.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 76.1 mt -139.6 150.52 45.09 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -100.56 118.49 36.84 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 104.189 -2.523 . . . . 0.0 104.189 178.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.6 m -131.89 -170.74 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 125.036 1.334 . . . . 0.0 109.937 -178.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -147.34 159.29 42.41 Favored Pre-proline 0 CA--C 1.534 0.345 0 O-C-N 121.007 -1.058 . . . . 0.0 109.972 178.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -56.8 -23.58 51.08 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.971 2.447 . . . . 0.0 114.856 -179.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 43.5 m -115.24 32.59 5.95 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.676 0.79 . . . . 0.0 111.124 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -92.83 129.63 38.69 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 104.125 -2.546 . . . . 0.0 104.125 178.077 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.1 p -77.18 159.5 29.67 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 119.777 1.171 . . . . 0.0 111.833 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.1 mm -63.59 -30.73 50.62 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.003 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -56.39 -39.52 73.12 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.823 0.849 . . . . 0.0 110.551 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -74.79 -55.53 5.74 Favored 'General case' 0 C--O 1.224 -0.275 0 C-N-CA 123.486 0.714 . . . . 0.0 109.339 178.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.6 t -54.02 -46.18 65.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 124.819 1.248 . . . . 0.0 113.068 -177.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -75.0 -15.64 60.65 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.612 0.765 . . . . 0.0 111.137 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.59 -41.63 11.87 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 177.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.0 mttm -53.77 -40.56 66.35 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.231 1.012 . . . . 0.0 110.573 179.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 29.2 pt -60.45 -27.22 39.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-O 118.128 -0.939 . . . . 0.0 111.16 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -80.43 -20.17 44.5 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.099 1.36 . . . . 0.0 111.087 179.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -88.46 -24.3 23.03 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.974 1.31 . . . . 0.0 109.11 178.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 32.7 tptt -99.0 -20.54 16.7 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.122 1.769 . . . . 0.0 112.389 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -144.37 150.28 37.51 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.838 2.055 . . . . 0.0 106.174 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -82.28 82.37 1.63 Allowed Glycine 0 C--N 1.333 0.374 0 CA-C-O 118.793 -1.004 . . . . 0.0 111.784 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.7 pt -131.18 108.29 15.0 Favored Pre-proline 0 CA--C 1.546 0.796 0 CA-C-N 118.413 1.107 . . . . 0.0 109.866 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -58.66 155.96 34.55 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.98 3.12 . . . . 0.0 114.001 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -86.2 57.17 3.95 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 123.469 2.779 . . . . 0.0 106.624 177.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -146.15 136.68 24.05 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 129.471 3.109 . . . . 0.0 103.726 -178.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.4 pt20 48.01 50.92 15.28 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.468 1.507 . . . . 0.0 112.29 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -145.41 148.71 33.63 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 121.052 -1.03 . . . . 0.0 110.371 179.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -154.59 135.04 13.37 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 125.14 1.376 . . . . 0.0 109.514 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 54.9 tp -89.08 136.55 32.95 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 125.106 1.362 . . . . 0.0 110.178 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.3 mm -133.92 145.88 32.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 125.24 1.416 . . . . 0.0 111.08 -178.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -138.92 126.47 21.84 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 176.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.58 34.76 16.36 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.708 1.203 . . . . 0.0 111.719 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.32 -8.02 59.35 Favored Glycine 0 CA--C 1.531 1.033 0 O-C-N 120.919 -1.113 . . . . 0.0 114.203 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.2 mmtp -92.17 130.37 37.9 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 125.864 1.666 . . . . 0.0 109.169 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -73.68 136.37 43.78 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.794 0.838 . . . . 0.0 108.868 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.9 mt -115.19 150.43 36.11 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 179.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -152.09 176.31 11.67 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -72.18 156.23 39.38 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 122.112 0.958 . . . . 0.0 110.555 -178.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.98 -21.14 30.06 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 126.416 1.96 . . . . 0.0 109.855 -178.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 40.3 mmt-85 -107.12 169.38 8.59 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.364 1.466 . . . . 0.0 111.948 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.9 p -123.65 167.59 13.77 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.905 1.682 . . . . 0.0 111.327 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -52.41 -47.22 66.41 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.158 0.983 . . . . 0.0 112.39 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.2 t -65.26 -31.43 72.57 Favored 'General case' 0 C--O 1.227 -0.115 0 C-N-CA 123.77 0.828 . . . . 0.0 112.763 -179.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -59.6 -47.36 85.87 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 119.996 1.271 . . . . 0.0 109.271 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -82.09 0.69 39.44 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.22 0.608 . . . . 0.0 110.236 178.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.5 t30 53.96 47.49 23.32 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 127.639 2.376 . . . . 0.0 110.646 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.5 mt -85.26 122.5 38.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 104.318 -2.475 . . . . 0.0 104.318 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -92.83 175.35 6.83 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.289 0.566 . . . . 0.0 110.189 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.8 pttt -64.71 156.76 29.36 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.293 0.568 . . . . 0.0 110.295 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 52.72 35.34 18.21 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 128.252 2.621 . . . . 0.0 111.608 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 72.3 m -85.82 158.22 20.03 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 120.848 -1.157 . . . . 0.0 109.467 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 28.3 m -119.16 120.35 36.83 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.612 1.165 . . . . 0.0 110.246 -178.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.2 mp -107.36 162.69 13.69 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.865 1.666 . . . . 0.0 110.722 -179.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -119.91 160.59 22.41 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 126.008 1.723 . . . . 0.0 111.616 179.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 90.4 mt -123.64 131.9 53.73 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.427 1.491 . . . . 0.0 110.257 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.4 m -140.5 161.7 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-N 119.63 1.104 . . . . 0.0 111.19 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -143.7 -172.04 3.65 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 178.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.1 mmt-85 -159.93 127.98 4.79 Favored 'General case' 0 C--N 1.344 0.335 0 C-N-CA 125.362 1.465 . . . . 0.0 109.064 176.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 12.6 mt -157.02 142.07 17.1 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 127.824 2.449 . . . . 0.0 107.493 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -107.42 -28.14 10.02 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 118.77 0.714 . . . . 0.0 111.208 177.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -93.52 18.93 55.4 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 125.367 1.46 . . . . 0.0 110.897 178.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.189 0 C-N-CA 128.366 2.888 . . . . 0.0 106.422 -179.836 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.5 ttt . . . . . 0 CA--C 1.509 -0.618 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -119.29 145.64 45.95 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 124.279 0.987 . . . . 0.0 109.734 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.2 pt -134.17 169.7 21.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 C-N-CA 125.288 1.435 . . . . 0.0 108.077 177.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -124.47 149.91 46.31 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.882 1.673 . . . . 0.0 110.47 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.6 t -139.77 131.57 33.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 177.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -97.58 117.14 31.18 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 105.426 -2.065 . . . . 0.0 105.426 177.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 41.6 p -74.29 165.85 24.47 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 118.522 0.601 . . . . 0.0 111.067 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.452 HD23 HG23 ' A' ' 9' ' ' THR . 1.1 pt? -67.63 -10.54 53.08 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.32 178.28 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.452 HG23 HD23 ' A' ' 8' ' ' LEU . 77.2 p -91.71 -12.46 33.97 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.569 1.547 . . . . 0.0 110.66 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.1 5.88 57.09 Favored Glycine 0 C--N 1.34 0.791 0 C-N-CA 126.177 1.846 . . . . 0.0 112.9 179.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.8 164.04 23.01 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 119.151 1.475 . . . . 0.0 107.801 179.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 50.1 m -114.08 133.57 55.45 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 102.599 -3.111 . . . . 0.0 102.599 177.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 40.1 mm -114.57 157.87 15.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 C-N-CA 125.849 1.66 . . . . 0.0 107.837 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.6 m -131.36 130.8 43.11 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 128.823 2.849 . . . . 0.0 104.886 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.646 HD11 HG23 ' A' ' 30' ' ' ILE . 12.8 mt -140.17 144.47 36.65 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 124.018 0.927 . . . . 0.0 110.349 179.018 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -105.26 110.5 22.89 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 127.382 2.273 . . . . 0.0 105.621 177.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.1 m -134.34 -169.16 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -141.8 160.6 55.4 Favored Pre-proline 0 C--O 1.238 0.459 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -56.43 -18.55 25.51 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.734 2.29 . . . . 0.0 113.386 178.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 39.1 m -115.66 30.43 7.35 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 119.023 0.828 . . . . 0.0 112.991 -178.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -94.74 134.17 37.63 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 104.993 -2.225 . . . . 0.0 104.993 177.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.1 p -73.54 157.55 36.51 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 119.07 -1.052 . . . . 0.0 109.204 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.2 mm -64.1 -26.29 40.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 177.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -56.58 -42.06 78.0 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.82 1.248 . . . . 0.0 109.647 179.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -74.14 -54.93 6.75 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 123.786 0.834 . . . . 0.0 109.73 178.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.7 t -54.32 -40.03 46.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -178.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -75.68 -16.28 60.2 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.395 0.678 . . . . 0.0 111.015 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.58 -41.73 11.82 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.395 1.078 . . . . 0.0 109.142 178.155 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.0 mttm -53.17 -40.46 64.36 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 118.727 0.694 . . . . 0.0 110.129 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.646 HG23 HD11 ' A' ' 15' ' ' LEU . 38.3 pt -62.3 -26.88 41.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 O-C-N 120.703 -1.248 . . . . 0.0 111.665 179.199 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -76.53 -20.11 57.23 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.344 1.058 . . . . 0.0 109.575 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.18 -39.43 40.82 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 177.189 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.3 mttm -88.59 -16.25 33.01 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 -178.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -141.41 150.54 42.48 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 179.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -87.08 85.65 1.54 Allowed Glycine 0 CA--C 1.52 0.392 0 O-C-N 121.419 -0.801 . . . . 0.0 111.987 -178.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.0 pt -134.18 107.97 11.38 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 124.608 1.163 . . . . 0.0 108.149 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -69.29 168.46 20.87 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 124.197 3.265 . . . . 0.0 113.755 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -82.35 56.83 5.91 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 122.975 2.45 . . . . 0.0 108.427 177.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -154.1 136.57 15.04 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 129.695 3.198 . . . . 0.0 103.713 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 62.4 mm-40 53.76 50.17 17.61 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.441 1.096 . . . . 0.0 108.333 -178.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -142.0 134.43 28.02 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -178.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 47.5 ttm-85 -159.56 132.27 6.74 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 30.6 tp -99.4 137.25 38.16 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 124.218 1.007 . . . . 0.0 109.47 -178.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.5 mm -135.06 141.9 41.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.235 1.014 . . . . 0.0 109.305 -178.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -138.99 126.1 21.26 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.02 33.22 14.35 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.027 0.531 . . . . 0.0 110.674 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.42 -16.21 19.58 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 124.74 1.162 . . . . 0.0 112.73 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -79.35 126.52 30.92 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 119.33 1.565 . . . . 0.0 108.133 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.7 mp0 -75.61 137.12 40.55 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.102 -1.074 . . . . 0.0 108.102 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.6 mt -114.26 154.64 27.59 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.716 1.207 . . . . 0.0 108.794 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -162.47 175.25 11.69 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 179.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -72.76 160.96 31.35 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 126.879 2.072 . . . . 0.0 114.078 -177.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.47 -29.39 12.0 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 127.578 2.513 . . . . 0.0 109.081 -178.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 50.0 mtt180 -107.95 169.01 8.88 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 117.979 0.89 . . . . 0.0 110.961 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 37.5 p -117.5 171.58 7.91 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.488 1.115 . . . . 0.0 112.033 -178.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.7 mp -52.2 -41.77 62.97 Favored 'General case' 0 C--O 1.227 -0.128 0 C-N-CA 123.572 0.749 . . . . 0.0 111.157 178.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.1 t -59.21 -46.0 89.62 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.559 1.544 . . . . 0.0 109.983 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -64.2 -39.66 94.45 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 123.533 0.733 . . . . 0.0 110.152 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -84.68 -0.69 54.44 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.54 0.736 . . . . 0.0 111.487 179.008 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 61.3 t30 53.85 46.12 26.38 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.887 2.075 . . . . 0.0 112.383 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 84.6 mt -93.7 126.09 46.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 -179.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -100.48 172.68 6.97 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 123.963 0.905 . . . . 0.0 111.19 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 49.2 pttt -66.62 156.77 34.22 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 54.92 35.58 24.78 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.511 1.524 . . . . 0.0 111.778 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.0 p -86.79 158.53 19.35 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 120.323 -1.486 . . . . 0.0 107.485 177.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 26.7 m -126.12 119.91 28.79 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 178.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.7 mp -106.06 169.53 8.44 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.252 1.021 . . . . 0.0 110.873 -179.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 21.4 m80 -118.54 153.07 34.82 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.865 1.666 . . . . 0.0 108.694 178.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 17.9 mt -123.03 126.47 47.17 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.866 1.666 . . . . 0.0 106.72 178.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.1 m -139.03 172.61 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 124.538 1.135 . . . . 0.0 111.367 -178.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -142.79 -170.93 3.33 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.251 1.42 . . . . 0.0 108.085 177.216 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.7 tpt180 -151.11 129.12 11.76 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 104.72 -2.326 . . . . 0.0 104.72 177.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -145.88 134.01 21.58 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -178.46 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 40.9 mmm-85 -104.3 -14.42 15.8 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 123.352 0.661 . . . . 0.0 110.044 179.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -84.03 18.38 22.27 Favored Glycine 0 CA--C 1.539 1.541 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 177.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.235 0 N-CA-C 103.86 -3.696 . . . . 0.0 103.86 -179.755 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 ttt . . . . . 0 N--CA 1.467 0.424 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -121.0 151.66 39.49 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 177.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 28.7 pt -132.84 169.62 21.65 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 178.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -123.13 151.85 41.69 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 124.517 1.127 . . . . 0.0 108.913 179.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 56.7 t -137.32 127.01 37.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 106.56 -1.645 . . . . 0.0 106.56 178.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -94.24 116.56 28.96 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 103.981 -2.6 . . . . 0.0 103.981 177.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.6 p -77.75 168.1 20.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 118.418 0.554 . . . . 0.0 110.335 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -67.23 -12.51 60.25 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.204 1.001 . . . . 0.0 111.512 178.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.5 p -93.74 -12.67 28.65 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.819 1.648 . . . . 0.0 111.129 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.06 7.3 56.39 Favored Glycine 0 CA--C 1.531 1.067 0 O-C-N 121.365 -0.834 . . . . 0.0 111.917 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.8 164.62 22.57 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 119.055 1.428 . . . . 0.0 107.276 179.023 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.5 m -121.73 131.75 54.25 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 105.05 -2.204 . . . . 0.0 105.05 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.1 mm -114.64 157.18 15.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 105.689 -1.967 . . . . 0.0 105.689 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 56.0 m -134.33 125.47 27.7 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 104.067 -2.568 . . . . 0.0 104.067 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.5 mt -137.73 147.72 44.99 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -104.89 107.11 17.91 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 127.561 2.344 . . . . 0.0 106.322 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.8 m -127.89 -168.45 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 125.791 1.636 . . . . 0.0 109.2 -178.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -141.85 159.53 59.2 Favored Pre-proline 0 N--CA 1.451 -0.377 0 C-N-CA 124.09 0.956 . . . . 0.0 109.654 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -55.44 -17.02 15.29 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.856 3.037 . . . . 0.0 113.004 178.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.7 m -114.23 31.31 6.67 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 124.03 0.932 . . . . 0.0 112.575 -178.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -98.8 132.22 44.32 Favored 'General case' 0 C--O 1.242 0.666 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 176.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -72.66 157.89 36.67 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 119.42 1.009 . . . . 0.0 110.998 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.8 mm -63.71 -29.74 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 177.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -53.37 -48.9 68.19 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.96 1.304 . . . . 0.0 109.729 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 41.6 m-20 -67.83 -52.87 31.83 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.846 0.858 . . . . 0.0 109.551 179.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.2 t -54.04 -42.92 57.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 123.736 0.815 . . . . 0.0 111.381 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 20.0 ttpt -75.53 -16.04 60.32 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 118.432 -0.794 . . . . 0.0 111.094 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -88.07 -43.66 11.52 Favored 'General case' 0 C--O 1.226 -0.165 0 CA-C-N 119.857 1.208 . . . . 0.0 108.244 177.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -50.08 -40.0 44.15 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.0 1.32 . . . . 0.0 110.434 179.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 35.8 pt -66.09 -25.26 35.41 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 O-C-N 121.267 -0.896 . . . . 0.0 112.584 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -76.16 -23.84 54.78 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 120.014 1.279 . . . . 0.0 109.094 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.88 -39.14 57.0 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.243 -0.911 . . . . 0.0 108.641 179.059 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.0 mttm -89.72 -19.91 24.21 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 115.99 1.848 . . . . 0.0 115.99 -179.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -136.53 158.86 43.45 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 121.819 2.099 . . . . 0.0 108.886 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.01 63.43 4.3 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 110.524 -1.03 . . . . 0.0 110.524 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.5 pt -131.38 107.3 14.62 Favored Pre-proline 0 CA--C 1.538 0.503 0 CA-C-N 117.91 0.855 . . . . 0.0 108.718 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -77.13 169.94 20.55 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 123.925 3.084 . . . . 0.0 109.805 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -76.56 58.64 5.93 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 123.087 2.524 . . . . 0.0 108.19 177.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -146.82 135.41 22.04 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 128.926 2.891 . . . . 0.0 105.319 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.6 mm-40 52.17 48.15 23.28 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.234 1.814 . . . . 0.0 108.368 -177.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -154.85 134.9 13.04 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.526 1.131 . . . . 0.0 109.62 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.0 ttm-85 -151.2 133.52 15.37 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 101.986 -3.339 . . . . 0.0 101.986 178.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.4 tp -87.9 142.01 28.13 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -177.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.2 mm -134.21 144.94 33.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 125.02 1.328 . . . . 0.0 109.584 -178.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -135.54 115.76 13.42 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 177.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.31 42.86 26.36 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.389 1.076 . . . . 0.0 110.692 -179.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.25 -13.93 30.72 Favored Glycine 0 CA--C 1.531 1.037 0 CA-C-O 118.519 -1.156 . . . . 0.0 114.518 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.9 ttmt -79.59 125.87 30.16 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 120.671 2.235 . . . . 0.0 107.554 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.4 mp0 -74.74 136.2 41.76 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 179.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.8 mt -122.34 153.35 39.09 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.618 1.167 . . . . 0.0 109.757 -178.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -160.09 175.69 12.66 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 124.679 1.192 . . . . 0.0 108.755 178.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -71.73 158.17 36.61 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 122.78 1.276 . . . . 0.0 111.86 -177.217 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 108.59 -29.44 9.94 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 127.448 2.452 . . . . 0.0 108.591 -177.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 46.4 mtt180 -107.75 165.56 11.35 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.0 1.72 . . . . 0.0 111.76 178.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 65.9 p -117.61 173.92 6.45 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.299 1.839 . . . . 0.0 112.655 -178.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.9 mp -52.14 -49.9 62.81 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 123.678 0.791 . . . . 0.0 111.541 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.55 -31.56 72.37 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 112.351 0.501 . . . . 0.0 112.351 -179.034 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -65.29 -47.15 77.62 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.415 1.007 . . . . 0.0 109.325 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -81.29 -2.5 49.22 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.1 t30 57.68 46.94 16.57 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 130.363 3.465 . . . . 0.0 112.215 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 79.3 mt -85.71 123.19 39.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 105.531 -2.026 . . . . 0.0 105.531 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 75.1 mm-40 -95.47 173.47 7.49 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 123.255 0.622 . . . . 0.0 109.747 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 43.6 pttt -69.72 157.0 38.12 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.116 0.484 . . . . 0.0 110.783 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 53.58 38.8 29.04 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 127.154 2.182 . . . . 0.0 110.992 -179.127 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.4 p -87.26 163.23 16.98 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.957 1.303 . . . . 0.0 109.459 178.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 93.7 m -126.05 110.22 13.3 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.7 mp -98.5 160.19 14.44 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 126.233 1.813 . . . . 0.0 108.53 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 45.1 m80 -119.28 160.37 22.34 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 124.982 1.313 . . . . 0.0 110.161 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.7 mt -122.82 126.76 48.01 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 104.964 -2.236 . . . . 0.0 104.964 177.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.2 m -140.62 161.45 24.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 CA-C-O 121.447 0.641 . . . . 0.0 110.421 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -134.71 -172.07 2.94 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.32 1.048 . . . . 0.0 108.585 177.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.5 tpt180 -158.67 138.1 11.68 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 103.098 -2.927 . . . . 0.0 103.098 178.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.1 tt -145.21 129.71 17.91 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 -179.269 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 47.1 mmm-85 -88.36 -2.37 58.56 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 118.905 0.775 . . . . 0.0 111.93 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -86.7 37.57 3.16 Favored Glycine 0 CA--C 1.54 1.619 0 N-CA-C 106.286 -2.726 . . . . 0.0 106.286 175.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.102 0 C-N-CA 129.781 3.562 . . . . 0.0 105.895 -179.102 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.7 ttt . . . . . 0 N--CA 1.47 0.535 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -120.64 151.1 39.91 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 178.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 32.5 pt -132.53 170.08 20.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 C-N-CA 124.929 1.292 . . . . 0.0 108.014 178.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -126.22 150.85 48.09 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.934 1.294 . . . . 0.0 109.005 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.0 t -138.52 133.07 42.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 178.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -103.03 118.35 36.61 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.213 1.005 . . . . 0.0 108.428 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 48.5 p -72.57 171.05 13.15 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.712 0.768 . . . . 0.0 110.059 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -70.45 -12.49 61.61 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.834 -0.541 . . . . 0.0 111.457 177.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.0 p -94.03 -12.1 29.34 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 126.409 1.884 . . . . 0.0 112.627 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.85 7.5 50.43 Favored Glycine 0 C--N 1.339 0.741 0 C-N-CA 124.0 0.81 . . . . 0.0 113.764 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -80.56 164.66 22.77 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 119.017 1.408 . . . . 0.0 107.279 179.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 86.9 m -123.65 132.34 53.83 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 103.523 -2.769 . . . . 0.0 103.523 177.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.5 mm -115.05 148.3 17.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 105.577 -2.009 . . . . 0.0 105.577 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 78.5 m -124.42 126.15 45.46 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 105.312 -2.106 . . . . 0.0 105.312 178.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.6 mt -128.72 150.66 50.17 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 118.339 0.518 . . . . 0.0 110.302 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -101.47 115.54 30.73 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 103.257 -2.868 . . . . 0.0 103.257 178.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.1 m -131.26 -169.92 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 124.415 1.086 . . . . 0.0 109.457 -178.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -143.66 160.84 49.26 Favored Pre-proline 0 N--CA 1.448 -0.568 0 C-N-CA 126.264 1.826 . . . . 0.0 106.591 178.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -58.09 -18.15 34.94 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.864 2.376 . . . . 0.0 113.079 178.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.6 m -116.25 32.95 5.81 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.827 1.251 . . . . 0.0 112.148 -179.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -90.29 128.86 36.53 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 103.187 -2.894 . . . . 0.0 103.187 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.5 p -77.8 159.03 29.28 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 118.965 0.802 . . . . 0.0 112.659 -177.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 23.9 mm -63.56 -29.81 48.23 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.324 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 178.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -59.0 -42.1 89.25 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.2 0.909 . . . . 0.0 110.44 179.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -73.88 -52.75 11.94 Favored 'General case' 0 CA--C 1.521 -0.166 0 C-N-CA 124.665 1.186 . . . . 0.0 109.792 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.4 t -57.44 -38.39 62.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-N 119.62 1.1 . . . . 0.0 110.585 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -74.64 -14.27 60.74 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.208 -0.933 . . . . 0.0 110.592 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.98 -47.19 8.01 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 176.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.6 mttm -49.46 -40.31 36.61 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.333 1.853 . . . . 0.0 111.017 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 36.6 pt -65.69 -28.05 43.09 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-N 118.81 0.732 . . . . 0.0 112.556 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -76.28 -23.06 54.38 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 119.946 1.248 . . . . 0.0 109.742 -178.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.44 -36.3 45.63 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 178.232 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -86.55 -21.47 26.88 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 114.144 1.164 . . . . 0.0 114.144 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -147.51 150.99 35.6 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 120.99 1.723 . . . . 0.0 106.778 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.1 80.99 1.66 Allowed Glycine 0 CA--C 1.521 0.408 0 CA-C-O 119.244 -0.753 . . . . 0.0 111.846 -179.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.2 pt -133.95 106.14 11.53 Favored Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 106.773 -1.565 . . . . 0.0 106.773 178.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -62.87 166.09 14.85 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 124.571 3.514 . . . . 0.0 115.462 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -83.02 55.9 5.37 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.599 2.199 . . . . 0.0 108.295 177.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -147.26 134.52 20.6 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 128.839 2.856 . . . . 0.0 105.247 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.7 mm-40 47.76 49.36 16.66 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.858 1.663 . . . . 0.0 108.032 -177.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -143.67 134.09 24.71 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 60.3 ttm-85 -156.24 133.82 10.93 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 125.978 1.711 . . . . 0.0 106.868 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 22.1 tp -87.9 140.88 29.06 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -178.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.0 mm -131.53 143.87 39.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 126.036 1.734 . . . . 0.0 109.376 -178.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -138.38 124.58 20.33 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 178.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.79 36.07 20.37 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.464 1.106 . . . . 0.0 110.439 -179.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.18 -14.09 29.48 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 125.343 1.449 . . . . 0.0 113.502 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.1 ttmt -79.57 129.3 34.35 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 119.752 1.776 . . . . 0.0 108.258 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.9 mp0 -74.59 137.42 42.32 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 178.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.422 HD22 ' CD1' ' A' ' 59' ' ' TYR . 7.6 mt -113.21 155.33 25.24 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.252 1.021 . . . . 0.0 108.352 -178.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -151.87 175.15 12.76 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.673 1.189 . . . . 0.0 109.446 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -72.75 157.97 36.48 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 125.229 1.412 . . . . 0.0 111.127 -178.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.17 -21.25 38.22 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 126.226 1.87 . . . . 0.0 110.383 -178.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 39.4 mtt180 -108.28 168.95 8.94 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 118.37 1.085 . . . . 0.0 113.534 178.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 49.0 p -117.45 172.46 7.31 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.945 2.098 . . . . 0.0 111.068 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -51.96 -50.67 60.78 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.286 1.435 . . . . 0.0 112.622 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.06 -31.83 73.25 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 123.021 0.528 . . . . 0.0 112.258 -178.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -60.25 -44.95 94.83 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 119.449 1.022 . . . . 0.0 109.469 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.422 ' CD1' HD22 ' A' ' 50' ' ' LEU . 76.7 m-85 -82.27 1.22 37.78 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.189 0.595 . . . . 0.0 111.085 178.19 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 57.89 46.84 16.12 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 128.405 2.682 . . . . 0.0 110.794 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.3 mt -85.82 122.64 38.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 105.013 -2.218 . . . . 0.0 105.013 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -97.62 177.46 5.49 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.73 0.812 . . . . 0.0 108.94 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 43.9 pttt -68.19 156.56 37.3 Favored 'General case' 0 C--O 1.239 0.531 0 O-C-N 121.681 -0.637 . . . . 0.0 110.87 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 49.52 35.05 7.62 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.613 1.965 . . . . 0.0 111.088 -178.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.4 p -77.16 158.24 30.49 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 178.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 59.9 m -125.47 110.64 14.15 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.4 mp -96.04 165.67 12.14 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 124.429 1.091 . . . . 0.0 109.814 -178.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 25.3 m80 -118.77 156.34 29.55 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 125.423 1.489 . . . . 0.0 110.19 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 25.7 mt -123.34 124.68 43.5 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 178.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.1 m -139.12 167.75 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -142.05 -169.74 3.0 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 127.154 2.182 . . . . 0.0 109.687 178.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -152.1 130.18 11.87 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 105.22 -2.141 . . . . 0.0 105.22 177.457 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -148.45 138.81 22.63 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 105.312 -2.107 . . . . 0.0 105.312 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 40.2 mmm-85 -106.11 -13.28 15.49 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 119.269 0.94 . . . . 0.0 112.788 179.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -81.51 19.74 8.41 Favored Glycine 0 CA--C 1.534 1.237 0 CA-C-O 118.684 -1.065 . . . . 0.0 111.658 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.05 0 N-CA-C 105.665 -2.974 . . . . 0.0 105.665 -179.638 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 ttp . . . . . 0 N--CA 1.467 0.394 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -120.69 157.1 30.34 Favored 'General case' 0 CA--C 1.53 0.18 0 O-C-N 121.1 -1.0 . . . . 0.0 112.146 -178.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.3 pt -132.81 169.32 22.23 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 176.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -126.44 152.19 46.72 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.806 1.242 . . . . 0.0 107.822 179.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.9 t -138.96 128.49 30.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.2 tppp? -96.23 117.86 31.63 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 119.081 0.855 . . . . 0.0 109.485 178.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.8 p -81.09 165.62 21.46 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.051 0.94 . . . . 0.0 110.433 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.43 -4.88 12.49 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.062 0.945 . . . . 0.0 113.212 178.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.0 p -92.41 -12.61 31.76 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.487 1.115 . . . . 0.0 110.704 178.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.88 5.93 58.3 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 125.806 1.67 . . . . 0.0 111.434 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.56 164.24 16.2 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.351 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.6 m -123.97 142.46 51.14 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 178.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.3 mm -114.79 155.21 16.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 C-N-CA 126.557 1.943 . . . . 0.0 106.169 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 54.8 m -126.23 128.15 46.76 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 104.124 -2.547 . . . . 0.0 104.124 178.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.4 mt -133.21 150.07 51.98 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -105.14 110.97 23.56 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 103.671 -2.715 . . . . 0.0 103.671 178.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.3 m -134.72 -174.78 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -146.44 166.7 15.9 Favored Pre-proline 0 C--N 1.327 -0.372 0 O-C-N 120.842 -1.161 . . . . 0.0 109.508 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -54.27 -18.81 15.07 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.096 2.531 . . . . 0.0 114.034 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.4 m -115.03 31.22 6.83 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 123.922 0.889 . . . . 0.0 112.453 -178.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -99.08 130.05 45.38 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 103.94 -2.615 . . . . 0.0 103.94 176.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.9 p -78.06 158.14 29.3 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 119.425 1.011 . . . . 0.0 111.711 -178.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.3 mm -63.77 -28.27 44.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -57.1 -42.79 81.43 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.881 0.872 . . . . 0.0 109.383 178.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -73.04 -52.54 13.97 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 124.889 1.275 . . . . 0.0 109.417 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.3 t -54.74 -38.42 43.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-N 119.227 0.921 . . . . 0.0 110.764 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -74.82 -15.55 60.73 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 121.252 -0.905 . . . . 0.0 111.642 -179.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.9 -45.27 8.86 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.552 1.541 . . . . 0.0 108.193 176.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.8 mttm -50.44 -40.4 50.31 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.608 1.563 . . . . 0.0 110.406 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 36.1 pt -64.07 -25.34 37.87 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 O-C-N 121.54 -0.725 . . . . 0.0 112.113 178.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -76.27 -23.64 54.45 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 120.145 1.339 . . . . 0.0 109.262 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.99 -36.33 41.5 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.6 mmtt -85.65 -22.11 28.08 Favored 'General case' 0 C--N 1.337 0.061 0 CA-C-O 117.391 -1.29 . . . . 0.0 114.204 -178.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -150.63 158.04 43.68 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 121.582 1.992 . . . . 0.0 108.808 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.7 82.35 1.59 Allowed Glycine 0 C--N 1.333 0.366 0 N-CA-C 111.843 -0.503 . . . . 0.0 111.843 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.4 pt -140.89 106.62 6.3 Favored Pre-proline 0 CA--C 1.543 0.692 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -71.1 169.59 20.2 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 124.763 3.642 . . . . 0.0 112.658 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -78.65 56.91 6.11 Favored 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 123.054 2.503 . . . . 0.0 109.6 177.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -146.84 130.13 16.62 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 127.857 2.463 . . . . 0.0 104.639 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.2 mm-40 51.01 53.52 12.91 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -177.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -143.06 133.1 24.27 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.275 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 55.8 ttm-85 -161.57 133.33 5.58 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 125.853 1.661 . . . . 0.0 107.174 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 24.2 tp -88.64 142.5 27.63 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.309 1.044 . . . . 0.0 109.674 -178.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.7 mm -135.03 144.56 34.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 125.908 1.683 . . . . 0.0 109.955 -178.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -133.45 117.23 16.95 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 106.714 -1.588 . . . . 0.0 106.714 178.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.57 43.46 20.24 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.933 1.293 . . . . 0.0 111.141 -179.055 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.45 -17.67 13.34 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-O 118.351 -1.249 . . . . 0.0 114.635 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.3 ttmt -79.25 128.71 33.65 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 120.603 2.201 . . . . 0.0 107.149 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.4 mp0 -74.56 136.87 42.11 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.51 HD22 ' CD1' ' A' ' 59' ' ' TYR . 8.9 mt -113.19 155.05 25.71 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -178.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -151.99 175.05 12.91 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 124.381 1.072 . . . . 0.0 109.076 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -73.05 160.03 32.68 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 126.197 1.799 . . . . 0.0 111.412 -179.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.0 -27.51 19.16 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 126.271 1.891 . . . . 0.0 109.85 -178.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.9 mtt180 -107.11 170.52 7.9 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.95 1.3 . . . . 0.0 111.449 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 67.2 p -117.3 171.01 8.25 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 127.108 2.163 . . . . 0.0 111.905 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.21 -48.56 65.03 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.06 0.944 . . . . 0.0 112.419 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.03 -31.72 73.01 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 118.932 -0.556 . . . . 0.0 111.512 -179.121 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -61.13 -44.03 97.96 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 119.352 0.978 . . . . 0.0 108.696 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.51 ' CD1' HD22 ' A' ' 50' ' ' LEU . 92.7 m-85 -82.0 1.7 34.33 Favored 'General case' 0 C--O 1.237 0.4 0 O-C-N 121.603 -0.686 . . . . 0.0 110.814 178.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 52.9 t30 56.48 47.19 19.25 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 127.087 2.155 . . . . 0.0 110.07 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.5 mt -84.48 122.79 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -178.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 57.2 mm-40 -89.57 169.14 11.6 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.447 -0.797 . . . . 0.0 108.995 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 51.8 pttt -69.18 156.73 38.22 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.012 0.434 . . . . 0.0 111.354 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 49.55 34.2 6.69 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 128.407 2.683 . . . . 0.0 111.5 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.2 p -80.17 163.95 23.68 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.2 m -125.31 112.51 16.45 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.1 mp -96.19 168.14 10.77 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.961 1.304 . . . . 0.0 108.666 -179.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.3 m80 -119.64 154.92 33.27 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.155 1.382 . . . . 0.0 109.878 179.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 18.1 mt -123.22 123.47 40.85 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 103.866 -2.642 . . . . 0.0 103.866 177.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.7 m -141.59 170.96 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-N 120.06 1.3 . . . . 0.0 113.635 -179.041 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.8 -169.82 2.89 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 126.354 1.862 . . . . 0.0 109.576 178.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.4 tpt180 -150.39 129.16 12.41 Favored 'General case' 0 CA--C 1.521 -0.144 0 N-CA-C 103.413 -2.81 . . . . 0.0 103.413 177.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.521 HD23 ' H ' ' A' ' 75' ' ' GLY . 1.1 tt -139.68 127.64 22.2 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 -179.003 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 49.4 mmm-85 -103.3 -7.43 21.11 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 118.817 0.735 . . . . 0.0 112.157 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.521 ' H ' HD23 ' A' ' 73' ' ' LEU . . . -92.45 21.29 39.03 Favored Glycine 0 CA--C 1.536 1.384 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 177.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.881 0 N-CA-C 106.399 -2.68 . . . . 0.0 106.399 -179.45 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.8 ttt . . . . . 0 N--CA 1.471 0.59 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -120.82 157.14 30.4 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 178.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.7 pt -132.69 169.4 22.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 178.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -126.13 151.01 47.83 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.2 t -138.52 129.6 35.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 179.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.4 tppt? -96.24 119.08 34.09 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 177.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 45.7 p -71.15 167.25 19.73 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 118.663 0.665 . . . . 0.0 109.352 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -67.72 -12.96 61.65 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 119.201 -0.428 . . . . 0.0 111.191 178.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.4 p -94.1 -12.48 28.39 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.815 1.246 . . . . 0.0 111.273 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.41 7.77 48.19 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-N 118.845 0.748 . . . . 0.0 113.524 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.22 164.82 23.87 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 104.507 -2.405 . . . . 0.0 104.507 178.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 45.1 m -123.2 131.21 53.6 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 -179.037 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.8 mm -116.28 155.25 17.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 127.531 2.332 . . . . 0.0 107.802 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.6 m -135.18 130.4 35.29 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 128.146 2.578 . . . . 0.0 105.428 178.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 79.5 mt -139.01 151.27 46.69 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.722 1.147 . . . . 0.0 110.84 -179.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -102.28 117.94 35.82 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 179.009 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.7 m -131.28 -170.67 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 124.622 1.169 . . . . 0.0 109.982 -177.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -144.1 160.66 48.5 Favored Pre-proline 0 C--O 1.238 0.494 0 N-CA-C 106.517 -1.661 . . . . 0.0 106.517 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -57.96 -17.98 33.26 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.461 2.108 . . . . 0.0 112.941 178.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 29.3 m -114.64 31.62 6.52 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 119.219 0.918 . . . . 0.0 111.464 -178.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -91.27 129.42 37.26 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 101.302 -3.592 . . . . 0.0 101.302 177.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.0 p -71.03 158.25 36.83 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 121.392 -0.817 . . . . 0.0 109.439 -178.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.0 mm -63.33 -29.35 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 178.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -56.27 -49.32 74.53 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 126.045 1.738 . . . . 0.0 108.834 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 20.1 m-80 -65.43 -52.15 55.26 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 124.67 1.188 . . . . 0.0 109.552 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 84.4 t -54.05 -44.03 61.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 123.328 0.651 . . . . 0.0 110.744 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 24.2 ttpt -75.57 -12.83 60.3 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.279 1.032 . . . . 0.0 112.166 -178.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.04 -46.93 8.16 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.608 1.563 . . . . 0.0 107.513 177.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.4 mttm -50.98 -40.51 58.06 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.405 1.482 . . . . 0.0 110.418 179.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 43.3 pt -64.58 -25.69 38.48 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 O-C-N 121.334 -0.854 . . . . 0.0 112.31 178.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -76.35 -22.77 54.46 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 120.598 1.545 . . . . 0.0 109.262 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -82.27 -22.94 35.53 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.737 1.215 . . . . 0.0 108.607 177.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.1 mmtt -97.68 -16.01 20.14 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 120.481 -1.387 . . . . 0.0 114.347 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -152.04 160.68 43.39 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 121.116 1.78 . . . . 0.0 107.063 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.02 70.98 2.97 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.8 pt -130.8 108.27 15.52 Favored Pre-proline 0 CA--C 1.543 0.703 0 CA-C-N 117.988 0.894 . . . . 0.0 110.752 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -77.82 169.74 20.18 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.822 3.015 . . . . 0.0 110.092 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -79.19 57.0 6.27 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.855 2.37 . . . . 0.0 109.195 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -150.61 135.32 17.38 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 127.206 2.203 . . . . 0.0 105.862 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 55.2 mm-40 53.89 48.78 20.49 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.799 1.64 . . . . 0.0 106.788 -177.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -146.19 143.07 29.03 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 123.711 0.805 . . . . 0.0 110.535 -178.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 43.9 ttm-85 -162.3 134.06 5.38 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.879 1.218 . . . . 0.0 108.289 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 18.9 tp -93.21 140.01 29.99 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.627 1.171 . . . . 0.0 111.204 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.5 mm -135.54 145.35 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 126.229 1.812 . . . . 0.0 108.816 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -139.11 119.77 14.12 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.923 1.289 . . . . 0.0 108.376 178.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.72 35.2 17.85 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.233 1.013 . . . . 0.0 111.151 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.55 -13.75 33.42 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 124.887 1.232 . . . . 0.0 113.248 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.5 ttmt -80.56 129.76 34.71 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 119.484 1.642 . . . . 0.0 107.746 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.8 mp0 -74.47 134.05 42.33 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 51.6 mt -114.01 148.96 36.1 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.576 1.15 . . . . 0.0 108.571 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -151.55 176.73 11.05 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 124.868 1.267 . . . . 0.0 108.217 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.29 160.59 32.14 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.793 1.637 . . . . 0.0 111.767 -177.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.32 -25.6 26.48 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 125.53 1.538 . . . . 0.0 111.243 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 42.7 mtt180 -108.09 168.85 9.0 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.554 1.141 . . . . 0.0 112.908 178.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.4 p -117.71 169.48 9.55 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.876 1.67 . . . . 0.0 109.167 178.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.0 mp -52.5 -43.1 64.85 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.207 0.603 . . . . 0.0 111.202 178.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.1 t -58.2 -45.91 86.77 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 125.916 1.686 . . . . 0.0 111.156 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -59.74 -45.2 92.96 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 118.586 0.63 . . . . 0.0 109.973 -178.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -82.1 1.71 34.71 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.492 0.717 . . . . 0.0 112.088 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.6 t30 55.45 46.42 23.23 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 127.581 2.352 . . . . 0.0 111.026 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 40.6 mt -86.09 123.05 39.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -93.64 169.98 9.92 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.264 0.554 . . . . 0.0 111.469 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.7 pttt -66.32 156.98 32.88 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.237 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 51.22 37.52 18.71 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 126.41 1.884 . . . . 0.0 112.001 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.7 p -87.13 164.15 16.57 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.761 1.224 . . . . 0.0 108.615 178.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.9 m -125.93 113.92 17.83 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.4 mp -96.91 161.64 13.75 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.259 1.023 . . . . 0.0 109.09 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 17.2 m80 -115.78 156.4 26.1 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.903 1.281 . . . . 0.0 109.85 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.8 mt -122.83 124.87 44.28 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.026 1.73 . . . . 0.0 107.891 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 23.3 m -141.38 171.57 11.77 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 124.795 1.238 . . . . 0.0 113.753 -178.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -143.02 -170.72 3.31 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.485 1.514 . . . . 0.0 108.389 176.447 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.8 tpt180 -151.83 129.4 11.47 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 104.358 -2.46 . . . . 0.0 104.358 177.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.2 mt -151.2 138.57 19.43 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 118.357 0.526 . . . . 0.0 110.587 -178.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 56.8 mmm-85 -99.46 -24.15 14.88 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 177.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -88.81 37.3 3.32 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 126.587 2.042 . . . . 0.0 108.743 177.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.912 0 N-CA-C 106.623 -2.591 . . . . 0.0 106.623 -179.18 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.4 ttt . . . . . 0 N--CA 1.474 0.73 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -121.51 157.27 31.03 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.226 0.611 . . . . 0.0 109.813 178.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.7 pt -132.75 171.12 18.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 C-N-CA 125.493 1.517 . . . . 0.0 107.668 177.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -126.19 152.49 45.96 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.188 0.995 . . . . 0.0 108.623 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.3 t -138.34 128.8 35.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.2 tptp -96.64 117.53 31.18 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.3 p -77.03 166.15 23.69 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 118.511 0.596 . . . . 0.0 110.084 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -71.34 -10.09 59.2 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 121.651 -0.656 . . . . 0.0 111.615 178.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -91.85 -10.96 37.84 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 128.368 2.667 . . . . 0.0 111.737 -179.392 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.45 7.09 56.2 Favored Glycine 0 C--N 1.34 0.797 0 C-N-CA 125.605 1.574 . . . . 0.0 114.137 178.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.2 mmmm -80.53 166.66 20.96 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 119.089 1.444 . . . . 0.0 109.622 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.5 m -123.72 131.28 53.57 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 103.453 -2.795 . . . . 0.0 103.453 177.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.5 mm -116.43 156.24 17.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 126.338 1.855 . . . . 0.0 107.214 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.1 m -132.93 128.9 37.51 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.156 1.782 . . . . 0.0 106.504 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.9 mt -139.47 151.0 45.85 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.188 0.995 . . . . 0.0 111.322 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -97.54 117.84 32.71 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 127.005 2.122 . . . . 0.0 105.383 178.009 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.1 m -134.91 -175.61 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 125.071 1.349 . . . . 0.0 109.631 -179.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -144.41 164.27 29.56 Favored Pre-proline 0 CA--C 1.532 0.278 0 C-N-CA 124.323 1.049 . . . . 0.0 109.817 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -57.87 -18.87 36.68 Favored 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 122.87 2.38 . . . . 0.0 113.865 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.3 m -115.86 31.65 6.58 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 119.21 0.914 . . . . 0.0 110.856 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -92.45 128.81 38.44 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 102.294 -3.224 . . . . 0.0 102.294 177.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.4 p -78.53 158.14 28.64 Favored 'General case' 0 CA--C 1.519 -0.232 0 O-C-N 121.2 -0.938 . . . . 0.0 110.917 -178.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.7 mm -64.08 -25.45 38.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 177.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -56.29 -49.83 73.16 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.518 1.127 . . . . 0.0 108.63 178.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -66.44 -52.63 44.35 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.851 1.26 . . . . 0.0 109.842 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.7 t -55.42 -38.62 49.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-N 118.623 0.647 . . . . 0.0 110.903 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -75.27 -18.11 60.15 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 120.956 -1.09 . . . . 0.0 111.412 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.93 -45.03 9.5 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.532 1.533 . . . . 0.0 110.328 178.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.4 mttm -54.31 -40.24 67.76 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 118.631 0.65 . . . . 0.0 111.039 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 34.6 pt -62.59 -24.9 36.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 CA-C-O 119.011 -0.519 . . . . 0.0 111.644 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -77.0 -23.11 52.25 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 120.162 1.346 . . . . 0.0 109.392 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.98 -32.59 26.93 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 176.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 51.2 mmtt -87.17 -15.37 38.55 Favored 'General case' 0 C--N 1.343 0.303 0 N-CA-C 115.499 1.666 . . . . 0.0 115.499 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -150.66 157.89 43.51 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 121.051 1.75 . . . . 0.0 106.567 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -80.99 74.83 2.37 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-O 119.177 -0.791 . . . . 0.0 111.256 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.3 pt -135.82 107.69 9.84 Favored Pre-proline 0 CA--C 1.545 0.784 0 CA-C-N 118.404 1.102 . . . . 0.0 111.155 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -71.13 169.3 20.94 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 123.336 2.691 . . . . 0.0 110.764 178.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -80.52 56.31 6.03 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 122.701 2.267 . . . . 0.0 109.679 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -146.7 135.14 21.92 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 127.874 2.47 . . . . 0.0 105.083 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 71.1 mm-40 50.05 49.97 19.39 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.769 1.628 . . . . 0.0 109.55 -177.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 12.2 m-80 -148.09 134.85 19.99 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.519 1.128 . . . . 0.0 109.52 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 45.8 ttm-85 -153.0 134.18 14.17 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 127.293 2.237 . . . . 0.0 107.475 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 23.3 tp -88.18 139.89 30.04 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.037 1.335 . . . . 0.0 109.154 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.3 mm -132.47 145.9 33.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 125.743 1.617 . . . . 0.0 108.161 -179.188 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -136.62 117.5 14.16 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 124.727 1.211 . . . . 0.0 108.465 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.85 43.53 21.46 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.708 1.203 . . . . 0.0 110.944 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.38 -15.66 22.42 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 124.899 1.237 . . . . 0.0 114.23 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -80.69 124.34 28.93 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 119.874 1.837 . . . . 0.0 107.531 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.5 mp0 -74.47 135.96 42.27 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.7 mt -114.19 156.17 24.76 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 125.187 1.395 . . . . 0.0 109.944 -178.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -151.07 174.14 13.53 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 178.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -76.52 159.91 29.94 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.85 1.26 . . . . 0.0 111.761 -179.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.01 -27.81 14.96 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 125.811 1.672 . . . . 0.0 109.709 -178.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 44.5 mtt180 -106.59 167.04 10.13 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 118.973 1.386 . . . . 0.0 111.353 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.6 p -117.7 170.46 8.76 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 125.995 1.718 . . . . 0.0 111.169 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.6 mp -52.67 -43.56 65.63 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 123.506 0.723 . . . . 0.0 111.869 179.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.7 m -59.78 -38.32 81.54 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 118.632 0.651 . . . . 0.0 112.172 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -62.44 -47.08 85.62 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 123.068 0.547 . . . . 0.0 109.992 -178.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -82.66 1.36 38.81 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.083 0.953 . . . . 0.0 111.698 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 48.0 t30 54.4 46.24 25.45 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 127.53 2.332 . . . . 0.0 111.17 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 81.8 mt -88.25 123.06 40.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 179.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -101.47 175.75 5.47 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.5 pttt -64.81 157.11 28.58 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.285 0.564 . . . . 0.0 110.661 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 55.59 35.64 25.59 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.737 2.015 . . . . 0.0 111.682 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.9 p -86.19 164.17 17.37 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 120.683 -1.261 . . . . 0.0 108.367 178.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.9 m -126.03 115.48 19.93 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.3 mp -103.73 160.72 14.53 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.576 1.151 . . . . 0.0 108.779 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 43.3 m80 -119.46 159.62 23.91 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 125.236 1.414 . . . . 0.0 110.13 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 61.8 mt -123.24 124.29 42.66 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 125.188 1.395 . . . . 0.0 109.22 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.8 m -141.01 170.16 14.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -178.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -141.58 -170.49 3.11 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 127.989 2.516 . . . . 0.0 108.288 178.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -157.27 128.84 6.95 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 104.727 -2.323 . . . . 0.0 104.727 177.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 66.7 mt -150.09 142.05 23.88 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.473 1.109 . . . . 0.0 108.848 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 56.1 mmm-85 -100.94 -25.77 13.96 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 124.731 1.213 . . . . 0.0 111.471 179.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -81.24 18.43 10.31 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-O 119.046 -0.863 . . . . 0.0 114.622 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.804 0 CA-C-N 120.489 2.145 . . . . 0.0 107.746 179.512 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.6 ttt . . . . . 0 N--CA 1.473 0.686 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -122.31 144.92 48.7 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 177.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.9 pt -132.81 168.86 23.2 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 177.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -126.39 152.27 46.54 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 125.082 1.353 . . . . 0.0 109.327 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.4 t -138.72 131.1 38.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 178.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.51 117.8 33.76 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 178.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 54.9 p -74.17 171.12 14.15 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.007 0.923 . . . . 0.0 112.191 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -74.99 -7.75 54.54 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.069 177.194 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.3 p -94.61 -13.01 26.35 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.858 1.663 . . . . 0.0 111.15 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.81 6.08 57.29 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 126.565 2.031 . . . . 0.0 113.553 178.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.7 mmmm -81.95 164.84 21.23 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 118.416 1.108 . . . . 0.0 108.031 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.7 m -120.35 132.39 55.26 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 104.2 -2.518 . . . . 0.0 104.2 178.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 22.1 mm -107.7 156.96 8.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 125.949 1.699 . . . . 0.0 106.754 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.0 m -135.29 126.27 27.71 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 179.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.7 mt -140.21 147.39 39.99 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.335 1.054 . . . . 0.0 111.199 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -104.9 106.73 17.35 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 126.694 1.998 . . . . 0.0 107.585 178.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.2 m -135.7 -170.63 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 125.041 1.336 . . . . 0.0 108.457 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -147.24 167.94 12.45 Favored Pre-proline 0 C--O 1.232 0.165 0 O-C-N 120.615 -1.303 . . . . 0.0 111.047 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -55.56 -17.6 17.57 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 123.058 2.505 . . . . 0.0 112.821 178.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.1 m -112.57 30.2 7.31 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 119.948 1.249 . . . . 0.0 111.773 -177.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -104.48 140.59 37.74 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 107.518 -1.289 . . . . 0.0 107.518 176.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.2 p -78.72 158.29 28.34 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 122.408 1.099 . . . . 0.0 111.258 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.3 mm -64.74 -25.23 37.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 176.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -55.23 -49.61 71.54 Favored 'General case' 0 C--N 1.344 0.351 0 CA-C-N 119.385 0.993 . . . . 0.0 108.834 178.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.7 m-20 -60.37 -52.3 65.84 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.108 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 42.9 t -55.52 -41.36 63.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-O 119.111 -0.471 . . . . 0.0 111.231 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -74.74 -18.36 60.51 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-N 119.275 0.943 . . . . 0.0 111.424 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.24 -46.13 9.01 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 119.652 1.115 . . . . 0.0 108.432 177.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -53.41 -40.21 64.93 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.519 1.128 . . . . 0.0 111.211 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 41.8 pt -63.33 -26.82 41.75 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 CA-C-N 118.808 0.731 . . . . 0.0 111.43 178.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -76.3 -22.69 54.7 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 119.828 1.195 . . . . 0.0 109.323 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.71 -39.49 36.31 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 120.597 -1.315 . . . . 0.0 108.783 178.188 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -86.98 -15.89 37.42 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 114.549 1.314 . . . . 0.0 114.549 -178.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -148.16 151.27 35.29 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 179.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.1 87.29 1.36 Allowed Glycine 0 C--N 1.335 0.485 0 CA-C-O 119.555 -0.581 . . . . 0.0 112.715 -178.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.5 pt -144.32 107.13 4.81 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 124.448 1.099 . . . . 0.0 109.769 178.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -70.8 170.59 17.46 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 124.05 3.167 . . . . 0.0 110.282 178.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -80.27 55.58 5.72 Favored 'Trans proline' 0 CA--C 1.545 1.061 0 C-N-CA 122.656 2.237 . . . . 0.0 107.607 177.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -146.68 131.33 17.86 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 128.239 2.616 . . . . 0.0 104.765 -179.04 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 60.1 mm-40 53.95 49.51 18.83 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.992 1.317 . . . . 0.0 107.579 -177.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -155.2 133.35 11.62 Favored 'General case' 0 N--CA 1.452 -0.365 0 O-C-N 121.695 -0.628 . . . . 0.0 110.621 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 53.9 ttm-85 -152.1 137.39 17.53 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 105.319 -2.104 . . . . 0.0 105.319 179.295 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 28.2 tp -88.31 139.41 30.52 Favored 'General case' 0 C--O 1.226 -0.181 0 C-N-CA 124.182 0.993 . . . . 0.0 109.567 -178.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.6 mm -135.28 144.22 34.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 124.728 1.211 . . . . 0.0 109.093 -178.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -134.69 119.37 18.2 Favored 'General case' 0 C--O 1.226 -0.156 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 178.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.72 38.78 16.18 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.307 1.043 . . . . 0.0 112.077 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.47 -15.77 22.3 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 123.973 0.796 . . . . 0.0 113.582 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.1 ttmt -80.49 118.47 22.13 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 178.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.0 mp0 -75.27 136.68 40.9 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.4 mt -119.82 155.04 33.35 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 126.708 2.003 . . . . 0.0 109.548 -178.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -155.14 176.08 13.01 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 124.604 1.162 . . . . 0.0 108.517 177.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -72.17 160.82 31.8 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 126.116 1.767 . . . . 0.0 112.363 -178.046 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.62 -27.27 21.0 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 126.042 1.782 . . . . 0.0 110.484 -178.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 47.2 mtt180 -107.33 168.9 8.9 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 124.292 1.037 . . . . 0.0 110.333 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.5 p -117.22 165.56 13.29 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 123.445 0.698 . . . . 0.0 111.601 -179.178 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.9 mp -52.3 -41.8 63.24 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.714 0.806 . . . . 0.0 111.236 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.9 t -60.52 -45.23 94.61 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 126.391 1.876 . . . . 0.0 110.032 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -60.26 -46.12 90.93 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -81.11 -3.86 53.41 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.212 0.605 . . . . 0.0 111.375 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.9 t30 53.8 47.84 22.73 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 127.718 2.407 . . . . 0.0 112.605 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 82.3 mt -85.61 126.52 40.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 105.499 -2.037 . . . . 0.0 105.499 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 78.0 mm-40 -89.92 169.25 11.39 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.551 0.691 . . . . 0.0 110.939 -179.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -68.02 157.24 35.59 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.389 1.076 . . . . 0.0 109.513 178.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 52.27 35.76 17.81 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.406 1.482 . . . . 0.0 112.879 179.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.4 p -86.32 162.89 17.99 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.728 1.211 . . . . 0.0 110.052 178.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.0 m -126.72 108.77 11.37 Favored 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.4 mp -96.25 169.6 9.83 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.828 1.251 . . . . 0.0 110.658 -178.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -120.05 154.17 35.01 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 126.889 2.076 . . . . 0.0 108.946 178.227 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.4 mt -123.47 123.89 41.64 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 176.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.9 m -140.75 172.73 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-N 119.53 1.059 . . . . 0.0 112.315 -178.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -141.38 -170.8 3.16 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 126.333 1.853 . . . . 0.0 108.93 178.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -158.82 129.87 6.23 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 104.721 -2.325 . . . . 0.0 104.721 176.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.485 HD23 ' H ' ' A' ' 75' ' ' GLY . 1.2 tt -139.41 140.4 37.37 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 -178.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 58.4 mmm-85 -104.97 -2.57 24.37 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.538 0.735 . . . . 0.0 112.36 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.485 ' H ' HD23 ' A' ' 73' ' ' LEU . . . -91.07 18.38 51.54 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 124.72 1.153 . . . . 0.0 110.597 178.249 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.003 0 N-CA-C 105.215 -3.154 . . . . 0.0 105.215 -179.59 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.6 ttt . . . . . 0 N--CA 1.471 0.624 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -120.84 156.09 32.7 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 177.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.3 pt -132.33 169.45 21.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.489 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -123.32 149.54 44.73 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.541 1.136 . . . . 0.0 108.61 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.6 t -139.19 127.59 27.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -93.36 116.95 29.49 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.141 0.976 . . . . 0.0 109.161 178.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 80.4 p -84.06 167.6 16.67 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.983 0.913 . . . . 0.0 111.904 179.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.7 -3.98 10.82 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 126.342 1.857 . . . . 0.0 113.048 177.594 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.0 p -99.02 -15.49 19.04 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.699 1.199 . . . . 0.0 109.484 178.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.67 6.25 57.36 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 127.01 2.243 . . . . 0.0 112.041 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.1 mmmm -80.34 163.44 23.91 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 119.441 1.621 . . . . 0.0 107.144 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.6 m -124.62 132.04 53.44 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 104.351 -2.463 . . . . 0.0 104.351 178.384 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.8 mm -104.6 157.73 5.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 -179.383 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 97.8 m -133.95 123.48 24.73 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 104.236 -2.505 . . . . 0.0 104.236 178.163 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 66.3 mt -139.59 150.7 45.32 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.682 0.793 . . . . 0.0 109.775 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 71.9 tt0 -93.83 117.89 30.71 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 105.132 -2.173 . . . . 0.0 105.132 178.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.0 m -131.59 -171.47 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 124.561 1.144 . . . . 0.0 109.078 -178.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -147.09 164.59 22.49 Favored Pre-proline 0 CA--C 1.537 0.47 0 C-N-CA 123.976 0.91 . . . . 0.0 110.112 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -62.68 -18.87 66.29 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 121.92 1.747 . . . . 0.0 112.721 178.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.54 31.66 6.48 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.894 0.877 . . . . 0.0 111.873 -177.534 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -92.67 131.84 37.41 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 178.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.0 p -75.08 157.6 34.51 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 119.817 1.189 . . . . 0.0 109.013 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 30.1 mm -64.27 -31.18 52.41 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.282 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 177.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -55.91 -48.54 75.49 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.907 1.283 . . . . 0.0 110.045 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.7 m-20 -64.34 -52.38 58.67 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.191 0.996 . . . . 0.0 109.482 179.452 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.2 t -55.13 -41.72 61.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 122.81 0.444 . . . . 0.0 110.405 179.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.1 ttpt -74.88 -13.28 60.53 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 118.107 -0.949 . . . . 0.0 110.94 -179.057 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.34 -47.18 8.21 Favored 'General case' 0 C--O 1.226 -0.154 0 CA-C-N 120.269 1.395 . . . . 0.0 108.791 178.283 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -52.34 -40.06 61.45 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.056 0.942 . . . . 0.0 111.466 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 40.3 pt -63.96 -25.36 37.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 O-C-N 121.727 -0.608 . . . . 0.0 111.582 178.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -76.77 -23.15 52.93 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 119.921 1.237 . . . . 0.0 109.382 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.38 -39.51 59.08 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 177.461 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.6 mttm -86.62 -18.26 31.82 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 115.659 1.725 . . . . 0.0 115.659 -177.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -141.97 150.79 41.85 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 120.686 1.585 . . . . 0.0 108.039 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.59 82.03 1.61 Allowed Glycine 0 C--N 1.334 0.421 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.7 pt -136.09 108.38 9.69 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 124.622 1.169 . . . . 0.0 109.515 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -78.62 169.32 19.93 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.497 2.798 . . . . 0.0 109.016 179.047 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -77.84 56.68 5.76 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 123.56 2.84 . . . . 0.0 109.632 178.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -146.65 135.27 22.11 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 104.716 -2.328 . . . . 0.0 104.716 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 64.1 mm-40 53.22 48.65 21.65 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 126.17 1.788 . . . . 0.0 109.235 -177.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 -154.73 138.95 16.58 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.567 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 52.1 ttm-85 -155.97 135.33 12.3 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 127.859 2.464 . . . . 0.0 105.412 178.207 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 23.8 tp -87.75 139.45 30.52 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.2 mm -133.63 144.65 35.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 126.05 1.74 . . . . 0.0 108.096 -178.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -138.8 124.99 20.19 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 178.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.59 39.27 12.92 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.799 0.839 . . . . 0.0 111.608 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.03 -16.72 14.44 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 125.064 1.316 . . . . 0.0 113.948 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.5 ttmt -78.92 129.06 34.09 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 119.811 1.806 . . . . 0.0 108.172 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.5 mp0 -74.1 136.18 42.97 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 106.749 -1.575 . . . . 0.0 106.749 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.5 mt -119.19 155.88 30.87 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 125.268 1.427 . . . . 0.0 110.419 -179.159 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -160.23 176.18 12.03 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 126.186 1.794 . . . . 0.0 107.971 178.085 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -71.88 161.0 31.6 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 126.792 2.037 . . . . 0.0 113.106 -178.029 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.42 -27.52 19.54 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 126.465 1.983 . . . . 0.0 110.222 -179.006 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 47.9 mtt180 -107.99 169.31 8.69 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.374 1.07 . . . . 0.0 111.694 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 45.7 p -122.83 171.16 9.4 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.946 1.298 . . . . 0.0 112.145 -178.239 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.3 mp -52.56 -41.72 63.82 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 123.296 0.638 . . . . 0.0 110.564 178.216 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.8 t -58.53 -45.48 88.78 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.899 1.68 . . . . 0.0 110.628 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -61.58 -47.06 87.24 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.816 0.846 . . . . 0.0 109.522 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -81.76 -1.21 46.38 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 118.763 -0.637 . . . . 0.0 112.473 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 52.7 t30 54.24 46.68 24.73 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 127.571 2.348 . . . . 0.0 111.267 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.2 mt -87.5 123.83 40.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 87.8 mm-40 -94.09 172.46 8.21 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 123.23 0.612 . . . . 0.0 111.846 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 41.3 pttt -66.7 157.21 33.24 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.012 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 50.79 41.78 26.83 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 125.907 1.683 . . . . 0.0 110.664 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.0 p -86.86 163.22 17.32 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 178.011 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.3 m -126.34 106.28 9.39 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 179.273 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.1 mp -98.16 161.16 13.85 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 125.109 1.364 . . . . 0.0 108.614 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 11.4 m80 -119.3 155.6 31.54 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 123.927 0.891 . . . . 0.0 109.223 178.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 16.9 mt -122.53 123.35 41.05 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 102.571 -3.122 . . . . 0.0 102.571 178.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.6 m -141.7 168.93 14.66 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 -178.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -142.06 -174.11 4.0 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.277 1.031 . . . . 0.0 111.692 177.265 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.1 ttt180 -161.2 130.33 4.65 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 124.752 1.221 . . . . 0.0 108.481 178.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 33.6 mt -138.87 137.91 36.97 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 120.154 1.343 . . . . 0.0 108.317 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 37.1 mmm-85 -89.11 -11.01 45.17 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 178.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -90.94 18.42 51.03 Favored Glycine 0 CA--C 1.538 1.499 0 N-CA-C 109.266 -1.533 . . . . 0.0 109.266 177.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.853 0 N-CA-C 107.914 -2.074 . . . . 0.0 107.914 -179.724 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.0 ttt . . . . . 0 CA--C 1.512 -0.519 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -121.22 156.69 31.89 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 178.453 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 34.9 pt -133.14 170.15 20.57 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 C-N-CA 125.515 1.526 . . . . 0.0 106.993 177.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -126.21 152.82 45.53 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 178.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.9 t -137.94 124.62 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.8 tppp? -93.28 109.58 21.11 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 104.348 -2.464 . . . . 0.0 104.348 178.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.414 ' HA ' HD12 ' A' ' 69' ' ' LEU . 25.3 p -72.6 165.37 24.83 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 121.074 0.464 . . . . 0.0 110.597 -179.162 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -69.0 -6.85 30.38 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.468 0.707 . . . . 0.0 111.36 178.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.1 p -93.88 -12.36 29.09 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.692 1.197 . . . . 0.0 109.692 179.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.51 5.78 57.71 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 126.862 2.172 . . . . 0.0 111.508 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.86 164.76 22.42 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 118.454 1.127 . . . . 0.0 108.933 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.1 m -124.42 132.31 53.51 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 179.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.5 mm -114.09 156.83 14.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 125.963 1.705 . . . . 0.0 106.468 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 31.6 m -132.45 123.66 27.07 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 127.239 2.216 . . . . 0.0 105.832 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.4 mt -133.92 150.83 51.34 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 119.09 0.859 . . . . 0.0 109.922 -179.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -103.41 109.12 20.64 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 104.735 -2.32 . . . . 0.0 104.735 178.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.3 m -123.37 -172.33 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 125.53 1.532 . . . . 0.0 109.816 -177.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -146.17 162.42 35.17 Favored Pre-proline 0 C--O 1.234 0.279 0 O-C-N 121.357 -0.839 . . . . 0.0 109.637 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -58.46 -18.53 39.52 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.407 2.071 . . . . 0.0 113.21 179.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.2 m -114.38 31.34 6.67 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 118.763 0.71 . . . . 0.0 111.573 -177.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -98.17 129.34 44.95 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 104.007 -2.59 . . . . 0.0 104.007 178.108 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.7 p -78.09 157.47 29.5 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 119.814 1.188 . . . . 0.0 110.128 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 51.3 mm -64.5 -26.0 39.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 177.475 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -55.4 -44.13 75.87 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.356 1.462 . . . . 0.0 109.436 178.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -70.97 -52.37 20.16 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.623 1.169 . . . . 0.0 108.545 179.049 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.7 t -54.74 -38.52 43.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 124.222 1.009 . . . . 0.0 111.41 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -76.56 -18.54 58.62 Favored 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 124.192 0.997 . . . . 0.0 111.097 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -88.74 -42.27 12.05 Favored 'General case' 0 C--O 1.228 -0.049 0 CA-C-N 119.633 1.106 . . . . 0.0 110.145 179.154 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -54.16 -40.58 67.59 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.216 0.606 . . . . 0.0 110.86 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.5 pt -63.05 -25.42 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 O-C-N 120.851 -1.156 . . . . 0.0 111.549 178.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -77.93 -21.63 50.82 Favored 'General case' 0 C--N 1.332 -0.169 0 O-C-N 120.79 -1.194 . . . . 0.0 109.967 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -78.11 -30.61 49.58 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.021 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.8 mttm -100.57 -15.05 17.95 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 115.799 1.777 . . . . 0.0 115.799 -179.5 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -139.52 158.71 43.66 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 121.437 1.926 . . . . 0.0 108.936 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.31 70.22 3.13 Favored Glycine 0 CA--C 1.524 0.622 0 C-N-CA 124.87 1.224 . . . . 0.0 110.914 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.6 pt -137.23 107.62 8.72 Favored Pre-proline 0 CA--C 1.544 0.731 0 CA-C-N 118.826 1.313 . . . . 0.0 111.579 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -76.05 168.98 23.03 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 123.756 2.971 . . . . 0.0 109.33 178.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -78.74 57.23 6.28 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.572 2.181 . . . . 0.0 109.875 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -149.4 135.91 19.31 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 128.401 2.68 . . . . 0.0 105.451 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 47.1 mm-40 54.03 48.54 20.88 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.474 1.509 . . . . 0.0 108.501 -177.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -147.83 134.53 19.95 Favored 'General case' 0 C--N 1.339 0.137 0 O-C-N 121.39 -0.819 . . . . 0.0 110.323 -179.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 52.4 ttm-85 -155.55 133.55 11.42 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 29.1 tp -89.14 135.31 33.63 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.826 1.65 . . . . 0.0 110.581 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.4 mm -135.74 147.33 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 125.03 1.332 . . . . 0.0 108.009 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -139.0 115.14 10.28 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 178.064 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.49 40.75 15.72 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.085 1.354 . . . . 0.0 110.505 -178.137 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.71 -10.03 53.22 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 125.481 1.515 . . . . 0.0 114.955 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.6 ttmt -79.71 129.84 34.83 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 120.488 2.144 . . . . 0.0 107.732 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.5 mp0 -74.31 125.53 28.66 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.4 mt -114.15 140.73 48.28 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 106.095 -1.816 . . . . 0.0 106.095 179.023 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -162.88 -179.91 7.13 Favored 'General case' 0 C--N 1.32 -0.686 0 O-C-N 121.658 -0.651 . . . . 0.0 110.206 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -70.49 160.13 32.98 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.089 1.356 . . . . 0.0 112.8 -176.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.85 -29.55 12.26 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 128.153 2.787 . . . . 0.0 110.067 -178.299 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 49.8 mtt180 -108.28 169.6 8.53 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 126.191 1.796 . . . . 0.0 112.065 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 78.3 p -117.73 167.52 11.29 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 126.865 2.066 . . . . 0.0 111.04 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.7 mp -52.4 -42.02 63.66 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 123.282 0.633 . . . . 0.0 111.131 178.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.7 t -58.65 -43.17 89.72 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.48 1.512 . . . . 0.0 110.605 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -59.87 -46.9 87.85 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 118.741 0.7 . . . . 0.0 109.574 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -81.83 -4.08 55.59 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.246 1.018 . . . . 0.0 113.476 -179.247 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 37.6 t30 58.34 47.44 13.92 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.609 1.964 . . . . 0.0 110.963 -178.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.9 mt -86.28 122.99 39.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 104.775 -2.306 . . . . 0.0 104.775 179.036 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 92.1 mm-40 -93.37 170.32 9.7 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 122.862 0.465 . . . . 0.0 110.677 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 49.4 pttt -68.76 157.36 36.52 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.238 0.542 . . . . 0.0 111.228 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 53.16 37.83 26.0 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 127.379 2.272 . . . . 0.0 110.566 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.3 p -87.14 161.69 17.95 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.121 1.368 . . . . 0.0 109.63 178.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 95.2 m -126.33 110.17 13.08 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.3 mp -97.17 158.84 15.25 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.202 1.801 . . . . 0.0 108.857 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 72.1 m80 -120.07 163.64 17.36 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 125.341 1.456 . . . . 0.0 111.823 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 7' ' ' THR . 54.5 mt -120.19 133.45 55.49 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 125.13 1.372 . . . . 0.0 107.49 178.277 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.1 m -140.63 168.98 16.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 C-N-CA 124.413 1.085 . . . . 0.0 109.664 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.25 -170.6 3.3 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.123 1.369 . . . . 0.0 107.338 176.537 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.4 tpt180 -151.07 133.93 15.8 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 103.724 -2.695 . . . . 0.0 103.724 178.089 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -155.3 125.01 6.47 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 118.823 0.738 . . . . 0.0 109.051 -178.582 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 30.3 mmm-85 -89.1 -15.82 33.01 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 118.991 0.814 . . . . 0.0 111.023 179.082 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -80.93 18.54 9.11 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-O 119.186 -0.786 . . . . 0.0 112.485 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.186 0 N-CA-C 105.781 -2.927 . . . . 0.0 105.781 -179.817 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 33.6 ttm . . . . . 0 N--CA 1.469 0.477 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -122.67 150.48 42.65 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 175.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.9 pt -132.65 168.63 23.74 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 176.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -126.1 151.79 46.74 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 123.892 0.877 . . . . 0.0 109.587 -179.563 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.9 t -138.37 133.06 42.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 178.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -98.27 117.27 32.28 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 105.241 -2.133 . . . . 0.0 105.241 177.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.3 p -80.36 167.08 20.66 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 118.878 0.763 . . . . 0.0 110.471 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -71.94 -7.98 51.8 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 122.747 0.419 . . . . 0.0 111.173 177.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.4 p -93.51 -12.35 29.84 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.549 1.14 . . . . 0.0 109.411 178.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.77 7.48 55.44 Favored Glycine 0 C--N 1.342 0.861 0 C-N-CA 125.005 1.288 . . . . 0.0 112.622 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -80.86 164.34 22.73 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 119.617 1.709 . . . . 0.0 108.186 179.085 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.2 m -124.11 131.46 53.55 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 102.953 -2.98 . . . . 0.0 102.953 177.481 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.9 mm -115.11 157.4 15.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 C-N-CA 125.81 1.644 . . . . 0.0 106.686 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 42.2 m -134.68 125.97 28.16 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 128.503 2.721 . . . . 0.0 104.945 177.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 81.1 mt -139.89 149.21 43.11 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.85 1.26 . . . . 0.0 110.17 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -102.13 114.25 28.22 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 126.116 1.767 . . . . 0.0 107.372 178.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.456 HG12 ' HE3' ' A' ' 29' ' ' LYS . 2.2 m -134.33 -175.0 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 124.77 1.228 . . . . 0.0 108.118 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -142.45 168.89 12.1 Favored Pre-proline 0 C--O 1.236 0.364 0 O-C-N 121.235 -0.916 . . . . 0.0 110.256 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -54.56 -22.12 26.93 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.683 2.256 . . . . 0.0 114.388 -179.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.5 m -115.11 31.77 6.48 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -178.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -95.68 128.92 42.96 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 101.133 -3.655 . . . . 0.0 101.133 175.361 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.2 p -76.57 159.0 30.71 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 119.778 1.172 . . . . 0.0 109.762 -179.336 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 51.8 mm -62.54 -26.19 39.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.525 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -53.86 -49.24 68.91 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.599 1.16 . . . . 0.0 108.457 178.229 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 -68.24 -52.02 38.73 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 126.436 1.894 . . . . 0.0 110.345 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.3 t -53.92 -43.68 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-N 119.232 0.923 . . . . 0.0 110.122 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -75.21 -13.48 60.45 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.182 0.993 . . . . 0.0 112.05 -178.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.51 -45.14 9.62 Favored 'General case' 0 C--O 1.225 -0.229 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 177.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.456 ' HE3' HG12 ' A' ' 17' ' ' VAL . 12.3 mtmm -50.84 -39.74 54.23 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.187 1.395 . . . . 0.0 110.385 179.166 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 37.5 pt -65.88 -25.41 36.16 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 CA-C-N 118.956 0.798 . . . . 0.0 112.332 178.475 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -76.37 -23.45 54.13 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 120.017 1.281 . . . . 0.0 109.372 -179.294 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.02 -38.88 56.75 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 177.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 45.6 mttm -87.43 -16.01 36.08 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 116.526 2.047 . . . . 0.0 116.526 -178.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -147.55 160.62 42.42 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 121.371 1.896 . . . . 0.0 110.511 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.31 64.09 4.23 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 124.427 1.013 . . . . 0.0 113.393 -179.085 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.1 pt -134.72 106.39 10.73 Favored Pre-proline 0 CA--C 1.541 0.61 0 CA-C-N 119.114 1.457 . . . . 0.0 108.341 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -71.54 169.45 20.93 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 123.7 2.933 . . . . 0.0 112.374 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -78.23 56.91 5.98 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 123.567 2.844 . . . . 0.0 110.263 178.081 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -149.5 136.16 19.41 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 127.958 2.503 . . . . 0.0 105.099 179.397 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 64.2 mm-40 51.91 48.83 22.01 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.303 1.441 . . . . 0.0 107.819 -177.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -152.55 133.14 13.85 Favored 'General case' 0 N--CA 1.455 -0.207 0 O-C-N 121.21 -0.932 . . . . 0.0 109.979 -178.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.0 ttm-85 -154.4 136.17 14.45 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 106.206 -1.775 . . . . 0.0 106.206 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 18.5 tp -88.22 137.85 31.96 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 124.427 1.091 . . . . 0.0 108.265 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.9 mm -135.12 150.2 29.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 126.002 1.721 . . . . 0.0 108.348 -178.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -137.17 115.41 11.72 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 178.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.39 42.32 18.04 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.884 1.274 . . . . 0.0 111.161 -178.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.33 -12.48 38.65 Favored Glycine 0 CA--C 1.53 0.97 0 CA-C-O 118.283 -1.287 . . . . 0.0 114.429 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.0 ttmt -79.11 125.17 29.06 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 120.86 2.33 . . . . 0.0 105.96 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.3 mp0 -74.31 136.0 42.56 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -179.027 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.3 mt -122.91 153.89 39.06 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -162.98 178.45 8.34 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 126.886 2.074 . . . . 0.0 107.802 177.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -71.78 160.56 32.39 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.057 1.343 . . . . 0.0 112.269 -177.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 108.34 -29.51 9.98 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 127.709 2.576 . . . . 0.0 108.626 -178.13 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 44.1 mtt180 -108.44 166.37 10.82 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.598 1.159 . . . . 0.0 112.329 178.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 49.5 p -117.44 169.59 9.4 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 126.067 1.747 . . . . 0.0 110.292 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.3 mp -52.73 -42.22 64.68 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 122.901 0.48 . . . . 0.0 111.207 178.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.2 t -59.06 -45.61 90.33 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.853 1.261 . . . . 0.0 110.799 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -59.46 -44.92 92.88 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.21 0.604 . . . . 0.0 110.506 -179.315 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -82.22 -0.3 44.58 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.518 0.727 . . . . 0.0 112.21 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 44.8 t30 53.65 47.49 23.71 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 127.141 2.176 . . . . 0.0 110.611 -179.365 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.1 mt -85.05 130.95 35.25 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 N-CA-C 104.397 -2.446 . . . . 0.0 104.397 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 68.7 mm-40 -89.63 167.14 13.16 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 123.079 0.551 . . . . 0.0 111.566 -178.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -72.74 156.68 38.68 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 177.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 50.86 35.74 13.06 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.205 1.402 . . . . 0.0 111.358 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.6 p -81.85 164.77 21.38 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.422 1.889 . . . . 0.0 109.494 179.091 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.5 m -125.97 107.03 10.06 Favored 'General case' 0 N--CA 1.461 0.12 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.6 mp -97.61 164.51 12.39 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.124 1.37 . . . . 0.0 109.21 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.2 m80 -119.93 157.66 28.31 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 126.028 1.731 . . . . 0.0 110.949 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 34.6 mt -123.16 125.47 45.2 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.584 1.554 . . . . 0.0 107.479 178.388 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.8 m -140.98 172.63 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-N 119.722 1.147 . . . . 0.0 113.937 -178.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -142.43 -170.49 3.2 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.478 1.911 . . . . 0.0 109.41 177.37 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -156.09 132.91 10.43 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 103.988 -2.597 . . . . 0.0 103.988 178.183 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.1 mt -147.81 140.65 24.81 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.6 mmm-85 -105.5 -14.1 15.41 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 118.939 0.79 . . . . 0.0 110.939 178.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -82.74 18.4 15.77 Favored Glycine 0 CA--C 1.537 1.459 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 177.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.83 0 N-CA-C 104.38 -3.488 . . . . 0.0 104.38 -179.578 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ttt . . . . . 0 N--CA 1.473 0.691 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -121.08 156.16 32.85 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 179.252 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.2 pt -133.71 170.85 19.02 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 C-N-CA 126.601 1.96 . . . . 0.0 107.883 177.596 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -126.14 152.43 45.96 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.187 1.395 . . . . 0.0 109.161 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.2 t -138.1 126.15 30.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 178.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -92.83 117.5 30.09 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 106.144 -1.799 . . . . 0.0 106.144 178.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 64.4 p -73.12 164.39 26.76 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -67.67 -12.63 60.9 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.7 178.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.6 p -92.55 -12.11 32.68 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.396 1.879 . . . . 0.0 110.454 179.379 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.55 6.92 56.24 Favored Glycine 0 C--N 1.338 0.644 0 O-C-N 121.091 -1.006 . . . . 0.0 112.752 179.411 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.01 163.36 23.32 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 104.996 -2.224 . . . . 0.0 104.996 178.323 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 47.3 m -125.1 140.54 52.79 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 178.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.2 mm -114.82 156.22 15.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 126.338 1.855 . . . . 0.0 106.001 179.189 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 47.6 m -132.23 125.84 32.07 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 103.571 -2.751 . . . . 0.0 103.571 178.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.2 mt -138.73 151.49 47.17 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.024 0.93 . . . . 0.0 110.397 -178.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -99.69 118.62 36.6 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 128.362 2.665 . . . . 0.0 105.728 178.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.1 m -134.21 -171.27 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 125.512 1.525 . . . . 0.0 108.467 -178.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -146.72 161.8 36.28 Favored Pre-proline 0 CA--C 1.536 0.435 0 C-N-CA 124.197 0.999 . . . . 0.0 108.344 179.312 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -51.19 -24.98 16.19 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.316 2.678 . . . . 0.0 114.844 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.4 m -115.42 33.09 5.65 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.756 0.822 . . . . 0.0 111.563 -179.231 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -90.69 129.65 36.77 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 103.131 -2.915 . . . . 0.0 103.131 178.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 21.3 p -69.58 158.08 35.96 Favored 'General case' 0 C--O 1.237 0.421 0 O-C-N 121.728 -0.607 . . . . 0.0 110.69 -178.223 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.7 mm -64.25 -32.14 56.3 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.47 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 177.107 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -55.49 -39.71 70.79 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 125.823 1.649 . . . . 0.0 110.171 179.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -73.86 -53.46 10.15 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.1 t -57.92 -39.13 70.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 O-C-N 121.162 -0.961 . . . . 0.0 112.397 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 27.2 ttpt -75.01 -15.75 60.64 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.622 1.169 . . . . 0.0 110.921 -179.195 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.75 -47.1 7.84 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.108 1.763 . . . . 0.0 108.14 177.176 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.1 mttm -50.36 -40.5 49.5 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.217 1.407 . . . . 0.0 110.898 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.3 pt -64.32 -27.94 43.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 O-C-N 121.472 -0.768 . . . . 0.0 111.667 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -78.02 -22.09 49.77 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.824 1.249 . . . . 0.0 110.412 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.34 -37.76 60.52 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 177.64 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -94.18 -17.75 22.42 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 116.104 1.891 . . . . 0.0 116.104 -179.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -136.45 150.21 48.61 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 121.401 1.909 . . . . 0.0 107.13 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -83.46 85.76 1.52 Allowed Glycine 0 CA--C 1.521 0.434 0 CA-C-O 119.14 -0.811 . . . . 0.0 111.285 -179.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.5 pt -141.17 108.78 6.29 Favored Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 118.327 1.064 . . . . 0.0 111.79 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -62.62 161.9 26.6 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 122.666 2.244 . . . . 0.0 110.547 178.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -84.23 56.66 5.03 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.569 2.179 . . . . 0.0 108.041 179.107 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -144.82 134.15 23.04 Favored 'General case' 0 CA--C 1.514 -0.415 0 C-N-CA 130.602 3.561 . . . . 0.0 103.515 -178.015 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 43.3 mm-40 50.89 49.55 20.86 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 125.353 1.461 . . . . 0.0 107.324 -176.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -147.89 133.0 18.27 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.771 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 42.9 ttm-85 -154.73 133.58 12.22 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 178.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 26.5 tp -88.25 137.06 32.66 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.17 1.388 . . . . 0.0 107.834 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.3 mm -127.98 144.46 37.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 125.718 1.607 . . . . 0.0 108.844 -178.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -136.77 126.07 24.85 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 178.035 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.36 33.15 9.48 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.049 0.94 . . . . 0.0 111.288 -179.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.27 -11.95 41.09 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 124.514 1.054 . . . . 0.0 112.483 -179.153 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -79.55 129.02 34.09 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 119.58 1.69 . . . . 0.0 107.515 179.566 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.9 mp0 -74.4 136.03 42.41 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.6 mt -122.98 155.67 36.31 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.29 1.036 . . . . 0.0 109.744 -178.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -161.7 -178.33 6.47 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 127.747 2.419 . . . . 0.0 107.393 177.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -70.63 160.42 32.6 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 127.621 2.368 . . . . 0.0 113.055 -176.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.5 -28.82 13.92 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 126.576 2.036 . . . . 0.0 110.264 -178.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 46.6 mtt180 -108.23 165.16 11.7 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.019 1.328 . . . . 0.0 112.3 179.07 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 64.4 p -118.52 174.21 6.39 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 126.87 2.068 . . . . 0.0 111.855 -179.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.67 -46.37 63.76 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.459 1.104 . . . . 0.0 110.98 179.211 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.1 t -58.6 -45.3 89.45 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.037 1.735 . . . . 0.0 111.503 -179.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -60.29 -45.09 94.56 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 122.966 0.506 . . . . 0.0 110.52 -178.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -81.53 1.84 31.74 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.04 0.536 . . . . 0.0 111.197 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.2 t30 54.72 46.19 25.15 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 128.039 2.535 . . . . 0.0 111.202 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 89.6 mt -88.38 125.51 41.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 81.5 mm-40 -101.93 176.94 5.04 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.253 1.021 . . . . 0.0 110.613 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.9 pttt -64.72 156.67 29.66 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 123.588 0.755 . . . . 0.0 110.431 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 49.17 39.33 15.2 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.518 1.927 . . . . 0.0 111.694 -178.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.8 p -83.95 161.64 20.73 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 120.447 -1.408 . . . . 0.0 108.129 178.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.5 m -126.29 108.8 11.6 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.4 mp -95.78 162.16 13.71 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.269 1.428 . . . . 0.0 109.004 -179.036 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -119.77 163.12 17.94 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.21 1.404 . . . . 0.0 109.928 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.3 mt -123.0 127.34 48.67 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.01 1.724 . . . . 0.0 108.337 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.6 m -141.21 163.44 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 114.255 1.205 . . . . 0.0 114.255 -178.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -142.86 -170.63 3.28 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 127.353 2.261 . . . . 0.0 108.819 177.305 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -159.35 129.38 5.64 Favored 'General case' 0 CA--C 1.521 -0.137 0 N-CA-C 105.021 -2.214 . . . . 0.0 105.021 176.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.6 mt -148.83 141.21 24.19 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 34.7 mmm-85 -91.68 -17.64 25.17 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 177.37 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -84.1 20.42 13.19 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 126.606 2.051 . . . . 0.0 110.923 178.231 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.158 0 N-CA-C 108.591 -1.804 . . . . 0.0 108.591 -179.562 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.2 ttm . . . . . 0 N--CA 1.468 0.466 0 N-CA-C 110.354 -0.239 . . . . 0.0 110.354 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -121.04 156.45 32.17 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 176.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.2 pt -132.98 169.39 22.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 178.119 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -126.12 149.57 48.84 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 179.006 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.7 t -138.33 124.52 25.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -92.8 117.78 30.39 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 105.345 -2.095 . . . . 0.0 105.345 178.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 50.1 p -72.19 167.06 21.12 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 121.564 0.697 . . . . 0.0 109.734 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.403 ' H ' HD23 ' A' ' 8' ' ' LEU . 2.6 pt? -67.26 -12.51 60.3 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.62 0.768 . . . . 0.0 111.738 178.787 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.3 p -97.44 -12.71 22.38 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.908 1.683 . . . . 0.0 112.249 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.35 6.65 47.44 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-O 118.313 -1.271 . . . . 0.0 113.863 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.3 163.52 20.62 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 120.138 1.969 . . . . 0.0 105.983 178.388 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.5 m -124.57 132.76 53.44 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.5 mm -115.66 156.9 16.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 127.458 2.303 . . . . 0.0 108.228 -179.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.7 m -133.54 130.55 38.62 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 127.85 2.46 . . . . 0.0 106.276 178.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 92.5 mt -134.3 151.87 51.49 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 126.16 1.784 . . . . 0.0 110.845 -179.017 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -102.68 117.69 35.21 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 104.548 -2.389 . . . . 0.0 104.548 177.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.1 m -135.18 -168.96 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 124.657 1.183 . . . . 0.0 109.768 -179.053 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -150.43 163.54 23.8 Favored Pre-proline 0 CA--C 1.537 0.462 0 C-N-CA 125.308 1.443 . . . . 0.0 109.196 178.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -57.12 -18.41 29.07 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.705 2.27 . . . . 0.0 113.274 178.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.4 m -114.22 31.27 6.7 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 123.74 0.816 . . . . 0.0 111.517 -178.375 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -94.97 130.07 41.76 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 102.309 -3.219 . . . . 0.0 102.309 176.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.5 p -71.62 156.69 39.1 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 119.798 1.181 . . . . 0.0 109.726 -179.256 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.7 mm -65.04 -29.33 47.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 177.03 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -57.74 -49.63 75.92 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 126.101 1.761 . . . . 0.0 107.9 178.313 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -63.04 -52.08 64.25 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.143 0.977 . . . . 0.0 109.421 178.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.8 t -56.37 -38.91 57.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 O-C-N 121.508 -0.745 . . . . 0.0 110.618 179.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -74.74 -17.83 60.59 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-O 117.763 -1.113 . . . . 0.0 109.948 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.29 -47.36 10.13 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 120.2 1.364 . . . . 0.0 108.177 178.103 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.0 mttm -50.32 -43.16 53.68 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.672 1.189 . . . . 0.0 111.808 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 36.8 pt -62.78 -27.73 43.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 O-C-N 121.501 -0.749 . . . . 0.0 112.684 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.423 HE22 ' HB3' ' A' ' 38' ' ' PRO . 34.8 mt-30 -77.21 -20.66 55.01 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 119.519 1.054 . . . . 0.0 110.479 -179.307 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -82.74 -38.08 23.76 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.171 -0.956 . . . . 0.0 108.974 178.27 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -86.03 -21.42 27.77 Favored 'General case' 0 N--CA 1.471 0.575 0 O-C-N 121.044 -1.035 . . . . 0.0 113.682 -178.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -140.5 150.81 44.22 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 178.64 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -80.89 85.29 1.38 Allowed Glycine 0 C--N 1.332 0.317 0 CA-C-N 118.907 0.776 . . . . 0.0 113.038 -178.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.3 pt -140.14 106.87 6.74 Favored Pre-proline 0 CA--C 1.54 0.59 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -66.09 170.4 11.85 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 123.772 2.982 . . . . 0.0 111.309 178.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.423 ' HB3' HE22 ' A' ' 31' ' ' GLN . 52.4 Cg_endo -83.46 55.99 5.19 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 N-CA-C 106.645 -2.098 . . . . 0.0 106.645 178.261 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -146.52 133.94 20.78 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 128.402 2.681 . . . . 0.0 106.746 -177.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 39.6 mm-40 46.84 49.43 14.39 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.073 1.749 . . . . 0.0 108.348 -177.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -154.3 134.41 13.18 Favored 'General case' 0 C--N 1.341 0.207 0 C-N-CA 124.761 1.224 . . . . 0.0 110.106 -179.422 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 52.1 ttm-85 -151.59 141.47 21.99 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 179.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 20.0 tp -88.45 138.89 31.02 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.749 1.22 . . . . 0.0 108.818 -179.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.2 mm -135.16 149.98 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 C-N-CA 125.989 1.716 . . . . 0.0 107.083 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -137.61 122.71 19.15 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 178.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.1 36.61 9.1 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.04 0.936 . . . . 0.0 111.494 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.76 -13.95 33.64 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-O 118.773 -1.015 . . . . 0.0 114.028 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.3 ttmt -79.76 128.97 34.07 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 120.304 2.052 . . . . 0.0 106.145 178.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.7 mp0 -73.75 136.17 43.63 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.141 1.376 . . . . 0.0 108.924 -178.491 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.4 mt -123.86 155.03 38.8 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.345 1.058 . . . . 0.0 109.069 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -161.78 179.46 8.08 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.269 1.428 . . . . 0.0 108.316 178.149 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -70.97 161.12 31.66 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 127.219 2.208 . . . . 0.0 112.993 -176.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.37 -25.18 29.08 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 126.24 1.876 . . . . 0.0 110.434 -178.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 47.3 mtt180 -108.29 171.56 7.34 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 118.715 1.257 . . . . 0.0 112.194 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.8 p -118.17 171.62 7.99 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 126.457 1.903 . . . . 0.0 109.322 178.27 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.7 mp -52.86 -42.16 64.97 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.357 0.663 . . . . 0.0 110.548 177.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.9 t -58.68 -45.44 89.42 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 126.251 1.82 . . . . 0.0 111.553 -179.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -57.73 -47.09 83.39 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 119.384 0.993 . . . . 0.0 109.871 -179.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -81.72 1.25 35.23 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.888 0.875 . . . . 0.0 112.378 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 54.8 t30 53.93 46.08 26.36 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 127.422 2.289 . . . . 0.0 111.405 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.0 mt -86.29 126.71 40.66 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.9 mm-40 -97.2 173.3 7.3 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.402 0.681 . . . . 0.0 111.215 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 42.8 pttt -66.06 156.77 32.83 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.021 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 51.81 35.33 15.16 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 127.328 2.251 . . . . 0.0 110.901 -179.319 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.3 p -75.59 162.74 28.02 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 178.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.3 m -122.77 106.24 10.75 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 -179.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.5 mp -101.63 159.4 15.34 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.314 1.446 . . . . 0.0 109.552 -178.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 4.1 m80 -120.25 163.64 17.47 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 126.406 1.882 . . . . 0.0 111.145 179.121 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 69.4 mt -122.24 125.41 45.99 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 177.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.9 m -139.77 163.75 24.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-O 121.85 0.833 . . . . 0.0 111.64 -179.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -141.94 -169.12 2.85 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 127.278 2.231 . . . . 0.0 108.409 178.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.9 tpt180 -151.92 130.07 11.92 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 102.27 -3.233 . . . . 0.0 102.27 176.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.524 HD23 ' H ' ' A' ' 75' ' ' GLY . 1.0 OUTLIER -143.09 123.22 13.67 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 -179.151 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 48.1 mmm-85 -97.7 -11.83 23.05 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 123.107 0.563 . . . . 0.0 111.753 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.524 ' H ' HD23 ' A' ' 73' ' ' LEU . . . -82.39 18.42 14.39 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 124.599 1.095 . . . . 0.0 111.259 178.325 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.039 0 N-CA-C 105.564 -3.014 . . . . 0.0 105.564 179.953 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 30.3 ttm . . . . . 0 CA--C 1.514 -0.415 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -120.99 148.43 44.11 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 178.122 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 34.0 pt -132.11 168.34 24.28 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 O-C-N 120.993 -1.067 . . . . 0.0 108.448 179.127 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -126.22 149.84 48.78 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.7 t -138.3 124.64 25.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -90.42 118.95 30.29 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 126.914 2.086 . . . . 0.0 111.071 179.262 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 51.1 p -83.05 163.98 20.61 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 177.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.66 -5.65 16.79 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.426 1.09 . . . . 0.0 112.881 178.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.9 p -92.77 -14.23 28.17 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.794 2.037 . . . . 0.0 110.555 178.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.5 6.39 57.47 Favored Glycine 0 C--N 1.337 0.593 0 C-N-CA 125.637 1.589 . . . . 0.0 112.459 179.526 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.8 mmmm -81.77 164.48 21.66 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 118.28 1.04 . . . . 0.0 108.334 179.562 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.1 m -125.09 137.19 54.2 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 177.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 48.8 mm -115.95 154.0 17.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 105.507 -2.034 . . . . 0.0 105.507 178.373 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.8 m -132.71 130.13 39.63 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 178.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 78.5 mt -139.17 151.2 46.42 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 124.899 1.28 . . . . 0.0 111.857 -178.301 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -98.94 117.63 33.89 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 127.482 2.313 . . . . 0.0 105.024 178.064 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.6 m -134.39 -171.99 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 125.323 1.449 . . . . 0.0 109.729 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -148.09 165.59 17.98 Favored Pre-proline 0 CA--C 1.536 0.406 0 C-N-CA 124.136 0.974 . . . . 0.0 110.507 179.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.78 -19.27 14.34 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.725 2.95 . . . . 0.0 115.547 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.1 m -115.73 30.83 7.1 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 119.132 0.878 . . . . 0.0 111.693 -179.342 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -91.46 129.31 37.46 Favored 'General case' 0 C--O 1.244 0.784 0 N-CA-C 102.846 -3.02 . . . . 0.0 102.846 177.044 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.9 p -76.65 158.34 31.13 Favored 'General case' 0 C--O 1.233 0.205 0 O-C-N 121.118 -0.989 . . . . 0.0 110.697 -178.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.2 mm -63.07 -27.02 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 179.193 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -54.18 -46.5 72.4 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.387 1.075 . . . . 0.0 109.633 178.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 56.7 m-80 -69.57 -52.36 26.95 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.659 1.584 . . . . 0.0 109.445 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.4 t -54.45 -40.98 51.57 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 CA-C-N 118.835 0.743 . . . . 0.0 109.971 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.1 ttpt -75.49 -12.92 60.33 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.953 1.301 . . . . 0.0 111.637 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.11 -47.44 7.82 Favored 'General case' 0 CA--C 1.52 -0.198 0 C-N-CA 124.614 1.166 . . . . 0.0 109.46 178.011 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 55.7 mttm -51.21 -40.24 58.29 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.918 1.287 . . . . 0.0 110.485 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.7 pt -61.64 -31.0 49.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-O 118.44 -0.79 . . . . 0.0 112.413 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -77.38 -19.97 55.41 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.029 1.332 . . . . 0.0 110.724 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -83.89 -40.03 19.12 Favored 'General case' 0 CA--C 1.53 0.193 0 O-C-N 121.412 -0.805 . . . . 0.0 110.484 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.8 mttm -89.87 -14.97 33.18 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 -179.414 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -138.95 150.79 46.29 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.72 64.54 4.19 Favored Glycine 0 CA--C 1.524 0.603 0 CA-C-O 118.136 -1.369 . . . . 0.0 112.729 -179.018 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.5 pt -127.41 106.72 21.28 Favored Pre-proline 0 CA--C 1.552 1.02 0 CA-C-N 118.928 1.364 . . . . 0.0 111.162 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -65.88 165.41 23.7 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 124.13 3.22 . . . . 0.0 114.694 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -81.79 57.52 6.35 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 124.756 3.637 . . . . 0.0 110.163 178.544 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -145.12 134.06 22.49 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 128.69 2.796 . . . . 0.0 105.501 -178.527 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.8 mm-40 44.23 51.1 7.57 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 126.603 1.961 . . . . 0.0 110.05 -177.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 23.3 m-20 -150.59 134.2 16.51 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.3 ttm-85 -153.28 142.65 21.63 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 124.883 1.273 . . . . 0.0 107.638 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.0 tp -88.62 142.9 27.31 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 125.246 1.419 . . . . 0.0 112.698 -177.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.6 mm -135.55 148.15 28.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 126.934 2.094 . . . . 0.0 108.265 179.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -138.18 115.07 10.76 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 177.375 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.45 43.06 19.46 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.268 1.027 . . . . 0.0 110.784 -178.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.66 -13.19 36.99 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 124.63 1.11 . . . . 0.0 114.738 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.6 ttmm -79.48 129.21 34.26 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 119.757 1.778 . . . . 0.0 109.33 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -74.81 129.36 37.54 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 125.82 1.648 . . . . 0.0 109.577 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 9.8 mt -123.74 148.85 46.24 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 123.726 0.811 . . . . 0.0 110.43 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.1 pm0 -151.61 175.96 11.83 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.12 1.368 . . . . 0.0 108.464 178.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -72.13 161.03 31.46 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 125.493 1.517 . . . . 0.0 113.628 -177.339 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.82 -22.52 39.97 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 125.672 1.606 . . . . 0.0 110.724 -179.058 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -107.27 169.97 8.24 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 118.572 1.186 . . . . 0.0 111.347 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 79.4 p -117.09 171.14 8.12 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.604 1.562 . . . . 0.0 113.026 -178.415 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.57 -47.13 67.02 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.074 0.95 . . . . 0.0 108.829 177.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.2 m -62.04 -32.5 73.02 Favored 'General case' 0 N--CA 1.46 0.063 0 C-N-CA 124.823 1.249 . . . . 0.0 112.93 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -67.41 -45.67 75.47 Favored 'General case' 0 CA--C 1.515 -0.398 0 O-C-N 121.077 -1.014 . . . . 0.0 109.819 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -82.95 1.39 39.91 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 119.208 -0.425 . . . . 0.0 110.93 178.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 36.5 t30 56.01 46.71 21.3 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 127.76 2.424 . . . . 0.0 111.167 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.6 mt -89.76 126.98 42.64 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 178.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -101.84 178.43 4.62 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 123.039 0.536 . . . . 0.0 110.216 179.385 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 58.4 pttt -64.68 156.88 28.85 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.176 0.59 . . . . 0.0 110.661 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 52.26 46.1 27.25 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.216 1.407 . . . . 0.0 111.221 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.1 p -88.75 161.26 16.89 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.994 1.718 . . . . 0.0 109.912 177.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.37 117.05 22.17 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 178.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mp -109.04 160.57 15.94 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 124.298 1.039 . . . . 0.0 109.256 -179.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 43.7 m80 -120.05 161.11 21.51 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 126.39 1.876 . . . . 0.0 109.526 178.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 33.6 mt -122.82 125.14 44.86 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 126.728 2.011 . . . . 0.0 108.014 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.0 m -141.02 166.14 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -178.607 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -142.79 -172.32 3.63 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.384 1.474 . . . . 0.0 108.955 177.088 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.79 128.66 5.08 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 103.926 -2.62 . . . . 0.0 103.926 177.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 76.4 mt -146.98 140.69 25.75 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.5 mmm180 -102.43 -15.35 16.53 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.675 0.79 . . . . 0.0 110.629 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -85.66 19.38 24.84 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 125.583 1.563 . . . . 0.0 110.88 178.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.126 0 N-CA-C 105.246 -3.142 . . . . 0.0 105.246 -179.762 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.0 ttm . . . . . 0 N--CA 1.471 0.624 0 CA-C-O 118.719 -0.658 . . . . 0.0 110.356 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -121.74 154.41 36.96 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 176.666 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.9 pt -133.42 169.22 22.34 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 176.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -123.04 149.53 44.26 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 179.103 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.7 t -138.95 125.69 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.1 tppp? -94.14 117.56 30.29 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.946 0.898 . . . . 0.0 108.903 178.428 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 37.4 p -83.22 166.18 18.8 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.889 0.768 . . . . 0.0 111.025 179.239 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -70.29 -2.56 13.81 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.35 0.66 . . . . 0.0 111.909 177.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 47.0 p -92.62 -15.16 27.19 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.915 1.286 . . . . 0.0 109.369 178.484 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.5 6.08 57.6 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 126.825 2.155 . . . . 0.0 112.435 179.091 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.3 mmmm -81.91 164.18 21.72 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 119.172 1.486 . . . . 0.0 109.636 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.5 m -113.2 132.08 55.63 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 101.896 -3.372 . . . . 0.0 101.896 176.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.8 mm -115.77 148.06 18.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 179.367 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.9 m -125.37 130.05 51.15 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 106.392 -1.706 . . . . 0.0 106.392 178.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 76.3 mt -139.12 143.26 38.16 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.518 0.727 . . . . 0.0 110.072 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -99.57 107.1 19.17 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.902 2.081 . . . . 0.0 106.58 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.4 m -133.58 -172.6 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 124.988 1.315 . . . . 0.0 109.929 -178.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -144.13 166.07 20.84 Favored Pre-proline 0 C--O 1.235 0.315 0 CA-C-N 121.031 1.741 . . . . 0.0 112.178 -178.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.05 -22.47 31.28 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 123.246 2.63 . . . . 0.0 115.416 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.5 m -115.11 31.03 6.96 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 118.527 0.603 . . . . 0.0 112.369 -178.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -104.31 136.17 44.41 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 103.974 -2.602 . . . . 0.0 103.974 175.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.4 p -78.09 157.97 29.32 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 122.017 0.913 . . . . 0.0 112.065 -178.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.1 mm -64.02 -25.43 38.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-O 118.373 -0.823 . . . . 0.0 110.018 178.233 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -55.83 -38.66 70.32 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 119.739 1.154 . . . . 0.0 109.382 179.007 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 57.7 m-20 -74.42 -52.96 10.56 Favored 'General case' 0 CA--C 1.521 -0.14 0 C-N-CA 124.723 1.209 . . . . 0.0 109.552 178.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 24.8 t -54.23 -42.65 57.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 123.036 0.534 . . . . 0.0 111.348 -179.176 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -74.95 -14.54 60.64 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.653 0.781 . . . . 0.0 111.421 -178.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.19 -45.65 8.95 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.397 1.079 . . . . 0.0 108.602 177.173 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.5 mttm -52.64 -39.92 62.25 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 124.715 1.206 . . . . 0.0 111.446 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 32.2 pt -60.53 -29.01 43.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-N 118.445 0.566 . . . . 0.0 111.08 178.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -76.91 -23.43 52.52 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 119.445 1.02 . . . . 0.0 109.983 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.54 -24.31 45.76 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 177.247 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.6 mmtt -93.56 -20.35 20.32 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -150.83 161.76 42.06 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 120.796 1.634 . . . . 0.0 109.526 -178.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -80.95 77.29 2.04 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 124.225 0.917 . . . . 0.0 111.957 -179.438 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.1 pt -135.41 108.51 10.25 Favored Pre-proline 0 CA--C 1.546 0.805 0 CA-C-N 118.245 1.023 . . . . 0.0 111.759 -179.329 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -65.22 166.69 18.29 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 123.151 2.567 . . . . 0.0 110.465 178.488 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -88.23 56.64 2.57 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.408 2.072 . . . . 0.0 107.813 179.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -145.91 136.01 23.71 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 127.909 2.484 . . . . 0.0 105.045 -178.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.0 mm-40 51.14 49.53 20.93 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.83 1.652 . . . . 0.0 109.192 -177.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 23.7 m-80 -148.68 133.75 18.22 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.356 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.4 ttm-85 -151.72 137.17 17.69 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 126.967 2.107 . . . . 0.0 105.547 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 28.6 tp -87.27 139.39 30.61 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.603 1.161 . . . . 0.0 108.794 -178.221 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.4 mm -132.26 145.6 34.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 126.05 1.74 . . . . 0.0 108.475 -178.426 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -133.4 119.22 19.36 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 178.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.05 39.88 24.25 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.355 1.062 . . . . 0.0 110.451 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.48 -16.59 17.82 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-O 118.506 -1.163 . . . . 0.0 113.905 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.4 ttmt -79.52 128.78 33.8 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 120.519 2.16 . . . . 0.0 106.661 178.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.1 mp0 -74.55 136.94 42.12 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -179.182 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.9 mt -122.39 155.84 35.22 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 126.078 1.751 . . . . 0.0 109.978 -179.406 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -151.99 176.38 11.55 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.922 1.289 . . . . 0.0 109.162 178.084 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -72.6 160.9 31.5 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 126.082 1.753 . . . . 0.0 110.959 -178.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.84 -26.08 24.41 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 125.06 1.314 . . . . 0.0 110.098 -178.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 30.3 mtt180 -106.55 170.34 7.99 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 118.736 1.268 . . . . 0.0 110.165 179.176 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.1 p -117.49 167.59 11.16 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.51 1.524 . . . . 0.0 110.086 179.222 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.4 mp -52.88 -41.66 64.56 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 121.5 -0.75 . . . . 0.0 111.087 178.161 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.4 t -58.33 -44.22 88.6 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.274 1.43 . . . . 0.0 110.608 -179.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -57.94 -46.9 84.35 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.348 0.659 . . . . 0.0 109.884 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -81.72 -4.31 55.95 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -179.286 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 31.8 t30 56.66 46.37 20.34 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.996 2.118 . . . . 0.0 109.997 -178.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 84.2 mt -86.35 127.22 40.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 N-CA-C 103.782 -2.673 . . . . 0.0 103.782 178.459 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 94.6 mm-40 -101.74 173.21 6.51 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 122.918 0.487 . . . . 0.0 110.851 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.1 pttt -64.71 157.25 27.9 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.25 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 51.6 39.08 24.18 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 125.562 1.545 . . . . 0.0 111.231 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.1 p -87.34 163.44 16.81 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 120.87 -1.144 . . . . 0.0 108.263 177.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 33.0 m -126.4 105.98 9.17 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.4 mp -97.09 160.25 14.45 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.655 1.582 . . . . 0.0 108.805 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 4.2 m80 -120.01 157.63 28.47 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 125.36 1.464 . . . . 0.0 108.194 178.135 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.1 mt -122.99 123.47 40.96 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 105.223 -2.139 . . . . 0.0 105.223 178.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.5 m -141.8 172.43 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-N 120.11 1.323 . . . . 0.0 113.582 -179.18 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.44 -172.99 3.64 Favored 'General case' 0 C--N 1.343 0.301 0 C-N-CA 124.718 1.207 . . . . 0.0 111.071 178.031 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 13.8 ttt180 -161.04 130.71 4.87 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 177.12 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -155.7 122.64 5.36 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 105.909 -1.886 . . . . 0.0 105.909 178.638 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.41 24.1 mmm-85 -91.12 -0.89 57.81 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -83.03 18.72 14.99 Favored Glycine 0 CA--C 1.539 1.586 0 N-CA-C 108.019 -2.032 . . . . 0.0 108.019 176.107 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.935 0 C-N-CA 129.423 3.392 . . . . 0.0 105.856 -179.859 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.3 ttt . . . . . 0 N--CA 1.469 0.502 0 N-CA-C 110.606 -0.146 . . . . 0.0 110.606 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -120.71 156.96 30.68 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 177.476 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.4 pt -132.51 169.46 21.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 178.233 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -122.58 150.03 43.16 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 124.867 1.267 . . . . 0.0 108.239 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.8 t -139.17 125.24 23.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 O-C-N 121.788 -0.57 . . . . 0.0 109.585 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -91.0 111.27 22.65 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 178.05 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.5 p -83.15 160.61 21.81 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.655 0.661 . . . . 0.0 110.397 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -67.52 -2.72 6.97 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.407 1.083 . . . . 0.0 112.744 179.283 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.9 p -91.3 -12.62 34.56 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 125.264 1.426 . . . . 0.0 110.039 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.64 7.46 57.84 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.3 mmmm -97.07 165.1 12.23 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 118.006 0.903 . . . . 0.0 109.078 179.367 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.46 132.81 53.5 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 103.911 -2.626 . . . . 0.0 103.911 178.027 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.0 mm -114.56 153.26 16.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 -178.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 89.8 m -124.77 130.11 51.76 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 104.395 -2.446 . . . . 0.0 104.395 178.148 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 75.1 mt -138.8 151.2 46.85 Favored 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 124.226 1.01 . . . . 0.0 111.04 -179.041 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -97.59 118.7 34.69 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 127.22 2.208 . . . . 0.0 107.17 179.247 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 23.0 m -134.36 -174.94 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.005 0.922 . . . . 0.0 110.094 -179.064 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -147.68 159.14 41.82 Favored Pre-proline 0 C--O 1.234 0.278 0 C-N-CA 124.231 1.012 . . . . 0.0 109.469 178.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -53.37 -23.35 23.72 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 123.349 2.699 . . . . 0.0 115.005 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 42.2 m -115.62 30.83 7.1 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -178.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -94.91 135.47 36.38 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 176.229 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.3 p -71.44 158.86 35.54 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 119.558 1.072 . . . . 0.0 112.686 -178.488 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.7 mm -63.78 -28.89 45.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 O-C-N 121.475 -0.766 . . . . 0.0 109.018 178.218 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -61.08 -49.83 75.73 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -61.08 -52.48 64.73 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 124.134 0.973 . . . . 0.0 109.635 179.249 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.0 t -56.53 -38.55 57.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 124.165 0.986 . . . . 0.0 111.421 -179.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.4 ttpt -80.59 -12.51 59.5 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 118.361 -0.828 . . . . 0.0 111.473 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.6 -43.01 11.07 Favored 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 125.211 1.404 . . . . 0.0 109.213 178.403 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.6 mttm -51.89 -39.71 59.48 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 121.423 -0.798 . . . . 0.0 111.723 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.1 pt -65.0 -25.01 36.7 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 O-C-N 121.679 -0.638 . . . . 0.0 111.683 178.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -76.15 -20.67 57.36 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.916 1.234 . . . . 0.0 108.911 -179.378 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.45 -38.92 40.06 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 120.936 -1.103 . . . . 0.0 108.234 177.267 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 51.4 mttm -86.95 -21.81 25.99 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 -178.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -140.29 150.16 43.7 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 121.266 1.848 . . . . 0.0 106.406 178.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.75 82.96 1.55 Allowed Glycine 0 N--CA 1.451 -0.323 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.8 pt -134.94 108.72 10.66 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 125.533 1.533 . . . . 0.0 106.865 179.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -82.87 170.23 12.68 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 124.532 3.488 . . . . 0.0 112.129 -179.172 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -74.9 55.39 3.88 Favored 'Trans proline' 0 CA--C 1.553 1.439 0 C-N-CA 123.056 2.504 . . . . 0.0 111.089 178.589 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -150.01 127.09 11.23 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 104.475 -2.417 . . . . 0.0 104.475 179.249 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 71.0 mm-40 54.72 50.81 15.0 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.066 1.346 . . . . 0.0 108.347 -176.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -143.21 132.42 23.2 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 179.344 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.6 ttm-85 -158.93 133.42 7.94 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 125.362 1.465 . . . . 0.0 107.32 -179.341 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 21.8 tp -92.92 140.63 29.28 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.057 0.943 . . . . 0.0 112.178 -178.46 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.0 mm -135.55 146.45 29.86 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 127.21 2.204 . . . . 0.0 108.209 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -137.69 120.57 16.46 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 125.95 1.7 . . . . 0.0 106.797 178.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.38 41.25 16.25 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.299 1.039 . . . . 0.0 111.535 -179.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.8 -17.39 11.3 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.644 1.116 . . . . 0.0 113.95 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.3 ttmt -79.67 128.46 33.43 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 125.389 1.476 . . . . 0.0 108.994 -179.087 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.6 mp0 -76.15 136.48 39.79 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 124.954 1.302 . . . . 0.0 109.468 -179.09 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 9.6 mt -121.09 154.23 36.4 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 124.729 1.212 . . . . 0.0 109.646 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -151.68 175.99 11.83 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 123.518 0.727 . . . . 0.0 109.471 179.05 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -72.35 160.04 33.02 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.726 1.61 . . . . 0.0 111.229 -178.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.21 -29.22 12.96 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 126.415 1.959 . . . . 0.0 110.856 -178.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 51.7 mtt180 -107.94 174.48 5.86 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 119.305 1.552 . . . . 0.0 112.813 179.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 50.3 p -117.55 175.67 5.53 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.984 1.714 . . . . 0.0 114.253 -177.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.17 -49.35 63.98 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.964 1.306 . . . . 0.0 112.253 179.457 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.37 -33.59 76.32 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 118.386 -0.816 . . . . 0.0 111.829 -179.03 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -59.59 -47.22 86.42 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.77 1.168 . . . . 0.0 108.658 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -82.05 1.64 34.87 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.171 0.988 . . . . 0.0 112.673 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.0 t30 54.3 46.77 24.46 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 126.873 2.069 . . . . 0.0 112.56 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 74.8 mt -89.25 122.99 41.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 104.148 -2.538 . . . . 0.0 104.148 178.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -101.88 177.56 4.86 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 123.163 0.585 . . . . 0.0 110.627 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -64.21 155.27 32.34 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-O 121.618 0.723 . . . . 0.0 112.315 -178.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 47.59 35.39 4.32 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 127.985 2.514 . . . . 0.0 112.454 -179.415 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.1 p -80.6 163.79 23.39 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.224 1.009 . . . . 0.0 109.316 178.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 43.9 m -126.22 111.08 14.17 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.6 mp -96.69 161.65 13.79 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.387 1.075 . . . . 0.0 109.469 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.4 m80 -119.2 153.45 34.92 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 125.284 1.433 . . . . 0.0 109.823 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.7 mt -122.58 126.76 48.39 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 126.35 1.86 . . . . 0.0 106.477 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.4 m -138.22 169.74 17.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -179.378 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -142.42 -171.0 3.31 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.846 2.058 . . . . 0.0 109.094 178.105 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -159.27 129.11 5.59 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 105.15 -2.167 . . . . 0.0 105.15 178.204 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 19.0 mt -141.16 141.13 34.15 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 120.372 1.442 . . . . 0.0 110.235 -179.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 49.0 mmm-85 -95.89 -22.34 17.5 Favored 'General case' 0 C--O 1.225 -0.185 0 C-N-CA 124.252 1.021 . . . . 0.0 110.768 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -81.2 18.8 9.2 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-N 118.865 0.757 . . . . 0.0 112.085 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.139 0 N-CA-C 106.309 -2.716 . . . . 0.0 106.309 -179.82 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 ttt . . . . . 0 CA--C 1.507 -0.711 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -121.18 156.81 31.58 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 177.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.4 pt -132.1 168.21 24.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 178.216 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -116.29 150.7 37.21 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 124.865 1.266 . . . . 0.0 107.999 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.2 t -137.96 125.31 29.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 178.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -91.21 117.33 29.55 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 178.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.9 p -72.53 165.3 24.93 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 179.335 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -67.42 -9.31 40.47 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.115 0.566 . . . . 0.0 112.077 178.454 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.3 p -102.64 -12.48 17.68 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 127.527 2.331 . . . . 0.0 113.024 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.03 6.5 42.59 Favored Glycine 0 C--N 1.335 0.518 0 CA-C-O 118.279 -1.29 . . . . 0.0 114.973 178.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.6 mmmm -81.22 163.52 22.96 Favored 'General case' 0 C--N 1.343 0.295 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 178.092 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.6 m -124.55 131.48 53.48 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 103.724 -2.695 . . . . 0.0 103.724 177.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.5 mm -105.49 157.38 6.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 -179.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 69.8 m -130.29 122.55 28.19 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 129.428 3.091 . . . . 0.0 103.229 178.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 72.4 mt -138.3 146.16 42.09 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.353 1.061 . . . . 0.0 110.037 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -95.71 117.46 30.56 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.47 1.508 . . . . 0.0 108.07 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.5 m -129.03 -168.97 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.431 0 C-N-CA 125.623 1.569 . . . . 0.0 109.456 -178.264 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -150.38 161.89 29.23 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 125.24 1.416 . . . . 0.0 107.702 178.072 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -59.48 -18.7 48.0 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.523 2.149 . . . . 0.0 114.34 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.2 m -114.72 30.48 7.3 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 118.753 0.706 . . . . 0.0 111.498 -178.162 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -92.96 129.59 38.83 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.9 p -77.88 158.25 29.51 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 119.918 1.235 . . . . 0.0 111.592 -178.523 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.1 mm -63.42 -29.88 48.38 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.316 0 CA-C-O 117.933 -1.032 . . . . 0.0 109.979 178.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -59.94 -40.45 88.98 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.916 1.234 . . . . 0.0 110.299 -179.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -67.42 -53.08 32.22 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.243 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.7 t -57.07 -40.09 70.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 123.045 0.538 . . . . 0.0 110.95 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt -75.34 -16.0 60.44 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.654 1.182 . . . . 0.0 111.798 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.86 -46.03 8.84 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 177.498 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.5 mttm -52.03 -40.05 60.47 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 124.713 1.205 . . . . 0.0 111.498 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 34.1 pt -63.61 -27.05 42.16 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-N 118.925 0.784 . . . . 0.0 111.279 178.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -77.02 -22.74 52.6 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 119.603 1.092 . . . . 0.0 109.548 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.84 -39.29 61.7 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 177.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 51.1 mttm -87.36 -22.52 25.02 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 115.281 1.586 . . . . 0.0 115.281 -178.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -138.68 150.9 46.7 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 120.633 1.56 . . . . 0.0 107.804 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.6 89.3 1.41 Allowed Glycine 0 C--N 1.334 0.426 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 -179.53 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.0 pt -141.49 107.61 6.06 Favored Pre-proline 0 CA--C 1.543 0.685 0 CA-C-N 118.11 0.955 . . . . 0.0 110.777 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -64.7 168.15 13.94 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 123.057 2.505 . . . . 0.0 110.858 178.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -84.1 55.46 4.68 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 122.251 1.967 . . . . 0.0 108.49 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -146.56 136.03 22.94 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 130.516 3.526 . . . . 0.0 104.456 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 66.5 mm-40 51.24 47.52 24.7 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.26 1.824 . . . . 0.0 109.594 -178.211 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -154.86 132.47 11.31 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 179.276 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 51.8 ttm-85 -157.52 135.13 10.58 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 103.533 -2.766 . . . . 0.0 103.533 179.011 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 15.5 tp -87.92 141.91 28.21 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -178.131 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.3 mm -134.41 141.52 43.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 125.923 1.689 . . . . 0.0 108.1 -178.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -139.39 125.86 20.39 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.29 33.32 15.32 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.528 0.68 . . . . 0.0 111.919 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.97 -13.19 32.63 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 124.461 1.029 . . . . 0.0 112.511 -179.324 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.5 tpmt? -78.58 123.11 26.75 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 -179.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -75.91 136.29 40.1 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.465 HD22 ' CG ' ' A' ' 59' ' ' TYR . 3.5 mt -115.17 154.76 28.41 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 123.867 0.867 . . . . 0.0 109.462 -178.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -158.98 179.52 8.99 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 126.302 1.841 . . . . 0.0 107.46 178.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.22 160.95 31.91 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.914 1.285 . . . . 0.0 112.458 -176.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.43 -27.13 21.87 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 113.784 -1.553 . . . . 0.0 111.303 -179.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 44.8 mtt180 -106.6 168.06 9.43 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 119.033 1.417 . . . . 0.0 111.074 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.1 p -117.81 173.1 6.94 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.599 1.559 . . . . 0.0 113.181 -178.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.44 -48.95 65.49 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.151 0.98 . . . . 0.0 111.657 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.4 -32.48 74.11 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 118.474 0.579 . . . . 0.0 111.493 -179.436 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -63.79 -45.68 88.6 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 119.498 1.044 . . . . 0.0 108.774 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.465 ' CG ' HD22 ' A' ' 50' ' ' LEU . 59.3 m-85 -82.16 2.08 33.26 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.683 -0.636 . . . . 0.0 111.69 179.366 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 54.47 47.12 23.51 Favored 'General case' 0 C--N 1.342 0.277 0 C-N-CA 128.041 2.536 . . . . 0.0 111.193 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 74.2 mt -89.99 122.27 41.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 103.553 -2.758 . . . . 0.0 103.553 178.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 94.2 mm-40 -98.57 177.48 5.31 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.038 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 40.8 pttt -64.51 156.05 30.94 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -179.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.255 5.4 mp0 45.65 44.38 10.24 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.935 2.094 . . . . 0.0 113.597 179.486 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.8 p -87.94 164.85 15.62 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.619 1.968 . . . . 0.0 109.508 177.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.2 m -126.51 107.3 10.12 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 119.437 1.017 . . . . 0.0 108.755 178.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.1 mp -96.44 163.18 13.16 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.788 1.635 . . . . 0.0 110.547 -178.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 16.1 m80 -119.26 161.0 21.14 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.133 1.373 . . . . 0.0 111.815 178.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 39.9 mt -123.29 128.85 50.52 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.897 1.679 . . . . 0.0 107.855 178.093 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.1 m -140.66 162.74 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-N 118.868 0.758 . . . . 0.0 112.253 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -140.55 -172.37 3.43 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 126.394 1.878 . . . . 0.0 109.51 178.604 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -158.88 130.05 6.26 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 177.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.6 mt -142.55 140.37 31.75 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 -179.523 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 49.0 mmm-85 -106.43 -11.94 15.79 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.101 0.961 . . . . 0.0 110.548 179.108 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -82.58 17.78 18.31 Favored Glycine 0 CA--C 1.537 1.459 0 N-CA-C 110.576 -1.01 . . . . 0.0 110.576 177.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.118 0 N-CA-C 104.366 -3.494 . . . . 0.0 104.366 -179.649 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.6 ttt . . . . . 0 N--CA 1.469 0.516 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -121.83 154.23 37.3 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 175.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 32.8 pt -132.55 169.72 21.38 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 177.64 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -123.49 150.07 44.37 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.9 t -138.21 125.23 27.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 178.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.9 tppp? -91.42 117.47 29.71 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 104.624 -2.361 . . . . 0.0 104.624 178.188 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.0 p -72.8 168.99 17.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 118.456 0.571 . . . . 0.0 110.277 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -66.87 -12.59 59.79 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 121.11 -0.236 . . . . 0.0 111.044 178.155 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.7 p -93.74 -12.4 29.27 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.572 1.949 . . . . 0.0 112.023 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.8 7.28 55.63 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-O 118.801 -1.0 . . . . 0.0 113.49 178.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -79.88 164.01 23.9 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-N 119.484 1.642 . . . . 0.0 106.992 179.425 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.1 m -114.7 130.43 56.82 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 103.289 -2.856 . . . . 0.0 103.289 178.398 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.8 mm -115.55 154.08 17.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 105.602 -1.999 . . . . 0.0 105.602 179.269 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.2 m -134.96 125.3 26.36 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 126.924 2.09 . . . . 0.0 105.395 179.033 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 82.1 mt -140.13 151.05 44.99 Favored 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 124.543 1.137 . . . . 0.0 109.851 -179.348 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -94.84 118.33 31.59 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 105.504 -2.036 . . . . 0.0 105.504 178.239 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.6 m -129.82 -174.2 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 124.523 1.129 . . . . 0.0 108.824 -179.008 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -149.71 168.35 11.18 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 124.404 1.082 . . . . 0.0 108.574 -179.408 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -59.54 -21.24 61.16 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.473 2.115 . . . . 0.0 113.48 178.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.3 m -114.85 31.78 6.45 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 118.463 0.574 . . . . 0.0 111.857 -178.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -91.69 128.21 37.44 Favored 'General case' 0 C--O 1.242 0.711 1 N-CA-C 99.671 -4.196 . . . . 0.0 99.671 177.194 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.1 p -76.72 158.59 30.85 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -179.04 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.8 mm -63.49 -27.31 42.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 119.254 -0.978 . . . . 0.0 109.388 178.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -61.58 -37.84 85.34 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.885 1.221 . . . . 0.0 109.017 178.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.0 m-80 -69.24 -52.93 22.8 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 178.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 25.8 t -55.73 -38.53 51.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-N 119.049 0.84 . . . . 0.0 110.93 179.555 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.1 ttpt -75.08 -18.18 60.33 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.327 1.051 . . . . 0.0 111.686 -179.284 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.01 -46.83 8.24 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 126.767 2.027 . . . . 0.0 109.187 178.292 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -51.5 -40.68 60.03 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.407 1.483 . . . . 0.0 110.831 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 31.6 pt -64.79 -25.21 37.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 O-C-N 121.138 -0.976 . . . . 0.0 111.879 179.137 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -76.85 -23.37 52.69 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 120.671 -1.268 . . . . 0.0 109.626 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.78 -24.57 55.99 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 176.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.2 mttm -100.74 -15.29 17.73 Favored 'General case' 0 C--N 1.341 0.203 0 N-CA-C 116.236 1.939 . . . . 0.0 116.236 -179.222 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -145.55 158.56 43.83 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 120.918 1.69 . . . . 0.0 108.111 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.14 68.64 3.4 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.6 pt -131.6 108.57 14.5 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 118.131 0.966 . . . . 0.0 110.507 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -75.18 169.58 22.22 Favored 'Trans proline' 0 CA--C 1.544 0.992 0 C-N-CA 123.172 2.581 . . . . 0.0 109.372 178.531 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -78.69 56.62 6.01 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.374 2.049 . . . . 0.0 110.665 179.376 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -146.78 135.93 22.58 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 129.218 3.007 . . . . 0.0 106.939 -179.137 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 68.9 mm-40 52.73 47.91 23.65 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 127.928 2.491 . . . . 0.0 109.524 -178.348 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 25.9 m-80 -153.0 136.44 15.87 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 121.785 -0.572 . . . . 0.0 109.754 179.435 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 54.4 ttm-85 -151.92 134.91 15.72 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 126.558 1.943 . . . . 0.0 105.891 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 19.6 tp -87.74 140.83 29.11 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 124.09 0.956 . . . . 0.0 109.484 -178.348 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.2 mm -132.7 144.7 35.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 125.655 1.582 . . . . 0.0 109.355 -178.502 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -138.36 121.27 16.58 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 177.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.22 40.59 26.44 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.463 1.105 . . . . 0.0 110.55 -179.257 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.13 -16.13 18.32 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 125.264 1.412 . . . . 0.0 113.85 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.0 ttmt -79.05 128.93 33.89 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 119.832 1.816 . . . . 0.0 109.014 -179.095 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.0 mp0 -74.26 134.36 42.65 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.0 mt -117.93 154.98 31.01 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.826 1.25 . . . . 0.0 109.537 -179.33 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -162.5 176.91 9.96 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 126.803 2.041 . . . . 0.0 107.404 177.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -71.44 161.59 30.8 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.205 1.402 . . . . 0.0 112.285 -178.008 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 108.43 -28.98 10.56 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 127.386 2.422 . . . . 0.0 108.049 -178.122 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 46.2 mtt180 -107.62 169.83 8.35 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 124.934 1.294 . . . . 0.0 110.473 178.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 80.8 p -123.84 169.45 11.56 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 127.161 2.184 . . . . 0.0 110.178 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.9 mp -53.01 -42.07 65.29 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 123.064 0.545 . . . . 0.0 111.259 177.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.4 t -59.31 -44.96 92.5 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.595 1.158 . . . . 0.0 109.916 -179.465 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -58.96 -46.37 88.22 Favored 'General case' 0 C--N 1.341 0.233 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -81.35 1.32 33.31 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -179.31 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 36.9 t30 54.31 45.91 26.25 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.199 1.799 . . . . 0.0 111.228 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 81.3 mt -87.98 123.4 40.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 87.5 mm-40 -95.1 175.16 6.73 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.43 0.633 . . . . 0.0 111.203 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -70.99 157.11 38.77 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.386 0.674 . . . . 0.0 109.201 178.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 54.1 35.37 22.12 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.441 1.496 . . . . 0.0 110.958 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.9 p -87.2 162.12 17.65 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.529 1.132 . . . . 0.0 109.19 178.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.1 m -124.96 107.93 11.35 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 122.365 1.079 . . . . 0.0 109.539 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.2 mp -96.44 160.46 14.39 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.734 1.214 . . . . 0.0 108.802 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -119.07 160.7 21.57 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.709 1.204 . . . . 0.0 111.745 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 25.6 mt -123.08 124.61 43.49 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.987 1.715 . . . . 0.0 108.16 179.467 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.9 m -141.1 167.9 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 124.775 1.23 . . . . 0.0 113.174 -179.19 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.83 -170.98 3.25 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.262 1.425 . . . . 0.0 110.076 177.457 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -155.23 132.75 11.17 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 103.339 -2.837 . . . . 0.0 103.339 178.665 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.445 HD23 ' H ' ' A' ' 75' ' ' GLY . 0.5 OUTLIER -147.66 131.62 17.17 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 105.297 -2.112 . . . . 0.0 105.297 -179.396 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 50.0 mmm-85 -105.03 -10.93 16.87 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 118.577 -0.725 . . . . 0.0 111.324 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.445 ' H ' HD23 ' A' ' 73' ' ' LEU . . . -86.52 19.1 30.03 Favored Glycine 0 CA--C 1.537 1.421 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 177.65 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.991 0 C-N-CA 129.136 3.255 . . . . 0.0 105.061 -179.947 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.469 0.481 0 N-CA-C 111.25 0.093 . . . . 0.0 111.25 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -121.48 157.57 30.33 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 176.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.0 pt -132.37 169.96 20.88 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 C-N-CA 125.287 1.435 . . . . 0.0 108.346 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -126.24 149.53 49.02 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 124.925 1.29 . . . . 0.0 107.89 178.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.5 t -139.62 131.48 34.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -97.6 117.78 32.65 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.3 p -83.27 168.79 16.37 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.027 0.931 . . . . 0.0 110.976 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.9 -5.0 22.99 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.582 0.753 . . . . 0.0 112.632 178.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.0 p -93.28 -14.14 27.36 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 177.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.18 7.13 57.45 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 124.903 1.24 . . . . 0.0 111.349 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.82 163.95 23.06 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 119.084 1.442 . . . . 0.0 107.567 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.2 m -120.5 137.42 54.37 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 103.629 -2.73 . . . . 0.0 103.629 178.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.2 mm -114.69 157.02 15.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 38.1 m -134.73 124.26 24.95 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 127.954 2.502 . . . . 0.0 104.343 178.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 29.5 mt -139.93 150.81 45.0 Favored 'General case' 0 CA--C 1.515 -0.373 0 C-N-CA 124.79 1.236 . . . . 0.0 111.589 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -98.25 119.01 36.17 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 127.274 2.23 . . . . 0.0 106.519 178.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.0 m -134.09 -171.19 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 125.949 1.7 . . . . 0.0 108.287 -179.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -142.38 161.17 51.52 Favored Pre-proline 0 CA--C 1.536 0.437 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -61.25 -18.01 56.16 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.442 2.095 . . . . 0.0 112.899 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.8 m -114.96 30.97 6.99 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 124.216 1.007 . . . . 0.0 111.402 -177.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -93.06 130.95 38.49 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 126.277 1.831 . . . . 0.0 106.825 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.3 p -77.15 158.18 30.54 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 119.775 1.171 . . . . 0.0 110.301 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.7 mm -63.61 -30.72 50.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -61.24 -37.36 82.81 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 119.348 0.976 . . . . 0.0 111.554 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -73.46 -53.33 10.89 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 123.94 0.896 . . . . 0.0 108.591 179.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.2 t -55.94 -38.16 51.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 123.035 0.534 . . . . 0.0 110.723 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.8 ttpt -75.14 -16.55 60.52 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 118.172 -0.918 . . . . 0.0 110.952 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.69 -45.38 14.53 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 177.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.6 mttm -50.98 -40.17 57.19 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.953 1.301 . . . . 0.0 112.105 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.3 pt -64.71 -27.29 42.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 O-C-N 120.978 -1.076 . . . . 0.0 111.001 179.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -76.6 -22.81 53.7 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 119.399 0.999 . . . . 0.0 109.162 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.76 -40.17 63.68 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.296 87.1 mttt -92.42 -15.32 27.35 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-O 117.435 -1.269 . . . . 0.0 114.257 -179.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -140.46 150.58 43.98 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 121.881 2.128 . . . . 0.0 106.682 178.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -83.47 87.15 1.5 Allowed Glycine 0 C--N 1.334 0.428 0 CA-C-O 118.977 -0.902 . . . . 0.0 111.782 -178.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.5 pt -137.46 108.22 8.62 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 124.271 1.028 . . . . 0.0 111.45 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -69.83 170.13 17.39 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 124.786 3.657 . . . . 0.0 110.733 178.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -82.39 54.72 5.05 Favored 'Trans proline' 0 CA--C 1.547 1.143 0 N-CA-C 107.827 -1.644 . . . . 0.0 107.827 177.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -150.53 135.91 17.94 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 127.898 2.479 . . . . 0.0 105.519 -178.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 54.7 mm-40 53.03 46.47 26.69 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 128.024 2.53 . . . . 0.0 106.175 -176.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -156.38 135.93 12.37 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.231 1.012 . . . . 0.0 111.919 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.1 ttm-85 -154.93 136.08 13.93 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 127.13 2.172 . . . . 0.0 105.995 178.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 23.7 tp -87.97 137.37 32.39 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.643 0.777 . . . . 0.0 109.481 -178.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.4 mm -135.3 148.57 28.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 125.644 1.578 . . . . 0.0 108.796 -178.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -138.51 121.13 16.26 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 178.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.0 33.52 12.04 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 119.315 0.961 . . . . 0.0 111.353 -179.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.15 -7.79 62.66 Favored Glycine 0 CA--C 1.532 1.099 0 O-C-N 121.298 -0.876 . . . . 0.0 113.123 -179.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.2 tpmt? -78.64 118.11 20.43 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 104.743 -2.317 . . . . 0.0 104.743 179.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.5 mp0 -74.95 133.0 41.82 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.2 mt -114.12 155.47 25.96 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.558 1.143 . . . . 0.0 109.837 -178.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -157.25 174.72 15.02 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.458 1.503 . . . . 0.0 108.161 178.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -73.73 159.8 32.44 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.401 1.48 . . . . 0.0 112.327 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 106.07 -27.53 17.03 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 126.46 1.981 . . . . 0.0 109.526 -178.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 46.0 mtt180 -107.39 169.26 8.69 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 118.124 0.962 . . . . 0.0 110.689 178.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 80.4 p -119.02 168.95 10.33 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 126.268 1.827 . . . . 0.0 110.72 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.8 mp -52.4 -42.89 64.43 Favored 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 123.625 0.77 . . . . 0.0 112.784 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 68.9 m -65.81 -32.63 74.27 Favored 'General case' 0 N--CA 1.462 0.125 0 CA-C-N 118.929 0.786 . . . . 0.0 112.535 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -64.09 -44.38 92.5 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -81.45 1.61 32.42 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.592 1.157 . . . . 0.0 111.519 178.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 55.45 46.73 22.59 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 127.167 2.187 . . . . 0.0 112.326 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 15.0 mt -96.18 123.78 48.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 86.8 mm-40 -101.24 178.25 4.71 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.978 1.311 . . . . 0.0 110.609 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.1 pttt -64.47 156.65 28.9 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 122.87 0.468 . . . . 0.0 111.279 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 48.43 41.06 16.13 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.386 2.274 . . . . 0.0 112.585 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.5 p -87.2 153.79 21.22 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.408 1.083 . . . . 0.0 108.082 177.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 14.4 m -118.72 114.57 22.92 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.5 mp -101.07 168.29 9.69 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.786 1.635 . . . . 0.0 110.861 -178.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.7 m80 -119.96 154.76 34.01 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 127.106 2.162 . . . . 0.0 109.327 178.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 16.7 mt -123.44 125.08 44.29 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 178.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.4 m -139.79 166.15 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 CA-C-N 120.789 1.631 . . . . 0.0 113.436 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.464 0.259 0 C-N-CA 125.983 1.713 . . . . 0.0 110.898 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.3 ttt . . . . . 0 N--CA 1.473 0.676 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -120.77 158.72 26.92 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 114.668 1.359 . . . . 0.0 114.668 -177.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.9 pp -131.57 168.78 23.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 176.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -126.66 149.79 49.33 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 125.262 1.425 . . . . 0.0 108.106 179.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.8 t -138.68 125.47 25.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -89.99 116.39 28.0 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 103.085 -2.932 . . . . 0.0 103.085 177.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.5 p -72.55 168.75 17.93 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 122.574 1.178 . . . . 0.0 113.294 -178.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -67.75 -12.64 60.98 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 114.648 -1.16 . . . . 0.0 111.094 178.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 65.9 p -102.64 -12.56 17.61 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.771 1.169 . . . . 0.0 110.882 179.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.61 7.31 34.37 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 124.883 1.23 . . . . 0.0 114.89 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.2 mmmm -80.88 165.24 22.0 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 120.069 1.935 . . . . 0.0 108.053 178.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 83.7 m -119.06 130.4 55.6 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 104.233 -2.506 . . . . 0.0 104.233 178.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.0 mm -115.78 154.2 17.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 125.398 1.479 . . . . 0.0 107.775 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.2 m -135.13 128.59 32.43 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 178.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 74.4 mt -139.8 150.47 44.76 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 118.678 0.672 . . . . 0.0 111.05 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -94.32 118.48 31.66 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.231 1.412 . . . . 0.0 107.771 178.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.8 m -134.57 179.23 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 126.581 1.953 . . . . 0.0 108.461 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -147.98 162.69 30.22 Favored Pre-proline 0 CA--C 1.536 0.42 0 O-C-N 120.908 -1.12 . . . . 0.0 109.401 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -51.95 -22.56 14.55 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.773 2.982 . . . . 0.0 115.572 -179.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.6 t -114.6 30.92 6.98 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 119.951 1.251 . . . . 0.0 111.051 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -95.22 129.4 42.36 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 103.759 -2.682 . . . . 0.0 103.759 177.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.6 p -76.74 159.53 30.08 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 118.775 0.716 . . . . 0.0 109.764 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 39.8 mm -58.98 -26.0 31.41 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 CA-C-O 118.611 -0.709 . . . . 0.0 110.084 178.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -64.28 -46.18 84.79 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 125.108 1.363 . . . . 0.0 109.645 178.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.5 m-80 -62.22 -52.51 63.46 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.3 t -57.18 -37.36 55.55 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 122.725 0.41 . . . . 0.0 109.922 178.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.7 ttpt -75.02 -19.84 59.89 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 120.903 -1.123 . . . . 0.0 110.547 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.29 -45.36 26.5 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 104.908 -2.256 . . . . 0.0 104.908 177.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.6 mttm -54.53 -43.29 71.8 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.156 1.382 . . . . 0.0 111.385 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.1 pt -63.81 -28.24 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-N 120.148 1.34 . . . . 0.0 110.456 178.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -76.16 -22.64 55.16 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 119.926 1.239 . . . . 0.0 110.897 -179.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.27 -23.24 51.2 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 177.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -99.56 -23.96 14.91 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 114.387 1.255 . . . . 0.0 114.387 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -152.37 149.54 28.73 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 178.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -88.78 87.15 1.47 Allowed Glycine 0 CA--C 1.519 0.296 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.2 pt -132.23 107.4 13.54 Favored Pre-proline 0 CA--C 1.539 0.548 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.23 156.86 15.45 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.062 2.508 . . . . 0.0 113.315 -179.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -83.31 55.96 5.25 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.572 2.181 . . . . 0.0 107.763 178.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -156.6 137.53 13.49 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 128.585 2.754 . . . . 0.0 106.165 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 50.56 45.27 26.84 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 127.405 2.282 . . . . 0.0 108.228 -178.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -157.75 135.46 10.59 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 129.042 2.937 . . . . 0.0 106.212 178.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.7 ttm105 -151.66 141.06 21.52 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 121.424 1.92 . . . . 0.0 106.539 177.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.416 ' O ' HD13 ' A' ' 44' ' ' ILE . 0.5 OUTLIER -88.25 140.19 29.73 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 124.393 1.077 . . . . 0.0 109.48 -178.966 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.416 HD13 ' O ' ' A' ' 43' ' ' LEU . 3.9 mm -135.49 146.41 29.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 125.275 1.43 . . . . 0.0 108.887 -179.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -135.82 115.09 12.48 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 125.005 1.322 . . . . 0.0 108.679 178.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.88 41.25 14.23 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.281 1.432 . . . . 0.0 111.771 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.17 -14.95 52.02 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 125.696 1.617 . . . . 0.0 113.959 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.6 tpmt? -79.69 124.82 28.91 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -74.44 137.06 42.38 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 178.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.6 mt -114.01 142.21 46.45 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -152.8 176.28 11.97 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.661 1.984 . . . . 0.0 107.86 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -72.57 159.81 33.3 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 125.457 1.503 . . . . 0.0 111.089 -178.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 105.99 -29.14 11.68 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 127.769 2.604 . . . . 0.0 110.618 -178.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.343 34.3 mtm105 -109.91 168.41 9.44 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 60.9 p -120.49 171.31 8.63 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 126.702 2.001 . . . . 0.0 111.504 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.2 mp -51.26 -41.5 60.43 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 124.358 1.063 . . . . 0.0 111.674 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 11.4 t -59.17 -45.78 90.12 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.418 1.487 . . . . 0.0 110.422 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -62.21 -44.51 96.4 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.969 0.908 . . . . 0.0 110.615 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -82.16 -2.04 50.89 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.926 0.891 . . . . 0.0 112.833 -179.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 40.8 t30 53.7 46.34 26.12 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 126.237 1.815 . . . . 0.0 110.631 -179.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 93.2 mt -85.02 123.23 39.05 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.153 0 N-CA-C 104.6 -2.37 . . . . 0.0 104.6 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 92.8 mm-40 -89.27 166.79 13.55 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.606 -178.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 46.6 pttt -64.44 155.39 32.77 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.007 178.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 45.33 34.67 1.56 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 128.338 2.655 . . . . 0.0 112.179 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 51.6 m -77.3 160.57 28.75 Favored 'General case' 0 N--CA 1.462 0.174 0 O-C-N 120.908 -1.12 . . . . 0.0 111.42 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.9 m -115.15 113.66 24.27 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.5 mp -108.68 163.51 13.19 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.72 1.608 . . . . 0.0 109.763 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -119.39 162.33 18.99 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.605 1.162 . . . . 0.0 112.131 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.2 mt -121.42 129.91 53.28 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 126.434 1.894 . . . . 0.0 106.37 178.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.4 m -135.42 173.06 14.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 C-N-CA 125.0 1.32 . . . . 0.0 108.695 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.4 pp . . . . . 0 N--CA 1.455 -0.22 0 C-N-CA 123.69 0.796 . . . . 0.0 110.271 179.455 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.9 ttt . . . . . 0 CA--C 1.514 -0.431 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -120.6 156.95 30.56 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.2 pt -132.85 169.8 21.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.553 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 177.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -124.9 152.45 44.05 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 125.799 1.64 . . . . 0.0 108.23 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.4 t -138.33 125.13 26.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 178.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -90.64 116.25 28.38 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 104.035 -2.58 . . . . 0.0 104.035 178.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 44.1 p -72.42 166.81 21.83 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.317 0.579 . . . . 0.0 110.291 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -67.48 -12.08 59.44 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.199 178.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.7 p -96.78 -12.71 23.31 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 127.693 2.397 . . . . 0.0 112.273 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.57 6.43 56.41 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 125.895 1.712 . . . . 0.0 114.074 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -82.99 165.47 19.63 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-N 118.954 1.377 . . . . 0.0 107.322 178.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 43.6 m -123.07 132.43 54.1 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.7 mm -107.17 155.47 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 179.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.1 m -132.86 130.38 39.68 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 103.76 -2.682 . . . . 0.0 103.76 178.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 76.1 mt -139.6 150.52 45.09 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -100.56 118.49 36.84 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 104.189 -2.523 . . . . 0.0 104.189 178.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.6 m -131.89 -170.74 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 125.036 1.334 . . . . 0.0 109.937 -178.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -147.34 159.29 42.41 Favored Pre-proline 0 CA--C 1.534 0.345 0 O-C-N 121.007 -1.058 . . . . 0.0 109.972 178.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -56.8 -23.58 51.08 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.971 2.447 . . . . 0.0 114.856 -179.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 43.5 m -115.24 32.59 5.95 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.676 0.79 . . . . 0.0 111.124 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -92.83 129.63 38.69 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 104.125 -2.546 . . . . 0.0 104.125 178.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.1 p -77.18 159.5 29.67 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 119.777 1.171 . . . . 0.0 111.833 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.1 mm -63.59 -30.73 50.62 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -56.39 -39.52 73.12 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.823 0.849 . . . . 0.0 110.551 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -74.79 -55.53 5.74 Favored 'General case' 0 C--O 1.224 -0.275 0 C-N-CA 123.486 0.714 . . . . 0.0 109.339 178.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.6 t -54.02 -46.18 65.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 124.819 1.248 . . . . 0.0 113.068 -177.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -75.0 -15.64 60.65 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.612 0.765 . . . . 0.0 111.137 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.59 -41.63 11.87 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 177.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.0 mttm -53.77 -40.56 66.35 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.231 1.012 . . . . 0.0 110.573 179.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 29.2 pt -60.45 -27.22 39.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-O 118.128 -0.939 . . . . 0.0 111.16 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -80.43 -20.17 44.5 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.099 1.36 . . . . 0.0 111.087 179.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -88.46 -24.3 23.03 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.974 1.31 . . . . 0.0 109.11 178.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 32.7 tptt -99.0 -20.54 16.7 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.122 1.769 . . . . 0.0 112.389 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -144.37 150.28 37.51 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.838 2.055 . . . . 0.0 106.174 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -82.28 82.37 1.63 Allowed Glycine 0 C--N 1.333 0.374 0 CA-C-O 118.793 -1.004 . . . . 0.0 111.784 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.7 pt -131.18 108.29 15.0 Favored Pre-proline 0 CA--C 1.546 0.796 0 CA-C-N 118.413 1.107 . . . . 0.0 109.866 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -58.66 155.96 34.55 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.98 3.12 . . . . 0.0 114.001 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -86.2 57.17 3.95 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 123.469 2.779 . . . . 0.0 106.624 177.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -146.15 136.68 24.05 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 129.471 3.109 . . . . 0.0 103.726 -178.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.4 pt20 48.01 50.92 15.28 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.468 1.507 . . . . 0.0 112.29 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -145.41 148.71 33.63 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 121.052 -1.03 . . . . 0.0 110.371 179.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -154.59 135.04 13.37 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 125.14 1.376 . . . . 0.0 109.514 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 54.9 tp -89.08 136.55 32.95 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 125.106 1.362 . . . . 0.0 110.178 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.3 mm -133.92 145.88 32.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 125.24 1.416 . . . . 0.0 111.08 -178.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -138.92 126.47 21.84 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 176.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.58 34.76 16.36 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.708 1.203 . . . . 0.0 111.719 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.32 -8.02 59.35 Favored Glycine 0 CA--C 1.531 1.033 0 O-C-N 120.919 -1.113 . . . . 0.0 114.203 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.2 mmtp -92.17 130.37 37.9 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 125.864 1.666 . . . . 0.0 109.169 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -73.68 136.37 43.78 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.794 0.838 . . . . 0.0 108.868 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.9 mt -115.19 150.43 36.11 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 179.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -152.09 176.31 11.67 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -72.18 156.23 39.38 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 122.112 0.958 . . . . 0.0 110.555 -178.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.98 -21.14 30.06 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 126.416 1.96 . . . . 0.0 109.855 -178.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 40.3 mmt-85 -107.12 169.38 8.59 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.364 1.466 . . . . 0.0 111.948 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.9 p -123.65 167.59 13.77 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.905 1.682 . . . . 0.0 111.327 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -52.41 -47.22 66.41 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.158 0.983 . . . . 0.0 112.39 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.2 t -65.26 -31.43 72.57 Favored 'General case' 0 C--O 1.227 -0.115 0 C-N-CA 123.77 0.828 . . . . 0.0 112.763 -179.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -59.6 -47.36 85.87 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 119.996 1.271 . . . . 0.0 109.271 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -82.09 0.69 39.44 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.22 0.608 . . . . 0.0 110.236 178.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.5 t30 53.96 47.49 23.32 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 127.639 2.376 . . . . 0.0 110.646 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.5 mt -85.26 122.5 38.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 104.318 -2.475 . . . . 0.0 104.318 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -92.83 175.35 6.83 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.289 0.566 . . . . 0.0 110.189 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.8 pttt -64.71 156.76 29.36 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.293 0.568 . . . . 0.0 110.295 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 52.72 35.34 18.21 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 128.252 2.621 . . . . 0.0 111.608 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 72.3 m -85.82 158.22 20.03 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 120.848 -1.157 . . . . 0.0 109.467 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 28.3 m -119.16 120.35 36.83 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.612 1.165 . . . . 0.0 110.246 -178.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.2 mp -107.36 162.69 13.69 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.865 1.666 . . . . 0.0 110.722 -179.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -119.91 160.59 22.41 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 126.008 1.723 . . . . 0.0 111.616 179.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 90.4 mt -123.64 131.9 53.73 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.427 1.491 . . . . 0.0 110.257 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.4 m -140.5 161.7 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-N 119.63 1.104 . . . . 0.0 111.19 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.466 0.364 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.5 ttt . . . . . 0 CA--C 1.509 -0.618 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -119.29 145.64 45.95 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 124.279 0.987 . . . . 0.0 109.734 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.2 pt -134.17 169.7 21.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 C-N-CA 125.288 1.435 . . . . 0.0 108.077 177.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -124.47 149.91 46.31 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.882 1.673 . . . . 0.0 110.47 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.6 t -139.77 131.57 33.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 177.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -97.58 117.14 31.18 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 105.426 -2.065 . . . . 0.0 105.426 177.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 41.6 p -74.29 165.85 24.47 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 118.522 0.601 . . . . 0.0 111.067 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.452 HD23 HG23 ' A' ' 9' ' ' THR . 1.1 pt? -67.63 -10.54 53.08 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.32 178.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.452 HG23 HD23 ' A' ' 8' ' ' LEU . 77.2 p -91.71 -12.46 33.97 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.569 1.547 . . . . 0.0 110.66 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.1 5.88 57.09 Favored Glycine 0 C--N 1.34 0.791 0 C-N-CA 126.177 1.846 . . . . 0.0 112.9 179.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.8 164.04 23.01 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 119.151 1.475 . . . . 0.0 107.801 179.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 50.1 m -114.08 133.57 55.45 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 102.599 -3.111 . . . . 0.0 102.599 177.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 40.1 mm -114.57 157.87 15.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 C-N-CA 125.849 1.66 . . . . 0.0 107.837 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.6 m -131.36 130.8 43.11 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 128.823 2.849 . . . . 0.0 104.886 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.646 HD11 HG23 ' A' ' 30' ' ' ILE . 12.8 mt -140.17 144.47 36.65 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 124.018 0.927 . . . . 0.0 110.349 179.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -105.26 110.5 22.89 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 127.382 2.273 . . . . 0.0 105.621 177.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.1 m -134.34 -169.16 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -141.8 160.6 55.4 Favored Pre-proline 0 C--O 1.238 0.459 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -56.43 -18.55 25.51 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.734 2.29 . . . . 0.0 113.386 178.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 39.1 m -115.66 30.43 7.35 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 119.023 0.828 . . . . 0.0 112.991 -178.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -94.74 134.17 37.63 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 104.993 -2.225 . . . . 0.0 104.993 177.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.1 p -73.54 157.55 36.51 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 119.07 -1.052 . . . . 0.0 109.204 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.2 mm -64.1 -26.29 40.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 177.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -56.58 -42.06 78.0 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.82 1.248 . . . . 0.0 109.647 179.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -74.14 -54.93 6.75 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 123.786 0.834 . . . . 0.0 109.73 178.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.7 t -54.32 -40.03 46.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -178.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -75.68 -16.28 60.2 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.395 0.678 . . . . 0.0 111.015 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.58 -41.73 11.82 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.395 1.078 . . . . 0.0 109.142 178.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.0 mttm -53.17 -40.46 64.36 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 118.727 0.694 . . . . 0.0 110.129 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.646 HG23 HD11 ' A' ' 15' ' ' LEU . 38.3 pt -62.3 -26.88 41.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 O-C-N 120.703 -1.248 . . . . 0.0 111.665 179.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -76.53 -20.11 57.23 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.344 1.058 . . . . 0.0 109.575 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.18 -39.43 40.82 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 177.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.3 mttm -88.59 -16.25 33.01 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 -178.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -141.41 150.54 42.48 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 179.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -87.08 85.65 1.54 Allowed Glycine 0 CA--C 1.52 0.392 0 O-C-N 121.419 -0.801 . . . . 0.0 111.987 -178.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.0 pt -134.18 107.97 11.38 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 124.608 1.163 . . . . 0.0 108.149 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -69.29 168.46 20.87 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 124.197 3.265 . . . . 0.0 113.755 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -82.35 56.83 5.91 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 122.975 2.45 . . . . 0.0 108.427 177.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -154.1 136.57 15.04 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 129.695 3.198 . . . . 0.0 103.713 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 62.4 mm-40 53.76 50.17 17.61 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.441 1.096 . . . . 0.0 108.333 -178.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -142.0 134.43 28.02 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -178.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 47.5 ttm-85 -159.56 132.27 6.74 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 30.6 tp -99.4 137.25 38.16 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 124.218 1.007 . . . . 0.0 109.47 -178.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.5 mm -135.06 141.9 41.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.235 1.014 . . . . 0.0 109.305 -178.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -138.99 126.1 21.26 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.02 33.22 14.35 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.027 0.531 . . . . 0.0 110.674 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.42 -16.21 19.58 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 124.74 1.162 . . . . 0.0 112.73 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -79.35 126.52 30.92 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 119.33 1.565 . . . . 0.0 108.133 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.7 mp0 -75.61 137.12 40.55 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.102 -1.074 . . . . 0.0 108.102 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.6 mt -114.26 154.64 27.59 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.716 1.207 . . . . 0.0 108.794 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -162.47 175.25 11.69 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 179.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -72.76 160.96 31.35 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 126.879 2.072 . . . . 0.0 114.078 -177.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.47 -29.39 12.0 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 127.578 2.513 . . . . 0.0 109.081 -178.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 50.0 mtt180 -107.95 169.01 8.88 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 117.979 0.89 . . . . 0.0 110.961 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 37.5 p -117.5 171.58 7.91 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.488 1.115 . . . . 0.0 112.033 -178.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.7 mp -52.2 -41.77 62.97 Favored 'General case' 0 C--O 1.227 -0.128 0 C-N-CA 123.572 0.749 . . . . 0.0 111.157 178.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.1 t -59.21 -46.0 89.62 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.559 1.544 . . . . 0.0 109.983 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -64.2 -39.66 94.45 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 123.533 0.733 . . . . 0.0 110.152 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -84.68 -0.69 54.44 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.54 0.736 . . . . 0.0 111.487 179.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 61.3 t30 53.85 46.12 26.38 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.887 2.075 . . . . 0.0 112.383 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 84.6 mt -93.7 126.09 46.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 -179.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -100.48 172.68 6.97 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 123.963 0.905 . . . . 0.0 111.19 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 49.2 pttt -66.62 156.77 34.22 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 54.92 35.58 24.78 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.511 1.524 . . . . 0.0 111.778 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.0 p -86.79 158.53 19.35 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 120.323 -1.486 . . . . 0.0 107.485 177.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 26.7 m -126.12 119.91 28.79 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 178.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.7 mp -106.06 169.53 8.44 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.252 1.021 . . . . 0.0 110.873 -179.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 21.4 m80 -118.54 153.07 34.82 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.865 1.666 . . . . 0.0 108.694 178.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 17.9 mt -123.03 126.47 47.17 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.866 1.666 . . . . 0.0 106.72 178.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.1 m -139.03 172.61 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 124.538 1.135 . . . . 0.0 111.367 -178.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.532 0.276 0 C-N-CA 125.251 1.42 . . . . 0.0 108.085 177.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 ttt . . . . . 0 N--CA 1.467 0.424 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -121.0 151.66 39.49 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 177.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 28.7 pt -132.84 169.62 21.65 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 178.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -123.13 151.85 41.69 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 124.517 1.127 . . . . 0.0 108.913 179.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 56.7 t -137.32 127.01 37.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 106.56 -1.645 . . . . 0.0 106.56 178.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -94.24 116.56 28.96 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 103.981 -2.6 . . . . 0.0 103.981 177.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.6 p -77.75 168.1 20.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 118.418 0.554 . . . . 0.0 110.335 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -67.23 -12.51 60.25 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.204 1.001 . . . . 0.0 111.512 178.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.5 p -93.74 -12.67 28.65 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.819 1.648 . . . . 0.0 111.129 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.06 7.3 56.39 Favored Glycine 0 CA--C 1.531 1.067 0 O-C-N 121.365 -0.834 . . . . 0.0 111.917 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.8 164.62 22.57 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 119.055 1.428 . . . . 0.0 107.276 179.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.5 m -121.73 131.75 54.25 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 105.05 -2.204 . . . . 0.0 105.05 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.1 mm -114.64 157.18 15.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 105.689 -1.967 . . . . 0.0 105.689 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 56.0 m -134.33 125.47 27.7 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 104.067 -2.568 . . . . 0.0 104.067 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.5 mt -137.73 147.72 44.99 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -104.89 107.11 17.91 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 127.561 2.344 . . . . 0.0 106.322 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.8 m -127.89 -168.45 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 125.791 1.636 . . . . 0.0 109.2 -178.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -141.85 159.53 59.2 Favored Pre-proline 0 N--CA 1.451 -0.377 0 C-N-CA 124.09 0.956 . . . . 0.0 109.654 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -55.44 -17.02 15.29 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.856 3.037 . . . . 0.0 113.004 178.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.7 m -114.23 31.31 6.67 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 124.03 0.932 . . . . 0.0 112.575 -178.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -98.8 132.22 44.32 Favored 'General case' 0 C--O 1.242 0.666 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 176.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -72.66 157.89 36.67 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 119.42 1.009 . . . . 0.0 110.998 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.8 mm -63.71 -29.74 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 177.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -53.37 -48.9 68.19 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.96 1.304 . . . . 0.0 109.729 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 41.6 m-20 -67.83 -52.87 31.83 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.846 0.858 . . . . 0.0 109.551 179.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.2 t -54.04 -42.92 57.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 123.736 0.815 . . . . 0.0 111.381 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 20.0 ttpt -75.53 -16.04 60.32 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 118.432 -0.794 . . . . 0.0 111.094 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -88.07 -43.66 11.52 Favored 'General case' 0 C--O 1.226 -0.165 0 CA-C-N 119.857 1.208 . . . . 0.0 108.244 177.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -50.08 -40.0 44.15 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.0 1.32 . . . . 0.0 110.434 179.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 35.8 pt -66.09 -25.26 35.41 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 O-C-N 121.267 -0.896 . . . . 0.0 112.584 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -76.16 -23.84 54.78 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 120.014 1.279 . . . . 0.0 109.094 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.88 -39.14 57.0 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.243 -0.911 . . . . 0.0 108.641 179.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.0 mttm -89.72 -19.91 24.21 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 115.99 1.848 . . . . 0.0 115.99 -179.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -136.53 158.86 43.45 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 121.819 2.099 . . . . 0.0 108.886 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.01 63.43 4.3 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 110.524 -1.03 . . . . 0.0 110.524 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.5 pt -131.38 107.3 14.62 Favored Pre-proline 0 CA--C 1.538 0.503 0 CA-C-N 117.91 0.855 . . . . 0.0 108.718 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -77.13 169.94 20.55 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 123.925 3.084 . . . . 0.0 109.805 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -76.56 58.64 5.93 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 123.087 2.524 . . . . 0.0 108.19 177.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -146.82 135.41 22.04 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 128.926 2.891 . . . . 0.0 105.319 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.6 mm-40 52.17 48.15 23.28 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.234 1.814 . . . . 0.0 108.368 -177.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -154.85 134.9 13.04 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.526 1.131 . . . . 0.0 109.62 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.0 ttm-85 -151.2 133.52 15.37 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 101.986 -3.339 . . . . 0.0 101.986 178.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.4 tp -87.9 142.01 28.13 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -177.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.2 mm -134.21 144.94 33.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 125.02 1.328 . . . . 0.0 109.584 -178.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -135.54 115.76 13.42 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 177.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.31 42.86 26.36 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.389 1.076 . . . . 0.0 110.692 -179.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.25 -13.93 30.72 Favored Glycine 0 CA--C 1.531 1.037 0 CA-C-O 118.519 -1.156 . . . . 0.0 114.518 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.9 ttmt -79.59 125.87 30.16 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 120.671 2.235 . . . . 0.0 107.554 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.4 mp0 -74.74 136.2 41.76 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 179.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.8 mt -122.34 153.35 39.09 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.618 1.167 . . . . 0.0 109.757 -178.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -160.09 175.69 12.66 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 124.679 1.192 . . . . 0.0 108.755 178.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -71.73 158.17 36.61 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 122.78 1.276 . . . . 0.0 111.86 -177.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 108.59 -29.44 9.94 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 127.448 2.452 . . . . 0.0 108.591 -177.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 46.4 mtt180 -107.75 165.56 11.35 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.0 1.72 . . . . 0.0 111.76 178.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 65.9 p -117.61 173.92 6.45 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.299 1.839 . . . . 0.0 112.655 -178.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.9 mp -52.14 -49.9 62.81 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 123.678 0.791 . . . . 0.0 111.541 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.55 -31.56 72.37 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 112.351 0.501 . . . . 0.0 112.351 -179.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -65.29 -47.15 77.62 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.415 1.007 . . . . 0.0 109.325 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -81.29 -2.5 49.22 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.1 t30 57.68 46.94 16.57 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 130.363 3.465 . . . . 0.0 112.215 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 79.3 mt -85.71 123.19 39.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 105.531 -2.026 . . . . 0.0 105.531 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 75.1 mm-40 -95.47 173.47 7.49 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 123.255 0.622 . . . . 0.0 109.747 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 43.6 pttt -69.72 157.0 38.12 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.116 0.484 . . . . 0.0 110.783 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 53.58 38.8 29.04 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 127.154 2.182 . . . . 0.0 110.992 -179.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.4 p -87.26 163.23 16.98 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.957 1.303 . . . . 0.0 109.459 178.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 93.7 m -126.05 110.22 13.3 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.7 mp -98.5 160.19 14.44 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 126.233 1.813 . . . . 0.0 108.53 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 45.1 m80 -119.28 160.37 22.34 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 124.982 1.313 . . . . 0.0 110.161 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.7 mt -122.82 126.76 48.01 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 104.964 -2.236 . . . . 0.0 104.964 177.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.2 m -140.62 161.45 24.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 CA-C-O 121.447 0.641 . . . . 0.0 110.421 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.237 0.428 0 C-N-CA 124.32 1.048 . . . . 0.0 108.585 177.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.7 ttt . . . . . 0 N--CA 1.47 0.535 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -120.64 151.1 39.91 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 178.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 32.5 pt -132.53 170.08 20.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 C-N-CA 124.929 1.292 . . . . 0.0 108.014 178.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -126.22 150.85 48.09 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.934 1.294 . . . . 0.0 109.005 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.0 t -138.52 133.07 42.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 178.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -103.03 118.35 36.61 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.213 1.005 . . . . 0.0 108.428 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 48.5 p -72.57 171.05 13.15 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.712 0.768 . . . . 0.0 110.059 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -70.45 -12.49 61.61 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.834 -0.541 . . . . 0.0 111.457 177.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.0 p -94.03 -12.1 29.34 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 126.409 1.884 . . . . 0.0 112.627 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.85 7.5 50.43 Favored Glycine 0 C--N 1.339 0.741 0 C-N-CA 124.0 0.81 . . . . 0.0 113.764 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -80.56 164.66 22.77 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 119.017 1.408 . . . . 0.0 107.279 179.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 86.9 m -123.65 132.34 53.83 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 103.523 -2.769 . . . . 0.0 103.523 177.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.5 mm -115.05 148.3 17.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 105.577 -2.009 . . . . 0.0 105.577 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 78.5 m -124.42 126.15 45.46 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 105.312 -2.106 . . . . 0.0 105.312 178.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.6 mt -128.72 150.66 50.17 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 118.339 0.518 . . . . 0.0 110.302 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -101.47 115.54 30.73 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 103.257 -2.868 . . . . 0.0 103.257 178.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.1 m -131.26 -169.92 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 124.415 1.086 . . . . 0.0 109.457 -178.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -143.66 160.84 49.26 Favored Pre-proline 0 N--CA 1.448 -0.568 0 C-N-CA 126.264 1.826 . . . . 0.0 106.591 178.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -58.09 -18.15 34.94 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.864 2.376 . . . . 0.0 113.079 178.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.6 m -116.25 32.95 5.81 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.827 1.251 . . . . 0.0 112.148 -179.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -90.29 128.86 36.53 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 103.187 -2.894 . . . . 0.0 103.187 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.5 p -77.8 159.03 29.28 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 118.965 0.802 . . . . 0.0 112.659 -177.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 23.9 mm -63.56 -29.81 48.23 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.324 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 178.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -59.0 -42.1 89.25 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.2 0.909 . . . . 0.0 110.44 179.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -73.88 -52.75 11.94 Favored 'General case' 0 CA--C 1.521 -0.166 0 C-N-CA 124.665 1.186 . . . . 0.0 109.792 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.4 t -57.44 -38.39 62.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-N 119.62 1.1 . . . . 0.0 110.585 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -74.64 -14.27 60.74 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.208 -0.933 . . . . 0.0 110.592 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.98 -47.19 8.01 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 176.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.6 mttm -49.46 -40.31 36.61 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.333 1.853 . . . . 0.0 111.017 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 36.6 pt -65.69 -28.05 43.09 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-N 118.81 0.732 . . . . 0.0 112.556 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -76.28 -23.06 54.38 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 119.946 1.248 . . . . 0.0 109.742 -178.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.44 -36.3 45.63 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 178.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -86.55 -21.47 26.88 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 114.144 1.164 . . . . 0.0 114.144 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -147.51 150.99 35.6 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 120.99 1.723 . . . . 0.0 106.778 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.1 80.99 1.66 Allowed Glycine 0 CA--C 1.521 0.408 0 CA-C-O 119.244 -0.753 . . . . 0.0 111.846 -179.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.2 pt -133.95 106.14 11.53 Favored Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 106.773 -1.565 . . . . 0.0 106.773 178.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -62.87 166.09 14.85 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 124.571 3.514 . . . . 0.0 115.462 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -83.02 55.9 5.37 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.599 2.199 . . . . 0.0 108.295 177.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -147.26 134.52 20.6 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 128.839 2.856 . . . . 0.0 105.247 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.7 mm-40 47.76 49.36 16.66 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.858 1.663 . . . . 0.0 108.032 -177.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -143.67 134.09 24.71 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 60.3 ttm-85 -156.24 133.82 10.93 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 125.978 1.711 . . . . 0.0 106.868 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 22.1 tp -87.9 140.88 29.06 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -178.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.0 mm -131.53 143.87 39.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 126.036 1.734 . . . . 0.0 109.376 -178.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -138.38 124.58 20.33 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 178.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.79 36.07 20.37 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.464 1.106 . . . . 0.0 110.439 -179.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.18 -14.09 29.48 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 125.343 1.449 . . . . 0.0 113.502 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.1 ttmt -79.57 129.3 34.35 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 119.752 1.776 . . . . 0.0 108.258 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.9 mp0 -74.59 137.42 42.32 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 178.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.422 HD22 ' CD1' ' A' ' 59' ' ' TYR . 7.6 mt -113.21 155.33 25.24 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.252 1.021 . . . . 0.0 108.352 -178.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -151.87 175.15 12.76 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.673 1.189 . . . . 0.0 109.446 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -72.75 157.97 36.48 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 125.229 1.412 . . . . 0.0 111.127 -178.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.17 -21.25 38.22 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 126.226 1.87 . . . . 0.0 110.383 -178.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 39.4 mtt180 -108.28 168.95 8.94 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 118.37 1.085 . . . . 0.0 113.534 178.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 49.0 p -117.45 172.46 7.31 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.945 2.098 . . . . 0.0 111.068 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -51.96 -50.67 60.78 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.286 1.435 . . . . 0.0 112.622 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.06 -31.83 73.25 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 123.021 0.528 . . . . 0.0 112.258 -178.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -60.25 -44.95 94.83 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 119.449 1.022 . . . . 0.0 109.469 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.422 ' CD1' HD22 ' A' ' 50' ' ' LEU . 76.7 m-85 -82.27 1.22 37.78 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.189 0.595 . . . . 0.0 111.085 178.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 57.89 46.84 16.12 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 128.405 2.682 . . . . 0.0 110.794 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.3 mt -85.82 122.64 38.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 105.013 -2.218 . . . . 0.0 105.013 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -97.62 177.46 5.49 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.73 0.812 . . . . 0.0 108.94 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 43.9 pttt -68.19 156.56 37.3 Favored 'General case' 0 C--O 1.239 0.531 0 O-C-N 121.681 -0.637 . . . . 0.0 110.87 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 49.52 35.05 7.62 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.613 1.965 . . . . 0.0 111.088 -178.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.4 p -77.16 158.24 30.49 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 178.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 59.9 m -125.47 110.64 14.15 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.4 mp -96.04 165.67 12.14 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 124.429 1.091 . . . . 0.0 109.814 -178.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 25.3 m80 -118.77 156.34 29.55 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 125.423 1.489 . . . . 0.0 110.19 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 25.7 mt -123.34 124.68 43.5 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 178.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.1 m -139.12 167.75 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.239 0.534 0 C-N-CA 127.154 2.182 . . . . 0.0 109.687 178.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 ttp . . . . . 0 N--CA 1.467 0.394 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -120.69 157.1 30.34 Favored 'General case' 0 CA--C 1.53 0.18 0 O-C-N 121.1 -1.0 . . . . 0.0 112.146 -178.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.3 pt -132.81 169.32 22.23 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 176.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -126.44 152.19 46.72 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.806 1.242 . . . . 0.0 107.822 179.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.9 t -138.96 128.49 30.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.2 tppp? -96.23 117.86 31.63 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 119.081 0.855 . . . . 0.0 109.485 178.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.8 p -81.09 165.62 21.46 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.051 0.94 . . . . 0.0 110.433 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.43 -4.88 12.49 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.062 0.945 . . . . 0.0 113.212 178.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.0 p -92.41 -12.61 31.76 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.487 1.115 . . . . 0.0 110.704 178.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.88 5.93 58.3 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 125.806 1.67 . . . . 0.0 111.434 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.56 164.24 16.2 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.6 m -123.97 142.46 51.14 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 178.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.3 mm -114.79 155.21 16.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 C-N-CA 126.557 1.943 . . . . 0.0 106.169 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 54.8 m -126.23 128.15 46.76 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 104.124 -2.547 . . . . 0.0 104.124 178.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.4 mt -133.21 150.07 51.98 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -105.14 110.97 23.56 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 103.671 -2.715 . . . . 0.0 103.671 178.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.3 m -134.72 -174.78 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -146.44 166.7 15.9 Favored Pre-proline 0 C--N 1.327 -0.372 0 O-C-N 120.842 -1.161 . . . . 0.0 109.508 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -54.27 -18.81 15.07 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.096 2.531 . . . . 0.0 114.034 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.4 m -115.03 31.22 6.83 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 123.922 0.889 . . . . 0.0 112.453 -178.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -99.08 130.05 45.38 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 103.94 -2.615 . . . . 0.0 103.94 176.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.9 p -78.06 158.14 29.3 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 119.425 1.011 . . . . 0.0 111.711 -178.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.3 mm -63.77 -28.27 44.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -57.1 -42.79 81.43 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.881 0.872 . . . . 0.0 109.383 178.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -73.04 -52.54 13.97 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 124.889 1.275 . . . . 0.0 109.417 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.3 t -54.74 -38.42 43.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-N 119.227 0.921 . . . . 0.0 110.764 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -74.82 -15.55 60.73 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 121.252 -0.905 . . . . 0.0 111.642 -179.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.9 -45.27 8.86 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.552 1.541 . . . . 0.0 108.193 176.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.8 mttm -50.44 -40.4 50.31 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.608 1.563 . . . . 0.0 110.406 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 36.1 pt -64.07 -25.34 37.87 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 O-C-N 121.54 -0.725 . . . . 0.0 112.113 178.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -76.27 -23.64 54.45 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 120.145 1.339 . . . . 0.0 109.262 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.99 -36.33 41.5 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.6 mmtt -85.65 -22.11 28.08 Favored 'General case' 0 C--N 1.337 0.061 0 CA-C-O 117.391 -1.29 . . . . 0.0 114.204 -178.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -150.63 158.04 43.68 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 121.582 1.992 . . . . 0.0 108.808 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.7 82.35 1.59 Allowed Glycine 0 C--N 1.333 0.366 0 N-CA-C 111.843 -0.503 . . . . 0.0 111.843 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.4 pt -140.89 106.62 6.3 Favored Pre-proline 0 CA--C 1.543 0.692 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -71.1 169.59 20.2 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 124.763 3.642 . . . . 0.0 112.658 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -78.65 56.91 6.11 Favored 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 123.054 2.503 . . . . 0.0 109.6 177.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -146.84 130.13 16.62 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 127.857 2.463 . . . . 0.0 104.639 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.2 mm-40 51.01 53.52 12.91 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -177.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -143.06 133.1 24.27 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.275 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 55.8 ttm-85 -161.57 133.33 5.58 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 125.853 1.661 . . . . 0.0 107.174 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 24.2 tp -88.64 142.5 27.63 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.309 1.044 . . . . 0.0 109.674 -178.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.7 mm -135.03 144.56 34.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 125.908 1.683 . . . . 0.0 109.955 -178.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -133.45 117.23 16.95 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 106.714 -1.588 . . . . 0.0 106.714 178.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.57 43.46 20.24 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.933 1.293 . . . . 0.0 111.141 -179.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.45 -17.67 13.34 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-O 118.351 -1.249 . . . . 0.0 114.635 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.3 ttmt -79.25 128.71 33.65 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 120.603 2.201 . . . . 0.0 107.149 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.4 mp0 -74.56 136.87 42.11 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.51 HD22 ' CD1' ' A' ' 59' ' ' TYR . 8.9 mt -113.19 155.05 25.71 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -178.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -151.99 175.05 12.91 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 124.381 1.072 . . . . 0.0 109.076 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -73.05 160.03 32.68 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 126.197 1.799 . . . . 0.0 111.412 -179.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.0 -27.51 19.16 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 126.271 1.891 . . . . 0.0 109.85 -178.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.9 mtt180 -107.11 170.52 7.9 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.95 1.3 . . . . 0.0 111.449 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 67.2 p -117.3 171.01 8.25 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 127.108 2.163 . . . . 0.0 111.905 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.21 -48.56 65.03 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.06 0.944 . . . . 0.0 112.419 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.03 -31.72 73.01 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 118.932 -0.556 . . . . 0.0 111.512 -179.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -61.13 -44.03 97.96 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 119.352 0.978 . . . . 0.0 108.696 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.51 ' CD1' HD22 ' A' ' 50' ' ' LEU . 92.7 m-85 -82.0 1.7 34.33 Favored 'General case' 0 C--O 1.237 0.4 0 O-C-N 121.603 -0.686 . . . . 0.0 110.814 178.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 52.9 t30 56.48 47.19 19.25 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 127.087 2.155 . . . . 0.0 110.07 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.5 mt -84.48 122.79 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -178.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 57.2 mm-40 -89.57 169.14 11.6 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.447 -0.797 . . . . 0.0 108.995 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 51.8 pttt -69.18 156.73 38.22 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.012 0.434 . . . . 0.0 111.354 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 49.55 34.2 6.69 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 128.407 2.683 . . . . 0.0 111.5 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.2 p -80.17 163.95 23.68 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.2 m -125.31 112.51 16.45 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.1 mp -96.19 168.14 10.77 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.961 1.304 . . . . 0.0 108.666 -179.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.3 m80 -119.64 154.92 33.27 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.155 1.382 . . . . 0.0 109.878 179.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 18.1 mt -123.22 123.47 40.85 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 103.866 -2.642 . . . . 0.0 103.866 177.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.7 m -141.59 170.96 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-N 120.06 1.3 . . . . 0.0 113.635 -179.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.235 0.332 0 C-N-CA 126.354 1.862 . . . . 0.0 109.576 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.8 ttt . . . . . 0 N--CA 1.471 0.59 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -120.82 157.14 30.4 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 178.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.7 pt -132.69 169.4 22.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 178.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -126.13 151.01 47.83 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.2 t -138.52 129.6 35.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 179.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.4 tppt? -96.24 119.08 34.09 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 177.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 45.7 p -71.15 167.25 19.73 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 118.663 0.665 . . . . 0.0 109.352 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -67.72 -12.96 61.65 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 119.201 -0.428 . . . . 0.0 111.191 178.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.4 p -94.1 -12.48 28.39 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.815 1.246 . . . . 0.0 111.273 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.41 7.77 48.19 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-N 118.845 0.748 . . . . 0.0 113.524 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.22 164.82 23.87 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 104.507 -2.405 . . . . 0.0 104.507 178.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 45.1 m -123.2 131.21 53.6 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 -179.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.8 mm -116.28 155.25 17.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 127.531 2.332 . . . . 0.0 107.802 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.6 m -135.18 130.4 35.29 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 128.146 2.578 . . . . 0.0 105.428 178.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 79.5 mt -139.01 151.27 46.69 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.722 1.147 . . . . 0.0 110.84 -179.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -102.28 117.94 35.82 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 179.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.7 m -131.28 -170.67 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 124.622 1.169 . . . . 0.0 109.982 -177.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -144.1 160.66 48.5 Favored Pre-proline 0 C--O 1.238 0.494 0 N-CA-C 106.517 -1.661 . . . . 0.0 106.517 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -57.96 -17.98 33.26 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.461 2.108 . . . . 0.0 112.941 178.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 29.3 m -114.64 31.62 6.52 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 119.219 0.918 . . . . 0.0 111.464 -178.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -91.27 129.42 37.26 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 101.302 -3.592 . . . . 0.0 101.302 177.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.0 p -71.03 158.25 36.83 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 121.392 -0.817 . . . . 0.0 109.439 -178.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.0 mm -63.33 -29.35 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 178.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -56.27 -49.32 74.53 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 126.045 1.738 . . . . 0.0 108.834 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 20.1 m-80 -65.43 -52.15 55.26 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 124.67 1.188 . . . . 0.0 109.552 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 84.4 t -54.05 -44.03 61.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 123.328 0.651 . . . . 0.0 110.744 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 24.2 ttpt -75.57 -12.83 60.3 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.279 1.032 . . . . 0.0 112.166 -178.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.04 -46.93 8.16 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.608 1.563 . . . . 0.0 107.513 177.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.4 mttm -50.98 -40.51 58.06 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.405 1.482 . . . . 0.0 110.418 179.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 43.3 pt -64.58 -25.69 38.48 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 O-C-N 121.334 -0.854 . . . . 0.0 112.31 178.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -76.35 -22.77 54.46 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 120.598 1.545 . . . . 0.0 109.262 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -82.27 -22.94 35.53 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.737 1.215 . . . . 0.0 108.607 177.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.1 mmtt -97.68 -16.01 20.14 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 120.481 -1.387 . . . . 0.0 114.347 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -152.04 160.68 43.39 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 121.116 1.78 . . . . 0.0 107.063 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.02 70.98 2.97 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.8 pt -130.8 108.27 15.52 Favored Pre-proline 0 CA--C 1.543 0.703 0 CA-C-N 117.988 0.894 . . . . 0.0 110.752 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -77.82 169.74 20.18 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.822 3.015 . . . . 0.0 110.092 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -79.19 57.0 6.27 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.855 2.37 . . . . 0.0 109.195 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -150.61 135.32 17.38 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 127.206 2.203 . . . . 0.0 105.862 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 55.2 mm-40 53.89 48.78 20.49 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.799 1.64 . . . . 0.0 106.788 -177.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -146.19 143.07 29.03 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 123.711 0.805 . . . . 0.0 110.535 -178.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 43.9 ttm-85 -162.3 134.06 5.38 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.879 1.218 . . . . 0.0 108.289 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 18.9 tp -93.21 140.01 29.99 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.627 1.171 . . . . 0.0 111.204 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.5 mm -135.54 145.35 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 126.229 1.812 . . . . 0.0 108.816 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -139.11 119.77 14.12 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.923 1.289 . . . . 0.0 108.376 178.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.72 35.2 17.85 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.233 1.013 . . . . 0.0 111.151 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.55 -13.75 33.42 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 124.887 1.232 . . . . 0.0 113.248 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.5 ttmt -80.56 129.76 34.71 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 119.484 1.642 . . . . 0.0 107.746 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.8 mp0 -74.47 134.05 42.33 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 51.6 mt -114.01 148.96 36.1 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.576 1.15 . . . . 0.0 108.571 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -151.55 176.73 11.05 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 124.868 1.267 . . . . 0.0 108.217 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.29 160.59 32.14 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.793 1.637 . . . . 0.0 111.767 -177.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.32 -25.6 26.48 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 125.53 1.538 . . . . 0.0 111.243 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 42.7 mtt180 -108.09 168.85 9.0 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.554 1.141 . . . . 0.0 112.908 178.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.4 p -117.71 169.48 9.55 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.876 1.67 . . . . 0.0 109.167 178.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.0 mp -52.5 -43.1 64.85 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.207 0.603 . . . . 0.0 111.202 178.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.1 t -58.2 -45.91 86.77 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 125.916 1.686 . . . . 0.0 111.156 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -59.74 -45.2 92.96 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 118.586 0.63 . . . . 0.0 109.973 -178.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -82.1 1.71 34.71 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.492 0.717 . . . . 0.0 112.088 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.6 t30 55.45 46.42 23.23 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 127.581 2.352 . . . . 0.0 111.026 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 40.6 mt -86.09 123.05 39.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -93.64 169.98 9.92 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.264 0.554 . . . . 0.0 111.469 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.7 pttt -66.32 156.98 32.88 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.237 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 51.22 37.52 18.71 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 126.41 1.884 . . . . 0.0 112.001 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.7 p -87.13 164.15 16.57 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.761 1.224 . . . . 0.0 108.615 178.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.9 m -125.93 113.92 17.83 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.4 mp -96.91 161.64 13.75 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.259 1.023 . . . . 0.0 109.09 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 17.2 m80 -115.78 156.4 26.1 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.903 1.281 . . . . 0.0 109.85 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.8 mt -122.83 124.87 44.28 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.026 1.73 . . . . 0.0 107.891 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 23.3 m -141.38 171.57 11.77 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 124.795 1.238 . . . . 0.0 113.753 -178.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.534 0.345 0 C-N-CA 125.485 1.514 . . . . 0.0 108.389 176.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.4 ttt . . . . . 0 N--CA 1.474 0.73 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -121.51 157.27 31.03 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.226 0.611 . . . . 0.0 109.813 178.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.7 pt -132.75 171.12 18.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 C-N-CA 125.493 1.517 . . . . 0.0 107.668 177.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -126.19 152.49 45.96 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.188 0.995 . . . . 0.0 108.623 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.3 t -138.34 128.8 35.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.2 tptp -96.64 117.53 31.18 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.3 p -77.03 166.15 23.69 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 118.511 0.596 . . . . 0.0 110.084 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -71.34 -10.09 59.2 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 121.651 -0.656 . . . . 0.0 111.615 178.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -91.85 -10.96 37.84 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 128.368 2.667 . . . . 0.0 111.737 -179.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.45 7.09 56.2 Favored Glycine 0 C--N 1.34 0.797 0 C-N-CA 125.605 1.574 . . . . 0.0 114.137 178.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.2 mmmm -80.53 166.66 20.96 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 119.089 1.444 . . . . 0.0 109.622 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.5 m -123.72 131.28 53.57 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 103.453 -2.795 . . . . 0.0 103.453 177.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.5 mm -116.43 156.24 17.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 126.338 1.855 . . . . 0.0 107.214 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.1 m -132.93 128.9 37.51 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.156 1.782 . . . . 0.0 106.504 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.9 mt -139.47 151.0 45.85 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.188 0.995 . . . . 0.0 111.322 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -97.54 117.84 32.71 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 127.005 2.122 . . . . 0.0 105.383 178.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.1 m -134.91 -175.61 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 125.071 1.349 . . . . 0.0 109.631 -179.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -144.41 164.27 29.56 Favored Pre-proline 0 CA--C 1.532 0.278 0 C-N-CA 124.323 1.049 . . . . 0.0 109.817 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -57.87 -18.87 36.68 Favored 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 122.87 2.38 . . . . 0.0 113.865 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.3 m -115.86 31.65 6.58 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 119.21 0.914 . . . . 0.0 110.856 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -92.45 128.81 38.44 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 102.294 -3.224 . . . . 0.0 102.294 177.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.4 p -78.53 158.14 28.64 Favored 'General case' 0 CA--C 1.519 -0.232 0 O-C-N 121.2 -0.938 . . . . 0.0 110.917 -178.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.7 mm -64.08 -25.45 38.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 177.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -56.29 -49.83 73.16 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.518 1.127 . . . . 0.0 108.63 178.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -66.44 -52.63 44.35 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.851 1.26 . . . . 0.0 109.842 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.7 t -55.42 -38.62 49.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-N 118.623 0.647 . . . . 0.0 110.903 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -75.27 -18.11 60.15 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 120.956 -1.09 . . . . 0.0 111.412 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.93 -45.03 9.5 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.532 1.533 . . . . 0.0 110.328 178.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.4 mttm -54.31 -40.24 67.76 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 118.631 0.65 . . . . 0.0 111.039 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 34.6 pt -62.59 -24.9 36.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 CA-C-O 119.011 -0.519 . . . . 0.0 111.644 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.492 HE22 ' HB3' ' A' ' 38' ' ' PRO . 34.9 mt-30 -77.0 -23.11 52.25 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 120.162 1.346 . . . . 0.0 109.392 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.98 -32.59 26.93 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 176.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 51.2 mmtt -87.17 -15.37 38.55 Favored 'General case' 0 C--N 1.343 0.303 0 N-CA-C 115.499 1.666 . . . . 0.0 115.499 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -150.66 157.89 43.51 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 121.051 1.75 . . . . 0.0 106.567 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -80.99 74.83 2.37 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-O 119.177 -0.791 . . . . 0.0 111.256 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.3 pt -135.82 107.69 9.84 Favored Pre-proline 0 CA--C 1.545 0.784 0 CA-C-N 118.404 1.102 . . . . 0.0 111.155 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -71.13 169.3 20.94 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 123.336 2.691 . . . . 0.0 110.764 178.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.492 ' HB3' HE22 ' A' ' 31' ' ' GLN . 88.1 Cg_endo -80.52 56.31 6.03 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 122.701 2.267 . . . . 0.0 109.679 178.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -146.7 135.14 21.92 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 127.874 2.47 . . . . 0.0 105.083 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 71.1 mm-40 50.05 49.97 19.39 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.769 1.628 . . . . 0.0 109.55 -177.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 12.2 m-80 -148.09 134.85 19.99 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.519 1.128 . . . . 0.0 109.52 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 45.8 ttm-85 -153.0 134.18 14.17 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 127.293 2.237 . . . . 0.0 107.475 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 23.3 tp -88.18 139.89 30.04 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.037 1.335 . . . . 0.0 109.154 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.3 mm -132.47 145.9 33.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 125.743 1.617 . . . . 0.0 108.161 -179.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -136.62 117.5 14.16 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 124.727 1.211 . . . . 0.0 108.465 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.85 43.53 21.46 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.708 1.203 . . . . 0.0 110.944 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.38 -15.66 22.42 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 124.899 1.237 . . . . 0.0 114.23 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -80.69 124.34 28.93 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 119.874 1.837 . . . . 0.0 107.531 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.5 mp0 -74.47 135.96 42.27 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.7 mt -114.19 156.17 24.76 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 125.187 1.395 . . . . 0.0 109.944 -178.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -151.07 174.14 13.53 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 178.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -76.52 159.91 29.94 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.85 1.26 . . . . 0.0 111.761 -179.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.01 -27.81 14.96 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 125.811 1.672 . . . . 0.0 109.709 -178.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 44.5 mtt180 -106.59 167.04 10.13 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 118.973 1.386 . . . . 0.0 111.353 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.6 p -117.7 170.46 8.76 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 125.995 1.718 . . . . 0.0 111.169 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.6 mp -52.67 -43.56 65.63 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 123.506 0.723 . . . . 0.0 111.869 179.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.7 m -59.78 -38.32 81.54 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 118.632 0.651 . . . . 0.0 112.172 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -62.44 -47.08 85.62 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 123.068 0.547 . . . . 0.0 109.992 -178.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -82.66 1.36 38.81 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.083 0.953 . . . . 0.0 111.698 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 48.0 t30 54.4 46.24 25.45 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 127.53 2.332 . . . . 0.0 111.17 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 81.8 mt -88.25 123.06 40.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 179.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -101.47 175.75 5.47 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.5 pttt -64.81 157.11 28.58 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.285 0.564 . . . . 0.0 110.661 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 55.59 35.64 25.59 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.737 2.015 . . . . 0.0 111.682 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.9 p -86.19 164.17 17.37 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 120.683 -1.261 . . . . 0.0 108.367 178.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.9 m -126.03 115.48 19.93 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.3 mp -103.73 160.72 14.53 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.576 1.151 . . . . 0.0 108.779 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 43.3 m80 -119.46 159.62 23.91 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 125.236 1.414 . . . . 0.0 110.13 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 61.8 mt -123.24 124.29 42.66 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 125.188 1.395 . . . . 0.0 109.22 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.8 m -141.01 170.16 14.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -178.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.5 pt? . . . . . 0 C--O 1.236 0.367 0 C-N-CA 127.989 2.516 . . . . 0.0 108.288 178.453 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.6 ttt . . . . . 0 N--CA 1.473 0.686 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -122.31 144.92 48.7 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 177.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.9 pt -132.81 168.86 23.2 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 177.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -126.39 152.27 46.54 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 125.082 1.353 . . . . 0.0 109.327 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.4 t -138.72 131.1 38.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 178.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.51 117.8 33.76 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 178.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 54.9 p -74.17 171.12 14.15 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.007 0.923 . . . . 0.0 112.191 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -74.99 -7.75 54.54 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.069 177.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.3 p -94.61 -13.01 26.35 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.858 1.663 . . . . 0.0 111.15 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.81 6.08 57.29 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 126.565 2.031 . . . . 0.0 113.553 178.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.7 mmmm -81.95 164.84 21.23 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 118.416 1.108 . . . . 0.0 108.031 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.7 m -120.35 132.39 55.26 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 104.2 -2.518 . . . . 0.0 104.2 178.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 22.1 mm -107.7 156.96 8.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 125.949 1.699 . . . . 0.0 106.754 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.0 m -135.29 126.27 27.71 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 179.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.7 mt -140.21 147.39 39.99 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.335 1.054 . . . . 0.0 111.199 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -104.9 106.73 17.35 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 126.694 1.998 . . . . 0.0 107.585 178.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.2 m -135.7 -170.63 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 125.041 1.336 . . . . 0.0 108.457 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -147.24 167.94 12.45 Favored Pre-proline 0 C--O 1.232 0.165 0 O-C-N 120.615 -1.303 . . . . 0.0 111.047 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -55.56 -17.6 17.57 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 123.058 2.505 . . . . 0.0 112.821 178.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.1 m -112.57 30.2 7.31 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 119.948 1.249 . . . . 0.0 111.773 -177.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -104.48 140.59 37.74 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 107.518 -1.289 . . . . 0.0 107.518 176.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.2 p -78.72 158.29 28.34 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 122.408 1.099 . . . . 0.0 111.258 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.3 mm -64.74 -25.23 37.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 176.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -55.23 -49.61 71.54 Favored 'General case' 0 C--N 1.344 0.351 0 CA-C-N 119.385 0.993 . . . . 0.0 108.834 178.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.7 m-20 -60.37 -52.3 65.84 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 42.9 t -55.52 -41.36 63.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-O 119.111 -0.471 . . . . 0.0 111.231 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -74.74 -18.36 60.51 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-N 119.275 0.943 . . . . 0.0 111.424 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.24 -46.13 9.01 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 119.652 1.115 . . . . 0.0 108.432 177.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -53.41 -40.21 64.93 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.519 1.128 . . . . 0.0 111.211 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 41.8 pt -63.33 -26.82 41.75 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 CA-C-N 118.808 0.731 . . . . 0.0 111.43 178.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -76.3 -22.69 54.7 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 119.828 1.195 . . . . 0.0 109.323 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.71 -39.49 36.31 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 120.597 -1.315 . . . . 0.0 108.783 178.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -86.98 -15.89 37.42 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 114.549 1.314 . . . . 0.0 114.549 -178.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -148.16 151.27 35.29 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 179.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.1 87.29 1.36 Allowed Glycine 0 C--N 1.335 0.485 0 CA-C-O 119.555 -0.581 . . . . 0.0 112.715 -178.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.5 pt -144.32 107.13 4.81 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 124.448 1.099 . . . . 0.0 109.769 178.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -70.8 170.59 17.46 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 124.05 3.167 . . . . 0.0 110.282 178.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -80.27 55.58 5.72 Favored 'Trans proline' 0 CA--C 1.545 1.061 0 C-N-CA 122.656 2.237 . . . . 0.0 107.607 177.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -146.68 131.33 17.86 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 128.239 2.616 . . . . 0.0 104.765 -179.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 60.1 mm-40 53.95 49.51 18.83 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.992 1.317 . . . . 0.0 107.579 -177.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -155.2 133.35 11.62 Favored 'General case' 0 N--CA 1.452 -0.365 0 O-C-N 121.695 -0.628 . . . . 0.0 110.621 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 53.9 ttm-85 -152.1 137.39 17.53 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 105.319 -2.104 . . . . 0.0 105.319 179.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 28.2 tp -88.31 139.41 30.52 Favored 'General case' 0 C--O 1.226 -0.181 0 C-N-CA 124.182 0.993 . . . . 0.0 109.567 -178.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.6 mm -135.28 144.22 34.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 124.728 1.211 . . . . 0.0 109.093 -178.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -134.69 119.37 18.2 Favored 'General case' 0 C--O 1.226 -0.156 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 178.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.72 38.78 16.18 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.307 1.043 . . . . 0.0 112.077 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.47 -15.77 22.3 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 123.973 0.796 . . . . 0.0 113.582 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.1 ttmt -80.49 118.47 22.13 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 178.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.0 mp0 -75.27 136.68 40.9 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.4 mt -119.82 155.04 33.35 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 126.708 2.003 . . . . 0.0 109.548 -178.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -155.14 176.08 13.01 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 124.604 1.162 . . . . 0.0 108.517 177.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -72.17 160.82 31.8 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 126.116 1.767 . . . . 0.0 112.363 -178.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.62 -27.27 21.0 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 126.042 1.782 . . . . 0.0 110.484 -178.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 47.2 mtt180 -107.33 168.9 8.9 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 124.292 1.037 . . . . 0.0 110.333 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.5 p -117.22 165.56 13.29 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 123.445 0.698 . . . . 0.0 111.601 -179.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.9 mp -52.3 -41.8 63.24 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.714 0.806 . . . . 0.0 111.236 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.9 t -60.52 -45.23 94.61 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 126.391 1.876 . . . . 0.0 110.032 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -60.26 -46.12 90.93 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -81.11 -3.86 53.41 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.212 0.605 . . . . 0.0 111.375 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.9 t30 53.8 47.84 22.73 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 127.718 2.407 . . . . 0.0 112.605 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 82.3 mt -85.61 126.52 40.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 105.499 -2.037 . . . . 0.0 105.499 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 78.0 mm-40 -89.92 169.25 11.39 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.551 0.691 . . . . 0.0 110.939 -179.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -68.02 157.24 35.59 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.389 1.076 . . . . 0.0 109.513 178.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 52.27 35.76 17.81 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.406 1.482 . . . . 0.0 112.879 179.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.4 p -86.32 162.89 17.99 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.728 1.211 . . . . 0.0 110.052 178.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.0 m -126.72 108.77 11.37 Favored 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.4 mp -96.25 169.6 9.83 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.828 1.251 . . . . 0.0 110.658 -178.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -120.05 154.17 35.01 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 126.889 2.076 . . . . 0.0 108.946 178.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.4 mt -123.47 123.89 41.64 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 176.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.9 m -140.75 172.73 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-N 119.53 1.059 . . . . 0.0 112.315 -178.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.236 0.355 0 C-N-CA 126.333 1.853 . . . . 0.0 108.93 178.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.6 ttt . . . . . 0 N--CA 1.471 0.624 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -120.84 156.09 32.7 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 177.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.3 pt -132.33 169.45 21.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -123.32 149.54 44.73 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.541 1.136 . . . . 0.0 108.61 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.6 t -139.19 127.59 27.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -93.36 116.95 29.49 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.141 0.976 . . . . 0.0 109.161 178.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 80.4 p -84.06 167.6 16.67 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.983 0.913 . . . . 0.0 111.904 179.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.7 -3.98 10.82 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 126.342 1.857 . . . . 0.0 113.048 177.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.0 p -99.02 -15.49 19.04 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.699 1.199 . . . . 0.0 109.484 178.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.67 6.25 57.36 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 127.01 2.243 . . . . 0.0 112.041 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.1 mmmm -80.34 163.44 23.91 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 119.441 1.621 . . . . 0.0 107.144 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.6 m -124.62 132.04 53.44 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 104.351 -2.463 . . . . 0.0 104.351 178.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.8 mm -104.6 157.73 5.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 -179.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 97.8 m -133.95 123.48 24.73 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 104.236 -2.505 . . . . 0.0 104.236 178.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 66.3 mt -139.59 150.7 45.32 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.682 0.793 . . . . 0.0 109.775 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 71.9 tt0 -93.83 117.89 30.71 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 105.132 -2.173 . . . . 0.0 105.132 178.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.0 m -131.59 -171.47 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 124.561 1.144 . . . . 0.0 109.078 -178.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -147.09 164.59 22.49 Favored Pre-proline 0 CA--C 1.537 0.47 0 C-N-CA 123.976 0.91 . . . . 0.0 110.112 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -62.68 -18.87 66.29 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 121.92 1.747 . . . . 0.0 112.721 178.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.54 31.66 6.48 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.894 0.877 . . . . 0.0 111.873 -177.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -92.67 131.84 37.41 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 178.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.0 p -75.08 157.6 34.51 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 119.817 1.189 . . . . 0.0 109.013 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 30.1 mm -64.27 -31.18 52.41 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.282 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 177.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -55.91 -48.54 75.49 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.907 1.283 . . . . 0.0 110.045 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.7 m-20 -64.34 -52.38 58.67 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.191 0.996 . . . . 0.0 109.482 179.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.2 t -55.13 -41.72 61.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 122.81 0.444 . . . . 0.0 110.405 179.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.1 ttpt -74.88 -13.28 60.53 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 118.107 -0.949 . . . . 0.0 110.94 -179.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.34 -47.18 8.21 Favored 'General case' 0 C--O 1.226 -0.154 0 CA-C-N 120.269 1.395 . . . . 0.0 108.791 178.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -52.34 -40.06 61.45 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.056 0.942 . . . . 0.0 111.466 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 40.3 pt -63.96 -25.36 37.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 O-C-N 121.727 -0.608 . . . . 0.0 111.582 178.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -76.77 -23.15 52.93 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 119.921 1.237 . . . . 0.0 109.382 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.38 -39.51 59.08 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 177.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.6 mttm -86.62 -18.26 31.82 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 115.659 1.725 . . . . 0.0 115.659 -177.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -141.97 150.79 41.85 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 120.686 1.585 . . . . 0.0 108.039 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.59 82.03 1.61 Allowed Glycine 0 C--N 1.334 0.421 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.7 pt -136.09 108.38 9.69 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 124.622 1.169 . . . . 0.0 109.515 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -78.62 169.32 19.93 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.497 2.798 . . . . 0.0 109.016 179.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -77.84 56.68 5.76 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 123.56 2.84 . . . . 0.0 109.632 178.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -146.65 135.27 22.11 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 104.716 -2.328 . . . . 0.0 104.716 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 64.1 mm-40 53.22 48.65 21.65 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 126.17 1.788 . . . . 0.0 109.235 -177.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 -154.73 138.95 16.58 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.567 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 52.1 ttm-85 -155.97 135.33 12.3 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 127.859 2.464 . . . . 0.0 105.412 178.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 23.8 tp -87.75 139.45 30.52 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.2 mm -133.63 144.65 35.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 126.05 1.74 . . . . 0.0 108.096 -178.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -138.8 124.99 20.19 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 178.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.59 39.27 12.92 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.799 0.839 . . . . 0.0 111.608 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.03 -16.72 14.44 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 125.064 1.316 . . . . 0.0 113.948 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.5 ttmt -78.92 129.06 34.09 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 119.811 1.806 . . . . 0.0 108.172 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.5 mp0 -74.1 136.18 42.97 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 106.749 -1.575 . . . . 0.0 106.749 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.5 mt -119.19 155.88 30.87 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 125.268 1.427 . . . . 0.0 110.419 -179.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -160.23 176.18 12.03 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 126.186 1.794 . . . . 0.0 107.971 178.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -71.88 161.0 31.6 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 126.792 2.037 . . . . 0.0 113.106 -178.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.42 -27.52 19.54 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 126.465 1.983 . . . . 0.0 110.222 -179.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 47.9 mtt180 -107.99 169.31 8.69 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.374 1.07 . . . . 0.0 111.694 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 45.7 p -122.83 171.16 9.4 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.946 1.298 . . . . 0.0 112.145 -178.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.3 mp -52.56 -41.72 63.82 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 123.296 0.638 . . . . 0.0 110.564 178.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.8 t -58.53 -45.48 88.78 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.899 1.68 . . . . 0.0 110.628 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -61.58 -47.06 87.24 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.816 0.846 . . . . 0.0 109.522 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -81.76 -1.21 46.38 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 118.763 -0.637 . . . . 0.0 112.473 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 52.7 t30 54.24 46.68 24.73 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 127.571 2.348 . . . . 0.0 111.267 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.2 mt -87.5 123.83 40.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 87.8 mm-40 -94.09 172.46 8.21 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 123.23 0.612 . . . . 0.0 111.846 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 41.3 pttt -66.7 157.21 33.24 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 50.79 41.78 26.83 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 125.907 1.683 . . . . 0.0 110.664 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.0 p -86.86 163.22 17.32 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 178.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.3 m -126.34 106.28 9.39 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 179.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.1 mp -98.16 161.16 13.85 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 125.109 1.364 . . . . 0.0 108.614 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 11.4 m80 -119.3 155.6 31.54 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 123.927 0.891 . . . . 0.0 109.223 178.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 16.9 mt -122.53 123.35 41.05 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 102.571 -3.122 . . . . 0.0 102.571 178.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.6 m -141.7 168.93 14.66 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 -178.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.472 0.65 0 C-N-CA 124.277 1.031 . . . . 0.0 111.692 177.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.0 ttt . . . . . 0 CA--C 1.512 -0.519 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -121.22 156.69 31.89 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 178.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 34.9 pt -133.14 170.15 20.57 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 C-N-CA 125.515 1.526 . . . . 0.0 106.993 177.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -126.21 152.82 45.53 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 178.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.9 t -137.94 124.62 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.8 tppp? -93.28 109.58 21.11 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 104.348 -2.464 . . . . 0.0 104.348 178.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.414 ' HA ' HD12 ' A' ' 69' ' ' LEU . 25.3 p -72.6 165.37 24.83 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 121.074 0.464 . . . . 0.0 110.597 -179.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -69.0 -6.85 30.38 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.468 0.707 . . . . 0.0 111.36 178.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.1 p -93.88 -12.36 29.09 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.692 1.197 . . . . 0.0 109.692 179.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.51 5.78 57.71 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 126.862 2.172 . . . . 0.0 111.508 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.86 164.76 22.42 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 118.454 1.127 . . . . 0.0 108.933 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.1 m -124.42 132.31 53.51 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 179.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.5 mm -114.09 156.83 14.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 125.963 1.705 . . . . 0.0 106.468 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 31.6 m -132.45 123.66 27.07 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 127.239 2.216 . . . . 0.0 105.832 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.4 mt -133.92 150.83 51.34 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 119.09 0.859 . . . . 0.0 109.922 -179.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -103.41 109.12 20.64 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 104.735 -2.32 . . . . 0.0 104.735 178.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.3 m -123.37 -172.33 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 125.53 1.532 . . . . 0.0 109.816 -177.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -146.17 162.42 35.17 Favored Pre-proline 0 C--O 1.234 0.279 0 O-C-N 121.357 -0.839 . . . . 0.0 109.637 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -58.46 -18.53 39.52 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.407 2.071 . . . . 0.0 113.21 179.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.2 m -114.38 31.34 6.67 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 118.763 0.71 . . . . 0.0 111.573 -177.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -98.17 129.34 44.95 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 104.007 -2.59 . . . . 0.0 104.007 178.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.7 p -78.09 157.47 29.5 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 119.814 1.188 . . . . 0.0 110.128 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 51.3 mm -64.5 -26.0 39.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 177.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -55.4 -44.13 75.87 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.356 1.462 . . . . 0.0 109.436 178.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -70.97 -52.37 20.16 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.623 1.169 . . . . 0.0 108.545 179.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.7 t -54.74 -38.52 43.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 124.222 1.009 . . . . 0.0 111.41 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -76.56 -18.54 58.62 Favored 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 124.192 0.997 . . . . 0.0 111.097 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -88.74 -42.27 12.05 Favored 'General case' 0 C--O 1.228 -0.049 0 CA-C-N 119.633 1.106 . . . . 0.0 110.145 179.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -54.16 -40.58 67.59 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.216 0.606 . . . . 0.0 110.86 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.5 pt -63.05 -25.42 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 O-C-N 120.851 -1.156 . . . . 0.0 111.549 178.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -77.93 -21.63 50.82 Favored 'General case' 0 C--N 1.332 -0.169 0 O-C-N 120.79 -1.194 . . . . 0.0 109.967 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -78.11 -30.61 49.58 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.8 mttm -100.57 -15.05 17.95 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 115.799 1.777 . . . . 0.0 115.799 -179.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -139.52 158.71 43.66 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 121.437 1.926 . . . . 0.0 108.936 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.31 70.22 3.13 Favored Glycine 0 CA--C 1.524 0.622 0 C-N-CA 124.87 1.224 . . . . 0.0 110.914 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.6 pt -137.23 107.62 8.72 Favored Pre-proline 0 CA--C 1.544 0.731 0 CA-C-N 118.826 1.313 . . . . 0.0 111.579 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -76.05 168.98 23.03 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 123.756 2.971 . . . . 0.0 109.33 178.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -78.74 57.23 6.28 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.572 2.181 . . . . 0.0 109.875 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -149.4 135.91 19.31 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 128.401 2.68 . . . . 0.0 105.451 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 47.1 mm-40 54.03 48.54 20.88 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.474 1.509 . . . . 0.0 108.501 -177.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.44 HD21 HD13 ' A' ' 69' ' ' LEU . 5.8 t-20 -147.83 134.53 19.95 Favored 'General case' 0 C--N 1.339 0.137 0 O-C-N 121.39 -0.819 . . . . 0.0 110.323 -179.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 52.4 ttm-85 -155.55 133.55 11.42 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 29.1 tp -89.14 135.31 33.63 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.826 1.65 . . . . 0.0 110.581 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.4 mm -135.74 147.33 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 125.03 1.332 . . . . 0.0 108.009 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -139.0 115.14 10.28 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 178.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.49 40.75 15.72 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.085 1.354 . . . . 0.0 110.505 -178.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.71 -10.03 53.22 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 125.481 1.515 . . . . 0.0 114.955 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.6 ttmt -79.71 129.84 34.83 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 120.488 2.144 . . . . 0.0 107.732 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.5 mp0 -74.31 125.53 28.66 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.4 mt -114.15 140.73 48.28 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 106.095 -1.816 . . . . 0.0 106.095 179.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -162.88 -179.91 7.13 Favored 'General case' 0 C--N 1.32 -0.686 0 O-C-N 121.658 -0.651 . . . . 0.0 110.206 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -70.49 160.13 32.98 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.089 1.356 . . . . 0.0 112.8 -176.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.85 -29.55 12.26 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 128.153 2.787 . . . . 0.0 110.067 -178.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 49.8 mtt180 -108.28 169.6 8.53 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 126.191 1.796 . . . . 0.0 112.065 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 78.3 p -117.73 167.52 11.29 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 126.865 2.066 . . . . 0.0 111.04 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.7 mp -52.4 -42.02 63.66 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 123.282 0.633 . . . . 0.0 111.131 178.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.7 t -58.65 -43.17 89.72 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.48 1.512 . . . . 0.0 110.605 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -59.87 -46.9 87.85 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 118.741 0.7 . . . . 0.0 109.574 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -81.83 -4.08 55.59 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.246 1.018 . . . . 0.0 113.476 -179.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 37.6 t30 58.34 47.44 13.92 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.609 1.964 . . . . 0.0 110.963 -178.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.9 mt -86.28 122.99 39.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 104.775 -2.306 . . . . 0.0 104.775 179.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 92.1 mm-40 -93.37 170.32 9.7 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 122.862 0.465 . . . . 0.0 110.677 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 49.4 pttt -68.76 157.36 36.52 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.238 0.542 . . . . 0.0 111.228 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 53.16 37.83 26.0 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 127.379 2.272 . . . . 0.0 110.566 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.3 p -87.14 161.69 17.95 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.121 1.368 . . . . 0.0 109.63 178.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 95.2 m -126.33 110.17 13.08 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.3 mp -97.17 158.84 15.25 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.202 1.801 . . . . 0.0 108.857 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 72.1 m80 -120.07 163.64 17.36 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 125.341 1.456 . . . . 0.0 111.823 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.44 HD13 HD21 ' A' ' 41' ' ' ASN . 54.5 mt -120.19 133.45 55.49 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 125.13 1.372 . . . . 0.0 107.49 178.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.1 m -140.63 168.98 16.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 C-N-CA 124.413 1.085 . . . . 0.0 109.664 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.236 0.376 0 C-N-CA 125.123 1.369 . . . . 0.0 107.338 176.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 33.6 ttm . . . . . 0 N--CA 1.469 0.477 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -122.67 150.48 42.65 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 175.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.9 pt -132.65 168.63 23.74 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 176.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -126.1 151.79 46.74 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 123.892 0.877 . . . . 0.0 109.587 -179.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.9 t -138.37 133.06 42.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 178.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -98.27 117.27 32.28 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 105.241 -2.133 . . . . 0.0 105.241 177.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.3 p -80.36 167.08 20.66 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 118.878 0.763 . . . . 0.0 110.471 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -71.94 -7.98 51.8 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 122.747 0.419 . . . . 0.0 111.173 177.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.4 p -93.51 -12.35 29.84 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.549 1.14 . . . . 0.0 109.411 178.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.77 7.48 55.44 Favored Glycine 0 C--N 1.342 0.861 0 C-N-CA 125.005 1.288 . . . . 0.0 112.622 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -80.86 164.34 22.73 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 119.617 1.709 . . . . 0.0 108.186 179.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.2 m -124.11 131.46 53.55 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 102.953 -2.98 . . . . 0.0 102.953 177.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.9 mm -115.11 157.4 15.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 C-N-CA 125.81 1.644 . . . . 0.0 106.686 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 42.2 m -134.68 125.97 28.16 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 128.503 2.721 . . . . 0.0 104.945 177.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 81.1 mt -139.89 149.21 43.11 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.85 1.26 . . . . 0.0 110.17 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -102.13 114.25 28.22 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 126.116 1.767 . . . . 0.0 107.372 178.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.456 HG12 ' HE3' ' A' ' 29' ' ' LYS . 2.2 m -134.33 -175.0 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 124.77 1.228 . . . . 0.0 108.118 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -142.45 168.89 12.1 Favored Pre-proline 0 C--O 1.236 0.364 0 O-C-N 121.235 -0.916 . . . . 0.0 110.256 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -54.56 -22.12 26.93 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.683 2.256 . . . . 0.0 114.388 -179.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.5 m -115.11 31.77 6.48 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -178.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -95.68 128.92 42.96 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 101.133 -3.655 . . . . 0.0 101.133 175.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.2 p -76.57 159.0 30.71 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 119.778 1.172 . . . . 0.0 109.762 -179.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 51.8 mm -62.54 -26.19 39.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -53.86 -49.24 68.91 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.599 1.16 . . . . 0.0 108.457 178.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 -68.24 -52.02 38.73 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 126.436 1.894 . . . . 0.0 110.345 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.3 t -53.92 -43.68 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-N 119.232 0.923 . . . . 0.0 110.122 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -75.21 -13.48 60.45 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.182 0.993 . . . . 0.0 112.05 -178.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.51 -45.14 9.62 Favored 'General case' 0 C--O 1.225 -0.229 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 177.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.456 ' HE3' HG12 ' A' ' 17' ' ' VAL . 12.3 mtmm -50.84 -39.74 54.23 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.187 1.395 . . . . 0.0 110.385 179.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 37.5 pt -65.88 -25.41 36.16 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 CA-C-N 118.956 0.798 . . . . 0.0 112.332 178.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -76.37 -23.45 54.13 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 120.017 1.281 . . . . 0.0 109.372 -179.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.02 -38.88 56.75 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 177.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 45.6 mttm -87.43 -16.01 36.08 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 116.526 2.047 . . . . 0.0 116.526 -178.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -147.55 160.62 42.42 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 121.371 1.896 . . . . 0.0 110.511 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.31 64.09 4.23 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 124.427 1.013 . . . . 0.0 113.393 -179.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.1 pt -134.72 106.39 10.73 Favored Pre-proline 0 CA--C 1.541 0.61 0 CA-C-N 119.114 1.457 . . . . 0.0 108.341 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -71.54 169.45 20.93 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 123.7 2.933 . . . . 0.0 112.374 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -78.23 56.91 5.98 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 123.567 2.844 . . . . 0.0 110.263 178.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -149.5 136.16 19.41 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 127.958 2.503 . . . . 0.0 105.099 179.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 64.2 mm-40 51.91 48.83 22.01 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.303 1.441 . . . . 0.0 107.819 -177.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -152.55 133.14 13.85 Favored 'General case' 0 N--CA 1.455 -0.207 0 O-C-N 121.21 -0.932 . . . . 0.0 109.979 -178.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.0 ttm-85 -154.4 136.17 14.45 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 106.206 -1.775 . . . . 0.0 106.206 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 18.5 tp -88.22 137.85 31.96 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 124.427 1.091 . . . . 0.0 108.265 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.9 mm -135.12 150.2 29.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 126.002 1.721 . . . . 0.0 108.348 -178.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -137.17 115.41 11.72 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 178.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.39 42.32 18.04 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.884 1.274 . . . . 0.0 111.161 -178.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.33 -12.48 38.65 Favored Glycine 0 CA--C 1.53 0.97 0 CA-C-O 118.283 -1.287 . . . . 0.0 114.429 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.0 ttmt -79.11 125.17 29.06 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 120.86 2.33 . . . . 0.0 105.96 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.3 mp0 -74.31 136.0 42.56 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -179.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.3 mt -122.91 153.89 39.06 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -162.98 178.45 8.34 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 126.886 2.074 . . . . 0.0 107.802 177.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -71.78 160.56 32.39 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.057 1.343 . . . . 0.0 112.269 -177.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 108.34 -29.51 9.98 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 127.709 2.576 . . . . 0.0 108.626 -178.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 44.1 mtt180 -108.44 166.37 10.82 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.598 1.159 . . . . 0.0 112.329 178.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 49.5 p -117.44 169.59 9.4 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 126.067 1.747 . . . . 0.0 110.292 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.3 mp -52.73 -42.22 64.68 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 122.901 0.48 . . . . 0.0 111.207 178.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.2 t -59.06 -45.61 90.33 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.853 1.261 . . . . 0.0 110.799 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -59.46 -44.92 92.88 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.21 0.604 . . . . 0.0 110.506 -179.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -82.22 -0.3 44.58 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.518 0.727 . . . . 0.0 112.21 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 44.8 t30 53.65 47.49 23.71 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 127.141 2.176 . . . . 0.0 110.611 -179.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.1 mt -85.05 130.95 35.25 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 N-CA-C 104.397 -2.446 . . . . 0.0 104.397 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 68.7 mm-40 -89.63 167.14 13.16 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 123.079 0.551 . . . . 0.0 111.566 -178.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -72.74 156.68 38.68 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 177.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 50.86 35.74 13.06 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.205 1.402 . . . . 0.0 111.358 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.6 p -81.85 164.77 21.38 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.422 1.889 . . . . 0.0 109.494 179.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.5 m -125.97 107.03 10.06 Favored 'General case' 0 N--CA 1.461 0.12 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.6 mp -97.61 164.51 12.39 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.124 1.37 . . . . 0.0 109.21 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.2 m80 -119.93 157.66 28.31 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 126.028 1.731 . . . . 0.0 110.949 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 34.6 mt -123.16 125.47 45.2 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.584 1.554 . . . . 0.0 107.479 178.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.8 m -140.98 172.63 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-N 119.722 1.147 . . . . 0.0 113.937 -178.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.537 0.461 0 C-N-CA 126.478 1.911 . . . . 0.0 109.41 177.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ttt . . . . . 0 N--CA 1.473 0.691 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -121.08 156.16 32.85 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 179.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.2 pt -133.71 170.85 19.02 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 C-N-CA 126.601 1.96 . . . . 0.0 107.883 177.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -126.14 152.43 45.96 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.187 1.395 . . . . 0.0 109.161 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.2 t -138.1 126.15 30.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 178.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -92.83 117.5 30.09 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 106.144 -1.799 . . . . 0.0 106.144 178.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 64.4 p -73.12 164.39 26.76 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -67.67 -12.63 60.9 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.7 178.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.6 p -92.55 -12.11 32.68 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.396 1.879 . . . . 0.0 110.454 179.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.55 6.92 56.24 Favored Glycine 0 C--N 1.338 0.644 0 O-C-N 121.091 -1.006 . . . . 0.0 112.752 179.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.01 163.36 23.32 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 104.996 -2.224 . . . . 0.0 104.996 178.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 47.3 m -125.1 140.54 52.79 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 178.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.2 mm -114.82 156.22 15.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 126.338 1.855 . . . . 0.0 106.001 179.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 47.6 m -132.23 125.84 32.07 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 103.571 -2.751 . . . . 0.0 103.571 178.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.2 mt -138.73 151.49 47.17 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.024 0.93 . . . . 0.0 110.397 -178.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -99.69 118.62 36.6 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 128.362 2.665 . . . . 0.0 105.728 178.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.1 m -134.21 -171.27 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 125.512 1.525 . . . . 0.0 108.467 -178.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -146.72 161.8 36.28 Favored Pre-proline 0 CA--C 1.536 0.435 0 C-N-CA 124.197 0.999 . . . . 0.0 108.344 179.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -51.19 -24.98 16.19 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.316 2.678 . . . . 0.0 114.844 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.4 m -115.42 33.09 5.65 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.756 0.822 . . . . 0.0 111.563 -179.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -90.69 129.65 36.77 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 103.131 -2.915 . . . . 0.0 103.131 178.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 21.3 p -69.58 158.08 35.96 Favored 'General case' 0 C--O 1.237 0.421 0 O-C-N 121.728 -0.607 . . . . 0.0 110.69 -178.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.7 mm -64.25 -32.14 56.3 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.47 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 177.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -55.49 -39.71 70.79 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 125.823 1.649 . . . . 0.0 110.171 179.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -73.86 -53.46 10.15 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.1 t -57.92 -39.13 70.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 O-C-N 121.162 -0.961 . . . . 0.0 112.397 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 27.2 ttpt -75.01 -15.75 60.64 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.622 1.169 . . . . 0.0 110.921 -179.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.75 -47.1 7.84 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.108 1.763 . . . . 0.0 108.14 177.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.1 mttm -50.36 -40.5 49.5 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.217 1.407 . . . . 0.0 110.898 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.3 pt -64.32 -27.94 43.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 O-C-N 121.472 -0.768 . . . . 0.0 111.667 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -78.02 -22.09 49.77 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.824 1.249 . . . . 0.0 110.412 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.34 -37.76 60.52 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 177.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -94.18 -17.75 22.42 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 116.104 1.891 . . . . 0.0 116.104 -179.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -136.45 150.21 48.61 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 121.401 1.909 . . . . 0.0 107.13 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -83.46 85.76 1.52 Allowed Glycine 0 CA--C 1.521 0.434 0 CA-C-O 119.14 -0.811 . . . . 0.0 111.285 -179.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.5 pt -141.17 108.78 6.29 Favored Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 118.327 1.064 . . . . 0.0 111.79 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -62.62 161.9 26.6 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 122.666 2.244 . . . . 0.0 110.547 178.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -84.23 56.66 5.03 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.569 2.179 . . . . 0.0 108.041 179.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -144.82 134.15 23.04 Favored 'General case' 0 CA--C 1.514 -0.415 0 C-N-CA 130.602 3.561 . . . . 0.0 103.515 -178.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 43.3 mm-40 50.89 49.55 20.86 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 125.353 1.461 . . . . 0.0 107.324 -176.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -147.89 133.0 18.27 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.771 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 42.9 ttm-85 -154.73 133.58 12.22 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 178.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 26.5 tp -88.25 137.06 32.66 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.17 1.388 . . . . 0.0 107.834 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.3 mm -127.98 144.46 37.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 125.718 1.607 . . . . 0.0 108.844 -178.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -136.77 126.07 24.85 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 178.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.36 33.15 9.48 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.049 0.94 . . . . 0.0 111.288 -179.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.27 -11.95 41.09 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 124.514 1.054 . . . . 0.0 112.483 -179.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -79.55 129.02 34.09 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 119.58 1.69 . . . . 0.0 107.515 179.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.9 mp0 -74.4 136.03 42.41 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.6 mt -122.98 155.67 36.31 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.29 1.036 . . . . 0.0 109.744 -178.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -161.7 -178.33 6.47 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 127.747 2.419 . . . . 0.0 107.393 177.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -70.63 160.42 32.6 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 127.621 2.368 . . . . 0.0 113.055 -176.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.5 -28.82 13.92 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 126.576 2.036 . . . . 0.0 110.264 -178.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 46.6 mtt180 -108.23 165.16 11.7 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.019 1.328 . . . . 0.0 112.3 179.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 64.4 p -118.52 174.21 6.39 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 126.87 2.068 . . . . 0.0 111.855 -179.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.67 -46.37 63.76 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.459 1.104 . . . . 0.0 110.98 179.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.1 t -58.6 -45.3 89.45 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.037 1.735 . . . . 0.0 111.503 -179.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -60.29 -45.09 94.56 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 122.966 0.506 . . . . 0.0 110.52 -178.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -81.53 1.84 31.74 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.04 0.536 . . . . 0.0 111.197 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.2 t30 54.72 46.19 25.15 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 128.039 2.535 . . . . 0.0 111.202 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 89.6 mt -88.38 125.51 41.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 81.5 mm-40 -101.93 176.94 5.04 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.253 1.021 . . . . 0.0 110.613 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.9 pttt -64.72 156.67 29.66 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 123.588 0.755 . . . . 0.0 110.431 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 49.17 39.33 15.2 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.518 1.927 . . . . 0.0 111.694 -178.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.8 p -83.95 161.64 20.73 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 120.447 -1.408 . . . . 0.0 108.129 178.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.5 m -126.29 108.8 11.6 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.4 mp -95.78 162.16 13.71 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.269 1.428 . . . . 0.0 109.004 -179.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -119.77 163.12 17.94 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.21 1.404 . . . . 0.0 109.928 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.3 mt -123.0 127.34 48.67 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.01 1.724 . . . . 0.0 108.337 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.6 m -141.21 163.44 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 114.255 1.205 . . . . 0.0 114.255 -178.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.536 0.413 0 C-N-CA 127.353 2.261 . . . . 0.0 108.819 177.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.2 ttm . . . . . 0 N--CA 1.468 0.466 0 N-CA-C 110.354 -0.239 . . . . 0.0 110.354 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -121.04 156.45 32.17 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 176.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.2 pt -132.98 169.39 22.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 178.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -126.12 149.57 48.84 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 179.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.7 t -138.33 124.52 25.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -92.8 117.78 30.39 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 105.345 -2.095 . . . . 0.0 105.345 178.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 50.1 p -72.19 167.06 21.12 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 121.564 0.697 . . . . 0.0 109.734 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.403 ' H ' HD23 ' A' ' 8' ' ' LEU . 2.6 pt? -67.26 -12.51 60.3 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.62 0.768 . . . . 0.0 111.738 178.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.3 p -97.44 -12.71 22.38 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.908 1.683 . . . . 0.0 112.249 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.35 6.65 47.44 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-O 118.313 -1.271 . . . . 0.0 113.863 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.3 163.52 20.62 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 120.138 1.969 . . . . 0.0 105.983 178.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.5 m -124.57 132.76 53.44 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.5 mm -115.66 156.9 16.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 127.458 2.303 . . . . 0.0 108.228 -179.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.7 m -133.54 130.55 38.62 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 127.85 2.46 . . . . 0.0 106.276 178.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 92.5 mt -134.3 151.87 51.49 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 126.16 1.784 . . . . 0.0 110.845 -179.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -102.68 117.69 35.21 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 104.548 -2.389 . . . . 0.0 104.548 177.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.1 m -135.18 -168.96 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 124.657 1.183 . . . . 0.0 109.768 -179.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -150.43 163.54 23.8 Favored Pre-proline 0 CA--C 1.537 0.462 0 C-N-CA 125.308 1.443 . . . . 0.0 109.196 178.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -57.12 -18.41 29.07 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.705 2.27 . . . . 0.0 113.274 178.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.4 m -114.22 31.27 6.7 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 123.74 0.816 . . . . 0.0 111.517 -178.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -94.97 130.07 41.76 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 102.309 -3.219 . . . . 0.0 102.309 176.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.5 p -71.62 156.69 39.1 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 119.798 1.181 . . . . 0.0 109.726 -179.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.7 mm -65.04 -29.33 47.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 177.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -57.74 -49.63 75.92 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 126.101 1.761 . . . . 0.0 107.9 178.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -63.04 -52.08 64.25 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.143 0.977 . . . . 0.0 109.421 178.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.8 t -56.37 -38.91 57.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 O-C-N 121.508 -0.745 . . . . 0.0 110.618 179.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -74.74 -17.83 60.59 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-O 117.763 -1.113 . . . . 0.0 109.948 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.29 -47.36 10.13 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 120.2 1.364 . . . . 0.0 108.177 178.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.0 mttm -50.32 -43.16 53.68 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.672 1.189 . . . . 0.0 111.808 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 36.8 pt -62.78 -27.73 43.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 O-C-N 121.501 -0.749 . . . . 0.0 112.684 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.423 HE22 ' HB3' ' A' ' 38' ' ' PRO . 34.8 mt-30 -77.21 -20.66 55.01 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 119.519 1.054 . . . . 0.0 110.479 -179.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -82.74 -38.08 23.76 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.171 -0.956 . . . . 0.0 108.974 178.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -86.03 -21.42 27.77 Favored 'General case' 0 N--CA 1.471 0.575 0 O-C-N 121.044 -1.035 . . . . 0.0 113.682 -178.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -140.5 150.81 44.22 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 178.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -80.89 85.29 1.38 Allowed Glycine 0 C--N 1.332 0.317 0 CA-C-N 118.907 0.776 . . . . 0.0 113.038 -178.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.3 pt -140.14 106.87 6.74 Favored Pre-proline 0 CA--C 1.54 0.59 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -66.09 170.4 11.85 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 123.772 2.982 . . . . 0.0 111.309 178.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.423 ' HB3' HE22 ' A' ' 31' ' ' GLN . 52.4 Cg_endo -83.46 55.99 5.19 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 N-CA-C 106.645 -2.098 . . . . 0.0 106.645 178.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -146.52 133.94 20.78 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 128.402 2.681 . . . . 0.0 106.746 -177.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 39.6 mm-40 46.84 49.43 14.39 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.073 1.749 . . . . 0.0 108.348 -177.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.453 HD21 HD13 ' A' ' 69' ' ' LEU . 16.8 t-20 -154.3 134.41 13.18 Favored 'General case' 0 C--N 1.341 0.207 0 C-N-CA 124.761 1.224 . . . . 0.0 110.106 -179.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 52.1 ttm-85 -151.59 141.47 21.99 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 179.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 20.0 tp -88.45 138.89 31.02 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.749 1.22 . . . . 0.0 108.818 -179.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.2 mm -135.16 149.98 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 C-N-CA 125.989 1.716 . . . . 0.0 107.083 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -137.61 122.71 19.15 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 178.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.1 36.61 9.1 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.04 0.936 . . . . 0.0 111.494 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.76 -13.95 33.64 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-O 118.773 -1.015 . . . . 0.0 114.028 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.3 ttmt -79.76 128.97 34.07 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 120.304 2.052 . . . . 0.0 106.145 178.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.7 mp0 -73.75 136.17 43.63 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.141 1.376 . . . . 0.0 108.924 -178.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.4 mt -123.86 155.03 38.8 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.345 1.058 . . . . 0.0 109.069 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -161.78 179.46 8.08 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.269 1.428 . . . . 0.0 108.316 178.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -70.97 161.12 31.66 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 127.219 2.208 . . . . 0.0 112.993 -176.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.37 -25.18 29.08 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 126.24 1.876 . . . . 0.0 110.434 -178.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 47.3 mtt180 -108.29 171.56 7.34 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 118.715 1.257 . . . . 0.0 112.194 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.8 p -118.17 171.62 7.99 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 126.457 1.903 . . . . 0.0 109.322 178.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.7 mp -52.86 -42.16 64.97 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.357 0.663 . . . . 0.0 110.548 177.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.9 t -58.68 -45.44 89.42 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 126.251 1.82 . . . . 0.0 111.553 -179.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -57.73 -47.09 83.39 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 119.384 0.993 . . . . 0.0 109.871 -179.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -81.72 1.25 35.23 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.888 0.875 . . . . 0.0 112.378 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 54.8 t30 53.93 46.08 26.36 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 127.422 2.289 . . . . 0.0 111.405 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.0 mt -86.29 126.71 40.66 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.9 mm-40 -97.2 173.3 7.3 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.402 0.681 . . . . 0.0 111.215 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 42.8 pttt -66.06 156.77 32.83 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 51.81 35.33 15.16 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 127.328 2.251 . . . . 0.0 110.901 -179.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.3 p -75.59 162.74 28.02 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 178.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.3 m -122.77 106.24 10.75 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 -179.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.5 mp -101.63 159.4 15.34 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.314 1.446 . . . . 0.0 109.552 -178.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 4.1 m80 -120.25 163.64 17.47 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 126.406 1.882 . . . . 0.0 111.145 179.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.453 HD13 HD21 ' A' ' 41' ' ' ASN . 69.4 mt -122.24 125.41 45.99 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 177.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.9 m -139.77 163.75 24.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-O 121.85 0.833 . . . . 0.0 111.64 -179.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.6 pt? . . . . . 0 C--N 1.332 -0.173 0 C-N-CA 127.278 2.231 . . . . 0.0 108.409 178.719 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 30.3 ttm . . . . . 0 CA--C 1.514 -0.415 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -120.99 148.43 44.11 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 178.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 34.0 pt -132.11 168.34 24.28 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 O-C-N 120.993 -1.067 . . . . 0.0 108.448 179.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -126.22 149.84 48.78 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.7 t -138.3 124.64 25.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -90.42 118.95 30.29 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 126.914 2.086 . . . . 0.0 111.071 179.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 51.1 p -83.05 163.98 20.61 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 177.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.66 -5.65 16.79 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.426 1.09 . . . . 0.0 112.881 178.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.9 p -92.77 -14.23 28.17 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.794 2.037 . . . . 0.0 110.555 178.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.5 6.39 57.47 Favored Glycine 0 C--N 1.337 0.593 0 C-N-CA 125.637 1.589 . . . . 0.0 112.459 179.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.8 mmmm -81.77 164.48 21.66 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 118.28 1.04 . . . . 0.0 108.334 179.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.1 m -125.09 137.19 54.2 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 177.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 48.8 mm -115.95 154.0 17.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 105.507 -2.034 . . . . 0.0 105.507 178.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.8 m -132.71 130.13 39.63 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 178.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 78.5 mt -139.17 151.2 46.42 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 124.899 1.28 . . . . 0.0 111.857 -178.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -98.94 117.63 33.89 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 127.482 2.313 . . . . 0.0 105.024 178.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.6 m -134.39 -171.99 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 125.323 1.449 . . . . 0.0 109.729 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -148.09 165.59 17.98 Favored Pre-proline 0 CA--C 1.536 0.406 0 C-N-CA 124.136 0.974 . . . . 0.0 110.507 179.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.78 -19.27 14.34 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.725 2.95 . . . . 0.0 115.547 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.1 m -115.73 30.83 7.1 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 119.132 0.878 . . . . 0.0 111.693 -179.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -91.46 129.31 37.46 Favored 'General case' 0 C--O 1.244 0.784 0 N-CA-C 102.846 -3.02 . . . . 0.0 102.846 177.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.9 p -76.65 158.34 31.13 Favored 'General case' 0 C--O 1.233 0.205 0 O-C-N 121.118 -0.989 . . . . 0.0 110.697 -178.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.2 mm -63.07 -27.02 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 179.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -54.18 -46.5 72.4 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.387 1.075 . . . . 0.0 109.633 178.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 56.7 m-80 -69.57 -52.36 26.95 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.659 1.584 . . . . 0.0 109.445 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.4 t -54.45 -40.98 51.57 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 CA-C-N 118.835 0.743 . . . . 0.0 109.971 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.1 ttpt -75.49 -12.92 60.33 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.953 1.301 . . . . 0.0 111.637 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.11 -47.44 7.82 Favored 'General case' 0 CA--C 1.52 -0.198 0 C-N-CA 124.614 1.166 . . . . 0.0 109.46 178.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 55.7 mttm -51.21 -40.24 58.29 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.918 1.287 . . . . 0.0 110.485 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.7 pt -61.64 -31.0 49.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-O 118.44 -0.79 . . . . 0.0 112.413 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -77.38 -19.97 55.41 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.029 1.332 . . . . 0.0 110.724 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -83.89 -40.03 19.12 Favored 'General case' 0 CA--C 1.53 0.193 0 O-C-N 121.412 -0.805 . . . . 0.0 110.484 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.8 mttm -89.87 -14.97 33.18 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 -179.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -138.95 150.79 46.29 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.72 64.54 4.19 Favored Glycine 0 CA--C 1.524 0.603 0 CA-C-O 118.136 -1.369 . . . . 0.0 112.729 -179.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.5 pt -127.41 106.72 21.28 Favored Pre-proline 0 CA--C 1.552 1.02 0 CA-C-N 118.928 1.364 . . . . 0.0 111.162 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -65.88 165.41 23.7 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 124.13 3.22 . . . . 0.0 114.694 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -81.79 57.52 6.35 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 124.756 3.637 . . . . 0.0 110.163 178.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -145.12 134.06 22.49 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 128.69 2.796 . . . . 0.0 105.501 -178.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.8 mm-40 44.23 51.1 7.57 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 126.603 1.961 . . . . 0.0 110.05 -177.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 23.3 m-20 -150.59 134.2 16.51 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.3 ttm-85 -153.28 142.65 21.63 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 124.883 1.273 . . . . 0.0 107.638 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.0 tp -88.62 142.9 27.31 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 125.246 1.419 . . . . 0.0 112.698 -177.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.6 mm -135.55 148.15 28.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 126.934 2.094 . . . . 0.0 108.265 179.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -138.18 115.07 10.76 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 177.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.45 43.06 19.46 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.268 1.027 . . . . 0.0 110.784 -178.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.66 -13.19 36.99 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 124.63 1.11 . . . . 0.0 114.738 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.6 ttmm -79.48 129.21 34.26 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 119.757 1.778 . . . . 0.0 109.33 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -74.81 129.36 37.54 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 125.82 1.648 . . . . 0.0 109.577 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 9.8 mt -123.74 148.85 46.24 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 123.726 0.811 . . . . 0.0 110.43 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.1 pm0 -151.61 175.96 11.83 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.12 1.368 . . . . 0.0 108.464 178.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -72.13 161.03 31.46 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 125.493 1.517 . . . . 0.0 113.628 -177.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.82 -22.52 39.97 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 125.672 1.606 . . . . 0.0 110.724 -179.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -107.27 169.97 8.24 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 118.572 1.186 . . . . 0.0 111.347 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 79.4 p -117.09 171.14 8.12 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.604 1.562 . . . . 0.0 113.026 -178.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.57 -47.13 67.02 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.074 0.95 . . . . 0.0 108.829 177.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.2 m -62.04 -32.5 73.02 Favored 'General case' 0 N--CA 1.46 0.063 0 C-N-CA 124.823 1.249 . . . . 0.0 112.93 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -67.41 -45.67 75.47 Favored 'General case' 0 CA--C 1.515 -0.398 0 O-C-N 121.077 -1.014 . . . . 0.0 109.819 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -82.95 1.39 39.91 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 119.208 -0.425 . . . . 0.0 110.93 178.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 36.5 t30 56.01 46.71 21.3 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 127.76 2.424 . . . . 0.0 111.167 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.6 mt -89.76 126.98 42.64 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 178.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -101.84 178.43 4.62 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 123.039 0.536 . . . . 0.0 110.216 179.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 58.4 pttt -64.68 156.88 28.85 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.176 0.59 . . . . 0.0 110.661 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 52.26 46.1 27.25 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.216 1.407 . . . . 0.0 111.221 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.1 p -88.75 161.26 16.89 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.994 1.718 . . . . 0.0 109.912 177.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.37 117.05 22.17 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 178.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mp -109.04 160.57 15.94 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 124.298 1.039 . . . . 0.0 109.256 -179.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 43.7 m80 -120.05 161.11 21.51 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 126.39 1.876 . . . . 0.0 109.526 178.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 33.6 mt -122.82 125.14 44.86 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 126.728 2.011 . . . . 0.0 108.014 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.0 m -141.02 166.14 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -178.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.6 pt? . . . . . 0 CA--C 1.535 0.373 0 C-N-CA 125.384 1.474 . . . . 0.0 108.955 177.088 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.0 ttm . . . . . 0 N--CA 1.471 0.624 0 CA-C-O 118.719 -0.658 . . . . 0.0 110.356 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -121.74 154.41 36.96 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 176.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.9 pt -133.42 169.22 22.34 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 176.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -123.04 149.53 44.26 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 179.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.7 t -138.95 125.69 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.1 tppp? -94.14 117.56 30.29 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.946 0.898 . . . . 0.0 108.903 178.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 37.4 p -83.22 166.18 18.8 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.889 0.768 . . . . 0.0 111.025 179.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -70.29 -2.56 13.81 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.35 0.66 . . . . 0.0 111.909 177.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 47.0 p -92.62 -15.16 27.19 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.915 1.286 . . . . 0.0 109.369 178.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.5 6.08 57.6 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 126.825 2.155 . . . . 0.0 112.435 179.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.3 mmmm -81.91 164.18 21.72 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 119.172 1.486 . . . . 0.0 109.636 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.5 m -113.2 132.08 55.63 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 101.896 -3.372 . . . . 0.0 101.896 176.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.8 mm -115.77 148.06 18.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 179.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.9 m -125.37 130.05 51.15 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 106.392 -1.706 . . . . 0.0 106.392 178.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 76.3 mt -139.12 143.26 38.16 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.518 0.727 . . . . 0.0 110.072 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -99.57 107.1 19.17 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.902 2.081 . . . . 0.0 106.58 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.4 m -133.58 -172.6 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 124.988 1.315 . . . . 0.0 109.929 -178.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -144.13 166.07 20.84 Favored Pre-proline 0 C--O 1.235 0.315 0 CA-C-N 121.031 1.741 . . . . 0.0 112.178 -178.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.05 -22.47 31.28 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 123.246 2.63 . . . . 0.0 115.416 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.5 m -115.11 31.03 6.96 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 118.527 0.603 . . . . 0.0 112.369 -178.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -104.31 136.17 44.41 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 103.974 -2.602 . . . . 0.0 103.974 175.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.4 p -78.09 157.97 29.32 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 122.017 0.913 . . . . 0.0 112.065 -178.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.1 mm -64.02 -25.43 38.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-O 118.373 -0.823 . . . . 0.0 110.018 178.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -55.83 -38.66 70.32 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 119.739 1.154 . . . . 0.0 109.382 179.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 57.7 m-20 -74.42 -52.96 10.56 Favored 'General case' 0 CA--C 1.521 -0.14 0 C-N-CA 124.723 1.209 . . . . 0.0 109.552 178.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 24.8 t -54.23 -42.65 57.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 123.036 0.534 . . . . 0.0 111.348 -179.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -74.95 -14.54 60.64 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.653 0.781 . . . . 0.0 111.421 -178.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.19 -45.65 8.95 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.397 1.079 . . . . 0.0 108.602 177.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.5 mttm -52.64 -39.92 62.25 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 124.715 1.206 . . . . 0.0 111.446 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 32.2 pt -60.53 -29.01 43.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-N 118.445 0.566 . . . . 0.0 111.08 178.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -76.91 -23.43 52.52 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 119.445 1.02 . . . . 0.0 109.983 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.54 -24.31 45.76 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 177.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.6 mmtt -93.56 -20.35 20.32 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -150.83 161.76 42.06 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 120.796 1.634 . . . . 0.0 109.526 -178.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -80.95 77.29 2.04 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 124.225 0.917 . . . . 0.0 111.957 -179.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.1 pt -135.41 108.51 10.25 Favored Pre-proline 0 CA--C 1.546 0.805 0 CA-C-N 118.245 1.023 . . . . 0.0 111.759 -179.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -65.22 166.69 18.29 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 123.151 2.567 . . . . 0.0 110.465 178.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -88.23 56.64 2.57 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.408 2.072 . . . . 0.0 107.813 179.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -145.91 136.01 23.71 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 127.909 2.484 . . . . 0.0 105.045 -178.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.0 mm-40 51.14 49.53 20.93 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.83 1.652 . . . . 0.0 109.192 -177.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 23.7 m-80 -148.68 133.75 18.22 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.4 ttm-85 -151.72 137.17 17.69 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 126.967 2.107 . . . . 0.0 105.547 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 28.6 tp -87.27 139.39 30.61 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.603 1.161 . . . . 0.0 108.794 -178.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.4 mm -132.26 145.6 34.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 126.05 1.74 . . . . 0.0 108.475 -178.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -133.4 119.22 19.36 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 178.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.05 39.88 24.25 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.355 1.062 . . . . 0.0 110.451 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.48 -16.59 17.82 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-O 118.506 -1.163 . . . . 0.0 113.905 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.4 ttmt -79.52 128.78 33.8 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 120.519 2.16 . . . . 0.0 106.661 178.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.1 mp0 -74.55 136.94 42.12 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -179.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.9 mt -122.39 155.84 35.22 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 126.078 1.751 . . . . 0.0 109.978 -179.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -151.99 176.38 11.55 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.922 1.289 . . . . 0.0 109.162 178.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -72.6 160.9 31.5 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 126.082 1.753 . . . . 0.0 110.959 -178.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.84 -26.08 24.41 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 125.06 1.314 . . . . 0.0 110.098 -178.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 30.3 mtt180 -106.55 170.34 7.99 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 118.736 1.268 . . . . 0.0 110.165 179.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.1 p -117.49 167.59 11.16 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.51 1.524 . . . . 0.0 110.086 179.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.4 mp -52.88 -41.66 64.56 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 121.5 -0.75 . . . . 0.0 111.087 178.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.4 t -58.33 -44.22 88.6 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.274 1.43 . . . . 0.0 110.608 -179.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -57.94 -46.9 84.35 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.348 0.659 . . . . 0.0 109.884 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -81.72 -4.31 55.95 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -179.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 31.8 t30 56.66 46.37 20.34 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.996 2.118 . . . . 0.0 109.997 -178.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 84.2 mt -86.35 127.22 40.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 N-CA-C 103.782 -2.673 . . . . 0.0 103.782 178.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 94.6 mm-40 -101.74 173.21 6.51 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 122.918 0.487 . . . . 0.0 110.851 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.1 pttt -64.71 157.25 27.9 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 51.6 39.08 24.18 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 125.562 1.545 . . . . 0.0 111.231 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.1 p -87.34 163.44 16.81 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 120.87 -1.144 . . . . 0.0 108.263 177.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 33.0 m -126.4 105.98 9.17 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.4 mp -97.09 160.25 14.45 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.655 1.582 . . . . 0.0 108.805 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 4.2 m80 -120.01 157.63 28.47 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 125.36 1.464 . . . . 0.0 108.194 178.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.1 mt -122.99 123.47 40.96 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 105.223 -2.139 . . . . 0.0 105.223 178.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.5 m -141.8 172.43 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-N 120.11 1.323 . . . . 0.0 113.582 -179.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.343 0.301 0 C-N-CA 124.718 1.207 . . . . 0.0 111.071 178.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.3 ttt . . . . . 0 N--CA 1.469 0.502 0 N-CA-C 110.606 -0.146 . . . . 0.0 110.606 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -120.71 156.96 30.68 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 177.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.4 pt -132.51 169.46 21.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 178.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -122.58 150.03 43.16 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 124.867 1.267 . . . . 0.0 108.239 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.8 t -139.17 125.24 23.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 O-C-N 121.788 -0.57 . . . . 0.0 109.585 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -91.0 111.27 22.65 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 178.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.5 p -83.15 160.61 21.81 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.655 0.661 . . . . 0.0 110.397 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -67.52 -2.72 6.97 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.407 1.083 . . . . 0.0 112.744 179.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.9 p -91.3 -12.62 34.56 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 125.264 1.426 . . . . 0.0 110.039 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.64 7.46 57.84 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.3 mmmm -97.07 165.1 12.23 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 118.006 0.903 . . . . 0.0 109.078 179.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.46 132.81 53.5 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 103.911 -2.626 . . . . 0.0 103.911 178.027 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.0 mm -114.56 153.26 16.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 -178.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 89.8 m -124.77 130.11 51.76 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 104.395 -2.446 . . . . 0.0 104.395 178.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 75.1 mt -138.8 151.2 46.85 Favored 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 124.226 1.01 . . . . 0.0 111.04 -179.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -97.59 118.7 34.69 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 127.22 2.208 . . . . 0.0 107.17 179.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 23.0 m -134.36 -174.94 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.005 0.922 . . . . 0.0 110.094 -179.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -147.68 159.14 41.82 Favored Pre-proline 0 C--O 1.234 0.278 0 C-N-CA 124.231 1.012 . . . . 0.0 109.469 178.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -53.37 -23.35 23.72 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 123.349 2.699 . . . . 0.0 115.005 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 42.2 m -115.62 30.83 7.1 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -178.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -94.91 135.47 36.38 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 176.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.3 p -71.44 158.86 35.54 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 119.558 1.072 . . . . 0.0 112.686 -178.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.7 mm -63.78 -28.89 45.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 O-C-N 121.475 -0.766 . . . . 0.0 109.018 178.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -61.08 -49.83 75.73 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -61.08 -52.48 64.73 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 124.134 0.973 . . . . 0.0 109.635 179.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.0 t -56.53 -38.55 57.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 124.165 0.986 . . . . 0.0 111.421 -179.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.4 ttpt -80.59 -12.51 59.5 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 118.361 -0.828 . . . . 0.0 111.473 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.6 -43.01 11.07 Favored 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 125.211 1.404 . . . . 0.0 109.213 178.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.6 mttm -51.89 -39.71 59.48 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 121.423 -0.798 . . . . 0.0 111.723 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.1 pt -65.0 -25.01 36.7 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 O-C-N 121.679 -0.638 . . . . 0.0 111.683 178.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -76.15 -20.67 57.36 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.916 1.234 . . . . 0.0 108.911 -179.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.45 -38.92 40.06 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 120.936 -1.103 . . . . 0.0 108.234 177.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 51.4 mttm -86.95 -21.81 25.99 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 -178.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -140.29 150.16 43.7 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 121.266 1.848 . . . . 0.0 106.406 178.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.75 82.96 1.55 Allowed Glycine 0 N--CA 1.451 -0.323 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.8 pt -134.94 108.72 10.66 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 125.533 1.533 . . . . 0.0 106.865 179.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -82.87 170.23 12.68 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 124.532 3.488 . . . . 0.0 112.129 -179.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -74.9 55.39 3.88 Favored 'Trans proline' 0 CA--C 1.553 1.439 0 C-N-CA 123.056 2.504 . . . . 0.0 111.089 178.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -150.01 127.09 11.23 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 104.475 -2.417 . . . . 0.0 104.475 179.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 71.0 mm-40 54.72 50.81 15.0 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.066 1.346 . . . . 0.0 108.347 -176.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -143.21 132.42 23.2 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 179.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.6 ttm-85 -158.93 133.42 7.94 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 125.362 1.465 . . . . 0.0 107.32 -179.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 21.8 tp -92.92 140.63 29.28 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.057 0.943 . . . . 0.0 112.178 -178.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.0 mm -135.55 146.45 29.86 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 127.21 2.204 . . . . 0.0 108.209 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -137.69 120.57 16.46 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 125.95 1.7 . . . . 0.0 106.797 178.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.38 41.25 16.25 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.299 1.039 . . . . 0.0 111.535 -179.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.8 -17.39 11.3 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.644 1.116 . . . . 0.0 113.95 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.3 ttmt -79.67 128.46 33.43 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 125.389 1.476 . . . . 0.0 108.994 -179.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.6 mp0 -76.15 136.48 39.79 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 124.954 1.302 . . . . 0.0 109.468 -179.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 9.6 mt -121.09 154.23 36.4 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 124.729 1.212 . . . . 0.0 109.646 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -151.68 175.99 11.83 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 123.518 0.727 . . . . 0.0 109.471 179.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -72.35 160.04 33.02 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.726 1.61 . . . . 0.0 111.229 -178.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.21 -29.22 12.96 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 126.415 1.959 . . . . 0.0 110.856 -178.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 51.7 mtt180 -107.94 174.48 5.86 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 119.305 1.552 . . . . 0.0 112.813 179.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 50.3 p -117.55 175.67 5.53 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.984 1.714 . . . . 0.0 114.253 -177.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.17 -49.35 63.98 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.964 1.306 . . . . 0.0 112.253 179.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.37 -33.59 76.32 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 118.386 -0.816 . . . . 0.0 111.829 -179.03 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -59.59 -47.22 86.42 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.77 1.168 . . . . 0.0 108.658 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -82.05 1.64 34.87 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.171 0.988 . . . . 0.0 112.673 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.0 t30 54.3 46.77 24.46 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 126.873 2.069 . . . . 0.0 112.56 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 74.8 mt -89.25 122.99 41.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 104.148 -2.538 . . . . 0.0 104.148 178.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -101.88 177.56 4.86 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 123.163 0.585 . . . . 0.0 110.627 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -64.21 155.27 32.34 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-O 121.618 0.723 . . . . 0.0 112.315 -178.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 47.59 35.39 4.32 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 127.985 2.514 . . . . 0.0 112.454 -179.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.1 p -80.6 163.79 23.39 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.224 1.009 . . . . 0.0 109.316 178.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 43.9 m -126.22 111.08 14.17 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.6 mp -96.69 161.65 13.79 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.387 1.075 . . . . 0.0 109.469 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.4 m80 -119.2 153.45 34.92 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 125.284 1.433 . . . . 0.0 109.823 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.7 mt -122.58 126.76 48.39 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 126.35 1.86 . . . . 0.0 106.477 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.4 m -138.22 169.74 17.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -179.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.7 pt? . . . . . 0 N--CA 1.467 0.399 0 C-N-CA 126.846 2.058 . . . . 0.0 109.094 178.105 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 ttt . . . . . 0 CA--C 1.507 -0.711 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -121.18 156.81 31.58 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 177.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.4 pt -132.1 168.21 24.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 178.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -116.29 150.7 37.21 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 124.865 1.266 . . . . 0.0 107.999 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.2 t -137.96 125.31 29.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 178.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -91.21 117.33 29.55 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 178.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.9 p -72.53 165.3 24.93 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 179.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -67.42 -9.31 40.47 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.115 0.566 . . . . 0.0 112.077 178.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.3 p -102.64 -12.48 17.68 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 127.527 2.331 . . . . 0.0 113.024 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.03 6.5 42.59 Favored Glycine 0 C--N 1.335 0.518 0 CA-C-O 118.279 -1.29 . . . . 0.0 114.973 178.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.6 mmmm -81.22 163.52 22.96 Favored 'General case' 0 C--N 1.343 0.295 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 178.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.6 m -124.55 131.48 53.48 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 103.724 -2.695 . . . . 0.0 103.724 177.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.5 mm -105.49 157.38 6.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 -179.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 69.8 m -130.29 122.55 28.19 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 129.428 3.091 . . . . 0.0 103.229 178.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 72.4 mt -138.3 146.16 42.09 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.353 1.061 . . . . 0.0 110.037 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -95.71 117.46 30.56 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.47 1.508 . . . . 0.0 108.07 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.5 m -129.03 -168.97 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.431 0 C-N-CA 125.623 1.569 . . . . 0.0 109.456 -178.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -150.38 161.89 29.23 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 125.24 1.416 . . . . 0.0 107.702 178.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -59.48 -18.7 48.0 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.523 2.149 . . . . 0.0 114.34 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.2 m -114.72 30.48 7.3 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 118.753 0.706 . . . . 0.0 111.498 -178.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -92.96 129.59 38.83 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.9 p -77.88 158.25 29.51 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 119.918 1.235 . . . . 0.0 111.592 -178.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.1 mm -63.42 -29.88 48.38 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.316 0 CA-C-O 117.933 -1.032 . . . . 0.0 109.979 178.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -59.94 -40.45 88.98 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.916 1.234 . . . . 0.0 110.299 -179.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -67.42 -53.08 32.22 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.7 t -57.07 -40.09 70.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 123.045 0.538 . . . . 0.0 110.95 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt -75.34 -16.0 60.44 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.654 1.182 . . . . 0.0 111.798 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.86 -46.03 8.84 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 177.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.5 mttm -52.03 -40.05 60.47 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 124.713 1.205 . . . . 0.0 111.498 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 34.1 pt -63.61 -27.05 42.16 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-N 118.925 0.784 . . . . 0.0 111.279 178.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -77.02 -22.74 52.6 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 119.603 1.092 . . . . 0.0 109.548 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.84 -39.29 61.7 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 177.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 51.1 mttm -87.36 -22.52 25.02 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 115.281 1.586 . . . . 0.0 115.281 -178.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -138.68 150.9 46.7 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 120.633 1.56 . . . . 0.0 107.804 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.6 89.3 1.41 Allowed Glycine 0 C--N 1.334 0.426 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 -179.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.0 pt -141.49 107.61 6.06 Favored Pre-proline 0 CA--C 1.543 0.685 0 CA-C-N 118.11 0.955 . . . . 0.0 110.777 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -64.7 168.15 13.94 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 123.057 2.505 . . . . 0.0 110.858 178.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -84.1 55.46 4.68 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 122.251 1.967 . . . . 0.0 108.49 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -146.56 136.03 22.94 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 130.516 3.526 . . . . 0.0 104.456 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 66.5 mm-40 51.24 47.52 24.7 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.26 1.824 . . . . 0.0 109.594 -178.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -154.86 132.47 11.31 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 179.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 51.8 ttm-85 -157.52 135.13 10.58 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 103.533 -2.766 . . . . 0.0 103.533 179.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 15.5 tp -87.92 141.91 28.21 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -178.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.3 mm -134.41 141.52 43.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 125.923 1.689 . . . . 0.0 108.1 -178.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -139.39 125.86 20.39 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.29 33.32 15.32 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.528 0.68 . . . . 0.0 111.919 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.97 -13.19 32.63 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 124.461 1.029 . . . . 0.0 112.511 -179.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.5 tpmt? -78.58 123.11 26.75 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 -179.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -75.91 136.29 40.1 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.465 HD22 ' CG ' ' A' ' 59' ' ' TYR . 3.5 mt -115.17 154.76 28.41 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 123.867 0.867 . . . . 0.0 109.462 -178.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -158.98 179.52 8.99 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 126.302 1.841 . . . . 0.0 107.46 178.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.22 160.95 31.91 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.914 1.285 . . . . 0.0 112.458 -176.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.43 -27.13 21.87 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 113.784 -1.553 . . . . 0.0 111.303 -179.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 44.8 mtt180 -106.6 168.06 9.43 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 119.033 1.417 . . . . 0.0 111.074 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.1 p -117.81 173.1 6.94 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.599 1.559 . . . . 0.0 113.181 -178.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.44 -48.95 65.49 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.151 0.98 . . . . 0.0 111.657 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.4 -32.48 74.11 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 118.474 0.579 . . . . 0.0 111.493 -179.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -63.79 -45.68 88.6 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 119.498 1.044 . . . . 0.0 108.774 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.465 ' CG ' HD22 ' A' ' 50' ' ' LEU . 59.3 m-85 -82.16 2.08 33.26 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.683 -0.636 . . . . 0.0 111.69 179.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 54.47 47.12 23.51 Favored 'General case' 0 C--N 1.342 0.277 0 C-N-CA 128.041 2.536 . . . . 0.0 111.193 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 74.2 mt -89.99 122.27 41.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 103.553 -2.758 . . . . 0.0 103.553 178.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 94.2 mm-40 -98.57 177.48 5.31 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 40.8 pttt -64.51 156.05 30.94 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -179.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.255 5.4 mp0 45.65 44.38 10.24 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.935 2.094 . . . . 0.0 113.597 179.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.8 p -87.94 164.85 15.62 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.619 1.968 . . . . 0.0 109.508 177.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.2 m -126.51 107.3 10.12 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 119.437 1.017 . . . . 0.0 108.755 178.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.1 mp -96.44 163.18 13.16 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.788 1.635 . . . . 0.0 110.547 -178.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 16.1 m80 -119.26 161.0 21.14 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.133 1.373 . . . . 0.0 111.815 178.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 39.9 mt -123.29 128.85 50.52 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.897 1.679 . . . . 0.0 107.855 178.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.1 m -140.66 162.74 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-N 118.868 0.758 . . . . 0.0 112.253 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.463 0.198 0 C-N-CA 126.394 1.878 . . . . 0.0 109.51 178.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.6 ttt . . . . . 0 N--CA 1.469 0.516 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -121.83 154.23 37.3 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 175.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 32.8 pt -132.55 169.72 21.38 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 177.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -123.49 150.07 44.37 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.9 t -138.21 125.23 27.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 178.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.9 tppp? -91.42 117.47 29.71 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 104.624 -2.361 . . . . 0.0 104.624 178.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.0 p -72.8 168.99 17.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 118.456 0.571 . . . . 0.0 110.277 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -66.87 -12.59 59.79 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 121.11 -0.236 . . . . 0.0 111.044 178.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.7 p -93.74 -12.4 29.27 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.572 1.949 . . . . 0.0 112.023 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.8 7.28 55.63 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-O 118.801 -1.0 . . . . 0.0 113.49 178.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -79.88 164.01 23.9 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-N 119.484 1.642 . . . . 0.0 106.992 179.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.1 m -114.7 130.43 56.82 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 103.289 -2.856 . . . . 0.0 103.289 178.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.8 mm -115.55 154.08 17.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 105.602 -1.999 . . . . 0.0 105.602 179.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.2 m -134.96 125.3 26.36 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 126.924 2.09 . . . . 0.0 105.395 179.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 82.1 mt -140.13 151.05 44.99 Favored 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 124.543 1.137 . . . . 0.0 109.851 -179.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -94.84 118.33 31.59 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 105.504 -2.036 . . . . 0.0 105.504 178.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.6 m -129.82 -174.2 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 124.523 1.129 . . . . 0.0 108.824 -179.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -149.71 168.35 11.18 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 124.404 1.082 . . . . 0.0 108.574 -179.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -59.54 -21.24 61.16 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.473 2.115 . . . . 0.0 113.48 178.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.3 m -114.85 31.78 6.45 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 118.463 0.574 . . . . 0.0 111.857 -178.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -91.69 128.21 37.44 Favored 'General case' 0 C--O 1.242 0.711 1 N-CA-C 99.671 -4.196 . . . . 0.0 99.671 177.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.1 p -76.72 158.59 30.85 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -179.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.8 mm -63.49 -27.31 42.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 119.254 -0.978 . . . . 0.0 109.388 178.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -61.58 -37.84 85.34 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.885 1.221 . . . . 0.0 109.017 178.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.0 m-80 -69.24 -52.93 22.8 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 178.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 25.8 t -55.73 -38.53 51.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-N 119.049 0.84 . . . . 0.0 110.93 179.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.1 ttpt -75.08 -18.18 60.33 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.327 1.051 . . . . 0.0 111.686 -179.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.01 -46.83 8.24 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 126.767 2.027 . . . . 0.0 109.187 178.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -51.5 -40.68 60.03 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.407 1.483 . . . . 0.0 110.831 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 31.6 pt -64.79 -25.21 37.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 O-C-N 121.138 -0.976 . . . . 0.0 111.879 179.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -76.85 -23.37 52.69 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 120.671 -1.268 . . . . 0.0 109.626 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.78 -24.57 55.99 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 176.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.2 mttm -100.74 -15.29 17.73 Favored 'General case' 0 C--N 1.341 0.203 0 N-CA-C 116.236 1.939 . . . . 0.0 116.236 -179.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -145.55 158.56 43.83 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 120.918 1.69 . . . . 0.0 108.111 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.14 68.64 3.4 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.6 pt -131.6 108.57 14.5 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 118.131 0.966 . . . . 0.0 110.507 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -75.18 169.58 22.22 Favored 'Trans proline' 0 CA--C 1.544 0.992 0 C-N-CA 123.172 2.581 . . . . 0.0 109.372 178.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -78.69 56.62 6.01 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.374 2.049 . . . . 0.0 110.665 179.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -146.78 135.93 22.58 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 129.218 3.007 . . . . 0.0 106.939 -179.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 68.9 mm-40 52.73 47.91 23.65 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 127.928 2.491 . . . . 0.0 109.524 -178.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 25.9 m-80 -153.0 136.44 15.87 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 121.785 -0.572 . . . . 0.0 109.754 179.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 54.4 ttm-85 -151.92 134.91 15.72 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 126.558 1.943 . . . . 0.0 105.891 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 19.6 tp -87.74 140.83 29.11 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 124.09 0.956 . . . . 0.0 109.484 -178.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.2 mm -132.7 144.7 35.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 125.655 1.582 . . . . 0.0 109.355 -178.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -138.36 121.27 16.58 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 177.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.22 40.59 26.44 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.463 1.105 . . . . 0.0 110.55 -179.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.13 -16.13 18.32 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 125.264 1.412 . . . . 0.0 113.85 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.0 ttmt -79.05 128.93 33.89 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 119.832 1.816 . . . . 0.0 109.014 -179.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.0 mp0 -74.26 134.36 42.65 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.0 mt -117.93 154.98 31.01 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.826 1.25 . . . . 0.0 109.537 -179.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -162.5 176.91 9.96 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 126.803 2.041 . . . . 0.0 107.404 177.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -71.44 161.59 30.8 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.205 1.402 . . . . 0.0 112.285 -178.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 108.43 -28.98 10.56 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 127.386 2.422 . . . . 0.0 108.049 -178.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 46.2 mtt180 -107.62 169.83 8.35 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 124.934 1.294 . . . . 0.0 110.473 178.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 80.8 p -123.84 169.45 11.56 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 127.161 2.184 . . . . 0.0 110.178 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.9 mp -53.01 -42.07 65.29 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 123.064 0.545 . . . . 0.0 111.259 177.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.4 t -59.31 -44.96 92.5 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.595 1.158 . . . . 0.0 109.916 -179.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -58.96 -46.37 88.22 Favored 'General case' 0 C--N 1.341 0.233 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -81.35 1.32 33.31 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -179.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 36.9 t30 54.31 45.91 26.25 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.199 1.799 . . . . 0.0 111.228 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 81.3 mt -87.98 123.4 40.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 87.5 mm-40 -95.1 175.16 6.73 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.43 0.633 . . . . 0.0 111.203 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -70.99 157.11 38.77 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.386 0.674 . . . . 0.0 109.201 178.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 54.1 35.37 22.12 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.441 1.496 . . . . 0.0 110.958 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.9 p -87.2 162.12 17.65 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.529 1.132 . . . . 0.0 109.19 178.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.1 m -124.96 107.93 11.35 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 122.365 1.079 . . . . 0.0 109.539 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.2 mp -96.44 160.46 14.39 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.734 1.214 . . . . 0.0 108.802 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -119.07 160.7 21.57 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.709 1.204 . . . . 0.0 111.745 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 25.6 mt -123.08 124.61 43.49 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.987 1.715 . . . . 0.0 108.16 179.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.9 m -141.1 167.9 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 124.775 1.23 . . . . 0.0 113.174 -179.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.531 0.215 0 C-N-CA 125.262 1.425 . . . . 0.0 110.076 177.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.469 0.481 0 N-CA-C 111.25 0.093 . . . . 0.0 111.25 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -121.48 157.57 30.33 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 176.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.0 pt -132.37 169.96 20.88 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 C-N-CA 125.287 1.435 . . . . 0.0 108.346 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 41.9 m-85 -126.24 149.53 49.02 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 124.925 1.29 . . . . 0.0 107.89 178.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.5 t -139.62 131.48 34.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -97.6 117.78 32.65 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.3 p -83.27 168.79 16.37 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.027 0.931 . . . . 0.0 110.976 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.9 -5.0 22.99 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.582 0.753 . . . . 0.0 112.632 178.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 18.0 p -93.28 -14.14 27.36 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 177.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.18 7.13 57.45 Favored Glycine 0 CA--C 1.524 0.617 0 C-N-CA 124.903 1.24 . . . . 0.0 111.349 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.82 163.95 23.06 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 119.084 1.442 . . . . 0.0 107.567 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.2 m -120.5 137.42 54.37 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 103.629 -2.73 . . . . 0.0 103.629 178.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.2 mm -114.69 157.02 15.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 38.1 m -134.73 124.26 24.95 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 127.954 2.502 . . . . 0.0 104.343 178.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 29.5 mt -139.93 150.81 45.0 Favored 'General case' 0 CA--C 1.515 -0.373 0 C-N-CA 124.79 1.236 . . . . 0.0 111.589 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -98.25 119.01 36.17 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 127.274 2.23 . . . . 0.0 106.519 178.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.0 m -134.09 -171.19 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 125.949 1.7 . . . . 0.0 108.287 -179.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -142.38 161.17 51.52 Favored Pre-proline 0 CA--C 1.536 0.437 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -61.25 -18.01 56.16 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.442 2.095 . . . . 0.0 112.899 179.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.8 m -114.96 30.97 6.99 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 124.216 1.007 . . . . 0.0 111.402 -177.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -93.06 130.95 38.49 Favored 'General case' 0 C--O 1.241 0.642 0 C-N-CA 126.277 1.831 . . . . 0.0 106.825 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.3 p -77.15 158.18 30.54 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 119.775 1.171 . . . . 0.0 110.301 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.7 mm -63.61 -30.72 50.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -61.24 -37.36 82.81 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 119.348 0.976 . . . . 0.0 111.554 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -73.46 -53.33 10.89 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 123.94 0.896 . . . . 0.0 108.591 179.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.2 t -55.94 -38.16 51.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 123.035 0.534 . . . . 0.0 110.723 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.8 ttpt -75.14 -16.55 60.52 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 118.172 -0.918 . . . . 0.0 110.952 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -82.69 -45.38 14.53 Favored 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 177.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.6 mttm -50.98 -40.17 57.19 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.953 1.301 . . . . 0.0 112.105 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.3 pt -64.71 -27.29 42.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 O-C-N 120.978 -1.076 . . . . 0.0 111.001 179.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -76.6 -22.81 53.7 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 119.399 0.999 . . . . 0.0 109.162 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.76 -40.17 63.68 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . 0.296 87.1 mttt -92.42 -15.32 27.35 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-O 117.435 -1.269 . . . . 0.0 114.257 -179.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -140.46 150.58 43.98 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 121.881 2.128 . . . . 0.0 106.682 178.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -83.47 87.15 1.5 Allowed Glycine 0 C--N 1.334 0.428 0 CA-C-O 118.977 -0.902 . . . . 0.0 111.782 -178.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.5 pt -137.46 108.22 8.62 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 124.271 1.028 . . . . 0.0 111.45 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -69.83 170.13 17.39 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 124.786 3.657 . . . . 0.0 110.733 178.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -82.39 54.72 5.05 Favored 'Trans proline' 0 CA--C 1.547 1.143 0 N-CA-C 107.827 -1.644 . . . . 0.0 107.827 177.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -150.53 135.91 17.94 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 127.898 2.479 . . . . 0.0 105.519 -178.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 54.7 mm-40 53.03 46.47 26.69 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 128.024 2.53 . . . . 0.0 106.175 -176.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -156.38 135.93 12.37 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.231 1.012 . . . . 0.0 111.919 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.1 ttm-85 -154.93 136.08 13.93 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 127.13 2.172 . . . . 0.0 105.995 178.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 23.7 tp -87.97 137.37 32.39 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.643 0.777 . . . . 0.0 109.481 -178.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.4 mm -135.3 148.57 28.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 C-N-CA 125.644 1.578 . . . . 0.0 108.796 -178.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -138.51 121.13 16.26 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 178.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.0 33.52 12.04 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-N 119.315 0.961 . . . . 0.0 111.353 -179.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.15 -7.79 62.66 Favored Glycine 0 CA--C 1.532 1.099 0 O-C-N 121.298 -0.876 . . . . 0.0 113.123 -179.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.2 tpmt? -78.64 118.11 20.43 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 104.743 -2.317 . . . . 0.0 104.743 179.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.5 mp0 -74.95 133.0 41.82 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.2 mt -114.12 155.47 25.96 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.558 1.143 . . . . 0.0 109.837 -178.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -157.25 174.72 15.02 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.458 1.503 . . . . 0.0 108.161 178.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -73.73 159.8 32.44 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.401 1.48 . . . . 0.0 112.327 -179.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 106.07 -27.53 17.03 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 126.46 1.981 . . . . 0.0 109.526 -178.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 46.0 mtt180 -107.39 169.26 8.69 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 118.124 0.962 . . . . 0.0 110.689 178.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 80.4 p -119.02 168.95 10.33 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 126.268 1.827 . . . . 0.0 110.72 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.8 mp -52.4 -42.89 64.43 Favored 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 123.625 0.77 . . . . 0.0 112.784 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 68.9 m -65.81 -32.63 74.27 Favored 'General case' 0 N--CA 1.462 0.125 0 CA-C-N 118.929 0.786 . . . . 0.0 112.535 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -64.09 -44.38 92.5 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -81.45 1.61 32.42 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.592 1.157 . . . . 0.0 111.519 178.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 55.45 46.73 22.59 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 127.167 2.187 . . . . 0.0 112.326 179.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 15.0 mt -96.18 123.78 48.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 86.8 mm-40 -101.24 178.25 4.71 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.978 1.311 . . . . 0.0 110.609 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 26.1 pttt -64.47 156.65 28.9 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 122.87 0.468 . . . . 0.0 111.279 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 48.43 41.06 16.13 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 127.386 2.274 . . . . 0.0 112.585 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.5 p -87.2 153.79 21.22 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.408 1.083 . . . . 0.0 108.082 177.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 14.4 m -118.72 114.57 22.92 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 106.887 -1.523 . . . . 0.0 106.887 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.5 mp -101.07 168.29 9.69 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.786 1.635 . . . . 0.0 110.861 -178.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.7 m80 -119.96 154.76 34.01 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 127.106 2.162 . . . . 0.0 109.327 178.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 16.7 mt -123.44 125.08 44.29 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 178.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.4 m -139.79 166.15 21.12 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 CA-C-N 120.789 1.631 . . . . 0.0 113.436 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -134.2 -170.43 2.52 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 125.983 1.713 . . . . 0.0 110.898 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -152.54 131.59 12.64 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 178.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.442 HD23 ' H ' ' A' ' 75' ' ' GLY . 0.5 OUTLIER -145.06 135.01 23.74 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -178.911 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 44.0 mmm-85 -106.18 -11.51 16.04 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 123.413 0.685 . . . . 0.0 111.651 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.442 ' H ' HD23 ' A' ' 73' ' ' LEU . . . -85.68 18.43 30.08 Favored Glycine 0 CA--C 1.537 1.428 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 177.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.954 0 N-CA-C 105.256 -3.138 . . . . 0.0 105.256 -179.348 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.3 ttt . . . . . 0 N--CA 1.473 0.676 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -120.77 158.72 26.92 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 114.668 1.359 . . . . 0.0 114.668 -177.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 2.9 pp -131.57 168.78 23.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 176.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -126.66 149.79 49.33 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 125.262 1.425 . . . . 0.0 108.106 179.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.8 t -138.68 125.47 25.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? -89.99 116.39 28.0 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 103.085 -2.932 . . . . 0.0 103.085 177.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.5 p -72.55 168.75 17.93 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 122.574 1.178 . . . . 0.0 113.294 -178.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -67.75 -12.64 60.98 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 114.648 -1.16 . . . . 0.0 111.094 178.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 65.9 p -102.64 -12.56 17.61 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.771 1.169 . . . . 0.0 110.882 179.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.61 7.31 34.37 Favored Glycine 0 CA--C 1.529 0.913 0 C-N-CA 124.883 1.23 . . . . 0.0 114.89 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.2 mmmm -80.88 165.24 22.0 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 120.069 1.935 . . . . 0.0 108.053 178.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 83.7 m -119.06 130.4 55.6 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 104.233 -2.506 . . . . 0.0 104.233 178.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.0 mm -115.78 154.2 17.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 125.398 1.479 . . . . 0.0 107.775 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.2 m -135.13 128.59 32.43 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 178.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 74.4 mt -139.8 150.47 44.76 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 118.678 0.672 . . . . 0.0 111.05 -179.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -94.32 118.48 31.66 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 125.231 1.412 . . . . 0.0 107.771 178.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.8 m -134.57 179.23 4.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 126.581 1.953 . . . . 0.0 108.461 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -147.98 162.69 30.22 Favored Pre-proline 0 CA--C 1.536 0.42 0 O-C-N 120.908 -1.12 . . . . 0.0 109.401 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -51.95 -22.56 14.55 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 123.773 2.982 . . . . 0.0 115.572 -179.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.6 t -114.6 30.92 6.98 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 119.951 1.251 . . . . 0.0 111.051 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -95.22 129.4 42.36 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 103.759 -2.682 . . . . 0.0 103.759 177.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 52.6 p -76.74 159.53 30.08 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 118.775 0.716 . . . . 0.0 109.764 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 39.8 mm -58.98 -26.0 31.41 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 CA-C-O 118.611 -0.709 . . . . 0.0 110.084 178.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -64.28 -46.18 84.79 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 125.108 1.363 . . . . 0.0 109.645 178.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.5 m-80 -62.22 -52.51 63.46 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.3 t -57.18 -37.36 55.55 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 C-N-CA 122.725 0.41 . . . . 0.0 109.922 178.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.7 ttpt -75.02 -19.84 59.89 Favored 'General case' 0 CA--C 1.536 0.42 0 O-C-N 120.903 -1.123 . . . . 0.0 110.547 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -77.29 -45.36 26.5 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 104.908 -2.256 . . . . 0.0 104.908 177.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 39.6 mttm -54.53 -43.29 71.8 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.156 1.382 . . . . 0.0 111.385 179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.1 pt -63.81 -28.24 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-N 120.148 1.34 . . . . 0.0 110.456 178.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -76.16 -22.64 55.16 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 119.926 1.239 . . . . 0.0 110.897 -179.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.27 -23.24 51.2 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 177.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -99.56 -23.96 14.91 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 114.387 1.255 . . . . 0.0 114.387 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -152.37 149.54 28.73 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 178.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -88.78 87.15 1.47 Allowed Glycine 0 CA--C 1.519 0.296 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 -179.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.2 pt -132.23 107.4 13.54 Favored Pre-proline 0 CA--C 1.539 0.548 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.23 156.86 15.45 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.062 2.508 . . . . 0.0 113.315 -179.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -83.31 55.96 5.25 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.572 2.181 . . . . 0.0 107.763 178.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -156.6 137.53 13.49 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 128.585 2.754 . . . . 0.0 106.165 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 50.56 45.27 26.84 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 127.405 2.282 . . . . 0.0 108.228 -178.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -157.75 135.46 10.59 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 129.042 2.937 . . . . 0.0 106.212 178.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 33.7 ttm105 -151.66 141.06 21.52 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 121.424 1.92 . . . . 0.0 106.539 177.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.416 ' O ' HD13 ' A' ' 44' ' ' ILE . 0.5 OUTLIER -88.25 140.19 29.73 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 124.393 1.077 . . . . 0.0 109.48 -178.966 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.416 HD13 ' O ' ' A' ' 43' ' ' LEU . 3.9 mm -135.49 146.41 29.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 125.275 1.43 . . . . 0.0 108.887 -179.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -135.82 115.09 12.48 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 125.005 1.322 . . . . 0.0 108.679 178.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.88 41.25 14.23 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.281 1.432 . . . . 0.0 111.771 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.17 -14.95 52.02 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 125.696 1.617 . . . . 0.0 113.959 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.6 tpmt? -79.69 124.82 28.91 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -74.44 137.06 42.38 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 178.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.6 mt -114.01 142.21 46.45 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -152.8 176.28 11.97 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.661 1.984 . . . . 0.0 107.86 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -72.57 159.81 33.3 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 125.457 1.503 . . . . 0.0 111.089 -178.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 105.99 -29.14 11.68 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 127.769 2.604 . . . . 0.0 110.618 -178.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . 0.343 34.3 mtm105 -109.91 168.41 9.44 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 60.9 p -120.49 171.31 8.63 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 126.702 2.001 . . . . 0.0 111.504 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.2 mp -51.26 -41.5 60.43 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 124.358 1.063 . . . . 0.0 111.674 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 11.4 t -59.17 -45.78 90.12 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.418 1.487 . . . . 0.0 110.422 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -62.21 -44.51 96.4 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 123.969 0.908 . . . . 0.0 110.615 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -82.16 -2.04 50.89 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.926 0.891 . . . . 0.0 112.833 -179.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 40.8 t30 53.7 46.34 26.12 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 126.237 1.815 . . . . 0.0 110.631 -179.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 93.2 mt -85.02 123.23 39.05 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.153 0 N-CA-C 104.6 -2.37 . . . . 0.0 104.6 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 92.8 mm-40 -89.27 166.79 13.55 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.606 -178.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 46.6 pttt -64.44 155.39 32.77 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.007 178.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 45.33 34.67 1.56 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 128.338 2.655 . . . . 0.0 112.179 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 51.6 m -77.3 160.57 28.75 Favored 'General case' 0 N--CA 1.462 0.174 0 O-C-N 120.908 -1.12 . . . . 0.0 111.42 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.9 m -115.15 113.66 24.27 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.5 mp -108.68 163.51 13.19 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.72 1.608 . . . . 0.0 109.763 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -119.39 162.33 18.99 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.605 1.162 . . . . 0.0 112.131 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 2.2 mt -121.42 129.91 53.28 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 126.434 1.894 . . . . 0.0 106.37 178.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.4 m -135.42 173.06 14.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 C-N-CA 125.0 1.32 . . . . 0.0 108.695 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.4 pp -141.46 -172.09 3.45 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.69 0.796 . . . . 0.0 110.271 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.18 142.08 12.84 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 128.087 2.555 . . . . 0.0 104.174 178.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.4 mt -137.56 121.8 18.07 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 119.803 1.183 . . . . 0.0 109.553 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.264 18.3 mmm-85 -109.34 -0.08 19.24 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 127.19 2.196 . . . . 0.0 112.396 177.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -78.84 37.43 1.91 Allowed Glycine 0 CA--C 1.528 0.871 0 O-C-N 120.636 -1.29 . . . . 0.0 114.526 -177.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.018 0 C-N-CA 126.539 2.019 . . . . 0.0 108.933 179.547 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.9 ttt . . . . . 0 CA--C 1.514 -0.431 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -120.6 156.95 30.56 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.2 pt -132.85 169.8 21.28 Favored 'Isoleucine or valine' 0 C--O 1.239 0.553 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 177.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -124.9 152.45 44.05 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 125.799 1.64 . . . . 0.0 108.23 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.4 t -138.33 125.13 26.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 178.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.2 tppp? -90.64 116.25 28.38 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 104.035 -2.58 . . . . 0.0 104.035 178.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 44.1 p -72.42 166.81 21.83 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.317 0.579 . . . . 0.0 110.291 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -67.48 -12.08 59.44 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.199 178.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.7 p -96.78 -12.71 23.31 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 127.693 2.397 . . . . 0.0 112.273 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.57 6.43 56.41 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 125.895 1.712 . . . . 0.0 114.074 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -82.99 165.47 19.63 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-N 118.954 1.377 . . . . 0.0 107.322 178.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 43.6 m -123.07 132.43 54.1 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.7 mm -107.17 155.47 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 179.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.1 m -132.86 130.38 39.68 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 103.76 -2.682 . . . . 0.0 103.76 178.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 76.1 mt -139.6 150.52 45.09 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -100.56 118.49 36.84 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 104.189 -2.523 . . . . 0.0 104.189 178.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.6 m -131.89 -170.74 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 125.036 1.334 . . . . 0.0 109.937 -178.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -147.34 159.29 42.41 Favored Pre-proline 0 CA--C 1.534 0.345 0 O-C-N 121.007 -1.058 . . . . 0.0 109.972 178.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -56.8 -23.58 51.08 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.971 2.447 . . . . 0.0 114.856 -179.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 43.5 m -115.24 32.59 5.95 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 123.676 0.79 . . . . 0.0 111.124 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -92.83 129.63 38.69 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 104.125 -2.546 . . . . 0.0 104.125 178.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.1 p -77.18 159.5 29.67 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 119.777 1.171 . . . . 0.0 111.833 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.1 mm -63.59 -30.73 50.62 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.278 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -56.39 -39.52 73.12 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.823 0.849 . . . . 0.0 110.551 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -74.79 -55.53 5.74 Favored 'General case' 0 C--O 1.224 -0.275 0 C-N-CA 123.486 0.714 . . . . 0.0 109.339 178.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.6 t -54.02 -46.18 65.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 124.819 1.248 . . . . 0.0 113.068 -177.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -75.0 -15.64 60.65 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 123.612 0.765 . . . . 0.0 111.137 -179.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.59 -41.63 11.87 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 177.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.0 mttm -53.77 -40.56 66.35 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 124.231 1.012 . . . . 0.0 110.573 179.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 29.2 pt -60.45 -27.22 39.51 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-O 118.128 -0.939 . . . . 0.0 111.16 179.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.9 mt-30 -80.43 -20.17 44.5 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.099 1.36 . . . . 0.0 111.087 179.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -88.46 -24.3 23.03 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.974 1.31 . . . . 0.0 109.11 178.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 32.7 tptt -99.0 -20.54 16.7 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.122 1.769 . . . . 0.0 112.389 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -144.37 150.28 37.51 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.838 2.055 . . . . 0.0 106.174 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -82.28 82.37 1.63 Allowed Glycine 0 C--N 1.333 0.374 0 CA-C-O 118.793 -1.004 . . . . 0.0 111.784 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.7 pt -131.18 108.29 15.0 Favored Pre-proline 0 CA--C 1.546 0.796 0 CA-C-N 118.413 1.107 . . . . 0.0 109.866 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -58.66 155.96 34.55 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 123.98 3.12 . . . . 0.0 114.001 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -86.2 57.17 3.95 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 123.469 2.779 . . . . 0.0 106.624 177.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -146.15 136.68 24.05 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 129.471 3.109 . . . . 0.0 103.726 -178.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.4 pt20 48.01 50.92 15.28 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.468 1.507 . . . . 0.0 112.29 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -145.41 148.71 33.63 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 121.052 -1.03 . . . . 0.0 110.371 179.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 -154.59 135.04 13.37 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 125.14 1.376 . . . . 0.0 109.514 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 54.9 tp -89.08 136.55 32.95 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 125.106 1.362 . . . . 0.0 110.178 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 18.3 mm -133.92 145.88 32.54 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 125.24 1.416 . . . . 0.0 111.08 -178.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -138.92 126.47 21.84 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 176.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.58 34.76 16.36 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.708 1.203 . . . . 0.0 111.719 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.32 -8.02 59.35 Favored Glycine 0 CA--C 1.531 1.033 0 O-C-N 120.919 -1.113 . . . . 0.0 114.203 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.2 mmtp -92.17 130.37 37.9 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 125.864 1.666 . . . . 0.0 109.169 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -73.68 136.37 43.78 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 123.794 0.838 . . . . 0.0 108.868 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.9 mt -115.19 150.43 36.11 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 179.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -152.09 176.31 11.67 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -72.18 156.23 39.38 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 122.112 0.958 . . . . 0.0 110.555 -178.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.98 -21.14 30.06 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 126.416 1.96 . . . . 0.0 109.855 -178.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 40.3 mmt-85 -107.12 169.38 8.59 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.364 1.466 . . . . 0.0 111.948 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.9 p -123.65 167.59 13.77 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.905 1.682 . . . . 0.0 111.327 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -52.41 -47.22 66.41 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.158 0.983 . . . . 0.0 112.39 179.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.2 t -65.26 -31.43 72.57 Favored 'General case' 0 C--O 1.227 -0.115 0 C-N-CA 123.77 0.828 . . . . 0.0 112.763 -179.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -59.6 -47.36 85.87 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 119.996 1.271 . . . . 0.0 109.271 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -82.09 0.69 39.44 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.22 0.608 . . . . 0.0 110.236 178.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 22.5 t30 53.96 47.49 23.32 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 127.639 2.376 . . . . 0.0 110.646 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.5 mt -85.26 122.5 38.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.308 0 N-CA-C 104.318 -2.475 . . . . 0.0 104.318 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 76.3 mm-40 -92.83 175.35 6.83 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.289 0.566 . . . . 0.0 110.189 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 53.8 pttt -64.71 156.76 29.36 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.293 0.568 . . . . 0.0 110.295 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 52.72 35.34 18.21 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 128.252 2.621 . . . . 0.0 111.608 -179.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 72.3 m -85.82 158.22 20.03 Favored 'General case' 0 N--CA 1.468 0.446 0 O-C-N 120.848 -1.157 . . . . 0.0 109.467 178.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 28.3 m -119.16 120.35 36.83 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.612 1.165 . . . . 0.0 110.246 -178.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.2 mp -107.36 162.69 13.69 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.865 1.666 . . . . 0.0 110.722 -179.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -119.91 160.59 22.41 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 126.008 1.723 . . . . 0.0 111.616 179.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 90.4 mt -123.64 131.9 53.73 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.427 1.491 . . . . 0.0 110.257 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.4 m -140.5 161.7 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-N 119.63 1.104 . . . . 0.0 111.19 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -143.7 -172.04 3.65 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 178.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.1 mmt-85 -159.93 127.98 4.79 Favored 'General case' 0 C--N 1.344 0.335 0 C-N-CA 125.362 1.465 . . . . 0.0 109.064 176.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 12.6 mt -157.02 142.07 17.1 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 127.824 2.449 . . . . 0.0 107.493 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -107.42 -28.14 10.02 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 118.77 0.714 . . . . 0.0 111.208 177.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -93.52 18.93 55.4 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 125.367 1.46 . . . . 0.0 110.897 178.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.189 0 C-N-CA 128.366 2.888 . . . . 0.0 106.422 -179.836 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.5 ttt . . . . . 0 CA--C 1.509 -0.618 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -119.29 145.64 45.95 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 124.279 0.987 . . . . 0.0 109.734 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.2 pt -134.17 169.7 21.15 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 C-N-CA 125.288 1.435 . . . . 0.0 108.077 177.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -124.47 149.91 46.31 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 125.882 1.673 . . . . 0.0 110.47 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.6 t -139.77 131.57 33.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 177.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -97.58 117.14 31.18 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 105.426 -2.065 . . . . 0.0 105.426 177.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 41.6 p -74.29 165.85 24.47 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 118.522 0.601 . . . . 0.0 111.067 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.452 HD23 HG23 ' A' ' 9' ' ' THR . 1.1 pt? -67.63 -10.54 53.08 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.32 178.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.452 HG23 HD23 ' A' ' 8' ' ' LEU . 77.2 p -91.71 -12.46 33.97 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.569 1.547 . . . . 0.0 110.66 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.1 5.88 57.09 Favored Glycine 0 C--N 1.34 0.791 0 C-N-CA 126.177 1.846 . . . . 0.0 112.9 179.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.8 164.04 23.01 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 119.151 1.475 . . . . 0.0 107.801 179.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 50.1 m -114.08 133.57 55.45 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 102.599 -3.111 . . . . 0.0 102.599 177.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 40.1 mm -114.57 157.87 15.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 C-N-CA 125.849 1.66 . . . . 0.0 107.837 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.6 m -131.36 130.8 43.11 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 128.823 2.849 . . . . 0.0 104.886 178.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.646 HD11 HG23 ' A' ' 30' ' ' ILE . 12.8 mt -140.17 144.47 36.65 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 124.018 0.927 . . . . 0.0 110.349 179.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -105.26 110.5 22.89 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 127.382 2.273 . . . . 0.0 105.621 177.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.1 m -134.34 -169.16 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -141.8 160.6 55.4 Favored Pre-proline 0 C--O 1.238 0.459 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -56.43 -18.55 25.51 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.734 2.29 . . . . 0.0 113.386 178.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 39.1 m -115.66 30.43 7.35 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 119.023 0.828 . . . . 0.0 112.991 -178.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -94.74 134.17 37.63 Favored 'General case' 0 C--O 1.241 0.636 0 N-CA-C 104.993 -2.225 . . . . 0.0 104.993 177.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.1 p -73.54 157.55 36.51 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 119.07 -1.052 . . . . 0.0 109.204 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 42.2 mm -64.1 -26.29 40.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 177.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -56.58 -42.06 78.0 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.82 1.248 . . . . 0.0 109.647 179.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -74.14 -54.93 6.75 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 123.786 0.834 . . . . 0.0 109.73 178.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 40.7 t -54.32 -40.03 46.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -178.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -75.68 -16.28 60.2 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.395 0.678 . . . . 0.0 111.015 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.58 -41.73 11.82 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.395 1.078 . . . . 0.0 109.142 178.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.0 mttm -53.17 -40.46 64.36 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 118.727 0.694 . . . . 0.0 110.129 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.646 HG23 HD11 ' A' ' 15' ' ' LEU . 38.3 pt -62.3 -26.88 41.47 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 O-C-N 120.703 -1.248 . . . . 0.0 111.665 179.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 -76.53 -20.11 57.23 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.344 1.058 . . . . 0.0 109.575 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.18 -39.43 40.82 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 177.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.3 mttm -88.59 -16.25 33.01 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 -178.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -141.41 150.54 42.48 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 179.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -87.08 85.65 1.54 Allowed Glycine 0 CA--C 1.52 0.392 0 O-C-N 121.419 -0.801 . . . . 0.0 111.987 -178.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.0 pt -134.18 107.97 11.38 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 124.608 1.163 . . . . 0.0 108.149 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -69.29 168.46 20.87 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 124.197 3.265 . . . . 0.0 113.755 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -82.35 56.83 5.91 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 122.975 2.45 . . . . 0.0 108.427 177.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -154.1 136.57 15.04 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 129.695 3.198 . . . . 0.0 103.713 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 62.4 mm-40 53.76 50.17 17.61 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.441 1.096 . . . . 0.0 108.333 -178.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -142.0 134.43 28.02 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 -178.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 47.5 ttm-85 -159.56 132.27 6.74 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 30.6 tp -99.4 137.25 38.16 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 124.218 1.007 . . . . 0.0 109.47 -178.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 4.5 mm -135.06 141.9 41.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.235 1.014 . . . . 0.0 109.305 -178.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -138.99 126.1 21.26 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 178.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.02 33.22 14.35 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.027 0.531 . . . . 0.0 110.674 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.42 -16.21 19.58 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 124.74 1.162 . . . . 0.0 112.73 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -79.35 126.52 30.92 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 119.33 1.565 . . . . 0.0 108.133 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.7 mp0 -75.61 137.12 40.55 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.102 -1.074 . . . . 0.0 108.102 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 25.6 mt -114.26 154.64 27.59 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.716 1.207 . . . . 0.0 108.794 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -162.47 175.25 11.69 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 179.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -72.76 160.96 31.35 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 126.879 2.072 . . . . 0.0 114.078 -177.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.47 -29.39 12.0 Favored Glycine 0 N--CA 1.445 -0.723 0 C-N-CA 127.578 2.513 . . . . 0.0 109.081 -178.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 50.0 mtt180 -107.95 169.01 8.88 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 117.979 0.89 . . . . 0.0 110.961 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 37.5 p -117.5 171.58 7.91 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 124.488 1.115 . . . . 0.0 112.033 -178.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.7 mp -52.2 -41.77 62.97 Favored 'General case' 0 C--O 1.227 -0.128 0 C-N-CA 123.572 0.749 . . . . 0.0 111.157 178.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.1 t -59.21 -46.0 89.62 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.559 1.544 . . . . 0.0 109.983 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -64.2 -39.66 94.45 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 123.533 0.733 . . . . 0.0 110.152 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -84.68 -0.69 54.44 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.54 0.736 . . . . 0.0 111.487 179.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 61.3 t30 53.85 46.12 26.38 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 126.887 2.075 . . . . 0.0 112.383 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 84.6 mt -93.7 126.09 46.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 -179.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -100.48 172.68 6.97 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 123.963 0.905 . . . . 0.0 111.19 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 49.2 pttt -66.62 156.77 34.22 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 54.92 35.58 24.78 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.511 1.524 . . . . 0.0 111.778 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.0 p -86.79 158.53 19.35 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 120.323 -1.486 . . . . 0.0 107.485 177.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 26.7 m -126.12 119.91 28.79 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 178.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.7 mp -106.06 169.53 8.44 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.252 1.021 . . . . 0.0 110.873 -179.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 21.4 m80 -118.54 153.07 34.82 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.865 1.666 . . . . 0.0 108.694 178.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 17.9 mt -123.03 126.47 47.17 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.866 1.666 . . . . 0.0 106.72 178.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.1 m -139.03 172.61 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 124.538 1.135 . . . . 0.0 111.367 -178.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -142.79 -170.93 3.33 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.251 1.42 . . . . 0.0 108.085 177.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.7 tpt180 -151.11 129.12 11.76 Favored 'General case' 0 CA--C 1.521 -0.171 0 N-CA-C 104.72 -2.326 . . . . 0.0 104.72 177.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -145.88 134.01 21.58 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -178.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 40.9 mmm-85 -104.3 -14.42 15.8 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 123.352 0.661 . . . . 0.0 110.044 179.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -84.03 18.38 22.27 Favored Glycine 0 CA--C 1.539 1.541 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 177.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.235 0 N-CA-C 103.86 -3.696 . . . . 0.0 103.86 -179.755 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 ttt . . . . . 0 N--CA 1.467 0.424 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -121.0 151.66 39.49 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 177.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 28.7 pt -132.84 169.62 21.65 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 178.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -123.13 151.85 41.69 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 124.517 1.127 . . . . 0.0 108.913 179.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 56.7 t -137.32 127.01 37.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 106.56 -1.645 . . . . 0.0 106.56 178.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -94.24 116.56 28.96 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 103.981 -2.6 . . . . 0.0 103.981 177.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 72.6 p -77.75 168.1 20.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 118.418 0.554 . . . . 0.0 110.335 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -67.23 -12.51 60.25 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.204 1.001 . . . . 0.0 111.512 178.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.5 p -93.74 -12.67 28.65 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.819 1.648 . . . . 0.0 111.129 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.06 7.3 56.39 Favored Glycine 0 CA--C 1.531 1.067 0 O-C-N 121.365 -0.834 . . . . 0.0 111.917 -179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.8 164.62 22.57 Favored 'General case' 0 C--N 1.342 0.244 0 CA-C-N 119.055 1.428 . . . . 0.0 107.276 179.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.5 m -121.73 131.75 54.25 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 105.05 -2.204 . . . . 0.0 105.05 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.1 mm -114.64 157.18 15.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 105.689 -1.967 . . . . 0.0 105.689 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 56.0 m -134.33 125.47 27.7 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 104.067 -2.568 . . . . 0.0 104.067 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.5 mt -137.73 147.72 44.99 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -104.89 107.11 17.91 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 127.561 2.344 . . . . 0.0 106.322 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.8 m -127.89 -168.45 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 125.791 1.636 . . . . 0.0 109.2 -178.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -141.85 159.53 59.2 Favored Pre-proline 0 N--CA 1.451 -0.377 0 C-N-CA 124.09 0.956 . . . . 0.0 109.654 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -55.44 -17.02 15.29 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.856 3.037 . . . . 0.0 113.004 178.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.7 m -114.23 31.31 6.67 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 124.03 0.932 . . . . 0.0 112.575 -178.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -98.8 132.22 44.32 Favored 'General case' 0 C--O 1.242 0.666 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 176.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -72.66 157.89 36.67 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 119.42 1.009 . . . . 0.0 110.998 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.8 mm -63.71 -29.74 48.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 177.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -53.37 -48.9 68.19 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.96 1.304 . . . . 0.0 109.729 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 41.6 m-20 -67.83 -52.87 31.83 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.846 0.858 . . . . 0.0 109.551 179.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.2 t -54.04 -42.92 57.0 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 C-N-CA 123.736 0.815 . . . . 0.0 111.381 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 20.0 ttpt -75.53 -16.04 60.32 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 118.432 -0.794 . . . . 0.0 111.094 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -88.07 -43.66 11.52 Favored 'General case' 0 C--O 1.226 -0.165 0 CA-C-N 119.857 1.208 . . . . 0.0 108.244 177.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -50.08 -40.0 44.15 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.0 1.32 . . . . 0.0 110.434 179.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 35.8 pt -66.09 -25.26 35.41 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 O-C-N 121.267 -0.896 . . . . 0.0 112.584 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -76.16 -23.84 54.78 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 120.014 1.279 . . . . 0.0 109.094 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.88 -39.14 57.0 Favored 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.243 -0.911 . . . . 0.0 108.641 179.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 55.0 mttm -89.72 -19.91 24.21 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 115.99 1.848 . . . . 0.0 115.99 -179.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -136.53 158.86 43.45 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 121.819 2.099 . . . . 0.0 108.886 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.01 63.43 4.3 Favored Glycine 0 C--N 1.336 0.574 0 N-CA-C 110.524 -1.03 . . . . 0.0 110.524 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.5 pt -131.38 107.3 14.62 Favored Pre-proline 0 CA--C 1.538 0.503 0 CA-C-N 117.91 0.855 . . . . 0.0 108.718 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -77.13 169.94 20.55 Favored 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 123.925 3.084 . . . . 0.0 109.805 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -76.56 58.64 5.93 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 123.087 2.524 . . . . 0.0 108.19 177.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -146.82 135.41 22.04 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 128.926 2.891 . . . . 0.0 105.319 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 79.6 mm-40 52.17 48.15 23.28 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.234 1.814 . . . . 0.0 108.368 -177.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -154.85 134.9 13.04 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.526 1.131 . . . . 0.0 109.62 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.0 ttm-85 -151.2 133.52 15.37 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 101.986 -3.339 . . . . 0.0 101.986 178.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.4 tp -87.9 142.01 28.13 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -177.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.2 mm -134.21 144.94 33.9 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 125.02 1.328 . . . . 0.0 109.584 -178.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -135.54 115.76 13.42 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 177.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.31 42.86 26.36 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.389 1.076 . . . . 0.0 110.692 -179.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.25 -13.93 30.72 Favored Glycine 0 CA--C 1.531 1.037 0 CA-C-O 118.519 -1.156 . . . . 0.0 114.518 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.9 ttmt -79.59 125.87 30.16 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 120.671 2.235 . . . . 0.0 107.554 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.4 mp0 -74.74 136.2 41.76 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 179.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.8 mt -122.34 153.35 39.09 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 124.618 1.167 . . . . 0.0 109.757 -178.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -160.09 175.69 12.66 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 124.679 1.192 . . . . 0.0 108.755 178.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -71.73 158.17 36.61 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 122.78 1.276 . . . . 0.0 111.86 -177.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 108.59 -29.44 9.94 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 127.448 2.452 . . . . 0.0 108.591 -177.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 46.4 mtt180 -107.75 165.56 11.35 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.0 1.72 . . . . 0.0 111.76 178.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 65.9 p -117.61 173.92 6.45 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.299 1.839 . . . . 0.0 112.655 -178.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 1.9 mp -52.14 -49.9 62.81 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 123.678 0.791 . . . . 0.0 111.541 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.55 -31.56 72.37 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 112.351 0.501 . . . . 0.0 112.351 -179.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -65.29 -47.15 77.62 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 119.415 1.007 . . . . 0.0 109.325 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -81.29 -2.5 49.22 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.1 t30 57.68 46.94 16.57 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 130.363 3.465 . . . . 0.0 112.215 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 79.3 mt -85.71 123.19 39.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 105.531 -2.026 . . . . 0.0 105.531 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 75.1 mm-40 -95.47 173.47 7.49 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 123.255 0.622 . . . . 0.0 109.747 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 43.6 pttt -69.72 157.0 38.12 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.116 0.484 . . . . 0.0 110.783 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 53.58 38.8 29.04 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 127.154 2.182 . . . . 0.0 110.992 -179.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.4 p -87.26 163.23 16.98 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.957 1.303 . . . . 0.0 109.459 178.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 93.7 m -126.05 110.22 13.3 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.7 mp -98.5 160.19 14.44 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 126.233 1.813 . . . . 0.0 108.53 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 45.1 m80 -119.28 160.37 22.34 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 124.982 1.313 . . . . 0.0 110.161 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.7 mt -122.82 126.76 48.01 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 104.964 -2.236 . . . . 0.0 104.964 177.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.2 m -140.62 161.45 24.08 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 CA-C-O 121.447 0.641 . . . . 0.0 110.421 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -134.71 -172.07 2.94 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.32 1.048 . . . . 0.0 108.585 177.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 7.5 tpt180 -158.67 138.1 11.68 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 103.098 -2.927 . . . . 0.0 103.098 178.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.1 tt -145.21 129.71 17.91 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 106.153 -1.795 . . . . 0.0 106.153 -179.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 47.1 mmm-85 -88.36 -2.37 58.56 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 118.905 0.775 . . . . 0.0 111.93 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -86.7 37.57 3.16 Favored Glycine 0 CA--C 1.54 1.619 0 N-CA-C 106.286 -2.726 . . . . 0.0 106.286 175.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.102 0 C-N-CA 129.781 3.562 . . . . 0.0 105.895 -179.102 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.7 ttt . . . . . 0 N--CA 1.47 0.535 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -120.64 151.1 39.91 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 178.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 32.5 pt -132.53 170.08 20.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 C-N-CA 124.929 1.292 . . . . 0.0 108.014 178.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -126.22 150.85 48.09 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.934 1.294 . . . . 0.0 109.005 179.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.0 t -138.52 133.07 42.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 178.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -103.03 118.35 36.61 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.213 1.005 . . . . 0.0 108.428 179.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 48.5 p -72.57 171.05 13.15 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.712 0.768 . . . . 0.0 110.059 179.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -70.45 -12.49 61.61 Favored 'General case' 0 CA--C 1.533 0.313 0 O-C-N 121.834 -0.541 . . . . 0.0 111.457 177.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.0 p -94.03 -12.1 29.34 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 126.409 1.884 . . . . 0.0 112.627 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.85 7.5 50.43 Favored Glycine 0 C--N 1.339 0.741 0 C-N-CA 124.0 0.81 . . . . 0.0 113.764 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -80.56 164.66 22.77 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 119.017 1.408 . . . . 0.0 107.279 179.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 86.9 m -123.65 132.34 53.83 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 103.523 -2.769 . . . . 0.0 103.523 177.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.5 mm -115.05 148.3 17.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 105.577 -2.009 . . . . 0.0 105.577 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 78.5 m -124.42 126.15 45.46 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 105.312 -2.106 . . . . 0.0 105.312 178.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.6 mt -128.72 150.66 50.17 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 118.339 0.518 . . . . 0.0 110.302 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -101.47 115.54 30.73 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 103.257 -2.868 . . . . 0.0 103.257 178.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.1 m -131.26 -169.92 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 124.415 1.086 . . . . 0.0 109.457 -178.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -143.66 160.84 49.26 Favored Pre-proline 0 N--CA 1.448 -0.568 0 C-N-CA 126.264 1.826 . . . . 0.0 106.591 178.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -58.09 -18.15 34.94 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.864 2.376 . . . . 0.0 113.079 178.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.6 m -116.25 32.95 5.81 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.827 1.251 . . . . 0.0 112.148 -179.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -90.29 128.86 36.53 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 103.187 -2.894 . . . . 0.0 103.187 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.5 p -77.8 159.03 29.28 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 118.965 0.802 . . . . 0.0 112.659 -177.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 23.9 mm -63.56 -29.81 48.23 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.324 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 178.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -59.0 -42.1 89.25 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.2 0.909 . . . . 0.0 110.44 179.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -73.88 -52.75 11.94 Favored 'General case' 0 CA--C 1.521 -0.166 0 C-N-CA 124.665 1.186 . . . . 0.0 109.792 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.4 t -57.44 -38.39 62.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 CA-C-N 119.62 1.1 . . . . 0.0 110.585 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -74.64 -14.27 60.74 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.208 -0.933 . . . . 0.0 110.592 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.98 -47.19 8.01 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 176.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 32.6 mttm -49.46 -40.31 36.61 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.333 1.853 . . . . 0.0 111.017 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 36.6 pt -65.69 -28.05 43.09 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-N 118.81 0.732 . . . . 0.0 112.556 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -76.28 -23.06 54.38 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 119.946 1.248 . . . . 0.0 109.742 -178.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.44 -36.3 45.63 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 178.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -86.55 -21.47 26.88 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 114.144 1.164 . . . . 0.0 114.144 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -147.51 150.99 35.6 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 120.99 1.723 . . . . 0.0 106.778 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.1 80.99 1.66 Allowed Glycine 0 CA--C 1.521 0.408 0 CA-C-O 119.244 -0.753 . . . . 0.0 111.846 -179.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.2 pt -133.95 106.14 11.53 Favored Pre-proline 0 CA--C 1.544 0.729 0 N-CA-C 106.773 -1.565 . . . . 0.0 106.773 178.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -62.87 166.09 14.85 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 124.571 3.514 . . . . 0.0 115.462 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -83.02 55.9 5.37 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.599 2.199 . . . . 0.0 108.295 177.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -147.26 134.52 20.6 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 128.839 2.856 . . . . 0.0 105.247 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 73.7 mm-40 47.76 49.36 16.66 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.858 1.663 . . . . 0.0 108.032 -177.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -143.67 134.09 24.71 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 60.3 ttm-85 -156.24 133.82 10.93 Favored 'General case' 0 CA--C 1.517 -0.29 0 C-N-CA 125.978 1.711 . . . . 0.0 106.868 179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 22.1 tp -87.9 140.88 29.06 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -178.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 15.0 mm -131.53 143.87 39.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 126.036 1.734 . . . . 0.0 109.376 -178.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 38.4 t80 -138.38 124.58 20.33 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 178.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.79 36.07 20.37 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.464 1.106 . . . . 0.0 110.439 -179.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.18 -14.09 29.48 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 125.343 1.449 . . . . 0.0 113.502 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.1 ttmt -79.57 129.3 34.35 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-N 119.752 1.776 . . . . 0.0 108.258 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.9 mp0 -74.59 137.42 42.32 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 178.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.422 HD22 ' CD1' ' A' ' 59' ' ' TYR . 7.6 mt -113.21 155.33 25.24 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 124.252 1.021 . . . . 0.0 108.352 -178.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -151.87 175.15 12.76 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.673 1.189 . . . . 0.0 109.446 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -72.75 157.97 36.48 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 125.229 1.412 . . . . 0.0 111.127 -178.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.17 -21.25 38.22 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 126.226 1.87 . . . . 0.0 110.383 -178.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 39.4 mtt180 -108.28 168.95 8.94 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 118.37 1.085 . . . . 0.0 113.534 178.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 49.0 p -117.45 172.46 7.31 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 126.945 2.098 . . . . 0.0 111.068 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -51.96 -50.67 60.78 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.286 1.435 . . . . 0.0 112.622 179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.06 -31.83 73.25 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 123.021 0.528 . . . . 0.0 112.258 -178.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -60.25 -44.95 94.83 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 119.449 1.022 . . . . 0.0 109.469 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.422 ' CD1' HD22 ' A' ' 50' ' ' LEU . 76.7 m-85 -82.27 1.22 37.78 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.189 0.595 . . . . 0.0 111.085 178.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 57.89 46.84 16.12 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 128.405 2.682 . . . . 0.0 110.794 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.3 mt -85.82 122.64 38.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 105.013 -2.218 . . . . 0.0 105.013 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 97.5 mm-40 -97.62 177.46 5.49 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.73 0.812 . . . . 0.0 108.94 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 43.9 pttt -68.19 156.56 37.3 Favored 'General case' 0 C--O 1.239 0.531 0 O-C-N 121.681 -0.637 . . . . 0.0 110.87 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 49.52 35.05 7.62 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.613 1.965 . . . . 0.0 111.088 -178.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.4 p -77.16 158.24 30.49 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 178.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 59.9 m -125.47 110.64 14.15 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 7.4 mp -96.04 165.67 12.14 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 124.429 1.091 . . . . 0.0 109.814 -178.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 25.3 m80 -118.77 156.34 29.55 Favored 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 125.423 1.489 . . . . 0.0 110.19 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 25.7 mt -123.34 124.68 43.5 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 178.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.1 m -139.12 167.75 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -142.05 -169.74 3.0 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 127.154 2.182 . . . . 0.0 109.687 178.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -152.1 130.18 11.87 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 105.22 -2.141 . . . . 0.0 105.22 177.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -148.45 138.81 22.63 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 105.312 -2.107 . . . . 0.0 105.312 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 40.2 mmm-85 -106.11 -13.28 15.49 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 119.269 0.94 . . . . 0.0 112.788 179.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -81.51 19.74 8.41 Favored Glycine 0 CA--C 1.534 1.237 0 CA-C-O 118.684 -1.065 . . . . 0.0 111.658 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.05 0 N-CA-C 105.665 -2.974 . . . . 0.0 105.665 -179.638 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 ttp . . . . . 0 N--CA 1.467 0.394 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -120.69 157.1 30.34 Favored 'General case' 0 CA--C 1.53 0.18 0 O-C-N 121.1 -1.0 . . . . 0.0 112.146 -178.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.3 pt -132.81 169.32 22.23 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 176.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -126.44 152.19 46.72 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.806 1.242 . . . . 0.0 107.822 179.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.9 t -138.96 128.49 30.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 179.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.2 tppp? -96.23 117.86 31.63 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 119.081 0.855 . . . . 0.0 109.485 178.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.8 p -81.09 165.62 21.46 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.051 0.94 . . . . 0.0 110.433 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.43 -4.88 12.49 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.062 0.945 . . . . 0.0 113.212 178.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.0 p -92.41 -12.61 31.76 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.487 1.115 . . . . 0.0 110.704 178.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.88 5.93 58.3 Favored Glycine 0 CA--C 1.528 0.887 0 C-N-CA 125.806 1.67 . . . . 0.0 111.434 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.56 164.24 16.2 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.6 m -123.97 142.46 51.14 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 178.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 17.3 mm -114.79 155.21 16.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 C-N-CA 126.557 1.943 . . . . 0.0 106.169 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 54.8 m -126.23 128.15 46.76 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 104.124 -2.547 . . . . 0.0 104.124 178.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.4 mt -133.21 150.07 51.98 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -105.14 110.97 23.56 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 103.671 -2.715 . . . . 0.0 103.671 178.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.3 m -134.72 -174.78 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -146.44 166.7 15.9 Favored Pre-proline 0 C--N 1.327 -0.372 0 O-C-N 120.842 -1.161 . . . . 0.0 109.508 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -54.27 -18.81 15.07 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.096 2.531 . . . . 0.0 114.034 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.4 m -115.03 31.22 6.83 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 123.922 0.889 . . . . 0.0 112.453 -178.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -99.08 130.05 45.38 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 103.94 -2.615 . . . . 0.0 103.94 176.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.9 p -78.06 158.14 29.3 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 119.425 1.011 . . . . 0.0 111.711 -178.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.3 mm -63.77 -28.27 44.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -57.1 -42.79 81.43 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.881 0.872 . . . . 0.0 109.383 178.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -73.04 -52.54 13.97 Favored 'General case' 0 CA--C 1.515 -0.386 0 C-N-CA 124.889 1.275 . . . . 0.0 109.417 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.3 t -54.74 -38.42 43.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 CA-C-N 119.227 0.921 . . . . 0.0 110.764 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt -74.82 -15.55 60.73 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 121.252 -0.905 . . . . 0.0 111.642 -179.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.9 -45.27 8.86 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 125.552 1.541 . . . . 0.0 108.193 176.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.8 mttm -50.44 -40.4 50.31 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.608 1.563 . . . . 0.0 110.406 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 36.1 pt -64.07 -25.34 37.87 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 O-C-N 121.54 -0.725 . . . . 0.0 112.113 178.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -76.27 -23.64 54.45 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 120.145 1.339 . . . . 0.0 109.262 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.99 -36.33 41.5 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 177.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.6 mmtt -85.65 -22.11 28.08 Favored 'General case' 0 C--N 1.337 0.061 0 CA-C-O 117.391 -1.29 . . . . 0.0 114.204 -178.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -150.63 158.04 43.68 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 121.582 1.992 . . . . 0.0 108.808 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.7 82.35 1.59 Allowed Glycine 0 C--N 1.333 0.366 0 N-CA-C 111.843 -0.503 . . . . 0.0 111.843 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.4 pt -140.89 106.62 6.3 Favored Pre-proline 0 CA--C 1.543 0.692 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -71.1 169.59 20.2 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 124.763 3.642 . . . . 0.0 112.658 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -78.65 56.91 6.11 Favored 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 123.054 2.503 . . . . 0.0 109.6 177.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -146.84 130.13 16.62 Favored 'General case' 0 CA--C 1.517 -0.308 0 C-N-CA 127.857 2.463 . . . . 0.0 104.639 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.2 mm-40 51.01 53.52 12.91 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -177.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -143.06 133.1 24.27 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.275 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 55.8 ttm-85 -161.57 133.33 5.58 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 125.853 1.661 . . . . 0.0 107.174 179.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 24.2 tp -88.64 142.5 27.63 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.309 1.044 . . . . 0.0 109.674 -178.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.7 mm -135.03 144.56 34.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 C-N-CA 125.908 1.683 . . . . 0.0 109.955 -178.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -133.45 117.23 16.95 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 106.714 -1.588 . . . . 0.0 106.714 178.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.57 43.46 20.24 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.933 1.293 . . . . 0.0 111.141 -179.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.45 -17.67 13.34 Favored Glycine 0 CA--C 1.526 0.756 0 CA-C-O 118.351 -1.249 . . . . 0.0 114.635 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.3 ttmt -79.25 128.71 33.65 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-N 120.603 2.201 . . . . 0.0 107.149 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.4 mp0 -74.56 136.87 42.11 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.51 HD22 ' CD1' ' A' ' 59' ' ' TYR . 8.9 mt -113.19 155.05 25.71 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -178.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -151.99 175.05 12.91 Favored 'General case' 0 N--CA 1.445 -0.681 0 C-N-CA 124.381 1.072 . . . . 0.0 109.076 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -73.05 160.03 32.68 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 126.197 1.799 . . . . 0.0 111.412 -179.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.0 -27.51 19.16 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 126.271 1.891 . . . . 0.0 109.85 -178.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.9 mtt180 -107.11 170.52 7.9 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 124.95 1.3 . . . . 0.0 111.449 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 67.2 p -117.3 171.01 8.25 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 127.108 2.163 . . . . 0.0 111.905 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.21 -48.56 65.03 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.06 0.944 . . . . 0.0 112.419 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.03 -31.72 73.01 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 118.932 -0.556 . . . . 0.0 111.512 -179.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -61.13 -44.03 97.96 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 119.352 0.978 . . . . 0.0 108.696 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.51 ' CD1' HD22 ' A' ' 50' ' ' LEU . 92.7 m-85 -82.0 1.7 34.33 Favored 'General case' 0 C--O 1.237 0.4 0 O-C-N 121.603 -0.686 . . . . 0.0 110.814 178.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 52.9 t30 56.48 47.19 19.25 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 127.087 2.155 . . . . 0.0 110.07 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.5 mt -84.48 122.79 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 N-CA-C 106.011 -1.848 . . . . 0.0 106.011 -178.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 57.2 mm-40 -89.57 169.14 11.6 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.447 -0.797 . . . . 0.0 108.995 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 51.8 pttt -69.18 156.73 38.22 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.012 0.434 . . . . 0.0 111.354 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 49.55 34.2 6.69 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 128.407 2.683 . . . . 0.0 111.5 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.2 p -80.17 163.95 23.68 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 178.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.2 m -125.31 112.51 16.45 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.1 mp -96.19 168.14 10.77 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.961 1.304 . . . . 0.0 108.666 -179.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.3 m80 -119.64 154.92 33.27 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.155 1.382 . . . . 0.0 109.878 179.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 18.1 mt -123.22 123.47 40.85 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 103.866 -2.642 . . . . 0.0 103.866 177.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.7 m -141.59 170.96 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-N 120.06 1.3 . . . . 0.0 113.635 -179.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -140.8 -169.82 2.89 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 126.354 1.862 . . . . 0.0 109.576 178.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.4 tpt180 -150.39 129.16 12.41 Favored 'General case' 0 CA--C 1.521 -0.144 0 N-CA-C 103.413 -2.81 . . . . 0.0 103.413 177.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.521 HD23 ' H ' ' A' ' 75' ' ' GLY . 1.1 tt -139.68 127.64 22.2 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 -179.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 49.4 mmm-85 -103.3 -7.43 21.11 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 118.817 0.735 . . . . 0.0 112.157 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.521 ' H ' HD23 ' A' ' 73' ' ' LEU . . . -92.45 21.29 39.03 Favored Glycine 0 CA--C 1.536 1.384 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 177.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.881 0 N-CA-C 106.399 -2.68 . . . . 0.0 106.399 -179.45 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.8 ttt . . . . . 0 N--CA 1.471 0.59 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -120.82 157.14 30.4 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 178.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.7 pt -132.69 169.4 22.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 178.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -126.13 151.01 47.83 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.2 t -138.52 129.6 35.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 179.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.4 tppt? -96.24 119.08 34.09 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 177.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 45.7 p -71.15 167.25 19.73 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-N 118.663 0.665 . . . . 0.0 109.352 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -67.72 -12.96 61.65 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 119.201 -0.428 . . . . 0.0 111.191 178.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.4 p -94.1 -12.48 28.39 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.815 1.246 . . . . 0.0 111.273 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.41 7.77 48.19 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-N 118.845 0.748 . . . . 0.0 113.524 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.22 164.82 23.87 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 104.507 -2.405 . . . . 0.0 104.507 178.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 45.1 m -123.2 131.21 53.6 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 -179.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.8 mm -116.28 155.25 17.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 127.531 2.332 . . . . 0.0 107.802 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.6 m -135.18 130.4 35.29 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 128.146 2.578 . . . . 0.0 105.428 178.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 79.5 mt -139.01 151.27 46.69 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.722 1.147 . . . . 0.0 110.84 -179.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -102.28 117.94 35.82 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 179.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.7 m -131.28 -170.67 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 124.622 1.169 . . . . 0.0 109.982 -177.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -144.1 160.66 48.5 Favored Pre-proline 0 C--O 1.238 0.494 0 N-CA-C 106.517 -1.661 . . . . 0.0 106.517 178.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -57.96 -17.98 33.26 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.461 2.108 . . . . 0.0 112.941 178.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 29.3 m -114.64 31.62 6.52 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 119.219 0.918 . . . . 0.0 111.464 -178.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.6 t0 -91.27 129.42 37.26 Favored 'General case' 0 C--O 1.243 0.712 0 N-CA-C 101.302 -3.592 . . . . 0.0 101.302 177.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.0 p -71.03 158.25 36.83 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 121.392 -0.817 . . . . 0.0 109.439 -178.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.0 mm -63.33 -29.35 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 178.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -56.27 -49.32 74.53 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 126.045 1.738 . . . . 0.0 108.834 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 20.1 m-80 -65.43 -52.15 55.26 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 124.67 1.188 . . . . 0.0 109.552 179.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 84.4 t -54.05 -44.03 61.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 C-N-CA 123.328 0.651 . . . . 0.0 110.744 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 24.2 ttpt -75.57 -12.83 60.3 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.279 1.032 . . . . 0.0 112.166 -178.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.04 -46.93 8.16 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 125.608 1.563 . . . . 0.0 107.513 177.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.4 mttm -50.98 -40.51 58.06 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.405 1.482 . . . . 0.0 110.418 179.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 43.3 pt -64.58 -25.69 38.48 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 O-C-N 121.334 -0.854 . . . . 0.0 112.31 178.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -76.35 -22.77 54.46 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 120.598 1.545 . . . . 0.0 109.262 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -82.27 -22.94 35.53 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.737 1.215 . . . . 0.0 108.607 177.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.1 mmtt -97.68 -16.01 20.14 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 120.481 -1.387 . . . . 0.0 114.347 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -152.04 160.68 43.39 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 121.116 1.78 . . . . 0.0 107.063 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.02 70.98 2.97 Favored Glycine 0 CA--C 1.522 0.496 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 15.8 pt -130.8 108.27 15.52 Favored Pre-proline 0 CA--C 1.543 0.703 0 CA-C-N 117.988 0.894 . . . . 0.0 110.752 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -77.82 169.74 20.18 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.822 3.015 . . . . 0.0 110.092 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -79.19 57.0 6.27 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.855 2.37 . . . . 0.0 109.195 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -150.61 135.32 17.38 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 127.206 2.203 . . . . 0.0 105.862 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 55.2 mm-40 53.89 48.78 20.49 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 125.799 1.64 . . . . 0.0 106.788 -177.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -146.19 143.07 29.03 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 123.711 0.805 . . . . 0.0 110.535 -178.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 43.9 ttm-85 -162.3 134.06 5.38 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.879 1.218 . . . . 0.0 108.289 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 18.9 tp -93.21 140.01 29.99 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.627 1.171 . . . . 0.0 111.204 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.5 mm -135.54 145.35 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 126.229 1.812 . . . . 0.0 108.816 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -139.11 119.77 14.12 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.923 1.289 . . . . 0.0 108.376 178.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.72 35.2 17.85 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.233 1.013 . . . . 0.0 111.151 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.55 -13.75 33.42 Favored Glycine 0 CA--C 1.532 1.108 0 C-N-CA 124.887 1.232 . . . . 0.0 113.248 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 17.5 ttmt -80.56 129.76 34.71 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 119.484 1.642 . . . . 0.0 107.746 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.8 mp0 -74.47 134.05 42.33 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 51.6 mt -114.01 148.96 36.1 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.576 1.15 . . . . 0.0 108.571 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -151.55 176.73 11.05 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 124.868 1.267 . . . . 0.0 108.217 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -72.29 160.59 32.14 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.793 1.637 . . . . 0.0 111.767 -177.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.32 -25.6 26.48 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 125.53 1.538 . . . . 0.0 111.243 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 42.7 mtt180 -108.09 168.85 9.0 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.554 1.141 . . . . 0.0 112.908 178.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.4 p -117.71 169.48 9.55 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.876 1.67 . . . . 0.0 109.167 178.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.0 mp -52.5 -43.1 64.85 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.207 0.603 . . . . 0.0 111.202 178.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 42.1 t -58.2 -45.91 86.77 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 125.916 1.686 . . . . 0.0 111.156 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -59.74 -45.2 92.96 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 118.586 0.63 . . . . 0.0 109.973 -178.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -82.1 1.71 34.71 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.492 0.717 . . . . 0.0 112.088 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.6 t30 55.45 46.42 23.23 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 127.581 2.352 . . . . 0.0 111.026 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 40.6 mt -86.09 123.05 39.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -93.64 169.98 9.92 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.264 0.554 . . . . 0.0 111.469 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.7 pttt -66.32 156.98 32.88 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.237 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 51.22 37.52 18.71 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 126.41 1.884 . . . . 0.0 112.001 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.7 p -87.13 164.15 16.57 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.761 1.224 . . . . 0.0 108.615 178.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.9 m -125.93 113.92 17.83 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 179.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.4 mp -96.91 161.64 13.75 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.259 1.023 . . . . 0.0 109.09 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 17.2 m80 -115.78 156.4 26.1 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.903 1.281 . . . . 0.0 109.85 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.8 mt -122.83 124.87 44.28 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.026 1.73 . . . . 0.0 107.891 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 23.3 m -141.38 171.57 11.77 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 124.795 1.238 . . . . 0.0 113.753 -178.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -143.02 -170.72 3.31 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.485 1.514 . . . . 0.0 108.389 176.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.8 tpt180 -151.83 129.4 11.47 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 104.358 -2.46 . . . . 0.0 104.358 177.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.2 mt -151.2 138.57 19.43 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 118.357 0.526 . . . . 0.0 110.587 -178.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 56.8 mmm-85 -99.46 -24.15 14.88 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 177.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -88.81 37.3 3.32 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 126.587 2.042 . . . . 0.0 108.743 177.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.912 0 N-CA-C 106.623 -2.591 . . . . 0.0 106.623 -179.18 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.4 ttt . . . . . 0 N--CA 1.474 0.73 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -121.51 157.27 31.03 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.226 0.611 . . . . 0.0 109.813 178.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 30.7 pt -132.75 171.12 18.67 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 C-N-CA 125.493 1.517 . . . . 0.0 107.668 177.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -126.19 152.49 45.96 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.188 0.995 . . . . 0.0 108.623 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.3 t -138.34 128.8 35.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.2 tptp -96.64 117.53 31.18 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.3 p -77.03 166.15 23.69 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 118.511 0.596 . . . . 0.0 110.084 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -71.34 -10.09 59.2 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 121.651 -0.656 . . . . 0.0 111.615 178.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -91.85 -10.96 37.84 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 128.368 2.667 . . . . 0.0 111.737 -179.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.45 7.09 56.2 Favored Glycine 0 C--N 1.34 0.797 0 C-N-CA 125.605 1.574 . . . . 0.0 114.137 178.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.2 mmmm -80.53 166.66 20.96 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 119.089 1.444 . . . . 0.0 109.622 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.5 m -123.72 131.28 53.57 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 103.453 -2.795 . . . . 0.0 103.453 177.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 24.5 mm -116.43 156.24 17.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 C-N-CA 126.338 1.855 . . . . 0.0 107.214 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.1 m -132.93 128.9 37.51 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 126.156 1.782 . . . . 0.0 106.504 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.9 mt -139.47 151.0 45.85 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.188 0.995 . . . . 0.0 111.322 -179.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -97.54 117.84 32.71 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 127.005 2.122 . . . . 0.0 105.383 178.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.1 m -134.91 -175.61 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 125.071 1.349 . . . . 0.0 109.631 -179.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -144.41 164.27 29.56 Favored Pre-proline 0 CA--C 1.532 0.278 0 C-N-CA 124.323 1.049 . . . . 0.0 109.817 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -57.87 -18.87 36.68 Favored 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 122.87 2.38 . . . . 0.0 113.865 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.3 m -115.86 31.65 6.58 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 119.21 0.914 . . . . 0.0 110.856 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -92.45 128.81 38.44 Favored 'General case' 0 C--O 1.24 0.569 0 N-CA-C 102.294 -3.224 . . . . 0.0 102.294 177.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.4 p -78.53 158.14 28.64 Favored 'General case' 0 CA--C 1.519 -0.232 0 O-C-N 121.2 -0.938 . . . . 0.0 110.917 -178.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.7 mm -64.08 -25.45 38.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 177.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -56.29 -49.83 73.16 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.518 1.127 . . . . 0.0 108.63 178.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -66.44 -52.63 44.35 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.851 1.26 . . . . 0.0 109.842 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.7 t -55.42 -38.62 49.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 CA-C-N 118.623 0.647 . . . . 0.0 110.903 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -75.27 -18.11 60.15 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 120.956 -1.09 . . . . 0.0 111.412 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.93 -45.03 9.5 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.532 1.533 . . . . 0.0 110.328 178.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.4 mttm -54.31 -40.24 67.76 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 118.631 0.65 . . . . 0.0 111.039 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 34.6 pt -62.59 -24.9 36.67 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 CA-C-O 119.011 -0.519 . . . . 0.0 111.644 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.492 HE22 ' HB3' ' A' ' 38' ' ' PRO . 34.9 mt-30 -77.0 -23.11 52.25 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 120.162 1.346 . . . . 0.0 109.392 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.98 -32.59 26.93 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 176.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 51.2 mmtt -87.17 -15.37 38.55 Favored 'General case' 0 C--N 1.343 0.303 0 N-CA-C 115.499 1.666 . . . . 0.0 115.499 -179.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -150.66 157.89 43.51 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 121.051 1.75 . . . . 0.0 106.567 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -80.99 74.83 2.37 Favored Glycine 0 CA--C 1.525 0.687 0 CA-C-O 119.177 -0.791 . . . . 0.0 111.256 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.3 pt -135.82 107.69 9.84 Favored Pre-proline 0 CA--C 1.545 0.784 0 CA-C-N 118.404 1.102 . . . . 0.0 111.155 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -71.13 169.3 20.94 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 123.336 2.691 . . . . 0.0 110.764 178.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.492 ' HB3' HE22 ' A' ' 31' ' ' GLN . 88.1 Cg_endo -80.52 56.31 6.03 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 122.701 2.267 . . . . 0.0 109.679 178.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -146.7 135.14 21.92 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 127.874 2.47 . . . . 0.0 105.083 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 71.1 mm-40 50.05 49.97 19.39 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.769 1.628 . . . . 0.0 109.55 -177.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 12.2 m-80 -148.09 134.85 19.99 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 124.519 1.128 . . . . 0.0 109.52 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 45.8 ttm-85 -153.0 134.18 14.17 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 127.293 2.237 . . . . 0.0 107.475 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 23.3 tp -88.18 139.89 30.04 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.037 1.335 . . . . 0.0 109.154 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.3 mm -132.47 145.9 33.78 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 125.743 1.617 . . . . 0.0 108.161 -179.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -136.62 117.5 14.16 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 124.727 1.211 . . . . 0.0 108.465 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.85 43.53 21.46 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.708 1.203 . . . . 0.0 110.944 -179.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.38 -15.66 22.42 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 124.899 1.237 . . . . 0.0 114.23 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.8 ttmt -80.69 124.34 28.93 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 119.874 1.837 . . . . 0.0 107.531 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.5 mp0 -74.47 135.96 42.27 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.7 mt -114.19 156.17 24.76 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 125.187 1.395 . . . . 0.0 109.944 -178.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -151.07 174.14 13.53 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 178.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -76.52 159.91 29.94 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.85 1.26 . . . . 0.0 111.761 -179.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 107.01 -27.81 14.96 Favored Glycine 0 CA--C 1.528 0.878 0 C-N-CA 125.811 1.672 . . . . 0.0 109.709 -178.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 44.5 mtt180 -106.59 167.04 10.13 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 118.973 1.386 . . . . 0.0 111.353 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 68.6 p -117.7 170.46 8.76 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 125.995 1.718 . . . . 0.0 111.169 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.6 mp -52.67 -43.56 65.63 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 123.506 0.723 . . . . 0.0 111.869 179.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.7 m -59.78 -38.32 81.54 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 118.632 0.651 . . . . 0.0 112.172 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -62.44 -47.08 85.62 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 123.068 0.547 . . . . 0.0 109.992 -178.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -82.66 1.36 38.81 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.083 0.953 . . . . 0.0 111.698 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 48.0 t30 54.4 46.24 25.45 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 127.53 2.332 . . . . 0.0 111.17 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 81.8 mt -88.25 123.06 40.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 179.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -101.47 175.75 5.47 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 39.5 pttt -64.81 157.11 28.58 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.285 0.564 . . . . 0.0 110.661 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 55.59 35.64 25.59 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.737 2.015 . . . . 0.0 111.682 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.9 p -86.19 164.17 17.37 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 120.683 -1.261 . . . . 0.0 108.367 178.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.9 m -126.03 115.48 19.93 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.3 mp -103.73 160.72 14.53 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.576 1.151 . . . . 0.0 108.779 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 43.3 m80 -119.46 159.62 23.91 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 125.236 1.414 . . . . 0.0 110.13 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 61.8 mt -123.24 124.29 42.66 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 125.188 1.395 . . . . 0.0 109.22 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.8 m -141.01 170.16 14.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -178.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -141.58 -170.49 3.11 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 127.989 2.516 . . . . 0.0 108.288 178.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.1 tpt180 -157.27 128.84 6.95 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 104.727 -2.323 . . . . 0.0 104.727 177.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 66.7 mt -150.09 142.05 23.88 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.473 1.109 . . . . 0.0 108.848 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 56.1 mmm-85 -100.94 -25.77 13.96 Favored 'General case' 0 N--CA 1.463 0.211 0 C-N-CA 124.731 1.213 . . . . 0.0 111.471 179.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -81.24 18.43 10.31 Favored Glycine 0 CA--C 1.53 1.023 0 CA-C-O 119.046 -0.863 . . . . 0.0 114.622 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.804 0 CA-C-N 120.489 2.145 . . . . 0.0 107.746 179.512 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.6 ttt . . . . . 0 N--CA 1.473 0.686 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -122.31 144.92 48.7 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 177.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 36.9 pt -132.81 168.86 23.2 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 177.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -126.39 152.27 46.54 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 125.082 1.353 . . . . 0.0 109.327 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.4 t -138.72 131.1 38.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 178.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.51 117.8 33.76 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 178.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 54.9 p -74.17 171.12 14.15 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.007 0.923 . . . . 0.0 112.191 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -74.99 -7.75 54.54 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.069 177.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.3 p -94.61 -13.01 26.35 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.858 1.663 . . . . 0.0 111.15 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.81 6.08 57.29 Favored Glycine 0 CA--C 1.525 0.718 0 C-N-CA 126.565 2.031 . . . . 0.0 113.553 178.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.7 mmmm -81.95 164.84 21.23 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 118.416 1.108 . . . . 0.0 108.031 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.7 m -120.35 132.39 55.26 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 104.2 -2.518 . . . . 0.0 104.2 178.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 22.1 mm -107.7 156.96 8.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 125.949 1.699 . . . . 0.0 106.754 -179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 26.0 m -135.29 126.27 27.71 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 179.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.7 mt -140.21 147.39 39.99 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.335 1.054 . . . . 0.0 111.199 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -104.9 106.73 17.35 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 126.694 1.998 . . . . 0.0 107.585 178.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.2 m -135.7 -170.63 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.465 0 C-N-CA 125.041 1.336 . . . . 0.0 108.457 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.4 pm0 -147.24 167.94 12.45 Favored Pre-proline 0 C--O 1.232 0.165 0 O-C-N 120.615 -1.303 . . . . 0.0 111.047 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -55.56 -17.6 17.57 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 123.058 2.505 . . . . 0.0 112.821 178.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.1 m -112.57 30.2 7.31 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 119.948 1.249 . . . . 0.0 111.773 -177.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -104.48 140.59 37.74 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 107.518 -1.289 . . . . 0.0 107.518 176.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.2 p -78.72 158.29 28.34 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 122.408 1.099 . . . . 0.0 111.258 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 37.3 mm -64.74 -25.23 37.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 176.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -55.23 -49.61 71.54 Favored 'General case' 0 C--N 1.344 0.351 0 CA-C-N 119.385 0.993 . . . . 0.0 108.834 178.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.7 m-20 -60.37 -52.3 65.84 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 42.9 t -55.52 -41.36 63.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-O 119.111 -0.471 . . . . 0.0 111.231 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -74.74 -18.36 60.51 Favored 'General case' 0 C--O 1.223 -0.295 0 CA-C-N 119.275 0.943 . . . . 0.0 111.424 -178.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.24 -46.13 9.01 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 119.652 1.115 . . . . 0.0 108.432 177.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -53.41 -40.21 64.93 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.519 1.128 . . . . 0.0 111.211 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 41.8 pt -63.33 -26.82 41.75 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 CA-C-N 118.808 0.731 . . . . 0.0 111.43 178.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -76.3 -22.69 54.7 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 119.828 1.195 . . . . 0.0 109.323 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.71 -39.49 36.31 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 120.597 -1.315 . . . . 0.0 108.783 178.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 86.1 mttt -86.98 -15.89 37.42 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 114.549 1.314 . . . . 0.0 114.549 -178.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -148.16 151.27 35.29 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 179.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.1 87.29 1.36 Allowed Glycine 0 C--N 1.335 0.485 0 CA-C-O 119.555 -0.581 . . . . 0.0 112.715 -178.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.5 pt -144.32 107.13 4.81 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 124.448 1.099 . . . . 0.0 109.769 178.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -70.8 170.59 17.46 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 124.05 3.167 . . . . 0.0 110.282 178.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -80.27 55.58 5.72 Favored 'Trans proline' 0 CA--C 1.545 1.061 0 C-N-CA 122.656 2.237 . . . . 0.0 107.607 177.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -146.68 131.33 17.86 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 128.239 2.616 . . . . 0.0 104.765 -179.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 60.1 mm-40 53.95 49.51 18.83 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.992 1.317 . . . . 0.0 107.579 -177.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 -155.2 133.35 11.62 Favored 'General case' 0 N--CA 1.452 -0.365 0 O-C-N 121.695 -0.628 . . . . 0.0 110.621 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 53.9 ttm-85 -152.1 137.39 17.53 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 105.319 -2.104 . . . . 0.0 105.319 179.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 28.2 tp -88.31 139.41 30.52 Favored 'General case' 0 C--O 1.226 -0.181 0 C-N-CA 124.182 0.993 . . . . 0.0 109.567 -178.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.6 mm -135.28 144.22 34.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 C-N-CA 124.728 1.211 . . . . 0.0 109.093 -178.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -134.69 119.37 18.2 Favored 'General case' 0 C--O 1.226 -0.156 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 178.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.72 38.78 16.18 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.307 1.043 . . . . 0.0 112.077 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.47 -15.77 22.3 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 123.973 0.796 . . . . 0.0 113.582 -179.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.1 ttmt -80.49 118.47 22.13 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 178.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.0 mp0 -75.27 136.68 40.9 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.4 mt -119.82 155.04 33.35 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 126.708 2.003 . . . . 0.0 109.548 -178.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -155.14 176.08 13.01 Favored 'General case' 0 C--O 1.238 0.5 0 C-N-CA 124.604 1.162 . . . . 0.0 108.517 177.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -72.17 160.82 31.8 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 126.116 1.767 . . . . 0.0 112.363 -178.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.62 -27.27 21.0 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 126.042 1.782 . . . . 0.0 110.484 -178.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 47.2 mtt180 -107.33 168.9 8.9 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 124.292 1.037 . . . . 0.0 110.333 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 44.5 p -117.22 165.56 13.29 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 123.445 0.698 . . . . 0.0 111.601 -179.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.9 mp -52.3 -41.8 63.24 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.714 0.806 . . . . 0.0 111.236 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.9 t -60.52 -45.23 94.61 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 126.391 1.876 . . . . 0.0 110.032 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -60.26 -46.12 90.93 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -81.11 -3.86 53.41 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.212 0.605 . . . . 0.0 111.375 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.9 t30 53.8 47.84 22.73 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 127.718 2.407 . . . . 0.0 112.605 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 82.3 mt -85.61 126.52 40.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 105.499 -2.037 . . . . 0.0 105.499 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 78.0 mm-40 -89.92 169.25 11.39 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.551 0.691 . . . . 0.0 110.939 -179.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.6 pttt -68.02 157.24 35.59 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.389 1.076 . . . . 0.0 109.513 178.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 52.27 35.76 17.81 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.406 1.482 . . . . 0.0 112.879 179.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.4 p -86.32 162.89 17.99 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.728 1.211 . . . . 0.0 110.052 178.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.0 m -126.72 108.77 11.37 Favored 'General case' 0 CA--C 1.528 0.11 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.4 mp -96.25 169.6 9.83 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.828 1.251 . . . . 0.0 110.658 -178.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 37.0 m80 -120.05 154.17 35.01 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 126.889 2.076 . . . . 0.0 108.946 178.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 36.4 mt -123.47 123.89 41.64 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 176.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.9 m -140.75 172.73 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 CA-C-N 119.53 1.059 . . . . 0.0 112.315 -178.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -141.38 -170.8 3.16 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 126.333 1.853 . . . . 0.0 108.93 178.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -158.82 129.87 6.23 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 104.721 -2.325 . . . . 0.0 104.721 176.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.485 HD23 ' H ' ' A' ' 75' ' ' GLY . 1.2 tt -139.41 140.4 37.37 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 -178.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 58.4 mmm-85 -104.97 -2.57 24.37 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.538 0.735 . . . . 0.0 112.36 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.485 ' H ' HD23 ' A' ' 73' ' ' LEU . . . -91.07 18.38 51.54 Favored Glycine 0 CA--C 1.536 1.352 0 C-N-CA 124.72 1.153 . . . . 0.0 110.597 178.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.003 0 N-CA-C 105.215 -3.154 . . . . 0.0 105.215 -179.59 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.6 ttt . . . . . 0 N--CA 1.471 0.624 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -120.84 156.09 32.7 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 177.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.3 pt -132.33 169.45 21.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -123.32 149.54 44.73 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.541 1.136 . . . . 0.0 108.61 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.6 t -139.19 127.59 27.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -93.36 116.95 29.49 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.141 0.976 . . . . 0.0 109.161 178.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 80.4 p -84.06 167.6 16.67 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 123.983 0.913 . . . . 0.0 111.904 179.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.7 -3.98 10.82 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 126.342 1.857 . . . . 0.0 113.048 177.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.0 p -99.02 -15.49 19.04 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.699 1.199 . . . . 0.0 109.484 178.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.67 6.25 57.36 Favored Glycine 0 C--N 1.338 0.671 0 C-N-CA 127.01 2.243 . . . . 0.0 112.041 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.1 mmmm -80.34 163.44 23.91 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 119.441 1.621 . . . . 0.0 107.144 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.6 m -124.62 132.04 53.44 Favored 'General case' 0 N--CA 1.444 -0.733 0 N-CA-C 104.351 -2.463 . . . . 0.0 104.351 178.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 10.8 mm -104.6 157.73 5.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 -179.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 97.8 m -133.95 123.48 24.73 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 104.236 -2.505 . . . . 0.0 104.236 178.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 66.3 mt -139.59 150.7 45.32 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 123.682 0.793 . . . . 0.0 109.775 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 71.9 tt0 -93.83 117.89 30.71 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 105.132 -2.173 . . . . 0.0 105.132 178.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.0 m -131.59 -171.47 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 124.561 1.144 . . . . 0.0 109.078 -178.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -147.09 164.59 22.49 Favored Pre-proline 0 CA--C 1.537 0.47 0 C-N-CA 123.976 0.91 . . . . 0.0 110.112 179.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -62.68 -18.87 66.29 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 121.92 1.747 . . . . 0.0 112.721 178.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.54 31.66 6.48 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.894 0.877 . . . . 0.0 111.873 -177.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -92.67 131.84 37.41 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 178.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 46.0 p -75.08 157.6 34.51 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 119.817 1.189 . . . . 0.0 109.013 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 30.1 mm -64.27 -31.18 52.41 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.282 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 177.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -55.91 -48.54 75.49 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 124.907 1.283 . . . . 0.0 110.045 179.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.7 m-20 -64.34 -52.38 58.67 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.191 0.996 . . . . 0.0 109.482 179.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 90.2 t -55.13 -41.72 61.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 122.81 0.444 . . . . 0.0 110.405 179.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.1 ttpt -74.88 -13.28 60.53 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 118.107 -0.949 . . . . 0.0 110.94 -179.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.34 -47.18 8.21 Favored 'General case' 0 C--O 1.226 -0.154 0 CA-C-N 120.269 1.395 . . . . 0.0 108.791 178.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -52.34 -40.06 61.45 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.056 0.942 . . . . 0.0 111.466 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 40.3 pt -63.96 -25.36 37.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 O-C-N 121.727 -0.608 . . . . 0.0 111.582 178.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -76.77 -23.15 52.93 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 119.921 1.237 . . . . 0.0 109.382 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.38 -39.51 59.08 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 177.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.6 mttm -86.62 -18.26 31.82 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 115.659 1.725 . . . . 0.0 115.659 -177.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -141.97 150.79 41.85 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 120.686 1.585 . . . . 0.0 108.039 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.59 82.03 1.61 Allowed Glycine 0 C--N 1.334 0.421 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.7 pt -136.09 108.38 9.69 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 124.622 1.169 . . . . 0.0 109.515 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -78.62 169.32 19.93 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.497 2.798 . . . . 0.0 109.016 179.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -77.84 56.68 5.76 Favored 'Trans proline' 0 CA--C 1.543 0.952 0 C-N-CA 123.56 2.84 . . . . 0.0 109.632 178.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -146.65 135.27 22.11 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 104.716 -2.328 . . . . 0.0 104.716 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 64.1 mm-40 53.22 48.65 21.65 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 126.17 1.788 . . . . 0.0 109.235 -177.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 -154.73 138.95 16.58 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.567 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 52.1 ttm-85 -155.97 135.33 12.3 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 127.859 2.464 . . . . 0.0 105.412 178.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 23.8 tp -87.75 139.45 30.52 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.2 mm -133.63 144.65 35.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 126.05 1.74 . . . . 0.0 108.096 -178.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -138.8 124.99 20.19 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 178.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.59 39.27 12.92 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.799 0.839 . . . . 0.0 111.608 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.03 -16.72 14.44 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 125.064 1.316 . . . . 0.0 113.948 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.5 ttmt -78.92 129.06 34.09 Favored 'General case' 0 CA--C 1.517 -0.292 0 CA-C-N 119.811 1.806 . . . . 0.0 108.172 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.5 mp0 -74.1 136.18 42.97 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 106.749 -1.575 . . . . 0.0 106.749 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.5 mt -119.19 155.88 30.87 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 125.268 1.427 . . . . 0.0 110.419 -179.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -160.23 176.18 12.03 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 126.186 1.794 . . . . 0.0 107.971 178.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -71.88 161.0 31.6 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 126.792 2.037 . . . . 0.0 113.106 -178.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.42 -27.52 19.54 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 126.465 1.983 . . . . 0.0 110.222 -179.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 47.9 mtt180 -107.99 169.31 8.69 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 124.374 1.07 . . . . 0.0 111.694 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 45.7 p -122.83 171.16 9.4 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.946 1.298 . . . . 0.0 112.145 -178.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.3 mp -52.56 -41.72 63.82 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 123.296 0.638 . . . . 0.0 110.564 178.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.8 t -58.53 -45.48 88.78 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.899 1.68 . . . . 0.0 110.628 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -61.58 -47.06 87.24 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.816 0.846 . . . . 0.0 109.522 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -81.76 -1.21 46.38 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 118.763 -0.637 . . . . 0.0 112.473 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 52.7 t30 54.24 46.68 24.73 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 127.571 2.348 . . . . 0.0 111.267 -179.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.2 mt -87.5 123.83 40.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 87.8 mm-40 -94.09 172.46 8.21 Favored 'General case' 0 N--CA 1.464 0.265 0 C-N-CA 123.23 0.612 . . . . 0.0 111.846 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 41.3 pttt -66.7 157.21 33.24 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 50.79 41.78 26.83 Favored 'General case' 0 N--CA 1.446 -0.655 0 C-N-CA 125.907 1.683 . . . . 0.0 110.664 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.0 p -86.86 163.22 17.32 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 178.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.3 m -126.34 106.28 9.39 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 179.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.1 mp -98.16 161.16 13.85 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 125.109 1.364 . . . . 0.0 108.614 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 11.4 m80 -119.3 155.6 31.54 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 123.927 0.891 . . . . 0.0 109.223 178.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 16.9 mt -122.53 123.35 41.05 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 102.571 -3.122 . . . . 0.0 102.571 178.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.6 m -141.7 168.93 14.66 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 -178.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -142.06 -174.11 4.0 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.277 1.031 . . . . 0.0 111.692 177.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.1 ttt180 -161.2 130.33 4.65 Favored 'General case' 0 C--O 1.232 0.174 0 C-N-CA 124.752 1.221 . . . . 0.0 108.481 178.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 33.6 mt -138.87 137.91 36.97 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 120.154 1.343 . . . . 0.0 108.317 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 37.1 mmm-85 -89.11 -11.01 45.17 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 178.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -90.94 18.42 51.03 Favored Glycine 0 CA--C 1.538 1.499 0 N-CA-C 109.266 -1.533 . . . . 0.0 109.266 177.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.853 0 N-CA-C 107.914 -2.074 . . . . 0.0 107.914 -179.724 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.0 ttt . . . . . 0 CA--C 1.512 -0.519 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -121.22 156.69 31.89 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 178.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 34.9 pt -133.14 170.15 20.57 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 C-N-CA 125.515 1.526 . . . . 0.0 106.993 177.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -126.21 152.82 45.53 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 178.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 12.9 t -137.94 124.62 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.8 tppp? -93.28 109.58 21.11 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 104.348 -2.464 . . . . 0.0 104.348 178.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.414 ' HA ' HD12 ' A' ' 69' ' ' LEU . 25.3 p -72.6 165.37 24.83 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 121.074 0.464 . . . . 0.0 110.597 -179.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -69.0 -6.85 30.38 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.468 0.707 . . . . 0.0 111.36 178.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.1 p -93.88 -12.36 29.09 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.692 1.197 . . . . 0.0 109.692 179.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.51 5.78 57.71 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 126.862 2.172 . . . . 0.0 111.508 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.86 164.76 22.42 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 118.454 1.127 . . . . 0.0 108.933 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.1 m -124.42 132.31 53.51 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 179.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.5 mm -114.09 156.83 14.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 C-N-CA 125.963 1.705 . . . . 0.0 106.468 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 31.6 m -132.45 123.66 27.07 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 127.239 2.216 . . . . 0.0 105.832 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.4 mt -133.92 150.83 51.34 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 119.09 0.859 . . . . 0.0 109.922 -179.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -103.41 109.12 20.64 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 104.735 -2.32 . . . . 0.0 104.735 178.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.3 m -123.37 -172.33 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 125.53 1.532 . . . . 0.0 109.816 -177.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -146.17 162.42 35.17 Favored Pre-proline 0 C--O 1.234 0.279 0 O-C-N 121.357 -0.839 . . . . 0.0 109.637 179.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -58.46 -18.53 39.52 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.407 2.071 . . . . 0.0 113.21 179.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 6.2 m -114.38 31.34 6.67 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 118.763 0.71 . . . . 0.0 111.573 -177.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -98.17 129.34 44.95 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 104.007 -2.59 . . . . 0.0 104.007 178.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.7 p -78.09 157.47 29.5 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 119.814 1.188 . . . . 0.0 110.128 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 51.3 mm -64.5 -26.0 39.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 177.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -55.4 -44.13 75.87 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 125.356 1.462 . . . . 0.0 109.436 178.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 20.8 m-80 -70.97 -52.37 20.16 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.623 1.169 . . . . 0.0 108.545 179.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 94.7 t -54.74 -38.52 43.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 124.222 1.009 . . . . 0.0 111.41 -179.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -76.56 -18.54 58.62 Favored 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 124.192 0.997 . . . . 0.0 111.097 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -88.74 -42.27 12.05 Favored 'General case' 0 C--O 1.228 -0.049 0 CA-C-N 119.633 1.106 . . . . 0.0 110.145 179.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -54.16 -40.58 67.59 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.216 0.606 . . . . 0.0 110.86 179.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.5 pt -63.05 -25.42 38.5 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 O-C-N 120.851 -1.156 . . . . 0.0 111.549 178.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -77.93 -21.63 50.82 Favored 'General case' 0 C--N 1.332 -0.169 0 O-C-N 120.79 -1.194 . . . . 0.0 109.967 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -78.11 -30.61 49.58 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.8 mttm -100.57 -15.05 17.95 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 115.799 1.777 . . . . 0.0 115.799 -179.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -139.52 158.71 43.66 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 121.437 1.926 . . . . 0.0 108.936 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.31 70.22 3.13 Favored Glycine 0 CA--C 1.524 0.622 0 C-N-CA 124.87 1.224 . . . . 0.0 110.914 -179.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.6 pt -137.23 107.62 8.72 Favored Pre-proline 0 CA--C 1.544 0.731 0 CA-C-N 118.826 1.313 . . . . 0.0 111.579 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -76.05 168.98 23.03 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 123.756 2.971 . . . . 0.0 109.33 178.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -78.74 57.23 6.28 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.572 2.181 . . . . 0.0 109.875 179.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -149.4 135.91 19.31 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 128.401 2.68 . . . . 0.0 105.451 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 47.1 mm-40 54.03 48.54 20.88 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.474 1.509 . . . . 0.0 108.501 -177.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.44 HD21 HD13 ' A' ' 69' ' ' LEU . 5.8 t-20 -147.83 134.53 19.95 Favored 'General case' 0 C--N 1.339 0.137 0 O-C-N 121.39 -0.819 . . . . 0.0 110.323 -179.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 52.4 ttm-85 -155.55 133.55 11.42 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 29.1 tp -89.14 135.31 33.63 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.826 1.65 . . . . 0.0 110.581 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.4 mm -135.74 147.33 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 125.03 1.332 . . . . 0.0 108.009 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -139.0 115.14 10.28 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 178.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.49 40.75 15.72 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.085 1.354 . . . . 0.0 110.505 -178.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.71 -10.03 53.22 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 125.481 1.515 . . . . 0.0 114.955 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.6 ttmt -79.71 129.84 34.83 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 120.488 2.144 . . . . 0.0 107.732 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.5 mp0 -74.31 125.53 28.66 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 179.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 77.4 mt -114.15 140.73 48.28 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 106.095 -1.816 . . . . 0.0 106.095 179.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -162.88 -179.91 7.13 Favored 'General case' 0 C--N 1.32 -0.686 0 O-C-N 121.658 -0.651 . . . . 0.0 110.206 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -70.49 160.13 32.98 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 125.089 1.356 . . . . 0.0 112.8 -176.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.85 -29.55 12.26 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 128.153 2.787 . . . . 0.0 110.067 -178.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 49.8 mtt180 -108.28 169.6 8.53 Favored 'General case' 0 N--CA 1.467 0.375 0 C-N-CA 126.191 1.796 . . . . 0.0 112.065 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 78.3 p -117.73 167.52 11.29 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 126.865 2.066 . . . . 0.0 111.04 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.7 mp -52.4 -42.02 63.66 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 123.282 0.633 . . . . 0.0 111.131 178.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.7 t -58.65 -43.17 89.72 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 125.48 1.512 . . . . 0.0 110.605 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -59.87 -46.9 87.85 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 118.741 0.7 . . . . 0.0 109.574 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -81.83 -4.08 55.59 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.246 1.018 . . . . 0.0 113.476 -179.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 37.6 t30 58.34 47.44 13.92 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.609 1.964 . . . . 0.0 110.963 -178.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.9 mt -86.28 122.99 39.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 104.775 -2.306 . . . . 0.0 104.775 179.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 92.1 mm-40 -93.37 170.32 9.7 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 122.862 0.465 . . . . 0.0 110.677 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 49.4 pttt -68.76 157.36 36.52 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 121.238 0.542 . . . . 0.0 111.228 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 53.16 37.83 26.0 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 127.379 2.272 . . . . 0.0 110.566 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.3 p -87.14 161.69 17.95 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.121 1.368 . . . . 0.0 109.63 178.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 95.2 m -126.33 110.17 13.08 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.3 mp -97.17 158.84 15.25 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.202 1.801 . . . . 0.0 108.857 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 72.1 m80 -120.07 163.64 17.36 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 125.341 1.456 . . . . 0.0 111.823 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.44 HD13 HD21 ' A' ' 41' ' ' ASN . 54.5 mt -120.19 133.45 55.49 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 125.13 1.372 . . . . 0.0 107.49 178.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.1 m -140.63 168.98 16.07 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 C-N-CA 124.413 1.085 . . . . 0.0 109.664 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.25 -170.6 3.3 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 125.123 1.369 . . . . 0.0 107.338 176.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.4 tpt180 -151.07 133.93 15.8 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 103.724 -2.695 . . . . 0.0 103.724 178.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -155.3 125.01 6.47 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 118.823 0.738 . . . . 0.0 109.051 -178.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 30.3 mmm-85 -89.1 -15.82 33.01 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 118.991 0.814 . . . . 0.0 111.023 179.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -80.93 18.54 9.11 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-O 119.186 -0.786 . . . . 0.0 112.485 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.186 0 N-CA-C 105.781 -2.927 . . . . 0.0 105.781 -179.817 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 33.6 ttm . . . . . 0 N--CA 1.469 0.477 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -122.67 150.48 42.65 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 175.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.9 pt -132.65 168.63 23.74 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 176.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 86.2 m-85 -126.1 151.79 46.74 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 123.892 0.877 . . . . 0.0 109.587 -179.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.9 t -138.37 133.06 42.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 178.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.7 tppp? -98.27 117.27 32.28 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 105.241 -2.133 . . . . 0.0 105.241 177.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.3 p -80.36 167.08 20.66 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 118.878 0.763 . . . . 0.0 110.471 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -71.94 -7.98 51.8 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 122.747 0.419 . . . . 0.0 111.173 177.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.4 p -93.51 -12.35 29.84 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.549 1.14 . . . . 0.0 109.411 178.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.77 7.48 55.44 Favored Glycine 0 C--N 1.342 0.861 0 C-N-CA 125.005 1.288 . . . . 0.0 112.622 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -80.86 164.34 22.73 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 119.617 1.709 . . . . 0.0 108.186 179.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.2 m -124.11 131.46 53.55 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 102.953 -2.98 . . . . 0.0 102.953 177.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 7.9 mm -115.11 157.4 15.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 C-N-CA 125.81 1.644 . . . . 0.0 106.686 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 42.2 m -134.68 125.97 28.16 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 128.503 2.721 . . . . 0.0 104.945 177.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 81.1 mt -139.89 149.21 43.11 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.85 1.26 . . . . 0.0 110.17 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -102.13 114.25 28.22 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 126.116 1.767 . . . . 0.0 107.372 178.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.456 HG12 ' HE3' ' A' ' 29' ' ' LYS . 2.2 m -134.33 -175.0 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 124.77 1.228 . . . . 0.0 108.118 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -142.45 168.89 12.1 Favored Pre-proline 0 C--O 1.236 0.364 0 O-C-N 121.235 -0.916 . . . . 0.0 110.256 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -54.56 -22.12 26.93 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 122.683 2.256 . . . . 0.0 114.388 -179.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.5 m -115.11 31.77 6.48 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -178.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -95.68 128.92 42.96 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 101.133 -3.655 . . . . 0.0 101.133 175.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.2 p -76.57 159.0 30.71 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 119.778 1.172 . . . . 0.0 109.762 -179.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 51.8 mm -62.54 -26.19 39.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -53.86 -49.24 68.91 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.599 1.16 . . . . 0.0 108.457 178.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 -68.24 -52.02 38.73 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 126.436 1.894 . . . . 0.0 110.345 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.3 t -53.92 -43.68 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-N 119.232 0.923 . . . . 0.0 110.122 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -75.21 -13.48 60.45 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.182 0.993 . . . . 0.0 112.05 -178.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.51 -45.14 9.62 Favored 'General case' 0 C--O 1.225 -0.229 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 177.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.456 ' HE3' HG12 ' A' ' 17' ' ' VAL . 12.3 mtmm -50.84 -39.74 54.23 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.187 1.395 . . . . 0.0 110.385 179.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 37.5 pt -65.88 -25.41 36.16 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 CA-C-N 118.956 0.798 . . . . 0.0 112.332 178.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -76.37 -23.45 54.13 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 120.017 1.281 . . . . 0.0 109.372 -179.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.02 -38.88 56.75 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 177.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 45.6 mttm -87.43 -16.01 36.08 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 116.526 2.047 . . . . 0.0 116.526 -178.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -147.55 160.62 42.42 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 121.371 1.896 . . . . 0.0 110.511 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.31 64.09 4.23 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 124.427 1.013 . . . . 0.0 113.393 -179.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.1 pt -134.72 106.39 10.73 Favored Pre-proline 0 CA--C 1.541 0.61 0 CA-C-N 119.114 1.457 . . . . 0.0 108.341 179.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -71.54 169.45 20.93 Favored 'Trans proline' 0 CA--C 1.539 0.751 0 C-N-CA 123.7 2.933 . . . . 0.0 112.374 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -78.23 56.91 5.98 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 123.567 2.844 . . . . 0.0 110.263 178.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -149.5 136.16 19.41 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 127.958 2.503 . . . . 0.0 105.099 179.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 64.2 mm-40 51.91 48.83 22.01 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.303 1.441 . . . . 0.0 107.819 -177.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -152.55 133.14 13.85 Favored 'General case' 0 N--CA 1.455 -0.207 0 O-C-N 121.21 -0.932 . . . . 0.0 109.979 -178.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.0 ttm-85 -154.4 136.17 14.45 Favored 'General case' 0 CA--C 1.519 -0.246 0 N-CA-C 106.206 -1.775 . . . . 0.0 106.206 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 18.5 tp -88.22 137.85 31.96 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 124.427 1.091 . . . . 0.0 108.265 -179.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 9.9 mm -135.12 150.2 29.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 126.002 1.721 . . . . 0.0 108.348 -178.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 25.2 t80 -137.17 115.41 11.72 Favored 'General case' 0 N--CA 1.462 0.137 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 178.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.39 42.32 18.04 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.884 1.274 . . . . 0.0 111.161 -178.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.33 -12.48 38.65 Favored Glycine 0 CA--C 1.53 0.97 0 CA-C-O 118.283 -1.287 . . . . 0.0 114.429 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.0 ttmt -79.11 125.17 29.06 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 120.86 2.33 . . . . 0.0 105.96 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.3 mp0 -74.31 136.0 42.56 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -179.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.3 mt -122.91 153.89 39.06 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -162.98 178.45 8.34 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 126.886 2.074 . . . . 0.0 107.802 177.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -71.78 160.56 32.39 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 125.057 1.343 . . . . 0.0 112.269 -177.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 108.34 -29.51 9.98 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 127.709 2.576 . . . . 0.0 108.626 -178.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 44.1 mtt180 -108.44 166.37 10.82 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.598 1.159 . . . . 0.0 112.329 178.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 49.5 p -117.44 169.59 9.4 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 126.067 1.747 . . . . 0.0 110.292 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.3 mp -52.73 -42.22 64.68 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 122.901 0.48 . . . . 0.0 111.207 178.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.2 t -59.06 -45.61 90.33 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.853 1.261 . . . . 0.0 110.799 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -59.46 -44.92 92.88 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.21 0.604 . . . . 0.0 110.506 -179.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -82.22 -0.3 44.58 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 123.518 0.727 . . . . 0.0 112.21 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 44.8 t30 53.65 47.49 23.71 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 127.141 2.176 . . . . 0.0 110.611 -179.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 97.1 mt -85.05 130.95 35.25 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 N-CA-C 104.397 -2.446 . . . . 0.0 104.397 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 68.7 mm-40 -89.63 167.14 13.16 Favored 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 123.079 0.551 . . . . 0.0 111.566 -178.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -72.74 156.68 38.68 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 177.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 50.86 35.74 13.06 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.205 1.402 . . . . 0.0 111.358 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.6 p -81.85 164.77 21.38 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 126.422 1.889 . . . . 0.0 109.494 179.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.5 m -125.97 107.03 10.06 Favored 'General case' 0 N--CA 1.461 0.12 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.6 mp -97.61 164.51 12.39 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.124 1.37 . . . . 0.0 109.21 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 22.2 m80 -119.93 157.66 28.31 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 126.028 1.731 . . . . 0.0 110.949 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 34.6 mt -123.16 125.47 45.2 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.584 1.554 . . . . 0.0 107.479 178.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.8 m -140.98 172.63 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 CA-C-N 119.722 1.147 . . . . 0.0 113.937 -178.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -142.43 -170.49 3.2 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.478 1.911 . . . . 0.0 109.41 177.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -156.09 132.91 10.43 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 103.988 -2.597 . . . . 0.0 103.988 178.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.1 mt -147.81 140.65 24.81 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 -179.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.6 mmm-85 -105.5 -14.1 15.41 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 118.939 0.79 . . . . 0.0 110.939 178.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -82.74 18.4 15.77 Favored Glycine 0 CA--C 1.537 1.459 0 N-CA-C 110.447 -1.061 . . . . 0.0 110.447 177.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.83 0 N-CA-C 104.38 -3.488 . . . . 0.0 104.38 -179.578 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ttt . . . . . 0 N--CA 1.473 0.691 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.8 pt20 -121.08 156.16 32.85 Favored 'General case' 0 CA--C 1.529 0.14 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 179.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 42.2 pt -133.71 170.85 19.02 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 C-N-CA 126.601 1.96 . . . . 0.0 107.883 177.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -126.14 152.43 45.96 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.187 1.395 . . . . 0.0 109.161 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.2 t -138.1 126.15 30.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 178.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? -92.83 117.5 30.09 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 106.144 -1.799 . . . . 0.0 106.144 178.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 64.4 p -73.12 164.39 26.76 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 178.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -67.67 -12.63 60.9 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.7 178.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.6 p -92.55 -12.11 32.68 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.396 1.879 . . . . 0.0 110.454 179.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.55 6.92 56.24 Favored Glycine 0 C--N 1.338 0.644 0 O-C-N 121.091 -1.006 . . . . 0.0 112.752 179.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.01 163.36 23.32 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 104.996 -2.224 . . . . 0.0 104.996 178.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 47.3 m -125.1 140.54 52.79 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 178.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.2 mm -114.82 156.22 15.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 126.338 1.855 . . . . 0.0 106.001 179.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 47.6 m -132.23 125.84 32.07 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 103.571 -2.751 . . . . 0.0 103.571 178.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.2 mt -138.73 151.49 47.17 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.024 0.93 . . . . 0.0 110.397 -178.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -99.69 118.62 36.6 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 128.362 2.665 . . . . 0.0 105.728 178.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.1 m -134.21 -171.27 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 125.512 1.525 . . . . 0.0 108.467 -178.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -146.72 161.8 36.28 Favored Pre-proline 0 CA--C 1.536 0.435 0 C-N-CA 124.197 0.999 . . . . 0.0 108.344 179.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -51.19 -24.98 16.19 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.316 2.678 . . . . 0.0 114.844 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 46.4 m -115.42 33.09 5.65 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.756 0.822 . . . . 0.0 111.563 -179.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.5 t0 -90.69 129.65 36.77 Favored 'General case' 0 C--O 1.241 0.621 0 N-CA-C 103.131 -2.915 . . . . 0.0 103.131 178.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 21.3 p -69.58 158.08 35.96 Favored 'General case' 0 C--O 1.237 0.421 0 O-C-N 121.728 -0.607 . . . . 0.0 110.69 -178.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.7 mm -64.25 -32.14 56.3 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.47 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 177.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -55.49 -39.71 70.79 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 125.823 1.649 . . . . 0.0 110.171 179.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -73.86 -53.46 10.15 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 59.1 t -57.92 -39.13 70.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 O-C-N 121.162 -0.961 . . . . 0.0 112.397 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 27.2 ttpt -75.01 -15.75 60.64 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.622 1.169 . . . . 0.0 110.921 -179.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.75 -47.1 7.84 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.108 1.763 . . . . 0.0 108.14 177.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.1 mttm -50.36 -40.5 49.5 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.217 1.407 . . . . 0.0 110.898 179.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 33.3 pt -64.32 -27.94 43.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 O-C-N 121.472 -0.768 . . . . 0.0 111.667 179.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -78.02 -22.09 49.77 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.824 1.249 . . . . 0.0 110.412 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.34 -37.76 60.52 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 177.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -94.18 -17.75 22.42 Favored 'General case' 0 N--CA 1.466 0.369 0 N-CA-C 116.104 1.891 . . . . 0.0 116.104 -179.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -136.45 150.21 48.61 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 121.401 1.909 . . . . 0.0 107.13 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -83.46 85.76 1.52 Allowed Glycine 0 CA--C 1.521 0.434 0 CA-C-O 119.14 -0.811 . . . . 0.0 111.285 -179.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.5 pt -141.17 108.78 6.29 Favored Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 118.327 1.064 . . . . 0.0 111.79 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -62.62 161.9 26.6 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 122.666 2.244 . . . . 0.0 110.547 178.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -84.23 56.66 5.03 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 122.569 2.179 . . . . 0.0 108.041 179.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -144.82 134.15 23.04 Favored 'General case' 0 CA--C 1.514 -0.415 0 C-N-CA 130.602 3.561 . . . . 0.0 103.515 -178.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 43.3 mm-40 50.89 49.55 20.86 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 125.353 1.461 . . . . 0.0 107.324 -176.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -147.89 133.0 18.27 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.771 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 42.9 ttm-85 -154.73 133.58 12.22 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 178.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 26.5 tp -88.25 137.06 32.66 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 125.17 1.388 . . . . 0.0 107.834 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 24.3 mm -127.98 144.46 37.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 125.718 1.607 . . . . 0.0 108.844 -178.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -136.77 126.07 24.85 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 178.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.36 33.15 9.48 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.049 0.94 . . . . 0.0 111.288 -179.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.27 -11.95 41.09 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 124.514 1.054 . . . . 0.0 112.483 -179.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -79.55 129.02 34.09 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 119.58 1.69 . . . . 0.0 107.515 179.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.9 mp0 -74.4 136.03 42.41 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.6 mt -122.98 155.67 36.31 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.29 1.036 . . . . 0.0 109.744 -178.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -161.7 -178.33 6.47 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 127.747 2.419 . . . . 0.0 107.393 177.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -70.63 160.42 32.6 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 127.621 2.368 . . . . 0.0 113.055 -176.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.5 -28.82 13.92 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 126.576 2.036 . . . . 0.0 110.264 -178.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 46.6 mtt180 -108.23 165.16 11.7 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.019 1.328 . . . . 0.0 112.3 179.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 64.4 p -118.52 174.21 6.39 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 126.87 2.068 . . . . 0.0 111.855 -179.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.67 -46.37 63.76 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.459 1.104 . . . . 0.0 110.98 179.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.1 t -58.6 -45.3 89.45 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.037 1.735 . . . . 0.0 111.503 -179.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -60.29 -45.09 94.56 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 122.966 0.506 . . . . 0.0 110.52 -178.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -81.53 1.84 31.74 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.04 0.536 . . . . 0.0 111.197 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.2 t30 54.72 46.19 25.15 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 128.039 2.535 . . . . 0.0 111.202 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 89.6 mt -88.38 125.51 41.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 81.5 mm-40 -101.93 176.94 5.04 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.253 1.021 . . . . 0.0 110.613 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 60.9 pttt -64.72 156.67 29.66 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 123.588 0.755 . . . . 0.0 110.431 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 49.17 39.33 15.2 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.518 1.927 . . . . 0.0 111.694 -178.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.8 p -83.95 161.64 20.73 Favored 'General case' 0 CA--C 1.538 0.501 0 O-C-N 120.447 -1.408 . . . . 0.0 108.129 178.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.5 m -126.29 108.8 11.6 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.4 mp -95.78 162.16 13.71 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 125.269 1.428 . . . . 0.0 109.004 -179.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -119.77 163.12 17.94 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.21 1.404 . . . . 0.0 109.928 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 22.3 mt -123.0 127.34 48.67 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.01 1.724 . . . . 0.0 108.337 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.6 m -141.21 163.44 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 114.255 1.205 . . . . 0.0 114.255 -178.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -142.86 -170.63 3.28 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 127.353 2.261 . . . . 0.0 108.819 177.305 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -159.35 129.38 5.64 Favored 'General case' 0 CA--C 1.521 -0.137 0 N-CA-C 105.021 -2.214 . . . . 0.0 105.021 176.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 18.6 mt -148.83 141.21 24.19 Favored 'General case' 0 CA--C 1.51 -0.574 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 34.7 mmm-85 -91.68 -17.64 25.17 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 177.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -84.1 20.42 13.19 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 126.606 2.051 . . . . 0.0 110.923 178.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.158 0 N-CA-C 108.591 -1.804 . . . . 0.0 108.591 -179.562 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.2 ttm . . . . . 0 N--CA 1.468 0.466 0 N-CA-C 110.354 -0.239 . . . . 0.0 110.354 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -121.04 156.45 32.17 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 105.863 -1.903 . . . . 0.0 105.863 176.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.2 pt -132.98 169.39 22.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 178.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -126.12 149.57 48.84 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 179.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.7 t -138.33 124.52 25.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.6 tppp? -92.8 117.78 30.39 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 105.345 -2.095 . . . . 0.0 105.345 178.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 50.1 p -72.19 167.06 21.12 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 121.564 0.697 . . . . 0.0 109.734 -179.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.403 ' H ' HD23 ' A' ' 8' ' ' LEU . 2.6 pt? -67.26 -12.51 60.3 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.62 0.768 . . . . 0.0 111.738 178.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 34.3 p -97.44 -12.71 22.38 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.908 1.683 . . . . 0.0 112.249 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.35 6.65 47.44 Favored Glycine 0 CA--C 1.526 0.779 0 CA-C-O 118.313 -1.271 . . . . 0.0 113.863 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.3 163.52 20.62 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 120.138 1.969 . . . . 0.0 105.983 178.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.5 m -124.57 132.76 53.44 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 15.5 mm -115.66 156.9 16.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 C-N-CA 127.458 2.303 . . . . 0.0 108.228 -179.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.7 m -133.54 130.55 38.62 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 127.85 2.46 . . . . 0.0 106.276 178.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 92.5 mt -134.3 151.87 51.49 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 126.16 1.784 . . . . 0.0 110.845 -179.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -102.68 117.69 35.21 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 104.548 -2.389 . . . . 0.0 104.548 177.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.1 m -135.18 -168.96 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 124.657 1.183 . . . . 0.0 109.768 -179.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -150.43 163.54 23.8 Favored Pre-proline 0 CA--C 1.537 0.462 0 C-N-CA 125.308 1.443 . . . . 0.0 109.196 178.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -57.12 -18.41 29.07 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.705 2.27 . . . . 0.0 113.274 178.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.4 m -114.22 31.27 6.7 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 123.74 0.816 . . . . 0.0 111.517 -178.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -94.97 130.07 41.76 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 102.309 -3.219 . . . . 0.0 102.309 176.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.5 p -71.62 156.69 39.1 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 119.798 1.181 . . . . 0.0 109.726 -179.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 34.7 mm -65.04 -29.33 47.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 177.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -57.74 -49.63 75.92 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 126.101 1.761 . . . . 0.0 107.9 178.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -63.04 -52.08 64.25 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.143 0.977 . . . . 0.0 109.421 178.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.8 t -56.37 -38.91 57.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 O-C-N 121.508 -0.745 . . . . 0.0 110.618 179.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -74.74 -17.83 60.59 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-O 117.763 -1.113 . . . . 0.0 109.948 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -85.29 -47.36 10.13 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 120.2 1.364 . . . . 0.0 108.177 178.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.0 mttm -50.32 -43.16 53.68 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.672 1.189 . . . . 0.0 111.808 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 36.8 pt -62.78 -27.73 43.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 O-C-N 121.501 -0.749 . . . . 0.0 112.684 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.423 HE22 ' HB3' ' A' ' 38' ' ' PRO . 34.8 mt-30 -77.21 -20.66 55.01 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 119.519 1.054 . . . . 0.0 110.479 -179.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -82.74 -38.08 23.76 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.171 -0.956 . . . . 0.0 108.974 178.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -86.03 -21.42 27.77 Favored 'General case' 0 N--CA 1.471 0.575 0 O-C-N 121.044 -1.035 . . . . 0.0 113.682 -178.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -140.5 150.81 44.22 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 178.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -80.89 85.29 1.38 Allowed Glycine 0 C--N 1.332 0.317 0 CA-C-N 118.907 0.776 . . . . 0.0 113.038 -178.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.3 pt -140.14 106.87 6.74 Favored Pre-proline 0 CA--C 1.54 0.59 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -66.09 170.4 11.85 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 123.772 2.982 . . . . 0.0 111.309 178.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.423 ' HB3' HE22 ' A' ' 31' ' ' GLN . 52.4 Cg_endo -83.46 55.99 5.19 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 N-CA-C 106.645 -2.098 . . . . 0.0 106.645 178.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -146.52 133.94 20.78 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 128.402 2.681 . . . . 0.0 106.746 -177.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 39.6 mm-40 46.84 49.43 14.39 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.073 1.749 . . . . 0.0 108.348 -177.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.453 HD21 HD13 ' A' ' 69' ' ' LEU . 16.8 t-20 -154.3 134.41 13.18 Favored 'General case' 0 C--N 1.341 0.207 0 C-N-CA 124.761 1.224 . . . . 0.0 110.106 -179.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 52.1 ttm-85 -151.59 141.47 21.99 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 179.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 20.0 tp -88.45 138.89 31.02 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.749 1.22 . . . . 0.0 108.818 -179.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 13.2 mm -135.16 149.98 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 C-N-CA 125.989 1.716 . . . . 0.0 107.083 -179.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -137.61 122.71 19.15 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 178.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 49.1 36.61 9.1 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.04 0.936 . . . . 0.0 111.494 -179.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.76 -13.95 33.64 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-O 118.773 -1.015 . . . . 0.0 114.028 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.3 ttmt -79.76 128.97 34.07 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 120.304 2.052 . . . . 0.0 106.145 178.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.7 mp0 -73.75 136.17 43.63 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.141 1.376 . . . . 0.0 108.924 -178.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.4 mt -123.86 155.03 38.8 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.345 1.058 . . . . 0.0 109.069 -179.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -161.78 179.46 8.08 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.269 1.428 . . . . 0.0 108.316 178.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -70.97 161.12 31.66 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 127.219 2.208 . . . . 0.0 112.993 -176.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.37 -25.18 29.08 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 126.24 1.876 . . . . 0.0 110.434 -178.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 47.3 mtt180 -108.29 171.56 7.34 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 118.715 1.257 . . . . 0.0 112.194 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 70.8 p -118.17 171.62 7.99 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 126.457 1.903 . . . . 0.0 109.322 178.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.7 mp -52.86 -42.16 64.97 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 123.357 0.663 . . . . 0.0 110.548 177.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.9 t -58.68 -45.44 89.42 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 126.251 1.82 . . . . 0.0 111.553 -179.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -57.73 -47.09 83.39 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 119.384 0.993 . . . . 0.0 109.871 -179.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -81.72 1.25 35.23 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.888 0.875 . . . . 0.0 112.378 -179.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 54.8 t30 53.93 46.08 26.36 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 127.422 2.289 . . . . 0.0 111.405 179.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.0 mt -86.29 126.71 40.66 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.9 mm-40 -97.2 173.3 7.3 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.402 0.681 . . . . 0.0 111.215 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 42.8 pttt -66.06 156.77 32.83 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 51.81 35.33 15.16 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 127.328 2.251 . . . . 0.0 110.901 -179.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.3 p -75.59 162.74 28.02 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 178.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.3 m -122.77 106.24 10.75 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 -179.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.5 mp -101.63 159.4 15.34 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.314 1.446 . . . . 0.0 109.552 -178.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 4.1 m80 -120.25 163.64 17.47 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 126.406 1.882 . . . . 0.0 111.145 179.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.453 HD13 HD21 ' A' ' 41' ' ' ASN . 69.4 mt -122.24 125.41 45.99 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 177.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.9 m -139.77 163.75 24.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 CA-C-O 121.85 0.833 . . . . 0.0 111.64 -179.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -141.94 -169.12 2.85 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 127.278 2.231 . . . . 0.0 108.409 178.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.9 tpt180 -151.92 130.07 11.92 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 102.27 -3.233 . . . . 0.0 102.27 176.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.524 HD23 ' H ' ' A' ' 75' ' ' GLY . 1.0 OUTLIER -143.09 123.22 13.67 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 -179.151 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 48.1 mmm-85 -97.7 -11.83 23.05 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 123.107 0.563 . . . . 0.0 111.753 -179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.524 ' H ' HD23 ' A' ' 73' ' ' LEU . . . -82.39 18.42 14.39 Favored Glycine 0 CA--C 1.537 1.457 0 C-N-CA 124.599 1.095 . . . . 0.0 111.259 178.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.039 0 N-CA-C 105.564 -3.014 . . . . 0.0 105.564 179.953 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 30.3 ttm . . . . . 0 CA--C 1.514 -0.415 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -120.99 148.43 44.11 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 178.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 34.0 pt -132.11 168.34 24.28 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 O-C-N 120.993 -1.067 . . . . 0.0 108.448 179.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -126.22 149.84 48.78 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.7 t -138.3 124.64 25.88 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -90.42 118.95 30.29 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 126.914 2.086 . . . . 0.0 111.071 179.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 51.1 p -83.05 163.98 20.61 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 177.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.66 -5.65 16.79 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.426 1.09 . . . . 0.0 112.881 178.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.9 p -92.77 -14.23 28.17 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.794 2.037 . . . . 0.0 110.555 178.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.5 6.39 57.47 Favored Glycine 0 C--N 1.337 0.593 0 C-N-CA 125.637 1.589 . . . . 0.0 112.459 179.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.8 mmmm -81.77 164.48 21.66 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 118.28 1.04 . . . . 0.0 108.334 179.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 4.1 m -125.09 137.19 54.2 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 177.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 48.8 mm -115.95 154.0 17.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 105.507 -2.034 . . . . 0.0 105.507 178.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.8 m -132.71 130.13 39.63 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 178.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 78.5 mt -139.17 151.2 46.42 Favored 'General case' 0 N--CA 1.464 0.225 0 C-N-CA 124.899 1.28 . . . . 0.0 111.857 -178.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -98.94 117.63 33.89 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 127.482 2.313 . . . . 0.0 105.024 178.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.6 m -134.39 -171.99 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 125.323 1.449 . . . . 0.0 109.729 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -148.09 165.59 17.98 Favored Pre-proline 0 CA--C 1.536 0.406 0 C-N-CA 124.136 0.974 . . . . 0.0 110.507 179.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.78 -19.27 14.34 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 123.725 2.95 . . . . 0.0 115.547 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 47.1 m -115.73 30.83 7.1 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 119.132 0.878 . . . . 0.0 111.693 -179.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -91.46 129.31 37.46 Favored 'General case' 0 C--O 1.244 0.784 0 N-CA-C 102.846 -3.02 . . . . 0.0 102.846 177.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 35.9 p -76.65 158.34 31.13 Favored 'General case' 0 C--O 1.233 0.205 0 O-C-N 121.118 -0.989 . . . . 0.0 110.697 -178.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.2 mm -63.07 -27.02 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 179.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -54.18 -46.5 72.4 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.387 1.075 . . . . 0.0 109.633 178.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 56.7 m-80 -69.57 -52.36 26.95 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.659 1.584 . . . . 0.0 109.445 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 61.4 t -54.45 -40.98 51.57 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 CA-C-N 118.835 0.743 . . . . 0.0 109.971 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.1 ttpt -75.49 -12.92 60.33 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.953 1.301 . . . . 0.0 111.637 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.11 -47.44 7.82 Favored 'General case' 0 CA--C 1.52 -0.198 0 C-N-CA 124.614 1.166 . . . . 0.0 109.46 178.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 55.7 mttm -51.21 -40.24 58.29 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.918 1.287 . . . . 0.0 110.485 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.7 pt -61.64 -31.0 49.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-O 118.44 -0.79 . . . . 0.0 112.413 179.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -77.38 -19.97 55.41 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.029 1.332 . . . . 0.0 110.724 179.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -83.89 -40.03 19.12 Favored 'General case' 0 CA--C 1.53 0.193 0 O-C-N 121.412 -0.805 . . . . 0.0 110.484 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 31.8 mttm -89.87 -14.97 33.18 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 -179.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -138.95 150.79 46.29 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.72 64.54 4.19 Favored Glycine 0 CA--C 1.524 0.603 0 CA-C-O 118.136 -1.369 . . . . 0.0 112.729 -179.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.5 pt -127.41 106.72 21.28 Favored Pre-proline 0 CA--C 1.552 1.02 0 CA-C-N 118.928 1.364 . . . . 0.0 111.162 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -65.88 165.41 23.7 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 124.13 3.22 . . . . 0.0 114.694 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -81.79 57.52 6.35 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 124.756 3.637 . . . . 0.0 110.163 178.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -145.12 134.06 22.49 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 128.69 2.796 . . . . 0.0 105.501 -178.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.8 mm-40 44.23 51.1 7.57 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 126.603 1.961 . . . . 0.0 110.05 -177.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 23.3 m-20 -150.59 134.2 16.51 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 41.3 ttm-85 -153.28 142.65 21.63 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 124.883 1.273 . . . . 0.0 107.638 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.0 tp -88.62 142.9 27.31 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 125.246 1.419 . . . . 0.0 112.698 -177.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.6 mm -135.55 148.15 28.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 C-N-CA 126.934 2.094 . . . . 0.0 108.265 179.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -138.18 115.07 10.76 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 177.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.45 43.06 19.46 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.268 1.027 . . . . 0.0 110.784 -178.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.66 -13.19 36.99 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 124.63 1.11 . . . . 0.0 114.738 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.6 ttmm -79.48 129.21 34.26 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 119.757 1.778 . . . . 0.0 109.33 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -74.81 129.36 37.54 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 125.82 1.648 . . . . 0.0 109.577 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 9.8 mt -123.74 148.85 46.24 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 123.726 0.811 . . . . 0.0 110.43 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 10.1 pm0 -151.61 175.96 11.83 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.12 1.368 . . . . 0.0 108.464 178.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -72.13 161.03 31.46 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 125.493 1.517 . . . . 0.0 113.628 -177.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.82 -22.52 39.97 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 125.672 1.606 . . . . 0.0 110.724 -179.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -107.27 169.97 8.24 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 118.572 1.186 . . . . 0.0 111.347 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 79.4 p -117.09 171.14 8.12 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 125.604 1.562 . . . . 0.0 113.026 -178.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.57 -47.13 67.02 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.074 0.95 . . . . 0.0 108.829 177.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.2 m -62.04 -32.5 73.02 Favored 'General case' 0 N--CA 1.46 0.063 0 C-N-CA 124.823 1.249 . . . . 0.0 112.93 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -67.41 -45.67 75.47 Favored 'General case' 0 CA--C 1.515 -0.398 0 O-C-N 121.077 -1.014 . . . . 0.0 109.819 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -82.95 1.39 39.91 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 119.208 -0.425 . . . . 0.0 110.93 178.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 36.5 t30 56.01 46.71 21.3 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 127.76 2.424 . . . . 0.0 111.167 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.6 mt -89.76 126.98 42.64 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 178.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -101.84 178.43 4.62 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 123.039 0.536 . . . . 0.0 110.216 179.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 58.4 pttt -64.68 156.88 28.85 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.176 0.59 . . . . 0.0 110.661 179.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 52.26 46.1 27.25 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.216 1.407 . . . . 0.0 111.221 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.1 p -88.75 161.26 16.89 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.994 1.718 . . . . 0.0 109.912 177.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -126.37 117.05 22.17 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 178.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.4 mp -109.04 160.57 15.94 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 124.298 1.039 . . . . 0.0 109.256 -179.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 43.7 m80 -120.05 161.11 21.51 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 126.39 1.876 . . . . 0.0 109.526 178.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 33.6 mt -122.82 125.14 44.86 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 126.728 2.011 . . . . 0.0 108.014 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.0 m -141.02 166.14 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -178.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -142.79 -172.32 3.63 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.384 1.474 . . . . 0.0 108.955 177.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.79 128.66 5.08 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 103.926 -2.62 . . . . 0.0 103.926 177.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 76.4 mt -146.98 140.69 25.75 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 -179.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.5 mmm180 -102.43 -15.35 16.53 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.675 0.79 . . . . 0.0 110.629 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -85.66 19.38 24.84 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 125.583 1.563 . . . . 0.0 110.88 178.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.126 0 N-CA-C 105.246 -3.142 . . . . 0.0 105.246 -179.762 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.0 ttm . . . . . 0 N--CA 1.471 0.624 0 CA-C-O 118.719 -0.658 . . . . 0.0 110.356 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -121.74 154.41 36.96 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 176.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 38.9 pt -133.42 169.22 22.34 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 176.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -123.04 149.53 44.26 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 179.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.7 t -138.95 125.69 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.1 tppp? -94.14 117.56 30.29 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.946 0.898 . . . . 0.0 108.903 178.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 37.4 p -83.22 166.18 18.8 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.889 0.768 . . . . 0.0 111.025 179.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -70.29 -2.56 13.81 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.35 0.66 . . . . 0.0 111.909 177.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 47.0 p -92.62 -15.16 27.19 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.915 1.286 . . . . 0.0 109.369 178.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.5 6.08 57.6 Favored Glycine 0 C--N 1.34 0.768 0 C-N-CA 126.825 2.155 . . . . 0.0 112.435 179.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.3 mmmm -81.91 164.18 21.72 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 119.172 1.486 . . . . 0.0 109.636 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.5 m -113.2 132.08 55.63 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 101.896 -3.372 . . . . 0.0 101.896 176.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 13.8 mm -115.77 148.06 18.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 105.645 -1.983 . . . . 0.0 105.645 179.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.9 m -125.37 130.05 51.15 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 106.392 -1.706 . . . . 0.0 106.392 178.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 76.3 mt -139.12 143.26 38.16 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.518 0.727 . . . . 0.0 110.072 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -99.57 107.1 19.17 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.902 2.081 . . . . 0.0 106.58 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.4 m -133.58 -172.6 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 124.988 1.315 . . . . 0.0 109.929 -178.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -144.13 166.07 20.84 Favored Pre-proline 0 C--O 1.235 0.315 0 CA-C-N 121.031 1.741 . . . . 0.0 112.178 -178.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.05 -22.47 31.28 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 123.246 2.63 . . . . 0.0 115.416 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 10.5 m -115.11 31.03 6.96 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 118.527 0.603 . . . . 0.0 112.369 -178.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -104.31 136.17 44.41 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 103.974 -2.602 . . . . 0.0 103.974 175.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.4 p -78.09 157.97 29.32 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 122.017 0.913 . . . . 0.0 112.065 -178.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 35.1 mm -64.02 -25.43 38.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-O 118.373 -0.823 . . . . 0.0 110.018 178.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -55.83 -38.66 70.32 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 119.739 1.154 . . . . 0.0 109.382 179.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 57.7 m-20 -74.42 -52.96 10.56 Favored 'General case' 0 CA--C 1.521 -0.14 0 C-N-CA 124.723 1.209 . . . . 0.0 109.552 178.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 24.8 t -54.23 -42.65 57.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 123.036 0.534 . . . . 0.0 111.348 -179.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -74.95 -14.54 60.64 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.653 0.781 . . . . 0.0 111.421 -178.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.19 -45.65 8.95 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.397 1.079 . . . . 0.0 108.602 177.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 63.5 mttm -52.64 -39.92 62.25 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 124.715 1.206 . . . . 0.0 111.446 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 32.2 pt -60.53 -29.01 43.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-N 118.445 0.566 . . . . 0.0 111.08 178.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -76.91 -23.43 52.52 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 119.445 1.02 . . . . 0.0 109.983 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.54 -24.31 45.76 Favored 'General case' 0 CA--C 1.544 0.734 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 177.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.6 mmtt -93.56 -20.35 20.32 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 179.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -150.83 161.76 42.06 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 120.796 1.634 . . . . 0.0 109.526 -178.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -80.95 77.29 2.04 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 124.225 0.917 . . . . 0.0 111.957 -179.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 19.1 pt -135.41 108.51 10.25 Favored Pre-proline 0 CA--C 1.546 0.805 0 CA-C-N 118.245 1.023 . . . . 0.0 111.759 -179.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -65.22 166.69 18.29 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 123.151 2.567 . . . . 0.0 110.465 178.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -88.23 56.64 2.57 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.408 2.072 . . . . 0.0 107.813 179.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -145.91 136.01 23.71 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 127.909 2.484 . . . . 0.0 105.045 -178.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.0 mm-40 51.14 49.53 20.93 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.83 1.652 . . . . 0.0 109.192 -177.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 23.7 m-80 -148.68 133.75 18.22 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.4 ttm-85 -151.72 137.17 17.69 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 126.967 2.107 . . . . 0.0 105.547 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 28.6 tp -87.27 139.39 30.61 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.603 1.161 . . . . 0.0 108.794 -178.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.4 mm -132.26 145.6 34.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 126.05 1.74 . . . . 0.0 108.475 -178.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -133.4 119.22 19.36 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 178.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.05 39.88 24.25 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.355 1.062 . . . . 0.0 110.451 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.48 -16.59 17.82 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-O 118.506 -1.163 . . . . 0.0 113.905 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 28.4 ttmt -79.52 128.78 33.8 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 120.519 2.16 . . . . 0.0 106.661 178.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.1 mp0 -74.55 136.94 42.12 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -179.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.9 mt -122.39 155.84 35.22 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 126.078 1.751 . . . . 0.0 109.978 -179.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -151.99 176.38 11.55 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.922 1.289 . . . . 0.0 109.162 178.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -72.6 160.9 31.5 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 126.082 1.753 . . . . 0.0 110.959 -178.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 103.84 -26.08 24.41 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 125.06 1.314 . . . . 0.0 110.098 -178.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 30.3 mtt180 -106.55 170.34 7.99 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 118.736 1.268 . . . . 0.0 110.165 179.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 41.1 p -117.49 167.59 11.16 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 125.51 1.524 . . . . 0.0 110.086 179.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.4 mp -52.88 -41.66 64.56 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 121.5 -0.75 . . . . 0.0 111.087 178.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.4 t -58.33 -44.22 88.6 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.274 1.43 . . . . 0.0 110.608 -179.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -57.94 -46.9 84.35 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.348 0.659 . . . . 0.0 109.884 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -81.72 -4.31 55.95 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -179.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 31.8 t30 56.66 46.37 20.34 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.996 2.118 . . . . 0.0 109.997 -178.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 84.2 mt -86.35 127.22 40.48 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 N-CA-C 103.782 -2.673 . . . . 0.0 103.782 178.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 94.6 mm-40 -101.74 173.21 6.51 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 122.918 0.487 . . . . 0.0 110.851 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 31.1 pttt -64.71 157.25 27.9 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 51.6 39.08 24.18 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 125.562 1.545 . . . . 0.0 111.231 -179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.1 p -87.34 163.44 16.81 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 120.87 -1.144 . . . . 0.0 108.263 177.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 33.0 m -126.4 105.98 9.17 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.4 mp -97.09 160.25 14.45 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.655 1.582 . . . . 0.0 108.805 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 4.2 m80 -120.01 157.63 28.47 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 125.36 1.464 . . . . 0.0 108.194 178.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 15.1 mt -122.99 123.47 40.96 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 105.223 -2.139 . . . . 0.0 105.223 178.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.5 m -141.8 172.43 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-N 120.11 1.323 . . . . 0.0 113.582 -179.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.44 -172.99 3.64 Favored 'General case' 0 C--N 1.343 0.301 0 C-N-CA 124.718 1.207 . . . . 0.0 111.071 178.031 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 13.8 ttt180 -161.04 130.71 4.87 Favored 'General case' 0 N--CA 1.45 -0.425 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 177.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -155.7 122.64 5.36 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 105.909 -1.886 . . . . 0.0 105.909 178.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . 0.41 24.1 mmm-85 -91.12 -0.89 57.81 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -83.03 18.72 14.99 Favored Glycine 0 CA--C 1.539 1.586 0 N-CA-C 108.019 -2.032 . . . . 0.0 108.019 176.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.935 0 C-N-CA 129.423 3.392 . . . . 0.0 105.856 -179.859 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.3 ttt . . . . . 0 N--CA 1.469 0.502 0 N-CA-C 110.606 -0.146 . . . . 0.0 110.606 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -120.71 156.96 30.68 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 177.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 41.4 pt -132.51 169.46 21.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 178.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -122.58 150.03 43.16 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 124.867 1.267 . . . . 0.0 108.239 179.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.8 t -139.17 125.24 23.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 O-C-N 121.788 -0.57 . . . . 0.0 109.585 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.0 tppp? -91.0 111.27 22.65 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 178.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.5 p -83.15 160.61 21.81 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.655 0.661 . . . . 0.0 110.397 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -67.52 -2.72 6.97 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.407 1.083 . . . . 0.0 112.744 179.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.9 p -91.3 -12.62 34.56 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 125.264 1.426 . . . . 0.0 110.039 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.64 7.46 57.84 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 110.361 -1.096 . . . . 0.0 110.361 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.3 mmmm -97.07 165.1 12.23 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 118.006 0.903 . . . . 0.0 109.078 179.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.46 132.81 53.5 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 103.911 -2.626 . . . . 0.0 103.911 178.027 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.0 mm -114.56 153.26 16.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 -178.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 89.8 m -124.77 130.11 51.76 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 104.395 -2.446 . . . . 0.0 104.395 178.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 75.1 mt -138.8 151.2 46.85 Favored 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 124.226 1.01 . . . . 0.0 111.04 -179.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -97.59 118.7 34.69 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 127.22 2.208 . . . . 0.0 107.17 179.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 23.0 m -134.36 -174.94 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 C-N-CA 124.005 0.922 . . . . 0.0 110.094 -179.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -147.68 159.14 41.82 Favored Pre-proline 0 C--O 1.234 0.278 0 C-N-CA 124.231 1.012 . . . . 0.0 109.469 178.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -53.37 -23.35 23.72 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 123.349 2.699 . . . . 0.0 115.005 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 42.2 m -115.62 30.83 7.1 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -178.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -94.91 135.47 36.38 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 105.078 -2.193 . . . . 0.0 105.078 176.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.3 p -71.44 158.86 35.54 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 119.558 1.072 . . . . 0.0 112.686 -178.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 15.7 mm -63.78 -28.89 45.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 O-C-N 121.475 -0.766 . . . . 0.0 109.018 178.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -61.08 -49.83 75.73 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -61.08 -52.48 64.73 Favored 'General case' 0 C--O 1.231 0.127 0 C-N-CA 124.134 0.973 . . . . 0.0 109.635 179.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 71.0 t -56.53 -38.55 57.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 124.165 0.986 . . . . 0.0 111.421 -179.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.4 ttpt -80.59 -12.51 59.5 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 118.361 -0.828 . . . . 0.0 111.473 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.6 -43.01 11.07 Favored 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 125.211 1.404 . . . . 0.0 109.213 178.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.6 mttm -51.89 -39.71 59.48 Favored 'General case' 0 N--CA 1.468 0.452 0 O-C-N 121.423 -0.798 . . . . 0.0 111.723 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 30.1 pt -65.0 -25.01 36.7 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 O-C-N 121.679 -0.638 . . . . 0.0 111.683 178.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -76.15 -20.67 57.36 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.916 1.234 . . . . 0.0 108.911 -179.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.45 -38.92 40.06 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 120.936 -1.103 . . . . 0.0 108.234 177.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 51.4 mttm -86.95 -21.81 25.99 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 -178.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -140.29 150.16 43.7 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 121.266 1.848 . . . . 0.0 106.406 178.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.75 82.96 1.55 Allowed Glycine 0 N--CA 1.451 -0.323 0 N-CA-C 110.101 -1.2 . . . . 0.0 110.101 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.8 pt -134.94 108.72 10.66 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 125.533 1.533 . . . . 0.0 106.865 179.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -82.87 170.23 12.68 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 124.532 3.488 . . . . 0.0 112.129 -179.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -74.9 55.39 3.88 Favored 'Trans proline' 0 CA--C 1.553 1.439 0 C-N-CA 123.056 2.504 . . . . 0.0 111.089 178.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -150.01 127.09 11.23 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 104.475 -2.417 . . . . 0.0 104.475 179.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 71.0 mm-40 54.72 50.81 15.0 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.066 1.346 . . . . 0.0 108.347 -176.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -143.21 132.42 23.2 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 179.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 49.6 ttm-85 -158.93 133.42 7.94 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 125.362 1.465 . . . . 0.0 107.32 -179.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 21.8 tp -92.92 140.63 29.28 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.057 0.943 . . . . 0.0 112.178 -178.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.0 mm -135.55 146.45 29.86 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 127.21 2.204 . . . . 0.0 108.209 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -137.69 120.57 16.46 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 125.95 1.7 . . . . 0.0 106.797 178.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.38 41.25 16.25 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.299 1.039 . . . . 0.0 111.535 -179.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.8 -17.39 11.3 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.644 1.116 . . . . 0.0 113.95 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.3 ttmt -79.67 128.46 33.43 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 125.389 1.476 . . . . 0.0 108.994 -179.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.6 mp0 -76.15 136.48 39.79 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 124.954 1.302 . . . . 0.0 109.468 -179.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 9.6 mt -121.09 154.23 36.4 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 124.729 1.212 . . . . 0.0 109.646 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -151.68 175.99 11.83 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 123.518 0.727 . . . . 0.0 109.471 179.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -72.35 160.04 33.02 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 125.726 1.61 . . . . 0.0 111.229 -178.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 102.21 -29.22 12.96 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 126.415 1.959 . . . . 0.0 110.856 -178.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 51.7 mtt180 -107.94 174.48 5.86 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 119.305 1.552 . . . . 0.0 112.813 179.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 50.3 p -117.55 175.67 5.53 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.984 1.714 . . . . 0.0 114.253 -177.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.17 -49.35 63.98 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.964 1.306 . . . . 0.0 112.253 179.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.37 -33.59 76.32 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 118.386 -0.816 . . . . 0.0 111.829 -179.03 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -59.59 -47.22 86.42 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 119.77 1.168 . . . . 0.0 108.658 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -82.05 1.64 34.87 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.171 0.988 . . . . 0.0 112.673 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 51.0 t30 54.3 46.77 24.46 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 126.873 2.069 . . . . 0.0 112.56 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 74.8 mt -89.25 122.99 41.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 104.148 -2.538 . . . . 0.0 104.148 178.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -101.88 177.56 4.86 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 123.163 0.585 . . . . 0.0 110.627 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 55.7 pttt -64.21 155.27 32.34 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-O 121.618 0.723 . . . . 0.0 112.315 -178.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 47.59 35.39 4.32 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 127.985 2.514 . . . . 0.0 112.454 -179.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.1 p -80.6 163.79 23.39 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.224 1.009 . . . . 0.0 109.316 178.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 43.9 m -126.22 111.08 14.17 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.6 mp -96.69 161.65 13.79 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.387 1.075 . . . . 0.0 109.469 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 28.4 m80 -119.2 153.45 34.92 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 125.284 1.433 . . . . 0.0 109.823 179.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 29.7 mt -122.58 126.76 48.39 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 126.35 1.86 . . . . 0.0 106.477 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 24.4 m -138.22 169.74 17.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -179.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -142.42 -171.0 3.31 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 126.846 2.058 . . . . 0.0 109.094 178.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -159.27 129.11 5.59 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 105.15 -2.167 . . . . 0.0 105.15 178.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 19.0 mt -141.16 141.13 34.15 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 120.372 1.442 . . . . 0.0 110.235 -179.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 49.0 mmm-85 -95.89 -22.34 17.5 Favored 'General case' 0 C--O 1.225 -0.185 0 C-N-CA 124.252 1.021 . . . . 0.0 110.768 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -81.2 18.8 9.2 Favored Glycine 0 CA--C 1.532 1.139 0 CA-C-N 118.865 0.757 . . . . 0.0 112.085 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.139 0 N-CA-C 106.309 -2.716 . . . . 0.0 106.309 -179.82 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 ttt . . . . . 0 CA--C 1.507 -0.711 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -121.18 156.81 31.58 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 177.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.4 pt -132.1 168.21 24.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 178.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -116.29 150.7 37.21 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 124.865 1.266 . . . . 0.0 107.999 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.2 t -137.96 125.31 29.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 178.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -91.21 117.33 29.55 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 106.279 -1.748 . . . . 0.0 106.279 178.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 33.9 p -72.53 165.3 24.93 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 179.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -67.42 -9.31 40.47 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.115 0.566 . . . . 0.0 112.077 178.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.3 p -102.64 -12.48 17.68 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 127.527 2.331 . . . . 0.0 113.024 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.03 6.5 42.59 Favored Glycine 0 C--N 1.335 0.518 0 CA-C-O 118.279 -1.29 . . . . 0.0 114.973 178.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.6 mmmm -81.22 163.52 22.96 Favored 'General case' 0 C--N 1.343 0.295 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 178.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 96.6 m -124.55 131.48 53.48 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 103.724 -2.695 . . . . 0.0 103.724 177.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 11.5 mm -105.49 157.38 6.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 -179.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 69.8 m -130.29 122.55 28.19 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 129.428 3.091 . . . . 0.0 103.229 178.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 72.4 mt -138.3 146.16 42.09 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.353 1.061 . . . . 0.0 110.037 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -95.71 117.46 30.56 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.47 1.508 . . . . 0.0 108.07 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.5 m -129.03 -168.97 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.431 0 C-N-CA 125.623 1.569 . . . . 0.0 109.456 -178.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -150.38 161.89 29.23 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 125.24 1.416 . . . . 0.0 107.702 178.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -59.48 -18.7 48.0 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.523 2.149 . . . . 0.0 114.34 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 9.2 m -114.72 30.48 7.3 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 118.753 0.706 . . . . 0.0 111.498 -178.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -92.96 129.59 38.83 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 179.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.9 p -77.88 158.25 29.51 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 119.918 1.235 . . . . 0.0 111.592 -178.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.1 mm -63.42 -29.88 48.38 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.316 0 CA-C-O 117.933 -1.032 . . . . 0.0 109.979 178.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -59.94 -40.45 88.98 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.916 1.234 . . . . 0.0 110.299 -179.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -67.42 -53.08 32.22 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.7 t -57.07 -40.09 70.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 123.045 0.538 . . . . 0.0 110.95 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt -75.34 -16.0 60.44 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.654 1.182 . . . . 0.0 111.798 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -89.86 -46.03 8.84 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 177.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.5 mttm -52.03 -40.05 60.47 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 124.713 1.205 . . . . 0.0 111.498 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 34.1 pt -63.61 -27.05 42.16 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-N 118.925 0.784 . . . . 0.0 111.279 178.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -77.02 -22.74 52.6 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 119.603 1.092 . . . . 0.0 109.548 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.84 -39.29 61.7 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 177.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 51.1 mttm -87.36 -22.52 25.02 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 115.281 1.586 . . . . 0.0 115.281 -178.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -138.68 150.9 46.7 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 120.633 1.56 . . . . 0.0 107.804 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.6 89.3 1.41 Allowed Glycine 0 C--N 1.334 0.426 0 N-CA-C 111.052 -0.819 . . . . 0.0 111.052 -179.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 5.0 pt -141.49 107.61 6.06 Favored Pre-proline 0 CA--C 1.543 0.685 0 CA-C-N 118.11 0.955 . . . . 0.0 110.777 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -64.7 168.15 13.94 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 123.057 2.505 . . . . 0.0 110.858 178.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -84.1 55.46 4.68 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 122.251 1.967 . . . . 0.0 108.49 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -146.56 136.03 22.94 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 130.516 3.526 . . . . 0.0 104.456 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 66.5 mm-40 51.24 47.52 24.7 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.26 1.824 . . . . 0.0 109.594 -178.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -154.86 132.47 11.31 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 179.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 51.8 ttm-85 -157.52 135.13 10.58 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 103.533 -2.766 . . . . 0.0 103.533 179.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 15.5 tp -87.92 141.91 28.21 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 -178.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 8.3 mm -134.41 141.52 43.28 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 125.923 1.689 . . . . 0.0 108.1 -178.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -139.39 125.86 20.39 Favored 'General case' 0 CA--C 1.52 -0.174 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.29 33.32 15.32 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.528 0.68 . . . . 0.0 111.919 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.97 -13.19 32.63 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 124.461 1.029 . . . . 0.0 112.511 -179.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.5 tpmt? -78.58 123.11 26.75 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 -179.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -75.91 136.29 40.1 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.465 HD22 ' CG ' ' A' ' 59' ' ' TYR . 3.5 mt -115.17 154.76 28.41 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 123.867 0.867 . . . . 0.0 109.462 -178.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -158.98 179.52 8.99 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 126.302 1.841 . . . . 0.0 107.46 178.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.22 160.95 31.91 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.914 1.285 . . . . 0.0 112.458 -176.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.43 -27.13 21.87 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 113.784 -1.553 . . . . 0.0 111.303 -179.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 44.8 mtt180 -106.6 168.06 9.43 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 119.033 1.417 . . . . 0.0 111.074 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 81.1 p -117.81 173.1 6.94 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.599 1.559 . . . . 0.0 113.181 -178.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.44 -48.95 65.49 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.151 0.98 . . . . 0.0 111.657 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.4 -32.48 74.11 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 118.474 0.579 . . . . 0.0 111.493 -179.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -63.79 -45.68 88.6 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 119.498 1.044 . . . . 0.0 108.774 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.465 ' CG ' HD22 ' A' ' 50' ' ' LEU . 59.3 m-85 -82.16 2.08 33.26 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.683 -0.636 . . . . 0.0 111.69 179.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 54.47 47.12 23.51 Favored 'General case' 0 C--N 1.342 0.277 0 C-N-CA 128.041 2.536 . . . . 0.0 111.193 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 74.2 mt -89.99 122.27 41.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 103.553 -2.758 . . . . 0.0 103.553 178.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 94.2 mm-40 -98.57 177.48 5.31 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 40.8 pttt -64.51 156.05 30.94 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -179.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . 0.255 5.4 mp0 45.65 44.38 10.24 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.935 2.094 . . . . 0.0 113.597 179.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.8 p -87.94 164.85 15.62 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.619 1.968 . . . . 0.0 109.508 177.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.2 m -126.51 107.3 10.12 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 119.437 1.017 . . . . 0.0 108.755 178.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.1 mp -96.44 163.18 13.16 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.788 1.635 . . . . 0.0 110.547 -178.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 16.1 m80 -119.26 161.0 21.14 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.133 1.373 . . . . 0.0 111.815 178.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 39.9 mt -123.29 128.85 50.52 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.897 1.679 . . . . 0.0 107.855 178.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.1 m -140.66 162.74 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-N 118.868 0.758 . . . . 0.0 112.253 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -140.55 -172.37 3.43 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 126.394 1.878 . . . . 0.0 109.51 178.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -158.88 130.05 6.26 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 177.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.6 mt -142.55 140.37 31.75 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 -179.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 49.0 mmm-85 -106.43 -11.94 15.79 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.101 0.961 . . . . 0.0 110.548 179.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -82.58 17.78 18.31 Favored Glycine 0 CA--C 1.537 1.459 0 N-CA-C 110.576 -1.01 . . . . 0.0 110.576 177.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.118 0 N-CA-C 104.366 -3.494 . . . . 0.0 104.366 -179.649 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.6 ttt . . . . . 0 N--CA 1.469 0.516 0 N-CA-C 112.184 0.439 . . . . 0.0 112.184 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -121.83 154.23 37.3 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 175.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 32.8 pt -132.55 169.72 21.38 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 177.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -123.49 150.07 44.37 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.9 t -138.21 125.23 27.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 178.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.9 tppp? -91.42 117.47 29.71 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 104.624 -2.361 . . . . 0.0 104.624 178.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.0 p -72.8 168.99 17.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 118.456 0.571 . . . . 0.0 110.277 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -66.87 -12.59 59.79 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 121.11 -0.236 . . . . 0.0 111.044 178.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 16.7 p -93.74 -12.4 29.27 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 126.572 1.949 . . . . 0.0 112.023 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.8 7.28 55.63 Favored Glycine 0 C--N 1.337 0.636 0 CA-C-O 118.801 -1.0 . . . . 0.0 113.49 178.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -79.88 164.01 23.9 Favored 'General case' 0 C--N 1.342 0.282 0 CA-C-N 119.484 1.642 . . . . 0.0 106.992 179.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 97.1 m -114.7 130.43 56.82 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 103.289 -2.856 . . . . 0.0 103.289 178.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.8 mm -115.55 154.08 17.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 105.602 -1.999 . . . . 0.0 105.602 179.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 22.2 m -134.96 125.3 26.36 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 126.924 2.09 . . . . 0.0 105.395 179.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 82.1 mt -140.13 151.05 44.99 Favored 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 124.543 1.137 . . . . 0.0 109.851 -179.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -94.84 118.33 31.59 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 105.504 -2.036 . . . . 0.0 105.504 178.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.6 m -129.82 -174.2 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 124.523 1.129 . . . . 0.0 108.824 -179.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -149.71 168.35 11.18 Favored Pre-proline 0 CA--C 1.535 0.385 0 C-N-CA 124.404 1.082 . . . . 0.0 108.574 -179.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -59.54 -21.24 61.16 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.473 2.115 . . . . 0.0 113.48 178.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.3 m -114.85 31.78 6.45 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 118.463 0.574 . . . . 0.0 111.857 -178.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -91.69 128.21 37.44 Favored 'General case' 0 C--O 1.242 0.711 1 N-CA-C 99.671 -4.196 . . . . 0.0 99.671 177.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.1 p -76.72 158.59 30.85 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -179.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 44.8 mm -63.49 -27.31 42.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 119.254 -0.978 . . . . 0.0 109.388 178.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -61.58 -37.84 85.34 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 119.885 1.221 . . . . 0.0 109.017 178.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.0 m-80 -69.24 -52.93 22.8 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 178.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 25.8 t -55.73 -38.53 51.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-N 119.049 0.84 . . . . 0.0 110.93 179.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.1 ttpt -75.08 -18.18 60.33 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.327 1.051 . . . . 0.0 111.686 -179.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -90.01 -46.83 8.24 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 126.767 2.027 . . . . 0.0 109.187 178.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -51.5 -40.68 60.03 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.407 1.483 . . . . 0.0 110.831 179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 31.6 pt -64.79 -25.21 37.25 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 O-C-N 121.138 -0.976 . . . . 0.0 111.879 179.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -76.85 -23.37 52.69 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 120.671 -1.268 . . . . 0.0 109.626 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.78 -24.57 55.99 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 176.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 30.2 mttm -100.74 -15.29 17.73 Favored 'General case' 0 C--N 1.341 0.203 0 N-CA-C 116.236 1.939 . . . . 0.0 116.236 -179.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -145.55 158.56 43.83 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 120.918 1.69 . . . . 0.0 108.111 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.14 68.64 3.4 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.6 pt -131.6 108.57 14.5 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 118.131 0.966 . . . . 0.0 110.507 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -75.18 169.58 22.22 Favored 'Trans proline' 0 CA--C 1.544 0.992 0 C-N-CA 123.172 2.581 . . . . 0.0 109.372 178.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -78.69 56.62 6.01 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.374 2.049 . . . . 0.0 110.665 179.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -146.78 135.93 22.58 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 129.218 3.007 . . . . 0.0 106.939 -179.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 68.9 mm-40 52.73 47.91 23.65 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 127.928 2.491 . . . . 0.0 109.524 -178.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 25.9 m-80 -153.0 136.44 15.87 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 121.785 -0.572 . . . . 0.0 109.754 179.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 54.4 ttm-85 -151.92 134.91 15.72 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 126.558 1.943 . . . . 0.0 105.891 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 19.6 tp -87.74 140.83 29.11 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 124.09 0.956 . . . . 0.0 109.484 -178.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 12.2 mm -132.7 144.7 35.95 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 125.655 1.582 . . . . 0.0 109.355 -178.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -138.36 121.27 16.58 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 177.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.22 40.59 26.44 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.463 1.105 . . . . 0.0 110.55 -179.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.13 -16.13 18.32 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 125.264 1.412 . . . . 0.0 113.85 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.0 ttmt -79.05 128.93 33.89 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 119.832 1.816 . . . . 0.0 109.014 -179.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 16.0 mp0 -74.26 134.36 42.65 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.0 mt -117.93 154.98 31.01 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.826 1.25 . . . . 0.0 109.537 -179.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -162.5 176.91 9.96 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 126.803 2.041 . . . . 0.0 107.404 177.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -71.44 161.59 30.8 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.205 1.402 . . . . 0.0 112.285 -178.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 108.43 -28.98 10.56 Favored Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 127.386 2.422 . . . . 0.0 108.049 -178.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 46.2 mtt180 -107.62 169.83 8.35 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 124.934 1.294 . . . . 0.0 110.473 178.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 80.8 p -123.84 169.45 11.56 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 127.161 2.184 . . . . 0.0 110.178 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.9 mp -53.01 -42.07 65.29 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 123.064 0.545 . . . . 0.0 111.259 177.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.4 t -59.31 -44.96 92.5 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.595 1.158 . . . . 0.0 109.916 -179.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -58.96 -46.37 88.22 Favored 'General case' 0 C--N 1.341 0.233 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -81.35 1.32 33.31 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -179.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 36.9 t30 54.31 45.91 26.25 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.199 1.799 . . . . 0.0 111.228 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 81.3 mt -87.98 123.4 40.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 87.5 mm-40 -95.1 175.16 6.73 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.43 0.633 . . . . 0.0 111.203 -179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 54.8 pttt -70.99 157.11 38.77 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.386 0.674 . . . . 0.0 109.201 178.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 54.1 35.37 22.12 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.441 1.496 . . . . 0.0 110.958 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.9 p -87.2 162.12 17.65 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.529 1.132 . . . . 0.0 109.19 178.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 91.1 m -124.96 107.93 11.35 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 122.365 1.079 . . . . 0.0 109.539 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.2 mp -96.44 160.46 14.39 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.734 1.214 . . . . 0.0 108.802 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -119.07 160.7 21.57 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.709 1.204 . . . . 0.0 111.745 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 25.6 mt -123.08 124.61 43.49 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.987 1.715 . . . . 0.0 108.16 179.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.9 m -141.1 167.9 16.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 124.775 1.23 . . . . 0.0 113.174 -179.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.83 -170.98 3.25 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.262 1.425 . . . . 0.0 110.076 177.457 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -155.23 132.75 11.17 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 103.339 -2.837 . . . . 0.0 103.339 178.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.445 HD23 ' H ' ' A' ' 75' ' ' GLY . 0.5 OUTLIER -147.66 131.62 17.17 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 105.297 -2.112 . . . . 0.0 105.297 -179.396 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 50.0 mmm-85 -105.03 -10.93 16.87 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 118.577 -0.725 . . . . 0.0 111.324 179.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.445 ' H ' HD23 ' A' ' 73' ' ' LEU . . . -86.52 19.1 30.03 Favored Glycine 0 CA--C 1.537 1.421 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 177.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.991 0 C-N-CA 129.136 3.255 . . . . 0.0 105.061 -179.947 . . . . . . . . 0 0 . 1 stop_ save_